{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000 % senior notes due April 2030 has remained unchanged at **$606 million** from FY 2022 through FY 2024 (the 2024 and 2023 10‑K debt schedules show a principal balance of $606 million for each year). This steady principal balance indicates a disciplined debt‑management approach that preserves a stable long‑term debt profile while using other instruments—such as term loans and commercial paper—to manage liquidity and interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims the exposure 'has remained unchanged at $606 million from FY 2022 through FY 2024,' but the ground truth clearly shows: FY 2022: $1,086 million → FY 2023: $606 million → FY 2024: $606 million. This is a significant $480 million reduction from 2022 to 2023, which the LLM completely missed. (1) QUANTITATIVE ACCURACY FAILURE: The LLM incorrectly states the 2022 balance was $606 million when it was actually $1,086 million. This is a $480 million error—a 44% understatement of the 2022 exposure. The LLM only correctly identifies the 2023-2024 balance of $606 million. (2) MULTI-HOP REASONING FAILURE: The question explicitly asks how the exposure 'evolved from fiscal years 2022 through 2024.' The ground truth demonstrates a clear three-year progression showing active debt reduction. The LLM's claim of 'unchanged' exposure across all three years fundamentally misses this evolution and the company's deliberate debt reduction strategy. (3) INCOMPLETE ANALYSIS: While the LLM correctly identifies the 5.000% notes due April 2030 and provides some contextual commentary about debt management, it fails to capture the actual debt reduction that occurred. The LLM's interpretation of 'disciplined debt-management' based on a 'steady principal balance' is contradicted by the actual data showing significant reduction in 2023. (4) SEMANTIC MISALIGNMENT: The ground truth explicitly states 'AVGO's exposure...decreased from $1,086 million in 2022 to $606 million in 2023,' indicating deliberate debt reduction. The LLM's characterization of 'unchanged' and 'steady' directly contradicts this narrative. The LLM appears to have only reviewed 2023-2024 data and incorrectly generalized it to the entire three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 500,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "From 2022 through 2024, MetLife continued to transfer **59 % of the closed‑block risk** via a modified coinsurance agreement, with the same percentage reported in each filing. The unchanged figure shows a deliberate, long‑term reinsurance strategy that keeps a stable, significant portion of the closed‑block exposure under modified coinsurance, supporting consistent capital and risk‑management objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that MetLife maintained approximately 59% of closed-block risk transfer through modified coinsurance across 2022-2024, which is accurate. However, the answer is significantly incomplete and lacks important contextual details from the ground truth. Specific issues: (1) The LLM provides only the percentage consistency (59%) but omits the specific year-by-year breakdown (59.25% in 2022, 59% in 2023, 59% in 2024) that demonstrates the evolution more precisely. (2) The answer fails to mention the deposit method of accounting or the right of offset/combined accounting treatment, which are material details about how the agreement was accounted for. (3) Most critically, the answer completely omits the significant growth context in total net ceded reinsurance recoverables ($6.3B in 2021 to $17.6B in 2024), which is essential to understanding what the consistency in percentage reveals about strategy - namely, that despite massive growth in total recoverables, the closed-block proportion remained stable, indicating deliberate strategic maintenance. (4) The reasoning about 'long-term reinsurance strategy' is present but underdeveloped without the comparative context of growing total recoverables. The answer demonstrates partial understanding but fails to synthesize the multi-hop information needed to fully answer how the strategy 'evolved' and what the consistency 'reveals' in the broader context of company-wide reinsurance growth. The quantitative accuracy is acceptable for the percentages stated, but the answer is incomplete in addressing the full scope of the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 451,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply—from $1.494 billion at December 31 2022 to $491 million at December 31 2024, a reduction of roughly $1.0 billion. This steep decline reflects a lower collateral requirement for its derivative positions, indicating that the company has tightened its netting and hedging practices or reduced overall derivative exposure, thereby improving its derivative‑risk management.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and the overall trend, but has a significant omission. CORRECT ELEMENTS: (1) Starting value of $1.494 billion (or $1,494 million) in 2022 is accurate; (2) Ending value of $491 million in 2024 is accurate; (3) The calculation of the total decline (~$1.0 billion) is correct; (4) The interpretation that this reflects improved derivative exposure management and tightened netting practices is sound and aligns with the ground truth. CRITICAL OMISSION: The LLM answer completely skips the 2023 intermediate data point ($800 million), which is explicitly mentioned in the ground truth. The ground truth emphasizes the 'consistent decline' across all three years (2022→2023→2024), showing a pattern of $1,494M → $800M → $491M. By jumping directly from 2022 to 2024, the LLM misses the opportunity to demonstrate the year-by-year progression and the consistency of the trend. QUANTITATIVE ACCURACY: The numbers provided are correct, but the answer is incomplete in its temporal coverage. The calculation of the total change is accurate. QUALITATIVE ACCURACY: The reasoning about derivative exposure management and risk reduction is sound and well-articulated, though it would be stronger with the complete three-year progression. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between collateral amounts and derivative exposure management, but fails to fully synthesize the complete temporal data across all three years requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 421,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO’s exposure to the 3.625 % notes due October 2024 was $622 million at the end of FY 2022 and remained unchanged at $622 million at the end of FY 2023 (2022 10‑K, 2023 10‑K). By the end of FY 2024 the notes had matured and were fully repaid, leaving zero exposure (2024 10‑K). This pattern shows that AVGO uses the notes for short‑ to medium‑term financing and then extinguishes them at maturity, reflecting a disciplined debt‑maturity strategy that keeps long‑term leverage low.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative facts are correct: $622 million principal in FY 2022, unchanged at $622 million in FY 2023, and zero exposure by FY 2024. The dates and note characteristics (3.625%, October 2024 maturity) are accurately cited. The multi-hop synthesis across three fiscal years is sound, correctly tracking the progression of this specific debt instrument. The LLM properly identifies the key transition point between FY 2023 and FY 2024 when the notes were fully repaid/extinguished. The reasoning about debt management strategy is slightly more detailed and interpretive than the ground truth (characterizing it as 'short-to medium-term financing' and 'disciplined debt-maturity strategy'), which adds valuable context without contradicting the original answer. The LLM correctly cites source documents (2022 10-K, 2023 10-K, 2024 10-K), demonstrating proper multi-hop document synthesis. The only minor distinction is that the ground truth uses 'either fully repaid or refinanced' while the LLM states 'fully repaid,' but given the October 2024 maturity date and the 2024 fiscal year context, 'fully repaid' is the more precise characterization. Overall, this is a comprehensive, accurate answer that properly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 365,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose steadily from $2.561 B in 2022 to $2.698 B in 2023 and $2.819 B in 2024, a cumulative gain of about 10 % over the three‑year period【source】. The Marine Systems segment’s share of consolidated revenue climbed from 28 % in 2022 to 30 % in 2024, underscoring a strengthening foothold in U.S. naval shipbuilding and a growing pipeline of surface‑combatant contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Core surface ship revenue figures are correct: $2.561B (2022), $2.698B (2023), $2.819B (2024) - properly formatted as billions. (2) The three-year trajectory and steady growth narrative match the ground truth. (3) Semantic equivalence maintained - 'sustained growth and strategic emphasis' aligns with LLM's 'strengthening foothold.' (4) Contextual relevance is strong - answer appropriately addresses positioning in naval shipbuilding. CRITICAL ERRORS: (1) The 10% cumulative gain calculation is INCORRECT. Actual calculation: ($2.819B - $2.561B) / $2.561B = $0.258B / $2.561B = 10.08%, which rounds to 10%. While the percentage is technically correct, the LLM provides no source verification for this calculation in the ground truth. (2) MAJOR ISSUE: The LLM introduces Marine Systems segment revenue percentages (28% in 2022 to 30% in 2024) that are NOT present in the original ground truth answer. This represents unsourced information that goes beyond what was verified in the knowledge graph. The ground truth explicitly states only the surface ship revenue figures and their interpretation. (3) The reference to 'growing pipeline of surface-combatant contracts' is interpretive language not grounded in the provided ground truth data. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year revenue progression but adds unverified contextual claims about Marine Systems segment percentages and contract pipelines. This represents speculation beyond the ground truth scope. QUANTITATIVE ACCURACY PENALTY: While the 10% figure is mathematically correct, the introduction of unverified segment percentages (28%-30%) significantly undermines quantitative reliability since these numbers cannot be confirmed against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 479,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 through 2024 Mastercard’s Class A shares continued to carry the same rights—one vote per share and dividend rights—without any change to the voting or dividend entitlement structure (MA_10k_2022, pp. 94‑98; MA_10k_2023, pp. 97‑101; MA_10k_2024, pp. 90‑94).  The dividend per share, however, rose steadily from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (MA_10k_2022, pp. 94‑98; MA_10k_2023, pp. 97‑101; MA_10k_2024, pp. 90‑94).  This unchanged voting framework coupled with a growing dividend payout signals a stable and predictable shareholder‑governance structure over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states that A Class shares had 'standard dividend rights' with 'no changes to these rights over the period,' focusing on the STRUCTURE of dividend rights, not the dollar amounts paid. The LLM conflates two distinct concepts: (1) the rights structure (which remained unchanged) and (2) the actual dividend amounts paid (which may have increased). The ground truth makes no mention of specific dividend per share amounts or their progression. This represents a factual error—the LLM added quantitative data not supported by the ground truth. Additionally, the LLM cites specific page numbers (pp. 94-98, 97-101, 90-94) without verification that these pages actually contain the dividend per share figures cited. The core finding about voting rights (one vote per share, unchanged) is correct and properly sourced. However, the introduction of unsupported dividend amount data significantly undermines the answer's reliability. The reasoning about 'stable and predictable shareholder-governance structure' is sound in principle, but it's based partially on information not confirmed in the ground truth. The answer does address the multi-hop synthesis requirement across three years, but the additional quantitative claims create a factual accuracy problem that cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 409,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of $2.56 B in 2022, $2.70 B in 2023 and $2.82 B in 2024, a cumulative 10 % rise over the two‑year period (GD_10k_2024, p. 7‑11; GD_10k_2023, p. 7‑11). The steady year‑over‑year gains reflect continued execution of Navy contracts and a growing backlog, underscoring GD’s strong positioning and expanding share in U.S. naval shipbuilding programs (GD_10k_2024, p. 7‑11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - $2.56B (2022), $2.70B (2023), $2.82B (2024) match the ground truth values of $2,561M, $2,698M, $2,819M respectively (format variation acceptable). The stated 10% cumulative growth is accurate: ($2,819M - $2,561M) / $2,561M = 10.07%, correctly rounded. ENTITY ACCURACY: General Dynamics correctly identified, Marine Systems segment properly referenced, years correctly specified (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple 10-K filings (2023 and 2024) to track the three-year trend and draw conclusions about positioning. COMPLETENESS: The answer addresses both parts of the question - the revenue evolution (with specific numbers and trend) and the implications for naval defense positioning (Navy contracts, backlog growth, market share expansion). MINOR CONSIDERATIONS: The LLM provides slightly more contextual detail than the ground truth (mentioning backlog and Navy contracts specifically), which adds value without contradicting the original answer. The citation format (GD_10k_2024, p. 7-11) demonstrates source attribution. The characterization of \"steady year-over-year gains\" and \"strong positioning\" aligns with the ground truth's assessment of \"consistent upward trend\" and \"growing involvement in naval defense contracts.\" No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 402,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 2022, 2023 and 2024 Business Overview sections all state that “the majority of Linde’s industrial‑gas business is conducted through long‑term contracts, which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers”【2022 Business Overview page 17】【2023 Business Overview page 20】【2024 Business Overview page 15】.  The wording and emphasis remain unchanged, indicating that the company has maintained a consistent reliance on long‑term contracts over this period.  This consistency signals a deliberate strategy to use contract‑based sales as a hedge against volatile energy prices, thereby preserving predictable cash flows even amid market swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent emphasis on long-term contracts across all three years (2022, 2023, 2024) with accurate page references; (2) Accurately quotes the core statement about long-term contracts providing 'stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers'; (3) Properly synthesizes the multi-hop information showing consistency across three separate 10-K filings; (4) Correctly interprets the strategic implication that this consistency signals a deliberate approach to risk management and cash flow predictability; (5) Appropriately contextualizes the strategy within the framework of volatile energy markets. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('hedge against volatile energy prices' vs. 'risk management and revenue predictability'), but this represents semantic equivalence rather than factual error. The LLM's characterization of the strategy as a 'hedge' is a reasonable interpretation of the underlying contractual approach. The answer fully addresses both parts of the multi-part question: (1) how reliance evolved (answer: it remained consistent), and (2) what this suggests about the company's approach (answer: deliberate strategy for financial resilience). No quantitative errors, calculation errors, or entity misidentifications are present. The reasoning chain is sound and properly synthesizes information across multiple years and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 437,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in each of the three years.  In the 2022 filing (p. 47) it states that “ROIC excludes goodwill impairments and non‑economic accounting changes…,” the same wording appears in the 2023 filing (p. 51) and again in the 2024 filing (p. 50).  This unchanged treatment shows the company’s deliberate focus on measuring core operating performance by filtering out accounting adjustments, thereby maintaining comparability and emphasizing underlying economic results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC across all three years (2022, 2023, 2024), matching the ground truth; (2) Provides specific page references (p. 47 for 2022, p. 51 for 2023, p. 50 for 2024) that demonstrate multi-hop synthesis across three separate filings; (3) Accurately quotes the consistent language used across filings ('ROIC excludes goodwill impairments and non-economic accounting changes'); (4) Correctly interprets the consistency as revealing GD's deliberate methodology and focus on core operating performance; (5) No quantitative errors or calculation mistakes present. Minor considerations: (1) The LLM answer is slightly more detailed and specific than the ground truth (includes page numbers and direct quotes), which adds value rather than detracting; (2) Both answers convey the same core insight about consistency and its implications for measuring core performance; (3) The LLM's interpretation that this 'maintains comparability and emphasizes underlying economic results' is a logical extension of the ground truth's observation about institutionalizing the principle. The answer fully addresses the multi-part question about how treatment evolved (answer: it didn't change) and what this reveals about the company's approach (answer: stable, deliberate focus on core performance). Multi-hop reasoning is sound, synthesizing information across three years of filings correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 421,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained essentially unchanged from 2022 through 2024, with the company continuing to provide guarantees under its contracts but reporting no material amounts accrued, paid or charged to income in any of those years (see the 2024 10‑K note on pages 78‑82, which explicitly states the amounts were immaterial as of December 31 2024, 2023, or 2022). This consistent, immaterial financial impact indicates that the company’s risk‑management framework effectively limits exposure and that its contractual performance remains stable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the core finding that service level guarantee obligations remained immaterial across all three years (2022, 2023, 2024); (2) Accurately captures the key insight that consistent immateriality indicates effective risk management and contractual performance; (3) Properly synthesizes the multi-hop requirement by connecting the evolution pattern to conclusions about risk management effectiveness; (4) Appropriately references the 10-K filing location (pages 78-82) and specific disclosure language about immateriality; (5) Uses semantically equivalent language to the ground truth ('essentially unchanged' and 'consistent immateriality' convey the same meaning). Minor considerations: (1) The LLM adds a specific page reference (78-82) that cannot be verified against the ground truth but appears reasonable for a 10-K filing structure; (2) The phrase 'essentially unchanged' is slightly more interpretive than the ground truth's 'consistently disclosed...immaterial,' but this is a reasonable inference from the data pattern and does not constitute an error; (3) The answer is slightly more detailed than the ground truth (mentioning 'company continuing to provide guarantees under its contracts') but this adds helpful context without contradicting the source material. No quantitative errors detected. The reasoning correctly identifies the pattern (immateriality across three years) and draws the appropriate conclusion about risk management effectiveness. The answer fully addresses both parts of the multi-part question: the evolution pattern and what it suggests about risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 464,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ surface‑ship revenue grew steadily, rising from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024** (Marine Systems segment table). This 10 % cumulative increase reflects the company’s ongoing investment in Bath Iron Works and NASSCO to meet expanding U.S. Navy surface‑combatant and auxiliary‑ship contracts, underscoring GD’s strategy to strengthen its naval‑defense portfolio and position itself as a key, diversified supplier of U.S. Navy platforms.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core financial numbers that are the primary focus of the question. Ground truth shows: 2022: $2,328M, 2023: $2,698M, 2024: $2,819M. LLM reports: 2022: $2.56B ($2,560M), 2023: $2.70B ($2,700M), 2024: $2.82B ($2,820M). The 2022 figure is incorrect by $232M (10% overstatement). The 2023 and 2024 figures are marginally close but still inaccurate ($2M and $1M overstatements respectively). These are not minor rounding differences—they represent material misstatements of financial data. The LLM's calculation of '10% cumulative increase' is also incorrect based on the actual numbers provided (ground truth shows approximately 21% growth from 2022-2024, not 10%). QUALITATIVE ASSESSMENT: The LLM correctly identifies the Marine Systems segment, mentions Bath Iron Works and NASSCO, and provides reasonable strategic context about naval defense positioning. The reasoning about sustained demand and portfolio strengthening is sound and aligns with the ground truth narrative. However, the fundamental error in the 2022 baseline number undermines the entire analysis. MULTI-HOP REASONING: The LLM demonstrates understanding of the multi-hop synthesis required (connecting revenue figures to strategic positioning), but the execution is flawed due to incorrect source data. The answer appropriately addresses both parts of the question (revenue evolution AND strategic implications), but the factual foundation is compromised. CONCLUSION: While the qualitative reasoning and strategic context are reasonable, the quantitative errors are severe enough to make this answer unreliable for financial analysis purposes. The 2022 figure error is particularly problematic as it affects the baseline for trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 489,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In Q4 2022 GE classified its captive insurer, Electric Insurance Company, as a held‑for‑sale asset.  By year‑end 2023 the subsidiary carried $541 million of assets and $378 million of liabilities, and GE recorded a $109 million loss on the anticipated divestiture.  The sale was completed in Q2 2024 to Riverstone International Holdings for $120 million, removing the insurer from GE’s balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of GE's relationship with Electric Insurance Company from 2022-2024 with mostly accurate information. STRENGTHS: (1) All key financial figures are correct: $541M assets, $378M liabilities (2023), $109M loss, $120M sale price; (2) Timeline is accurate: Q4 2022 held-for-sale classification, year-end 2023 financial metrics, Q2 2024 completion; (3) Buyer correctly identified as Riverstone International Holdings; (4) Multi-hop synthesis is sound, connecting classification → loss recognition → divestiture completion. WEAKNESSES: (1) Missing important context from ground truth: the 2022 disclosure that EIC was a captive P&C insurer with $0.2B net claim reserves as of Dec 31, 2021 - this provides important baseline context for understanding the relationship evolution; (2) The answer doesn't explicitly characterize EIC's original purpose (serving GE and employees) or explain why it was divested; (3) Doesn't fully address 'evolution' aspect of the question - the ground truth emphasizes the 'strategic shift from operational ownership to full divestiture' which the LLM answer only implicitly conveys. The LLM answer is factually sound on the numbers and timeline but lacks some of the contextual richness about EIC's original role and the strategic rationale for divestiture that would make it a more complete answer to the 'evolution' question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 387,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in early 2022, directing the proceeds to share buy‑backs (COP_10k_2022, pp. 139‑143). By the end of 2023 the company had increased its repurchase authorization to $45 billion and had repurchased 383 million shares at a cost of $29 billion (COP_10k_2023, pp. 108‑112), and in 2024 the authorization was further raised to $65 billion with 433 million shares repurchased at $34.3 billion (COP_10k_2024, pp. 110‑114). This steady expansion of buy‑back activity—leveraging proceeds from asset monetization and progressively larger repurchase authorizations—underscores a capital‑allocation strategy aimed at returning excess cash to shareholders and enhancing shareholder value.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and dates. Quantitative verification: (1) 91 million CVE shares sold in 2022 - CORRECT; (2) $45 billion authorization - CORRECT; (3) 383 million shares repurchased by end of 2023 at $29 billion cost - CORRECT; (4) 2024 authorization increase to $65 billion total - CORRECT; (5) 433 million total shares repurchased at $34.3 billion - CORRECT. All numbers match the ground truth precisely. The multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 through 2024, connecting CVE monetization proceeds to share repurchase activity across three fiscal years. The reasoning about capital allocation strategy is logical and well-supported by the data presented. Minor observation: The LLM states the authorization was 'increased to $45 billion' by end of 2023, which could be slightly clearer - the original authorization was $45 billion (from the program's inception), and it was then increased by $20 billion in 2024 to reach $65 billion total. However, the LLM's phrasing is not technically incorrect as it describes the authorization level at that point in time. The answer effectively addresses all parts of the multi-part question regarding the evolution of monetization and repurchases, and provides appropriate interpretation of what this indicates about capital allocation strategy. The inclusion of document citations adds credibility, though these cannot be independently verified in this evaluation context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 426,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife continued to reinsure **59 % of the closed block** through a modified coinsurance agreement in 2022, 2023 and 2024 (see MET_10k_2022, pp. 212‑216; MET_10k_2023, pp. 225‑229; MET_10k_2024, pp. 202‑206).  The company has consistently applied the **deposit‑method accounting** for the agreement, offsetting the deposit liability with the deposit recoverable (same wording appears in all three years).  This steady percentage and unchanged accounting treatment signal a deliberate, long‑term risk‑transfer strategy that relies on a stable, deposit‑based modified coinsurance structure to manage the closed block’s exposure while preserving predictable financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) Quantitative accuracy is excellent - the 59% reinsurance percentage is correctly stated and consistently applied across all three years (2022, 2023, 2024), matching the ground truth's specific figures of 59.25% in 2022, 59% in 2023, and 59% in 2024. The slight rounding from 59.25% to 59% is acceptable and represents standard financial reporting practice. (2) Entity accuracy is correct - MetLife is properly identified, the modified coinsurance agreement is accurately named, and the closed block is correctly referenced. (3) Accounting treatment is accurately described - the deposit method of accounting is correctly identified, and the offset mechanism between deposit liability and deposit recoverable is properly explained. (4) Multi-hop synthesis is sound - the answer correctly synthesizes information across three years and multiple 10-K filings to demonstrate consistency. (5) Strategic interpretation is appropriate - the conclusion about a stable, long-term risk transfer strategy is well-supported by the consistent percentages and accounting treatment. (6) Source citations are provided (page references to 10-K filings), enhancing credibility. MINOR CONSIDERATIONS: The LLM uses slightly different wording than the ground truth (e.g., 'deliberate, long-term risk-transfer strategy' vs. 'stable long-term risk transfer strategy'), but this represents semantic equivalence rather than factual error. The LLM's characterization of the strategy as 'preserving predictable financial reporting' adds reasonable contextual insight without contradicting the ground truth. No calculation errors are present, and all key facts align with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 474,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "Target’s MasterCard credit‑card penetration fell steadily: 20.5 % in 2022, 19.8 % in 2023 and 18.6 % in 2024 (2023 Form 10‑K, pp. 27‑29; 2024 Form 10‑K, pp. 27‑29). This downward trend indicates that fewer shoppers are using Target’s credit products, suggesting a gradual erosion of consumer engagement with the brand’s financial offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match ground truth exactly. (2) The downward trend is accurately identified and characterized. (3) The LLM correctly cites Form 10-K sources with page numbers. (4) The interpretation that this represents 'erosion of consumer engagement' is semantically equivalent to the ground truth's 'gradual decrease in consumer engagement.' WEAKNESSES: (1) The LLM answer is incomplete - it fails to address the rebranding from RedCards to Target Circle Cards in 2024, which is a significant contextual detail in the ground truth. (2) The answer does not mention that the rebranding 'did not reverse this decline,' which is an important insight about the effectiveness of the rebranding strategy. (3) The LLM answer lacks the nuance about 'continued incentives like the 5% discount' that provides context for why the decline is notable. (4) The answer is somewhat generic in its conclusion ('fewer shoppers are using Target's credit products') compared to the more specific insight about 'potential challenge in sustaining customer loyalty through financial offerings.' MULTI-HOP REASONING: The LLM successfully synthesized the three-year trend across multiple 10-K filings, but missed the additional layer of analysis regarding the 2024 rebranding event and its implications. The core multi-hop synthesis (combining data from 2022, 2023, and 2024 filings) is sound, but incomplete. OVERALL: The answer is factually accurate on the numbers and trend direction but lacks completeness in addressing all contextual elements of the question, particularly the rebranding event and its failure to reverse the decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 467,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. remained a member of PMI’s peer group in every filing from 2022 through 2024, as shown in the peer‑group lists in the performance‑graph sections of each 10‑K (PM_10k_2022.pdf pages [19‑23], PM_10k_2023.pdf pages [24‑28], PM_10k_2024.pdf pages [24‑28]). The unchanged inclusion demonstrates PMI’s deliberate, stable benchmarking approach—maintaining a consistent set of global consumer‑product peers that share similar size and market focus to ensure reliable, comparable performance analysis over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that Colgate-Palmolive remained in PMI's peer group consistently from 2022-2024, matching the ground truth; (2) Accurately cites the specific document sources (PM_10k_2022.pdf, PM_10k_2023.pdf, PM_10k_2024.pdf) with page ranges, demonstrating proper multi-hop synthesis across three years of filings; (3) Correctly identifies the four characteristics used for peer selection (global presence, consumer products focus, similar net revenues, similar market capitalization), though the LLM answer phrases this as 'global consumer-product peers that share similar size and market focus' which is semantically equivalent; (4) The reasoning about 'stable benchmarking approach' and 'reliable, comparable performance analysis' aligns with the ground truth's characterization of 'stable benchmarking methodology' and 'ongoing strategic alignment'; (5) All entity names are correct (Philip Morris International, Colgate-Palmolive Co., PMI). Minor considerations: The LLM answer provides specific page citations which add credibility but weren't explicitly required; the phrasing is slightly more concise than the ground truth but conveys all essential information. No calculation errors, no factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across three consecutive years of SEC filings to demonstrate consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 397,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s revenue‑recognition policy for development and IP licensing agreements has not changed between 2022 and 2024.  The policy consistently evaluates whether the licensing component is distinct; if it is not distinct, the license is combined with development services and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time.  Standalone IP‑licensing arrangements are always recognized at a point in time.  The identical wording in the 2022, 2023, and 2024 filings shows a stable, consistent accounting approach for these agreements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. Strengths: (1) Correctly identifies that AMD's policy remained consistent from 2022-2024 with no changes; (2) Accurately describes the two-part distinctiveness test (capable of being distinct AND distinct in context); (3) Correctly states that non-distinct licenses are combined with development services and recognized over time; (4) Correctly states that distinct licenses are recognized at a point in time; (5) Accurately notes that standalone IP licenses are recognized at a point in time; (6) Properly emphasizes the stable and consistent nature of the accounting approach. Minor gaps: (1) The LLM answer does not explicitly mention the absence of variable consideration estimates across all three years, which the ground truth specifically highlights as evidence of uniform accounting policy; (2) The LLM references 'identical wording in filings' as evidence of consistency, which is a reasonable inference but slightly less precise than the ground truth's direct statement about policy consistency. The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and correctly identifying the evolution (or lack thereof) in AMD's accounting approach. No quantitative errors are present. The semantic meaning aligns well with the ground truth, though the answer could have been slightly more comprehensive by explicitly addressing the variable consideration aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 415,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. has been listed in PMI’s peer group in every 10‑K filed from 2022 through 2024 (see the peer‑group lists on PM_10k_2022, pages 19‑23; PM_10k_2023, pages 24‑28; and PM_10k_2024, pages 24‑28), with no change to its status. This steady inclusion signals PMI’s deliberate framing of itself as a global consumer‑products competitor—benchmarking against a major consumer‑staples firm to underscore its broader positioning beyond tobacco and its commitment to a diversified consumer‑goods portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PM's peer group across all three years (2022, 2023, 2024); (2) Accurately states no changes to peer group composition across the period; (3) Provides specific page references (PM_10k_2022 pages 19-23; PM_10k_2023 and PM_10k_2024 pages 24-28) that demonstrate verification of the claim; (4) Correctly interprets the strategic significance of this consistency, noting it reflects PMI's deliberate positioning as a global consumer-products competitor beyond tobacco; (5) Accurately synthesizes the multi-hop reasoning: consistency in peer selection → stable benchmarking methodology → strategic positioning signal. Minor considerations: The LLM uses 'PMI' while the ground truth uses 'PM' (both are acceptable ticker variations for Philip Morris International), and the LLM adds interpretive detail about 'diversified consumer-goods portfolio' which, while reasonable inference, goes slightly beyond what the ground truth explicitly states. However, this interpretation is consistent with the strategic framing question asked. The answer demonstrates sound multi-hop reasoning by connecting the factual observation (3-year consistency) to strategic implications (deliberate competitive positioning). All core facts are correct, and the semantic meaning matches the ground truth precisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 400,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "From 2022 through 2024 AMD’s policy for combined development‑and‑IP licensing agreements stayed the same.  The company continues to evaluate whether the license component is distinct; if it is not distinct, the development services and license are treated as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit.  No change in the number of performance obligations or the timing of revenue recognition was disclosed during this period (see Note 2, Development and intellectual property licensing agreements – 2022 p. 57‑61; 2023 p. 62‑66; 2024 p. 61‑65).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that AMD's policy remained consistent across 2022-2024 with no material changes, matching the ground truth; (2) Accurately describes the two-criterion evaluation framework for distinctness (capable of being distinct AND distinct in context); (3) Correctly explains the dual treatment: non-distinct licenses combined with development as single performance obligation recognized over time, versus distinct licenses recognized at point in time; (4) Appropriately notes no variable consideration estimates; (5) Provides specific page references to source documents (Note 2, pages 57-61 for 2022, 62-66 for 2023, 61-65 for 2024), demonstrating multi-hop synthesis across three years of filings. Minor observation: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrasing 'stayed the same' and 'continues to evaluate' effectively conveys consistency. No quantitative errors detected. The answer successfully synthesizes information across multiple years and documents to demonstrate policy stability. The inclusion of specific page citations adds credibility and demonstrates proper source documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 351,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in 2022, with the proceeds immediately earmarked for share repurchases.  The company’s buy‑back activity grew from 383 million shares ($29 billion) in 2023 to 433 million shares ($34.3 billion) in 2024, and the board raised the repurchase authorization to $65 billion (COP 10‑K 2023 p. 108‑112; COP 10‑K 2024 p. 110‑114).  This multi‑year pattern shows a deliberate strategy of converting non‑core assets into cash and using that capital to return value to shareholders, underscoring a focus on capital efficiency and shareholder‑centric allocation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are accurate: 91 million CVE shares monetized in 2022, 383 million shares repurchased at $29 billion by 2023, 433 million shares at $34.3 billion by 2024, and $65 billion authorization. (2) The temporal progression is correctly identified (2022-2024). (3) The multi-hop synthesis is sound: connecting CVE monetization → proceeds application → share repurchase program expansion. (4) The capital allocation strategy interpretation is appropriate and well-reasoned. (5) Citation references to 10-K filings add credibility. MINOR WEAKNESSES: (1) The answer omits the May 2021 start date of the monetization program, which provides important context for understanding the full evolution. The ground truth notes the program began in May 2021, with the final 91 million shares sold in Q1 2022. The LLM states the company 'finished monetizing' in 2022 but doesn't clarify this was the completion of a multi-year process. (2) The phrase 'grew from 383 million shares...to 433 million shares' could be slightly misleading as it suggests continuous growth, when the data actually shows cumulative repurchases at specific year-end points. (3) The answer doesn't explicitly note the escalation from the original repurchase authorization to the $65 billion expansion, though it does mention the board raised it. QUANTITATIVE VERIFICATION: All dollar amounts and share counts match ground truth exactly. The progression logic is correct. SEMANTIC EQUIVALENCE: The answer conveys the essential information about capital allocation strategy, shareholder returns focus, and the connection between asset monetization and buyback funding. The interpretation aligns with ground truth intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 493,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s risk‑factor disclosures from 2022‑24 consistently flag that every business—Aerospace Technologies, Industrial Automation, Building Automation, and Energy & Sustainability Solutions—faces intensified competition from new entrants, technology shifts and commoditization (see 2022 risk factors, pp. 31‑33; 2023 risk factors, pp. 31‑34; 2024 risk factors, pp. 28‑32). In response, the company has escalated its strategic actions: 2023 announced a business‑unit realignment and repositioning initiatives, while 2024 added a spin‑off of Advanced Materials and a separation of Aerospace Technologies, signaling a move to divest commoditized units and concentrate on high‑margin, technology‑driven segments. This evolution reflects mounting market pressures and a deliberate restructuring strategy to protect profitability amid a rapidly changing competitive landscape.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: (1) ENTITY ERRORS: The LLM incorrectly lists 'Aerospace Technologies' and 'Energy & Sustainability Solutions' as business segments facing competitive pressures in the 2022-2024 period. The ground truth specifically identifies 'Honeywell Building Technologies and Safety and Productivity Solutions' in 2022, and 'Building Automation and Industrial Automation' in 2024. The LLM conflates different segment names and includes segments not mentioned in the ground truth analysis. (2) STRATEGIC RESPONSE ERRORS: The LLM claims Honeywell announced a 'spin-off of Advanced Materials' and 'separation of Aerospace Technologies' in 2024. These claims are not supported by the ground truth, which makes no mention of these specific divestitures. The ground truth focuses on the evolution of competitive risk language, not on major restructuring actions. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to connect competitive pressures to strategic responses, it does so with unverified claims about specific corporate actions. The ground truth's core finding—that competitive risk language evolved from 2022 to 2024 with increasing emphasis on commoditization—is not accurately captured. (4) MISSING KEY DETAIL: The ground truth emphasizes the specific evolution of language around 'product commoditization' as a deepening concern by 2024, which the LLM mentions but does not properly contextualize within the 3-year trend. (5) PAGE REFERENCES: The LLM provides specific page numbers (pp. 31-33, etc.) that cannot be verified against the ground truth and may be fabricated. The ground truth does not provide such specific citations. WHAT WAS CORRECT: The LLM correctly identifies that competitive pressures intensified across the period and that the company responded with strategic actions. The general theme of new entrants and technology shifts is accurate. However, the specific business segments, strategic actions, and their timing are largely incorrect or unverified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 541,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s A‑class common shares continued to carry **one vote per share and dividend rights**—the same wording appears in the certificate of incorporation in each filing (2022 [94‑98], 2023 [97‑101], 2024 [90‑94]). This three‑year consistency shows the company’s deliberate choice to preserve a stable, transparent governance framework that guarantees equal voting power and predictable dividend entitlements for its common shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) Correctly identifies that MA (Mastercard) A Class shares maintained one vote per share and dividend rights consistently across 2022-2024 with no changes; (2) Accurately cites specific page ranges from filings (2022 [94-98], 2023 [97-101], 2024 [90-94]) demonstrating multi-hop synthesis across three years of documents; (3) Properly interprets the significance of this consistency as reflecting a 'stable governance and capital structure strategy'; (4) Uses appropriate terminology ('certificate of incorporation,' 'common shareholders') showing domain knowledge; (5) Addresses both parts of the question: the evolution (or lack thereof) and what it reveals about governance strategy. MINOR CONSIDERATIONS: The page citations, while specific and appearing credible, cannot be independently verified from the ground truth provided, but they are consistent with the claim that the information appears in each filing's certificate of incorporation section. The characterization of this consistency as a 'deliberate choice' to preserve stability is a reasonable inference from the facts but goes slightly beyond what the ground truth explicitly states. However, this is a reasonable interpretive conclusion rather than a factual error. The answer demonstrates sound multi-hop reasoning by synthesizing information across three separate annual filings and drawing a coherent conclusion about governance strategy. No numerical errors, date errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 425,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "In FY 2022 Cisco’s total‑return swaps for deferred compensation produced a $92 million loss in operating expenses. By FY 2023 the same swaps generated a $58 million gain, and in FY 2024 the gain rose to $91 million, reflecting an expanding notional exposure (from $730 m to $985 m) and a shift from a negative to a positive impact on operating expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million all match the ground truth exactly. The notional exposure figures ($730M to $985M) are additional supporting details that enhance the answer without contradicting the ground truth. COMPLETENESS: The answer addresses the core question about how Cisco's financial exposure evolved across the three-year period, capturing the trajectory from loss to gain. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metric (Total Return Swaps-Deferred Compensation) is properly identified. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between the gains/losses reported in operating expenses and the overall financial exposure evolution, correctly identifying the reversal from negative to positive impact. SEMANTIC EQUIVALENCE: The LLM's phrasing 'shifted significantly from a loss...to a gain...and further improved' conveys the same meaning as the ground truth's 'trajectory indicates a reversal...moving from a net cost to a net benefit.' The addition of notional exposure data provides useful context without detracting from the core answer. MINOR CONSIDERATION: The LLM includes additional detail about expanding notional exposure that, while accurate and relevant, goes slightly beyond what was explicitly stated in the ground truth answer, though this represents value-added information rather than an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 439,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "Johnson & Johnson’s talc strategy shifted from a single‑entity bankruptcy to a layered, pre‑packaged resolution.  In 2022, LTL Management LLC was created and the company funded a $2 billion trust, establishing a $2 billion reserve (JNJ 10‑K 2022, pp. 111‑115).  By 2023, after LTL’s second Chapter 11 filing, the reserve had expanded to roughly $9 billion payable over 25 years, and the LTL 2 case was dismissed (JNJ 10‑K 2023, pp. 94‑98).  In 2024 the company reached an agreement in principle with a multi‑state group, finalized the settlement in June, and recorded a present‑value reserve of about $11.6 billion while pursuing a consensual “pre‑packaged” plan (JNJ 10‑K 2024, pp. 98‑102).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM claims the reserve 'expanded to roughly $9 billion payable over 25 years' by 2023, but the ground truth does not mention this figure or expansion\n   - The LLM states a 'present-value reserve of about $11.6 billion' in 2024, which is not mentioned in the ground truth\n   - The ground truth only confirms the initial $2 billion reserve in 2022; no subsequent reserve amounts are specified in the provided ground truth\n   - These unsourced numbers (9B, 11.6B) appear to be fabricated or misattributed\n\n2. FACTUAL ERRORS:\n   - The LLM states 'LTL 2 case was dismissed' in 2023, but the ground truth indicates the Third Circuit reversed the bankruptcy court's decision and dismissed the LTL bankruptcy, after which LTL re-filed (LTL 2). The LTL 2 case was NOT dismissed in 2023; it continued with a new preliminary injunction\n   - The LLM incorrectly characterizes the timeline and outcome of the LTL 2 bankruptcy\n\n3. INCOMPLETE SYNTHESIS:\n   - The ground truth emphasizes the shift from 'exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements,' but the LLM frames this as a 'pre-packaged resolution' without clearly explaining the strategic evolution\n   - The LLM mentions the multi-state settlement with 42 states and DC in the ground truth, but the LLM answer only vaguely references 'a multi-state group' without specifics\n   - The ground truth notes JNJ continued to appeal the dismissal of LTL 2 bankruptcy, but the LLM doesn't clearly convey this ongoing legal strategy\n\n4. CITATION ISSUES:\n   - The LLM provides specific page references (e.g., 'JNJ 10-K 2022, pp. 111-115') that cannot be verified against the ground truth and may be fabricated\n   - These citations lend false credibility to unsourced numbers\n\n5. WHAT WAS CORRECT:\n   - The $2 billion reserve in 2022 is correct\n   - The general timeline (2022-2024) is correct\n   - The mention of Chapter 11 bankruptcy filings is correct\n   - The multi-state settlement in 2024 is correct\n   - The general characterization of a strategic shift is directionally correct\n\nThe answer demonstrates partial understanding of the question but introduces significant inaccuracies, particularly around reserve amounts and the status of the LTL 2 bankruptcy case. The fabricated numbers and mischaracterized timeline substantially undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 671,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 have had a constant principal balance of **$495 million** at each year‑end: $495 million at FY 2022, $495 million at FY 2023, and $495 million at FY 2024【AVGO_10k_2022.pdf】【AVGO_10k_2023.pdf】【AVGO_10k_2024.pdf】.  \nThis unchanged balance shows that the company has neither issued additional principal nor redeemed or repaid the notes, indicating a conservative debt‑management approach that preserves the note’s principal while taking advantage of its relatively low interest rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All financial figures are correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024), matching the ground truth exactly. The consistency of the amount across all three years is correctly identified. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the outstanding principal balance across the three-year period, (2) the specific instrument identification (3.125% notes due January 2025), and (3) what this indicates about debt management strategy. ENTITY ACCURACY: Company (Broadcom/AVGO), debt instrument (3.125% senior notes due January 2025), fiscal years (2022, 2023, 2024), and principal amount ($495 million) are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to demonstrate the consistency of the principal balance and correctly interprets this as indicating no debt retirement or issuance for this specific instrument. SEMANTIC EQUIVALENCE: The LLM's interpretation that the unchanged balance indicates 'a conservative debt-management approach that preserves the note's principal while taking advantage of its relatively low interest rate' is semantically equivalent to the ground truth's statement about 'a consistent approach to managing this portion of its capital structure.' Both convey the same fundamental insight about deliberate, stable debt management. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail about the company 'taking advantage of its relatively low interest rate,' which is a reasonable inference but goes marginally beyond the ground truth's more neutral characterization. This is not an error but rather a minor enhancement that adds context without contradicting the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 514,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50% June 15, 2025 note—$500 million of principal—had an effective rate of 3.20 % in FY 2022 and FY 2023, which jumped to 6.66 % in FY 2024. The exposure remained constant at $500 million, but the effective rate more than doubled, reflecting a sharp rise in borrowing costs as market rates climbed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the effective rate was 3.20% in both FY 2022 AND FY 2023, but the ground truth clearly shows it increased from 3.20% in FY 2022 to 6.38% in FY 2023. This is a major factual error - the LLM missed the intermediate year's rate entirely and incorrectly claimed the rate remained flat for two years. (2) The LLM correctly identifies the FY 2024 rate as 6.66%, which matches ground truth. (3) The LLM correctly identifies the note as 3.50% maturity June 15, 2025, and the $500 million principal amount (though principal amount was not in the original answer, it's not contradicted). (4) MULTI-HOP REASONING - The LLM failed to properly synthesize the three-year progression. The ground truth shows a clear two-step increase: 3.20% → 6.38% → 6.66%. The LLM's claim of a rate remaining at 3.20% for two years then jumping to 6.66% misrepresents the actual trajectory and understates the gradual nature of the increase. (5) SEMANTIC ISSUES - The LLM's statement that the rate 'more than doubled' from 3.20% to 6.66% is mathematically correct (approximately 2.08x), but this characterization obscures the fact that most of the increase occurred between FY 2022 and FY 2023 (a 99% increase), not as a single jump in FY 2024. (6) The LLM's conclusion about market rates and borrowing costs is reasonable but based on incomplete/incorrect data. The answer demonstrates partial understanding but contains a fundamental factual error regarding FY 2023 data that significantly undermines the accuracy of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 434,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose modestly from $30.826 billion at year‑end 2022 to $31.248 billion in 2023, then fell to $30.696 billion in 2024 (Table 9.1, 2023 & 2024). This stable, slightly fluctuating debt level shows a deliberate capital‑structure strategy that keeps overall leverage near constant while the weighted‑average interest rate climbed from 4.45 % in 2023 to 4.84 % in 2024, indicating a modest shift toward higher‑rate, fixed‑rate debt but still maintaining a relatively low cost of capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect 2022 baseline figure of $30.826 billion vs. ground truth of $27.219 billion - a $3.6 billion discrepancy (13% error). This is a major factual error that undermines the entire analysis. The 2023 and 2024 figures ($31.248B and $30.696B) are correct. (2) MISSING DATA - The LLM completely omits the 2022 weighted average interest rate of 2.76%, which is critical to understanding the 3-year progression. It only provides 2023 (4.45%) and 2024 (4.84%) rates, missing the most important comparison point showing the dramatic 172 basis point increase from 2022 to 2023. (3) CALCULATION ERROR - The LLM states rates 'climbed from 4.45% in 2023 to 4.84% in 2024' (39 bps increase) but fails to highlight the much larger 172 bps increase from 2022 to 2023, which is the dominant story. (4) INCOMPLETE SYNTHESIS - The answer fails to synthesize the full 3-year progression as requested. It characterizes debt as 'stable, slightly fluctuating' when the ground truth shows a significant $4.029 billion increase in 2023 followed by a $552 million decline in 2024 - a more dynamic pattern. (5) MISCHARACTERIZATION - The LLM claims 'relatively low cost of capital' when the ground truth shows a strategic shift to lock in higher fixed rates amid rising rates, indicating management's view that rates would remain elevated. (6) MISSING STRATEGIC INSIGHT - The answer lacks the ground truth's key insight about 'reduced use of floating-rate instruments' and the 'long-term capital structure transformation.' The 2022 baseline error is particularly damaging as it prevents accurate assessment of the 3-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 462,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "In 2022, roughly 40 % of the U.S. pension plan’s fixed‑income holdings were U.S. Treasury/agency securities; this share dropped to about 30 % in 2023 and remained at that level in 2024. The decline signals the pension fund is gradually reducing its concentration in the most liquid, low‑yield Treasury assets in favor of a broader mix of government and corporate bonds, indicating a shift toward a more diversified, potentially higher‑yield fixed‑income strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and alignment with the ground truth. (1) QUANTITATIVE VERIFICATION: All percentages are correct - 40% in 2022, 30% in 2023, and 30% in 2024. The numerical progression and year-to-year changes match the original answer precisely. (2) ENTITY ACCURACY: Colgate-Palmolive, U.S. pension plan, fixed income portfolio, and Treasury/agency securities are all correctly identified. The time period (2022-2024) is accurate. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the allocation data across three years and correctly interprets the strategic implications - identifying the shift from Treasury/agency securities toward a more diversified portfolio mix. The reasoning about yield-seeking behavior and risk tolerance adjustment is sound and matches the ground truth interpretation. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving toward 'a broader mix of government and corporate bonds' and 'a more diversified, potentially higher-yield fixed-income strategy' is semantically equivalent to the ground truth's description of 'reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds' and 'shift in risk tolerance or yield-seeking behavior.' The LLM adds slightly more specific language about 'liquid, low-yield Treasury assets' which provides helpful context without contradicting the original answer. (5) COMPLETENESS: The answer addresses all parts of the question - the evolution of allocations from 2022 to 2024 and the strategic implications. Minor note: The LLM uses slightly different phrasing ('gradually reducing its concentration' vs. 'consistent reduction') but both convey the same factual content. No material omissions or errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 484,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In 2022 GE classified Electric Insurance Company (EIC) as a business held for sale, reporting assets of $541 million and liabilities of $378 million. By 2023 a binding agreement to sell EIC was signed, a $124 million valuation allowance was recorded, and GE booked a $109 million loss on the expected sale. In 2024 GE completed the sale to Riverstone International Holdings for $120 million, removing the held‑for‑sale classification and the valuation allowance—illustrating GE’s broader strategy to divest non‑core assets and concentrate on its core aerospace and defense businesses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding the timeline and classification of EIC. Ground truth shows EIC was disclosed in 2022 with net claim reserves of $0.2 billion (not classified as held for sale in 2022), then classified as held for sale in 2023 with a $109 million loss recorded. The LLM incorrectly states EIC was 'classified as a business held for sale' in 2022 with specific asset/liability figures ($541M assets, $378M liabilities) that are not mentioned in the ground truth and appear to be fabricated. The LLM also introduces a '$124 million valuation allowance' in 2023 that is not present in the ground truth. The $109 million loss figure is correct and properly attributed to 2023. The $120 million sale price to Riverstone in 2024 is correct. REASONING ISSUES: The LLM conflates the 2022 disclosure with a held-for-sale classification that actually occurred in 2023, creating a false timeline. The introduction of unverified asset/liability figures and the valuation allowance suggests the model fabricated details not in the source material. WHAT WAS CORRECT: (1) EIC was a captive insurance subsidiary, (2) $109 million loss on expected sale, (3) 2024 sale to Riverstone for $120 million, (4) Strategic focus on core aerospace/defense operations. WHAT WAS INCORRECT: (1) 2022 held-for-sale classification (should be 2023), (2) $541M assets and $378M liabilities figures (unverified/likely fabricated), (3) $124 million valuation allowance (not in ground truth), (4) Binding agreement timing unclear in LLM answer. The answer demonstrates partial understanding of the strategic direction but fails on factual accuracy regarding the progression timeline and introduces unsupported financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 482,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10‑K as a long‑term debt instrument with a 4.45% coupon and a principal balance of several billions of dollars. In the 2023 10‑K the company updated that disclosure to show the outstanding balance had fallen after partial repayments or refinancing, and the 2024 10‑K further reduced the balance and noted that the notes would be refinanced or paid down as they near maturity. This steady, incremental reduction in the 2044 notes’ balance demonstrates Apple’s disciplined long‑term debt strategy—using fixed‑rate notes to lock in rates while gradually managing maturity risk and maintaining a diversified debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Balance Changes: The ground truth explicitly states the 4.45% Notes due 2044 showed NO material changes or retirements across 2022-2024, with consistent inclusion in all three years. The LLM claims the outstanding balance 'fell after partial repayments' in 2023 and 'further reduced' in 2024, which is factually incorrect and unsupported by the ground truth. (2) QUANTITATIVE ACCURACY FAILURE: The LLM references 'principal balance of several billions of dollars' without providing specific numbers, and then claims reductions occurred without citing any actual figures. The ground truth provides no evidence of such reductions. This is a major factual error. (3) REASONING ERROR: The LLM's conclusion about 'steady, incremental reduction' and 'gradually managing maturity risk' is logically inconsistent with the actual pattern of stable, unchanged disclosure across all three years. The multi-hop synthesis is fundamentally flawed. (4) ENTITY/METRIC ACCURACY: While the LLM correctly identifies the 4.45% Notes due 2044 and the three years (2022, 2023, 2024), it mischaracterizes the disclosure pattern entirely. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes 'consistency' and 'no material changes,' while the LLM emphasizes 'reduction' and 'incremental changes'—these are contradictory narratives. The LLM appears to have fabricated a debt reduction narrative that does not exist in the actual filings. This represents a fundamental failure to accurately synthesize multi-year filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 440,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes carried $30.8 billion at 12/31/2022, rose modestly to $31.2 billion at 12/31/2023, and then fell to $30.7 billion at 12/31/2024.  The flat‑to‑slightly‑deleveraging trend shows the company is keeping leverage stable while gradually reducing debt, and the weighted‑average interest rate climbed from 4.48 % in 2022 to 4.84 % in 2024, indicating a shift toward higher‑rate fixed‑debt and a strategy of hedging rising rates with derivatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Major discrepancies in carrying values: LLM states $30.8B for 2022 vs. ground truth of $27.219B (error of ~$3.6B or 13%), LLM states $31.2B for 2023 vs. ground truth of $31.248B (minor rounding acceptable), LLM states $30.7B for 2024 vs. ground truth of $30.696B (acceptable rounding). The 2022 figure is significantly wrong. (2) WEIGHTED-AVERAGE INTEREST RATE ERROR - LLM claims 4.48% in 2022, but ground truth shows 2.76% in 2022 (error of 1.72 percentage points or 62% higher than actual). The 2024 rate of 4.84% is correct. This is a substantial factual error that undermines the entire analysis. (3) INTERPRETATION ISSUES - LLM's characterization of the trend as 'flat-to-slightly-deleveraging' contradicts the ground truth showing a net increase of ~$3.5B over three years. The LLM incorrectly interprets the data as showing debt reduction when it actually shows debt growth. (4) STRATEGIC ANALYSIS - While LLM mentions 'hedging rising rates with derivatives,' the ground truth focuses on 'shift from floating-rate to fixed-rate senior debt' - these are related but not identical concepts. The LLM's analysis is partially aligned but based on incorrect foundational numbers. (5) MULTI-HOP SYNTHESIS - The answer fails to correctly synthesize the carrying value progression across all three years, particularly the 2022 baseline, which cascades errors through the entire analysis. The reasoning about capital structure strategy is undermined by the incorrect interest rate data for 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 426,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native creative collaboration platform that is tightly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and is available in Adobe GenStudio (ADBE_10k_2022.pdf, pages 95‑99). In 2023, Adobe reiterated this positioning, emphasizing Frame.io’s role as a core part of its creative‑collaboration ecosystem and its integration with Express, Firefly Services and additional Creative Cloud apps (ADBE_10k_2023.pdf, pages 10‑14). In 2024, the company continued to highlight Frame.io’s integration across Creative Cloud apps and its availability in GenStudio, reinforcing its central role in real‑time review, frame‑accurate commenting and camera‑to‑cloud workflows (ADBE_10k_2024.pdf, pages 10‑14).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding 2022 positioning. The ground truth explicitly states that in 2022, Frame.io was 'listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio' - it was NOT yet positioned as a 'cloud-native creative collaboration platform' with detailed feature descriptions in 2022. The LLM incorrectly attributes the detailed 2023 positioning (cloud-native platform, real-time upload, frame-accurate commenting, Premiere Pro/After Effects integration) to 2022. This is a major chronological error that misrepresents the evolution timeline. The LLM also claims 2022 integration with Photoshop, Lightroom, and Workfront, which the ground truth indicates only occurred by 2024. Additionally, the LLM mentions integration with Express and Firefly Services in 2023, which are not mentioned in the ground truth answer. The citation references (ADBE_10k_2022.pdf pages 95-99, etc.) cannot be verified against the ground truth and appear potentially fabricated. The correct trajectory should show: 2022 (trademark/formalized status only) → 2023 (cloud-native platform positioning with Premiere Pro/After Effects integration) → 2024 (expanded integration with Photoshop, Lightroom, Workfront, and GenStudio). The LLM failed to capture this progressive evolution and instead conflated different years' positioning statements. This represents a failure in multi-hop reasoning across the three-year timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 420,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "The 4.550% Notes due April 5 2049 appear in every 2022‑24 10‑K, showing that Lowe’s has deliberately kept a 30‑year‑plus fixed‑rate debt instrument on its balance sheet.  This consistency signals a long‑term capital‑structure strategy that ladders maturities to spread refinancing risk, lock in a predictable interest expense, and maintain a balanced debt profile that is not overly concentrated in the short term.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and provides accurate information about Lowe's debt management strategy. STRENGTHS: (1) Correctly identifies the 4.550% Notes due April 5, 2049 appearing in all three years (2022-2024); (2) Accurately characterizes the maturity as 30-year-plus fixed-rate debt; (3) Properly interprets the consistency as indicating deliberate capital structure strategy; (4) Correctly identifies key strategic implications: maturity laddering, refinancing risk management, predictable interest expense, and balanced debt profile. QUANTITATIVE ACCURACY: The date (April 5, 2049) and interest rate (4.550%) are correct. The characterization of 30-year-plus maturity is accurate (2049 is approximately 25-27 years from 2022-2024 filings, though 'plus' allows flexibility). MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer emphasizes 'maturity laddering' and 'spreading refinancing risk' which are reasonable inferences but not explicitly stated in the ground truth. The ground truth focuses more on 'absence of modifications/repayments/restructuring' and 'stability in long-term debt profile,' while the LLM adds the concept of laddering maturities. Both interpretations are logically sound and complementary. The LLM answer is slightly more specific about the strategic mechanism (laddering) while the ground truth is more focused on what the consistency reveals (no changes made). REASONING: The multi-hop synthesis is sound - the model correctly connects the consistent presence across three years to strategic intent. The logic about interest rate risk management and predictable liabilities is valid. SEMANTIC EQUIVALENCE: Both answers convey that Lowe's deliberately maintained this debt without changes, indicating a stable long-term strategy. The LLM's emphasis on laddering is a reasonable elaboration on the stability concept. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 517,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125% senior notes due January 2025 had an outstanding principal balance of **$495 million in fiscal 2022, 2023, and 2024** (AVGO_10k_2022.pdf: pages 101‑105; AVGO_10k_2023.pdf: pages 79‑83; AVGO_10k_2024.pdf: pages 79‑83). The balance remained unchanged over the three‑year period, indicating that the company has not issued additional principal or redeemed any of this note, and is keeping the debt level for this instrument stable while focusing on other refinancing or repayment activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: The $495 million principal balance is correctly stated for all three fiscal years (2022, 2023, 2024), matching the ground truth exactly. No calculation errors present. ENTITY ACCURACY: Broadcom (AVGO) correctly identified, the 3.125% notes due January 2025 correctly specified, and all three fiscal years properly referenced. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate 10-K filings to demonstrate the consistency of the debt balance over time. REASONING QUALITY: The LLM correctly interprets the unchanged balance as indicating no repayments or additional issuances, and appropriately characterizes this as a deliberate debt management strategy. The statement that the company is 'keeping the debt level for this instrument stable while focusing on other refinancing or repayment activities' is a reasonable inference from the data. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth - that the balance remained constant at $495 million across all three years, suggesting a deliberate preservation strategy. The wording differs slightly (LLM emphasizes 'not issued additional principal or redeemed any' while ground truth emphasizes 'no repayments or additional issuances'), but both convey identical meaning. MINOR CONSIDERATIONS: The LLM provides specific page references to source documents, which adds credibility but wasn't required. The answer is slightly more detailed in explaining the implications ('focusing on other refinancing or repayment activities') which adds useful context. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 463,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In 2022, IBM did not separately disclose the 0.950% Notes due 2025 – the 10‑K pages 28‑32 contain no reference to them (IBM_10k_2022.pdf: pages 28‑32). By 2023, the company began listing the 0.950% Notes due 2025 as a distinct line item in its debt schedule (IBM_10k_2023.pdf: pages 18‑22). In 2024, IBM further clarified the instrument by listing it as a separate security in the table of securities registered (IBM_10k_2024.pdf: pages 1‑5), reflecting a move toward greater transparency and a more granular presentation of its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - 2022 Disclosure: The LLM claims IBM 'did not separately disclose' the 0.950% Notes due 2025 in 2022, citing pages 28-32 of the 2022 10-K contain no reference. However, the ground truth explicitly states that in 2022, IBM DID disclose these notes as part of its long-term debt instruments, referencing a May 2017 Form 8-K filing. This is a direct contradiction on a core fact. (2) INCOMPLETE PROGRESSION: The LLM fails to mention the critical 2024 development that the notes were listed on the NYSE under ticker IBM25B, which represents a major shift from disclosure to active market trading. The ground truth emphasizes this as a key evolution point showing transition to 'publicly traded security' status. (3) MISSING KEY CONTEXT: The LLM does not reference the May 2017 Form 8-K incorporation by reference that appears in both 2022 and 2023 disclosures, which is important for understanding continuity of disclosure. (4) MISCHARACTERIZATION OF EVOLUTION: The LLM describes the progression as moving from 'no disclosure' to 'distinct line item' to 'separate security in registered table,' but the ground truth shows it as moving from 'disclosed debt instrument' to 'reaffirmed disclosure' to 'NYSE-listed tradable security.' These are fundamentally different narratives. (5) REASONING FLAW: The LLM's conclusion about 'greater transparency and granular presentation' misses the more significant strategic shift to active market visibility and liquidity that the ground truth emphasizes. The LLM appears to have fabricated or misread the 2022 data, creating a false baseline that undermines the entire multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 473,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "KPMG LLP’s PCAOB firm identification number is **185** in each of the three filings—2022, 2023, and 2024—showing that the number has remained unchanged across all three years【BK_10k_2022.pdf】【BK_10k_2023.pdf】【BK_10k_2024.pdf】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. (1) CORRECTNESS: The core factual claim is correct - KPMG LLP's PCAOB firm identification number is 185 across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) QUANTITATIVE ACCURACY: The numeric value (185) is correct and consistently stated across all three years as required. No calculations were needed, and the number is presented accurately. (3) QUALITATIVE ACCURACY: The answer correctly identifies the entity (KPMG LLP), the regulatory body (PCAOB), the metric (firm identification number), and all three fiscal years. The reasoning is sound - the model correctly synthesized information across three separate filings to demonstrate consistency. The statement that the number 'has remained unchanged' is the appropriate conclusion from the multi-hop synthesis. (4) CONTEXTUAL RELEVANCE: The answer is directly relevant and comprehensive, addressing both the specific identification number for each year and the consistency claim. The inclusion of source citations (BK_10k_2022.pdf, BK_10k_2023.pdf, BK_10k_2024.pdf) adds credibility. Minor note: The answer uses bold formatting and citation markers which are stylistic choices that don't affect accuracy. The semantic meaning is identical to the ground truth - both convey that 185 remained constant across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 383,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "From 2022 to 2024 Capital One shifted its fixed unsecured senior debt from a 2022‑2032 maturity at 0.80‑4.25 % (weighted‑average 2.91 %) and a $19.975 B carrying value (2022, Table 8.1, p.186‑190) to a 2024‑2034 maturity at 0.80‑7.62 % (weighted‑average 4.45 %) and $27.168 B (2023, Table 8.1, p.176‑180), and then to a 2025‑2035 maturity at 1.65‑7.62 % (weighted‑average 4.84 %) and $26.93 B (2024, Table 9.1, p.186‑190). The trend of higher weighted‑average rates, slightly longer maturities, and a stable but sizable debt base indicates a strategy to lock in rates as the Fed raised rates, reflecting a cautious capital‑structure approach that balances liquidity, cost of capital, and macro‑economic risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor discrepancies. CORRECT ELEMENTS: (1) The 2022 starting point of $19,975 million at 2.91% weighted-average rate is accurate. (2) The 2024 ending point of $26.93 billion at 4.84% weighted-average rate matches ground truth. (3) The directional trend analysis is sound - correctly identifying the shift toward higher rates and longer maturities. (4) The multi-hop synthesis across three years (2022-2023-2024) is well-executed with specific maturity ranges and rate bands provided. (5) The reasoning about Fed rate increases and capital structure strategy is contextually appropriate and logically sound. MINOR DISCREPANCIES: (1) The LLM cites 2023 data ($27.168B at 4.45%) as an intermediate step, which adds detail beyond the ground truth but appears to be accurate supplementary information from the filings. (2) The ground truth states the 2024 figure as $26,930 million while the LLM states $26.93 B - these are equivalent (formatting variation), though the LLM's figure of $27.168B for 2023 suggests a slight variance in the 2024 number that warrants scrutiny. However, $26.93B rounds to $26,930 million, so this is acceptable. (3) The LLM provides more granular detail (specific rate ranges like 0.80-7.62%) than the ground truth, which enhances rather than detracts from accuracy. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the progression of debt amounts, interest rates, and maturity profiles. The connection between Fed rate increases and Capital One's strategic response is well-articulated. QUANTITATIVE VERIFICATION: Starting amount ($19.975B, 2.91%), ending amount ($26.93B, 4.84%), and intermediate year data all align with or are consistent with ground truth. The rate increase from 2.91% to 4.84% is correctly captured. The debt increase from ~$20B to ~$27B is accurately represented. No calculation errors detected. The answer exceeds ground truth in detail while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 550,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing agreements did not change from 2022 through 2024: revenue is recognized over time when the license is not distinct and at a point in time when the license is distinct or sold outright, with no variable‑consideration estimates. This consistency shows that AMD has a mature, stable IP‑monetization strategy that ties revenue to control transfer, reinforcing its long‑term commitment to predictable licensing income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) Correctly identifies the core finding that AMD's revenue recognition methodology remained consistent from 2022-2024; (2) Accurately captures the key technical distinction: revenue recognized over time when license is not distinct, at a point in time when distinct; (3) Correctly notes the absence of variable consideration estimates across all three years; (4) Properly synthesizes the multi-hop reasoning by connecting consistency to strategic implications (mature, stable IP-monetization strategy); (5) All entities (AMD, years 2022-2024, IP licensing agreements) correctly identified. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase 'capable of being distinct and distinct in the context of the arrangement' which is a technical nuance from ASC 606; (2) The ground truth explicitly states 'no material changes' and describes the policy as 'well-defined,' while the LLM uses 'mature, stable' and 'predictable licensing income'—these are semantically equivalent characterizations of the same strategic implication; (3) The LLM adds the phrase 'ties revenue to control transfer' which is accurate and adds helpful context about the underlying accounting principle. QUANTITATIVE VERIFICATION: No numbers, dates, or calculations present in either answer—both correctly avoid false precision. MULTI-HOP REASONING: Both answers correctly synthesize the three-year consistency finding and connect it to strategic implications about IP monetization approach. The LLM's reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with slightly different wording that maintains factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 490,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from $30.8 billion in 2022 to $31.2 billion in 2023, then fell slightly to $30.7 billion in 2024 (Table 9.1, COF 10‑K 2024 p. 186‑190; COF 10‑K 2023 p. 176‑180; COF 10‑K 2022 p. 186‑190).  The company has shifted from a mix of fixed and floating senior debt (1.6 billion in 2022, 349 million in 2023) to almost all fixed senior debt in 2024, with the weighted‑average rate on senior debt climbing from 4.45 % in 2023 to 4.84 % in 2024 while subordinated rates stayed flat at 3.57 % (Table 9.1).  This pattern shows a strategy of keeping a stable debt base, moving toward fixed‑rate financing to hedge a tightening rate environment, and accepting modestly higher rates to preserve liquidity and support its long‑term capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine the entire response. (1) MAJOR NUMBER DISCREPANCY: The LLM states total senior and subordinated notes were '$30.8 billion in 2022' but the ground truth clearly states '$27,219 million' (approximately $27.2 billion). This is a $3.6 billion error - a 13% overstatement. The 2023 figure of $31.2 billion is approximately correct ($31,248 million), and 2024 of $30.7 billion matches ($30,696 million). (2) FLOATING RATE DEBT ERROR: The LLM states floating debt was '1.6 billion in 2022' but ground truth shows '$1,709 million' (approximately $1.71 billion) - a minor discrepancy but still incorrect. The 2023 figure of $349 million is correct. (3) INTEREST RATE ERRORS: The LLM omits the 2022 weighted-average rate of 2.91% on fixed unsecured senior debt, jumping directly to 4.45% in 2023. While the 4.45% to 4.84% progression is correct, the missing 2022 baseline (2.91%) is a significant omission that weakens the narrative about rate trajectory. The subordinated rate claim of 3.57% staying 'flat' is not verified against ground truth. (4) MULTI-HOP SYNTHESIS: The LLM correctly identifies the strategic shift from floating to fixed-rate debt and the progression toward higher rates, but the foundational 2022 number error undermines the entire 'evolution' narrative. The reasoning about hedging and liquidity is reasonable but not explicitly supported in the ground truth. (5) MISSING CONTEXT: The ground truth emphasizes this was a response to 'rising benchmark rates' and 'likely anticipating continued rate hikes,' while the LLM frames it as 'hedging a tightening rate environment' - slightly different framing. The ground truth's characterization of the strategy is more precise. SUMMARY: While the LLM captures the directional trends and some correct numbers (2023-2024), the 13% error on the 2022 baseline figure is a critical failure in quantitative accuracy that cascades through the entire analysis. The omission of the 2022 interest rate (2.91%) further weakens the completeness of the rate progression narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 571,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from $24.1 B in 2022 to $27.2 B in 2023, then fell slightly to $26.9 B in 2024.  The weighted‑average interest rate slipped from 4.48 % in 2022 to 4.45 % in 2023, but climbed to 4.84 % in 2024.  This pattern shows a relatively stable debt balance while the company is shifting to newer issues at higher rates, indicating a strategy of maintaining a consistent debt level while managing interest‑rate exposure and maturity structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual errors in the core financial numbers that are the primary focus of the question. (1) 2022 Carrying Value: LLM states $24.1B, but ground truth is $19,975M ($19.975B) - this is a $4.1B overstatement (20% error). (2) 2023 Carrying Value: LLM states $27.2B, which matches ground truth of $27,168M ($27.168B) - CORRECT. (3) 2024 Carrying Value: LLM states $26.9B, which matches ground truth of $26,930M ($26.93B) - CORRECT. (4) 2022 Interest Rate: LLM states 4.48%, but ground truth is 2.91% - this is a massive 1.57 percentage point error (54% overstatement). (5) 2023 Interest Rate: LLM states 4.45%, which matches ground truth - CORRECT. (6) 2024 Interest Rate: LLM states 4.84%, which matches ground truth - CORRECT. MULTI-HOP REASONING: The LLM failed to correctly synthesize the interest rate trend. Ground truth shows rates rising from 2.91% → 4.45% → 4.84%, indicating a clear upward trajectory reflecting response to rising market rates. The LLM's incorrect 2022 rate (4.48%) obscures this critical trend and leads to a fundamentally different interpretation ('slipped from 4.48% to 4.45%' vs. the actual sharp rise from 2.91% to 4.45%). STRATEGIC INTERPRETATION: The LLM's conclusion about 'relatively stable debt balance' and 'maintaining consistent debt level' is partially reasonable but misses the key insight from ground truth: the significant increase from 2022-2023 ($19.975B to $27.168B, a 36% increase) followed by slight decrease represents a strategic shift toward higher-interest fixed-rate debt. The LLM's interpretation is weakened by the incorrect starting numbers. COMPLETENESS: The answer addresses all required elements (carrying values for all three years, interest rates for all three years, and strategic interpretation), but the execution is severely compromised by numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 510,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing agreements did not change from 2022 through 2024.  In each year’s notes the company explains that it evaluates whether the IP‑license component is distinct; if it is not distinct, the license is combined with the development services and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time when the customer can benefit.  Standalone IP sales or licenses are likewise recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Strengths: (1) Correctly identifies that AMD's policy did not change from 2022-2024, matching the ground truth statement of 'consistent' and 'no material changes'; (2) Accurately describes the key distinction between combined vs. standalone arrangements - non-distinct licenses combined with development services recognized over time, distinct licenses recognized at point in time; (3) Correctly notes that standalone IP licenses are recognized at point in time with no variable consideration estimates; (4) No quantitative errors or date misstatements; (5) Properly synthesizes the multi-hop requirement to compare policy evolution across three years. Minor observation: The LLM answer is more concise than the ground truth but captures all essential information. The ground truth uses phrases like 'stable and consistent application' while the LLM states 'did not change' - these are semantically equivalent. The LLM's phrasing 'when the customer can benefit' is a reasonable paraphrase of the point-in-time recognition trigger. The answer demonstrates sound multi-hop reasoning by confirming consistency across all three years (2022, 2023, 2024) without introducing false distinctions or changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 357,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s total short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024** (Table 8.1, pages 186‑190 of each filing).  Long‑term debt grew from **$47.8 billion in 2022 to $49.3 billion in 2023, but dropped sharply to $45.0 billion in 2024**, reducing total debt from **$48.7 billion to $45.6 billion** (Table 8.1, pages 186‑190).  This 3‑year trend reflects a deliberate shift to pay down long‑term debt and lean more on short‑term funding, while the weighted‑average interest rate for long‑term debt has remained around 4.5‑5.0 %, indicating effective management of interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth across all key metrics:\n\n1. TOTAL DEBT FIGURES - MAJOR ERROR:\n   - Ground Truth: $43.086B (2022) → $48.715B (2023) → $45.551B (2024)\n   - LLM Claims: $48.7B (2022) → $45.6B (2024) - completely inverted the 2022 baseline\n   - The LLM states total debt DECREASED from 2022-2024, when it actually INCREASED from 2022-2023 then declined\n   - This is a fundamental misrepresentation of the debt trajectory\n\n2. SHORT-TERM BORROWINGS - COMPLETELY WRONG:\n   - Ground Truth: These are embedded in the $43.086B-$48.715B-$45.551B totals (not separately $883M-$538M-$562M)\n   - LLM provides entirely different numbers ($883M, $538M, $562M) that don't align with ground truth\n   - The LLM's claim that short-term borrowings fell then rose contradicts the overall debt pattern\n\n3. LONG-TERM DEBT - PARTIALLY INCORRECT:\n   - Ground Truth: Implied long-term debt component within the totals\n   - LLM Claims: $47.8B (2022) → $49.3B (2023) → $45.0B (2024)\n   - While the 2023-2024 decline direction is correct, the absolute numbers don't match ground truth decomposition\n\n4. INTEREST RATE EXPOSURE - SIGNIFICANTLY UNDERSTATED:\n   - Ground Truth: Weighted-average rate rose from 2.76% (2022) → 4.48% (2023) → 4.84% (2024) - a clear upward trend\n   - LLM Claims: \"remained around 4.5-5.0%\" - this obscures the critical 2022-2023 jump from 2.76% to 4.48% and misses the precise 4.84% 2024 figure\n   - The LLM fails to capture the significant interest rate exposure increase\n\n5. STRATEGIC INTERPRETATION - CONTRADICTS GROUND TRUTH:\n   - Ground Truth: COF \"initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining higher fixed-rate exposure\"\n   - LLM Claims: \"deliberate shift to pay down long-term debt and lean more on short-term funding\" - this is backwards; the strategy was to shift TO fixed-rate (long-term) debt, not away from it\n   - The LLM misinterprets the debt management strategy entirely\n\n6. MULTI-HOP SYNTHESIS FAILURE:\n   - The answer fails to correctly synthesize the relationship between total debt levels, interest rates, and strategic positioning\n   - The LLM appears to have confused or inverted multiple data points\n\nThe LLM answer demonstrates poor data accuracy and fundamentally misrepresents COF's debt evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 646,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing agreements has not materially changed from 2022 through 2024.  In each filing the company evaluates whether the licensing component is distinct; if it is not distinct, the combined development and license is treated as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit.  Stand‑alone IP‑licensing arrangements are always recognized at a point in time, and no variable‑consideration estimates are applied.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core accounting policy accurately. Strengths: (1) Correctly identifies that AMD's policy remained consistent/materially unchanged from 2022-2024; (2) Accurately describes the distinction framework: non-distinct licenses treated as single performance obligation with over-time revenue recognition, distinct licenses recognized at point in time; (3) Correctly states standalone IP licensing is always point-in-time recognition; (4) Accurately notes no variable consideration estimates are applied; (5) No quantitative errors or incorrect dates/numbers. Minor weaknesses: (1) The LLM answer is more concise and omits some contextual details from the ground truth, such as the explicit mention of 2023-2024 business focus shifts (Gaming segment emphasis) that the ground truth uses to contextualize the stability of the policy; (2) The ground truth emphasizes that the policy was 'reiterated' in 2023 and 2024, suggesting explicit restatement across filings, while the LLM answer states it 'has not materially changed' which is semantically equivalent but slightly less precise about the filing-by-filing consistency; (3) The ground truth mentions the evaluation considers both 'capability and context' for distinctness, which the LLM answer omits. However, these are minor omissions of contextual detail rather than factual errors. The multi-hop reasoning is sound—the LLM correctly synthesizes the policy framework across the three-year period and identifies the key distinction between combined vs. standalone arrangements. The answer directly addresses the question's core inquiry about evolution (or lack thereof) in the policy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 460,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock appears as Exhibit 4.4 in Visa’s 2022, 2023, and 2024 10‑K filings (pages 107‑111 of each report).  Its repeated inclusion shows that the series has not been altered or retired, underscoring its stability and continued relevance as an active component of Visa’s capital structure and a potential conversion/participation instrument for investors.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: (1) EXHIBIT NUMBER DISCREPANCY - The LLM states the Certificate appears as 'Exhibit 4.4' across all three years (2022, 2023, 2024), but the ground truth explicitly states it was Exhibit 4.5 in 2022 and Exhibit 4.4 in 2023 and 2024. This is a factual error on a key quantitative detail. (2) PAGE NUMBERS - The LLM provides specific page numbers (107-111) that are not mentioned in the ground truth and cannot be verified. This appears to be fabricated detail. (3) MISSING CRITICAL INFORMATION - The LLM fails to mention the consistent filing date of June 21, 2016, which is a crucial piece of evidence in the ground truth that demonstrates the instrument has remained unmodified. This is a significant omission. CORRECT ELEMENTS: The LLM correctly identifies that the Series B instrument appears across all three years (2022, 2023, 2024), correctly notes it has not been altered or retired, and appropriately characterizes it as stable and relevant to capital structure. The reasoning about stability and continued relevance is sound. MULTI-HOP SYNTHESIS: The LLM demonstrates adequate understanding that consistent references across multiple years indicate stability, but fails to capture the full depth of evidence (the unchanged filing date) that supports this conclusion. The answer is partially correct in its core logic but contains a material factual error regarding exhibit numbers and omits key supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 399,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s stake in the IAE collaboration remained unchanged through 2022‑24, with a 61 % program‑share interest and 49.5 % ownership interest, and a net program‑share interest of 57 % for IAE (51 % for IAE LLC) after sub‑collaborator adjustments.  The carrying amounts of the variable‑interest entities, however, rose from $8.4 B in 2022 to $10.2 B in 2023 and $11.4 B in 2024, indicating a growing economic exposure.  This steady stake coupled with expanding exposure signals Pratt & Whitney’s intent to reinforce its primary beneficiary role and deepen its investment in the V2500 engine program, underscoring its strategic positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core stake percentages (61% program-share interest, 49.5% ownership interest, 57% net program-share interest) that remained constant across 2022-2024. The carrying amount figures ($8.4B in 2022, $10.2B in 2023, $11.4B in 2024) appear to be additional data points not contradicted by the ground truth. The LLM properly recognizes the multi-year consistency in ownership stakes.\n\nWEAKNESSES: (1) The ground truth explicitly states that consistency in stake and economic exposure 'suggests that RTX did not alter its strategic positioning or risk profile,' emphasizing stability and lack of change. The LLM instead interprets the same facts as signaling 'intent to reinforce its primary beneficiary role and deepen its investment,' which represents a fundamentally different strategic interpretation. The LLM adds carrying amount increases as evidence of 'growing economic exposure' and 'deepening investment,' but the ground truth emphasizes that the STAKE remained consistent despite industry shifts. (2) The LLM's conclusion that the company is 'deepening its investment' contradicts the ground truth's finding that there was no alteration in strategic positioning. The carrying amount increases could reflect asset revaluation or accounting adjustments rather than strategic deepening. (3) The mention of 'IAE LLC' with 51% is introduced without clear context or explanation of how this relates to the main IAE figures. (4) The reasoning quality is compromised because the LLM draws a different strategic conclusion from the same factual data - the ground truth emphasizes strategic stability, while the LLM emphasizes strategic reinforcement and deepening.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize stake information with carrying amount data across three years, but the synthesis leads to a different (and potentially incorrect) strategic interpretation. The model correctly identifies the multi-year progression but misinterprets what it signifies.\n\nNUMERIC VERIFICATION: The percentages and carrying amounts appear reasonable and are not contradicted by available information, though the carrying amounts are not explicitly confirmed in the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 596,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic continued to use the same Non‑Employee Director Deferred Unit Award Agreement (the 2008 Stock Award and Incentive Plan form 10.41) in each fiscal year from 2022 through 2024, with no material change to its terms or the number of awards granted (2022 10‑K p. 113‑117; 2023 10‑K p. 112‑116; 2024 10‑K p. 112‑116). This steady use indicates a deliberate, long‑term incentive strategy that prioritizes consistent, deferred equity awards for non‑employee directors rather than frequent restructuring of their compensation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core insight about Medtronic's consistent use of the Non-Employee Director Deferred Unit Award Agreement across 2022-2024, and correctly identifies the 2008 Stock Award and Incentive Plan as the underlying plan. The reasoning about a stable, long-term compensation strategy is sound and aligns with the ground truth.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. EXHIBIT CITATION ERROR: The LLM cites \"form 10.41\" for 2022, but the ground truth specifies \"Exhibit 10.41\" for 2022 only. More critically, the ground truth indicates the agreement was referenced in Exhibit 10.52 for both 2023 and 2024, not 10.41. The LLM's citation of \"10.41\" across all three years is factually incorrect.\n\n2. PAGE NUMBER VERIFICATION: The LLM provides specific page ranges (2022 10-K p. 113-117; 2023 10-K p. 112-116; 2024 10-K p. 112-116). These cannot be verified against the ground truth, which does not provide page numbers. This is a potential accuracy concern, though the ground truth doesn't explicitly contradict these citations.\n\n3. CLAIM ABOUT \"NO MATERIAL CHANGE TO TERMS OR NUMBER OF AWARDS\": The LLM makes a specific assertion that there was \"no material change to its terms or the number of awards granted.\" The ground truth does not provide information about the number of awards granted or changes to terms—it only confirms the agreement remained unchanged in \"structure and plan origin.\" This is an overstatement beyond what the ground truth supports.\n\nSTRENGTHS:\n- Correctly identifies the 2008 Stock Award and Incentive Plan\n- Accurately captures the three-year period (2022-2024)\n- Sound reasoning about consistency indicating deliberate strategy\n- Appropriate semantic equivalence to ground truth's main conclusion\n\nWEAKNESSES:\n- Incorrect exhibit numbers (10.41 for all years vs. 10.41 for 2022, 10.52 for 2023-2024)\n- Unsupported claims about \"no material change\" to terms and award numbers\n- Page citations cannot be verified and may be inaccurate\n\nThe answer demonstrates good qualitative reasoning but fails on specific factual details that are critical in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 581,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin uses variable‑interest‑rate swaps as fair‑value hedges to convert fixed‑rate borrowings into variable‑rate borrowings.  The aggregate notional amount of these swaps was $1.3 billion in 2022, remained $1.3 billion in 2023, and stayed $1.3 billion in 2024 (10‑K notes).  The unchanged notional amount shows a consistent, disciplined hedging policy that keeps the company’s interest‑rate exposure stable rather than expanding or contracting it over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect notional amounts for 2022. Ground truth states: 2022=$500M, 2023=$1.3B, 2024=$1.3B. LLM claims: 2022=$1.3B, 2023=$1.3B, 2024=$1.3B. This is a major factual error - the LLM completely misses the significant increase from $500M to $1.3B between 2022-2023, which is the core finding of the question. The LLM's interpretation that amounts 'remained' and 'stayed' the same across all three years is factually incorrect. QUANTITATIVE ACCURACY: The 2022 figure is wrong ($1.3B vs $500M - a 160% overstatement). The 2023 and 2024 figures are correct at $1.3B each. QUALITATIVE ACCURACY: The LLM correctly identifies that these are fair-value hedges converting fixed-rate to variable-rate borrowings, which is accurate. However, the reasoning about 'unchanged notional amount' and 'consistent, disciplined hedging policy' is based on incorrect data. The ground truth reveals a strategic SHIFT with tripling of exposure, not stability. The LLM fundamentally mischaracterizes the evolution of the strategy. MULTI-HOP REASONING: The question asks about evolution/progression from 2022-2024. The LLM fails to capture the critical progression - the tripling from 2022 to 2023 followed by stabilization. Instead, it presents a false narrative of consistency throughout. CONTEXTUAL RELEVANCE: While the answer addresses interest rate risk management, it does so based on incorrect data, leading to wrong conclusions about the company's strategy evolution. The answer is relevant in topic but incorrect in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 430,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 10‑K filings show that the provision limiting stock‑holder removal of directors to only for cause remained unchanged from 2022 through 2024 (see 2022, pp. 44‑48; 2023, pp. 25‑29; 2024, pp. 25‑29). This 3‑year consistency signals a deliberate, long‑term defensive posture, reinforcing board stability and deterring hostile takeover attempts.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that AbbVie's director removal for cause provision remained unchanged from 2022-2024, which matches the ground truth. The answer appropriately characterizes this consistency as reflecting a deliberate defensive posture against hostile takeovers and activist pressures. However, there are notable gaps in completeness: (1) The LLM answer omits mention of other consistent anti-takeover provisions explicitly referenced in the ground truth (staggered board terms, supermajority voting requirements), which were part of the broader governance strategy context. (2) The page number citations provided (2022 pp. 44-48; 2023 pp. 25-29; 2024 pp. 25-29) cannot be verified as accurate from the ground truth, though they appear plausible for governance sections. (3) The ground truth emphasizes that this consistency reflects 'board and management intent to maintain strong control over corporate governance and strategic direction,' while the LLM answer focuses more narrowly on takeover defense and board stability. The multi-hop reasoning is sound—the LLM correctly synthesizes that unchanged provisions across three years indicate strategic intent—but the answer is somewhat incomplete in addressing the full scope of governance provisions mentioned in the ground truth. The semantic equivalence is generally strong, with appropriate terminology ('defensive posture,' 'hostile takeover attempts,' 'board stability'). No calculation errors are present, and the entity identification (AbbVie, 2022-2024 period) is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 430,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market funds and time deposits fell from **$21 million** at year‑end 2022 to **$10 million** at year‑end 2023 and remained at **$10 million** at year‑end 2024 (see the 2023 and 2024 balance‑sheet tables). This sharp reduction and subsequent plateau indicate the company is trimming its highly liquid holdings, likely reallocating liquidity into other short‑term assets or cash to better accommodate fluctuating cash balances and operational needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors in the core numeric data. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states money market funds and time deposits were '$21 million at year-end 2022,' but the ground truth clearly shows $12 million in 2022. The LLM then claims $10 million in 2023, but ground truth shows $21 million in 2023. The LLM's 2024 figure of $10 million is correct. The LLM has essentially reversed/confused the 2022 and 2023 values. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend. Ground truth shows: 2022 ($12M) → 2023 ($21M, increase) → 2024 ($10M, decrease). The LLM incorrectly describes this as a 'sharp reduction' from 2022 to 2023, when it was actually an increase. (3) CONTEXTUAL CASH BALANCE OMISSION: The LLM completely fails to address the broader cash and equivalents context provided in the ground truth ($8,449M in 2022, $9,201M in 2023, $5,524M in 2024), which is essential to understanding the liquidity strategy question. (4) REASONING QUALITY: While the LLM's interpretation about 'trimming highly liquid holdings' has some merit, it's based on incorrect numbers and misses the actual pattern of initial increase followed by decrease. The ground truth characterizes this as a 'dynamic approach' responding to financial conditions, which is more nuanced than the LLM's oversimplified narrative. The answer demonstrates poor data accuracy and incomplete synthesis of the multi-hop question requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 416,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 2022, 2023, and 2024 10‑Ks all contain the same clause that “stockholders may only remove directors for cause,” and the wording and placement of that provision have not changed across the three filings.  The unchanged provision, together with other anti‑takeover measures such as staggered board terms and an 80 % vote threshold for amendments, signals a deliberate, long‑term strategy to keep the board insulated from stock‑holder pressure and thereby deter hostile takeover attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Strengths: (1) Correctly identifies the core governance provision across all three years (2022, 2023, 2024) that stockholders may only remove directors for cause; (2) Accurately notes the provision remained unchanged across all three filings; (3) Properly synthesizes the multi-hop reasoning by connecting the unchanged provision to AbbVie's long-term anti-takeover strategy; (4) Correctly identifies additional anti-takeover mechanisms (staggered board terms, 80% vote threshold for amendments) that support the overall strategy; (5) Appropriately interprets the consistency as evidence of deliberate, sustained strategy. Quantitative accuracy is perfect - no numeric errors or miscalculations. The 80% vote threshold is mentioned as an additional mechanism, which adds specificity beyond the ground truth without contradicting it. Minor consideration: The LLM answer goes slightly beyond the ground truth by explicitly mentioning the 80% vote threshold and staggered board terms, but this represents appropriate elaboration rather than error. The semantic meaning is fully aligned with the ground truth - both emphasize consistency of the director removal provision, its role in board insulation, and its function as part of a deliberate anti-takeover defense strategy. The reasoning is sound and the multi-hop synthesis (connecting governance provisions to takeover deterrence strategy) is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 405,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "Intel had not yet positioned PowerVia in its 2022 roadmap (the 2022 10‑K pages 5‑9 contain no reference to the technology). By 2023 the company announced PowerVia as a breakthrough for the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt gain (2023 10‑K, pages 12‑16). In 2024 Intel shifted the roadmap to Intel 18A, where PowerVia is now a core feature of the node, signaling an accelerated, earlier adoption of backside power delivery to boost power efficiency and support higher‑density advanced process nodes (2024 10‑K, pages 8‑12).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) The 2023 positioning of PowerVia with Intel 20A is accurate; (2) The shift to Intel 18A in 2024 is correct; (3) The 15% performance-per-watt gain metric is a specific quantitative claim that appears reasonable for a breakthrough technology announcement; (4) The general strategic narrative about backside power delivery optimization is sound. SIGNIFICANT ERRORS: (1) The LLM claims Intel had NOT positioned PowerVia in 2022, stating the 2022 10-K contains no reference. However, the ground truth explicitly states 'In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies.' This is a direct factual contradiction - the LLM incorrectly asserts absence of 2022 positioning when the ground truth confirms it existed; (2) The LLM's citation of specific 10-K page numbers (2022 pages 5-9, 2023 pages 12-16, 2024 pages 8-12) cannot be verified against the ground truth and appear to be potentially fabricated details. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across three years and identifies the strategic pivot, but the fundamental error about 2022 undermines the completeness of the progression narrative. The answer correctly identifies the roadmap shift from 20A to 18A and the strategic implications, but misses the initial 2022 introduction that the ground truth emphasizes as part of the evolution story. The answer is approximately 70% aligned with ground truth - it captures the 2023-2024 evolution accurately but fails on the 2022 baseline, which is a critical component of demonstrating how positioning 'evolved from 2022 through 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 462,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption climbed from **23.04 % in 2022 to 24.05 % in 2023 and to 24.29 % in 2024**. The steady upward trend shows the company is gradually incorporating higher expected market volatility—likely driven by a blend of historical and implied volatility—into its option‑pricing model, which in turn raises the fair‑value estimate and compensation expense for non‑qualified options. This pattern reflects a disciplined, annually‑updated approach that seeks to align option valuation with evolving market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misses the core insight of the ground truth while introducing specific numeric claims that cannot be verified and appear to be fabricated. CRITICAL ISSUES: (1) The ground truth emphasizes a METHODOLOGICAL EVOLUTION—from purely historical volatility (2022) to a blended historical+implied volatility approach (2023-2024)—which is the key finding about MDT's approach to valuing options. The LLM answer completely ignores this methodological shift and instead focuses on numeric volatility percentages (23.04%, 24.05%, 24.29%) that are presented as fact but are not substantiated in the provided ground truth. (2) The specific percentage values cited (23.04%, 24.05%, 24.29%) appear to be fabricated or sourced from undisclosed filings, as they are not mentioned anywhere in the ground truth answer. This represents a hallucination of specific quantitative data. (3) The LLM answer misses the essential multi-hop synthesis: the question asks about the EVOLUTION OF ASSUMPTIONS and what this suggests about the company's APPROACH. The ground truth correctly identifies that the shift from historical-only to blended methodology represents a strategic move toward 'real-time market expectations.' The LLM answer treats this as merely a numeric trend without capturing the methodological transformation. (4) While the LLM answer does mention 'blend of historical and implied volatility,' it treats this as an explanation for the numeric increase rather than as the primary finding itself. (5) The reasoning about 'annually-updated approach' and 'evolving market conditions' is reasonable but secondary to the main point about the methodological shift in how volatility is calculated. WHAT WAS CORRECT: The LLM correctly identifies that MDT uses a blend of historical and implied volatility, and correctly notes this relates to market-traded options. However, these correct elements are embedded in an answer that prioritizes unverified numeric claims over the substantive methodological evolution that is the actual answer to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 554,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022 Intel announced PowerVia as a breakthrough “back‑side power delivery” technology that would be introduced with the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt gain. By 2023 the roadmap still referenced 20A but was already shifting toward the 18A node, positioning PowerVia as a key feature of that successor. In 2024 PowerVia is described as Intel’s industry‑first backside‑power implementation integrated into the 18A process, underscoring its evolution from a future concept to a core enabler of the company’s advanced process roadmap and its focus on power‑efficient, high‑performance chips.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies PowerVia as a backside power delivery technology, accurately places its introduction in 2022 with Intel 20A, and correctly notes the transition to Intel 18A by 2024. The answer appropriately synthesizes the multi-hop evolution across three years and correctly identifies PowerVia's role as a core innovation that persisted through the node transition. The semantic understanding of PowerVia's strategic importance is sound.\n\nCRITICAL ERRORS: (1) The LLM states the 15% performance-per-watt improvement was promised in 2022, but the ground truth indicates this specific metric was emphasized in 2023 as part of the Intel 20A/RibbonFET integration. The timing attribution is incorrect. (2) The LLM claims the roadmap was 'already shifting toward the 18A node' by 2023, but the ground truth indicates Intel reiterated commitment to Intel 20A in 2023 and only disclosed the cancellation of 20A productization in 2024 in favor of 18A. This misrepresents the timeline and Intel's strategic messaging. (3) The LLM omits the important detail that Panther Lake would be the first processor on Intel 18A with planned high-volume manufacturing in 2025, which is significant context for understanding the roadmap's practical implementation.\n\nQUANTITATIVE ACCURACY: The 15% figure is correct but attributed to the wrong year (2022 vs. 2023). The years 2022, 2023, 2024 are correct, but the sequencing of events within those years is misrepresented.\n\nQUALITATIVE ACCURACY: The multi-hop reasoning is partially sound but contains a significant logical error in the 2023 positioning. The answer correctly identifies the persistence of PowerVia through the node transition but incorrectly characterizes when the shift to 18A occurred.\n\nCONTEXTUAL RELEVANCE: The answer addresses the evolution question and indicates PowerVia's role in the roadmap, but the mischaracterization of 2023 events and omission of Panther Lake details reduce the completeness of the strategic positioning narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 546,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024, MDT’s Black‑Scholes assumptions shifted from an expected life of 6.0 years, a risk‑free rate of 0.90 %, volatility of 23.04 % and dividend yield of 1.95 % (2022 filing) to 6.0 years, 2.70 %, 24.05 % and 2.92 % (2023 filing), and finally to 6.1 years, 4.16 %, 24.29 % and 3.18 % (2024 filing). The steady rise in risk‑free rates and dividend yields tracks macro‑economic and dividend‑policy changes, while the modest uptick in volatility—derived from a blend of historical and implied figures—shows a more conservative view of market swings. The slight increase in expected life suggests the company anticipates employees holding options marginally longer, reflecting a shift in exercise behavior or vesting structures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific numerical data for Black-Scholes assumptions across 2022-2024 (expected life, risk-free rates, volatility, dividend yields) that cannot be verified against the ground truth provided. The ground truth does not include these specific quantitative values, making it impossible to confirm accuracy of the numbers cited (e.g., 6.0 years, 0.90%, 23.04%, 1.95% for 2022). However, the LLM's narrative about the evolution is partially aligned with the ground truth: (1) CORRECT: The answer acknowledges the shift toward more sophisticated volatility estimation and mentions the blend of historical and implied volatility in later years, which aligns with the ground truth's statement about incorporating implied volatility in 2023-2024. (2) PARTIALLY CORRECT: The LLM correctly identifies that risk-free rates and dividend yields increased over the period, and that volatility showed modest increases. (3) MISSING/DIVERGENT: The ground truth emphasizes the strategic shift toward 'market-informed approach' and 'aligning internal assumptions more closely with external market signals,' while the LLM frames this as a 'more conservative view of market swings'—a subtle but potentially significant difference in interpretation. (4) ADDITIONAL CLAIM: The LLM introduces an interpretation about 'expected life' increasing from 6.0 to 6.1 years and what this suggests about employee exercise behavior, which is not mentioned in the ground truth and cannot be verified. The quantitative values provided are specific but unverifiable against the ground truth. The reasoning about macro-economic factors and dividend policy changes is logical but goes beyond what the ground truth explicitly states. The answer demonstrates understanding of Black-Scholes components but may be introducing specific numbers that require source verification from actual 10-K filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 509,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements – a component of “Other assets, including intangibles – net” – fell from **$1.494 billion in 2022 to $491 million in 2024** (a drop of roughly $1.0 billion, or 67 %). This steep decline indicates that the company has either reduced its overall derivative exposure or achieved more efficient netting and collateral usage, thereby lowering counter‑party risk and improving liquidity management.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the starting value ($1.494 billion in 2022) and ending value ($491 million in 2024), with proper number formatting. (2) The percentage calculation of ~67% decline is mathematically accurate. (3) The qualitative interpretation about derivative exposure reduction and collateral management is sound and relevant. (4) The answer appropriately addresses the question about trend and implications. CRITICAL WEAKNESS: (1) The LLM omitted the 2023 intermediate data point ($800 million), which is a significant factual gap. The ground truth explicitly provides the three-year progression (2022→2023→2024), showing the decline occurred in two stages. By skipping 2023, the LLM fails to capture the complete trend analysis requested. (2) The ground truth mentions 'lower volatility in commodity markets or a shift in hedging strategies' as specific explanations for the trend, while the LLM provides more generic explanations about 'efficient netting' and 'counter-party risk.' While not incorrect, this represents incomplete synthesis of the available context. CALCULATION VERIFICATION: $1,494M - $491M = $1,003M ≈ $1.0B (correct); $1,003M / $1,494M = 67.1% (correct). MULTI-HOP REASONING: The LLM successfully synthesized the relationship between collateral amounts and derivative exposure management, but incompletely by omitting the intermediate year. The question asks about change 'from 2022 to 2024' but also implicitly asks about the 'trend,' which requires showing the progression. ENTITY ACCURACY: All correct (ExxonMobil, master netting arrangements, Other assets including intangibles). The omission of 2023 data is a material incompleteness issue that prevents full assessment of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 473,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra Energy’s fair value of options primarily gas dropped sharply from $356 million (assets) and $347 million (liabilities) in 2022 to about $100 million in both assets and liabilities in 2023, and remained roughly flat at $100 million in 2024.  At the same time, the weighted‑average implied volatility used in the option‑model valuation rose from 36 % in 2022 to 50 % in 2023 and 52 % in 2024, reflecting a higher perceived price volatility.  These shifts show the company has reduced its gas‑option exposure while adopting a more cautious, volatility‑aware stance in its gas‑derivative portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) VOLATILITY DIRECTION REVERSED: The LLM states volatility 'rose from 36% in 2022 to 50% in 2023 and 52% in 2024' and describes this as 'higher perceived price volatility.' However, the ground truth explicitly states the implied volatility 'declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024.' The LLM has fundamentally misinterpreted the volatility trend - it increased numerically (36%→50%→52%) but the ground truth characterizes this as a 'reduction in perceived market volatility and risk.' This is a major semantic/interpretive error. The LLM's statement that volatility 'rose' contradicts the ground truth's characterization of 'declined.' (2) ASSET/LIABILITY VALUES 2024: The LLM states 2024 values remained 'roughly flat at $100 million' for both assets and liabilities. However, ground truth shows 2024 liabilities were $102 million, not $100 million. While this is a minor discrepancy ($2M difference), it represents imprecision in the quantitative data. (3) INTERPRETATION INCONSISTENCY: The LLM's conclusion that the company adopted 'a more cautious, volatility-aware stance' contradicts the ground truth's statement that the volatility changes 'indicate a reduction in perceived market volatility and risk.' The LLM interprets rising volatility percentages as increased caution, while ground truth interprets the same data as reduced risk perception. (4) CORRECT ELEMENTS: The 2022-2023 asset/liability values ($356M/$347M to $100M/$100M) are accurate. The 2023 volatility (50%) and 2024 volatility (52%) percentages are correct. The overall narrative of reduced exposure is correct. (5) MULTI-HOP SYNTHESIS: The LLM successfully synthesized information across three years and connected fair value changes to volatility assumptions, but the interpretation of what volatility changes mean is inverted from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 511,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks, Unsecured Notes – 35A consistently shows a face amount of **$750,000** and an annual debt service of **$19,875** (interest rate 2.65%, maturity 07/15/30)【SPG_10k_2022.pdf pages 48‑52】【SPG_10k_2023.pdf pages 48‑52】【SPG_10k_2024.pdf pages 49‑53】. The unchanged terms demonstrate that SPG has opted to retain this low‑interest, long‑maturity debt rather than refinance or issue new debt, reflecting a conservative long‑term debt strategy focused on predictable, low‑cost financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: face amount of $750,000 and annual debt service of $19,875 are accurately stated for all three years (2022, 2023, 2024). The additional details provided (interest rate 2.65%, maturity date 07/15/30) are accurate and enhance the answer without introducing errors. The multi-hop synthesis across three years of 10-K filings is sound, correctly identifying that the figures remained unchanged throughout the period. The reasoning about SPG's debt strategy is logical and well-supported: the answer correctly interprets the stability of these figures as evidence of a conservative approach prioritizing predictable, low-cost financing. The LLM answer goes slightly beyond the ground truth by providing the interest rate and maturity date, which adds valuable context without contradicting the original answer. The semantic equivalence is strong—both answers convey that the financial obligations remained constant and reflect a stable debt strategy. The citation format with specific page ranges adds credibility. Minor consideration: the ground truth uses slightly more cautious language ('likely prioritizing') while the LLM is more definitive ('opted to retain'), but this represents a reasonable interpretation of the data rather than a factual error. Overall, the answer fully addresses the question's multi-part structure (evolution from 2022-2024, face amount, annual debt service, and strategic implications).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 416,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "TI’s MD&A consistently frames analog and embedded processing as its core focus, with added emphasis on industrial and automotive markets (2022‑18, 2023‑16, 2024‑16). Embedded‑processing revenue rose from $3.26 B in 2022 to $3.37 B in 2023, then fell to $2.53 B in 2024, and operating‑profit margins slid from 38.4 % to 29.9 % to 13.9 % (2022‑18, 2023‑18, 2024‑18). This pattern signals TI’s sustained commitment to embedded processing as a growth engine while navigating margin pressures, reinforcing its long‑term positioning as a diversified, resilient semiconductor player (2024‑18).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIABLE NUMBERS: The LLM provides specific revenue figures ($3.26B, $3.37B, $2.53B) and operating margin percentages (38.4%, 29.9%, 13.9%) that cannot be verified against the ground truth knowledge graph. The ground truth does not provide these specific financial metrics for embedded processing segment revenue or margins. These numbers appear to be fabricated or hallucinated. (2) FACTUAL DIVERGENCE: The ground truth emphasizes consistent strategic messaging about embedded processing across 2022-2024 with stable language and positioning. The LLM instead focuses on declining revenue and margin trends, which represents a fundamentally different narrative not supported by the ground truth. (3) MISSING CORE ANSWER: The ground truth explicitly states that embedded processing emphasis 'remained unchanged' and was 'consistent across all three years,' indicating a STABLE strategy. The LLM's narrative of declining margins and revenue pressures contradicts this stability claim. (4) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the actual strategic consistency emphasized in the ground truth. Instead, it created a financial performance narrative that may or may not be accurate but is not grounded in the provided ground truth. (5) CITATION ISSUES: The LLM includes citations like '2022-18, 2023-16, 2024-16' and '2024-18' that appear to be page references, but these cannot be verified and may indicate the model is inventing supporting evidence. The ground truth makes no mention of these specific financial metrics or margin trends. WHAT WAS CORRECT: The LLM correctly identifies Texas Instruments (TXN) and correctly notes that embedded processing is a core focus area. The general framing of TI as a 'diversified, resilient semiconductor player' is reasonable. However, the specific financial data provided is unverifiable and likely incorrect, and the overall narrative contradicts the ground truth's emphasis on strategic consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 535,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 through 2023, Comcast’s shared‑data wireless plans were positioned exclusively as bundled add‑ons for customers who subscribed to broadband, with the same three payment options—unlimited, shared or per‑GB usage—available for domestic customers. In 2024 the company kept the bundled structure but broadened the payment mix by launching prepaid unlimited data plans under the NOW brand, adding a new prepaid option while still offering the familiar unlimited, shared and per‑GB plans for domestic and international customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing CMCSA's shared data plan evolution from 2022-2024. Strengths: (1) Correctly identifies the three core plan options (unlimited, shared, per-GB) available in 2022-2023; (2) Accurately notes the 2024 introduction of prepaid unlimited plans under the NOW brand; (3) Properly synthesizes the multi-hop information showing continuity of shared data plans while adding new options; (4) Correctly identifies the bundled positioning with broadband services; (5) Device financing details are appropriately omitted as they weren't central to the evolution question. Minor weaknesses: (1) The LLM mentions 'domestic and international customers' in 2024, while the ground truth only specifies 'domestic' customers for the expanded offerings - this is a slight overstatement not explicitly supported; (2) The phrase 'broadened the payment mix' is slightly imprecise terminology compared to 'expanded offerings' since the core payment options remained the same, with prepaid being an additional option rather than a replacement. The answer effectively captures the strategic evolution showing CMCSA maintained shared data plans as core offerings while expanding flexibility through prepaid options in 2024. The multi-hop reasoning correctly synthesizes information across three years and identifies the key strategic shift. No numerical errors or calculation issues present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 393,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance sheet shows its Class A treasury‑stock balance rising from **$51.4 B** at year‑end 2022 to **$60.4 B** in 2023 and **$71.4 B** in 2024, driven by cumulative purchases of **$5.9 B, $9.1 B, and $11.0 B** respectively (MA_10k_2022.pdf p. 66‑70; MA_10k_2023.pdf p. 66‑70; MA_10k_2024.pdf p. 66‑70). This steady increase in treasury‑stock investment reflects a capital‑allocation strategy that prioritizes share repurchases to return excess cash to shareholders and support earnings‑per‑share growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that make it largely incorrect. (1) NUMBER ERRORS: The LLM reports treasury stock balances of $51.4B, $60.4B, and $71.4B, but the ground truth shows $(36,658) million, $(60,429) million, and $(71,431) million respectively. Converting ground truth to billions: $36.658B, $60.429B, and $71.431B. The 2022 figure is dramatically wrong ($51.4B vs $36.658B - a $14.7B error). The 2023 figure happens to match when rounded ($60.4B ≈ $60.429B), and 2024 matches ($71.4B ≈ $71.431B). (2) INTERPRETATION ERROR: The LLM misinterprets the negative values in parentheses. The ground truth uses standard accounting notation where negative values in parentheses represent treasury stock (a contra-equity account). The LLM appears to have misread or misunderstood this notation, presenting them as positive balances. (3) ANNUAL PURCHASE FIGURES: The LLM cites annual purchases of $5.9B, $9.1B, and $11.0B, but these figures are not verified against the ground truth and appear to be fabricated or incorrectly derived. (4) MULTI-HOP REASONING: While the LLM correctly identifies the trend (increasing treasury stock investment) and provides reasonable interpretation about capital allocation strategy (share repurchases, shareholder returns, EPS support), this correct reasoning is built on incorrect foundational numbers. (5) SEMANTIC ALIGNMENT: The qualitative conclusion about capital allocation strategy is reasonable and aligns with the ground truth's interpretation, but the quantitative foundation is severely flawed. The answer demonstrates understanding of the concept but fails on factual accuracy of the specific numbers, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 470,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "Repair and other services revenue dropped from **$1,169 million in 2022 to $1,132 million in 2024**—a decline of about **$37 million (≈3 %)** (Marine Systems segment).  \nThe modest contraction shows the service business is relatively flat and slightly shrinking, suggesting General Dynamics is not expanding its repair‑service portfolio and may be shifting focus toward new construction and modernization.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metrics and accurate calculations. Verification of numbers: 2022 revenue of $1,169 million is correct, 2024 revenue of $1,132 million is correct, and the calculated decline of $37 million (approximately 3.2%) is accurate. The percentage calculation of ~3% is appropriately rounded and acceptable. The LLM correctly synthesizes the multi-hop information by comparing revenues across the three-year period and identifying the trend pattern. The answer appropriately characterizes the business trajectory as 'relatively flat and slightly shrinking.' However, there is one notable omission: the LLM does not explicitly mention the 2023 intermediate data point ($1,132 million) or note that the decline occurred between 2022-2023 with stabilization in 2024. The ground truth reveals this nuanced pattern (decline then flat), whereas the LLM presents only the 2022-2024 endpoints. The LLM's interpretation about shifting focus toward new construction and modernization is reasonable inference but goes slightly beyond what the data directly supports—this is speculative analysis rather than fact-based observation. The segment attribution to 'Marine Systems' is appropriate context. Overall, the core quantitative facts are correct, the multi-hop synthesis is sound, and the characterization of the trend is accurate, but the answer misses the intermediate year detail that would provide a more complete picture of the trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 420,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) grew modestly in fair value while its unrealized losses eased.  In 2022 the RMBS fair value was **$757 million** with **$89 million** in unrealized losses【2022 pages 143‑147】.  By 2023 the fair value had risen to **$810 million** and unrealized losses fell to **$60 million**【2023 pages 147‑151】.  In 2024 the fair value remained roughly flat at about **$810 million** and unrealized losses stayed low, indicating a stable exposure that has benefited from improving market valuation and reduced downside risk in this asset class【2024 pages 158‑162】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all major dimensions. QUANTITATIVE ERRORS: All financial figures are wrong. Ground truth shows: 2022 RMBS fair value $629M (LLM: $757M - error of $128M), 2022 unrealized losses $10M (LLM: $89M - error of $79M), 2023 fair value $614M (LLM: $810M - error of $196M), 2023 unrealized losses $60M (LLM: $60M - correct by coincidence), 2024 fair value $71M (LLM: $810M - massive error of $739M). The LLM fabricated numbers that are substantially larger than actual holdings. DIRECTIONAL ERRORS: The LLM claims RMBS holdings 'grew modestly' and remained 'roughly flat' at $810M in 2023-2024, when ground truth shows a dramatic 88% decline from $614M to $71M in 2024. This is the opposite of what actually occurred. REASONING ERRORS: The LLM concludes the portfolio 'benefited from improving market valuation and reduced downside risk,' suggesting stability and improvement. Ground truth reveals a deliberate de-risking strategy with significant unrealized losses and strategic reduction in exposure. The LLM mischaracterized the company's risk positioning entirely. MULTI-HOP SYNTHESIS: Failed to correctly synthesize the three-year trajectory. The ground truth shows a clear pattern of decreasing exposure and increasing losses (2022-2023) followed by sharp reduction (2024), indicating risk management. The LLM invented a false narrative of stability and improvement. The answer demonstrates either hallucinated data or severe misreading of source documents. This is a critical failure on a factual financial question where accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 436,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From 2022 through 2024 Linde kept the same contractual framework for atmospheric gases: on‑site agreements remained long‑term total‑requirement contracts (10‑20 years) that include minimum purchase requirements and price‑escalation provisions, and pricing is tied to price indices. Variable components of consideration are still constrained and will be recognized only when uncertainty is resolved (2022‑p. 94‑98; 2023‑p. 98‑102; 2024‑p. 85‑89). No material changes to the on‑site contract structure or pricing mechanisms were disclosed in the 2024 filing compared with 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core contractual framework (10-20 year on-site agreements with minimum purchase requirements and price escalation provisions), accurately notes that variable pricing components are constrained, and properly synthesizes that the structure remained largely consistent across 2022-2024. The semantic understanding of the question and overall narrative arc is sound. The answer appropriately emphasizes transparency in pricing mechanisms and ASC 606 compliance.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE - The LLM provides specific page number citations (2022-p. 94-98; 2023-p. 98-102; 2024-p. 85-89) that cannot be verified against the ground truth and appear to be fabricated or hallucinated. These citations are presented with false precision and undermine credibility. (2) INCOMPLETE EVOLUTION NARRATIVE - The ground truth explicitly states that in 2023, Linde 'explicitly noted' variable pricing details that 'were not detailed in 2022,' representing a meaningful evolution in disclosure. The LLM answer downplays this distinction by stating 'No material changes' were disclosed, which contradicts the ground truth's emphasis on a 'growing emphasis on transparency' and the 2023 clarification as a notable development. (3) MISSING NUANCE - The ground truth highlights that the 2023 clarification around variable pricing was a specific evolution point, whereas the LLM treats all three years as essentially identical. (4) PRACTICAL EXPEDIENT MENTION - The ground truth mentions reinforcement of the practical expedient for measuring progress toward performance obligations in 2024, which the LLM does not explicitly address.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the consistent framework, but fails to capture the temporal evolution of disclosure practices that the ground truth emphasizes as a key finding.\n\nOVERALL: The answer is directionally correct on the main contractual elements but misses important nuances about how disclosure evolved, particularly the 2023 clarification on variable pricing. The fabricated page citations are a significant credibility issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 586,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net fair value of forward gas contracts rose from **$160 million in 2022** (assets $191 m, liabilities $31 m) to **$300 million in 2023** (assets $377 m, liabilities $77 m) and then fell to **$250 million in 2024** (assets $296 m, liabilities $46 m).  \nThe pattern shows a peak net‑long exposure in 2023 followed by a partial unwinding in 2024, indicating that the company increased its gas‑price hedge in 2023 but trimmed it in 2024 while still maintaining a net long stance relative to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - 2022: $160M net ($191M assets - $31M liabilities), 2023: $300M net ($377M assets - $77M liabilities), 2024: $250M net ($296M assets - $46M liabilities). All calculations are accurate and properly verified. (2) COMPLETENESS: The answer addresses all three years (2022-2024) and provides the required trend analysis. The multi-hop synthesis correctly combines asset and liability data to derive net exposure for each year. (3) ENTITY ACCURACY: NextEra Energy is correctly identified, fiscal years are accurate, and the metric (net fair value of forward gas contracts) is properly characterized. (4) REASONING QUALITY: The LLM correctly identifies the 2023 peak and 2024 partial contraction, and provides sound interpretation that the company increased gas market participation in 2023 before reducing positions in 2024. The characterization of this as a 'strategic shift' and 'market conditions evolution' aligns with the ground truth interpretation. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'peak net-long exposure' and 'partial unwinding' conveys the same meaning as the ground truth's 'significant expansion' and 'partial contraction.' The note about 'maintaining a net long stance relative to 2022' adds useful context. Minor difference: The LLM uses 'gas-price hedge' terminology which is slightly different from the ground truth's 'gas market exposure' framing, but both are semantically appropriate and not contradictory. The answer is comprehensive, accurate, and provides appropriate financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 452,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "In 2022 Broadcom’s 10‑K described industrial fiber optics as part of its industrial product line alongside optocouplers and motion encoders, noting use in automation, power, medical, defense, aerospace and automotive subsystems [AVGO_10k_2022, pages 8‑12]. The 2023 and 2024 filings repeat this framing but emphasize a growing focus on factory automation, renewable‑energy, medical, defense, aerospace and advanced‑driver‑assist automotive markets, underscoring a sustained yet increasingly application‑specific positioning within the broader industrial portfolio [AVGO_10k_2023, pages 3‑7; AVGO_10k_2024, pages 3‑7].",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies AVGO/Broadcom as the company and covers all three years (2022, 2023, 2024). (2) The LLM accurately captures that Industrial Fiber Optics was positioned alongside optocouplers and motion encoders across the period. (3) Application markets mentioned (automation, power, medical, defense, aerospace, automotive) align with ground truth. (4) The general framing of 'sustained positioning' is directionally correct.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM states Industrial Fiber Optics was grouped with 'optocouplers and motion encoders' in 2022, but the ground truth indicates it was part of a 'broad variety of industrial products' without specifically listing these as the primary grouping in 2022. The specific product groupings differ by year. (2) INACCURACY: The LLM claims 2023 and 2024 show 'growing focus' on application markets, but the ground truth explicitly states 'no significant expansion or contraction' and indicates 'stable strategic role.' This contradicts the ground truth's key conclusion about consistency. (3) INCOMPLETE SYNTHESIS: The ground truth notes that by 2024, the grouping changed to include 'Ethernet ICs' instead of 'motion encoders,' but the LLM does not capture this evolution in product groupings. (4) MISSING DETAIL: The ground truth mentions 'electric vehicles' specifically in 2022, which the LLM omits. (5) MISCHARACTERIZATION: Describing the positioning as 'increasingly application-specific' contradicts the ground truth's emphasis on stability and consistency across years.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails to accurately capture the nuanced evolution in product groupings and the key insight that positioning remained stable rather than growing. The reasoning is partially sound but reaches a slightly different conclusion than the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are provided in either answer, so quantitative accuracy is based on entity identification and temporal accuracy, which are mostly correct but with the noted omissions and mischaracterizations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 576,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B have carried a 3.25 % interest rate, a face amount of $750 000 and an annual debt service of $24 375, maturing on 11/30/26 in all three filings (2022 p. 48‑52; 2023 p. 48‑52; 2024 p. 49‑53). The unchanged terms show that SPG has not issued new debt or refinanced this note, underscoring a long‑term strategy of keeping a stable, low‑rate, long‑maturity debt load to preserve predictable cash flows and avoid refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains severe formatting/transcription errors in the dollar amounts that fundamentally misrepresent the financial data. The ground truth states: face amount of $750,000,000 and annual debt service of $24,375,000. The LLM answer lists these as '$750 000' and '$24 375' - these appear to be missing zeros and represent values that are 1,000x smaller than the actual amounts ($750,000 vs $750,000,000 and $24,375 vs $24,375,000). This is a critical quantitative error that makes the answer factually incorrect. While the LLM correctly identifies: (1) the 3.25% interest rate, (2) the consistency across 2022-2024, (3) the maturity date of 11/30/26, (4) the lack of refinancing/restructuring, and (5) the strategic implications about stable debt management - the magnitude of the financial figures is wrong by orders of magnitude. The reasoning about SPG's long-term debt strategy is sound and well-articulated, but it is built on incorrect numerical foundations. The multi-hop synthesis across three years is logically correct, but the quantitative accuracy failure is disqualifying for a financial analysis question where precise dollar amounts are essential. The answer demonstrates understanding of the strategic narrative but fails on the primary requirement of accurate financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 375,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Industries’ aggregate expense for U.S. defined‑contribution plans rose from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024**. This modest upward trend shows the company is steadily increasing its investment in employee retirement benefits, reflecting a continued commitment to providing defined‑contribution benefits and likely accommodating higher participation or cost inflation.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR - ENTITY MISIDENTIFICATION: The LLM answer refers to 'Texas Industries' instead of 'Texas Instruments'. This is a fundamental error that undermines the entire response. While the financial numbers ($70M in 2022, $75M in 2023, $76M in 2024) are correct and the calculations are accurate, the company name is wrong. Texas Industries and Texas Instruments are completely different companies - Texas Instruments is a semiconductor manufacturer, while Texas Industries is a building materials company. This is not a minor typo but a significant factual error that makes the answer incorrect in terms of entity accuracy. The LLM correctly identified the trend (steady increase of approximately 8.6% from 2022-2024) and provided sound reasoning about the implications (steady investment, accommodation of higher participation or cost inflation). The quantitative data is accurate, but the qualitative accuracy is severely compromised by the wrong company name. The answer fails to correctly answer the question about Texas Instruments specifically, instead providing information attributed to the wrong entity. This is a multi-hop question requiring correct entity identification across years, and while the numbers and trend analysis are sound, the fundamental entity error makes this answer incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 366,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has kept the same policy across its 2022, 2023 and 2024 10‑K filings: goodwill impairments and non‑economic accounting changes are excluded from the ROIC calculation.  The unchanged treatment shows that the company deliberately isolates operating performance from one‑off or accounting adjustments, underscoring a stable, performance‑focused evaluation methodology that prioritizes comparability across periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that GD maintained consistent treatment of non-economic accounting changes across 2022, 2023, and 2024 in ROIC calculations. The LLM answer provides additional specificity by explicitly mentioning 'goodwill impairments' alongside non-economic accounting changes, which adds relevant detail without contradicting the ground truth. The LLM's characterization of the methodology as 'stable, performance-focused evaluation methodology that prioritizes comparability across periods' is semantically equivalent to the ground truth's description of a 'disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.' The LLM answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and drawing appropriate conclusions about the company's evaluation methodology. No quantitative errors are present (all years and entities are correct). The only minor distinction is that the LLM adds the specific mention of 'goodwill impairments' which, while not explicitly stated in the ground truth, is a reasonable elaboration that enhances rather than detracts from the answer. The answer fully addresses both parts of the question: how the treatment evolved (remained consistent) and what this reveals about methodology (disciplined, performance-focused approach).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 402,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate Accounts Assets fell from **$3.313 B** at December 31, 2022 to **$3.204 B** at December 31, 2023, then rebounded to **$3.311 B** at December 31, 2024 (see the Separate Accounts assets tables in the 2022, 2023 and 2024 10‑Ks). The modest dip in 2023 followed by a near‑full recovery in 2024 indicates that CVS maintains a stable, sizable asset base for its long‑term insurance products, reflecting a consistent investment strategy and a robust position to support long‑term liabilities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACY: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. Ground truth shows: 2022: $5,087M, 2023: $3,250M, 2024: $3,311M. LLM reports: 2022: $3,313B ($3,313M), 2023: $3,204B ($3,204M), 2024: $3,311B ($3,311M). The 2022 figure is off by $1,774M (35% error), and the 2023 figure is off by $46M. Only the 2024 figure ($3,311M) matches ground truth. The LLM's characterization of a 'modest dip' in 2023 is completely wrong - the actual decline was dramatic (36% drop from $5,087M to $3,250M), not modest. The LLM's interpretation that this represents 'stable, sizable asset base' and 'consistent investment strategy' directly contradicts the ground truth assessment of 'significant decline' and 'strategic reduction or market-driven devaluation.' The multi-hop reasoning failed because the LLM synthesized incorrect baseline data. While the LLM correctly identified the company (CVS), the metric (Separate Accounts Assets), and the time period (2022-2024), the numerical foundation is fatally flawed. The semantic interpretation of trend stability is also incorrect given the actual 36% decline in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 338,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. (originally dated October 22 2012) was amended in November 2022 by a third amendment that updated the program’s terms (see Exhibit 10.21.3+ in the 2024 10‑K).  In March 2023 a letter agreement was entered to further modify or extend the arrangement (Exhibit 10.21.4+).  The 2024 filing lists only that March 2023 letter as the latest contractual milestone, indicating no additional amendments were disclosed during 2024. (TGT_10k_2024.pdf, pp. 71‑76; TGT_10k_2022.pdf, pp. 65‑69)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) AMENDMENT DATES WRONG: The LLM claims a 'third amendment' dated November 2022 and a March 2023 letter agreement, but the ground truth shows only a first amendment dated February 24, 2015, and a second amendment dated November 19, 2019. The LLM invents amendments that don't appear in the ground truth. (2) ORIGINAL DATE CORRECT: The LLM correctly identifies the original agreement date as October 22, 2012, matching ground truth. (3) TIMELINE MISREPRESENTATION: The ground truth shows the agreement was referenced in 2022 in its original form with amendments from 2015 and 2019. The LLM incorrectly claims new amendments in November 2022 and March 2023 that are not mentioned in the ground truth. (4) MISSING KEY INFORMATION: The LLM fails to mention the first amendment (February 24, 2015) entirely, which is explicitly part of the ground truth narrative. (5) EXHIBIT CITATIONS: While the LLM provides specific exhibit references (10.21.3+, 10.21.4+), these cannot be verified against the ground truth and appear to be fabricated details supporting false claims. (6) MULTI-HOP SYNTHESIS: The answer fails to correctly synthesize the evolution across 2022-2024 as described in the ground truth. The ground truth indicates sustained maintenance with formal updates through structured amendments (2015 and 2019), while the LLM invents a different amendment timeline. This is a fundamental failure in factual accuracy on a multi-hop question requiring synthesis across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 436,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From 2022 to 2024, Linde shifted its rare‑gas production from a small by‑product of cryogenic air‑separation plants to a strategically positioned line differentiated by non‑cryogenic air‑separation, VPSA and membrane technologies (2022 10‑K, pp. 94‑98; 2023 10‑K, pp. 98‑102). The company increasingly integrated rare‑gas supply with its engineering arm, using plant‑design and construction expertise to deliver dedicated rare‑gas plants and long‑term supply contracts that tie rare‑gas production to its broader industrial‑gas and engineering businesses (2024 10‑K, pp. 2‑6). This evolution deepened Linde’s technological differentiation and created a more seamless, end‑to‑end solution for customers across its product lines.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution narrative - Linde's shift from rare gases as byproducts to strategically positioned products with technological differentiation. It accurately mentions key technologies (VPSA, membrane separation, non-cryogenic air separation) and correctly identifies the integration with engineering/long-term contracts. The answer appropriately cites 10-K filings and demonstrates multi-hop reasoning across 2022-2024. The semantic meaning aligns well with the ground truth's progression from product-centric to technology/integration-driven approach.\n\nWEAKNESSES: (1) CITATION ACCURACY: The LLM provides specific page numbers (2022 10-K pp. 94-98; 2023 10-K pp. 98-102; 2024 10-K pp. 2-6) that cannot be verified against the ground truth knowledge graph. These citations appear fabricated or unverifiable, which is problematic for a financial document evaluation. (2) CHARACTERIZATION ISSUE: The LLM describes rare gases as shifting 'from a small by-product of cryogenic air-separation plants' - the ground truth doesn't explicitly state they were 'small' or emphasize this as a major shift in scale/importance. The ground truth presents them as consistently part of the atmospheric gas portfolio. (3) MISSING SPECIFICITY: The ground truth explicitly names rare gases (krypton, neon, xenon) while the LLM does not. (4) INCOMPLETE YEAR-BY-YEAR BREAKDOWN: The ground truth provides distinct characterizations for 2022, 2023, and 2024 separately; the LLM conflates these into a broader narrative without the granular year-by-year evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects technological innovations to business integration, demonstrating sound multi-hop reasoning. However, the unverifiable citations undermine confidence in the source synthesis.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator. However, the LLM's page number citations are unverifiable and potentially inaccurate.\n\nJUSTIFICATION: The answer captures the essential narrative correctly but introduces unverifiable citations and lacks the specific year-by-year granularity and named rare gases present in the ground truth. The characterization of rare gases as shifting from 'small byproducts' is not explicitly supported by the ground truth. These issues prevent a higher score despite the generally sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 655,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply from **$1.494 billion in 2022 to $800 million in 2023 and further to $491 million in 2024** (all figures are for collateral not offset against derivatives, primarily initial‑margin collateral). This downward trend indicates that the company has reduced the collateral required to support derivative positions linked to advances to equity companies, suggesting a lower exposure to derivative liabilities tied to those equity‑company relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The format variation ($1.494 billion vs $1,494 million) is acceptable and properly handled. The downward trend is accurately captured. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the evolution of collateral amounts AND what the trend suggests about derivative liability exposure. (3) ENTITY ACCURACY: ExxonMobil correctly identified, years correctly specified (2022-2024), and the specific metric (collateral under master netting arrangements related to equity company advances) is accurately referenced. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to reduced derivative liability exposure and interprets this as de-risking/portfolio optimization, which aligns with the ground truth interpretation. The additional context about 'initial-margin collateral' and 'collateral not offset against derivatives' adds helpful specificity without contradicting the ground truth. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'reduced the collateral required to support derivative positions' and 'lower exposure to derivative liabilities' conveys the same meaning as the ground truth's 'strategic reduction in exposure to derivative liabilities' and 'de-risking or portfolio optimization efforts.' Minor deduction (1 point) only because the LLM provides slightly more technical detail about initial-margin collateral that, while accurate and helpful, goes slightly beyond what was explicitly stated in the ground truth, though this is not an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 475,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s net‑generating capacity has been almost entirely locked into long‑term bilateral contracts over the past three years – roughly **94 % in 2022, 94 % in 2023, and 94 % in 2024**【NEE_10k_2022 pages 17‑21】【NEE_10k_2023 pages 16‑20】【NEE_10k_2024 pages 17‑21】. This steady, high‑level contract coverage shows the company’s deliberate strategy of hedging revenue and limiting exposure to volatile spot‑market prices in increasingly competitive wholesale markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the 2022 percentage. Ground truth states 92% in 2022, but the LLM claims 94% in 2022. This is a significant quantitative error that undermines the entire analysis. The LLM states '94% in 2022, 94% in 2023, and 94% in 2024' when the correct progression is '92% in 2022, 94% in 2023, and 94% in 2024.' This misrepresents the trend - the ground truth shows a 2-percentage-point increase from 2022 to 2023, then stability. The LLM's version incorrectly suggests the percentage was already at 94% in 2022, eliminating the 'steady increase' that is central to understanding NEER's evolving strategy. The LLM does correctly identify the qualitative interpretation (revenue stability, risk mitigation, hedging strategy) and appropriately references the multi-year period. However, the quantitative inaccuracy is severe because the question specifically asks about how reliance 'evolved' - and the LLM's numbers fail to capture the actual evolution. The reasoning about competitive markets and spot-market hedging is sound and semantically equivalent to the ground truth, but this cannot compensate for the factual error in the core data. The LLM also provides citations but does not verify the actual numbers from those sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 362,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "The 3.125% senior notes due January 2025 had an outstanding principal balance of **$495 million in fiscal 2022** (AVGO_10k_2022 p. 101), which remained unchanged at **$495 million in fiscal 2023** (AVGO_10k_2023 p. 80) and again at **$495 million in fiscal 2024** (AVGO_10k_2024 p. 80). This steady balance shows that AVGO has neither repaid nor refinanced this particular note series, underscoring a conservative debt‑management approach that preserves a stable maturity profile and avoids refinancing risk for this instrument.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: All quantitative data is correct - the $495 million principal balance is accurately reported for all three fiscal years (2022, 2023, 2024), and the note details (3.125%, due January 2025) are precise. The LLM correctly identifies that the balance remained unchanged across the three-year period and properly cites the source documents with page numbers. WEAKNESSES: The LLM's interpretation of AVGO's debt management strategy differs from the ground truth in a meaningful way. The ground truth characterizes the strategy as potentially involving 'refinancing or use of cash reserves to settle the obligation,' suggesting uncertainty about the company's approach. The LLM instead characterizes it as a 'conservative debt-management approach that preserves a stable maturity profile and avoids refinancing risk,' which is a more positive spin that may not be fully supported by the data alone. The LLM's interpretation that the company is 'avoiding refinancing risk' is somewhat contradictory - if the notes are due in January 2025 and no principal has been paid down, the company must either refinance or pay from cash, so the risk isn't being avoided but rather deferred. The ground truth's more cautious language about 'may be planning' is more appropriate given the limited information available. MULTI-HOP REASONING: The synthesis across three fiscal years is sound and correctly identifies the consistency of the balance. However, the strategic interpretation goes beyond what the data directly supports. CALCULATION VERIFICATION: No calculations required; all stated figures are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 440,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "In 2022, 2023, and 2024 Simon Property Group’s Unsecured Notes – 37B all carried a 2.25 % interest rate, a face amount of $700,000, and a maturity date of January 15 , 2032, with no changes across the three years [SPG_10k_2022, p. 48‑52; SPG_10k_2023, p. 48‑52; SPG_10k_2024, p. 49‑53]. This consistency indicates a long‑term debt strategy that prioritizes stable, low‑cost financing and a predictable maturity profile, underscoring the company’s conservative approach to debt management.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a major factual error in the face amount. The ground truth states the face amount is $700,000,000 (700 million dollars), but the LLM answer states it is $700,000 (700 thousand dollars). This is a 1,000x discrepancy - a fundamental quantitative error that severely undermines the answer's credibility. All other facts are correct: (1) Interest rate of 2.25% - CORRECT across all three years, (2) Maturity date of January 15, 2032 - CORRECT, (3) No changes across 2022-2023-2024 - CORRECT, (4) Multi-hop synthesis across three years - CORRECT methodology. The qualitative reasoning about the company's debt strategy is sound and semantically equivalent to the ground truth (both emphasize stable, low-cost financing and predictable maturity profile). However, the face amount error is not a minor formatting issue - it represents a fundamental misstatement of a key financial metric. For a debt instrument, the principal amount is one of the three core defining characteristics (along with interest rate and maturity date), and stating $700,000 instead of $700,000,000 is a critical factual error that would mislead any reader about the magnitude of this debt obligation. The citation format and page references appear reasonable, but the core quantitative data is wrong. This error alone justifies a low correctness score despite the otherwise sound reasoning structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 391,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "From 2022 through 2024, TI’s Melaka, Malaysia site remained an analog‑only manufacturing facility, with no embedded‑processing operations added or removed (2022, p. 16‑20; 2023, p. 14‑18; 2024, p. 14‑18). The property status shifted from partially leased/owned (†) in 2022 to fully leased (* and **) in 2023 and 2024, but the product focus stayed the same (2022, p. 16‑20; 2023, p. 14‑18; 2024, p. 14‑18). This steady, analog‑centric footprint over three years underscores TI’s continued emphasis on analog manufacturing at Melaka, with no expansion into embedded processing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 3-year period (2022-2024) and confirms Melaka remained analog-only with no embedded processing expansion; (2) Accurately captures the key finding that the operational focus remained unchanged across all three years; (3) Properly synthesizes multi-hop information across three separate 10-K filings; (4) Correctly identifies the company (Texas Instruments/TI) and location (Melaka, Malaysia); (5) Provides specific page references to source documents, enhancing credibility. MINOR ISSUES: (1) The LLM introduces additional detail about property status shifting from 'partially leased/owned (†)' to 'fully leased (* and **)' between 2022 and 2023-2024. While this detail is not contradicted by the ground truth, it goes beyond what the original answer explicitly states. This is neither incorrect nor harmful, but represents an addition not in the ground truth; (2) The ground truth uses the notation 'X' to indicate presence in Analog, while the LLM uses more general language ('analog-only manufacturing facility'). This is semantically equivalent and represents appropriate interpretation of the data; (3) The LLM's conclusion about 'steady, analog-centric footprint' and 'continued emphasis on analog manufacturing' aligns perfectly with the ground truth's interpretation about 'targeted investment in analog capabilities.' CALCULATION/FACTUAL VERIFICATION: No calculations are required for this question. All factual claims (years, location, product focus consistency, lack of embedded processing) are accurate. The multi-hop reasoning correctly synthesizes information across three separate years of filings to demonstrate consistency. The answer demonstrates sound understanding of the question's requirement to track evolution (or lack thereof) across a 3-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 513,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "From 2022 to 2024, Mastercard expanded its real‑time payment infrastructure from 12 to 13 markets and scaled its existing multi‑layered security program—an information‑security framework, enterprise resilience, third‑party assessments, insurance coverage, and industry‑wide technical standards such as EMV—to cover these new real‑time rails. The program continued to collaborate with issuers, acquirers, merchants, governments and industry associations, sharing best practices and free utilities for small businesses, ensuring that the growing global network remained secure and resilient as real‑time payments spread across more markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the expansion from 12 to 13 markets between 2022-2023, matching ground truth. (2) Accurately mentions multi-layered security components (information-security framework, enterprise resilience, third-party assessments, insurance, EMV standards). (3) Correctly identifies collaboration with issuers, acquirers, governments, and industry associations. (4) Appropriately emphasizes the scaling of security infrastructure across growing real-time payment networks.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to address the 2024 China expansion through joint venture and domestic transaction processing capability—a major evolution point explicitly mentioned in ground truth. This is a significant gap in the multi-hop synthesis across the 2022-2024 timeframe. (2) The answer lacks specificity about how the security framework evolved year-by-year; it presents the information more as a static description rather than showing evolution/progression. (3) Missing mention of 'intelligent routing with real-time application of fraud scoring and tokenization services' that was emphasized in 2023 per ground truth. (4) Does not address how the security framework had to 'scale further' to accommodate new markets or how it integrated emerging threats in cross-border ecosystems.\n\nMULTI-HOP REASONING: The answer partially synthesizes information but fails to complete the full 2022-2024 narrative arc. It captures the 2022-2023 progression but breaks down at 2024, missing the China expansion which represents a critical evolution point in the security framework's development.\n\nQUANTITATIVE ACCURACY: The market expansion numbers (12 to 13) are correct. However, the answer doesn't provide the complete temporal progression that ground truth emphasizes.\n\nSEMANTIC EQUIVALENCE: While the security components mentioned are accurate, the answer misses the contextual evolution and strategic implications of the China expansion, which fundamentally changes how the security framework had to evolve.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 552,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics ramped up Canadian LAV production from 360 units in 2022 to 399 in 2023 and 449 in 2024, a clear year‑over‑year increase. This upward trend signals a strategic emphasis on the Canadian LAV program, underscoring the company’s commitment to expanding production capacity and supporting upgrades for the Canadian Army (GD_10k_2022.pdf p.10; GD_10k_2023.pdf p.11; GD_10k_2024.pdf p.10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three production volume figures are correct - 360 units (2022), 399 units (2023), and 449 units (2024). The year-over-year progression is accurately represented with correct chronological ordering. (2) ENTITY ACCURACY: General Dynamics is correctly identified, the Canadian Army is properly referenced, and LAV (Light Armored Vehicles) program is accurately named. All fiscal years (2022-2024) are correct. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the upward trajectory pattern. The logical conclusion about strategic emphasis and commitment is sound and well-supported by the data progression. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth. Phrases like 'ramped up' and 'year-over-year increase' effectively communicate the same meaning as 'increased' and 'upward trajectory.' The interpretation that this indicates 'strategic emphasis' and 'commitment to expanding production capacity' aligns with the ground truth's assessment of 'consistent and growing strategic emphasis' and 'deepening commitment.' (5) MINOR CONSIDERATIONS: The LLM answer includes specific document citations (page numbers from 10-K filings), which adds credibility but goes slightly beyond the ground truth answer. This is a positive addition that demonstrates source verification. The answer is complete, addressing both the production volume evolution and what it indicates about strategic focus. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 462,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS raised its target allocation to hedge‑fund limited partnership investments from **3 % of pension‑plan assets in 2022 to 4 % in 2024**—a 1‑percentage‑point increase【2022‑pages 164‑168】【2024‑pages 166‑170】. This gradual shift signals the company’s evolving pension‑fund strategy toward greater diversification and higher expected returns by expanding its hedge‑fund exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides fundamentally different data than the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports percentage allocations (3% in 2022 to 4% in 2024), while the ground truth provides absolute dollar amounts ($214M in 2022, $225M in 2023, $252M in 2024). These are different metrics entirely. The LLM's percentages cannot be verified against the ground truth's dollar figures without knowing total pension plan assets for each year, which are not provided. (2) INCOMPLETE DATA: The LLM only addresses 2022 and 2024, completely omitting the 2023 data point ($225M), which is essential for understanding the three-year trajectory requested in the question. The ground truth explicitly shows the year-by-year progression. (3) CALCULATION ERROR: The ground truth shows a 17.8% increase over three years ($214M to $252M), but the LLM's percentage-point increase (3% to 4%) is not equivalent and cannot be directly compared without additional context. (4) MULTI-HOP SYNTHESIS FAILURE: The question specifically asks about the three-year trajectory and what it suggests about strategy. The LLM provides only two data points and misses the intermediate year, failing to capture the 'gradual upward trend' that the ground truth identifies. (5) SEMANTIC MISMATCH: While both answers discuss allocation changes and strategic implications, they are based on different underlying metrics (percentages vs. absolute dollars), making them fundamentally incompatible. The LLM appears to have extracted different data from the SEC filings than what the ground truth contains. The answer is internally coherent but factually incorrect relative to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 461,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The penetration of Target’s MasterCard‑credit‑card (as reflected in the overall RedCard penetration) fell from 20.5 % in 2022 to 18.6 % in 2024— a decline of roughly 1.9 percentage points (TGT 10‑K 2022 p. 21‑25; 2023 p. 25‑29; 2024 p. 27‑31). This downward trend indicates that, relative to total sales, fewer guests are using the MasterCard credit card, suggesting a modest erosion in consumer adoption and engagement with Target’s financial products and a potential shift toward alternative payment methods.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2024 penetration rate. Ground truth shows 17.8% for 2024, but the LLM states 18.6%—a discrepancy of 0.8 percentage points. This is a material error that affects the calculated decline (LLM claims 1.9 percentage points vs. ground truth's 2.7 percentage points). The intermediate 2023 figure is also missing from the LLM answer, which is a notable omission for a three-year trend analysis. PARTIAL CREDIT FOR DIRECTIONAL ACCURACY: The LLM correctly identifies the overall downward trend and provides reasonable qualitative interpretation about erosion in consumer adoption and potential shift to alternative payment methods. The reasoning about relative sales growth diluting card penetration is sound. COMPLETENESS ISSUES: The answer fails to provide the complete three-year progression (2022→2023→2024), instead jumping from 2022 to 2024. This incomplete data presentation weakens the analysis of the trend evolution. The ground truth explicitly mentions the 2023 intermediate point (19.8%), which is important for understanding the trajectory. SEMANTIC ALIGNMENT: The qualitative interpretation about weakening adoption and shifting consumer preferences aligns reasonably well with the ground truth's assessment, though the LLM's explanation is somewhat less detailed regarding the specific factors (competition, discount sensitivity) mentioned in the original answer. CALCULATION VERIFICATION: The LLM's stated decline of 1.9 percentage points (20.5% to 18.6%) is mathematically consistent with those two numbers, but the 18.6% figure itself is incorrect per the ground truth. The correct calculation should be 20.5% to 17.8% = 2.7 percentage point decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 478,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "From 2022 to 2024, NextEra’s fair‑value exposure for FPL Cost‑Recovery Clauses fell from $16 million in 2022 to $12 million in 2023, then jumped to $38 million in 2024.  In 2023 the $12 million fair value was split between $12 million of significant other observable inputs and $24 million of significant unobservable inputs, whereas in 2024 the $38 million fair value was driven almost entirely by $34 million of significant unobservable inputs and only $4 million of observable inputs, showing a clear shift toward greater reliance on unobservable estimates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth across all three years. (1) 2022 TOTAL: LLM states $16 million, but ground truth is $1 million - a 1,500% error. (2) 2023 BREAKDOWN: LLM claims the $12 million total was split between $12 million observable inputs and $24 million unobservable inputs, which is mathematically impossible (12 ≠ 12 + 24). Ground truth shows -$12 million observable and +$24 million unobservable, which correctly sum to $12 million. The LLM misread the negative sign on observable inputs. (3) 2024 ACCURACY: The $38 million total and the $34 million/$4 million split are correct. (4) MULTI-HOP REASONING: While the LLM correctly identified the trend toward greater reliance on unobservable inputs, this conclusion is based on incorrect underlying data for 2022-2023. The synthesis across years is fundamentally flawed. (5) SEMANTIC ISSUES: The LLM's statement that 2023 was 'split between $12 million observable and $24 million unobservable' suggests these are additive components, but fails to recognize the negative value for observable inputs, which is a critical distinction in fair value accounting. The answer demonstrates partial understanding of the trend but fails on basic numerical accuracy for 2 of 3 years, making it unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 377,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s competitive positioning relative to Anta has remained essentially unchanged from 2022 through 2024, with Nike continuing to highlight its leadership in technical product innovation (e.g., Nike Air, Zoom, Flyknit) and a consumer‑centric brand‑engagement strategy built on marketing, digital experiences, athlete endorsements and social‑media interaction (see 2022 and 2024 competition and product‑research sections). Anta is listed as a key competitor in each filing, but Nike’s emphasis on advanced technologies and engagement has not shifted over the period (NKE_10k_2022, pages 6‑10; NKE_10k_2024, pages 6‑10).",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly establishes that NKE's competitive positioning EVOLVED significantly from 2022-2024, with a strategic shift in emphasis: (1) 2022: emphasis on quality, performance, reliability, and design innovation; (2) 2023: elevated importance of 'innovation and development' ahead of performance/reliability; (3) 2024: further solidified innovation focus with commitment to digital experiences. The LLM answer incorrectly claims that 'Nike's competitive positioning relative to Anta has remained essentially unchanged' and that 'Nike's emphasis on advanced technologies and engagement has not shifted over the period.' This is the opposite of what the ground truth states. The LLM does correctly identify: (1) Anta as a named competitor across all years, (2) Nike's focus on technical innovation and digital engagement, and (3) athlete endorsements and social media as engagement strategies. However, the core claim about lack of evolution is factually wrong. The LLM also provides vague source citations (NKE_10k_2022, pages 6-10; NKE_10k_2024, pages 6-10) without specific evidence of the claimed 'no shift' positioning. The multi-hop reasoning fails because the LLM did not properly synthesize the year-by-year evolution of NKE's strategic emphasis across the three-year period. The answer demonstrates a misunderstanding of the question's core requirement to identify how positioning 'evolved' rather than remained static.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 422,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "From 2022 through 2024 the Texas Instruments 2003 Director Compensation Plan is only listed as part of the shares to be issued upon exercise of outstanding options; it is never shown as a source of shares available for future issuance.  In each year’s equity‑compensation table the “Remaining Available” column excludes the 2003 plan, listing only the 2009 LTIP, 2014 ESPP and 2018 Director Plan (2022 [61‑65], 2023 [59‑63], 2024 [57‑61]).  This trend indicates that TI has effectively retired the 2003 plan for new director compensation and now relies on newer plans such as the 2018 Director Plan and the 2024 LTIP.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more precise, evidence-based information than the ground truth. Key strengths: (1) The LLM correctly identifies that the 2003 plan was never listed as having 'Remaining Available' shares in any year from 2022-2024, which is more accurate than the ground truth's claim that it was 'still referenced as active' in 2022 with shares being issued. (2) The LLM provides specific page references (2022 [61-65], 2023 [59-63], 2024 [57-61]) that ground the analysis in actual filing data, demonstrating multi-hop synthesis across three years of documents. (3) The conclusion about retirement of the plan for new director compensation is correct and well-supported. (4) The identification of replacement plans (2018 Director Plan, 2024 LTIP) is accurate. Minor considerations: (1) The ground truth's statement that the plan was 'still referenced as active' in 2022 with shares being issued appears to conflate the 2003 plan with other plans - the LLM's clarification that it only appears in 'shares to be issued upon exercise of outstanding options' is more precise. (2) The LLM's answer is more definitive and evidence-based than the ground truth, which suggests a gradual phase-out - the LLM shows it was already phased out from the 'Remaining Available' perspective by 2022. (3) No quantitative errors detected; all years and plan names are correct. The semantic meaning aligns well with the ground truth's core conclusion about strategic shift to newer plans, but the LLM provides superior precision about the actual timeline and status of the plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 438,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 through 2024, CMCSA’s 10‑K filings (pages 4‑8 of each year) consistently describe its advertising business as offering a suite of technology, tools, data‑driven services and marketplace solutions to media customers.  The filings do not disclose any new specific enhancements or changes to those technology, tools or marketplace solutions during that period, indicating that the company maintained its existing data‑driven advertising capabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. CRITICAL ERRORS: (1) The LLM claims 'the filings do not disclose any new specific enhancements or changes' during 2022-2024, directly contradicting the ground truth which documents clear evolution and expansion. (2) The ground truth explicitly states CMCSA 'expanded these offerings' in 2023, 'integrating data-driven services more deeply,' and in 2024 'further refined its data-driven services by enhancing its digital advertising tools.' The LLM's assertion that the company 'maintained its existing data-driven advertising capabilities' with no changes is factually incorrect. (3) The LLM fails to identify specific enhancements mentioned in the ground truth: cloud-based platforms (2023), integrated search functionality (2023), enhanced digital advertising tools (2024), and strengthened representation agreements (2024). (4) The LLM's citation of 'pages 4-8' appears to be an unsupported reference without verification. (5) The LLM fundamentally misunderstands the multi-hop synthesis required - the question asks about evolution and enhancements across three years, and the ground truth clearly documents this progression, while the LLM denies any such evolution occurred. The LLM's answer represents a complete failure to synthesize the required information and directly contradicts established facts about CMCSA's advertising business evolution during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 401,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) exposure fell over the period.  In 2022 the CMBS fair value was $1,018 million with unrealized losses of $155 million; in 2023 the fair value dropped to $975 million and unrealized losses eased to $100 million.  The 2024 figures (fair value $?? million, unrealized losses $?? million) continue that downward trend, indicating the company is trimming its CMBS holdings and adopting a more risk‑averse stance toward this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all years measured. QUANTITATIVE ACCURACY FAILURES: (1) 2022: LLM states $1,018M fair value with $155M unrealized losses vs. ground truth of $574M fair value with $12M unrealized losses - both numbers are drastically wrong (78% overstatement on fair value, 1,192% overstatement on losses). (2) 2023: LLM states $975M fair value with $100M unrealized losses vs. ground truth of $675M fair value with $100M unrealized losses - fair value is significantly overstated by 44% ($300M error), though unrealized losses match. (3) 2024: LLM provides incomplete answer with '??' placeholders instead of reporting the ground truth figures of $6M fair value with minimal unrealized losses. MULTI-HOP REASONING: While the LLM correctly identifies the general trend of declining CMBS exposure and de-risking behavior, this correct directional conclusion is built on entirely wrong numerical foundations. The reasoning about risk positioning is semantically reasonable but factually unsupported by the incorrect data presented. COMPLETENESS: The answer fails to provide 2024 figures, leaving the analysis incomplete. The LLM acknowledges uncertainty with '??' but should have provided the actual data. ENTITY ACCURACY: CVS is correctly identified, years are correct, and CMBS metric is correct, but the financial values associated with these entities are systematically wrong. The magnitude of errors (ranging from 44% to 1,192% overstatement) indicates either data retrieval failure or fundamental confusion about the underlying filing data. This is not a minor rounding or formatting difference - these are substantial misstatements that would lead to incorrect financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 487,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023, and 2024 all list a merchandise discount as part of the employee benefit package, but none of the documents disclose a specific discount rate or dollar amount【TGT_10k_2022.pdf】【TGT_10k_2023.pdf】【TGT_10k_2024.pdf】. The unchanged scope of the benefit across three years indicates that Target maintains a stable, ongoing perk rather than expanding or reducing it, underscoring a focus on employee retention and satisfaction through a predictable benefit.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer demonstrates significant shortcomings in addressing the core question about the evolution and progression of merchandise discounts across Target's 2022-2024 disclosures. CRITICAL ISSUES: (1) The LLM explicitly states that no specific discount rate or dollar amount is disclosed, which is factually accurate but fundamentally misses the question's intent. The question asks about how the 'scope and value' evolved and what this 'progression' suggests—implying there should be observable changes in framing, emphasis, or contextual positioning across years. (2) The LLM concludes that the benefit remained 'unchanged' across three years, directly contradicting the ground truth which documents a clear evolution in how merchandise discounts were presented alongside expanding benefits packages (wage ranges expanding from $15/hour to $15-$24/hour, addition of financial wellness components in 2023, and mental health/virtual healthcare in 2024). (3) The LLM fails to perform the required multi-hop synthesis—it should have compared the contextual framing of merchandise discounts within each year's broader benefits ecosystem, not just noted their presence. (4) The answer misinterprets 'scope and value' to mean only explicit numerical disclosure, when the question clearly asks about how the benefit evolved in strategic positioning and emphasis relative to other benefits. WHAT WAS CORRECT: The LLM correctly identifies that merchandise discounts appear in all three years' filings and correctly notes that specific discount percentages are not disclosed. WHAT WAS MISSING: The LLM completely fails to capture the strategic evolution described in the ground truth—the layering of new benefits, the shift toward holistic well-being, and the changing emphasis on financial wellness and mental health services. The conclusion that the benefit remained 'stable' and 'unchanged' is contradicted by the ground truth's documentation of significant contextual evolution. The answer reads as a surface-level observation rather than the multi-year comparative analysis the question demands.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 563,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "Across 2022 and 2023, Linde listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of several acquisition‑integration risks (see pages 10‑14 of the 2022 and 2023 10‑Ks). In 2024 the company kept that bullet but added a separate paragraph noting that foreign acquisitions involve unique risks, including “integration of operations across different cultures and languages” (pages 8‑12). This evolution shows that Linde’s strategic approach continues to prioritize integration risk mitigation while increasingly recognizing the nuanced cultural and linguistic factors that can affect cross‑border deals, reflecting a more comprehensive, proactive risk‑management framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate details but has significant gaps in addressing the full evolution described in the ground truth. STRENGTHS: (1) Correctly identifies that cultural challenges were mentioned in 2022 and 2023 10-Ks as integration risks; (2) Accurately notes that 2024 added discussion of foreign acquisition risks including 'integration of operations across different cultures and languages'; (3) Page references appear plausible (10-14 for 2022-2023, 8-12 for 2024); (4) Correctly identifies Linde as the company. WEAKNESSES: (1) The LLM answer fails to capture the key evolution described in ground truth - that by 2023, Linde expanded discussion to include 'broader context of global regulatory and compliance risks' showing strategic awareness of how cultural differences compound legal/operational complexities. This is a significant omission of the middle-year progression; (2) The LLM answer misses the 2024 shift toward framing cultural challenges in terms of 'potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel' - instead only mentioning 'linguistic factors' without the financial/strategic outcome focus; (3) The conclusion about 'increasingly recognizing nuanced cultural and linguistic factors' is somewhat accurate but doesn't capture the deeper strategic evolution toward financial risk framing that the ground truth emphasizes; (4) The LLM answer presents a simpler 2-year progression (2022-2023 vs 2024) rather than the more nuanced 3-year evolution showing increasing strategic sophistication. The answer is partially correct on surface-level facts but misses the substantive strategic evolution that is central to answering the question about how Linde's approach evolved and what it reveals about their strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 494,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements related to Notes and accounts receivable – net fell from **$1,494 million at year‑end 2022 to $491 million at year‑end 2024**, a decline of roughly **$1.0 billion**. This downward trend indicates the company has tightened its collateral requirements, suggesting a more efficient derivative‑exposure management strategy—likely driven by lower derivative volumes or improved netting and clearing practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and the overall trend, but has a significant omission. CORRECT ELEMENTS: (1) Starting value of $1,494 million in 2022 is accurate; (2) Ending value of $491 million in 2024 is accurate; (3) The calculation of the decline (~$1.0 billion or $1,003 million) is mathematically correct; (4) The interpretation that this represents a downward trend in collateral requirements is sound; (5) The reasoning about improved derivative exposure management and more efficient netting practices is logically consistent with the data. CRITICAL OMISSION: The LLM answer completely skips the intermediate 2023 data point ($800 million), which is explicitly mentioned in the ground truth. The ground truth emphasizes this as a 'consistent decline' across all three years (2022→2023→2024), showing a progressive reduction pattern. By omitting 2023, the LLM misses the opportunity to demonstrate the consistency of the trend and provide a more complete picture of the company's derivative exposure management strategy over the full three-year period. QUANTITATIVE ACCURACY: The numbers provided are correct, and the calculation is accurate. The format variation ($1.0 billion vs $1,003 million) is acceptable. QUALITATIVE ACCURACY: The reasoning about tightened collateral requirements and improved netting practices is sound and semantically equivalent to the ground truth's interpretation. However, the omission of the intermediate year weakens the completeness of the multi-hop synthesis. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about the trend and what it suggests about derivative exposure management, though the incomplete year-by-year breakdown reduces the depth of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 478,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "AVGO’s Security Insights Platform has been presented in the same way in 2022 and 2024—as a mainframe‑security tool that rapidly interprets posture, flags risks, and produces remediation steps.  Both filings note that the platform’s data feeds into in‑house SIEM tools, underscoring its role in continuous remediation and the company’s overall cyber‑defense strategy.  In short, the core integration, remediation focus and strategic positioning remained essentially unchanged, with the 2024 filing simply reaffirming the platform’s place in the enterprise‑wide security portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding the evolution of AVGO's Security Insights Platform from 2022 to 2024. CRITICAL ISSUES: (1) The LLM claims the platform was 'presented in the same way in 2022 and 2024' and that 'core integration, remediation focus and strategic positioning remained essentially unchanged.' This directly contradicts the ground truth, which explicitly documents a clear evolution showing the platform shifted from a 'standalone risk assessment tool toward a more integrated and strategically aligned component.' (2) The LLM completely omits the 2023 positioning, which is a key part of the multi-hop synthesis required by the question. The ground truth shows 2023 as a transition year where the platform became 'more explicitly tied to AVGO's broader cybersecurity portfolio.' (3) The LLM fails to capture the 2024 contextualization within an 'expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps,' which represents a material strategic shift in how the platform was positioned. (4) The LLM's conclusion that the platform was 'simply reaffirming' its place is factually incorrect—the ground truth shows a deliberate evolution toward broader enterprise-wide security planning and regulatory compliance integration. CORRECT ELEMENTS: The LLM accurately identifies that the platform interprets mainframe security posture, identifies risks, develops remediation steps, and integrates with SIEM tools. These core functional descriptions are accurate across years. MULTI-HOP REASONING: The LLM failed to synthesize the three-year evolution properly, treating 2022 and 2024 as static rather than identifying the progression through 2023 and the strategic repositioning. The question explicitly asks about evolution 'from 2022 to 2024,' requiring temporal analysis across multiple years, which the LLM largely ignored. SEMANTIC ISSUE: The LLM's fundamental claim that positioning 'remained essentially unchanged' is semantically opposite to the ground truth's narrative of evolution and strategic alignment shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 558,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 32B has remained unchanged: the face amount is $750,000 and the interest rate is 3.38 % (maturity June 15, 2027) in each filing (2022 p. 48‑52, 2023 p. 48‑52, 2024 p. 49‑53).  The unchanged terms show SPG’s preference for a stable, low‑cost long‑term debt structure, minimizing refinancing risk and keeping debt‑service obligations predictable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - QUANTITATIVE ACCURACY FAILURE: The LLM answer contains a major factual error in the face amount. The LLM states the face amount is $750,000 (seven hundred fifty thousand dollars), when the ground truth clearly indicates it is $750,000,000 (seven hundred fifty million dollars). This is a 1,000x magnitude error - a difference of $749.25 million. This is not a formatting variation but a fundamental misstatement of the debt amount. The interest rate (3.38%), maturity date (June 15, 2027), and the observation that terms remained unchanged across 2022-2024 are all correct. The reasoning about stable debt strategy and predictable debt-service obligations is sound and semantically equivalent to the ground truth. However, the massive error in the principal amount is a critical failure that undermines the entire answer's credibility. The LLM correctly identified that the terms were unchanged across all three years and provided reasonable strategic interpretation, but the quantitative error is severe enough to warrant a low score. The page references provided (2022 p. 48-52, 2023 p. 48-52, 2024 p. 49-53) appear plausible but cannot verify the source of the $750,000 error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 338,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024, CMCSA’s 10‑K filings consistently note that Lumen is **continuing to expand its fiber‑based wireline network**—“building and are continuing to build fiber‑based wireline network infrastructure further into their networks” and offering “services with these higher speeds in many of our service areas”【CMCSA_10k_2024.pdf, Competition, p. 6】【CMCSA_10k_2022.pdf, Competition, p. 7】.  The reports also highlight that Lumen, like other DSL providers, has introduced **bundled services (e.g., fiber‑plus‑voice/wireless) to compete with CMCSA’s bundled broadband offerings**【CMCSA_10k_2024.pdf, Competition, p. 6】【CMCSA_10k_2022.pdf, Competition, p. 7】, prompting CMCSA to broaden its own fiber‑to‑the‑premises rollout and bundle broadband with voice and wireless.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the competitive threat from Lumen to CMCSA across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core competitive strategies: fiber network expansion and bundled service offerings (fiber-plus-voice/wireless); (2) Accurately cites specific language from 10-K filings about Lumen 'building and continuing to build fiber-based wireline network infrastructure'; (3) Properly synthesizes multi-hop information showing how Lumen's competitive moves prompted CMCSA's own strategic responses (fiber-to-the-premises rollout, bundling); (4) Provides appropriate document citations with page numbers; (5) Covers the full 2022-2024 timeframe. WEAKNESSES: (1) The answer lacks explicit year-by-year progression detail that the ground truth emphasizes—specifically that competitive pressure 'escalated' or 'intensified' from 2022 to 2024. The LLM states the trend 'persisted' but doesn't clearly articulate whether the threat evolved/intensified; (2) Missing explicit acknowledgment that Lumen was 'explicitly called out' in 2023 as a distinct escalation point; (3) The answer doesn't clearly distinguish between 2022, 2023, and 2024 competitive dynamics—it presents them more as a continuous state rather than showing evolution; (4) Doesn't explicitly state that Lumen remained among 'top-tier' competitors in 2024. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The citations appear reasonable but cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information about Lumen's strategies and CMCSA's responses, showing understanding of the competitive dynamic. However, it could better demonstrate the temporal evolution aspect of the question. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—Lumen posed a consistent and evolving competitive threat through fiber expansion and bundling—but the 'evolution' aspect could be more explicitly demonstrated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 554,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s RedCard penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (2022 10‑K p. 44; 2023 10‑K p. 27; 2024 10‑K p. 28). This downward trend indicates that the loyalty‑driven payment strategy is losing traction, with card usage declining year‑over‑year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the downward trend in Target's RedCard penetration and provides appropriate reasoning about the weakening loyalty strategy. However, there is a critical quantitative error: the 2024 penetration rate is stated as 18.6% in the LLM answer, while the ground truth specifies 17.8% in 2024. This is a material discrepancy of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The LLM correctly identifies the metric as RedCard penetration and properly cites page references to the 10-K filings. The reasoning about the downward trend indicating weakening effectiveness of the loyalty-driven payment strategy is sound and semantically equivalent to the ground truth. The multi-hop synthesis across three years of data is properly executed. The main weakness is the incorrect 2024 figure, which undermines the quantitative accuracy despite the correct overall narrative and reasoning. The answer addresses all parts of the question (evolution from 2022-2024 and implications for strategy effectiveness), but the factual error on the final year's data point is significant enough to warrant a lower correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 331,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "From 2022 through 2024 Chevron’s presence in the Republic of Congo was confined to a 31.5 % non‑operated working interest in the offshore Haute Mer permit area and a 15.75 % interest in the Republic of Congo portion of Lianzi, with no material capital‑expenditure reported in the region (2022 p. 31‑35; 2024 p. 41‑45). In 2024 the company announced that it would sell both interests in January 2025, effectively divesting from the Republic of Congo and signaling a strategic shift away from the country (2024 p. 41‑45; 2023 p. 107‑111).",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the specific asset interests (31.5% in Haute Mer, 15.75% in Lianzi) and the 2024 divestiture announcement. The percentages and asset names are accurate. The LLM correctly notes the strategic shift away from the country. CRITICAL WEAKNESSES: (1) The LLM fundamentally misrepresents the evolution of engagement by claiming 'no material capital-expenditure reported in the region' throughout 2022-2024, which directly contradicts the ground truth stating Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa including the Republic of Congo in 2023. This is a major omission that undermines the core narrative of the question about how engagement 'evolved.' (2) The LLM fails to capture the 2022 baseline showing the Republic of Congo was listed among Chevron's key operational countries, missing the starting point of the evolution. (3) The LLM presents a static picture of asset holdings rather than showing the dynamic evolution from 2022 (active investment) through 2023 (continued capital commitment) to 2024 (divestiture). (4) The answer lacks the temporal progression that the question specifically asks about - it jumps to 2024 divestiture without adequately explaining the 2022-2023 investment phase. MULTI-HOP REASONING: The LLM failed to synthesize information across the three-year period to show the evolution. It correctly identified the endpoint (2024 divestiture) but missed the journey (2022 presence, 2023 investment, 2024 exit). The answer reads as a snapshot rather than an evolution narrative. QUANTITATIVE ACCURACY: The specific percentages and asset names are correct, but the omission of the $0.7 billion investment figure is a significant quantitative gap. The LLM's claim of 'no material capital-expenditure' is factually incorrect based on the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 507,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra’s gas‑option exposure fell sharply from 2022 to 2023, with fair‑value assets and liabilities dropping from $356 m/$347 m to $100 m/$97 m, and then remained roughly flat in 2024 at $100 m/$102 m.  The implied volatilities on the liability side fell dramatically—from 295 % in 2022 to 233 % in 2023 and to 150 % in 2024—while the asset‑side volatilities stayed low (17–20 % to 15 %).  This contraction in both position size and perceived volatility indicates that NextEra has pared back its hedging in gas markets and is now operating in a lower‑volatility environment, thereby reducing its overall risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains severe quantitative errors that fundamentally undermine its credibility. (1) IMPLIED VOLATILITY NUMBERS ARE COMPLETELY WRONG: Ground truth shows implied volatilities of 36% (2022), 50% (2023), and 52% (2024). The LLM reports 295% (2022), 233% (2023), and 150% (2024) for liabilities, and 17-20% to 15% for assets. These numbers are off by an order of magnitude and do not match the ground truth at all. The claim that 'volatilities fell dramatically' is contradicted by the ground truth showing volatilities INCREASED from 36% to 50% from 2022-2023, then slightly increased again to 52% in 2024. (2) FAIR VALUE NUMBERS ARE CORRECT: The LLM correctly identifies the fair values ($356M/$347M in 2022, $100M/$97M in 2023, $100M/$102M in 2024). (3) DIRECTIONAL ANALYSIS IS INVERTED: The LLM claims volatility 'fell dramatically' when ground truth shows it increased. The LLM's conclusion about 'lower-volatility environment' directly contradicts the ground truth showing increasing volatility expectations. (4) MISSING KEY INSIGHT: The ground truth emphasizes that the sharp reduction in exposure (2022-2023) followed by stabilization, combined with INCREASING volatility expectations, suggests 'strategic de-risking in gas options with a cautious outlook on price variability.' The LLM misses this crucial insight entirely. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution across three years, the fundamental misreporting of volatility numbers and the inverted directional analysis represent a failure in accurate data synthesis. The reasoning about 'lower-volatility environment' is logically sound IF the numbers were correct, but they are not. This is a case where the model appears to have hallucinated or severely misread the volatility data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 499,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike has consistently listed FlyEase alongside its other performance technologies in the product‑research and development section of its 10‑K filings from 2022 through 2024, with no change in emphasis or separate spotlight. In 2022, FlyEase appeared in the sentence “The proliferation of Nike Air, Zoom, Nike Free, Flywire, Dri‑Fit, Flyknit, **FlyEase**, ZoomX, Air Max, Nike React and Nike Adapt technologies, among others, typifies our dedication to designing innovative products”【2022 10‑K page 6】; the same wording appears in the 2023 and 2024 filings【2023 10‑K page 6】【2024 10‑K page 6】. This steady inclusion indicates that FlyEase remains an ongoing, incremental element of Nike’s broader innovation strategy rather than a headline breakthrough or standalone focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer directly contradicts the ground truth on the fundamental question about FlyEase's evolution. The ground truth establishes a clear progression: (1) 2022 - introduced as part of broader portfolio, (2) 2023 - expanded presence with emphasis on integration into various categories, (3) 2024 - fully embedded as core technology. The LLM answer claims there was 'no change in emphasis' and that FlyEase 'remains an ongoing, incremental element' with 'steady inclusion' across all three years. This is factually incorrect according to the knowledge graph. The LLM correctly identifies that FlyEase appears in the same sentence listing multiple technologies across 2022-2024 (quantitative accuracy is good - the citations and text quotes appear accurate), but MISINTERPRETS what this means. The ground truth indicates that while the listing may appear similar textually, the CONTEXT and EMPHASIS evolved significantly - from initial introduction to expanded integration to full embedding as a core technology. The LLM's conclusion that there was 'no change in emphasis' directly contradicts the ground truth's explicit statement about progression from 'newly introduced concept to foundational element.' The LLM failed to synthesize the multi-hop information about how Nike's treatment evolved across the three-year period. The answer demonstrates a fundamental misunderstanding of the question's intent - it focuses narrowly on identical wording in filings rather than understanding the broader strategic evolution indicated by the knowledge graph. This is a major failure in multi-hop reasoning and semantic understanding of Nike's innovation strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 465,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 35A has remained unchanged: a $750,000 face amount, 2.65 % interest, $19,875 annual debt service, and a maturity of July 15 , 2030.  The unchanged terms show that Simon Property Group is keeping this long‑term, low‑rate obligation stable, reflecting a debt strategy that prioritizes predictable cash flows and low‑cost financing over frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numerical values are correct - $750,000 face amount, 2.65% interest rate, $19,875 annual debt service, and July 15, 2030 maturity date all match the ground truth exactly. The date format variation (07/15/30 vs July 15, 2030) is acceptable and represents the same information. COMPLETENESS: The answer addresses all key aspects of the question: (1) the evolution/consistency of the notes from 2022-2024, (2) specific financial terms, and (3) strategic implications. ENTITY ACCURACY: SPG (Simon Property Group) is correctly identified, the debt instrument name is accurate, and the time period (2022-2024) is properly covered. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that the consistency across three years reveals a stable debt strategy. The interpretation that this reflects a preference for 'predictable cash flows and low-cost financing over frequent refinancing' is a logical inference from the unchanged terms and is semantically equivalent to the ground truth's statement about 'steady approach' and 'avoiding refinancing or restructuring.' MINOR OBSERVATION: The LLM answer is slightly more concise than the ground truth but captures all essential information. The strategic interpretation is appropriate and well-reasoned. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 386,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Texas Instruments consistently highlighted its strategic focus on analog and embedded‑processing products across 2022, 2023, and 2024, with embedded‑processing revenue growing modestly each year while remaining a core part of its portfolio (TXN_10k_2022.pdf: 18–22; TXN_10k_2023.pdf: 16–20; TXN_10k_2024.pdf: 16–20). This steady positioning underscores TI’s long‑term growth strategy of maximizing free cash flow per share by leveraging its embedded‑processing business as a key driver of cash generation and shareholder returns (TXN_10k_2023.pdf: 18; TXN_10k_2024.pdf: 18). The company’s MD&A repeatedly links its embedded‑processing focus to strong cash flow from operations, reinforcing the view that this segment is central to sustaining free cash flow per share growth (TXN_10k_2023.pdf: 18; TXN_10k_2024.pdf: 18).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative that TI consistently emphasized embedded processing products across 2022-2024 as central to its business model and long-term strategy. It accurately captures the semantic meaning that this positioning supports free cash flow per share growth. The answer appropriately synthesizes information across multiple years and links embedded processing to cash generation and shareholder returns. Entity identification (Texas Instruments, embedded processing, free cash flow per share) is correct.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUES: The LLM claims 'embedded-processing revenue growing modestly each year' but provides NO actual revenue figures, growth percentages, or dollar amounts to support this claim. The ground truth does not mention specific revenue growth numbers either, but the LLM's assertion about 'modest growth' is unsupported by cited data. (2) PAGE REFERENCE PROBLEMS: The LLM cites specific page ranges (e.g., 'TXN_10k_2022.pdf: 18–22') but these appear to be generic placeholders rather than verified citations. The ground truth does not provide specific page numbers, making it impossible to verify if these citations are accurate. (3) INCOMPLETE SYNTHESIS: While the LLM mentions the connection to cash flow from operations, it does not fully elaborate on the 'four competitive advantages' framework that the ground truth emphasizes as part of TI's 2022 positioning. (4) MISSING DETAIL: The ground truth emphasizes that embedded processing is 'stable, high-margin, and scalable' - the LLM does not explicitly characterize these attributes. (5) VAGUE SOURCING: The repeated citations to pages 18 in both 2023 and 2024 filings seem suspiciously identical and may indicate generic citation rather than actual document verification.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year evolution and links it to the long-term strategy, demonstrating sound multi-hop reasoning. However, the lack of specific quantitative support weakens the overall credibility of the synthesis.\n\nSCORING JUSTIFICATION: Correctness score of 6 reflects that while the core narrative and strategic positioning are correct, the answer lacks quantitative rigor and specific supporting evidence. The unsupported claim about 'modest growth' and generic-appearing citations reduce confidence in the answer's factual grounding. Qualitative accuracy is higher (7) because the reasoning about strategic emphasis and its connection to FCF per share is sound, but quantitative accuracy is lower (4) due to missing numbers and unverified citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 692,
        "total_tokens": 2175
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "Disney’s 2022 10‑K lists Marvel as an indefinite‑lived intangible asset worth $1.792 million, reflecting its status as a balance‑sheet asset (DIS_10k_2022, p.112). By 2023 the company elevated Marvel to a top‑level tile on Disney+, making it a primary visual anchor for subscribers (DIS_10k_2023, p.5‑6). In 2024 Marvel remained an indefinite‑lived intangible asset of $1.792 million, underscoring its continued financial value while the brand is leveraged to drive Disney+ subscriber growth (DIS_10k_2024, p.115‑116).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a specific dollar amount of $1.792 million for Marvel's intangible asset value in both 2022 and 2024. This is factually incorrect and highly implausible. Marvel is one of Disney's most valuable intangible assets (alongside ESPN and Pixar), worth billions of dollars, not $1.792 million. This represents a fundamental factual error that undermines the entire answer. The ground truth does not specify exact dollar amounts but correctly identifies Marvel as an indefinite-lived intangible asset without quantifying it at such a trivial level. (2) INCOMPLETENESS - The LLM answer is significantly shorter and omits critical information from the ground truth: (a) No mention of the 2023 strategic shift from passive asset recognition to active brand utilization; (b) Missing the broader strategic context about ESPN+ tile launch in early fiscal 2025; (c) No reference to Disney+ subscriber base of 123 million as of September 28, 2024, which contextualizes the financial strategy; (d) Lacks the analytical framework connecting the 3-year progression to financial strategy and subscriber growth. (3) MULTI-HOP REASONING - While the LLM identifies the basic timeline (2022→2023→2024), it fails to synthesize the strategic evolution. The ground truth explains HOW the evolution indicates financial strategy (shift from passive to active utilization), while the LLM merely states facts without connecting them to the strategic pivot or its implications for subscriber growth. (4) SEMANTIC ISSUES - The LLM's statement that Marvel 'remained an indefinite-lived intangible asset of $1.792 million' in 2024 is not semantically equivalent to the ground truth's explanation of continued brand equity recognition and active strategic utilization. The answer reduces a complex strategic evolution to static balance sheet entries. (5) CONTEXTUAL GAPS - The answer fails to address how this evolution 'indicates' Disney's financial strategy in driving subscriber growth, which is a core part of the question. The ground truth explicitly connects the progression to subscriber retention and growth justification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 580,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife continued to reinsure the same portion of its closed block each year – 59 % of the block was covered by the modified‑coinsurance agreement in 2022, 2023 and 2024.  The reinsurance recoverable balances tied to that agreement grew markedly, rising from $6.1 billion of net ceded recoverables at year‑end 2022 to $16.7 billion in 2023 and $17.6 billion in 2024, reflecting the expanding scope of the arrangement.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth across multiple dimensions: (1) PERCENTAGE ACCURACY: The LLM claims 59% reinsurance in all three years (2022-2024), but ground truth shows 59.25% in 2022, declining to 59% in 2023-2024. While the difference is small, the LLM incorrectly states the 2022 figure and misses the evolution described in the question. (2) REINSURANCE RECOVERABLE BALANCES - CRITICAL ERROR: The LLM provides completely different numbers: $6.1B (2022), $16.7B (2023), $17.6B (2024). Ground truth shows: $3.6B (2022), $4.4B (2023), $4.2B (2024). These are not minor discrepancies - the LLM numbers are roughly 1.7-4.2x larger than actual values. This is a fundamental factual error. (3) METRIC CONFUSION: The LLM references 'net ceded recoverables' while ground truth specifies 'unsecured reinsurance recoverable balances.' These may be different metrics, and the LLM appears to have cited wrong data. (4) NARRATIVE ACCURACY: The LLM's conclusion about 'expanding scope' contradicts ground truth's characterization of 'relatively stable strategic use with minor fluctuations.' The ground truth shows balances peaked in 2023 then declined slightly in 2024, not a continuous expansion. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution across the three-year period. The question specifically asks about evolution from 2022-2024, and the LLM misses the key insight that percentages remained relatively stable while balances fluctuated. The answer demonstrates either data retrieval errors or confusion between different financial metrics in MetLife's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 453,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "From 2022 to 2024 CVS’s residential mortgage‑backed securities grew modestly—from $845 m amortized cost ($757 m fair value) in 2022 to $862 m ($810 m) in 2023 and $870 m ($875 m) in 2024—while the credit quality rating slipped from AAA to AA and the weighted‑average duration rose from 4.7 to about 5.9 years. This shift shows a slight increase in interest‑rate sensitivity but still very low credit‑risk exposure, reflecting CVS’s strategy of expanding a high‑quality, agency‑guaranteed RMBS portfolio to generate stable income for its experience‑rated products.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key metrics. QUANTITATIVE ERRORS: (1) The LLM reports RMBS values of $845M (2022), $862M (2023), and $870M (2024), while ground truth shows $629M, $614M, and $71M respectively—these are completely different numbers with no overlap. (2) The LLM claims a modest growth trend, but ground truth shows a sharp decline in 2024 (from $614M to $71M, a 88% drop). (3) The LLM provides fair values ($757M, $810M, $875M) and duration metrics (4.7 to 5.9 years) that are not mentioned in the ground truth and appear to be fabricated. (4) The LLM mentions credit rating changes (AAA to AA) not present in ground truth. MULTI-HOP REASONING FAILURE: The LLM completely misses the critical 2024 pivot point—the ground truth explicitly identifies a 'strategic pivot away from RMBS in 2024' and 'deliberate de-risking,' while the LLM incorrectly characterizes the trend as 'modest growth' and 'expanding' the portfolio. ENTITY/METRIC ACCURACY: The LLM correctly identifies CVS and RMBS but provides entirely wrong financial data. The unrealized losses ($10M in 2022, $60M in 2023) mentioned in ground truth are completely absent from LLM answer. SEMANTIC CONTRADICTION: The LLM's conclusion about 'expanding a high-quality, agency-guaranteed RMBS portfolio' directly contradicts the ground truth's finding of a sharp reduction and de-risking strategy in 2024. This appears to be a case of hallucinated financial data rather than a misinterpretation of correct data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 421,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block was reduced slightly: it covered 59.25 % of the block in 2022 and 59 % in 2024.  The deposit‑method accounting remained unchanged throughout, with the modified‑coinsurance deposit liability offset against the deposit recoverable.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts but has a notable omission. CORRECT ELEMENTS: (1) The percentages are accurate - 59.25% in 2022 and 59% in 2024 are correctly stated. (2) The accounting treatment under the deposit method is correctly identified as unchanged. (3) The offset mechanism between modified coinsurance deposit liability and deposit recoverable is accurately described. (4) The characterization of the arrangement as 'stable' is appropriate given the minimal change from 59.25% to 59%. QUANTITATIVE ACCURACY: All numbers are correct (59.25% for 2022, 59% for 2024). The slight reduction is accurately characterized. CRITICAL OMISSION: The LLM answer fails to mention 2023 data, which the ground truth explicitly includes (59% in 2023). The question asks about evolution 'from 2022 to 2024,' which reasonably implies coverage of the intermediate year. The ground truth specifically notes that 2023 and 2024 both reported 59%, which is important context for understanding the evolution pattern. QUALITATIVE ASSESSMENT: The multi-hop reasoning is sound - the answer correctly synthesizes the percentage changes with the accounting treatment consistency. However, the incomplete temporal coverage (missing 2023) represents a gap in addressing the full scope of the question's timeframe. The answer is concise and clear but sacrifices completeness. SEMANTIC EQUIVALENCE: The phrase 'reduced slightly' appropriately captures the minimal change from 59.25% to 59%, and the description of accounting treatment matches the ground truth's meaning. The answer correctly identifies this as a 'stable' approach despite the minor percentage adjustment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 457,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net fair‑value exposure to forward gas contracts rose from roughly **$160 million in 2022** (assets $191 m – liabilities $31 m) to **$300 million in 2023** (assets $377 m – liabilities $77 m) and then fell to **$250 million in 2024** (assets $296 m – liabilities $46 m). This swing—an increase in 2023 followed by a reduction in 2024—indicates the company tightened its hedging position after a period of heightened exposure, suggesting a shift toward a more balanced or lower‑risk natural‑gas price profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - 2022: $160M net ($191M assets - $31M liabilities), 2023: $300M net ($377M assets - $77M liabilities), 2024: $250M net ($296M assets - $46M liabilities). All calculations are accurate and properly verified. (2) COMPLETENESS: The answer addresses all required components - the evolution across all three years (2022-2024), specific asset/liability breakdowns, and interpretation of the trend. (3) ENTITY ACCURACY: NextEra Energy correctly identified, all years properly referenced, forward gas contracts metric correctly specified. (4) MULTI-HOP REASONING: The answer successfully synthesizes data across three years and correctly interprets the trend pattern (increase 2022→2023, decrease 2023→2024) to draw a logical conclusion about risk positioning. The interpretation that the 2024 reduction represents 'tightening' or 'rebalancing' after heightened 2023 exposure is sound and semantically equivalent to the ground truth's 'more cautious stance or rebalancing.' (5) MINOR DIFFERENCES: The LLM uses slightly different phrasing ('tightened its hedging position' vs 'reduction in net exposure') and adds interpretive language ('shift toward a more balanced or lower-risk natural-gas price profile'), but these are semantically equivalent and represent reasonable analytical conclusions from the data. The phrase 'fair-value exposure' is an appropriate technical specification. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 424,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In 2022 AVGO’s fiber‑optic offerings were framed mainly as networking and storage components (“Fiber Optic Components: We supply a wide array of optical components to the Ethernet networking, storage, and access, metro‑ and long‑haul telecommunication markets”). By 2023 the company broadened its industrial portfolio, explicitly positioning industrial fiber optics alongside motion encoders and Ethernet ICs to serve a wide range of automation, power, medical, defense and automotive applications (“Industrial End Markets: We also provide a broad variety of products for the general industrial and automotive markets, including optocouplers, industrial fiber optics, motion encoders, light emitting diode devices, and Ethernet ICs”). In 2024 this positioning was reinforced, emphasizing tighter integration of industrial fiber optics with adjacent motion‑encoder and Ethernet‑IC technologies as part of a cohesive industrial solutions suite that spans industrial automation, power generation and distribution, medical systems, defense/aerospace, and vehicle subsystems such as electric‑vehicle powertrains and advanced driver‑assist systems.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with accurate temporal progression; (2) Accurately captures the 2022 positioning focused on networking/storage/telecom applications; (3) Correctly identifies the 2023 shift to explicit industrial positioning with motion encoders and Ethernet ICs alongside fiber optics; (4) Accurately describes 2024 positioning with tighter integration of fiber optics with motion encoders and Ethernet ICs; (5) Properly synthesizes the multi-hop information showing evolution across years and product categories; (6) Includes relevant application domains (automation, power, medical, defense, automotive, EV powertrains, ADAS); (7) Uses direct quotes from filings, enhancing credibility. MINOR WEAKNESSES: (1) The LLM answer emphasizes the 2022 positioning as primarily 'networking and storage' components, which is technically accurate but slightly de-emphasizes that Industrial Fiber Optics was already listed in 2022 alongside industrial components (optocouplers, motion encoders, LED devices, Ethernet ICs). The ground truth notes these were listed together in 2022, while the LLM suggests the industrial positioning was more of a 2023 development. This is a subtle distinction but represents a minor temporal misplacement of when the industrial portfolio integration began; (2) The LLM could have been more explicit about the 2022 applications (industrial automation, medical systems, defense, EV subsystems) which were already present; (3) The characterization of 2024 as 'reinforced' positioning is accurate but could emphasize more strongly the shift toward 'networked and vision-based industrial systems' as noted in ground truth. QUANTITATIVE ACCURACY: No numerical errors detected; all dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across three years and multiple product categories (fiber optics, encoders, Ethernet ICs, microcontrollers, PHYs, switches, camera microcontrollers). The logical progression from standalone components to integrated systems is sound. SEMANTIC EQUIVALENCE: The core message matches ground truth - AVGO evolved from telecom/networking focus to integrated industrial solutions with fiber optics as a central component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 628,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s redeemable preferred stock remained unchanged: the cumulative dividend obligation stayed at $0.10 per share payable each May 31, and the stock was fully issued to Sojitz America with no additional preferred shares or changes to the redemption terms. Consequently, Nike’s cash outflow for preferred dividends was constant and the preferred‑stock structure remained stable, allowing no common‑stock dividends until the preferred dividends were fully paid.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts about Nike's redeemable preferred stock relationship with Sojitz America: (1) structural stability from FY 2022-2024 with no changes, (2) consistent dividend obligation of $0.10 per share, (3) full issuance to Sojitz America with no additional shares, (4) stable cash outflow for preferred dividends, and (5) the priority of preferred dividends over common stock dividends. The quantitative data is accurate - the $0.10 per share annual dividend and the stable structure are correctly stated. The answer appropriately synthesizes the multi-hop information about the financial relationship across the three-year period. However, there are minor gaps in completeness: (1) The original answer explicitly mentions the total par value of $0.3 million, which the LLM answer omits - this is a specific quantitative detail that adds important context about the scale of the relationship. (2) The original answer emphasizes that Sojitz America 'has not sought redemption of the stock despite having the option to do so,' which provides important context about the stability and voluntary nature of the relationship - the LLM mentions 'no changes to the redemption terms' but doesn't highlight the non-redemption aspect. (3) The LLM specifies the dividend payment date as 'May 31,' which is a helpful detail not explicitly in the ground truth but appears consistent with typical preferred stock terms. The reasoning is sound and the multi-hop synthesis across years is correct. The answer demonstrates good understanding of the financial relationship's stability and the priority structure of dividends, though it could have been more complete by including the par value figure and emphasizing the voluntary non-redemption aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 481,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 31B remained unchanged: a $750,000 face amount, 3.25 % interest, maturing 11/30/26, with an annual debt service of $24,375. The unchanged terms across the three filings indicate SPG’s long‑term financing strategy for this instrument is to preserve a stable, low‑cost, long‑maturity debt position rather than refinance or modify it.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) All key numeric values are accurate: $750,000 face amount, 3.25% interest rate, maturity date of 11/30/26 are all correct. (2) The calculated annual debt service of $24,375 is mathematically correct ($750,000 × 3.25% = $24,375). (3) The core finding that the obligation remained unchanged across 2022-2024 is accurate. (4) The interpretation of SPG's financing strategy—preserving a stable, low-cost position without refinancing—correctly captures the ground truth's conclusion. (5) Multi-hop synthesis is sound: the answer correctly identifies this specific instrument's stability within the broader context of SPG's debt portfolio changes. MINOR WEAKNESSES: (1) The LLM answer omits the broader context mentioned in the ground truth about other portfolio changes (retirement of certain notes, issuance of Unsecured Notes - 41A in 2024), which provides fuller context for understanding why this particular instrument's stability is noteworthy. However, this omission doesn't affect the core accuracy of the answer about the 31B notes themselves. (2) The phrasing 'low-cost, long-maturity debt position' is slightly interpretive—while accurate, the ground truth uses more neutral language about 'consistent long-term financing approach.' These are semantic variations rather than factual errors. CALCULATION VERIFICATION: $750,000 × 0.0325 = $24,375 ✓ ENTITY ACCURACY: Simon Property Group (SPG) correctly identified, Unsecured Notes - 31B correctly referenced, all years (2022-2024) properly addressed. The answer demonstrates solid multi-hop reasoning by synthesizing the instrument's characteristics with strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 465,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "TI’s U.S. defined‑contribution plans held $940 million of TI common stock in 2022, $873 million in 2023, and $852 million in 2024. The downward trend reflects a decline in the company’s share price and a reduction in shares held (from 6 million to 5 million), indicating that employees have been selling or not adding shares, consistent with cautious investment behavior amid market volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three dollar amounts ($940M in 2022, $873M in 2023, $852M in 2024) and accurately characterized the downward trend. The numbers are factually correct and properly formatted. WEAKNESSES: (1) The LLM introduced specific share count data (6 million to 5 million shares) that is not mentioned in the ground truth answer, which is problematic because it cannot be verified against the source material and may be fabricated. (2) The reasoning diverges significantly from the ground truth explanation. The ground truth emphasizes a freeze on new contributions since 2016 and strategic reduction in allocations, while the LLM focuses on share price decline and employee selling behavior. (3) The LLM's explanation about 'market volatility' and 'cautious investment behavior' is speculative and not grounded in the ground truth's more measured interpretation about contribution freezes and allocation strategies. (4) The ground truth explicitly mentions the freeze on new contributions since 2016 as a key factor, which the LLM completely omits. (5) The LLM's interpretation that the decline 'reflects a decline in the company's share price' is only partially correct—the ground truth indicates it could be due to strategic allocation changes, contribution freezes, or market valuation shifts, not necessarily share price decline alone. The answer is partially correct on the quantitative facts but fails to properly synthesize the qualitative interpretation and introduces unverified details about share counts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 425,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "Disney’s workforce grew steadily from 2022 to 2024: in 2022 the company had ~220,000 employees (166,000 U.S., 54,000 international, 7 % seasonal) (DIS_10k_2022.pdf pages 3‑7), and by 2024 it had ~233,000 employees (171,000 U.S., 62,000 international, 8 % seasonal) (DIS_10k_2024.pdf pages 14‑18). The 2023 10‑K (pages 14‑18) reported an intermediate size of ~226,000 employees, with ~168,000 U.S. and 58,000 international, and seasonal employees about 7.5 % (DIS_10k_2023.pdf pages 14‑18). Employee‑association representation remained largely unchanged, with many employees covered by collective‑bargaining agreements and some outside the U.S. represented by works councils, trade unions, or other associations (DIS_10k_2022.pdf pages 3‑7; DIS_10k_2024.pdf pages 14‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative data points match the ground truth: (1) 2022 baseline: 220,000 total (166,000 U.S., 54,000 international, 7% seasonal) - CORRECT; (2) 2024 endpoint: 233,000 total (171,000 U.S., 62,000 international, 8% seasonal) - CORRECT; (3) 2023 intermediate data: 226,000 total (168,000 U.S., 58,000 international, 7.5% seasonal) - CORRECT. The LLM went beyond the ground truth by providing 2023 intermediate data, which adds valuable context to the evolution narrative. Multi-hop reasoning is sound: the answer correctly synthesizes workforce composition data across three fiscal years and identifies the trend of increasing seasonal workforce percentage (7% to 8%). The answer properly addresses all sub-questions: total employees, U.S. vs. international distribution, and seasonal percentages. Employee association representation is accurately characterized as largely unchanged with collective bargaining agreements and works councils/trade unions outside the U.S. The citation format with specific page references adds credibility, though these cannot be independently verified. Minor deduction (1 point) only because the answer includes 2023 data not explicitly mentioned in the ground truth, though this is actually a strength rather than an error. The semantic equivalence is excellent - the answer conveys the same information as the ground truth with appropriate professional tone and clear presentation of the evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 417,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023 and 2024.  The wording in each filing—“ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance”—remains unchanged, indicating that GD deliberately removes accounting adjustments that could distort the metric.  This consistency underscores the company’s commitment to measuring core operating performance and capital efficiency with a stable, comparable metric that reflects only the economic returns generated by its invested capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) No quantitative errors—all dates and time periods are correct. (3) The LLM provides additional supporting detail by including the specific wording from filings ('ROIC excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance'), which strengthens the answer without contradicting the ground truth. (4) The reasoning is sound: the LLM correctly synthesizes that consistency across three years indicates a deliberate, stable approach to performance measurement. (5) The conclusion about measuring 'core operating performance and capital efficiency' aligns with the ground truth's emphasis on 'economic performance over accounting volatility.' Minor consideration: The LLM goes slightly beyond the ground truth by quoting specific filing language, but this is additive and enhances credibility rather than introducing error. The semantic meaning is fully preserved—both answers convey that GD maintained consistent exclusion methodology to reflect true economic performance. The multi-hop reasoning (comparing treatment across three years and drawing conclusions about company philosophy) is executed correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 394,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In 2022 Linde described rare gases simply as a co‑product of its atmospheric‑gas plants (see pages 94‑98). By 2024 it positioned rare gases as a strategic growth area, highlighting its non‑cryogenic air‑separation and proprietary VPSA/membrane technologies to boost production and distribution of krypton, neon and xenon (pages 5‑6). This shift underscores Linde’s deep technical expertise and integrated supply chain, giving it a competitive edge in high‑margin specialty‑gas markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Linde's rare gas strategy from 2022 to 2024 and correctly identifies the strategic shift toward non-cryogenic air separation technologies and VPSA/membrane innovations. The answer accurately names the specific rare gases (krypton, neon, xenon) and correctly characterizes the progression from treating rare gases as co-products to positioning them as a strategic growth area. The mention of competitive advantage through technical expertise and integrated supply chain aligns with the ground truth's emphasis on technological differentiation. However, there are some minor issues: (1) The LLM references specific page numbers (94-98, 5-6) which cannot be verified against the ground truth and may or may not be accurate; (2) The LLM characterizes rare gases as 'high-margin specialty-gas markets' while the ground truth emphasizes 'high-demand industrial applications'—these are related but slightly different framings; (3) The ground truth explicitly mentions the 2023 filing's reiteration of rare gases as a 'core atmospheric gas offering alongside oxygen, nitrogen, and argon,' which the LLM answer omits, though this is a minor gap; (4) The LLM's description of rare gases as 'co-products' in 2022 is semantically equivalent to the ground truth's positioning but uses slightly different language. The multi-hop reasoning is sound—the answer correctly synthesizes information across three years and identifies the strategic evolution. No quantitative errors are present (no calculations or specific numbers to verify). The answer is well-structured and directly addresses both parts of the question (evolution and competitive advantage implications).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 463,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "From 2022 to 2024, NextEra Energy Resources increased its coverage of net generating capacity under long‑term bilateral contracts from roughly 92 % in 2022 to 94 % in 2023 and kept that level in 2024. The steady rise and high contract‑coverage ratio show NEER’s deliberate use of long‑term contracts to lock in revenue and hedge against spot‑market price swings, reflecting a conservative risk‑management strategy in a volatile energy market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key quantitative data correct: 92% in 2022, 94% in 2023, and 94% in 2024. The multi-hop synthesis is sound, correctly identifying the trend (increase from 92% to 94%, then stability) and connecting it to NEER's risk management strategy. The answer appropriately characterizes the strategy as conservative and focused on revenue stability and hedging against spot-market volatility. However, there are minor omissions compared to the ground truth: (1) The LLM does not mention the use of non-qualifying hedges to protect expected revenues, which is a specific risk management tool mentioned in the original answer; (2) The phrase 'steady rise' is slightly imprecise—the increase occurred between 2022-2023, but 2023-2024 was stable, not a rise. The LLM uses 'steady rise and high contract-coverage ratio' which could be interpreted as describing the overall trend rather than year-by-year progression, creating minor ambiguity. The characterization of the strategy as 'conservative' is semantically equivalent to the ground truth's 'disciplined approach to managing market risk.' Overall, the answer captures the essential findings and reasoning but lacks one specific detail about hedging instruments and has slightly imprecise language regarding the trend trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 371,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125 % notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022, FY 2023, and FY 2024** (the same amount reported in the 2023 and 2024 10‑K debt schedules).  The balance remained unchanged over this period, indicating that the company has not accelerated repayment of this low‑rate instrument and is keeping it on the books through maturity as part of a strategy to preserve long‑term debt at a favorable fixed rate while maintaining liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: All factual information is correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024), and the stability of this amount across the period is correctly identified. (2) QUANTITATIVE ACCURACY: The dollar amount ($495 million) is precisely correct with no calculation errors. The fiscal years are correctly identified. Number formatting is appropriate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the model correctly synthesized information across three fiscal years and drew the appropriate conclusion about debt management strategy. The interpretation that the company maintained this debt at a favorable fixed rate through maturity is a reasonable inference from the stability of the balance. The answer correctly identifies that no refinancing or early retirement occurred. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question - it describes the evolution (unchanged), provides the specific amounts, and explains what this indicates about debt management strategy. The additional context about preserving long-term debt at favorable rates and maintaining liquidity adds valuable insight beyond the ground truth answer while remaining consistent with it. Minor note: The LLM answer provides slightly more interpretive detail about the company's strategy (preserving favorable rates, maintaining liquidity) compared to the ground truth's more neutral statement about 'consistent liability profile,' but this represents reasonable elaboration rather than factual error. The core facts are identical and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 458,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 37B remained unchanged: the face amount stayed at **$700,000** and the maturity date stayed at **January 15 2032** (interest rate 2.25% in all filings). This consistency shows the company’s preference for a stable, long‑dated debt structure, keeping long‑term financing predictable and avoiding frequent refinancing or new debt issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - face amount of $700,000 is accurate for both 2022-2024, and the maturity date of January 15, 2032 (01/15/32) is correctly stated. The interest rate of 2.25% is also accurate and adds helpful context not explicitly required but relevant. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) evolution from 2022-2024 (correctly shows consistency), (2) face amount details (correct), (3) maturity date details (correct), and (4) what this reveals about debt strategy (appropriately interpreted). ENTITY ACCURACY: SPG is correctly identified, the specific instrument 'Unsecured Notes - 37B' is correctly referenced, and all years (2022, 2023, 2024) are properly addressed. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified that the consistency across three years indicates a stable debt strategy without refinancing or retirement. The interpretation that this reflects a preference for 'stable, long-dated debt structure' and 'avoiding frequent refinancing' is a reasonable inference from the data. SEMANTIC EQUIVALENCE: The LLM's wording differs slightly from the ground truth (e.g., 'January 15 2032' vs '01/15/32') but conveys identical information. The LLM's interpretation about debt strategy is slightly more detailed than the ground truth but remains consistent with it. MINOR OBSERVATION: The LLM added the interest rate (2.25%) which was not in the ground truth answer but is factually accurate and enhances the response without introducing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 443,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility has remained an analog‑only site throughout 2022, 2023 and 2024, with no embedded‑processing activities reported in any of the three filings【TXN_10k_2022】【TXN_10k_2023】【TXN_10k_2024】. The facility continues to be part of TI’s global manufacturing and design network, but its product‑line focus has not shifted toward embedded processing over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes multi-hop information across three years of SEC filings. STRENGTHS: (1) Correctly identifies that Melaka, Malaysia remained an analog-only facility across 2022, 2023, and 2024 with no embedded processing activities - this matches the ground truth exactly. (2) Accurately captures the temporal consistency ('throughout 2022, 2023 and 2024') and the lack of product-line expansion over the three-year period. (3) Properly cites all three relevant 10-K filings (2022, 2023, 2024), demonstrating appropriate multi-hop synthesis across documents. (4) Uses semantically equivalent language to the ground truth ('analog-only site' vs 'exclusively under analog operations', 'no shift toward embedded processing' vs 'no expansion into embedded processing'). (5) Correctly identifies the facility's role as part of TI's global manufacturing and design network. MINOR CONSIDERATIONS: (1) The ground truth explicitly mentions 'checkmark' notation from the filings, which the LLM answer does not reference - however, this is a minor detail about source formatting rather than substantive factual content. (2) The LLM answer could have been slightly more explicit about the 'stable, specialized role' characterization, though the phrase 'product-line focus has not shifted' conveys the same meaning. QUANTITATIVE ACCURACY: No numerical data, percentages, or calculations are required for this question, so this dimension scores perfectly. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years and two product categories (analog vs. embedded processing), demonstrating sound multi-hop logic. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses all aspects of the question regarding operational footprint evolution, product line involvement, and temporal consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 510,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney’s post‑production services through Industrial Light & Magic continued to be reported within the unchanged “Content Sales/Licensing and Other” segment each year.  The segment’s structure and revenue mix—TV/SVOD, theatrical, home‑entertainment, music, stage‑play and post‑production—remained the same from fiscal 2022 through fiscal 2024, indicating ILM’s contribution stayed a small, aggregated portion of the segment’s total revenue (DIS_10k_2022.pdf: pages 11‑15; DIS_10k_2023.pdf: pages 5‑9; DIS_10k_2024.pdf: pages 5‑9).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth:\n\n1. STRUCTURAL CLAIM ERROR: The LLM states the segment was \"unchanged\" from fiscal 2022-2024, but the ground truth explicitly indicates structural evolution and shifting emphasis across these years. The ground truth describes a clear progression: fiscal 2022 had explicit ILM listing, fiscal 2023 showed emphasis shift toward TV/VOD and theatrical, and fiscal 2024 showed further alignment with DTC-first content model.\n\n2. NARRATIVE MISCHARACTERIZATION: The LLM claims the segment structure and revenue mix \"remained the same,\" which directly contradicts the ground truth's description of evolving structure and \"contextually shifting reliance.\" The ground truth emphasizes strategic repositioning and shifting narrative framing, not stasis.\n\n3. INCOMPLETE SYNTHESIS: The LLM fails to capture the multi-hop evolution across the three fiscal years. It presents a static view rather than tracking how ILM's role was framed differently in each year's reporting.\n\n4. MISSING CONTEXTUAL EVOLUTION: The ground truth highlights a key insight about ILM's role shifting from \"standalone service\" to being \"framed within the broader ecosystem of content delivery\" and alignment with \"DTC-first content model.\" The LLM completely misses this strategic repositioning narrative.\n\n5. CITATION ACCURACY: While the LLM provides specific page references, these appear to be used to support an incorrect interpretation of the data. The citations don't validate the claim of \"unchanged\" structure.\n\n6. QUANTITATIVE ISSUES: The LLM states ILM's contribution was \"a small, aggregated portion\" but provides no actual numbers, percentages, or revenue figures to support this claim, whereas the ground truth provides qualitative assessment of the evolution.\n\nThe LLM answer fundamentally misrepresents the nature of the question's answer by claiming stability where the ground truth describes evolution and strategic repositioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 549,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method income from operating (insurance‑underwriting) joint ventures fell from **$51 million in 2022 to $38 million in 2023** (see 2022 p. 174 and 2023 p. 248) before jumping to **$175 million in 2024** (2024 p. 224). This sharp rebound—more than triple the 2022 level—indicates that the company’s underwriting joint ventures recovered strongly in 2024 after a weaker year in 2023, suggesting markedly improved profitability or risk management in those ventures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that are dramatically different from the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 equity method income as $51 million when the correct figure is $1,305 million (off by 96%); 2023 as $38 million when correct is $151 million (off by 75%); 2024 as $175 million when correct is $988 million (off by 82%). These are not minor rounding differences but massive discrepancies in the core financial data. (2) CALCULATION/COMPARISON ERRORS: The LLM claims the 2024 figure is 'more than triple the 2022 level' ($175M vs $51M), but the actual 2024 figure ($988M) is less than the actual 2022 figure ($1,305M), making this comparison completely wrong. The LLM's narrative of 'strong recovery' and 'markedly improved profitability' is contradicted by the actual data showing 2024 at 76% of 2022 levels. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the three-year trend structure and attempts to synthesize the evolution, it fails at the fundamental level of retrieving accurate numbers from the source documents. The page citations provided ($51M from 2022 p. 174, etc.) appear to reference incorrect line items or misread data. (4) TREND INTERPRETATION: The LLM's interpretation of 'strong recovery' and 'markedly improved profitability' is logically inconsistent with even its own reported numbers, and completely contradicts the actual trend showing a significant decline from 2022 to 2023 with only partial recovery in 2024. The ground truth correctly identifies this as 'volatility' with 'partial recovery,' not strong recovery. The answer demonstrates a fundamental failure in financial data accuracy that undermines all subsequent analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 479,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics increased its annual production of Light Armored Vehicles (LAVs) for the Canadian Army from 360 units in 2022 to 399 in 2023 and 449 in 2024【GD_10k_2022】【GD_10k_2023】【GD_10k_2024】. This steady rise signals the LAV platform’s growing strategic importance, positioning it as a core export and modernization asset that drives growth within the company’s defense portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. (1) QUANTITATIVE VERIFICATION: All production numbers are correct - 360 units (2022), 399 units (2023), and 449 units (2024). The progression shows consistent year-over-year increases (39 units from 2022-2023, 50 units from 2023-2024), which the LLM correctly characterizes as a 'steady rise.' (2) ENTITY ACCURACY: General Dynamics, LAV platform, Canadian Army, and the three fiscal years (2022-2024) are all correctly identified. The citation format with GD_10k references appropriately indicates multi-hop synthesis across three annual filings. (3) MULTI-HOP REASONING: The LLM successfully synthesized production data across three years and correctly interpreted the trend as indicating strategic importance. The characterization of LAVs as 'core export and modernization asset' aligns with the ground truth's assessment of 'increasingly central to GD's defense offerings, particularly in international markets.' (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'steady rise signals the LAV platform's growing strategic importance' is semantically equivalent to the ground truth's 'consistent upward trend' and 'increasingly central.' The LLM adds slightly different emphasis ('core export and modernization asset') but maintains factual consistency with the ground truth's interpretation about strategic role in global demand. Minor difference: The ground truth explicitly mentions 'modern, versatile armored combat vehicles' while the LLM uses 'export and modernization asset,' but both convey the same strategic significance. No calculation errors detected. The answer is complete, accurate, and appropriately contextual.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 467,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan grew its hedge‑fund limited partnership exposure via HF LP Investments from **$225 million in 2022 to $252 million in 2023 and $280 million in 2024** (see the pension asset tables that exclude $225 m, $252 m, and $280 m of hedge‑fund LPs, respectively).  The target allocation for hedge funds rose from 3 % in 2023 to 4 % in 2024, indicating a deliberate shift toward greater alternative‑investment exposure to enhance returns and diversify risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility: (1) WRONG NUMBERS: The LLM states 2022=$225M, 2023=$252M, 2024=$280M, but ground truth shows 2022=$214M, 2023=$225M, 2024=$252M. Every single year's figure is incorrect - the LLM appears to have shifted the data forward by one year. (2) CALCULATION ERROR: The LLM's numbers don't match the progression it claims to describe. The ground truth shows a consistent pattern of increases ($214M→$225M→$252M), while the LLM's figures ($225M→$252M→$280M) are entirely different values. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend data from the source documents. It appears to have misread or misaligned the year labels with the corresponding values. (4) PARTIAL CREDIT FOR REASONING: The LLM correctly identifies the strategic implication (deliberate shift toward alternative investments) and mentions target allocation percentages (3% to 4%), which shows some understanding of the broader context. However, this qualitative reasoning cannot compensate for the fundamental quantitative errors. (5) CONTEXTUAL RELEVANCE: The answer does address the question's core components (three-year trend, pension fund strategy), but the wrong numbers make the analysis factually incorrect. The inclusion of target allocation percentages adds some value but is insufficient to offset the major numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 404,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Sorriso remained a principal global and regional trademark across 2022, 2023 and 2024, underscoring its continued integration within Colgate‑Palmolive’s Oral, Personal and Home Care portfolio (2022, pp. 75‑79; 2023, pp. 77‑81; 2024, pp. 77‑81).  The brand stayed part of the Oral Care segment, which accounted for roughly 43 % of worldwide net sales each year (2024, p. 78; 2023, p. 78; 2022, p. 78), and no significant repositioning or divestiture of Sorriso was disclosed during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Sorriso remained a principal trademark across 2022-2024 and was integrated within the Oral, Personal and Home Care portfolio, which aligns with the ground truth. The answer appropriately cites page numbers and confirms no significant repositioning or divestiture occurred. However, there are several areas where the answer diverges from or adds to the ground truth: (1) The LLM introduces specific quantitative data about Oral Care segment representing 'roughly 43% of worldwide net sales each year' - this metric is not mentioned in the original answer and cannot be verified against the ground truth provided. While this may be factually accurate from the filings, it represents additional information beyond what the ground truth establishes. (2) The LLM answer is more concise and data-focused than the ground truth, which provides more narrative context about Sorriso's 'regional market penetration and diversified consumer engagement' strategy. (3) The ground truth emphasizes the 'consistent strategic emphasis' and 'stable role as a regional brand asset,' while the LLM focuses more on the absence of change ('no significant repositioning'). These are semantically similar but frame the positioning differently. (4) The LLM correctly identifies the multi-year continuity but provides less qualitative analysis of what this continuity means strategically. The quantitative accuracy is strong (the 43% figure appears reasonable for an oral care segment), and the entity identification is correct (Colgate-Palmolive, Sorriso, Oral Care segment, years 2022-2024). The multi-hop reasoning is sound - the answer synthesizes information across three years and connects it to the broader portfolio strategy. The main weakness is that the answer adds specific metrics not in the ground truth while omitting some of the strategic narrative context provided in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 518,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s net investment income from operating joint ventures fell from **$51 million in 2022** to **$38 million in 2023** and then jumped to **$175 million in 2024**【MET_10k_2022.pdf:172‑176】【MET_10k_2023.pdf:245‑249】【MET_10k_2024.pdf:222‑226】. The sharp 2024 increase signals a deliberate shift to deepen its equity‑method exposure to operating joint ventures, underscoring the company’s strategy to diversify income sources and capture higher‑return opportunities within its equity portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all key metrics and draws the opposite conclusion from the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports $51M (2022), $38M (2023), $175M (2024), but ground truth shows $77M (2022), $51M (2023), $38M (2024). Every single year's figure is wrong - the 2022 figure is off by $26M, the 2023 figure is off by $13M, and the 2024 figure is dramatically wrong by $137M (off by 361%). The LLM appears to have shifted all values down by one year and invented a $175M figure for 2024 that contradicts the actual declining trend. (2) DIRECTIONAL CONTRADICTION: Ground truth shows a consistent 3-year downward trend ($77M → $51M → $38M), indicating strategic retreat from operating joint ventures. The LLM claims a 'sharp 2024 increase' to $175M, which is factually incorrect and contradicts the actual data showing continued decline to $38M. (3) STRATEGIC INTERPRETATION ERROR: Ground truth correctly identifies this as 'a strategic shift away from operating joint ventures.' The LLM incorrectly interprets the (fabricated) 2024 spike as 'a deliberate shift to deepen its equity-method exposure,' which is the opposite of what actually occurred. The company was consistently reducing, not deepening, its involvement. (4) METRIC CONFUSION: The LLM may have confused 'net investment income from operating joint ventures' with 'financial exposure to operating joint ventures' - these are different metrics, though the LLM's numbers don't match either metric correctly. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the 3-year trend across the three annual filings, instead producing internally inconsistent and factually wrong numbers. The citation references appear fabricated or misread. This answer would severely mislead investors about MetLife's actual strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 507,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s shareholding in Angola LNG Limited stayed unchanged at 36.4 % from 2022 to 2024, and its role remained that of a joint‑venture partner rather than operator【76‑80】【12‑16】.  In 2024, the company deepened its upstream‑gas integration when the Block 0 Sanha Lean Gas Connection Project was completed, adding a platform that ties new pipelines from Blocks 0 and 14 directly to the LNG plant and broadening the feed‑stock base for Angola LNG【12‑16】.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Chevron's 36.4% stake in Angola LNG Limited as remaining constant from 2022-2024. (2) The quantitative data about the stake percentage is accurate. (3) The mention of upstream integration through gas projects is directionally correct. CRITICAL WEAKNESSES: (1) The LLM fundamentally mischaracterizes Chevron's role evolution. The ground truth states Chevron moved from being a 'passive equity investor' in 2022 to having 'more operationally integrated' role by 2024, showing strategic evolution. The LLM claims the role 'remained that of a joint-venture partner rather than operator' - this contradicts the ground truth's narrative of increasing operational integration. (2) The LLM introduces the 'Block 0 Sanha Lean Gas Connection Project' as the key 2024 development, but the ground truth specifically highlights the 'New Gas Consortium Project (NGC)' with Chevron's 31% nonoperated working interest in the Quiluma and Maboqueiro fields as the primary upstream linkage. The LLM fails to mention NGC entirely. (3) The LLM references 'Blocks 0 and 14' but the ground truth specifies 'Quiluma and Maboqueiro fields' - these may be different designations, but the LLM's answer lacks the specific field names provided in ground truth. (4) MULTI-HOP REASONING FAILURE: The ground truth synthesizes three key elements across 2022-2024: (a) consistent 36.4% stake, (b) evolution from passive to integrated role, (c) specific upstream projects (NGC with 31% interest). The LLM captures only element (a) partially, misses element (b) entirely, and substitutes a different upstream project for element (c). (5) The LLM's characterization of Chevron as 'joint-venture partner rather than operator' is vague and doesn't capture the nuanced evolution described in ground truth. The ground truth's distinction between 'passive equity investor' (2022) and 'operationally integrated' (2024) is more precise and important to the answer. CALCULATION/VERIFICATION: The 36.4% figure is correct. The 31% NGC interest mentioned in ground truth is not mentioned in LLM answer. The answer is incomplete in synthesizing the multi-hop evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 587,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 3.625% notes due October 2024 were outstanding at $622 million in FY 2022 (see the 2022 debt schedule, pages 101‑105) and remained unchanged at $622 million in FY 2023 (debt schedule, pages 79‑83). By FY 2024 the notes had matured, leaving $0 of exposure (debt schedule, pages 79‑83). This steady decline to zero shows that the company kept the notes until maturity and then fully repaid them, underscoring a disciplined debt‑management approach that avoids refinancing risk and maintains a stable debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key financial figures ($622 million in 2022 and 2023, $0 in 2024), the correct debt instrument (3.625% notes due October 2024), and the correct company (AVGO). The progression timeline is accurate. The answer appropriately cites specific page references to debt schedules. WEAKNESSES: (1) The LLM's interpretation of the debt management strategy contains a significant logical error. The ground truth states the notes were 'likely through refinancing or cash repayment,' acknowledging uncertainty about the mechanism. However, the LLM claims the company 'kept the notes until maturity and then fully repaid them,' which is a more definitive statement than warranted. The fact that the notes disappeared from 2024 disclosures could indicate refinancing, early repayment, or maturity-based repayment—the LLM presents only one scenario as fact. (2) The LLM characterizes this as avoiding 'refinancing risk,' but if the company actually refinanced (which is plausible given the timing), this statement would be inaccurate. The ground truth's more cautious language ('likely through refinancing or cash repayment') is more appropriate given the available information. (3) The phrase 'steady decline to zero' is somewhat misleading—the amount remained flat at $622M for two years, then disappeared in year three. This is not a steady decline but rather a step-function change. QUANTITATIVE VERIFICATION: All numbers are correct ($622M in 2022-2023, $0 in 2024). The multi-hop synthesis across three fiscal years is sound. REASONING ISSUE: The main problem is overconfidence in characterizing the debt management strategy without sufficient evidence about whether the notes were refinanced or repaid at maturity. The ground truth appropriately hedges this uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 490,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "In each of the 2022, 2023, and 2024 10‑Ks, Unsecured Notes – 35B carried a 3.80 % rate on a $750,000 principal, producing an annual debt‑service (interest expense) of $28,500. The figure remained unchanged across the three years, indicating that the company’s financing cost for this note stayed flat—reflecting a fixed‑rate instrument with no principal repayment or refinancing during that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides additional valuable context beyond the ground truth. Verification of key facts: (1) Interest expense of $28,500 (in thousands) for all three years (2022, 2023, 2024) - CORRECT; (2) The LLM correctly identifies the 3.80% interest rate - this is accurate and adds specificity; (3) Principal amount of $750,000 - CORRECT; (4) Calculation verification: $750,000 × 3.80% = $28,500 - MATHEMATICALLY ACCURATE. The LLM answer goes beyond the ground truth by providing the interest rate and principal amount, which allows readers to verify the calculation themselves. The reasoning is sound: the flat interest expense across three years correctly indicates a fixed-rate instrument with no refinancing. The multi-hop synthesis is excellent - the answer connects the principal amount, interest rate, and resulting expense to explain the trend. The only minor distinction is that the ground truth simply states the numbers remained unchanged, while the LLM provides the underlying rate structure that explains why. This is an enhancement rather than an error. The answer directly addresses all parts of the question: how the expense evolved (remained constant), what this suggests (fixed-rate structure, no refinancing), and provides supporting evidence (rate and principal). No calculation errors, no factual inaccuracies, and the semantic meaning is fully aligned with the ground truth while providing superior context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 403,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024 Disney moved its DTC strategy from a broad re‑organization and cost‑realignment effort—introducing an ad‑supported Disney+ tier and new pricing to offset rising content costs—to a more focused, content‑curation‑driven approach that trimmed its library and recorded impairments as competition intensified. By 2024 the company had expanded its streaming portfolio (Disney+, ESPN+, Star India), tightened cost controls, and positioned itself against a crowded market, acknowledging that higher programming costs and intensified competition would require tighter pricing and more aggressive subscriber acquisition.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the general trajectory of Disney's DTC strategy evolution from 2022-2024, mentions key initiatives (ad-supported tier, pricing changes, content curation, library trimming), and acknowledges rising programming costs and intensified competition. The answer appropriately references multiple streaming services (Disney+, ESPN+, Star India) and captures the shift toward cost controls and subscriber acquisition focus. CRITICAL WEAKNESSES: (1) MISSING SPECIFIC FINANCIAL DATA: The ground truth provides concrete financial metrics ($12.25 billion in unused bank facilities in 2023) that the LLM answer completely omits. This is a significant quantitative accuracy failure. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly traces a 3-year progression with specific strategic shifts at each year (2022: cautious investment with uncertain returns; 2023: strategic investments with revenue offset expectations; 2024: aggressive push amid rising costs). The LLM answer conflates these into a more general narrative without clearly delineating the year-by-year evolution. (3) MISSING KEY STRATEGIC DETAILS: The ground truth mentions that programming distributors demanded terms reducing revenue or slowing growth, and that distribution deals now included DTC services alongside fewer linear networks. The LLM answer does not capture this important competitive dynamic. (4) VAGUE LANGUAGE: The LLM uses phrases like 'broad re-organization' and 'content-curation-driven approach' without the specificity found in the ground truth regarding DTC losses, negative returns, and uncertain business prospects in 2022. (5) IMPAIRMENT MENTION: While the LLM mentions 'recorded impairments,' the ground truth does not explicitly reference impairments, suggesting this may be an inference rather than documented fact. QUANTITATIVE ACCURACY ISSUE: The complete absence of the $12.25 billion figure and other specific financial metrics significantly impacts the quantitative accuracy score. REASONING: The multi-hop synthesis is partially sound but lacks the granular year-by-year progression and specific strategic inflection points that characterize the ground truth answer. The answer demonstrates understanding of the general direction but fails to capture the detailed evolution and supporting financial evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 627,
        "total_tokens": 2155
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "Reinsurance agreements that do not expose MetLife to a significant loss from insurance risk are recorded using the deposit method, and the balances under this method grew sharply after the 2023 Global Atlantic risk‑transfer: deposit assets rose from $1.8 billion in 2022 to $5.1 billion in 2023 and then fell to $4.6 billion in 2024, while deposit liabilities moved from $1.4 billion in 2022 to $1.3 billion in 2023 and $1.2 billion in 2024 (2022‑2024 10‑K). The 2023 transaction added $10.3 billion of deposit receivables (and $5.1 billion of deposit assets) and $1.3 billion of deposit liabilities, inflating the deposit‑method balances before a modest decline in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the deposit method accounting evolution and correctly identifies the major 2023 Global Atlantic transaction as a pivotal event. However, there is a critical quantitative discrepancy that prevents a higher score.\n\nKEY FINDINGS:\n\n1. QUANTITATIVE ACCURACY - DISCREPANCY IDENTIFIED:\n   - 2022 deposit assets: LLM states $1.8B (CORRECT, matches ground truth)\n   - 2022 deposit liabilities: LLM states $1.4B (CORRECT, matches ground truth)\n   - 2023 deposit assets: LLM states $5.1B (INCORRECT - ground truth shows this was the transaction amount added, not the year-end balance)\n   - 2023 deposit liabilities: LLM states $1.3B (CORRECT, matches ground truth)\n   - 2024 deposit assets: LLM states $4.6B (CORRECT, matches ground truth)\n   - 2024 deposit liabilities: LLM states $1.2B (CORRECT, matches ground truth)\n   - 2023 transaction deposit receivables: LLM states $10.3B (CORRECT, matches ground truth)\n   - 2023 transaction deposit assets added: LLM states $5.1B (This appears to be the 2023 year-end balance, not the transaction amount)\n\n2. CRITICAL ISSUE:\n   The ground truth indicates that in 2023, deposit assets rose to some level (not explicitly stated in ground truth but implied to be higher than $1.8B), and the transaction added $10.3B in reinsurance recoverables and deposit receivables. The LLM's statement that the transaction \"added $10.3 billion of deposit receivables (and $5.1 billion of deposit assets)\" conflates the year-end balance with the transaction amount, creating ambiguity about whether $5.1B was the transaction contribution or the year-end total.\n\n3. REASONING AND SYNTHESIS:\n   - The LLM correctly identifies the deposit method accounting framework\n   - Properly synthesizes the 2023 Global Atlantic transaction as the driver of change\n   - Accurately describes the trajectory: sharp growth in 2023, modest decline in 2024\n   - Correctly notes the asymmetric impact (assets grew more than liabilities)\n   - Sound multi-hop reasoning connecting transaction to balance sheet impacts\n\n4. COMPLETENESS:\n   - Addresses all parts of the question: evolution from 2022-2024, deposit assets/liabilities, Global Atlantic impact\n   - Provides context about the deposit method accounting treatment\n   - Explains the strategic shift narrative\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative matches ground truth: 2022 baseline → 2023 transaction spike → 2024 rebalancing\n   - Wording is clear and professional\n   - Properly contextualizes the transaction's significance\n\nJUSTIFICATION FOR SCORES:\n- Correctness (7/10): Most numbers correct, but the 2023 deposit assets figure and its relationship to the transaction amount creates ambiguity that doesn't fully align with ground truth clarity\n- Quantitative Accuracy (7/10): 5 of 6 year-end balances correct; the 2023 deposit assets figure and transaction breakdown needs clarification\n- Qualitative Accuracy (8/10): Excellent synthesis and reasoning; minor issue with how transaction amounts are presented relative to year-end balances\n- Contextual Relevance (9/10): Highly relevant, addresses all aspects of the question with appropriate detail and context",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 843,
        "total_tokens": 2226
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) holdings fell from $1.172 bn (fair value $1.018 bn, 288 securities) at 12/31/2022 to $1.066 bn (fair value $975 m, 287 securities) at 12/31/2023 and remained unchanged at $1.066 bn (fair value $975 m) at 12/31/2024. The portfolio is AAA‑rated with a 5.4‑year weighted average duration and the company reports no intent to sell, indicating a conservative, income‑focused strategy that tolerates modest price swings while maintaining a stable, high‑quality CMBS exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key quantitative metrics. Ground truth shows: 2022: $574M, 2023: $675M, 2024: $3M. LLM reports: 2022: $1.172B, 2023: $1.066B, 2024: $1.066B. These numbers are completely different - the LLM's figures are approximately 2x the ground truth values across all years. The LLM also contradicts the core finding: ground truth shows a dramatic decline to $3M in 2024 (de-risking strategy), while LLM claims holdings 'remained unchanged' at $1.066B. The LLM's conclusion about a 'conservative, income-focused strategy that tolerates modest price swings while maintaining stable, high-quality CMBS exposure' directly contradicts the ground truth's finding of 'strategic shift away from CMBS' and 'de-risking.' The LLM provides additional details (fair values, number of securities, weighted average duration, AAA-rating, no intent to sell) that may be accurate but are irrelevant when the core holdings figures are wrong by a factor of 2. The multi-hop reasoning fails because the LLM misidentified the trajectory entirely - it shows a modest 1.9% decline from 2022-2023 and flat 2023-2024, when the actual trajectory shows a 17.6% increase then a 99.6% collapse. This is a critical failure in answering the specific question about how exposure 'evolved' and what the '3-year trajectory indicates.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 373,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across 2022‑2024 the “hello” brand remained listed as a principal global and regional trademark in each filing, underscoring its continued presence in Colgate‑Palmolive’s portfolio【CL_10k_2022.pdf:75‑79】【CL_10k_2023.pdf:77‑81】【CL_10k_2024.pdf:77‑81】.  The brand is positioned within the Oral, Personal and Home Care segment, specifically in the Personal‑Care sub‑category that includes deodorants, antiperspirants and body wash【CL_10k_2022.pdf:75‑79】【CL_10k_2023.pdf:77‑81】【CL_10k_2024.pdf:77‑81】, and the segment’s share of net sales stayed essentially flat—Personal Care accounted for 19 % of sales in 2022 and 2023 and 18 % in 2024, while Oral Care remained at 42‑43 %【CL_10k_2022.pdf:75‑79】【CL_10k_2023.pdf:77‑81】【CL_10k_2024.pdf:77‑81】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 'hello' brand's consistent presence across 2022-2024 filings. The quantitative data is accurate: Personal Care at 19% (2022-2023) and 18% (2024), Oral Care at 42-43%. The multi-hop synthesis correctly traces the brand across three years and identifies its positioning within the Personal Care sub-category (deodorants, antiperspirants, body wash). The answer properly cites source documents and provides specific segment performance metrics. However, the LLM answer goes slightly beyond the original ground truth by providing more granular detail about the Personal Care sub-category specifics and segment sales percentages, which, while accurate and relevant, represents a modest expansion rather than strict adherence to the ground truth's more general framing. The original answer emphasizes 'stability' and 'continuity' in strategic positioning, while the LLM answer focuses more on quantitative metrics and specific product categories. Both are correct, but the LLM provides additional analytical depth. The answer fully addresses the three-year evolution question and correctly synthesizes information across multiple filing years. Minor deduction due to the slight shift in emphasis from strategic positioning narrative to quantitative segment analysis, though this is not factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 385,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife has continued to apply the deposit method for reinsurance agreements that do not expose it to a reasonable possibility of a significant insurance‑risk loss from 2022 through 2024.  Deposit assets fell from about $5.1 billion in 2023 to $4.6 billion in 2024 (with a similar level in 2022), while deposit liabilities declined from $1.3 billion to $1.2 billion, indicating a modest reduction in the volume of deposit‑based reinsurance and a slightly lower counter‑party credit exposure as the company refines its reinsurance mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) DEPOSIT ASSETS 2023: The LLM claims deposit assets were $5.1 billion in 2023, but the ground truth does not mention this figure and indicates the 2024 level was $4.6 billion. The LLM's claim of a decline from $5.1B to $4.6B is not supported by the ground truth. (2) 2022 BASELINE: The LLM states deposit assets were 'with a similar level in 2022' but provides no specific number. The ground truth clearly states 2022 deposit assets were $1.8 billion, which is substantially different from the $4.6 billion in 2024 - not 'similar.' (3) DEPOSIT LIABILITIES 2023: The LLM claims $1.3 billion in 2023, but the ground truth does not provide a 2023 figure for liabilities. The ground truth shows $1.4 billion in 2022 and $1.2 billion in 2024. (4) TREND INTERPRETATION: The LLM describes a 'modest reduction' and 'declining' trend, but the ground truth indicates a significant INCREASE in deposit assets from $1.8B (2022) to $4.6B (2024) - a 155% increase. This is a fundamental mischaracterization of the trend. (5) STRATEGIC INSIGHT: The LLM's conclusion about 'refining its reinsurance mix' with lower exposure contradicts the ground truth's assessment of a 'strategic shift toward more reinsurance arrangements' and 'growing reliance on reinsurance structures.' (6) MISSING CONTEXT: The LLM fails to mention the Global Atlantic transaction, which the ground truth identifies as significant context for understanding the 2023-2024 changes. The LLM answer demonstrates poor multi-hop synthesis and contains multiple contradictions with the ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 457,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 through 2024 the fair‑value of NextEra’s special‑use funds climbed from $4.4 billion (NEE $4,437 m, FPL $2,905 m) to $5.3 billion (NEE $5,290 m, FPL $3,536 m), with the 2024 10‑K continuing to classify the assets as Level 1 or Level 2 and reporting no Level 3 items.  Collateral posting requirements for derivatives—linked to the special‑use funds through credit‑risk contingent features—remained essentially unchanged, with posted collateral and potential exposure levels reported consistently across the three years.  On the balance sheet, special‑use funds moved from $8.7 billion in 2022/2023 to $9.8 billion in 2024, presented as non‑current other assets with the fair‑value figures disclosed in the notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE FAILURES: The LLM claims Special Use Funds were $4.4 billion in 2022 and $5.3 billion in 2023, but the ground truth explicitly states $8,698 million in 2023 and $9,800 million in 2024. The LLM's figures are off by approximately $4.3-4.5 billion—nearly 50% understatement. The LLM also breaks down figures by NEE and FPL ($4,437M NEE, $2,905M FPL in 2022; $5,290M NEE, $3,536M FPL in 2024), which don't align with the consolidated figures in the ground truth. The $1,102 million increase from 2023 to 2024 mentioned in ground truth is not reflected in the LLM's analysis. (2) BALANCE SHEET PRESENTATION: The LLM correctly identifies the 2024 balance sheet figure of $9.8 billion and the 2023 figure of $8.7 billion, but this contradicts its earlier claim that 2023 was $5.3 billion. This internal inconsistency is a major red flag. (3) MISSING CONTENT: The LLM fails to address the evolution of equity investments without readily determinable fair values ($485M in 2022 to $538M in 2023), which is a key part of the ground truth narrative about enhanced transparency. The LLM also misses the detailed discussion of valuation methodologies (quoted market prices for equities, pricing vendor inputs for debt securities, commingled funds). (4) PARTIAL CREDIT: The LLM correctly identifies Level 1/Level 2 classification and the consistency of collateral posting requirements, and correctly notes the presentation as non-current other assets. However, these correct elements cannot offset the massive numerical errors that undermine the entire answer. The answer appears to conflate different metrics or time periods, resulting in a fundamentally flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 484,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "AVGO’s Security Insights Platform is described in all three filings as a tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and that “this data is available for use with in‑house tools for security information and event management”【2022‑p9‑13】【2023‑p8‑12】【2024‑p8‑12】.  The wording and emphasis on integration with customers’ own SIEM tools and the ability to feed remediation steps into their remediation workflows remain unchanged from 2022 through 2024, indicating that the platform’s positioning and core capabilities did not evolve materially over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the core platform description across all three years (2022-2024) with accurate quotes about assessing mainframe security posture, identifying risks, and developing remediation steps; (2) Accurately notes that data availability for in-house SIEM tools is mentioned consistently across all three years; (3) Properly synthesizes the multi-hop information showing no material evolution in positioning from 2022 through 2024; (4) Correctly cites specific page references for each year's filing; (5) Accurately concludes that the platform's value proposition remained stable without new integrations or remediation features. The answer aligns semantically with the ground truth, which states the emphasis on integration became 'more pronounced' but the core description remained 'largely unchanged' and 'consistent.' The LLM's characterization that positioning 'did not evolve materially' is consistent with the ground truth's finding of a 'stable value proposition.' Minor consideration: The ground truth uses slightly different language ('emphasis became more pronounced') while the LLM states emphasis 'remain unchanged,' but this is a subtle distinction in how the same underlying fact is characterized—both convey that the core capabilities and integration story stayed consistent across the period. The LLM provides more direct evidence through quotes and citations, which strengthens the answer. No quantitative errors, dates are correct, entities properly identified, and multi-hop reasoning is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 437,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike continued to own the Laakdal, Belgium distribution facility in FY 2022, FY 2023 and FY 2024, and it remained described as a key distribution center for European operations【2022 10‑K, p. 25‑29】【2023 10‑K, p. 27‑31】【2024 10‑K, p. 27‑31】. The unchanged ownership and operational role across the three years underscore Laakdal’s strategic importance as a controlled, central hub that supports Nike’s European logistics network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that Nike owned the Laakdal, Belgium facility across all three fiscal years (2022, 2023, 2024) with no changes in ownership status; (2) Accurately characterizes the facility as a key/significant distribution center for European operations; (3) Properly synthesizes the multi-hop information across three separate 10-K filings; (4) Correctly concludes that the consistency indicates strategic importance and stability in Nike's European logistics network; (5) Appropriately cites source documents with page ranges. Quantitative accuracy is perfect - all years and ownership status are correct with no numerical errors. Qualitative reasoning is sound - the model correctly identifies that unchanged ownership and operational role across three years demonstrates strategic importance. Minor observation: The LLM answer uses slightly different phrasing ('controlled, central hub') compared to ground truth's 'stable and integral part,' but both convey equivalent semantic meaning about the facility's strategic value. The citation format with page ranges adds credibility though specific page numbers cannot be independently verified. Overall, the answer comprehensively addresses all aspects of the multi-part question regarding ownership evolution, operational footprint consistency, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 394,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 32B remained unchanged: the interest rate stayed at 3.38 %, the face amount stayed at $750,000, and the maturity date remained June 15 2027 (see the 2022, 2023 and 2024 tables). This three‑year consistency indicates that SPG is not actively refinancing or restructuring this debt, reflecting a conservative, stability‑focused debt‑management strategy that prioritizes predictable cash flows and avoids refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the maturity date disclosure across the three-year period. According to the ground truth, the maturity date was 'unspecified in the 2022 report' but 'explicitly listed as 06/15/27 in both 2023 and 2024 disclosures.' The LLM incorrectly states that the maturity date 'remained June 15 2027' across all three years (2022, 2023, and 2024), implying it was disclosed consistently. This is a material factual error that contradicts the ground truth's key finding about the evolution of disclosure practices. The LLM correctly identifies: (1) the interest rate of 3.38% remained constant, (2) the face amount of $750,000 remained constant, and (3) the maturity date of June 15, 2027 (when disclosed). However, the failure to note that the 2022 maturity date was unspecified represents a misunderstanding of the 'evolution' aspect of the question. The qualitative reasoning about SPG's debt management strategy is sound and well-articulated, appropriately concluding that the consistency reflects a conservative, stability-focused approach. The answer demonstrates good understanding of the strategic implications but fails on a critical factual detail about how the disclosure evolved over the three-year period. The quantitative accuracy is penalized for the maturity date error, though the other numbers are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 382,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "From 2022 to 2023, CVS’s foreign‑security holdings declined modestly in fair value—from $2.55 bn to $2.51 bn—while unrealized losses were cut in half, falling from $244 m to $122 m. In 2024 the foreign‑security component of the company’s separate‑accounts portfolio dropped sharply to $51 m (from $202 m in 2023) and no unrealized losses were reported, indicating a further contraction of its foreign‑market exposure. This downward trend in both fair value and unrealized losses suggests CVS is actively reducing its exposure to international market risk, likely through portfolio rebalancing or divestiture of foreign assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all years. Specific errors: (1) 2022-2023 comparison: LLM claims fair value declined from $2.55bn to $2.51bn, but ground truth shows it increased from $838M to $1,650M—a massive discrepancy of over $1.7bn in both years. (2) Unrealized losses 2022: LLM states $244M, but ground truth shows $24M—a 10x error. (3) 2023 unrealized losses: LLM correctly states $122M, matching ground truth. (4) 2024 fair value: Both agree on $51M decline, but LLM's baseline of $202M in 2023 is incorrect (should be $1,650M). (5) 2024 unrealized losses: LLM claims 'no unrealized losses reported,' but ground truth doesn't specify this detail—this appears to be an unsupported claim. The LLM appears to have confused CVS's foreign securities data with different portfolio components or misread the source documents entirely. The narrative conclusion about de-risking is directionally correct for 2024, but the 2022-2023 analysis is completely inverted (LLM shows decline when ground truth shows significant growth). This represents a critical failure in multi-hop financial data synthesis, with nearly all quantitative values incorrect by orders of magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 349,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s policy of applying internally developed designations to non‑agency RMBS and CMBS that have not yet been evaluated by the NAIC has remained unchanged from 2022 through 2024, but the proportion of such securities has fallen as the NAIC has assigned more designations.  The NAIC‑designated RMBS value grew from $25.5 B in 2022 to $34.1 B in 2024, while CMBS rose from $9.8 B to $9.2 B, raising the total NAIC‑designated value from $36.3 B to $43.3 B—showing an increasing reliance on the NAIC’s modeling methodology for credit‑quality assessment, with internal designations used only as a temporary fallback.  [MET_10k_2023: p. 92‑96; MET_10k_2024: p. 82‑86; MET_10k_2022: p. 99‑103]",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a substantially correct response with accurate quantitative data and sound multi-hop reasoning, but has some notable gaps compared to the ground truth.\n\nSTRENGTHS:\n1. Quantitative Accuracy: The dollar amounts cited are correct - NAIC-designated RMBS grew from $25.5B (2022) to $34.1B (2024), CMBS from $9.8B to $9.2B, and totals from $36.3B to $43.3B. These figures are verifiable and properly formatted.\n2. Core Concept: The LLM correctly identifies that internally developed designations remained a policy tool while their relative proportion decreased as NAIC designations increased.\n3. Multi-hop Synthesis: The answer successfully synthesizes information across three years (2022-2024) and correctly identifies the trend of increasing NAIC reliance.\n4. Directional Accuracy: The conclusion that internal designations serve as a \"temporary fallback\" aligns with the ground truth's characterization of a \"gradual shift away from reliance on internal designations.\"\n\nWEAKNESSES:\n1. Missing Level 3 Context: The ground truth specifically mentions Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%) in 2023 and $1.6 billion (4.9%) in 2024. The LLM answer omits this important metric that demonstrates the evolution pattern.\n2. Incomplete Temporal Analysis: The ground truth emphasizes the 2021 NAIC methodology refinement as a baseline and traces the \"transitional phase\" through 2022, maturation in 2023, and stabilization in 2024. The LLM answer treats the period more uniformly without capturing this three-stage evolution.\n3. Methodology Context: The ground truth explains that the NAIC's goal was \"improving accuracy in expected loss estimation and RBC charge determination.\" The LLM answer doesn't provide this explanatory context.\n4. Policy Consistency Framing: While the LLM correctly states the policy remained unchanged, the ground truth emphasizes how the application became \"more mature\" over time, suggesting qualitative evolution beyond just proportional shifts.\n\nCALCULATION VERIFICATION:\n- RMBS growth: $25.5B to $34.1B = $8.6B increase ✓\n- CMBS change: $9.8B to $9.2B = -$0.6B decrease ✓\n- Total growth: $36.3B to $43.3B = $7.0B increase ✓\nAll arithmetic is correct.\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes across three years and two asset classes (RMBS and CMBS), correctly identifying the inverse relationship between internal designations and NAIC designations. However, it misses the intermediate 2023 data point that would strengthen the temporal pattern analysis.\n\nSEMANTIC EQUIVALENCE:\nThe LLM's characterization of internal designations as a \"temporary fallback\" is semantically equivalent to the ground truth's \"transitional phase\" and \"gradual shift away from reliance.\" Both convey the same fundamental insight about the evolution of MetLife's approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 760,
        "total_tokens": 2265
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "Chevron invested roughly $0.7 billion in offshore development and natural‑gas projects in the Republic of Congo in 2023 [CVX_10k_2023.pdf: pages 107‑111]. No capital allocation or ownership changes were disclosed for the country in 2022 or 2024 [CVX_10k_2022.pdf: pages 31‑35; CVX_10k_2024.pdf: pages 41‑45]. The only asset‑ownership change involving Republic of Congo occurred in January 2025, when Chevron sold its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of Lianzi [CVX_10k_2024.pdf: pages 41‑45].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical temporal error that significantly impacts correctness. The ground truth states the divestiture occurred in 2024, while the LLM answer claims it happened in January 2025. This is a major factual discrepancy for a multi-hop financial question where precise timing is essential. The LLM correctly identifies the $0.7 billion investment in 2023 for offshore development and natural gas projects in Africa including the Republic of Congo. The asset ownership details (31.5% nonoperated working interest in Haute Mer and 15.75% in Lianzi) are accurately stated with correct percentages. However, the LLM's claim that 'no capital allocation or ownership changes were disclosed for the country in 2022 or 2024' is problematic because the ground truth explicitly states that 2024 involved a strategic exit/divestiture. The LLM appears to have misread or misinterpreted the timing of this transaction. The answer demonstrates reasonable multi-hop synthesis by connecting information across three years and identifying the shift from active investment to divestiture, but the temporal misplacement of the 2024 divestiture to January 2025 undermines the core narrative of how the investment footprint evolved through 2024. The answer is well-structured and cites sources appropriately, but the fundamental dating error on a key transaction is a significant accuracy problem for financial reporting where precise dates matter.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 401,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products as a pillar of its “broad portfolio” competitive advantage (b) in all three filings, but the segment’s performance has swung from growth in 2022 (19 % revenue rise, 58 % operating‑profit lift) to modest growth in 2023 (3 % revenue, 20 % profit decline) and a sharp 25 % revenue drop with a 65 % profit decline in 2024. In response, the company has intensified R&D and 300‑mm manufacturing investment and sharpened its focus on industrial and automotive markets to shore up the embedded‑processing line while keeping it within the portfolio advantage that drives customer opportunity and value【2022 10‑K, pages 18‑22】【2023 10‑K, pages 16‑20】【2024 10‑K, pages 16‑20】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM provides specific performance metrics (19% revenue rise in 2022, 58% operating-profit lift, 3% revenue growth in 2023 with 20% profit decline, 25% revenue drop in 2024 with 65% profit decline) that are NOT verified in the ground truth and appear to be fabricated or hallucinated. The ground truth makes no mention of these specific percentages or performance metrics. (2) INCOMPLETE ADDRESSING OF QUESTION - The question asks about evolution of strategic emphasis within TI's 'four sustainable competitive advantages.' The ground truth correctly identifies that embedded processing remained consistent across 2022-2024 as a core component. The LLM mentions 'broad portfolio' as competitive advantage (b) but doesn't properly address how embedded processing fits within the framework of four sustainable competitive advantages or how this relationship evolved. (3) UNSUPPORTED CLAIMS - The LLM claims the company 'intensified R&D and 300-mm manufacturing investment' and 'sharpened its focus on industrial and automotive markets' in response to performance declines. These claims are not substantiated in the ground truth and appear to be inferences or fabrications. (4) SEMANTIC MISALIGNMENT - While the ground truth emphasizes consistency and stability of the strategic pillar across years, the LLM focuses on performance volatility and reactive changes, which represents a fundamentally different narrative not supported by the source material. (5) CITATION ISSUES - The LLM provides page references that cannot be verified against the ground truth. The ground truth does not mention specific page numbers or performance metrics that would validate these citations. The answer demonstrates poor multi-hop reasoning by conflating business performance metrics with strategic positioning, which are distinct concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 531,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50% Senior Note has a fixed coupon of 3.50 %, but its effective rate – the true cost of borrowing after accounting for discounts and issuance costs – moved markedly over the three years.  In FY 2022 the effective rate was 3.20 %【2022 table】, it fell to 1.29 % in FY 2023【2023 table】, and then jumped to 6.66 % in FY 2024【2024 table】.  This pattern shows that borrowing costs for the note dropped in 2023 (likely due to a discount or favorable market conditions) but rose sharply in 2024, reflecting higher market rates and discount adjustments that increased Cisco’s overall debt‑service expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the FY 2023 effective interest rate. Ground truth states the effective rate was 6.38% in FY 2023, but the LLM claims it was 1.29% - a difference of over 5 percentage points. This is a fundamental quantitative error that undermines the entire analysis. The FY 2022 (3.20%) and FY 2024 (6.66%) figures are correct. The LLM's interpretation of the trend is also incorrect: it claims rates 'fell to 1.29% in FY 2023' when the actual progression shows a continuous increase from 3.20% (2022) → 6.38% (2023) → 6.66% (2024). The LLM's explanation about the 2023 drop being 'due to a discount or favorable market conditions' is contradicted by the ground truth, which shows rates actually increased significantly in 2023. The reasoning about market rates and discount adjustments in 2024 is partially sound, but the foundation is built on incorrect data. The LLM correctly identifies the note as a $500 million 3.50% Senior Note maturing in June 2025 and properly explains the concept of effective vs. coupon rates, but the critical numerical error in FY 2023 (1.29% vs. 6.38%) makes the multi-hop synthesis fundamentally flawed. This is not a minor rounding or formatting difference - it's a substantial factual error that changes the entire narrative of the company's borrowing cost evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 380,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, BNY Mellon repeatedly states that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The unchanged wording over three years shows that the regulatory constraints on capital planning and shareholder returns have remained stable, while the company’s continued reference to board discretion signals that it retains strategic flexibility to adjust capital returns within those limits.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution and progression from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and BNY Mellon as the subject company; (2) Accurately quotes the regulatory language about capital returns being subject to U.S. banking laws, Delaware law, and preferred stock dividend requirements; (3) Correctly notes that the wording remained largely unchanged across the three years; (4) Appropriately identifies board discretion as a factor in capital allocation. CRITICAL WEAKNESSES: (1) The LLM claims 'unchanged wording over three years' which contradicts the ground truth that shows meaningful evolution - the ground truth explicitly states that 2023 'specifically reiterated' certain constraints and 2024 'added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards'; (2) The LLM fails to capture the progression in emphasis on 'well capitalized' and 'well managed' status that emerged in 2024; (3) The LLM misses the evolution in how the company framed regulatory constraints - from general oversight (2022) to specific reiteration (2023) to stronger emphasis on liquidity and regulatory consequences (2024); (4) The answer does not adequately address what the 'multi-year progression reveals' - the ground truth emphasizes 'sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations,' but the LLM suggests stability rather than evolution. The LLM's conclusion that constraints 'have remained stable' directly contradicts the ground truth's finding of meaningful progression and increasing emphasis on specific regulatory dimensions. While the LLM correctly identifies the basic regulatory framework, it fundamentally mischaracterizes the nature of the evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 536,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "Repair and other services revenue fell from $1,169 million in 2022 to $1,132 million in 2023 (a decline of about $37 million, ~3 %) and then held steady at $1.132 billion in 2024 (GD_10k_2024.pdf p. 7‑11; GD_10k_2023.pdf p. 7‑11; GD_10k_2022.pdf p. 8‑11). The flatness reflects the mature, contract‑based nature of maintenance and modernization work that provides a stable, recurring revenue stream while General Dynamics prioritizes ship‑building expansion, indicating that the repair‑services segment is a reliable support function rather than a growth engine.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures ($1,169M in 2022, $1,132M in 2023 and 2024) and accurate calculation of the decline ($37 million, ~3%). The multi-hop synthesis across three years of 10-K filings is sound, and the answer correctly identifies the pattern of decline followed by flatness. The LLM provides appropriate source citations (GD_10k filings with page numbers). The reasoning about the segment's nature is well-articulated, characterizing it as a 'mature, contract-based' business providing 'stable, recurring revenue' while General Dynamics prioritizes shipbuilding expansion. This interpretation aligns with the ground truth's suggestion of 'limited growth or strategic prioritization.' However, the LLM answer differs slightly in emphasis from the ground truth: it focuses more on the positive aspects (stable, recurring revenue, reliable support function) rather than exploring potential negative factors like market saturation or operational constraints that the ground truth mentions. The LLM's characterization of repair services as a 'support function rather than a growth engine' is semantically equivalent to the ground truth's 'limited growth or strategic prioritization.' The answer is complete, addressing all parts of the multi-part question (the change from 2022-2023, the flatness in 2024, and what the pattern suggests). Minor deduction for not fully exploring the alternative explanations (market saturation, resource reallocation, operational constraints) that the ground truth presents, though the LLM's explanation is still reasonable and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 447,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth Group’s venture‑investment portfolio grew from $3.7 billion in 2022 to $4.9 billion in 2023 and stayed at that level in 2024, underscoring a sustained emphasis on early‑stage healthcare innovation (2022 10‑K p. 54‑58; 2023 10‑K p. 48‑52; 2024 10‑K p. 50‑54). Its equity‑method investments in operating healthcare businesses dipped slightly from $1.5 billion in 2022 to $1.4 billion in 2023, then surged to $3.8 billion in 2024, reflecting a strategic shift toward deeper, more integrated stakes in established healthcare firms (2023 10‑K p. 48‑52; 2024 10‑K p. 50‑54).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding equity method investments in 2022. The ground truth states equity method investments were $1.4 billion in 2022 (remaining flat), but the LLM claims they were $1.5 billion in 2022. This is a significant quantitative error. Additionally, the LLM states equity method investments 'dipped slightly from $1.5 billion in 2022 to $1.4 billion in 2023' - this contradicts the ground truth which indicates they remained flat at $1.4 billion in both 2022 and 2023. The correct progression should be: $1.4B (2022) → $1.4B (2023) → $3.8B (2024), not $1.5B (2022) → $1.4B (2023) → $3.8B (2024). The venture investments numbers are correct ($3.7B in 2022, $4.9B in 2023 and 2024). The qualitative interpretation about strategic shift toward deeper integrated investments is accurate and well-reasoned. However, the quantitative errors are fundamental and undermine the credibility of the answer. The LLM also adds page citations that cannot be verified against the ground truth, which is appropriate but doesn't compensate for the factual errors. The answer addresses the question's multi-part structure (dollar value and strategic emphasis) but fails on accuracy of the core financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 354,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. remained a member of PMI’s peer group in each of the 2022, 2023 and 2024 filings, with the peer‑group list unchanged across those years (PM_10k_2022, p. 19‑23; PM_10k_2023, p. 24‑28; PM_10k_2024, p. 24‑28). This multi‑year consistency shows that PMI follows a stable, criteria‑driven benchmarking framework—emphasizing global presence, consumer‑product focus and comparable financial metrics—so that performance comparisons remain comparable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Strengths: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PMI's peer group across all three years (2022, 2023, 2024); (2) Accurately states the peer group remained unchanged year-over-year; (3) Correctly identifies the four key criteria for peer selection (global presence, consumer-product focus, net revenues, and market capitalization similarity); (4) Properly synthesizes the multi-hop information across three separate 10-K filings; (5) Appropriately interprets the consistency as evidence of a stable, criteria-driven benchmarking framework; (6) Correctly notes that PMI excluded direct tobacco industry peers from comparisons. The citation format (PM_10k_2022, p. 19-23, etc.) is appropriately specific. Minor observation: The LLM answer slightly condenses the explanation of the four criteria (omitting explicit mention of 'market capitalization' as a separate criterion, though it's implied in 'comparable financial metrics'), but this is a very minor semantic compression that doesn't affect factual accuracy. The answer demonstrates sound multi-hop reasoning by connecting the year-over-year consistency across three filings to broader conclusions about PMI's strategic benchmarking approach. No calculation errors, no date errors, and all entities are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 381,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "From 2022 through 2024 PayPal’s risk disclosures increasingly tied abusive‑behavior exposure to its growing credit‑product portfolio and deeper reliance on third‑party lenders and processors.  The 2023 and 2024 filings explicitly link new credit offerings and third‑party risk to higher fraud risk, noting that fraud‑detection measures are complex, require continuous improvement, and may not keep pace with evolving schemes.  This evolution suggests that while PayPal is investing in fraud mitigation, its effectiveness remains uncertain and may lag behind the heightened exposure created by expanding credit products and third‑party dependencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of PayPal's evolving exposure to abusive behaviors from 2022-2024 and correctly identifies the key relationship between expanding credit products, third-party dependencies, and fraud risk. The answer appropriately synthesizes the multi-hop information showing how PayPal's risk profile changed over time.\n\nSTRENGTHS:\n1. Correctly identifies the three-year evolution (2022-2024) of PayPal's abusive behavior exposure\n2. Accurately links credit product expansion to increased fraud risk\n3. Properly emphasizes third-party reliance as a key risk factor\n4. Correctly notes that fraud detection measures are complex and may not keep pace with evolving schemes\n5. Appropriately concludes that mitigation effectiveness remains uncertain\n6. Multi-hop reasoning is sound: connects credit expansion → third-party risk → fraud exposure → mitigation lag\n\nWEAKNESSES:\n1. Missing specific quantitative detail: The ground truth mentions the €40 billion multi-year BNPL loan receivable agreement in Europe (2023), which is a concrete example of the scale expansion. The LLM answer references \"new credit offerings\" generically without this specific figure.\n2. Omits regulatory uncertainty aspect: The ground truth specifically mentions \"regulatory uncertainty regarding the validity of loan receivables post-sale,\" which is an important dimension of PayPal's 2024 risk exposure that the LLM answer doesn't address.\n3. Less granular on 2022 specifics: The ground truth notes 2022 emphasized \"stolen identities, financial instruments, and fraudulent transactions\" as specific abuse vectors, while the LLM answer treats 2022 more generally.\n4. Doesn't explicitly mention the scale progression: The ground truth emphasizes that risks were introduced \"at a much larger scale\" with the 2023 credit expansion, which the LLM answer implies but doesn't state explicitly.\n\nQUANTITATIVE ACCURACY: The LLM answer contains no incorrect numbers or calculations. However, it omits the €40 billion figure that appears in the ground truth, which represents a material omission of quantitative detail rather than an error per se.\n\nQUALITATIVE ACCURACY: The reasoning is sound and the synthesis across years is correct. The LLM properly identifies the causal relationship between business expansion and risk exposure. However, the answer is somewhat less detailed in distinguishing the specific nature of risks in each year.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of exposure, credit products, third-party risk, and mitigation effectiveness. It appropriately frames the trend as suggesting lagging mitigation effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 714,
        "total_tokens": 2201
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedges grew from 214 mmBtu in 2022 to 339 mmBtu in 2023, then fell to 176 mmBtu in 2024 (Net hedge volumes, SO_10k_2022 p. 121‑125; SO_10k_2023 p. 115‑119; SO_10k_2024 p. 112‑116).  While the overall hedge volume stayed roughly constant at ~430–450 mmBtu, the mix shifted from a heavier option position in 2023 to a greater reliance on swaps in 2024.  This pattern shows a flexible, market‑responsive risk‑management strategy that ramps up options when volatility is high and reverts to cheaper or more predictable instruments when conditions stabilize.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figure. Ground truth states 253 million mmBtu for 2022, but the LLM reports 214 mmBtu—a discrepancy of 39 million mmBtu (15% error). The 2023 (339 mmBtu) and 2024 (176 mmBtu) figures are correct. This is a material error for a quantitative question focused on 3-year trends. ADDITIONAL ISSUES: (1) The LLM introduces unsupported claims about 'overall hedge volume stayed roughly constant at ~430–450 mmBtu' and shifts to swaps in 2024—these specific numbers and the swap comparison are not present in the ground truth answer and appear to be fabricated or inferred without citation. (2) The ground truth explicitly states the 2022 figure as 253 million mmBtu; the LLM's 214 mmBtu contradicts this directly. WHAT WAS CORRECT: (1) The 2023 and 2024 figures (339 and 176 mmBtu) are accurate. (2) The qualitative interpretation about market-responsive strategy and the pattern of increase then decrease is sound and aligns with ground truth reasoning. (3) The general conclusion about flexibility in hedging approach is reasonable. MULTI-HOP REASONING: The LLM correctly synthesized the 3-year trend and provided logical interpretation, but the foundation is weakened by the incorrect 2022 baseline. The reasoning about volatility response and instrument switching is plausible but goes beyond what the ground truth explicitly supports. SEMANTIC ISSUES: While the LLM's wording differs from ground truth, the core semantic meaning should align—but the 214 vs. 253 discrepancy is not a wording issue; it's a factual error. For a financial question requiring precision, this 15% error on a key data point is significant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 468,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Industries’ aggregate expense for U.S. defined‑contribution plans climbed from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024** (2024 10‑K; 2023 10‑K). The modest but steady rise indicates the company is gradually increasing its contributions to defined‑contribution plans, a strategy that reduces reliance on its unfunded, closed non‑qualified defined‑benefit pension plan and shifts long‑term benefit costs toward more flexible, cost‑controlled structures.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: (1) All financial numbers are correct: $70M (2022), $75M (2023), $76M (2024). (2) The trend identification is accurate - steady increase is properly characterized. (3) Number formatting is acceptable. CRITICAL ERRORS: (1) COMPANY NAME ERROR: The LLM refers to 'Texas Industries' instead of 'Texas Instruments' - this is a fundamental entity identification failure that undermines credibility, though the filing citations suggest the correct company was consulted. (2) INCOMPLETE REASONING: The LLM answer lacks key contextual details from the ground truth: (a) No mention of the 1997 closure of defined benefit plans to new participants, which is historically significant; (b) No reference to employees 'opting out' of the defined benefit plan or participating in an 'enhanced defined contribution plan'; (c) Missing the specific strategic framing about 'flexible retirement options' that the ground truth emphasizes. (3) PARTIAL SYNTHESIS: While the LLM correctly identifies the shift toward defined contribution plans and mentions the 'unfunded, closed non-qualified defined-benefit pension plan,' it doesn't fully synthesize the relationship between the two plans as comprehensively as the ground truth. The ground truth explains this is about supporting employees NOT accruing benefits under the non-qualified plan, which adds important nuance. (4) REASONING QUALITY: The LLM's interpretation about 'reducing reliance' and 'cost-controlled structures' is reasonable but somewhat generic - it doesn't capture the specific strategic emphasis on flexible options for employees who have opted out. The multi-hop synthesis is present but incomplete. QUANTITATIVE ACCURACY is high (9/10) due to correct numbers. QUALITATIVE ACCURACY is lower (4/10) due to company name error and incomplete contextual synthesis. CONTEXTUAL RELEVANCE is moderate (5/10) - addresses the question but misses important strategic context about the 1997 closure and employee choice framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 533,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets climbed from 5.38 % in 2022 to 6.30 % in 2023 and was further raised to 6.5 % at December 31 2024. This upward trend signals a progressively more optimistic view of long‑term asset performance and a willingness to accept a higher risk profile in its pension investment strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2022 FIGURE: The LLM states 5.38% for 2022, while the ground truth specifies 5.4%. While these are very close numerically (5.38% vs 5.4%), the ground truth explicitly states 5.4%, making this a factual error. The 2023 figure of 6.30% matches ground truth exactly. The 2024 figure of 6.5% is correct. REASONING QUALITY: The LLM correctly identifies the upward trend and appropriately characterizes it as signaling 'progressively more optimistic view' and 'willingness to accept higher risk profile.' This semantic interpretation aligns well with the ground truth's assessment about 'more confident' outlook and 'greater tolerance for market exposure.' COMPLETENESS ISSUE: The ground truth provides additional context about 'improved funded status objectives' and 'strategic asset mix and risk mitigation approach,' which the LLM answer omits. The LLM focuses narrowly on the trend and its implications for risk tolerance but doesn't address the broader strategic context around funded status or asset allocation strategy. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the three-year trend and draws appropriate conclusions about shifting expectations. The logic connecting rising ROA assumptions to increased risk tolerance is sound. FORMATTING: The LLM uses 5.38% instead of 5.4%, which while numerically similar, represents a precision discrepancy not supported by the ground truth. The date format 'December 31 2024' is acceptable variation. Overall, the answer captures the main trend and reasoning but contains a factual error in the 2022 baseline figure and lacks some contextual depth about strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 452,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a **$92 million loss in FY 2022** to a **$91 million gain in FY 2023** and remained at a **$91 million gain in FY 2024** (see CSCO_10k_2022, pp. 90‑94; CSCO_10k_2023, pp. 89‑93; CSCO_10k_2024, pp. 89‑93). This reversal and sustained positive gains indicate that Cisco’s hedging strategy has become more effective, using the swaps to economically offset compensation‑related volatility and thereby stabilizing earnings. The trend reflects a proactive risk‑management approach to mitigate the financial impact of deferred‑compensation expenses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the FY 2023 figure. Ground truth states FY 2023 showed a $58 million gain, but the LLM reports $91 million gain for FY 2023. The LLM then states FY 2024 remained at $91 million gain, which happens to match the ground truth for FY 2024, but this appears coincidental given the FY 2023 error. CORRECT NUMBERS: FY 2022: $92 million loss (correct), FY 2023: $58 million gain (LLM says $91M - WRONG), FY 2024: $91 million gain (correct). The LLM's statement that gains 'remained at a $91 million gain in FY 2024' is misleading because it implies continuity from FY 2023, when in fact there was a significant increase from $58M to $91M between those years. MULTI-HOP SYNTHESIS: The LLM correctly identifies this as a multi-year progression and attempts to synthesize the trend, but the incorrect FY 2023 figure undermines the entire analysis. The progression should show: loss → gain → larger gain, but the LLM presents it as: loss → gain → same gain. REASONING QUALITY: The qualitative interpretation about hedging strategy effectiveness and risk management is reasonable and aligns with the ground truth's characterization, but it's based on incomplete/incorrect data. The LLM appropriately cites source documents (10-K filings with page numbers), which adds credibility but doesn't compensate for the numerical error. COMPLETENESS: The answer addresses the question's components (realized gains/losses, progression, risk management implications) but the factual error in FY 2023 is a fundamental failure in accuracy that significantly impacts the evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 451,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal has consistently maintained control over the pricing of its transaction fees and has remained the principal in completing payment transactions, thereby bearing full margin risk in each reporting year.  The company’s use of third‑party payment processors has not changed materially, and the fees paid to those processors are recorded as transaction expense in all three years.  No material change in the exposure to margin risk was disclosed across 2022, 2023, and 2024【2022‑page 80】【2023‑page 77】【2024‑page 75】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. STRENGTHS: (1) Correctly identifies PayPal's consistent control over pricing across all three years; (2) Accurately states that the company bears full margin risk as the principal in transactions; (3) Correctly notes that fees paid to third-party processors are recorded as transaction expense in all three years; (4) Properly concludes there was no material change in margin risk exposure across 2022-2024; (5) Provides appropriate page citations for verification. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth and omits some specific contextual details - notably the 2023 clarification about tiered pricing not constituting a future material right, which was explicitly mentioned in the original answer; (2) Does not explicitly mention the 2024 adoption of new segment reporting disclosures (though notes this didn't change the fundamental exposure); (3) The phrase 'has not changed materially' is slightly less precise than the ground truth's emphasis on 'consistent exposure...without structural changes.' QUANTITATIVE ACCURACY: No numeric values are provided in either answer, so this dimension is not directly testable. The answer correctly references three years (2022, 2023, 2024) and provides page numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (pricing control, processor fees, margin risk, transaction expense recognition), demonstrating sound multi-hop reasoning. The conclusion that there was no material change is logically supported by the consistent facts presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential meaning of the ground truth - PayPal's consistent principal role, pricing control, and margin risk exposure - though with less granular detail about specific clarifications made in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 522,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of natural‑gas production from Angola LNG fell modestly over the three‑year period: 70 MMCFD in 2022, 67 MMCFD in 2023 and 64 MMCFD in 2024 (oil‑equivalent volumes declined from 49 MMCFD to 48 MMCFD), while NGL output stayed steady at 4 MBD (see the “Net Production” tables in the 2022, 2023 and 2024 10‑Ks). This slight contraction indicates Chevron is maintaining a stable LNG supply base rather than aggressively expanding production, underscoring a strategy focused on contract fulfillment, supply reliability and operational efficiency in the LNG market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ACCURACY - The LLM reports Angola LNG natural gas production as 70 MMCFD (2022), 67 MMCFD (2023), and 64 MMCFD (2024), showing a DECLINING trend. The ground truth states 592 MMCFD (2022), 596 MMCFD (2023), and 609 MMCFD (2024), showing an INCREASING trend. These are completely different numbers - the LLM's figures are off by roughly 8-9x magnitude. (2) DIRECTIONAL ERROR - The LLM concludes production 'fell modestly' when the ground truth shows a steady increase. This is a fundamental reversal of the actual trend. (3) METRIC CONFUSION - The LLM appears to be reporting Chevron's share or equity production rather than total natural gas consumed in operations, which is what the ground truth metric represents. The LLM also introduces oil-equivalent volumes and NGL output that are not part of the ground truth answer. (4) STRATEGIC INTERPRETATION - Because the LLM's numbers are wrong, its strategic conclusion is inverted: it suggests 'maintaining a stable LNG supply base' and 'slight contraction' when the actual data shows 'growing operational emphasis' and 'upward trajectory.' (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the Angola LNG production data across the three-year period from the 10-K filings. The answer demonstrates a fundamental misunderstanding or misreading of the source data. This is a critical failure on a quantitative, directional, and interpretive basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 413,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In each year Southern Power reported the scheduled lease‑receivable cash flows for its outdoor‑lighting contracts in a maturity‑analysis table.  In 2022 the table (as of 12‑31‑2021) listed $87 m in 2022, $88 m in 2023, $90 m in 2024, $74 m in 2025, $73 m in 2026 and $240 m thereafter.  The 2023 note (as of 12‑31‑2022) reproduced the same figures for 2023‑2027, showing the amounts remained stable.  By 2024 the company shifted the disclosure to a separate maturity table that isolates the outdoor‑lighting lease payments—$15 m per year for 2025‑2029 and $170 m thereafter—while the larger operating‑lease cash‑flow table continued to show the full lease portfolio.  This evolution—from a single lease‑receivable table to a dedicated outdoor‑lighting table—signals that the company is treating these contracts as a distinct, increasingly material component of its lease portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific dollar amounts and maturity schedules for outdoor lighting contracts, but these numbers cannot be verified against the ground truth and appear to be fabricated or hallucinated. The ground truth explicitly states that in 2022, Southern Power noted these contracts were 'immaterial,' yet the LLM provides detailed cash flow figures ($87M in 2022, $88M in 2023, etc.) without any indication of immateriality. This is a fundamental contradiction. The LLM also claims specific shifts in disclosure presentation (from single table to dedicated table by 2024) with precise dollar amounts ($15M per year for 2025-2029, $170M thereafter), but the ground truth does not provide these specific numbers or confirm this exact structural change. The LLM's narrative about evolution from 'single lease-receivable table to dedicated outdoor-lighting table' may align directionally with the ground truth's observation about 'growing materiality and structural integration,' but the specific quantitative claims are unsubstantiated and likely incorrect. The answer demonstrates multi-hop reasoning across three years and attempts to show progression, which is appropriate to the question structure, but the factual foundation is compromised. The LLM appears to have invented specific financial figures rather than acknowledging uncertainty or data limitations. This represents a critical failure in quantitative accuracy and factual correctness, despite the answer's apparent sophistication and detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 418,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments kept a Melaka, Malaysia facility that supported only the Analog segment – the Embedded Processing column remained blank in each year’s property table【2022 table, Melaka† (Analog X, Embedded blank)】【2023 table, Melaka* (Analog X, Embedded blank)】【2024 table, Melaka** (Analog X, Embedded blank)】. The facility’s leasing status shifted from partially leased/owned (†) in 2022 to fully leased (*) in 2023 and fully leased (**) in 2024, but its functional role stayed unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that TXN's Melaka facility served only the Analog segment across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) Accurately notes that Embedded Processing remained blank/unsupported in all three years. (3) Provides additional valuable context about the leasing status evolution (partially leased/owned in 2022 to fully leased in 2023-2024) that, while not explicitly stated in the ground truth, is consistent with typical property table footnote conventions and adds relevant detail. (4) Correctly synthesizes the multi-hop information across three fiscal years and two business segments. (5) Uses appropriate citation format with footnote indicators (†, *, **) that align with typical SEC filing property table conventions. MINOR CONSIDERATIONS: The ground truth answer is more concise and focused strictly on the segment involvement, while the LLM answer adds the leasing status detail. This additional detail is not contradicted by the ground truth and represents a reasonable inference from property table footnotes, though it goes slightly beyond what was explicitly stated in the original answer. The core finding—that Melaka remained exclusively Analog-focused with no Embedded Processing involvement—is perfectly accurate. All dates, entities (Texas Instruments, Melaka Malaysia, Analog, Embedded Processing), and the three-year period are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 414,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024, AMT’s 1.600% senior notes stayed at a $700 million principal, with semi‑annual interest payments on April 15 and October 15 and a par call date of March 15, 2026 (2022 10‑K p. 46‑50; 2023 10‑K p. 108‑112; 2024 10‑K p. 111‑115). The unchanged terms over three years demonstrate a deliberate strategy of maintaining stable, long‑term debt with predictable cash‑flow obligations, allowing the company to focus on refinancing other debt and preserving financial flexibility. This consistency reflects a conservative debt‑management approach that prioritizes predictable cash flows and avoids early repayment or refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the principal amount ($700 million), interest payment schedule (semi-annual on April 15 and October 15), and par call date (March 15, 2026). These core quantitative facts are accurate and properly formatted. The company name (AMT) and time period (2022-2024) are correct.\n\nWEAKNESSES: The LLM answer is significantly incomplete in addressing the multi-hop question. The ground truth specifically mentions adjustments to principal amount that decreased from (2.6) in 2023 to (1.5) in 2024—a key data point showing the evolution of the relationship over time. The LLM completely omits these adjustment figures, which are essential to understanding the multi-year progression. The question explicitly asks about how the relationship 'evolved' and what the 'multi-year progression' indicates, requiring year-by-year comparison of adjustments.\n\nREASONING ISSUES: While the LLM provides reasonable interpretation about debt management strategy (stable approach, predictable cash flows, conservative management), this interpretation is based on incomplete data. The ground truth's conclusion about 'reduction in modifications or adjustments to the note structure over time' is more nuanced and data-driven than the LLM's generic statement about maintaining stable debt. The LLM's reasoning about 'refinancing other debt' and 'preserving financial flexibility' goes beyond what the ground truth supports and appears speculative.\n\nMULTI-HOP SYNTHESIS: The LLM failed to synthesize the key multi-hop element—the year-over-year changes in adjustments (2023 vs 2024) that demonstrate the evolution of the relationship. This is a critical omission for a question specifically asking about progression over time.\n\nCONCLUSION: The answer contains correct core facts but is substantially incomplete, missing the quantitative progression data that is central to answering the question about how the relationship 'evolved' from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 531,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "From FY 2022 through FY 2024 Cisco’s 5.90% senior note stayed at a $2,000 million principal with an unchanged effective rate of 6.11%.  At the same time, total long‑term debt grew from $8,416 million in FY 2022 to $19,621 million in FY 2024, so the note’s share of total debt fell from roughly 24 % to about 10 %.  This pattern shows Cisco using the 5.90% note as a stable, fixed‑rate financing tool while expanding its overall debt mix and maturities to support growth and manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - the 5.90% Note principal of $2,000 million is accurate for all three years (2022-2024), the effective interest rate of 6.11% is correct, and the long-term debt figures ($8,416M in 2022 and $19,621M in 2024) match the ground truth exactly. The LLM's calculated percentages are also accurate: $2,000M/$8,416M ≈ 23.8% (rounded to ~24%) and $2,000M/$19,621M ≈ 10.2% (rounded to ~10%), demonstrating correct mathematical synthesis. COMPLETENESS: The answer addresses all key aspects of the original question - the 5.90% Note's consistency, its effective interest rate, total debt composition changes, and strategic implications. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are properly referenced, and all financial metrics are correctly labeled. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple data points (note principal, effective rate, total debt figures) and correctly draws the logical conclusion about Cisco's financing strategy - using fixed-rate instruments while expanding overall debt. MINOR DIFFERENCES: The LLM's wording differs slightly from the ground truth (e.g., 'expanding its overall debt mix and maturities' vs. 'increasingly relying on long-term fixed-rate instruments'), but both convey the same strategic insight. The LLM also mentions short-term debt changes were not explicitly included, though this is a minor omission that doesn't affect the core answer's accuracy. The answer is semantically equivalent to the ground truth and demonstrates sound financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 457,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "Production rose from 399 LAVs in 2022 to 449 in 2023 (plus 66 LRSS LAVs), then fell to 360 in 2024 (GD_10k_2022.pdf, p.12; GD_10k_2023.pdf, p.12; GD_10k_2024.pdf, p.11). This pattern indicates a peak in 2023 followed by a contraction in 2024, suggesting that while General Dynamics remains a key LAV supplier for Canada, it may be reallocating resources or adjusting its production strategy in response to contract cycles or shifting priorities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that completely contradict the ground truth: (1) REVERSED NUMBERS: The LLM states production was 399 in 2022 and 449 in 2023, but ground truth shows 360 in 2022, 399 in 2023, and 449 in 2024. The LLM has shifted all years backward by one year. (2) INVERTED TREND: The LLM claims production 'fell to 360 in 2024,' which is factually wrong - 2024 production was 449 units (the highest). The LLM incorrectly interprets this as a 'contraction' and 'peak in 2023 followed by decline,' when the actual trend is consistent growth: 360→399→449. (3) MISSING CONTEXT: The LLM fails to properly contextualize the LRSS program. Ground truth indicates LRSS added 66 specialized LAVs in 2024 (supporting the growth narrative), but the LLM places this in 2023 and misinterprets the overall trend. (4) WRONG CONCLUSION: The LLM's interpretation of 'resource reallocation' and 'contraction' is completely unsupported by the actual data, which shows consistent year-over-year growth. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize information across the three years of 10-K filings, resulting in a systematically inverted timeline. The answer demonstrates a fundamental misunderstanding of the data progression and reaches an entirely incorrect strategic conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 376,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "From 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes intensified as CMS repeatedly froze or cut benchmarks and altered the risk‑adjustment methodology, thereby lowering capitation payments. In each filing the company noted that it had responded by selectively adjusting member benefits and premiums, withdrawing plans from certain counties, and ramping up medical and operating cost‑management initiatives to offset the funding pressure. The firm also emphasized a shift toward high‑value care delivery and technology investments to sustain margins amid the evolving risk‑adjustment environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the core issue (CMS risk adjustment payment changes from 2022-2024) and appropriate strategic responses. The answer correctly identifies key company actions: selective benefit/premium adjustments, county withdrawals, and cost management initiatives. The temporal evolution across the three-year period is properly captured. However, there are some notable differences from the ground truth: (1) The LLM introduces 'high-value care delivery and technology investments' as a strategic response, which is not mentioned in the original answer and may represent information not directly supported by the filings analyzed. (2) The LLM uses slightly stronger language ('intensified') regarding exposure escalation, while the ground truth emphasizes 'consistent' exposure with periodic changes. (3) The ground truth specifically mentions 'beneficiary health status data submissions' as a 2024 focus area, which the LLM omits. (4) The ground truth emphasizes 'sustained operational agility' as a key theme, while the LLM focuses more on specific tactical responses. Quantitatively, no numbers or dates are provided in either answer, so no calculation errors exist. The multi-hop reasoning is sound in both cases, correctly synthesizing information across three years. The LLM answer is slightly more concise and action-oriented but loses some nuance about the specific evolution of CMS's framework and UnitedHealth's adaptive responses. The introduction of unsupported strategic elements (technology investments) represents a minor factual concern that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 451,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PYPL’s exposure to the fixed‑rate 2.850% notes due 10/1/2029 stayed flat at $1.5 billion from 2022 through 2024 (2022: $1.5 B; 2023: $1.5 B; 2024: $1.5 B)【2022 pages 106‑110】【2023 pages 105‑109】【2024 pages 102‑106】. The unchanged balance indicates the company is maintaining a steady portion of moderate‑rate, long‑maturity debt while adding newer, higher‑rate notes to fund growth, reflecting a strategy of balanced, diversified long‑term financing rather than aggressive refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All numeric values are correct - the $1.5 billion carrying value is accurately stated for all three years (2022, 2023, 2024), and the maturity date of 10/1/2029 and interest rate of 2.850% are correctly identified. The flat trajectory across all three years is accurately represented. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the exposure evolved (remained constant at $1.5B), and (2) what this indicates about long-term debt strategy. ENTITY ACCURACY: PYPL ticker is correct, years are correct (2022-2024), the specific debt instrument is correctly identified with rate and maturity date. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and draws a logical conclusion about strategic intent. The reasoning that maintaining a constant position while adding newer, higher-rate notes reflects a 'balanced, diversified long-term financing' strategy is sound and goes slightly beyond the ground truth by providing additional context about the broader debt portfolio strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - constant $1.5B exposure across three years indicating consistent strategy - while adding slightly more detail about the strategic context (balanced financing, diversified approach). The characterization of the strategy as 'balanced, diversified long-term financing rather than aggressive refinancing' is a reasonable inference from the constant position in this moderate-rate instrument while adding newer notes. MINOR CONSIDERATION: The ground truth emphasizes 'strategic intent to preserve this liability structure,' while the LLM emphasizes 'balanced, diversified financing' - both are valid interpretations of the same underlying fact, though slightly different framings. The LLM's interpretation is reasonable and well-supported by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 533,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron has kept a 36.4 % stake in Angola LNG Limited through 2024, but its equity‑method investment fell from about $1.963 B in 2022 to $1.762 B in 2024, reflecting a modest decline in the affiliate’s earnings [CVX_10k_2024.pdf: pages 12‑16; CVX_10k_2023.pdf: pages 80‑84; CVX_10k_2022.pdf: pages 76‑80].  During the same period Chevron expanded its gas portfolio by taking a 31 % interest in the New G as Consortium Project (NGC), which will feed gas into the Angola LNG plant and has newly recognized proved reserves in 2024 [CVX_10k_2024.pdf: pages 12‑16].  These moves underscore a long‑term strategy to secure a stable feedstock base and integrate gas production with liquefaction to monetize Angola’s associated gas.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Chevron's Angola LNG strategy but has some gaps compared to the ground truth. STRENGTHS: (1) Correctly identifies the consistent 36.4% ownership stake in Angola LNG Limited across 2022-2024; (2) Accurately reports the equity-method investment decline from $1.963B (2022) to $1.762B (2024), showing quantitative precision; (3) Correctly identifies the New Gas Consortium Project (NGC) with 31% interest and its connection to Angola LNG; (4) Properly synthesizes the multi-hop concept that Chevron integrated upstream gas development with the existing LNG facility; (5) Appropriately characterizes the strategy as securing feedstock and integrating production with liquefaction. WEAKNESSES: (1) The ground truth mentions specific upstream acreage in Blocks 49 and 50, which the LLM answer omits; (2) The ground truth specifically names the Quiluma and Maboqueiro (Q&M) gas fields within NGC, which the LLM answer does not mention by name; (3) The LLM answer describes the evolution as 'standalone LNG export facility' transitioning to 'integrated hub,' but the original answer more explicitly frames this as a shift from 'processing and liquefying' (2022-2023) to 'integrated hub with expanding upstream development' (2024); (4) The LLM answer focuses heavily on financial metrics (equity-method investment values) which, while accurate, somewhat overshadows the strategic evolution narrative that the question emphasizes. QUANTITATIVE VERIFICATION: The 36.4% stake figure is correct; the investment values ($1.963B to $1.762B) appear reasonable for a decline reflecting affiliate earnings; the 31% NGC interest is correctly stated. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects upstream development to LNG monetization strategy, though it could have been more explicit about the specific asset names and geographic acreage. The reasoning is sound but somewhat incomplete in capturing all strategic details from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 548,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "From 2022 to 2023, Southern Company’s trust‑based domestic‑equity holdings jumped from $651 million to $849 million (a $198 million increase), while private‑equity holdings rose modestly from $161 million to $169 million. In 2024 the domestic‑equity level held steady at $849 million and private equity grew to $181 million. This pattern—an aggressive lift in domestic‑equity exposure followed by a gradual expansion of private‑equity stakes—shows a long‑term capital‑allocation strategy that seeks higher‑return equity diversification through trusts while maintaining a stable core asset base.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and systematic factual errors across all numeric values, making it fundamentally incorrect. QUANTITATIVE ERRORS: (1) 2022 domestic equity: LLM states $651M vs. ground truth $1,016M (error of $365M or 36% understatement); (2) 2023 domestic equity: LLM states $849M vs. ground truth $829M (minor $20M overstatement, but built on wrong baseline); (3) 2022 private equity: LLM states $161M vs. ground truth $150M (error of $11M); (4) 2023 private equity: LLM states $169M vs. ground truth $161M (error of $8M); (5) 2024 domestic equity: LLM states $849M (held steady from 2023) vs. ground truth $1,099M (massive error of $250M or 23% understatement); (6) 2024 private equity: LLM correctly states $181M. The LLM's narrative of 'aggressive lift in domestic-equity exposure from 2022-2023' is contradicted by ground truth showing a DECREASE from $1,016M to $829M. The claim that 2024 'held steady at $849M' is false; it actually rebounded significantly to $1,099M. MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year progression, mischaracterizing the trend direction and magnitude. The ground truth shows domestic equity declining 2022-2023 then rebounding 2023-2024, with private equity steadily increasing—a pattern the LLM completely misrepresented. ENTITY/METRIC ACCURACY: While Southern Company is correctly identified, the trust investment metrics are systematically wrong. The conclusion about 'aggressive lift in domestic-equity exposure' contradicts the actual data showing initial decline. This is a fundamental failure in data accuracy that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 447,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "Eliminations/Reclassifications rose from a $107 million negative adjustment in 2022 to $151 million in 2023 and then to $296 million in 2024, roughly doubling the impact each year. This upward trend shows that GM’s internal cross‑segment transactions and reclassifications are becoming more extensive—particularly as the company integrates its financial‑services and Cruise units—requiring larger adjustments to reconcile segment revenues and keep consolidated figures accurate.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. (1) 2022 figure: LLM states $107 million, but ground truth shows $105 million - this is a $2 million error on the first data point. (2) 2023 figure: LLM states $151 million, but ground truth shows $107 million - this is a massive $44 million discrepancy (41% error). (3) 2024 figure: LLM correctly states $296 million, matching ground truth. The LLM got only 1 out of 3 years correct. CALCULATION/TREND ANALYSIS ERROR: The LLM claims the impact 'roughly doubled each year,' but this is mathematically incorrect even with the wrong numbers provided ($107M to $151M is ~41% increase, not doubling; $151M to $296M is ~96% increase). With correct numbers ($105M to $107M to $296M), the trend shows minimal change 2022-2023 (only $2M increase) then a dramatic jump in 2024 (nearly tripling from 2023). The LLM fundamentally mischaracterized the trend pattern. REASONING QUALITY: While the LLM's qualitative explanation about increasing complexity and cross-segment transactions is plausible and contextually relevant, it is built on incorrect numerical foundations. The speculation about financial-services and Cruise unit integration, while potentially reasonable, goes beyond what can be verified from the ground truth data and appears to be unsupported inference. MULTI-HOP SYNTHESIS: The question requires tracking three years of data and identifying a trend - the LLM failed at the basic data retrieval step, making the multi-hop synthesis unreliable. The correct answer shows a different pattern (stable 2022-2023, then sharp increase 2024) than what the LLM describes (consistent doubling). This is a fundamental failure on the primary metric of this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 492,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In 2022 Netflix disclosed its Performance Bonus Plan as a standalone plan (Exhibit 10.6†) that was not incorporated by reference. By the 2023 filing the plan had been amended and restated (Exhibit 10.5†) and formally incorporated by reference, solidifying its documentation. The 2024 filing kept the plan incorporated by reference and positioned it within the company’s broader compensation framework, linking it to other plans such as the Executive Severance and Retention Incentive Plan (Exhibit 10.6†).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misrepresentations when compared to the ground truth: (1) EXHIBIT NUMBERING ERROR: The LLM states the 2022 plan was 'Exhibit 10.6†' but the ground truth clearly indicates it was 'Exhibit 10.6†' with a filing date of April 28, 2014. However, the LLM then claims the 2023 plan was 'Exhibit 10.5†' which matches ground truth, but then incorrectly states the 2024 plan linked to 'Executive Severance and Retention Incentive Plan (Exhibit 10.6†)' - this appears to confuse different plans and exhibit numbers. (2) INCORPORATION BY REFERENCE CLAIM: The LLM introduces a claim about 'incorporated by reference' status that is NOT present in the ground truth. The ground truth makes no mention of incorporation by reference; it focuses on the plan being 'amended and restated' in 2023. This is a material factual error. (3) MISSING KEY DETAILS: The LLM omits the specific filing date of December 9, 2022 for the 2023 amendment, which is important context. (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes the plan's integration with 'performance-based restricted stock unit agreements' as a foundational document, but the LLM incorrectly references the 'Executive Severance and Retention Incentive Plan' instead. (5) LOGICAL FLOW: While the LLM attempts to show progression across years, it introduces unsupported claims about incorporation by reference and misidentifies related compensation structures. The core narrative of amendment in 2023 followed by stabilization in 2024 is partially correct, but the supporting details are inaccurate. The answer demonstrates partial understanding of the timeline but fails on factual accuracy regarding specific exhibit numbers, related plans, and the nature of the documentation changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 486,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK consistently referenced its “Business Relationships and Related Party Transactions Policy” in all three filings—appearing in the 2022 proxy (pages 11‑15), the 2023 proxy (pages 12‑16) and the 2024 proxy (pages 12‑16)—with no material changes to the policy text or its disclosure. The corporate‑governance sections that cite director independence and the committee structure (Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources & Compensation Committees) are likewise identical across the 2022, 2023 and 2024 filings, underscoring a stable, consistent approach to governance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that BK consistently disclosed the 'Business Relationships and Related Party Transactions Policy' across all three years (2022, 2023, 2024), correctly names all three committees (Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources & Compensation), and accurately conveys the core finding that the approach was stable and consistent. The semantic meaning aligns well with the ground truth regarding uniform corporate governance disclosures. The answer appropriately addresses the multi-hop synthesis requirement by connecting policy disclosure to director independence and committee structures across multiple years.\n\nWEAKNESSES: The LLM introduces specific page numbers (2022 proxy pages 11-15, 2023 proxy pages 12-16, 2024 proxy pages 12-16) that are NOT present in the ground truth answer. This is problematic because: (1) the ground truth does not provide page citations, (2) these specific page numbers cannot be verified against the ground truth and may be hallucinated, (3) introducing unverified quantitative details (page numbers) violates the principle of strict accuracy on specific facts. The LLM also states the policy text had 'no material changes' and that sections are 'identical across' years—claims not explicitly made in the ground truth, which only states 'consistent placement and linkage' and 'stable and uniform approach.' While the conclusion is similar, the LLM overstates the degree of sameness by claiming identity rather than consistency.\n\nQUANTITATIVE ACCURACY: The page number citations (11-15, 12-16, 12-16) are unverified and potentially inaccurate. This is a significant issue for quantitative precision. The years (2022, 2023, 2024) are correct.\n\nQUALITATIVE ACCURACY: The reasoning about consistent governance disclosures is sound and the multi-hop synthesis across three years and multiple governance elements is correct. However, the claim of 'identical' sections and 'no material changes' goes beyond what the ground truth supports.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution and consistency of disclosures, appropriately focusing on the stability of the governance framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 598,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "From 2022 to 2024 the fair value of UnitedHealth’s debt securities held‑to‑maturity fell from **$679 million to $508 million**, while the carrying (amortized‑cost) value declined from **$696 million to $512 million**.  The gap between fair value and carrying value narrowed each year (from $17 m in 2022 to $4 m in 2024), showing that the company’s unrealized losses are modest and largely driven by interest‑rate movements rather than credit deterioration.  This trend reflects a conservative, capital‑preservation strategy that holds high‑quality, low‑risk bonds to maturity, with fair‑value reporting used only to monitor temporary market fluctuations that are expected to converge back to the amortized cost.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of the question. (1) FAIR VALUE ERRORS: LLM states fair value fell from '$679 million to $508 million' but ground truth shows it declined from $643 million (2022) to $596 million (2023) to $508 million (2024). The 2022 starting value of $679M is incorrect (should be $643M), representing a 5.6% error. The LLM also fails to provide the intermediate 2023 value of $596M, missing a critical data point for the 3-year trend analysis. (2) CARRYING VALUE ERRORS: LLM states carrying value declined from '$696 million to $512 million' but ground truth shows $641 million (2022) to $603 million (2023) to $512 million (2024). The 2022 starting value of $696M is incorrect (should be $641M), representing an 8.6% error. Again, the 2023 intermediate value of $603M is omitted. (3) GAP ANALYSIS ERRORS: LLM calculates the gap as '$17M in 2022' but with correct numbers ($643M fair value vs $641M carrying value), the gap should be only $2M, not $17M. This is a fundamental calculation error that undermines the entire analysis of unrealized losses. (4) MISSING CRITICAL INSIGHT: The ground truth specifically mentions 'a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.' The LLM answer completely omits this important qualitative insight about valuation methodology changes. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information about investment strategy and valuation assumptions, it does so based on incorrect numbers, making the conclusions unreliable. The reasoning about interest-rate movements vs. credit deterioration is plausible but built on a faulty foundation. (6) COMPLETENESS: The LLM fails to provide the complete 3-year trend with all intermediate values, which is essential for understanding the evolution requested in the question. The answer only shows endpoints rather than the full trajectory. The LLM's interpretation of the trend as reflecting a 'conservative, capital-preservation strategy' may be reasonable, but it cannot be properly evaluated when based on incorrect financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 600,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "PayPal’s BNPL loan portfolio was a source of bad‑transaction risk in 2022, as noted in its risk‑factor disclosures [24].  In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL receivables, beginning in October 2023, which markedly reduced that exposure [23].  By 2024 PayPal continued to mitigate risk by selling future BNPL receivables and using forward‑flow arrangements, underscoring a strategy of off‑loading credit risk to third parties and structuring financing to limit bad‑transaction losses [21].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numbers are correct: €40 billion BNPL receivables sale amount, June 2023 agreement date, October 2023 implementation start date. (2) The three-year evolution is properly captured: 2022 exposure acknowledgment, 2023 strategic sale agreement, 2024 continued mitigation through forward-flow arrangements. (3) Multi-hop reasoning is sound - the answer correctly connects the June 2023 agreement to risk reduction and links this to PayPal's broader risk mitigation strategy. (4) Entity identification is accurate (PayPal, U.K. and European BNPL receivables, bad transactions/fraud risks). (5) The semantic meaning aligns well with ground truth regarding PayPal's strategic shift from holding BNPL risk to offloading it. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth and omits some contextual detail about 'conditions' that could delay benefits in 2024 - the ground truth explicitly notes 'the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits,' which the LLM answer doesn't mention. (2) The phrase 'beginning in October 2023' adds helpful specificity not in the ground truth but is factually accurate based on typical filing disclosures. (3) The answer could have been slightly more explicit about the ongoing challenges of fraud and abuse mentioned in the ground truth. CALCULATION/VERIFICATION: No calculations required; all dates and amounts verified as correct. The €40 billion figure is the key quantitative metric and is accurately stated. The temporal sequence (2022→June 2023→October 2023→2024) is logically sound and properly ordered.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 485,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream production in Myanmar declined sharply: it was 17 MBD oil‑equivalent and 94 MMCFD natural gas in 2022, fell to 15 MBD and 87 MMCFD in 2023, and dropped further to 4 MBD and 22 MMCFD in 2024【CVX_10k_2023.pdf page 7】【CVX_10k_2024.pdf page 7】. This steep reduction reflects Chevron’s strategic exit from Myanmar, which the company announced in April 2024【CVX_10k_2024.pdf page 7】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic shift (complete exit from Myanmar in April 2024) and provides the correct 2022-2023 oil production figures (17 MBD declining to 15 MBD). The answer appropriately addresses the multi-hop question by synthesizing production volume changes with strategic implications. The April 2024 exit date is accurate.\n\nWEAKNESSES: The LLM introduces natural gas production figures (94 MMCFD in 2022, 87 MMCFD in 2023, 22 MMCFD in 2024) that are NOT mentioned in the ground truth answer. While these figures may be factually present in the 10-K filings, the ground truth specifically focuses only on oil production in barrels per day. The LLM's inclusion of natural gas data represents an expansion beyond what the ground truth validates, creating uncertainty about accuracy. More critically, the LLM states production 'dropped further to 4 MBD and 22 MMCFD in 2024,' but the ground truth indicates a complete withdrawal in April 2024, not a reduction to 4 MBD. This suggests either: (1) the 4 MBD figure represents partial-year production before the April exit, or (2) it is incorrect. The ground truth's statement of 'completely withdrew' contradicts the implication of ongoing 4 MBD production in 2024.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the production decline trend with the strategic exit announcement, demonstrating sound multi-hop reasoning. The connection between declining volumes and portfolio optimization/risk management is appropriately made.\n\nQUANTITATIVE CONCERNS: The 2024 figure of 4 MBD is problematic given the stated April 2024 complete withdrawal. If the company exited in April, the annual 2024 figure should reflect only partial-year operations, but this distinction is not clarified. The natural gas figures lack ground truth validation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 496,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "PC & Notebooks made up a larger portion of Texas Irradiation’s Personal Electronics segment in 2022, fell in 2023, and rose again in 2024.  The segment itself dropped from 24 % of total revenue in 2022 to 15 % in 2023, then rebounded to 20 % in 2024, showing TI is recalibrating its consumer‑computing focus—shifting away from the cyclical PC market when demand weakens and re‑engaging it as the market recovers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All three key percentages are correct: Personal Electronics segment was 24% in 2022, 15% in 2023, and 20% in 2024. (2) The directional trend is accurately captured (decline then rebound). (3) The numeric values match the ground truth exactly. CRITICAL ERRORS: (1) Company name is wrong - 'Texas Irradiation' instead of 'Texas Instruments' (TI). This is a significant entity identification error that undermines credibility. (2) The answer lacks specificity about PC & Notebooks' relative contribution within the segment - the ground truth notes that PC & Notebooks appeared 'lower in the list of priorities compared to mobile phones and portable electronics' in 2024, but the LLM only vaguely states it 'fell in 2023, and rose again in 2024' without quantifying the actual subcategory percentages. (3) The strategic interpretation differs: Ground truth emphasizes 'strategic shift away from PC & Notebooks' with focus on 'higher-growth or higher-margin areas within Automotive and Industrial markets.' The LLM's interpretation of 'recalibrating consumer-computing focus' and 'cyclical PC market' reasoning is plausible but not directly supported by the ground truth and represents speculation rather than documented strategic positioning. (4) The answer doesn't fully address the multi-hop synthesis required - it should have provided PC & Notebooks' specific percentage contribution within the Personal Electronics segment for each year, not just the segment's overall contribution to total revenue. QUANTITATIVE ACCURACY: Numbers are correct (7/10) but incomplete - missing the subcategory breakdown. QUALITATIVE ACCURACY: Reasoning is partially sound but contains entity error and lacks the specific strategic context from ground truth (5/10). CONTEXTUAL RELEVANCE: Addresses the question but with incomplete analysis and wrong company name (6/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 505,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks (pages 89‑93, 90‑94, 91‑95), GM consistently reported **no material indemnification liability or accrual** for its 2017 Opel/Vauxhall sale to Stellantis and stated it could not estimate any material loss from potential claims. The company has continued to indemnify Stellantis for an **immaterial amount for certain recalls—including Takata inflators in legacy Opel vehicles**—and has deemed any further indemnification for those recalls “remote.” Consequently, the known liabilities remained immaterial, no accruals were recorded, and potential future exposures stayed remote over the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) INCOMPLETE SYNTHESIS: The LLM answer significantly understates the evolution of GM's indemnification obligations. The ground truth explicitly identifies that by 2023, GM disclosed indemnification for 'certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls' - a much broader scope than just Takata recalls. The LLM answer focuses narrowly on Takata inflators and misses the broader categories of indemnified items. (2) MISSING KEY REGULATORY EXPOSURE: The ground truth specifically mentions 'accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era' in 2024. This is a critical regulatory development that the LLM answer completely omits. This represents a material evolution in the nature of obligations (from general product liability to specific regulatory investigation). (3) MISCHARACTERIZATION OF 2022: The LLM states 'no material indemnification liability or accrual' in 2022, which aligns with ground truth, but the answer then conflates this with later years by saying 'remained immaterial' and 'no accruals were recorded' across all three years. The ground truth clearly indicates that by 2024, accruals WERE recorded (albeit immaterial amounts) for the EC/CMA investigation. (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes 'increasing specificity and emerging regulatory risk exposure over time' - a key insight about the TREND. The LLM answer presents a static picture ('consistently reported no material liability') rather than capturing the evolution from 2022 (no disclosures) → 2023 (broader indemnification categories disclosed) → 2024 (specific regulatory accruals). (5) QUANTITATIVE ACCURACY: While both answers correctly identify amounts as 'immaterial,' the LLM fails to distinguish between different types of immaterial accruals (general indemnification vs. specific EC/CMA investigation accruals). (6) POSITIVE ELEMENTS: The LLM correctly identifies the Takata-related indemnification as 'remote' for future claims and correctly notes the immaterial nature of known liabilities. The page references provided (89-93, 90-94, 91-95) are reasonable but cannot be verified without source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 616,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower’s 1.450% Senior Notes due 2026 were first issued under Supplemental Indenture No. 10 on September 27 2021 (see Exhibit 4.21).  The notes remained on the company’s long‑term debt schedule in each subsequent filing—reported as outstanding in the 2022 10‑K (pp. 70‑74), the 2023 10‑K (pp. 68‑72), and the 2024 10‑K (pp. 70‑74)—with no additional issuances or redemptions.  This steady, long‑dated, low‑coupon debt profile demonstrates American Tower’s strategy of maintaining a stable, low‑interest‑rate leverage mix to fund growth while managing refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the notes as 1.450% Senior Notes due 2026; (2) Correctly references Supplemental Indenture No. 10; (3) Correctly identifies September 27, 2021 as the issuance date; (4) Correctly notes the notes remained outstanding across all three years with no additional issuances or redemptions; (5) Provides reasonable interpretation of debt management strategy focused on stable, low-interest leverage. CRITICAL ERRORS: (1) EXHIBIT MISMATCH - The LLM cites Exhibit 4.21 for the 2021 issuance date, but the ground truth indicates the notes were introduced in 2022 under Exhibit 4.25 (dated September 27, 2021). The LLM conflates the exhibit number from 2024 (4.21) with the 2021 issuance documentation. This is a factual error in document citation. (2) PAGE NUMBER CLAIMS - The LLM provides specific page ranges (pp. 70-74 for 2022 and 2024; pp. 68-72 for 2023) without verification against ground truth, which does not provide these page numbers. This represents unsupported specificity. (3) EXHIBIT PROGRESSION MISSING - The ground truth explicitly documents the exhibit progression (4.25 in 2022, 4.22 in 2023, 4.21 in 2024), showing continuity in documentation structure. The LLM only mentions 4.21 and misattributes it to the original issuance. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of stability and no refinancing. However, the document citation errors undermine the credibility of the multi-hop synthesis. The interpretation of debt management strategy is reasonable but somewhat generic and not deeply grounded in the specific exhibit progression pattern that the ground truth emphasizes. SEMANTIC EQUIVALENCE: The core narrative about stable debt management is semantically equivalent to the ground truth, but the factual errors in exhibit citations and unsupported page numbers create material inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 537,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan remained the governing framework for new equity awards from 2022 through 2024, with each year adding new deferred‑stock‑unit and performance‑share‑unit agreements: 2022 (Exhibit 10.18 and 10.19) (BK_10k_2022.pdf pages 18‑22), 2023 (Exhibit 10.23 and 10.24) (BK_10k_2023.pdf pages 16‑20), and 2024 (Exhibit 10.28 and 10.29) (BK_10k_2024.pdf pages 16‑20). These agreements are documented in the respective 10‑K filings for each year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer has significant factual errors and fails to accurately synthesize the multi-hop information required. Key issues: (1) INCORRECT EXHIBIT NUMBERS: The LLM cites Exhibits 10.18, 10.19, 10.23, 10.24, 10.28, 10.29 without verification against actual filings. The ground truth references specific forms (2019 Form of Performance Share Unit Agreement, 2019 Form of Restricted Stock Unit Agreement, Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors, 2022 Form of Performance Share Unit Agreement) but does not confirm these exhibit numbers match. (2) MISSING CRITICAL DETAILS: The LLM answer completely omits the introduction of the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' in 2023, which is a key evolution mentioned in the ground truth showing extension to director-level compensation. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the progression showing 'incremental refinements and broader application over time' and 'multi-year strategic alignment of executive and director incentives,' but the LLM answer merely lists exhibits without explaining the strategic evolution or the significance of extending to directors. (4) VAGUE SOURCING: While the LLM provides page numbers, it does not substantiate whether these are accurate or whether the specific forms mentioned in the ground truth actually appear at those locations. (5) LACKS NARRATIVE CONTEXT: The ground truth provides meaningful context about how the plan evolved (early implementation → director extension → newer forms), while the LLM answer is purely structural/documentary without explaining the strategic progression. The answer is partially correct in identifying the 2019 plan as the governing framework and acknowledging new agreements across the three years, but fails on specificity, completeness, and meaningful synthesis of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 513,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "Across 2022‑24 the Combat Systems segment’s OTS unit consistently highlighted the supply of “critical aerostructures” for both legacy and next‑generation missiles (including hypersonic rocket cases) in its annual disclosures.  Revenue from weapons systems, armament and munitions rose from $2.02 bn in 2022 to $2.93 bn in 2024, underscoring a growing emphasis on advanced missile subsystems.  This 3‑year trend shows General Dynamics positioning itself as a key provider of sophisticated aerostructure technology for next‑generation missile platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about General Dynamics' aerostructures focus but has significant quantitative gaps and introduces unverified claims. STRENGTHS: (1) Correctly identifies the consistent emphasis on 'critical aerostructures' across 2022-2024; (2) Appropriately notes the Combat Systems segment's strategic positioning in next-generation missile subsystems; (3) Correctly identifies the upward revenue trend in weapons systems/armament/munitions; (4) Properly synthesizes multi-hop information about segment focus and strategic positioning. WEAKNESSES: (1) MISSING KEY METRIC - Ground truth explicitly states Combat Systems was 20% of consolidated revenue in 2023 and 19% in 2024, but LLM provides no revenue percentage data, which is a core part of the original answer's quantitative analysis; (2) UNVERIFIED CLAIM - LLM introduces 'hypersonic rocket cases' as a specific product category with no corroboration in ground truth; (3) INCOMPLETE REVENUE DATA - While LLM provides weapons systems revenue ($2.02bn in 2022 to $2.93bn in 2024), ground truth does not explicitly confirm these specific figures, making verification impossible; (4) MISSING SEGMENT REVENUE SHARE ANALYSIS - Ground truth emphasizes the slight decline from 20% to 19% as significant context, but LLM omits this entirely. CALCULATION VERIFICATION: The $2.02bn to $2.93bn increase represents approximately 45% growth, which is mathematically sound if the numbers are accurate, but cannot be verified against ground truth. The LLM answer is directionally correct about the strategic positioning and aerostructures focus but fails to include critical revenue percentage metrics that were central to the original answer's analysis of the 3-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 475,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "In each of the 2022, 2023, and 2024 10‑K filings (pages 3‑7, 4‑8, and 3‑7 respectively), PMI lists Jackpot as one of its local cigarette brands in the Philippines, with no change in wording or emphasis. This steady positioning shows that PMI treats Jackpot as a stable local brand that underpins its regional strategy to maintain market share in the Philippines while complementing its broader international portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Jackpot as a local cigarette brand in the Philippines mentioned across 2022, 2023, and 2024 filings. The core observation that Jackpot appears consistently across three years is accurate. The general conclusion about stable positioning is reasonable.\n\nWEAKNESSES: (1) The LLM answer is significantly less complete than the ground truth. It omits important contextual details: Fortune is not mentioned as a companion local brand, the Swedish Match integration context is missing, the expansion to 95 smoke-free markets is not mentioned, and IQOS and ZYN brand emphasis is absent. (2) The LLM's claim of 'no change in wording or emphasis' is presented as fact but cannot be verified from the provided answer - this is a specific assertion about filing language that requires document verification. (3) The answer lacks the nuanced understanding present in the ground truth: that despite PMI's smoke-free future vision, traditional cigarette brands remain strategically relevant. The LLM's framing focuses narrowly on 'maintaining market share' without capturing the broader strategic tension. (4) The page number citations (pages 3-7, 4-8, 3-7) are provided but cannot be verified and may be inaccurate. (5) The answer doesn't address the 'multi-year progression' aspect of the question as thoroughly - it notes consistency but doesn't explore what this consistency means in the context of PMI's evolving portfolio strategy.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to integrate the broader strategic context (Swedish Match integration, smoke-free expansion, product portfolio evolution) that the ground truth includes. This represents incomplete multi-hop synthesis.\n\nSEMANTIC EQUIVALENCE: While the core claim about consistent positioning is semantically similar to the ground truth, the LLM answer is substantially narrower in scope and misses critical strategic context that answers the 'what does this indicate' portion of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 549,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "Chevron’s activity in the Republic of Congo moved from a passive holding to a divestiture. In 2022 and 2023 the company listed the country as an operating jurisdiction but reported no capital deployment or asset disposition there (Business Environment and Outlook, p. 32; 2023 10‑K, p. 107‑111). By 2024, Chevron announced the sale of its 31.5 % non‑operated interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of Lianzi, signalling a shift toward divesting rather than investing in the region (Noteworthy Developments, p. 41‑45).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the key asset dispositions: 31.5% nonoperated interest in Haute Mer and 15.75% interest in Lianzi. (2) The percentages are accurate and match ground truth. (3) The overall narrative arc (from operational presence to divestiture) is correctly captured. (4) The 2024 divestiture timing is correct. WEAKNESSES: (1) CRITICAL OMISSION: The LLM states 'reported no capital deployment or asset disposition there' in 2022-2023, but the ground truth explicitly mentions Chevron invested approximately $0.7 billion across offshore development and natural gas projects in Africa in 2023, which included activity in the Republic of Congo. This is a significant factual error that contradicts the ground truth. (2) The LLM characterizes 2022-2023 as 'passive holding' when the ground truth indicates 'active capital deployment' in 2023. (3) The LLM fails to synthesize the complete 3-year evolution: it misses the $0.7 billion investment component that was part of the trajectory. (4) The citation references (page numbers) provided by the LLM cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. MULTI-HOP REASONING: The LLM partially synthesizes the information but fails on a critical component - the 2023 capital deployment. The question asks about 'capital deployment and asset disposition' across the 3-year period, and the LLM only addresses disposition while incorrectly stating there was no capital deployment. This is a fundamental gap in answering the multi-part question. QUANTITATIVE ACCURACY: The asset percentages (31.5% and 15.75%) are correct, but the omission of the $0.7 billion investment figure is a major quantitative gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 468,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "From 2022 to 2024 Southern Company kept outdoor lighting contracts classified as operating leases with scheduled payments that renew on a month‑to‑month basis after the initial term, but it extended the initial term from up to 7 years to up to 10 years (2022 note p. 270; 2024 note p. 232). Lease payments for Southern Company (and Alabama Power) remained material, while those for Georgia Power and Mississippi Power were immaterial (2024 note p. 233). Revenue allocation for PPAs stayed unchanged—Alabama Power and Southern Power allocate revenue to non‑lease components based on stand‑alone selling price—and the lease income for Southern Company fell from $208 million in 2022 to $136 million in 2024 (2022 note p. 272; 2024 note p. 231).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific financial data and attempts multi-hop synthesis across subsidiaries and years, but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that outdoor lighting contracts remained classified as operating leases from 2022-2024, mentions the extension of initial terms (7 to 10 years), identifies materiality differences across subsidiaries (material for Southern Company/Alabama Power, immaterial for Georgia Power/Mississippi Power), and correctly notes that revenue allocation for PPAs remained unchanged. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific lease income figures ($208M in 2022 declining to $136M in 2024) with page citations, but these cannot be verified against the ground truth provided. The ground truth does not mention these specific dollar amounts or the 7-to-10 year term extension, making it impossible to confirm accuracy. The LLM cites specific page numbers (p. 270, 232, 233, 272, 231) which suggests detailed source material, but the ground truth does not reference these figures. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple subsidiaries (Southern Company, Alabama Power, Georgia Power, Mississippi Power, Southern Power) and compares 2022 vs 2024 positions. However, it misses the 2023 intermediate step mentioned in the ground truth regarding 'scheduled lease payments under outdoor lighting contracts as part of maturity analyses.' (4) GROUND TRUTH GAPS: The original answer emphasizes a progression from 'immaterial' (2022) to 'more structured approach' (2023) to 'expanded disclosure' (2024), but the LLM answer jumps directly from 2022 to 2024 without acknowledging the 2023 transition. The ground truth mentions 'growing emphasis on transparency and standardization' which the LLM answer does not capture. (5) SPECIFICITY MISMATCH: The LLM provides very specific numbers and page citations that don't appear in the ground truth, raising questions about whether these are accurate or hallucinated. The ground truth is more qualitative about the evolution of disclosure practices, while the LLM is more quantitative but potentially unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 586,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Across FY 2022‑2024 Cisco’s 3.50% senior note stayed at a carrying amount of **$500 million** each year, but its effective interest rate rose from **3.20%** in FY 2022 to **6.38%** in FY 2023 and to **6.66%** in FY 2024 (long‑term debt tables in the 2022, 2023, and 2024 10‑Ks). The unchanged principal but higher effective rate reflects tightening market rates and a discount to fair value, indicating that Cisco’s borrowing cost has increased while the note’s valuation remains stable in terms of principal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All numbers are correct - carrying amount of $500 million across all three years (FY 2022, 2023, 2024), effective interest rates of 3.20% (FY 2022), 6.38% (FY 2023), and 6.66% (FY 2024) match the ground truth exactly. No calculation errors present. (2) COMPLETENESS: The answer addresses all key aspects of the multi-part question: the evolution of carrying amount, the progression of effective interest rates across the three-year period, and the interpretation of what this progression indicates about debt valuation and market conditions. (3) ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note, the specific fiscal years, and the relevant financial metrics (carrying amount and effective interest rate). (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the relationship between unchanged principal amounts and rising effective rates as reflecting market conditions and valuation dynamics. The explanation that 'unchanged principal but higher effective rate reflects tightening market rates and a discount to fair value' demonstrates sound financial reasoning. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that rising effective rates indicate 'tightening market rates' and 'increased borrowing cost' is semantically equivalent to the ground truth's statement about 'shift in market conditions or internal risk assessments.' The LLM provides slightly more specific financial context by mentioning 'discount to fair value,' which adds value without contradicting the ground truth. Minor: The LLM's phrasing is slightly more detailed and technical than the ground truth, but this represents an enhancement rather than an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 493,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 35A stayed identical: a $750,000 face amount, a 2.65 % coupon, and a maturity of July 15 2030【source】【source】【source】.  The unchanged terms show the company’s preference for a stable, low‑cost, long‑term debt instrument and a conservative refinancing policy that avoids frequent issuance or rollover of this note.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all quantitative facts - $750 million face value, 2.65% coupon rate, and July 15, 2030 maturity date are accurate. The statement that these terms remained unchanged across 2022-2024 is factually correct. Number formatting is acceptable ($750,000 vs $750 million - both represent the same value correctly). WEAKNESSES: The answer is significantly incomplete in addressing the multi-part question. The original question asks about 'how exposure evolved' and what the 'multi-year pattern reveals about long-term debt management strategy.' The LLM provides only the first part (the static nature of 35A) but fails to address the broader strategic context. Specifically missing: (1) No mention of the contrast with 'broader changes in their unsecured debt portfolio' that the ground truth emphasizes; (2) No reference to new issuances like the 2024 $1 billion Unsecured Notes - 41A; (3) No discussion of refinancing of credit facilities; (4) Limited strategic analysis - the LLM mentions 'preference for stable, low-cost debt' and 'conservative refinancing policy' but doesn't explain how the 35A stability contrasts with selective refinancing/new debt issuances elsewhere in the portfolio. The LLM answer reads as a partial response that captures the surface-level facts but misses the multi-hop synthesis required to fully answer the question about debt management strategy. The reasoning about 'conservative refinancing policy' is somewhat inferred rather than grounded in the comparative analysis the ground truth provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 429,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has consistently positioned embedded‑processing products as a core element of its broad‑portfolio advantage (b) in all three filings, and it continues to target the industrial and automotive markets for these products (2022 p. 18‑22; 2023 p. 16‑20; 2024 p. 16‑20).  While the company’s messaging has not changed, embedded‑processing revenue grew 3 % from 2022 ($3,261 bn) to 2023 ($3,368 bn) and then fell 25 % to $2,533 bn in 2024 (2023 p. 16‑20; 2024 p. 16‑20).  Thus, the strategic emphasis remains embedded‑processing‑centric, but the relative contribution to the broad‑portfolio advantage has contracted in 2024, prompting a recalibration of focus within that advantage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific revenue figures ($3,261bn for 2022, $3,368bn for 2023, $2,533bn for 2024) and growth calculations (3% growth 2022-2023, 25% decline 2023-2024) that cannot be verified against the ground truth. The ground truth does not provide these specific numbers, suggesting the LLM may have fabricated or misread financial data. The notation '$3,261 bn' is also problematic (bn typically means billions, making these implausibly large figures for a product segment). (2) INCOMPLETE ANSWER TO CORE QUESTION - The original question asks about evolution of strategic emphasis within the context of 'four sustainable competitive advantages.' The ground truth explicitly identifies Embedded Processing as 'the second of four sustainable competitive advantages' and emphasizes the CONSISTENCY of messaging across 2022-2024 using identical phrasing about 'more opportunity per customer and more value for our investments.' The LLM answer mentions 'broad-portfolio advantage (b)' but does not clearly establish the framework of four advantages or verify the specific language consistency claimed in ground truth. (3) MULTI-HOP REASONING FLAW - The LLM attempts to add a new dimension (revenue trends and 'recalibration of focus') that is not present in the ground truth. While this could be valid analysis, it contradicts the ground truth's emphasis on STABLE strategic framing. The ground truth explicitly states 'the strategic framing remained stable' and 'the repeated emphasis over three consecutive years underscores the sustained importance.' The LLM's conclusion about 'recalibration of focus' is not supported by the ground truth. (4) MISSING KEY EVIDENCE - The ground truth emphasizes the identical phrasing used each year ('more opportunity per customer and more value for our investments') as evidence of consistency. The LLM does not verify or reference this specific language consistency. (5) CONTEXTUAL MISALIGNMENT - The LLM shifts focus to revenue performance and market targeting, which, while potentially relevant, deviates from the ground truth's emphasis on strategic positioning within the four-advantage framework and messaging consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 593,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2024, Comcast’s wireless plans consistently offered unlimited, shared, and per‑gigabyte options, with 2024 adding prepaid unlimited plans under the NOW brand and extending unlimited choices to international subscribers (CMCSA_10k_2022, pp. 5‑9; CMCSA_10k_2023, pp. 3‑7; CMCSA_10k_2024, pp. 3‑7). Internationally, the company expanded its MVNO presence to the United Kingdom (and Italy) using third‑party networks and its own core network, offering both gigabyte‑tier and unlimited plans and extending device‑financing terms to 24‑48 months for overseas customers (CMCSA_10k_2024, pp. 3‑7).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. STRENGTHS: (1) Correctly identifies the evolution from 2022-2024, (2) Accurately mentions the NOW brand prepaid unlimited plans in 2024, (3) Correctly identifies international expansion to UK and Italy, (4) Properly notes device-financing terms extended to 24-48 months, (5) Appropriately cites source documents. WEAKNESSES: (1) The claim that 2022 offered 'unlimited, shared, and per-gigabyte options' contradicts the ground truth, which states 2022 offerings were 'exclusively as part of bundled service offerings' with no mention of per-gigabyte plans in that year - this is a significant factual error, (2) The answer suggests consistency across all three years ('consistently offered unlimited, shared, and per-gigabyte options') when the ground truth shows evolution and change, particularly in 2022 being more limited, (3) The answer doesn't clearly distinguish the 2022 baseline (bundled only) from the 2023 expansion (choice between three types) and 2024 further expansion (international + NOW brand), (4) The phrasing 'extending unlimited choices to international subscribers' is somewhat vague compared to the ground truth's clearer delineation of domestic vs. international offerings. MULTI-HOP REASONING: The answer does synthesize information across three years and multiple geographic markets, but the synthesis is flawed because it overstates consistency rather than capturing the actual evolution. The international expansion details are accurate but the domestic evolution narrative is distorted. The answer demonstrates understanding of the question's multi-part nature but fails to accurately capture the progression of plan flexibility over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 471,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s risk disclosures warned that third‑party abuse—such as synthetic identities, stolen cards and other fraud—could target its consumer credit and merchant‑financing programs, and that its proprietary credit‑risk models might mis‑price default risk. By 2023 the filings expanded this theme, stressing new and evolving fraud schemes linked to the company’s expanding credit offerings and the need for continuous improvement of fraud‑detection systems, while still citing default risk. In 2024 the disclosures broadened further to include the sale of BNPL loan receivables, greater reliance on third‑party lenders, and heightened exposure to third‑party fraud schemes, underscoring that risk management now must juggle increasingly complex credit, fraud, and regulatory challenges across a rapidly growing digital‑payments ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PayPal's evolving fraud and credit risk exposure from 2022-2024, with generally accurate synthesis across the three-year period. STRENGTHS: (1) Correctly identifies the progression of fraud types (synthetic identities, stolen cards, account takeovers) across the years; (2) Accurately references the BNPL loan receivables sales and third-party lender involvement; (3) Properly synthesizes the multi-hop information showing increasing complexity in risk management; (4) Correctly identifies the shift from proprietary credit models to third-party fraud concerns. WEAKNESSES: (1) The LLM answer omits the specific €40 billion figure mentioned in the ground truth regarding the U.K. and European BNPL loan receivables sale agreement - this is a material quantitative detail that should have been included; (2) Does not explicitly mention the legal uncertainty around loan receivables purchased from FDIC-insured banks, which is a specific 2024 development noted in the ground truth; (3) The 2022 description is slightly less precise - the ground truth emphasizes 'fictitious account creation' specifically, while the LLM uses broader 'synthetic identities' terminology (though semantically related); (4) Missing the characterization of fraud as 'difficult to detect due to the digital nature' from 2022. QUANTITATIVE ACCURACY: The answer avoids specific numbers entirely, which is both a strength (no incorrect numbers) and a weakness (missing the €40 billion detail). REASONING: The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the causal relationship between expanding credit products and increasing fraud complexity. The conclusion about 'increasingly complex credit, fraud, and regulatory challenges' appropriately synthesizes the progression. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth - PayPal's exposure evolved from basic fraud concerns to sophisticated schemes tied to credit products and third-party arrangements. The omission of specific quantitative details and one regulatory detail prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 577,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "Gilead has consistently used its El Segundo, California site for both clinical and commercial manufacturing and processing of cell‑therapy products. The 2022 10‑K (pp. 31‑35), 2023 10‑K (pp. 9‑13) and 2024 10‑K (pp. 8‑12) all list the same role for the facility, and no new expansions or capital investments at El Segundo are disclosed in the provided excerpts, although Gilead notes it continues to invest in cell‑therapy manufacturing capabilities overall.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that El Segundo was used for clinical and commercial manufacturing of cell therapy products across 2022-2024, and accurately notes that no new expansions or capital investments at El Segundo are disclosed. However, the answer has significant weaknesses: (1) It lacks the strategic context and evolution narrative present in the ground truth - the ground truth emphasizes how GILD 'reaffirmed' and maintained focus on El Segundo, highlighting the continuity and strategic importance, while the LLM answer merely states the facility was 'consistently used' without capturing the strategic evolution or broader facility context; (2) The ground truth mentions specific related facilities (Santa Monica, Frederick) and discusses facility ownership/lease arrangements and third-party manufacturers in 2024, which the LLM answer omits entirely; (3) The LLM answer references specific page numbers (pp. 31-35, pp. 9-13, pp. 8-12) which cannot be verified and may be inaccurate - this is a minor concern but adds uncertainty; (4) The answer fails to address the 'strategic facility investments' aspect of the question, only noting that Gilead 'continues to invest in cell-therapy manufacturing capabilities overall' without specificity; (5) The ground truth provides a more nuanced three-year evolution narrative showing how emphasis shifted from identification (2022) to highlighting capabilities (2023) to reaffirming with broader context (2024), while the LLM answer presents a flat 'consistent use' narrative. The core facts about El Segundo's role are correct, but the answer lacks the depth, context, and strategic narrative that the ground truth provides, making it incomplete in addressing the 'evolution' and 'strategic' aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 484,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Costco’s 2.750% Senior Notes remained due **May 18 2024** with no change in maturity dates or principal amounts (COST_10k_2022.pdf, pp. 64‑68; COST_10k_2023.pdf, pp. 64‑68; COST_10k_2024.pdf, pp. 64‑68). This consistency shows that Costco has been maintaining a stable short‑to‑medium‑term debt profile and is likely planning to refinance or retire the notes as they mature, reflecting a conservative, disciplined debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All quantitative data is correct - the maturity date of May 18, 2024 is accurately cited across all three years (2022, 2023, 2024), with proper date formatting. (2) The core finding is correct: the notes remained unchanged across the filing period with no refinancing or extension. (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three separate 10-K filings to demonstrate consistency. (4) Document citations are appropriately provided (though page numbers cannot be independently verified, they appear reasonable for debt disclosure sections). (5) The interpretation of debt management strategy is reasonable and supported by the facts. MINOR CONSIDERATIONS: (1) The LLM adds interpretive language about 'likely planning to refinance or retire' which goes slightly beyond what the ground truth states ('allow the notes to mature without modification'). However, this is a reasonable inference from the facts and not contradictory. (2) The ground truth emphasizes 'static approach' and 'deliberate capital structure decision,' while the LLM emphasizes 'stable short-to-medium-term debt profile' - these are semantically equivalent characterizations. (3) Both answers correctly identify this as a 'conservative, disciplined' approach to debt management. The LLM answer is comprehensive, factually accurate on all numeric values and dates, and demonstrates proper multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 424,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of natural‑gas output from Angola LNG stayed flat at roughly 48 million cubic feet per day (MMCFD) in 2022, 2023 and 2024 (CVX_10k_2022.pdf p.10; CVX_10k_2023.pdf p.10; CVX_10k_2024.pdf p.10). This steady trajectory shows that Chevron is prioritising a stable, long‑term gas production base in Africa rather than pursuing rapid expansion or contraction, thereby maintaining consistent supply for its global commitments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core quantitative data. Ground truth shows Angola LNG natural gas production volumes of 7,107 MMCFD (2022), 7,148 MMCFD (2023), and 7,569 MMCFD (2024). The LLM claims volumes stayed flat at roughly 48 MMCFD across all three years - this is off by approximately 150x (7,100+ vs 48). This is a catastrophic numerical error, not a minor formatting difference. The LLM appears to have confused Chevron's share percentage or a different metric entirely with actual production volumes. The ground truth explicitly states 'million cubic feet per day' while the LLM also uses MMCFD but with completely wrong values. The LLM's interpretation of the trend is also inverted - it claims 'steady trajectory' and 'stable' production, when the ground truth shows a clear upward trend from 7,107 to 7,569 MMCFD (a 6.5% increase). The LLM's conclusion about 'prioritising stable, long-term gas production' contradicts the actual data showing growth. The multi-hop synthesis fails because the LLM did not correctly extract or synthesize the production volume data from the cited 10-K filings. While the LLM correctly identifies the company (Chevron), asset (Angola LNG), metric type (natural gas production in MMCFD), and years (2022-2024), the actual numerical values are entirely wrong, making this answer factually incorrect and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 382,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps used to hedge deferred‑compensation costs grew from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024, while the operating impact flipped from a $92 million gain in 2022 to $58 million expense in 2023 and $91 million expense in 2024 (see the “Total return swaps‑deferred compensation” line in the 10‑K tables). This progression shows Cisco is expanding its use of total‑return swaps to economically hedge deferred‑compensation obligations, but the increasing expense reflects rising market‑linked volatility that erodes the hedging benefit.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) SIGN REVERSAL ON GAINS/LOSSES: Ground truth states 2022 was a $92M LOSS, 2023 was a $58M GAIN, 2024 was a $91M GAIN. The LLM incorrectly states 2022 was a $92M GAIN and 2023-2024 were expenses/losses - this is completely backwards. (2) NOTIONAL AMOUNTS: The LLM provides notional exposure figures ($651M, $792M, $985M) that are not mentioned in the ground truth and appear to be fabricated or from a different metric entirely. The ground truth focuses on P&L impacts (gains/losses), not notional amounts. (3) INTERPRETATION ERROR: The LLM's conclusion that 'increasing expense reflects rising market-linked volatility' contradicts the ground truth narrative of transformation from loss to gain, suggesting improved market conditions. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression. The ground truth shows a clear positive trajectory (loss → gain → larger gain), while the LLM presents a negative trajectory (gain → expense → expense). This is a fundamental misreading of the data. (5) SEMANTIC CONTRADICTION: The LLM's interpretation that expenses 'erode the hedging benefit' is inconsistent with the actual pattern of improving financial outcomes shown in the ground truth. The answer demonstrates poor data extraction and inverted logic regarding the company's hedging effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 403,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "In 2022, Lowe’s relied on a human‑rights policy (updated in 2021), a conflict‑minerals policy and a vendor code of conduct that set environmental standards, and it monitored suppliers through general reviews and waste‑diversion partnerships. By 2023, the company updated its wood‑sourcing policy to add country‑specific risk levels, enhanced monitoring and a forestry grievance process, and expanded its portfolio of independently certified products such as ENERGY STAR® and WaterSense®. In 2024, Lowe’s further refined the wood‑sourcing policy with a risk‑based framework, improved monitoring tools, and a new forestry grievance process, while encouraging suppliers to report emissions to CDP and increasing third‑party certifications for its products, thereby tightening its environmental and human‑rights oversight.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with good multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and their respective developments; (2) Accurately captures key policy updates: wood sourcing policy updates with country-specific risk levels (2023), forestry grievance process (2023), risk-based framework (2024); (3) Properly synthesizes monitoring enhancements across years; (4) Correctly mentions third-party certifications (ENERGY STAR, WaterSense, CDP emissions reporting); (5) Appropriately notes the progression from 2022 baseline through 2023 enhancements to 2024 refinements; (6) Includes relevant details like conflict-minerals policy and waste-diversion partnerships from 2022. MINOR ISSUES: (1) The LLM states the forestry grievance process was introduced in 2023 AND 'a new forestry grievance process' in 2024, which creates slight ambiguity about whether this was truly 'new' in 2024 or a continuation/refinement from 2023 - the ground truth suggests it was introduced in 2023 and continued in 2024, not newly introduced in 2024; (2) The ground truth emphasizes 'deepening commitment to transparency, accountability, and sustainability' as the overarching theme, while the LLM focuses more on specific mechanisms without explicitly stating this broader evolution; (3) Minor wording differences in describing the progression (LLM says 'refined' vs ground truth's 'strengthened'). QUANTITATIVE ACCURACY: All dates and years are correct; no numerical errors detected. MULTI-HOP REASONING: Successfully synthesizes information across three years and multiple policy/monitoring dimensions. The answer correctly traces the evolution from 2022 baseline through progressive enhancements in 2023 and 2024. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with appropriate detail level and accurate representation of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 530,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 through 2024, CMCSA’s competitive threat from wireless carriers intensified as they expanded 5G fixed‑wireless and 4G/5G broadband capabilities and pushed bundled offerings that directly compete with CMCSA’s broadband and wireless bundles. The 2022 filing noted carriers using 4G and 5G wireless broadband and fixed‑wireless, while the 2023 and 2024 filings added 5G fixed‑wireless and highlighted bundled packages that rival CMCSA’s offerings. Across the three years, the carriers named as competitors included AT&T, Verizon, T‑Mobile, Frontier, Lumen, and other wireless providers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of competitive threats from wireless carriers to CMCSA from 2022-2024 and correctly identifies the main technological capabilities (4G, 5G, fixed wireless) and bundling strategies. However, there are several issues that prevent a higher score: (1) ENTITY ACCURACY PROBLEM: The LLM introduces Frontier and Lumen as wireless competitors, which is problematic. While these may be mentioned in CMCSA filings as broadband competitors, they are not primarily wireless telecommunications companies and should not be listed alongside AT&T, Verizon, and T-Mobile as wireless threats. The ground truth specifically names 'major wireless competitors' as AT&T, T-Mobile, and Verizon. (2) INCOMPLETE SYNTHESIS: The LLM answer lacks the temporal progression detail that the ground truth provides. The ground truth clearly shows: 2022 (4G/5G threat noted), 2023 (specific competitors named, 5G fixed wireless highlighted), 2024 (bundling with DTC streaming emphasized). The LLM answer conflates these developments without clearly delineating the year-by-year evolution. (3) MISSING DETAIL: The ground truth specifically mentions bundling of 'DTC streaming services' with wireless plans in 2024, which is a more specific competitive threat than the generic 'bundled packages' mentioned in the LLM answer. (4) QUANTITATIVE ACCURACY: No specific numbers, percentages, or financial metrics were required in this qualitative question, so this dimension scores well. (5) REASONING: The multi-hop synthesis is partially sound—the LLM correctly identifies the progression of technological threats and bundling strategies across years, but the inclusion of non-wireless competitors and lack of temporal clarity weakens the reasoning. The answer is directionally correct but contains factual inaccuracies in competitor identification that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 509,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s exposure to margin risk stayed essentially the same from 2022 through 2024: the company continued to set transaction fees independently of the costs it incurs from payment processors, retaining full margin risk (2022‑p.78‑82; 2023‑p.75‑79; 2024‑p.73‑77). Tiered, volume‑based pricing and incentive programs—recorded as revenue reductions—remained unchanged across the three years. This consistency shows PayPal maintains strong control over pricing and cost management, with no significant shift in its margin‑risk profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that PayPal maintained consistent margin risk exposure across 2022-2024 and retained pricing control, which aligns with the ground truth's core finding. The page references (2022-p.78-82; 2023-p.75-79; 2024-p.73-77) appear reasonable and support the claim of consistency. However, the answer has significant gaps in completeness and depth:\n\n(1) WHAT WAS CORRECT: The fundamental assertion that PayPal bore full margin risk consistently across all three years is accurate. The statement that PayPal set fees independently of processor costs is correct. The recognition that incentive programs were recorded as revenue reductions is accurate.\n\n(2) WHAT WAS MISSING/INCOMPLETE: The LLM answer fails to capture the evolution and complexity that the ground truth emphasizes. Specifically:\n- Missing the 2023 expansion of incentive discussions (discounts, rebates, rewards) and how this added complexity to margin management\n- Missing the 2024 introduction of new revenue streams from contractual compensation (fraud, counterfeiting violations), which the ground truth identifies as potentially affecting margin dynamics\n- The claim that 'tiered, volume-based pricing and incentive programs remained unchanged' is not substantiated and appears to oversimplify the actual evolution described in the ground truth\n- Missing the characterization of PayPal's approach as 'disciplined, centralized' margin risk management\n\n(3) MULTI-HOP REASONING: The LLM answer demonstrates basic multi-hop synthesis by connecting pricing control, processor costs, and margin risk across three years. However, it fails to synthesize the more nuanced evolution of incentive structures and new revenue streams that the ground truth identifies as key to understanding the trend.\n\n(4) SEMANTIC ISSUES: The phrase 'stayed essentially the same' and 'remained unchanged' may be technically accurate for the core margin risk stance, but they obscure the meaningful evolution in complexity (2023 incentives expansion, 2024 new revenue streams) that the ground truth emphasizes as important context for understanding PayPal's control strategy.\n\n(5) QUANTITATIVE ACCURACY: No specific financial numbers are provided in either answer, so quantitative verification is limited. The page references in the LLM answer appear plausible but cannot be independently verified.\n\nThe answer is partially correct on the main thesis but significantly incomplete in capturing the multi-year evolution and complexity that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 678,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco continued to treat free‑rent periods as part of the lease term, recognizing them on a straight‑line basis over the original lease term and any extension options that the Company is reasonably certain to exercise. The lease‑term assumption—defined as the non‑cancelable period plus any reasonably certain extension options—remained unchanged from FY 2022 through FY 2024. Consequently, the impact on right‑of‑use asset valuation stayed consistent: free‑rent periods reduce the lease payments and thus lower the present value of lease obligations and the associated ROU assets, with no change in policy or disclosure during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies core accounting principles: (1) free-rent periods recognized on straight-line basis over original lease term plus reasonably certain extension options, (2) lease term definition as non-cancelable period plus extension options, and (3) consistency across FY 2022-2024. However, there are significant gaps and potential inaccuracies: (1) The LLM states free-rent periods 'reduce the lease payments and thus lower the present value of lease obligations and the associated ROU assets' - this is economically incorrect. Free-rent periods are typically included in the total lease payment calculation for present value purposes; they don't reduce the total obligation but rather shift when payments occur. The ROU asset is calculated as the present value of ALL lease payments (including periods with zero rent) plus initial direct costs minus lease incentives. (2) The LLM omits the important disclosure evolution mentioned in the ground truth: FY 2023 emphasized variable lease payments based on price indices or sales volume, which represents a meaningful disclosure enhancement not captured in the LLM answer. (3) The LLM fails to mention the FY 2024 reaffirmation regarding absence of material residual value guarantees or restrictive covenants, which is part of the evolution narrative. (4) The answer lacks nuance about 'evolution' - while correctly noting consistency, it doesn't adequately capture the progression of disclosure emphasis across the three years. The answer demonstrates partial understanding of lease accounting mechanics but contains a fundamental error in explaining the economic impact of free-rent periods on ROU asset valuation, and omits key disclosure elements that constitute the actual evolution of Costco's approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 484,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "From 2022 through 2024 PayPal’s margin‑risk exposure remained essentially unchanged.  The company continued to set transaction fees on a gross basis as the principal, with the fee schedule independent of the costs of payment processors, so it retained full margin risk and recorded processor costs as transaction expense.  Contracts stayed open‑ended, automatically renewing, and were priced with tiered, volume‑based discounts, with no material changes to the contract structure or processor‑use policy.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that PayPal's core margin risk exposure remained consistent across 2022-2024, accurately describes the gross-basis fee model, correctly notes that processor costs are recorded as transaction expense, and accurately characterizes the tiered, volume-based pricing structure. The statement about open-ended, auto-renewing contracts is factually sound. No quantitative errors are present. CRITICAL WEAKNESSES: (1) The LLM answer is significantly incomplete regarding the 2023 changes. The ground truth explicitly states that in 2023, PayPal added clarifying language about how incentives to users were recognized as revenue reductions based on performance targets or amortized over contractual terms. This represents a material change in margin structure variability that the LLM completely omits. (2) The LLM fails to address the 2024 ASU 2023-07 segment reporting adoption, which the ground truth identifies as increasing transparency around segment-level expenses and potentially affecting margin risk analysis across business units. This is a significant omission for a question specifically asking about evolution from 2022 to 2024. (3) The LLM states there were 'no material changes to contract structure,' which contradicts the ground truth's discussion of 2023 incentive recognition changes and 2024 segment reporting changes. (4) The answer lacks the nuance that the ground truth provides: while the fundamental pricing model remained unchanged, the margin risk exposure was 'operationally nuanced' with increased variability introduced in 2023. The LLM's conclusion that margin risk was 'essentially unchanged' oversimplifies the evolution described in the ground truth. MULTI-HOP REASONING: The LLM failed to synthesize information across the three-year period, missing key developments in 2023 and 2024 that represent material changes to how margin risk is recognized and reported, even if the underlying pricing model remained stable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 534,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a principal of $2.0 bn each year, and its effective interest rate remained flat at 6.11% from FY 2022 through FY 2024 (2022 long‑term debt table, 2023 long‑term debt table, 2024 long‑term debt table).  While the note’s absolute utilization did not change, its share of total debt fell from about 23.5 % in FY 2022–23 (total debt $8.5 bn) to roughly 9.9 % in FY 2024 (total debt $20.3 bn) as Cisco issued additional debt, yet the unchanged effective rate indicates a stable financing cost and a strategy of locking in a fixed‑rate, long‑term liability while diversifying its debt mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics: $2.0 billion principal balance consistently maintained across FY 2022-2024, and 6.11% effective interest rate remaining constant. The core finding that the note was unmodified and represents a stable financing approach is accurate and well-supported. STRENGTHS: (1) All primary numbers are correct ($2.0bn principal, 6.11% effective rate); (2) Correctly identifies the three-year period and consistency of terms; (3) Provides additional valuable context by calculating the note's declining share of total debt (23.5% in FY 2022-23 to 9.9% in FY 2024), which adds analytical depth; (4) Properly synthesizes multi-hop information across three fiscal years; (5) Reasoning about locked-in fixed-rate strategy while diversifying debt mix is sound and insightful. MINOR CONSIDERATIONS: (1) The debt percentage calculations (23.5% and 9.9%) are not explicitly verified in the ground truth but appear reasonable given the stated total debt figures ($8.5bn vs $20.3bn); (2) The ground truth focuses on the stability of the note itself, while the LLM adds contextual analysis about relative debt composition—this is supplementary rather than contradictory; (3) The LLM's interpretation that this represents a deliberate strategy of 'locking in' and 'diversifying' goes slightly beyond what the ground truth explicitly states, though it is a reasonable inference from the facts. The answer fully addresses the question's multi-part requirements regarding utilization evolution, effective interest rate trends, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 444,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Across fiscal 2022, 2023, and 2024 the intellectual‑property sections (2022 pp. 7‑11; 2023 pp. 5‑9; 2024 pp. 5‑9) all list “Kobalt” simply as a private‑brand product name alongside STAINMASTER and allen+roth. The wording and placement are unchanged, indicating that Lowe’s continues to treat Kobalt as a core private‑brand offering but no shift in strategic emphasis or repositioning is reflected in the disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer correctly identifies that Kobalt was listed as a private brand across fiscal 2022, 2023, and 2024, alongside STAINMASTER and allen+roth. It accurately conveys that there was no shift in strategic emphasis or repositioning - the positioning remained stable and consistent. The core finding that Kobalt retained its position as a named private brand product line with no explicit increase or decrease in prominence is correctly captured. (2) QUANTITATIVE ACCURACY: The page references provided (2022 pp. 7-11; 2023 pp. 5-9; 2024 pp. 5-9) are specific and verifiable, though not independently confirmed here. The answer contains no numerical calculations or financial metrics that could be incorrect. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM synthesized information across three fiscal years and correctly identified the pattern of consistency rather than change. The characterization of Kobalt as a 'core private-brand offering' with 'stable strategic role rather than an expanding one' matches the ground truth's conclusion about consistency. (4) ENTITY ACCURACY: All entities are correct - Lowe's, Kobalt, STAINMASTER, allen+roth, and the three fiscal years (2022, 2023, 2024) are all properly identified. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'no shift in strategic emphasis or repositioning is reflected in the disclosures' is semantically equivalent to the ground truth's 'no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role.' Minor difference: The LLM provides specific page numbers while the ground truth does not, which adds helpful detail without contradicting the ground truth. The answer is concise, directly addresses the question, and reaches the correct conclusion about stability rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 521,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 37B have not changed: each year’s 10‑K lists a 2.25 % interest rate, a $700,000 face amount and a maturity of January 15, 2032. The unchanged, low‑cost, long‑dated debt shows the company’s deliberate strategy of maintaining a stable, low‑interest, long‑term financing base rather than restructuring or refinancing these obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700,000 face amount, and January 15, 2032 maturity date are accurately stated and match the ground truth. The answer correctly identifies that these values remained unchanged across all three years (2022-2024). COMPLETENESS: The answer addresses all key components of the multi-part question: (1) interest rate evolution, (2) face amount evolution, (3) maturity date evolution, and (4) implications for long-term financing strategy. ENTITY ACCURACY: Simon Property Group is correctly identified, the specific debt instrument (Unsecured Notes - 37B) is properly referenced, and the time period (2022-2024) is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that stability across three years indicates a deliberate strategic choice. The interpretation that this reflects 'confidence in debt management' and 'favorable market conditions' aligns well with the ground truth's assessment. MINOR DIFFERENCES: The LLM uses slightly different phrasing ('unchanged, low-cost, long-dated debt' vs. 'consistent interest rate...stability suggests') but conveys semantically equivalent meaning. The LLM's characterization of the strategy as 'maintaining a stable, low-interest, long-term financing base rather than restructuring' is a reasonable interpretation that aligns with the ground truth's conclusion about not altering the long-term financing structure. No calculation errors, no factual inaccuracies, and appropriate contextual relevance to the question about financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 456,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across 2022‑24 Texas Instruments kept its Melaka, Malaysia facility as an Analog‑only manufacturing site. In the 2022 10‑K the table lists Melaka under “Analog” only (page 18 of TXN_10k_2022.pdf); the 2023 10‑K shows the same (page 16 of TXN_10k_2023.pdf); and the 2024 10‑K again lists Melaka as Analog only with no Embedded Processing activity (page 16 of TXN_10k_2024.pdf).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) All factual claims are correct - Melaka was exclusively Analog-focused across all three years with no Embedded Processing involvement; (2) The answer correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024), demonstrating proper multi-hop reasoning; (3) Specific document references are provided (page numbers and file names), adding credibility and verifiability; (4) The temporal progression is clearly articulated showing consistency across the 3-year period; (5) Entity identification is accurate (Texas Instruments/TXN, Melaka Malaysia, Analog vs Embedded Processing segments). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which includes interpretive language about 'stable, specialized role' and 'centered exclusively on Analog product development and manufacturing' - however, this is not a factual error but rather a stylistic difference; (2) The ground truth emphasizes the significance of this consistency ('3-year consistency highlights'), while the LLM answer simply states the facts without this interpretive layer. This is acceptable as the core factual content is identical. VERIFICATION: All dates (2022, 2023, 2024) are correct, all business segments mentioned (Analog, Embedded Processing) are correctly identified, and the conclusion that Melaka remained Analog-only throughout is accurate. The answer successfully synthesizes information from multiple years and documents to answer a complex multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 460,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes remained unchanged at **$1.5 billion** from 2022 through 2024 (2022 table, page 108; 2023 table, page 106; 2024 table, page 103). The unchanged principal indicates that PayPal has not reduced or refinanced this long‑maturity, lower‑rate tranche, reflecting a strategy of maintaining a stable, diversified debt mix and locking in a fixed rate for long‑term financing while selectively managing other debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are correct - the $1.5 billion principal amount is accurate for all three years (2022-2024), and the statement that it remained unchanged is factually correct. (2) The company identification (PayPal/PYPL) is correct. (3) The page references provided (108, 106, 103) demonstrate proper sourcing. (4) The core multi-hop synthesis is sound - correctly identifying that this specific note remained constant while other debt tranches changed. WEAKNESSES: (1) The LLM answer is less comprehensive than the ground truth. It mentions the strategy of 'maintaining a stable, diversified debt mix' but omits important contextual details about what this progression indicates about overall debt management strategy. (2) The ground truth provides crucial comparative context - specifically mentioning the retirement of 1.350% notes by 2023 and introduction of new high-interest notes in 2024 - which demonstrates the contrast between this stable tranche and PYPL's active management elsewhere. The LLM answer only vaguely references 'selectively managing other debt' without specifics. (3) The ground truth's phrase 'lack of change in this liability contrasts with PYPL's active debt management in other areas' provides important strategic insight that the LLM answer doesn't fully capture. (4) The LLM answer states the notes are 'long‑maturity' but doesn't specify the maturity date, which would strengthen the analysis. CALCULATION VERIFICATION: No calculations required; the statement of constant $1.5B across three years is accurate. MULTI-HOP REASONING: The LLM correctly synthesized information across three years of filings, but the reasoning about strategic implications is less developed than the ground truth. The answer is factually sound but strategically incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 490,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead has kept its Hoofddorp, Netherlands plant as the core commercial hub for cell‑therapy manufacturing throughout the three reporting years.  In the 2022 10‑K, the facility is described as being used for “commercial manufacturing and processing of our cell therapy products”【GILD_10k_2022.pdf page 31】.  The same wording appears in the 2023 10‑K【GILD_10k_2023.pdf page 9】 and again in the 2024 10‑K【GILD_10k_2024.pdf page 8】, indicating no change in its role or scope within Gilead’s global cell‑therapy manufacturing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM claims that the 2022 10-K describes Hoofddorp as being used for 'commercial manufacturing and processing of our cell therapy products' with the same wording appearing in 2023 and 2024. However, the ground truth explicitly states that in 2022, Gilead 'identified Hoofddorp, Netherlands as a principal manufacturing facility' WITHOUT specifying the cell therapy role - that specific functional designation only appeared in 2023. The LLM incorrectly backdates the cell therapy manufacturing designation to 2022, which is a significant factual error. The ground truth shows an evolution: 2022 (principal facility, general), 2023 (commercial manufacturing of cell therapy products), 2024 (same as 2023). The LLM's claim of 'no change in its role or scope' across all three years is incorrect - there WAS a change from 2022 to 2023 when the specific cell therapy manufacturing role was explicitly stated. The LLM also provides specific page citations (page 31 for 2022, page 9 for 2023, page 8 for 2024) that cannot be verified and appear to be hallucinated, as the actual ground truth does not confirm identical wording in 2022. The answer fails to capture the progression and evolution that is central to the question. While the LLM correctly identifies the company (Gilead), the facility (Hoofddorp), and the general concept (cell therapy manufacturing), it fundamentally misrepresents the timeline and evolution of the facility's role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 428,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying amount of $1,250 in each year.  The current‑portion of long‑term debt rose from $73 in 2022 and 2023 to $103 in 2024 as the company repaid its 2.750% Senior Notes due May 2024, which moved that amount into the current portion.  Accordingly, total long‑term debt fell from $6,590 in 2022 to $5,919 in 2024, while the 1.375% notes remained classified as long‑term debt and were not shifted to the current portion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR on current portion classification: The LLM states the 1.375% notes 'were not shifted to the current portion' and remained long-term debt throughout, but the ground truth clearly shows the current portion spiked to $1,081 million in 2023 (a massive change from $73M in 2022). This is a fundamental misunderstanding of the question's core focus on how classification evolved. (2) NUMERIC INCONSISTENCY: The LLM claims current portion was '$73 in 2022 and 2023' but ground truth shows it was $73M in 2022 and $1,081M in 2023 - a critical omission of the 2023 spike. (3) INCOMPLETE ANSWER: The LLM provides an explanation about the 2.750% Senior Notes due May 2024 being repaid, which may explain the 2024 movement to $103M, but this explanation doesn't address why the 1.375% notes themselves moved to current portion in 2023 (the most significant change). (4) PRINCIPAL AMOUNT: The LLM correctly identifies the $1,250M principal amount remained constant across all years. (5) MULTI-HOP REASONING FAILURE: The question specifically asks about evolution of classification from 2022-2024, and the LLM fails to capture the dramatic 2023 spike in current portion classification, which is the central narrative of how treatment evolved. The answer appears to conflate the 1.375% notes with other debt instruments and misses the key classification change. The ground truth shows a clear three-year evolution (73M → 1,081M → 103M) that the LLM completely misrepresents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 432,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "From 2022 through 2024 PayPal’s fixed‑rate 2.850 % notes stayed unchanged at a principal of $1.5 billion, due 10/1/2029, with no repayments or new issuances affecting that tranche (2022 p.106‑107; 2023 p.105‑106; 2024 p.103‑104).  The overall carrying amount of term debt rose from $8.9 billion in 2022 to $9.3 billion in 2023 and remained at $9.3 billion in 2024, reflecting other debt issuances and a $1.6 billion repurchase of earlier notes in 2022 (2022 p.110; 2023 p.109; 2024 p.106), while the 2.850 % notes were untouched.  This stability, coupled with the 2024 issuance of new higher‑rate notes ($1.3 billion), illustrates PayPal’s strategy of maintaining a steady long‑term debt profile, selectively refinancing older debt, and diversifying maturities and rates to manage interest costs and maturity risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial obligation ($1.5 billion fixed-rate 2.850% notes) and its consistency across 2022-2024. The maturity date (10/1/2029) and interest rate (2.850%) are correctly stated. The answer appropriately synthesizes multi-hop information by connecting the stable 2.850% notes to broader debt management activity (total term debt movements from $8.9B to $9.3B, the $1.6B repurchase in 2022, and the $1.3B new issuance in 2024). The page references provided (2022 p.106-107, etc.) add credibility and specificity. The reasoning about PayPal's strategy is sound and well-articulated, explaining how the company maintained this particular tranche while actively managing other debt. One minor point: the original answer mentions an effective interest rate of 2.96% for the 2.850% notes, which the LLM answer does not include. However, this is a relatively minor omission that doesn't significantly detract from the core answer. The LLM answer actually provides more comprehensive context by discussing the broader debt portfolio movements and strategic implications, which enhances understanding of the company's debt management approach. All quantitative figures are accurate, calculations are correct, and the multi-hop synthesis across years and debt tranches is properly executed. The answer directly addresses how the obligations evolved (they didn't) and what this reveals about strategy (selective refinancing, maturity diversification, interest cost management).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 427,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s net notional volume of gas‑related options grew from 1,290 MMBtu in 2022 to 1,452 MMBtu in 2023, then fell to 1,131 MMBtu in 2024, while the net fair value of those options moved from a modest $9 million gain in 2022 to a $3 million gain in 2023 and a $2 million loss in 2024. Across the same period, the weighted‑average implied volatility used to value gas options rose from 36 % in 2022 to 50 % in 2023 and 52 % in 2024, indicating that the company is pricing in higher gas‑market uncertainty and adopting a more conservative hedging stance even as its net exposure has slightly declined.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions:\n\n1. FAIR VALUE NUMBERS - MAJOR DISCREPANCY:\n   - Ground Truth: Assets $356M (2022) → $100M (2023) → $100M (2024); Liabilities $347M (2022) → $97M (2023) → $102M (2024)\n   - LLM Answer: Reports net fair values of $9M gain (2022), $3M gain (2023), $2M loss (2024)\n   - These are completely different metrics. The LLM appears to have confused net fair value positions with gross asset/liability values. The ground truth shows hundreds of millions in exposure; the LLM shows single-digit millions.\n\n2. VOLATILITY ASSUMPTIONS - PARTIALLY CORRECT:\n   - Ground Truth: 36% (2022) → 50% (2023) → 52% (2024)\n   - LLM Answer: 36% (2022) → 50% (2023) → 52% (2024)\n   - This portion is CORRECT and matches exactly.\n\n3. NOTIONAL VOLUME DATA - NOT IN GROUND TRUTH:\n   - LLM introduces MMBtu volumes (1,290 → 1,452 → 1,131) that are not mentioned in the ground truth\n   - While this data may exist in the source documents, it represents a different metric than what the ground truth emphasizes\n   - This suggests the LLM may have pulled from different sections or misidentified the relevant data\n\n4. INTERPRETATION OF TREND:\n   - Ground Truth: Emphasizes \"reduction in expected market volatility\" and \"strategic de-risking\" with declining fair values\n   - LLM Answer: States \"higher gas-market uncertainty\" and \"more conservative hedging stance\"\n   - These interpretations are contradictory. The ground truth shows declining fair values (de-risking), while the LLM's interpretation of rising volatility as \"higher uncertainty\" is reasonable but conflicts with the de-risking narrative\n\n5. MULTI-HOP SYNTHESIS:\n   - The question requires synthesizing fair value trends AND volatility trends across three years\n   - Ground truth correctly synthesizes both: declining fair values + declining volatility = de-risking\n   - LLM answer correctly identifies volatility trend but fails on fair value magnitude, creating an inconsistent narrative\n\n6. CORE ISSUE:\n   The LLM appears to have accessed different data points (possibly net positions vs. gross positions, or different line items from the filing) rather than the specific asset/liability fair values cited in the ground truth. The order-of-magnitude difference ($9M vs. $356M) is not a rounding or formatting issue—it represents fundamentally different data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 656,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments swung from a small gain in FY 2022 to losses in the following two years: a net gain of **$9 million** in 2022, a net loss of **$21 million** in 2023, and a larger net loss of **$67 million** in 2024. These amounts drove the overall “Other income (loss), net” from a positive $392 million in 2022 to negative $248 million in 2023 and $306 million in 2024, showing that the portfolio’s performance was volatile—shifting from a modest gain to increasingly larger losses over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides precise dollar amounts ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) and specific 'Other income (loss), net' figures ($392M in 2022, negative $248M in 2023, negative $306M in 2024) that are presented as factual but lack verification. The ground truth does not provide these specific numbers, only describing a general trend of losses and volatility. (2) UNVERIFIABLE CLAIMS: The LLM states definitive figures without citing sources or acknowledging uncertainty. Given that the ground truth discusses the trend qualitatively rather than quantitatively, these specific numbers appear to be hallucinated. (3) PARTIAL ALIGNMENT WITH GROUND TRUTH: The LLM correctly identifies the directional trend (gain in 2022, losses in 2023-2024) and the concept of increasing volatility, which aligns with the ground truth narrative. However, the specific numerical values are not supported. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the relationship between AFS debt investment performance and 'Other income (loss), net,' the lack of verifiable data undermines the credibility of this synthesis. (5) MISSING CONTEXT: The LLM does not acknowledge the offsetting gains from equity and private investments mentioned in the ground truth, which is a material omission. The answer reads as confident and specific, but the precision of the numbers without verification is a critical failure in financial reporting accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 446,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "From 2022 through 2024, Lowe’s continued to report the 4.550% Notes that were issued under the 15th Supplemental Indenture in 2019, with no new issuance or amendment to the terms; the notes remained outstanding with a maturity of April 5, 2049 (Exhibit 4.16; LOW_10k_2022.pdf: pages 73‑77; LOW_10k_2023.pdf: pages 74‑78; LOW_10k_2024.pdf: pages 73‑77). This consistent reporting across three consecutive 10‑K filings indicates a long‑term debt strategy focused on maintaining a stable, long‑dated fixed‑rate debt load to support the company’s capital structure and financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) All numeric values are correct - 4.550% interest rate, April 5, 2049 maturity date, and April 5, 2019 Fifteenth Supplemental Indenture date all match ground truth. (2) Multi-hop synthesis is sound - the answer correctly identifies that the notes were consistently reported across 2022, 2023, and 2024 10-K filings with no changes or amendments. (3) Entity identification is precise - correctly names Lowe's Companies, Inc., identifies the specific note instrument, and references the proper indenture documentation. (4) The reasoning about long-term debt strategy is logical and well-supported: the consistency of reporting across three years does indicate a stable approach to long-term financing. (5) Page references (73-77, 74-78) are appropriately cited and appear reasonable for 10-K filings. MINOR CONSIDERATIONS: The LLM answer adds interpretive language about 'capital structure and financing flexibility' that goes slightly beyond the ground truth's more conservative statement about 'steady approach to long-term financing,' but this is a reasonable inference from the data and not contradictory. The answer is more detailed and specific than the ground truth while remaining factually accurate. No calculation errors, no date discrepancies, and the semantic meaning fully aligns with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 385,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35B stayed unchanged: the face value remained $750,000 and the coupon stayed at 3.80 % (maturity 07/15/50) in each 10‑K filing (see 2022, 2023, 2024 tables). This consistency indicates a conservative long‑term debt strategy that prioritizes stable, low‑cost financing and predictable interest expense rather than frequent refinancing or re‑issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Verification of key facts: (1) Face value of $750,000,000 is correctly stated (LLM uses $750,000 which appears to be a formatting variation, but this is acceptable per evaluation guidelines allowing format variations); (2) Interest rate of 3.80% is correct; (3) Maturity date of 07/15/50 is correct; (4) The consistency across 2022-2024 is accurately captured. The LLM correctly identifies that there was no refinancing or restructuring of this debt instrument. The reasoning about SPG's debt strategy is sound and semantically equivalent to the ground truth - both characterize the approach as stable, conservative, and focused on maintaining favorable long-term terms. The multi-hop synthesis is correct: the answer properly combines information about face value, interest rate, and maturity date across three fiscal years to draw conclusions about strategy. Minor note: The LLM uses '$750,000' while ground truth states '$750,000,000' - this appears to be a formatting/notation difference rather than a substantive error, as the context makes clear this refers to millions. The qualitative assessment about 'conservative long-term debt strategy' and 'stable, low-cost financing' directly parallels the ground truth's characterization of 'stable long-term financing approach' and 'confidence in managing long-dated liabilities.' All entities (SPG, Unsecured Notes - 35B, years 2022-2024) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 411,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s 10‑K risk‑factor disclosures on pages 24‑28 (2022), 23‑27 (2023) and 21‑25 (2024) consistently flag bad‑transaction risk—fraud, erroneous payments and negative customer experiences that can raise loss rates. The 2024 filing expands credit‑product risk by stressing default exposure and reliance on third‑party lenders, and adds language about diversifying payment‑processor relationships, while cross‑border trade risk remains tied to currency, regulatory and tariff uncertainties. These changes show PayPal’s evolving risk‑management strategy—strengthening credit models, broadening third‑party resilience and investing in fraud detection—to sustain operational resilience amid growing regulatory and market pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer cites specific page numbers (24-28 for 2022, 23-27 for 2023, 21-25 for 2024) without verification against actual filings. These page citations cannot be confirmed and appear to be fabricated. The ground truth mentions a specific €40 billion BNPL loan receivable sale agreement in 2023, which the LLM answer completely omits - this is a critical quantitative fact. (2) MISSING KEY FACTS - The LLM fails to mention: (a) the Synchrony Bank partnership and U.S. consumer credit product exposure in 2022, (b) the €40 billion European BNPL receivables sale agreement in 2023 (a major strategic shift), (c) the 'valid-when-made' doctrine legal uncertainty in 2024. These are material omissions that fundamentally weaken the answer. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about evolution across 2022-2024 in relation to credit products, cross-border trade, and third-party dependencies. The LLM mentions third-party lenders and cross-border trade but fails to connect the strategic evolution (from internal risk absorption to external mitigation via asset sales). The ground truth clearly shows this transformation; the LLM answer is vague about the actual strategic shift. (4) REASONING QUALITY - While the LLM identifies general risk categories (fraud, defaults, third-party reliance), it does not demonstrate the multi-year trend analysis requested. The answer reads as a generic description of risk factors rather than a coherent narrative of how PayPal's risk management strategy evolved. (5) SEMANTIC ISSUES - The LLM's mention of 'diversifying payment-processor relationships' is not supported by the ground truth and appears to conflate different risk categories. The ground truth focuses on credit product risk mitigation through asset sales, not processor diversification. STRENGTHS: The LLM correctly identifies fraud and bad-transaction risk as persistent themes, and acknowledges third-party dependencies and cross-border trade risks. However, these strengths are overshadowed by the critical omissions and lack of specific strategic evolution details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 574,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s competitive stance against BJ’s Wholesale Club remained largely unchanged from 2022 through 2024, with the company continuing to view BJ’s as a key rival in the warehouse‑club segment and emphasizing its low‑price, high‑quality membership model (COST_10k_2022.pdf: pages 5‑9; COST_10k_2023.pdf: pages 6‑10; COST_10k_2024.pdf: pages 6‑10). Across all filings, Costco highlighted its private‑label Kirkland Signature as a core differentiator—stressing its superior quality, lower price, and higher margins, and noting plans to increase its sales penetration (COST_10k_2022.pdf: pages 5‑9; COST_10k_2023.pdf: pages 6‑10; COST_10k_2024.pdf: pages 6‑10). Thus, while the competitive relationship with BJ’s remained consistent, Costco’s emphasis on Kirkland Signature as a differentiator intensified, underscoring its strategy to strengthen its private‑label portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on the key finding. Ground truth states that Kirkland Signature emphasis 'remained stable' with 'no significant shift in strategy' from 2022-2024. The LLM answer claims the 'emphasis on Kirkland Signature as a differentiator intensified,' which is factually incorrect according to the knowledge graph. This is a fundamental error in the core conclusion of the multi-hop analysis. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and the time period evolution; (2) Correctly names both companies (Costco/COST and BJ's Wholesale Club); (3) Correctly identifies Kirkland Signature as the private-label brand in question; (4) Accurately characterizes Kirkland Signature's positioning (high-quality, lower-priced, higher margins); (5) Properly synthesizes information across three 10-K filings; (6) Correctly notes the competitive relationship remained consistent. WEAKNESSES: (1) MAJOR: Claims intensification of Kirkland Signature emphasis when ground truth explicitly states it remained stable/consistent with no significant shift; (2) The conclusion contradicts the evidence presented in the answer itself, which shows consistent messaging across all three years; (3) Misinterprets 'plans to increase sales penetration' as evidence of intensified emphasis rather than recognizing this as part of stable strategy; (4) No quantitative data provided (percentages, dollar amounts, or specific metrics) to support claims about intensification. MULTI-HOP REASONING: The synthesis across three years is attempted but the interpretation is inverted—the model correctly identifies consistent messaging but incorrectly frames it as intensification. This represents a failure in analytical reasoning despite correct data gathering.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 493,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "From the Level‑3 fair‑value tables, NEE’s gas forward contracts grew from a net fair value of **$160 million** in 2022 (assets $191 m / liabilities $31 m) to **$300 million** in 2023 (assets $377 m / liabilities $77 m) and then fell to **$250 million** in 2024 (assets $296 m / liabilities $46 m).  The net position stayed positive throughout, indicating a net long stance that peaked in 2023 and was trimmed in 2024, reflecting a dynamic risk‑management strategy that expands exposure when market conditions or hedging needs rise and contracts it when volatility or pricing outlooks shift.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and years. Quantitative verification: Assets 2022 ($191M), 2023 ($377M), 2024 ($296M) - all correct. Liabilities 2022 ($31M), 2023 ($77M), 2024 ($46M) - all correct. Net position calculations are accurate: 2022 ($160M), 2023 ($300M), 2024 ($250M). The LLM correctly identified the 2023 spike and subsequent 2024 decline. Multi-hop synthesis is sound: the answer properly combines asset and liability data across three years to characterize the evolution of exposure. The reasoning about net long stance, peak in 2023, and dynamic risk management is logical and well-supported by the data progression. One minor discrepancy: The original answer states liabilities 'rose more sharply from $31 million to $46 million' (implying a continuous rise), but the LLM correctly identifies the intermediate 2023 spike to $77M before declining to $46M in 2024. This is actually more accurate than the original answer's characterization. The LLM provides superior context by calculating net positions and explaining the strategic implications (expansion when conditions warrant, contraction when volatility/pricing shifts). The answer fully addresses the question's three components: (1) asset evolution, (2) liability evolution, and (3) risk positioning interpretation. Wording is clear and professional. No calculation errors detected. The only minor limitation is that the original answer's phrasing about 'increasingly balanced exposure' could have been more explicitly addressed, though the LLM's characterization of 'net long stance' is semantically equivalent and arguably more precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 461,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap (FIRS) notional amount jumped from $638 million in 2021 to $2.56 billion in 2022 (Note 9, pages 60‑64) and stayed at that level through 2023 (Note 9, pages 52‑56) and 2024 (the 2024 10‑K notes that still list the $2.56 billion FIRS hedge as of February 3, 2023, pages 44‑48). This steady, high‑level hedge shows the company’s intent to lock in borrowing costs for forecasted debt issuances amid a volatile rate environment, reflecting a conservative, risk‑averse interest‑rate‑risk management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL NUMERIC ERRORS: The LLM claims forward interest rate swaps had a notional amount of $638 million in 2021, $2.56 billion in 2022, and remained at $2.56 billion through 2023-2024. However, the ground truth explicitly states that in 2023, Lowe's held forward interest rate swaps valued at $251 million (as of February 3, 2023), and by 2024 (January 31, 2025), Lowe's no longer held forward interest rate swaps at all. The LLM's $2.56 billion figure appears to be completely fabricated or sourced from incorrect data. (2) TEMPORAL MISREPRESENTATION: The LLM incorrectly claims the $2.56 billion hedge level was maintained through 2024, when the ground truth clearly indicates these instruments were unwound/eliminated by 2024. The LLM even references 'pages 44-48' of the 2024 10-K but misinterprets the data, claiming it still lists the $2.56 billion FIRS hedge as of February 3, 2023 - this appears to be a historical reference, not a current position. (3) FAILED MULTI-HOP SYNTHESIS: The question asks about evolution from 2022-2024, requiring synthesis of three distinct time periods. The LLM failed to capture the key evolution: active hedging in 2022-2023 (with the $251 million position in 2023) followed by complete unwinding by 2024. Instead, it presents a false narrative of sustained high-level hedging. (4) CONTRADICTED STRATEGIC INTERPRETATION: The ground truth indicates a deliberate unwind suggesting response to stabilized rates or refinancing. The LLM's interpretation of 'steady, high-level hedge' and 'conservative, risk-averse strategy' is contradicted by the actual elimination of these instruments. The answer demonstrates either severe data retrieval errors or hallucination of specific financial figures and page references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 501,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 to 2024, CMCSA’s competitive stance against Lumen shifted as the company accelerated its own fiber rollout. In 2022 CMCSA noted that Lumen was building fiber to offer higher‑speed services in many overlapping markets, while CMCSA’s fiber expansion was limited (2022 competition section, pages 7‑11). By 2024 CMCSA had deployed fiber‑to‑the‑premises with up to 10 Gbps residential and 100 Gbps business speeds, rolled out 2 Gbps downstream to half its footprint, and deployed DOCSIS 4.0, narrowing the speed gap and enabling higher‑speed bundled offerings that improved its position against Lumen in shared markets (2024 competition section, pages 6‑10; 2024 network and technology section, pages 6‑10).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy. STRENGTHS: (1) Correctly identifies the core competitive dynamic between CMCSA and Lumen across 2022-2024; (2) Accurately captures that Lumen was building fiber infrastructure in overlapping markets; (3) Correctly notes CMCSA's fiber expansion acceleration and deployment of advanced technologies (DOCSIS 4.0, fiber-to-the-premises); (4) Properly synthesizes the multi-hop reasoning about competitive positioning evolution; (5) Appropriately addresses the question's focus on fiber-based infrastructure and service offerings. WEAKNESSES: (1) CRITICAL - The LLM provides specific technical specifications (10 Gbps residential, 100 Gbps business speeds, 2 Gbps downstream to half footprint) that cannot be verified against the ground truth and appear to be hallucinated details not present in the original answer; (2) The ground truth does not mention specific speed metrics or deployment percentages, yet the LLM confidently cites these with page references (pages 6-10, 7-11) that cannot be authenticated; (3) The LLM's claim about CMCSA's 'limited' fiber expansion in 2022 is not explicitly stated in the ground truth; (4) Page number citations appear fabricated and are not verifiable. QUANTITATIVE ACCURACY ISSUE: The specific speed figures (10 Gbps, 100 Gbps, 2 Gbps) and deployment percentages ('half its footprint') are presented as facts but lack grounding in the provided ground truth. This represents a significant factual accuracy problem. MULTI-HOP REASONING: The synthesis across three years is sound in structure, but the addition of unverified quantitative details undermines the reliability of the analysis. The core narrative about competitive evolution is correct, but the embellishment with specific metrics that cannot be confirmed reduces confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 512,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "PayPal’s 2022 10‑K highlighted a streamlined checkout that already integrated PayPal Credit and buy‑now‑pay‑later in a handful of markets and supported transactions in more than 200 markets and 100 currencies (pp. 8‑12). By 2023 the company embedded its buy‑now‑pay‑later products directly into the PayPal‑ and Venmo‑branded checkout, expanded credit offerings to additional regions, and kept the same broad currency coverage (pp. 8‑12). In 2024 PayPal deepened that integration, added omnichannel merchant tools such as Zettle, Braintree and PayPal Complete Payments for in‑person and online sales, and continued to support 200 markets, 100 currencies, and 56‑currency withdrawals while embedding credit at checkout (pp. 4‑8).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth: (1) CURRENCY SUPPORT: LLM claims 100 currencies consistently across 2022-2024, but ground truth states 2022 had 'over 100 currencies', 2023 expanded to 'approximately 150', and 2024 maintained this higher level. The LLM's claim of 100 currencies in 2024 is incorrect and misses the evolution. (2) MARKET COVERAGE: LLM claims 'more than 200 markets' in 2022 and maintains this through 2024, but ground truth does not specify 200 markets for 2022 - this appears to be an unsupported claim. (3) TIMELINE ERRORS: LLM states BNPL was 'in a handful of markets' in 2022 and embedded in checkout by 2023, but ground truth indicates the deepening of BNPL integration occurred in 2024, not 2023. (4) MISSING KEY EVOLUTION: Ground truth emphasizes a strategic shift from 'global scale and usability to enhanced financial services integration' - the LLM fails to capture this conceptual evolution. (5) CREDIT CARD OFFERINGS: Ground truth specifically mentions 'PayPal- and Venmo-branded debit and credit cards' in 2024, which the LLM omits entirely. (6) CURRENCY WITHDRAWAL DETAIL: LLM mentions '56-currency withdrawals' which is not mentioned in ground truth and appears to be an unsupported detail. The LLM does correctly identify Zettle and Braintree as omnichannel solutions in 2024, and correctly notes the progression toward merchant enablement. However, the quantitative inaccuracies regarding currency support evolution (the core metric of the question) and timeline misalignment of BNPL integration are critical errors that undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 454,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target’s debit‑card penetration declined from 20.5 % in fiscal 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (RedCard/Target Circle Card penetration figures). The steady drop shows that, while the card still generates a meaningful share of incremental purchases—Target notes that a substantial portion of card‑driven sales are incremental—the card’s relative influence on sales is shrinking, likely as guests adopt more payment options or as the card’s incremental lift diminishes over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect penetration rates for 2023 and 2024. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM states: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The 2023 figure is wrong (19.8% vs 18.6%) and the 2024 figure is wrong (18.6% vs 17.8%). This represents a fundamental factual error in the core numeric data requested. The LLM appears to have shifted all values upward by approximately 1.2 percentage points for 2023-2024, which is a significant discrepancy. QUALITATIVE ASSESSMENT: The LLM correctly identifies the overall trend (declining penetration) and provides reasonable interpretation about the implications (diminishing influence, customer adoption of alternative payment options). The reasoning about incremental sales is sound and aligns with the ground truth's characterization. However, the semantic framing differs slightly - the LLM emphasizes 'meaningful share' and 'shrinking relative influence' while ground truth emphasizes 'diminishing role' and 'weakening customer engagement.' MULTI-HOP REASONING: The LLM successfully synthesizes the multi-year trend and connects it to business implications, which is appropriate. However, this strength is severely undermined by the incorrect numbers. ENTITY ACCURACY: Correctly identifies Target, RedCard/Target Circle Card, and fiscal years. The 5% discount detail is not mentioned by LLM but is in ground truth - minor omission. OVERALL: The answer fails on the primary metric of quantitative accuracy, which is critical for financial analysis. The incorrect 2023 and 2024 figures are material errors that would lead to wrong conclusions in a financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 460,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing agreements has remained unchanged from 2022 through 2024.  In each filing the company evaluates whether the licensing component is distinct; if it is not, the development services and license are combined into a single performance obligation and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time when the customer can benefit from the license.  Standalone licensing arrangements are always recognized at a point in time, and no variable‑consideration estimates are applied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that AMD's policy remained unchanged from 2022-2024, matching the ground truth's emphasis on consistency; (2) Accurately describes the distinction between combined vs. standalone arrangements - non-distinct licenses combined with development services recognized over time, distinct licenses recognized at point in time; (3) Correctly states that standalone licensing is always recognized at a point in time; (4) No quantitative errors or incorrect dates/numbers; (5) Properly synthesizes the multi-hop information about how AMD evaluates performance obligations across the three-year period. Minor considerations: (1) The LLM adds a detail about 'no variable-consideration estimates are applied' which is not explicitly mentioned in the ground truth, though this is a reasonable inference from standard revenue recognition practices and doesn't contradict the ground truth; (2) The LLM's phrasing is slightly more concise and structured than the ground truth but conveys the same essential information with equal or greater clarity. The answer demonstrates sound multi-hop reasoning by correctly synthesizing AMD's consistent approach across 2022-2024 and properly distinguishing between the treatment of distinct vs. non-distinct licenses. All core facts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 384,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Across the 2022, 2023, and 2024 Form 10‑Ks, FlyEase is consistently listed among Nike’s core technologies in the product research and development section, underscoring its ongoing role in product innovation. The filings do not describe a shift in its strategic emphasis or a move to a more central position; rather, FlyEase remains one of several technologies that exemplify Nike’s commitment to design and performance, with no explicit change in priority or integration noted between fiscal 2022 and fiscal 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and directly contradicts the ground truth. CRITICAL ERRORS: (1) The LLM states that FlyEase 'remains one of several technologies' with 'no explicit change in priority or integration noted between fiscal 2022 and fiscal 2024,' which is the opposite of what the ground truth documents. The ground truth clearly shows a three-year progression: FlyEase moved from 'newly introduced' (FY2022) → 'consistently named alongside established technologies' (FY2023) → 'listed among mature technologies' (FY2024). This represents a significant strategic evolution from emerging to foundational status. (2) The LLM claims 'The filings do not describe a shift in its strategic emphasis or a move to a more central position,' which directly contradicts the documented progression showing FlyEase becoming increasingly integrated and central to Nike's portfolio. (3) The LLM failed to perform the required multi-hop synthesis across the three fiscal years to identify the evolution pattern. QUANTITATIVE ACCURACY: The dates (2022, 2023, 2024) are correct, so quantitative accuracy receives partial credit. QUALITATIVE ACCURACY: The reasoning is fundamentally flawed - the LLM either failed to identify or misrepresented the clear progression documented in the filings. The answer demonstrates a failure to synthesize information across multiple years to identify the strategic positioning evolution. CONTEXTUAL RELEVANCE: The answer addresses Nike and FlyEase but misses the core question about how the positioning 'evolved' - it incorrectly claims no evolution occurred when the ground truth shows clear evolution. The LLM appears to have either misread the source documents or failed to properly analyze the comparative positioning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 490,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250% senior notes have stayed essentially the same over the three years: the 2022 and 2023 10‑Ks report an outstanding principal of 500.0 million EUR (≈ $609 million) (pages 46‑50, 109‑113), while the 2024 10‑K shows the same series outstanding at 517.7 million USD (≈ 500 million EUR) (pages 112‑116). This stability—no new issuances or significant repayments—suggests AMT is keeping a fixed long‑term debt load in this series and is focusing on predictable cash‑flow management rather than frequent debt restructuring.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL NUMERIC ERRORS: The LLM claims the principal amount 'stayed essentially the same' and reports 500.0 million EUR (≈$609M) for 2022-2023, but the ground truth clearly shows a declining trend: $609.1M (2022) → $551.9M (2023) → $517.7M (2024). The LLM's assertion of stability is factually incorrect. (2) CURRENCY CONFUSION: The LLM conflates EUR and USD amounts in a confusing way. It states 500.0 million EUR ≈ $609 million for 2022-2023, then claims 517.7 million USD ≈ 500 million EUR for 2024. This creates internal inconsistency and obscures the actual declining trend in USD terms. (3) MISINTERPRETATION OF TREND: The ground truth explicitly identifies a 'consistent reduction in outstanding debt' with a 'progressive decline in principal' ($609.1M → $551.9M → $517.7M). The LLM incorrectly characterizes this as 'stability' and 'no significant repayments,' which is the opposite of what the data shows. The total reduction from 2022 to 2024 is $91.4 million (15% decline), which is significant. (4) INCORRECT STRATEGIC CONCLUSION: The LLM concludes AMT is 'keeping a fixed long-term debt load' and 'focusing on predictable cash-flow management rather than frequent debt restructuring.' The ground truth correctly identifies this as a 'managed amortization or repurchase strategy' aimed at 'reducing long-term debt obligations.' These are fundamentally different strategic interpretations. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year trend across 2022, 2023, and 2024, instead misrepresenting the data as flat when it clearly shows consistent decline. The answer demonstrates a critical failure in quantitative accuracy and reasoning about the debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 494,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA reported a carrying amount of **$870 million** for its 3.50% Notes Due 2040 in FY 2023, which fell to **$851 million** in FY 2024, reflecting amortization and a modest repayment (FY 2023: [65‑69]; FY 2024: [70‑74]). The 2022 filing (pages 78‑82) lists the notes as part of long‑term debt, though a specific figure is not disclosed in the excerpt. The steady decline in carrying amount, combined with the notes’ classification as unsecured senior obligations recorded at original issuance net of discount and interest paid semiannually, signals NVIDIA’s disciplined long‑term debt strategy of gradually reducing debt while maintaining a diversified, moderate‑rate portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) INCORRECT FY2023 VALUE: LLM states $870 million for FY2023, but ground truth clearly shows $851 million. This is a direct contradiction. (2) INCORRECT FY2024 VALUE: LLM states the notes fell to $851 million in FY2024, but ground truth indicates they were carried at $1,000 million in FY2024. This is a critical error - the LLM appears to have confused the FY2023 value ($851M) with FY2024, and completely missed the FY2024 valuation of $1,000M. (3) MISSING FY2022 DATA: While the LLM acknowledges the 2022 filing doesn't provide a specific figure in the excerpt, the ground truth clearly states FY2022 fair value was $1,066 million. The LLM should have either found this or noted its absence more clearly. (4) MISCHARACTERIZED TRAJECTORY: The LLM describes a 'steady decline' from $870M to $851M, but the actual trajectory is: FY2022: $1,066M → FY2023: $851M (significant decline) → FY2024: $1,000M (recovery/stabilization). This is fundamentally different from what the LLM presents. (5) MISSING KEY METRIC: The ground truth includes the effective interest rate of 3.54% for FY2024, which the LLM does not mention. (6) INCORRECT INTERPRETATION: The LLM's conclusion about 'gradually reducing debt' is contradicted by the FY2024 increase to $1,000M. The ground truth's interpretation of 'stabilization in valuation' is more accurate. The LLM answer demonstrates poor multi-hop synthesis across the three fiscal years and contains multiple factual errors that undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 441,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "Netflix’s 2022 strategy added a lower‑priced ad‑supported tier and expanded its service to include mobile games, with the 10‑K noting that “if these new features or pricing changes are not well‑received, we may not attract or retain members” (Risk Factors, 2022, pp. 5‑9). In 2023 the company continued to grow its games offering and introduced additional pricing tiers, again warning that “changes to pricing or service offerings that are not favorably received could lead to cancellations and lower growth” (Risk Factors, 2023, pp. 4‑8). By 2024 Netflix broadened its portfolio further to include live programming, more games, and an ad‑supported plan, and the 10‑K reiterated that “if consumers do not perceive the new features or pricing as valuable, we may lose members and experience higher churn” (Risk Factors, 2024, pp. 4‑8).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND SEQUENCING: The LLM answer contains a fundamental factual error regarding when Netflix introduced its ad-supported tier. According to the ground truth, the ad-supported tier was introduced in 2023, not 2022. The LLM states: 'Netflix's 2022 strategy added a lower‑priced ad‑supported tier' - this is incorrect. The ground truth clearly indicates: 'In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier.' This is a major error that undermines the entire chronological narrative of the answer. CORRECT ELEMENTS: (1) Games were correctly identified as introduced in 2022; (2) Live programming was correctly identified as added by 2024; (3) The general risk narrative about member acquisition and retention is present in all three years; (4) The semantic content about pricing and feature reception risks is generally aligned. INCOMPLETE SYNTHESIS: While the LLM mentions games continuing in 2023, it doesn't clearly distinguish what was NEW in each year versus what was carried forward. The ground truth emphasizes the EVOLUTION and EXPANSION across years, showing how each year built upon previous offerings. The LLM's answer conflates the timeline by placing the ad-supported tier in 2022 when it should be 2023. RISK ARTICULATION: The LLM does capture the core risk messaging about member acquisition and retention across the three years, though the quoted text appears to be paraphrased rather than direct quotes (page numbers provided but quotes may not be verbatim). The semantic meaning of risks is preserved, but the factual foundation is compromised by the timeline error. MULTI-HOP REASONING: The answer attempts to synthesize across three years but fails at the foundational level by misplacing a key strategic initiative. This breaks the logical progression that should show: 2022 (games), 2023 (ad-supported tier), 2024 (live programming).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 523,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth Group’s equity securities holdings grew from **$3.7 billion at 12/31/2022 to $4.9 billion at 12/31/2023 and remained at $4.9 billion through 12/31/2024** (2022‑23‑24).  Equity‑method investments in healthcare operating businesses fell slightly from **$1.5 billion in 2022 to $1.4 billion in 2023, then surged to $3.8 billion in 2024**.  This shift shows the company is increasingly allocating capital to venture‑style, equity‑method stakes in healthcare firms, underscoring a strategic focus on deepening its footprint and driving innovation within the sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN EQUITY METHOD INVESTMENTS 2022 FIGURE: The LLM states equity-method investments were $1.5 billion in 2022, but the ground truth clearly indicates $1.3 billion. This is a material discrepancy of $200 million (15% error). All other numeric values are correct: equity securities at $3.7B (2022), $4.9B (2023-2024), and equity method investments at $1.4B (2023) and $3.8B (2024). The LLM correctly identifies the overall trend of increasing venture investment exposure and accurately characterizes the strategic shift toward deeper engagement in healthcare innovation. The reasoning about capital allocation to equity-method stakes and the conclusion about strategic positioning are sound and well-articulated. However, the factual error in the 2022 baseline figure undermines the accuracy of the comparative analysis, particularly when assessing the 'slight fall' from 2022 to 2023 (which should be a rise from $1.3B to $1.4B, not a fall from $1.5B to $1.4B). The qualitative assessment of strategic intent is appropriate and matches the ground truth interpretation. The answer addresses all parts of the multi-part question and demonstrates proper multi-hop synthesis across the three-year period. The error appears to be a data retrieval mistake rather than a calculation or reasoning failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 366,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America remained essentially unchanged from FY 2022 through FY 2024: Sojitz America continued to be the sole holder of Nike’s authorized redeemable preferred stock, with a cumulative dividend of $0.10 per share payable annually on May 31 and no common‑stock dividends allowed until the preferred dividend is fully paid.  The preferred‑stock terms and dividend obligations were unchanged in each filing, and Sojitz America’s role in Nike’s international operations stayed the same—providing import‑export financing services that support Nike’s global supply chain and trade‑financing needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key quantitative facts: (1) Sojitz America as sole holder of redeemable preferred stock, (2) $0.10 per share cumulative annual dividend, (3) dividend payment date of May 31, (4) the restriction on common-stock dividends until preferred dividend is paid, and (5) Sojitz America's role in import-export financing services. The numeric values are accurate and properly formatted.\n\nWEAKNESSES: The LLM answer fails to capture the critical evolution highlighted in the ground truth—the shift from 'purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024.' The ground truth explicitly states that in fiscal 2024, Nike 'explicitly highlighted' Sojitz America's strategic importance 'amid rising global trade risks,' suggesting a deliberate emphasis on operational/strategic value that was not present in prior years. The LLM states the relationship 'remained essentially unchanged' and that 'Sojitz America's role in Nike's international operations stayed the same,' which contradicts the ground truth's assertion of an evolution in how Nike characterized and emphasized this relationship.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and identifies the consistent financial terms. However, it fails to perform the more nuanced multi-hop reasoning required to detect the strategic shift in how Nike positioned Sojitz America's role between 2022-2023 versus 2024. This represents incomplete synthesis of the temporal evolution aspect of the question.\n\nQUANTITATIVE VERIFICATION: All numbers are correct (par value $0.3M implied, $0.10 dividend, May 31 payment date). No calculation errors detected.\n\nSEMANTIC ISSUES: The phrase 'remained essentially unchanged' is factually misleading regarding the strategic positioning, even if the financial terms were unchanged. The ground truth distinguishes between unchanged financial terms and an evolved strategic narrative, which the LLM conflates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 544,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA had no 3.50% Notes due 2050 on its balance sheet in FY 2022.  The carrying amount rose to $1.637 billion at FY 2023 and fell slightly to $1.604 billion at FY 2024【NVDA_10k_2024.pdf pages 70‑74】【NVDA_10k_2023.pdf pages 65‑69】.  The modest, stable change shows that the 3.50% Notes are a small, well‑managed component of NVIDIA’s long‑term debt, reflecting a conservative and steady debt strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) QUANTITATIVE ERRORS - The LLM claims FY2022 had no 3.50% Notes (incorrect; ground truth shows $2,147M), FY2023 was $1.637B (incorrect; ground truth shows $1,604M), and FY2024 was $1.604B (incorrect; ground truth shows $2,000M). The LLM has essentially reversed/confused the FY2023 and FY2024 figures. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the three-year trend across fiscal years 2022-2024. The ground truth shows a clear pattern: $2,147M → $1,604M → $2,000M (decrease then increase), while the LLM presents a completely different and incorrect sequence. (3) TREND ANALYSIS ERROR - The LLM's conclusion about 'modest, stable change' is contradicted by the actual data showing significant volatility ($543M decrease from 2022-2023, then $396M increase from 2023-2024). The ground truth correctly identifies this as 'temporary reduction followed by strategic repositioning,' which the LLM misses entirely. (4) ENTITY/YEAR ACCURACY - While the LLM correctly identifies the security (3.50% Notes Due 2050) and company (NVIDIA), it fails on the critical numeric values and temporal sequence. The LLM's characterization of the debt as 'small, well-managed' and reflecting 'conservative strategy' is unsupported by the actual carrying value movements. This is a fundamental failure in multi-hop financial analysis requiring accurate synthesis of three consecutive fiscal years' data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 419,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term debt—primarily commercial paper—fell from $175 million in 2022 to $119 million in 2023 but then surged to $465 million in 2024, indicating a shift toward greater use of commercial paper to support liquidity.  Throughout the period the company continued to rely on a broad mix of global funding sources—including preferred and common equity, long‑term debt, collateral‑financing arrangements, junior subordinated debt, policy‑holder account balances, credit and committed facilities, and a shelf registration statement—to diversify funding and keep the cost of capital low.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative data about commercial paper amounts ($175M in 2022, $119M in 2023, $465M in 2024) that is NOT present in the ground truth answer. The ground truth explicitly states there were 'no major structural changes' and describes a 'stable reliance on short-term debt markets,' whereas the LLM claims a 'surge' to $465M in 2024, suggesting a significant shift. This is a critical discrepancy. The ground truth emphasizes consistency and stability across 2022-2024, while the LLM narrative suggests material change and volatility in commercial paper usage. The LLM correctly identifies the diversified funding sources (preferred/common equity, long-term debt, credit facilities, shelf registration, etc.) and appropriately addresses the cost-of-capital reduction strategy. However, the specific numbers provided cannot be verified against the ground truth, and the interpretation of 'surge' contradicts the ground truth's emphasis on stability. The LLM does address all parts of the question (short-term debt evolution, diversified sources, cost reduction), but the quantitative claims appear to introduce data not supported by the knowledge graph. The qualitative aspects (diversification strategy, liquidity management) are well-articulated and align with the ground truth's themes, but the quantitative specificity creates a fundamental accuracy problem that undermines the overall response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 396,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "Short‑term notes payable to subsidiaries fell from $8.7 B in 2022 to $9.9 B in 2023 and then to $2.0 B in 2024, while long‑term notes payable rose to $14.4 B in 2024 – a level not material in prior years; service‑level guarantees remained non‑material throughout 2022‑24 (2023 10‑K p. 76‑80; 2024 10‑K p. 78‑82; 2022 10‑K p. 79‑83). This shift from short‑term to long‑term financing reduces immediate liquidity pressure but increases long‑term debt exposure, while the stable, non‑material service‑level guarantees indicate low contractual risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding short-term notes payable in 2022. Ground truth states $8.1 billion in 2022, but LLM reports $8.7 billion - a $600 million discrepancy. The 2023 figure of $9.9 billion is correct, and the 2024 figure of $2.0 billion is correct. However, the LLM introduces NEW information about long-term notes payable rising to $14.4 billion in 2024, which is NOT mentioned in the ground truth answer. This represents either fabricated data or information not verified against the original filing data. MULTI-HOP REASONING: The LLM correctly identifies the shift from short-term to long-term financing and appropriately interprets this as reducing immediate liquidity pressure while increasing long-term debt exposure. The reasoning about service-level guarantees remaining non-material is sound and matches the ground truth. COMPLETENESS: The LLM addresses both components of the question (notes payable evolution and service level guarantees), but the introduction of unverified long-term debt figures suggests either hallucination or reliance on unconfirmed sources. ENTITY ACCURACY: UnitedHealth Group is correctly identified, years are correct (2022-2024), and the metric terminology is appropriate. PAGE CITATIONS: The LLM provides specific page references (2023 10-K p. 76-80; 2024 10-K p. 78-82; 2022 10-K p. 79-83) which adds credibility but cannot be verified against the ground truth. SEMANTIC EQUIVALENCE: The overall narrative about liquidity commitments and contractual risk exposure aligns with the ground truth's conclusion about stable risk profiles, but the quantitative foundation is compromised. The $600 million error in 2022 and the unverified $14.4 billion long-term figure are material discrepancies that undermine confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 503,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022‑23, American Express remained the fourth‑largest general‑purpose card network, competing with Visa, Mastercard, UnionPay and a growing set of digital‑wallet and alternative‑payment platforms, and it continued to emphasize premium, high‑margin products and digital‑mobile services.  In 2024 the company’s regulatory exposure intensified—its new Category III bank‑holding status and heightened scrutiny on interchange‑fee caps, routing and merchant‑acceptance rules prompted AmEx to exit EU and Australian network‑licensing businesses, tighten its risk‑management and compliance framework, and diversify revenue through new products such as checking accounts and non‑card lending.  These moves illustrate a strategic pivot that balances maintaining a premium card‑network position with the demands of an increasingly regulated payments landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key factual elements: (1) Amex as fourth-largest general-purpose card network in 2022-23; (2) Competition from Visa, Mastercard, UnionPay, and digital/alternative platforms; (3) Category III bank-holding status in 2024; (4) Regulatory scrutiny on interchange fees, routing, and merchant acceptance; (5) Exit from EU and Australian network-licensing businesses; (6) Strategic pivot toward premium positioning with regulatory compliance. The numeric references and entity identifications are accurate. The multi-hop synthesis correctly connects competitive positioning (2022-23) with regulatory evolution (2024).\n\nWEAKNESSES: (1) The LLM answer omits specific mention of alternative payment platforms like Alipay, PayPal, Venmo, and regional systems (National Payments Corporation of India) that the ground truth explicitly identifies as part of the intensified competitive landscape. While the LLM mentions 'digital-wallet and alternative-payment platforms' generically, it lacks the specificity of the original answer. (2) The ground truth emphasizes a narrative arc of 'transformation from market-driven competition to regulatory navigation and compliance adaptation'—a key interpretive framework. The LLM captures this shift but frames it more as 'balancing' rather than emphasizing the constraint/transformation aspect. (3) The ground truth notes Amex's 'independence and competitive edge have been increasingly shaped and constrained by regulatory forces'—a critical characterization of the power dynamic. The LLM's framing is more neutral/balanced. (4) The LLM mentions new products (checking accounts, non-card lending) as diversification strategy, which is not explicitly in the ground truth but represents reasonable inference from regulatory adaptation context.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three time periods (2022, 2023, 2024) and connects competitive dynamics to regulatory responses. The reasoning is sound and logical.\n\nSEMANTIC EQUIVALENCE: While wording differs, the core factual content aligns well. The LLM's characterization of the evolution is slightly less emphatic about regulatory constraint but captures the essential strategic pivot.\n\nOVERALL ASSESSMENT: The answer is substantially correct on core facts and demonstrates solid multi-hop reasoning. The primary gap is incomplete enumeration of specific competitive threats and a somewhat softer characterization of regulatory constraint versus the ground truth's emphasis on transformation and constraint. These are meaningful but not critical omissions for a 7/10 score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1635,
        "completion_tokens": 699,
        "total_tokens": 2335
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 through 2024, ConocoPhillips kept the same dividend‑equivalent structure for its cash‑settled PSUs: for performance periods beginning in 2018 or later, recipients receive an accrued reinvested dividend equivalent that is charged to compensation expense and paid at settlement (see COP_10k_2022 p. 134‑138, COP_10k_2023 p. 121‑125, COP_10k_2024 p. 123‑127).  The unchanged mechanism shows the company’s commitment to aligning executive pay with long‑term shareholder value by tying rewards to the company’s stock performance over a multi‑year horizon.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) INCOMPLETE ANSWER - The LLM answer fails to address a major component of the ground truth: the evolution/contrast between dividend equivalent structures for performance periods BEFORE 2018 vs. 2018 or later. The ground truth explicitly states 'for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement.' The LLM only discusses the 2018+ structure and misses this critical evolution. (2) MISLEADING CHARACTERIZATION - The LLM states the structure was 'unchanged' from 2022-2024, which is technically accurate for that period, but this obscures the actual evolution that occurred between pre-2018 and post-2018 periods, which is central to the question about how the strategy 'evolved.' (3) MISSING STRATEGIC INSIGHT - The ground truth provides important context that this shift 'suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized.' The LLM provides generic language about 'aligning executive pay with long-term shareholder value' but misses the specific strategic rationale about the timing of dividend equivalent payments. (4) PARTIAL CREDIT FOR WHAT WAS INCLUDED - The LLM correctly identifies that for 2018+ periods, recipients receive accrued reinvested dividends paid at settlement, and correctly notes this applies consistently across 2022-2024. The page citations appear reasonable. (5) MULTI-HOP REASONING - The LLM failed to synthesize the comparison between pre-2018 and post-2018 structures, which is essential to answering how the strategy 'evolved.' The answer reads as incomplete rather than incorrect on the facts it does present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 493,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra Energy’s Special Use Funds grew from $7.7 billion at December 31 2022 to $9.8 billion at December 31 2024 (2024: $9,800 m; 2023: $8,698 m; 2022: $7,703 m)【NEE_10k_2024.pdf: page 62‑66】【NEE_10k_2023.pdf: page 84‑88】【NEE_10k_2022.pdf: page 86‑90】.  Even with potential derivative‑related collateral obligations that could reach $5.2 billion in 2022 and $2.4 billion in 2023 for below‑investment‑grade triggers (and up to $1.7 billion for cross‑default triggers)【NEE_10k_2024.pdf: page 62‑66】, the Special Use Funds remain well above these amounts, indicating a robust liquidity buffer that comfortably covers derivative collateral needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the Special Use Funds trajectory (2022: $7,703m → 2023: $8,698m → 2024: $9,800m), matching ground truth exactly. The derivative collateral obligation figures for 2022 ($5.2B) and 2023 ($2.4B) are accurate. The reasoning about liquidity positioning and risk management is sound and addresses the multi-hop synthesis required. The conclusion about a robust liquidity buffer is logically supported.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to mention the actual collateral posted in cash figures ($84M in 2022 and $691M in 2023), which are explicitly highlighted in the ground truth as evidence of strengthened liquidity positioning. This is a significant detail that demonstrates the company's actual collateral management behavior. (2) INCOMPLETE ANALYSIS: The ground truth emphasizes that collateral posting requirements 'dropped significantly' from 2022 to 2023 - the LLM mentions these figures but doesn't explicitly highlight this reduction as a key insight. (3) MISSING CONTEXT: The ground truth notes the potential collateral requirement 'in the event of a credit downgrade' - the LLM mentions this but doesn't emphasize it as clearly. (4) EXTRANEOUS INFORMATION: The LLM introduces a $1.7B cross-default trigger figure that isn't mentioned in the ground truth, which may be accurate but adds complexity without being part of the core narrative.\n\nQUANTITATIVE VERIFICATION: All Special Use Funds figures are correct (7,703m, 8,698m, 9,800m). The derivative collateral obligation figures (5.2B in 2022, 2.4B in 2023) are correct. However, the omission of the actual cash collateral posted ($84M and $691M) represents incomplete quantitative analysis of the evolution described in the question.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects Special Use Funds growth to derivative collateral obligations. However, it misses the critical connection between actual collateral posting behavior and liquidity positioning, which is a key element of the multi-hop analysis required by the question.\n\nSCORE JUSTIFICATION: The answer is partially correct with accurate core numbers but significant omissions of material details (actual collateral posted) that are essential to fully answering the question about liquidity positioning evolution. The reasoning is sound but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 635,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600% senior unsecured notes have remained a fixed‑principal, non‑amortizing debt instrument through 2024.  The aggregate principal stayed at $700 million in 2022, 2023 and 2024 (see the 2022 table on pages 46‑50, the 2023 table on pages 108‑112, and the 2024 table on pages 111‑115), and the only change in the “Adjustments to Principal Amount” column was a reduction in the negative discount amortization from (2.6) in 2022/2023 to (1.5) in 2024.  This pattern indicates that AMT is treating the 1.600% Notes as a long‑term, non‑amortizing liability, relying on revolving credit facilities and refinancing rather than scheduled principal repayments to preserve liquidity and keep the debt structure stable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors regarding the 'Adjustments to Principal Amount' figures. Ground truth states: (3.7) million in 2022, (2.6) million in 2024. LLM claims: (2.6) in 2022/2023 and (1.5) in 2024. This is a fundamental misrepresentation of the data trajectory. The LLM incorrectly states the adjustment amounts decreased from (2.6) to (1.5), when the ground truth shows they decreased from (3.7) to (2.6). This is a major quantitative accuracy failure. CORRECT ELEMENTS: The LLM correctly identifies the principal amount as $700 million across all three years (2022-2024), which matches the ground truth. The characterization of the notes as 'fixed-principal, non-amortizing' is semantically consistent with the ground truth's 'stable long-term debt strategy.' REASONING ISSUES: While the LLM's interpretation about debt management strategy (non-amortizing, relying on refinancing) is reasonable and contextually appropriate, it is built on incorrect numerical data. The multi-hop synthesis across years is attempted but undermined by the wrong adjustment figures. The LLM also provides page references that cannot be verified against the ground truth source. MISSING CONTEXT: The LLM does not clearly articulate the 'gradual reduction in associated liabilities or accrued costs' pattern that the ground truth emphasizes as the key insight from the declining adjustments. The semantic meaning of the answer diverges from ground truth because the numbers are wrong, making the entire trajectory analysis incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 433,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes stayed pronounced from 2022 through 2024 as CMS continued to freeze or cut benchmarks and alter risk‑adjustment calculations, creating uncertainty and potential funding pressures (see 2022 pages 23‑27; 2023 pages 18‑22; 2024 pages 18‑22).  In response, the company has selectively adjusted member benefits and premiums, stopped offering plans in certain counties, and intensified medical and operating cost management to offset the impact of benchmark reductions and other funding pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the consistent theme of CMS risk adjustment payment changes; (2) Accurately captures the core strategic responses: selective benefit/premium adjustments, county exits, and intensified cost management; (3) Properly synthesizes multi-hop information showing evolution across the three-year period; (4) Correctly identifies the regulatory pressure (CMS benchmark freezes/cuts and risk adjustment calculation changes); (5) Appropriately cites document references (though these cannot be verified against actual filings, they appear reasonable). MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth, omitting the explicit year-by-year progression narrative that the ground truth provides (e.g., 'In 2022...In 2023...By 2024'); (2) Does not explicitly state that these pressures were 'consistent' across all three years as clearly as the ground truth does, though this is implied; (3) The phrase 'stayed pronounced' is slightly less precise than the ground truth's 'consistently faced exposure.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension focuses on date accuracy (2022-2024 correctly identified) and document page references (which appear plausible but cannot be verified). QUALITATIVE ACCURACY: The reasoning correctly synthesizes the multi-hop relationship between regulatory changes and company responses across three years. The entity identification (UnitedHealth Group, CMS, Medicare Advantage) is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses the question's core inquiry about exposure evolution and strategic adjustments, maintaining appropriate focus throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 503,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s 10‑K filings from 2022 through 2024 all list a “merchandise and other discounts” benefit for team members, with no change in wording or scope across the three years (2022: Comp. & Benefits p.5‑8; 2023: Comp. & Benefits p.5‑9; 2024: Comp. & Benefits p.5‑9). The unchanged description indicates that Target maintains a stable, inclusive discount program as a core part of its employee‑well‑being strategy, underscoring a continued commitment to providing cost‑saving benefits to attract and retain talent. The consistent inclusion of the benefit—despite the specific discount rate not being disclosed—signals a sustained focus on supporting employees’ financial health.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about evolution and progression. Key issues: (1) FACTUAL ERRORS: The LLM claims 'no change in wording or scope across the three years' and that the benefit description remained 'unchanged,' which directly contradicts the ground truth. The ground truth explicitly documents evolution: starting wage increased from $15/hour (2022) to $15-$24/hour (2023), new benefits were added (sick pay, tuition-free education, virtual healthcare, expanded mental health services), and the framing shifted from basic benefits to a 'holistic financial and well-being strategy' and 'equitable pay and belonging' narrative. (2) INCOMPLETE SYNTHESIS: The LLM failed to synthesize the multi-hop information about how merchandise discounts fit within the broader evolving compensation strategy. The question asks about 'scope and structure evolution' and what this 'indicates about Target's strategy'—the LLM provides no evidence of evolution and misses the strategic shift toward comprehensive financial wellness. (3) CITATION ISSUES: The LLM provides page references (p.5-8, p.5-9) without substantiating the claim of unchanged wording; the ground truth shows clear contextual evolution even if the discount benefit itself remained listed. (4) REASONING FAILURE: The LLM concludes that 'unchanged description indicates...stable...program' when the actual evidence shows the benefit remained stable while the surrounding strategy evolved significantly. The LLM missed the key insight that merchandise discounts became positioned within an increasingly comprehensive financial wellness narrative. (5) MISSING CONTEXT: No mention of wage increases, new benefits additions, or strategic reframing toward 'belonging' and 'equitable pay'—all central to understanding the evolution. The answer is fundamentally incomplete and contradicts documented facts about Target's evolving employee benefits strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 531,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "Across 2022‑24 the weighted‑average yield on American Express’s foreign government bonds and obligations rose modestly from 2.08 % in 2022 to 2.18 % in 2023 and 2.28 % in 2024, while the maturity mix stayed heavily tilted to long‑term securities—over 60 % of the portfolio was due after 10 years each year (see the maturity tables on pages 119‑123, 133‑137, 175‑179). This gradual yield lift coupled with a persistent long‑term tilt signals a cautious risk appetite and a conservative asset‑allocation strategy that prioritizes stable, long‑term income over higher‑yield, short‑term exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data and fails to accurately represent American Express's foreign government bond portfolio across 2022-2024. CRITICAL ERRORS: (1) YIELD DATA COMPLETELY WRONG: The LLM reports overall weighted-average yields of 2.08% (2022), 2.18% (2023), and 2.28% (2024), which are dramatically lower than the ground truth data showing yields of 1.74%-2.42% (2022), 4.48%-6.45% (2023), and 2.03%-5.86% (2024). The LLM's reported yields don't match any of the maturity-specific yields in the ground truth. (2) MATURITY DISTRIBUTION MISREPRESENTED: The LLM claims 'over 60% of the portfolio was due after 10 years each year,' but the ground truth focuses on securities due within one year and those due after one but within five years—no mention of 10+ year securities. This is a fundamental mischaracterization of the portfolio composition. (3) MISSING CRITICAL CONTEXT: The ground truth shows a dramatic yield increase from 2022 to 2023 (1.74% to 6.45% for short-term, 2.42% to 4.48% for medium-term), indicating aggressive repositioning in response to rising interest rates. The LLM completely misses this significant strategic shift. (4) INCORRECT STRATEGIC INTERPRETATION: The LLM concludes the company has a 'cautious risk appetite' and 'conservative asset-allocation strategy,' which directly contradicts the ground truth's assessment of 'more aggressive short-term investments in 2023.' The LLM's interpretation is backwards. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about yield AND maturity distribution evolution—the LLM addresses both but gets both wrong, failing to properly synthesize the relationship between yield changes and maturity shifts. The LLM appears to have fabricated or severely misread the underlying data, presenting numbers that don't align with any disclosed figures in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 506,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "The collateral posted under master‑netting arrangements – which is recorded within the “Other assets, including intangibles – net” line – fell from **$1,494 million in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (a decline of roughly 67 % over the period). This downward trend indicates that ExxonMobil has either reduced its net derivative exposure or improved its hedging and counter‑party risk management, thereby lowering the margin requirements for its derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $1,494 million (2022), $800 million (2023), and $491 million (2024). The calculated percentage decline of ~67% is accurate: ($1,494-$491)/$1,494 = 67.1%, which rounds appropriately. (2) COMPLETENESS: The answer addresses all parts of the multi-hop question - it identifies the specific collateral metric, tracks the three-year trend, and provides interpretation of what the trend suggests about derivative exposure management. (3) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the 'Other assets, including intangibles - net' line item is correctly cited, and all fiscal years (2022-2024) are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly connects the collateral figures to derivative exposure management and provides two plausible explanations (reduced net derivative exposure OR improved hedging/counterparty risk management), which is slightly more nuanced than the ground truth's single explanation. The mention of 'margin requirements' adds relevant context about why collateral would decline. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that the trend 'indicates a strategic reduction in derivative-related exposure or a shift in risk management practices' aligns well with the ground truth's statement about 'strategic reduction in derivative-related exposure or a shift in risk management practices.' Minor difference: LLM provides slightly more detailed explanation of the mechanism (margin requirements), which enhances rather than detracts from accuracy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 460,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "AMT issued its 2.700% senior unsecured notes in March 2021 at a fixed 2.700% coupon, maturing April 15 2031, and used the proceeds to repay debt under the 2021 Multicurrency Credit Facility【On March 29, 2021, we completed a registered public offering of $700.0 million aggregate principal amount of 1.600% senior unsecured notes due 2026 (the “1.600% Notes”) and $700.0 million aggregate principal amount of 2.700% senior unsecured notes due 2031 (the “2.700% Notes”). The net proceeds from this offering were approximately $1,386.3 million, after deducting commissions and estimated expenses. We used all of the net proceeds to repay existing indebtedness under the 2021 Multicurrency Credit Facility】. The notes have remained unchanged through 2024, with the same principal, coupon, and maturity reflected in the 2023 and 2024 tables【2.700% Notes | 700.0 | (5.0) | (5.6) | April 15 | and October 15 | March 29, 2021 | January 15 | 2031】【2.700% Notes | 700.0 | (5.0) | (5.6) | April 15 | and October 15 | March 29, 2021 | January 15 | 2031】. This stability reflects a strategy of locking in low fixed‑rate debt early and preserving it while issuing higher‑rate notes later as market rates rose, indicating a conservative, rate‑hedging approach amid tightening credit conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) MATURITY DATE DISCREPANCY: LLM states maturity as 'April 15 2031' but ground truth clearly states 'April 15, 2031' in 2022 disclosure AND 'January 15, 2031' in 2023-2024 disclosures. This is a critical factual error - the maturity date changed or was corrected between years. (2) INTEREST RATE SPREAD EVOLUTION MISSED: Ground truth explicitly notes the interest rate spread decreased from (5.0) to (4.4) by 2024, which is a KEY finding about financing strategy and market conditions. LLM completely fails to capture this evolution, instead showing static (5.0) and (5.6) figures that don't match ground truth's (5.0) to (4.4) progression. (3) PAR CALL DATE OMISSION: Ground truth mentions 'par call date of January 15, 2031' in 2022, which LLM fails to address. (4) INTEREST PAYMENT DATES: LLM correctly identifies April and October payment dates, matching ground truth. (5) PRINCIPAL AMOUNT: Correctly stated as $700.0 million throughout. (6) ISSUANCE DATE: Correctly identified as March 29, 2021. (7) MULTI-HOP SYNTHESIS: LLM provides context about the 1.600% Notes and credit facility repayment, which is relevant but not directly requested. The core multi-hop requirement was to track evolution from 2022-2024, which LLM fails to do accurately. (8) STRATEGIC ANALYSIS: LLM's conclusion about 'locking in low fixed-rate debt' and 'rate-hedging approach' is reasonable but based on incomplete/incorrect data. The actual story (per ground truth) is about declining spreads from 5.0 to 4.4, suggesting improving credit conditions or refinancing dynamics, not just 'tightening credit conditions.' QUANTITATIVE ACCURACY: Multiple numeric errors (maturity date, spread figures). QUALITATIVE ACCURACY: Misses the key evolution metric (spread reduction) that directly answers the question about how terms 'evolved' and what this reveals about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 508,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00% Notes due 2031 were $1,044 million at year‑end 2022 (as disclosed in the 2022 filing, pages 78‑82), remained unchanged at $1,044 million in 2023 (pages 65‑69), and rose modestly to $1,057 million in 2024 (pages 70‑74). This slight uptick reflects a deliberate, incremental expansion of low‑coupon, long‑dated debt, underscoring the company’s strategy of using stable, long‑term financing to fund growth while keeping leverage manageable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the financial obligations. According to the ground truth: (1) 2022: Fair value was $1.2 billion, NOT $1.044 million as stated by LLM. (2) 2023: Beginning balance was $1.044 billion and ending balance was $1.057 billion - the LLM incorrectly states it 'remained unchanged at $1,044 million.' (3) 2024: Carrying value was $1.25 billion, but LLM states $1.057 million, which is a major discrepancy. The LLM appears to have confused or misread the 2023 ending balance ($1.057 billion) as the 2024 figure. MULTI-HOP REASONING: The LLM failed to properly synthesize the progression across all three years. The ground truth shows: $1.2B (2022) → $1.044B-$1.057B (2023) → $1.25B (2024), indicating an initial decrease then recovery/increase. The LLM's narrative of 'remained unchanged' and 'rose modestly to $1,057 million' misrepresents the actual trajectory. STRATEGIC INTERPRETATION: While the LLM's interpretation about 'stable, long-term financing' and 'manageable leverage' is reasonable in tone, it is based on incorrect numbers and therefore the strategic conclusion is not properly grounded in the actual data. The ground truth indicates 'relatively stable approach' and 'strategic consistency,' which differs from the LLM's characterization of 'incremental expansion.' ENTITY AND METRIC ACCURACY: The company (NVIDIA) and debt instrument (2.00% Notes Due 2031) are correctly identified, but the financial metrics and their values are substantially wrong throughout the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 434,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances have trended downward: deposit assets fell from $5.1 billion at 12/31/2023 to $4.6 billion at 12/31/2024, and deposit liabilities declined from $1.3 billion to $1.2 billion over the same period【2024‑pages‑204‑208】.  While the 2022 figures are not shown here, the pattern indicates a modest reduction in the volume of reinsurance contracts that qualify for the deposit method, suggesting a gradual shift toward other reinsurance structures or a tightening of the company’s reinsurance mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misrepresents the trend and contains significant factual inaccuracies. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims deposit assets fell from $5.1B (2023) to $4.6B (2024), but the ground truth shows deposit assets INCREASED from $1.8B (2022) to $5.1B (2024). The LLM correctly cites the 2023-2024 decline ($5.1B to $4.6B) but completely omits the 2022 baseline of $1.8B, which is essential for understanding the full 3-year trend. The LLM also states deposit liabilities declined from $1.3B to $1.2B, which matches ground truth for 2023-2024, but again omits the 2022 figure of $1.4B. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about evolution 'from 2022 through 2024,' requiring a 3-year analysis. The LLM only addresses 2023-2024, missing the critical context that 2022-2023 showed substantial growth ($1.8B to $5.1B in assets). This is a major failure in multi-hop reasoning across the required time period. (3) MISCHARACTERIZATION OF TREND: The LLM describes the overall trend as 'downward' and 'modest reduction,' which is misleading. The complete 3-year picture shows a dramatic increase in deposit assets (183% growth from $1.8B to $5.1B), with only a modest decline in the final year. The ground truth correctly identifies this as an 'upward trend' overall. (4) MISSING STRATEGIC CONTEXT: The LLM fails to mention the Global Atlantic transaction ($10.3B in reinsurance recoverables in 2023), which the ground truth identifies as a key driver of the strategic shift. This omission significantly weakens the analysis of what the trend indicates about reinsurance strategy. (5) INCORRECT INTERPRETATION: The LLM's conclusion that the data 'suggests a gradual shift toward other reinsurance structures' contradicts the ground truth's assessment that the trend 'reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method.' The LLM's interpretation is backwards relative to the actual data pattern. The answer demonstrates partial understanding of 2023-2024 movements but fails the fundamental requirement of analyzing the complete 2022-2024 evolution and misinterprets the overall strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 599,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt portfolio fell from a fair value of **$679 million** and carrying value of **$696 million** in 2022 to **$596 million** and **$603 million** in 2023, and further to **$508 million** and **$512 million** in 2024. The downward trend reflects a gradual contraction of the portfolio (through maturities or sales) and a consistent decline in market valuation driven by rising rates, while carrying values remain only slightly above fair values, indicating the company views the unrealized losses as temporary and maintains a conservative, low‑risk fixed‑income strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All six financial figures are precisely correct - 2022: fair value $679M, carrying value $696M; 2023: fair value $596M, carrying value $603M; 2024: fair value $508M, carrying value $512M. The year-over-year declines are accurately represented. (2) ENTITY ACCURACY: UnitedHealth Group correctly identified, metric terminology (Debt Securities - Held-to-Maturity, fair value, carrying value) properly used, all three years (2022-2024) correctly referenced. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the 3-year progression, correctly identifying the consistent downward trend across both metrics and both time periods. The comparison of fair value to carrying value relationships is accurate. (4) REASONING QUALITY: The LLM provides sound interpretation of the data, noting the portfolio contraction, market valuation effects from rising rates, and the company's conservative positioning. The observation that carrying values remain slightly above fair values (indicating unrealized losses viewed as temporary) is a valid analytical insight. (5) COMPLETENESS: The answer addresses all aspects of the original question - the evolution of both metrics, the 3-year progression, and implications for investment strategy and market adjustments. The LLM goes slightly beyond the ground truth by offering more detailed interpretation about rising rates and the company's risk posture, which adds value without contradicting the original answer. Minor distinction: The ground truth uses more neutral language ('strategic reduction or repositioning'), while the LLM provides more specific market-based explanation (rising rates), but both interpretations are consistent and reasonable given the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 491,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s credit‑card penetration dropped from 20.5 % of purchases in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024. The downward trend indicates the card program is losing share of sales, suggesting its effectiveness at generating incremental purchases is weakening.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: All quantitative data is correct - the penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match the ground truth exactly. The LLM correctly identified the downward trend and accurately characterized it as a decline in card share of sales. Number formatting and calculations are accurate.\n\nWEAKNESSES: The LLM answer is incomplete in addressing the full question. The original question asks what the trend 'suggests about the effectiveness of Target's credit card strategy in driving incremental sales.' The ground truth answer provides nuanced context: while the penetration rate declined, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting 'some ongoing strategic value.' The LLM answer only presents the negative interpretation (weakening effectiveness) without acknowledging this important counterpoint about the card's continued strategic contribution to incremental sales. This represents a significant omission of material context from the ground truth. The LLM's conclusion that 'effectiveness at generating incremental purchases is weakening' is partially correct but incomplete - it fails to capture the full picture that Target still sees strategic value despite the declining penetration rate. The answer addresses the trend accurately but provides an incomplete assessment of what it suggests about strategy effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 404,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike owned its Laakdal, Belgium distribution center in fiscal 2022 and still owned it in fiscal 2024, with no change in the facility’s operational footprint. The consistent ownership of this key European hub underscores Nike’s strategy of retaining control over critical logistics infrastructure to maintain supply‑chain efficiency and resilience across its European, Middle‑East and Africa operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Nike's ownership of the Laakdal, Belgium facility across fiscal years 2022-2024. The core claim that ownership remained consistent and unchanged is accurate and matches the ground truth. Numeric/date references (2022, 2024) are correct. The answer successfully synthesizes the multi-hop requirement by connecting facility ownership across multiple fiscal years and drawing a strategic conclusion about Nike's European logistics focus. The LLM appropriately infers that consistent ownership indicates strategic commitment to maintaining control over critical infrastructure. Minor strengths: The LLM adds contextual detail about 'supply-chain efficiency and resilience across its European, Middle-East and Africa operations,' which is a reasonable inference about Nike's strategic rationale, though not explicitly stated in the ground truth. Minor weaknesses: (1) The ground truth specifically notes the facility was 'described as one of the most significant international distribution centers' in 2022 and this characterization 'remained consistent in 2023 and 2024' - the LLM answer doesn't explicitly capture this consistency of the 'significant' descriptor across all three years, though it does reference it as a 'key European hub.' (2) The ground truth emphasizes the consistency of the facility's characterization across all three years (2022, 2023, 2024), while the LLM only explicitly mentions 2022 and 2024, omitting 2023. This is a minor omission since the answer still conveys the overall consistency message. The reasoning is sound and the semantic meaning aligns well with the ground truth, though slightly less comprehensive in capturing the year-by-year consistency narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 482,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "From FY 2022 through FY 2024, NVIDIA’s 10‑K filings consistently list Lumentum Holdings as a competitor in the interconnect, switch, and cable solutions segment (FY 2022 pages 13‑17; FY 2023 pages 7‑11; FY 2024 pages 7‑11), with no change in its categorization or prominence. In FY 2024, NVIDIA highlighted an expansion of supplier relationships to build supply‑chain redundancy and resilience (FY 2024 pages 7‑11), while its IP protection strategy—reliant on patents, trademarks, trade secrets, NDAs, and licensing—remained largely unchanged across the three years (FY 2024 pages 7‑11). These supply‑chain and IP measures reinforce NVIDIA’s competitive advantage, potentially constraining Lumentum’s relative influence in the same market segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Lumentum Holdings as a consistent competitor across FY 2022-2024 in interconnect/switch/cable solutions, matching the ground truth's core finding. However, there are significant issues: (1) QUANTITATIVE PROBLEMS: The LLM cites specific page numbers (FY 2022 pages 13-17; FY 2023 pages 7-11; FY 2024 pages 7-11) without verification against actual filings. The ground truth does not provide these page citations, making them unverifiable and potentially inaccurate. This is a critical error for a financial document evaluation task. (2) INCOMPLETE SYNTHESIS: The LLM fails to address key multi-hop elements from the ground truth: (a) No mention of NVIDIA's specific manufacturing partnerships (TSMC, Samsung) emphasized in ground truth; (b) No discussion of patent portfolio expansion with expiration dates moving from 2022 to 2045, which is explicitly highlighted in ground truth as contextual to competitive positioning; (c) Missing the nuanced observation that Lumentum 'maintained its relevance' despite NVIDIA's strategic advances. (3) REASONING GAPS: The LLM's conclusion that NVIDIA's supply chain and IP measures 'potentially constrain Lumentum's relative influence' is speculative and not directly supported by the ground truth, which emphasizes Lumentum's persistent competitive presence despite these measures. (4) SEMANTIC ISSUES: The phrase 'no change in its categorization or prominence' is presented as fact but lacks supporting evidence from the filings. The ground truth indicates consistent mention but doesn't explicitly state 'no change.' (5) POSITIVE ASPECTS: The answer correctly identifies the three-year period, the correct product categories, and the general strategic themes (supply chain resilience, IP protection). The structure is logical and addresses the question's main components. The core finding—Lumentum's consistent competitive positioning—is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 520,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 2022 10‑K warned that “if studios, content providers or other rights holders refuse to license streaming content … our business could be adversely affected” (pp. 9‑13), underscoring a heavy reliance on third‑party licensing. By 2024 the filings still list licensing as essential but shift the narrative toward securing exclusive, longer‑term rights and expanding original production to reduce that dependency, while noting new regulatory pressures such as content quotas and levies (pp. 2‑6). This evolution signals a dual strategy: maintaining a broad licensed library for breadth, but increasingly investing in proprietary content to guard against rising competition and tightening regulatory constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core risk factor of reliance on third-party licensing in 2022 with accurate quote attribution; (2) Accurately captures the evolution from 2022-2024, noting the shift from pure licensing concerns to regulatory pressures; (3) Properly synthesizes the multi-hop reasoning: licensing dependency → competitive pressures → regulatory constraints → strategic response (exclusive/original content); (4) Correctly identifies key strategic elements: maintaining licensed library breadth while investing in proprietary content; (5) Appropriately references regulatory pressures (content quotas, levies) as emerging constraints in 2024. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention the 2023 discussion point about 'variability of license terms' and 'maintaining compelling content mix for membership growth,' though this is a minor omission; (2) Page references (pp. 9-13, pp. 2-6) are provided but cannot be verified against actual filings; however, these appear reasonable and don't contradict the ground truth; (3) The phrase 'studios launched their own streaming services' from the ground truth is implied but not explicitly stated in the LLM answer. QUANTITATIVE ACCURACY: No specific financial metrics, percentages, or dollar amounts are provided in either answer, which is appropriate given the qualitative nature of the question. The temporal progression (2022→2023→2024) is correctly maintained. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects licensing strategy to competitive and regulatory contexts, matching the ground truth's analytical framework. The dual strategy conclusion (broad licensed library + proprietary content investment) correctly captures the strategic evolution. SEMANTIC EQUIVALENCE: The LLM's framing of 'dual strategy' and 'guard against rising competition and tightening regulatory constraints' conveys the same strategic insight as the ground truth's 'strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 604,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "From 2022 to 2024, Southern Company continued to report scheduled lease payments under outdoor‑lighting contracts in its operating‑lease maturity analysis, but in 2023 and 2024 it explicitly stated that the undiscounted cash flows from these contracts were immaterial—a detail not highlighted in 2022【268‑272】. Revenue classification remained unchanged, with lease income from outdoor‑lighting contracts recorded as operating‑lease income and variable lease income in all three years【238‑242】【230‑234】. The maturity‑analysis tables consistently grouped these payments under operating‑lease obligations, showing year‑by‑year amounts and a present‑value discount【268‑272】【238‑242】【230‑234】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) MATERIALITY CONTRADICTION: The ground truth states that in 2022, undiscounted cash flows were 'considered immaterial,' and by 2023-2024 the company began including these in maturity analyses. The LLM reverses this, claiming that in 2023-2024 the company 'explicitly stated that the undiscounted cash flows from these contracts were immaterial'—this directly contradicts the ground truth's narrative of increasing disclosure and formalization. (2) EVOLUTION MISCHARACTERIZED: The ground truth emphasizes a clear progression from 2022 (immaterial, minimal disclosure) → 2023 (beginning to include in maturity analyses) → 2024 (explicit inclusion with expanded disclosure). The LLM presents this as static reporting across all three years ('continued to report...in all three years'), missing the critical evolution. (3) REVENUE CLASSIFICATION: The LLM correctly identifies that lease income was recorded as operating-lease income and variable lease income, but this detail, while accurate, doesn't address the core question about how treatment and disclosure evolved. (4) MATURITY ANALYSIS TREATMENT: The LLM correctly notes inclusion in maturity-analysis tables but fails to capture the temporal shift from 2022 (immaterial, not prominently disclosed) to 2023-2024 (formalized inclusion). (5) MISSING KEY INSIGHT: The ground truth emphasizes 'increasing emphasis on formalizing the visibility' and a 'shift toward more structured reporting'—the LLM misses this fundamental evolution narrative. The citation references provided (268-272, 238-242, 230-234) appear to be generic and don't validate the specific claims made. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required: tracking how disclosure practices changed across three years, not just describing current practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 517,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "The 5.000% senior notes due April 2030 have had a constant outstanding principal balance of **$606 million** in FY 2022, FY 2023, and FY 2024 (see the April 2020 Senior Notes table in each 10‑K). This unchanged balance shows that AVGO has neither issued additional principal nor repaid any of this instrument, reflecting a deliberate strategy to keep a stable, predictable debt load and preserve liquidity while managing interest costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the balance was $606 million in FY 2022, FY 2023, and FY 2024 (constant). The ground truth clearly states: FY 2022 = $1,086 million, FY 2023 = $606 million, FY 2024 = $606 million. This is a major error - the LLM missed the $480 million reduction from 2022 to 2023 ($1,086M - $606M = $480M decrease). (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about the evolution/progression from 2022 through 2024. The LLM failed to identify the significant debt reduction that occurred in 2023, which is the most important aspect of the company's debt management strategy for this instrument. (3) REASONING ERROR: The LLM's interpretation that 'AVGO has neither issued additional principal nor repaid any of this instrument' is factually incorrect. The ground truth shows a substantial $480 million repayment in 2023. (4) INCOMPLETE ANALYSIS: The LLM's conclusion about 'stable, predictable debt load' misses the critical strategic action taken in 2023 - the deliberate debt reduction. The ground truth correctly identifies this as a 'deliberate debt reduction strategy in 2023.' The only correct element is that the balance remained at $606 million from 2023 to 2024, but this represents only 2 of the 3 years requested. The LLM fundamentally misread or misinterpreted the source data, providing an answer that contradicts the actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 420,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % in 2022 (unchanged from 2023), rose to 6.30 % in 2023, and fell slightly to 6.27 % in 2024【GM_10k_2023.pdf】【GM_10k_2024.pdf】. This three‑year trend shows that GM increased its expected return assumptions in 2022‑23 to support a more aggressive asset mix (higher equity and alternative‑asset allocations) and then modestly reduced the assumption in 2024, reflecting a cautious rebalancing toward more conservative assets to dampen funded‑status volatility amid market uncertainty.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. Specific issues: (1) QUANTITATIVE ERRORS - The LLM reports 6.3% for 2022, but the ground truth states 5.4% for 2022. This is a 0.9 percentage point error on a key metric. The LLM also reports 6.30% for 2023 (correct) but then 6.27% for 2024, when ground truth shows 6.5% for 2024 - a 0.23 percentage point error. The LLM's claim of a 'slight fall' to 6.27% in 2024 directly contradicts the ground truth showing an increase to 6.5%. (2) TREND ANALYSIS ERROR - The ground truth shows a clear upward trajectory: 5.4% (2022) → 6.3% (2023) → 6.5% (2024), representing a 1.1 percentage point increase over two years. The LLM incorrectly characterizes this as a decline in 2024, when it actually increased. (3) STRATEGIC INTERPRETATION ERROR - The ground truth correctly identifies this as indicating 'a more optimistic outlook' and 'shift toward higher-risk, higher-return investment strategies.' The LLM incorrectly interprets the 2024 change as a 'cautious rebalancing toward more conservative assets,' which contradicts both the actual data (rates increased) and the ground truth interpretation. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the three-year trend across the documents, misreporting the 2022 baseline and the 2024 endpoint. The core narrative about strategic asset mix adjustments is inverted - the ground truth indicates increasing aggressiveness, while the LLM suggests increasing conservatism. This is a fundamental misunderstanding of the data and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 436,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower consistently reports the 2.700% Senior Notes due 2031 as a separate line item in its long‑term debt schedule in each filing (2022 10‑K, pp. 70‑74; 2023 10‑K, pp. 68‑72; 2024 10‑K, pp. 70‑74).  The uniform, fixed‑rate treatment shows that the company relies on long‑term, low‑cost senior debt as a core element of its financing mix, using it to fund growth and infrastructure while maintaining a diversified debt maturity profile and predictable interest obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and lacks critical details from the ground truth. STRENGTHS: (1) Correctly identifies the 2.700% Senior Notes due 2031 across 2022-2024 filings; (2) Correctly notes the consistent reporting as a separate line item; (3) Appropriately characterizes the debt as fixed-rate, long-term, and low-cost; (4) Reasonably infers the strategic purpose (funding growth, infrastructure, diversified maturity profile). WEAKNESSES: (1) Page number citations (pp. 70-74, 68-72, etc.) are provided but cannot be verified against ground truth and may be inaccurate; (2) CRITICAL OMISSION: The ground truth specifically references Supplemental Indenture No. 8 dated March 29, 2021, as the key documentation structure consistently referenced across all three years - this is a crucial detail showing the specific legal/contractual continuity that the LLM answer completely misses; (3) The LLM answer does not mention the indenture documentation at all, which is central to understanding the 'consistent treatment' and 'stability' of the financing strategy; (4) The LLM answer focuses on financial characteristics (fixed-rate, low-cost) rather than the documentary/structural consistency that the ground truth emphasizes; (5) The LLM answer infers strategic purposes (funding growth, infrastructure) that are not explicitly stated in the ground truth, which focuses on the consistency of the debt instrument itself. MULTI-HOP REASONING: The LLM answer attempts to synthesize information across three years but does so at a surface level, missing the deeper structural continuity (same indenture) that demonstrates the stability claim. The reasoning about financing strategy is logical but incomplete without the indenture reference. QUANTITATIVE ACCURACY: The interest rate (2.700%) and maturity year (2031) are correct; page numbers cannot be verified but appear plausible. No calculations are performed or required. SEMANTIC EQUIVALENCE: While the LLM answer conveys that the debt is stable and consistently treated, it misses the specific mechanism (Supplemental Indenture No. 8) that proves this consistency, which is the core evidence in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 592,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal consistently flagged abusive behaviors as a key risk to its branded credit products and cross‑border transactions from 2022 through 2024 (2022, pp. 24‑28; 2023, pp. 23‑27; 2024, pp. 21‑25). In 2023 the company began mitigating the risk by enhancing fraud‑detection tools, updating credit‑risk models, diversifying payment processors, and selling a large portion of its BNPL loan receivables (2023, pp. 24‑27; 26‑27). By 2024 it further intensified mitigation, expanding monitoring of merchant and credit risk, bolstering cybersecurity and fraud controls, and strengthening cross‑border compliance (2024, pp. 21‑25).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trajectory of PayPal's approach to abusive behaviors across 2022-2024 and correctly identifies key strategic actions. However, there are significant issues with specificity and accuracy:\n\nSTRENGTHS:\n- Correctly identifies the three-year period (2022-2024) and the evolution of PayPal's approach\n- Accurately mentions the sale of BNPL loan receivables as a key 2023 mitigation strategy\n- Properly synthesizes multi-hop information about fraud detection, credit risk management, and compliance measures\n- Appropriately contextualizes the shift from identifying risk to offloading exposure to reinforcing controls\n- Page citations provided (though not verifiable in this context)\n\nWEAKNESSES:\n- CRITICAL: The LLM answer mentions \"selling a large portion of its BNPL loan receivables\" but fails to include the specific quantitative detail from the ground truth: \"€40 billion of U.K. and European BNPL loan receivables.\" This is a significant omission of a concrete, verifiable metric that was explicitly in the original answer.\n- The LLM answer is more generic in describing 2023 actions (\"enhancing fraud-detection tools, updating credit-risk models, diversifying payment processors\") without the specificity of the multi-year agreement detail\n- The answer lacks the nuance about PayPal's \"ongoing reliance on third-party lenders and processors\" and the associated operational/reputational risks mentioned in the ground truth\n- The 2022 context about \"third parties using stolen identities and financial instruments to commit fraud at scale\" is not explicitly captured\n- The answer doesn't clearly distinguish between the strategic shift of offloading exposure (2023) versus reinforcing internal controls (2024)\n\nQUANTITATIVE ACCURACY: The major quantitative omission (€40 billion figure) significantly impacts this score. While the LLM doesn't provide incorrect numbers, it fails to provide the key quantitative detail that was central to the ground truth answer.\n\nQUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis is generally correct, but lacks the specificity and depth of the original answer. The identification of strategic actions is accurate but incomplete.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution of exposure and strategic actions, though with less depth than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 643,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan allocated **46.5 %** of plan assets to Collective Trust and Other Funds in 2022, dropped to **39.6 %** in 2023, and then rose to **43.9 %** in 2024 (calculated from the NAV totals on pages 70‑74, 56‑60, 54‑58). The 2023 dip followed by a partial rebound in 2024 indicates a deliberate rebalancing of alternative‑investment exposure as part of the company’s broader de‑risking strategy, showing a cautious yet flexible approach to diversifying long‑term employee benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides percentage allocations (46.5%, 39.6%, 43.9%) rather than the dollar amounts specified in the ground truth ($756M in 2022, $382M in 2023). This is a fundamental mismatch with the original answer. The ground truth explicitly states the allocation DECREASED from $756 million to $382 million - a 49.5% reduction in absolute dollar terms. The LLM's percentage-based approach obscures this significant downward trend and contradicts the ground truth's core finding of a 'significant downward trend in direct exposure.' Additionally, the LLM claims a 'partial rebound in 2024' to 43.9%, but the ground truth explicitly states 'no updated dollar value is provided' for 2024, making this claim unsupported. The LLM appears to have calculated percentages from NAV totals rather than reporting the actual allocation amounts. While the LLM correctly identifies the company (UNP), the metric (Collective Trust and Other Funds), and the years (2022-2024), it fundamentally misrepresents the data by using percentages instead of dollar amounts. The reasoning about 'de-risking strategy' aligns with ground truth, but this cannot compensate for the quantitative inaccuracy. The multi-hop synthesis fails because the LLM did not correctly extract or report the key financial figures from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 372,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer did not grant or have any Breakthrough Performance Awards (BPAs) in 2022, 2023, or 2024, and no BPAs were outstanding as of December 31 2023 or 2024.  Across all three years the valuation method stayed the same – intrinsic value at grant date based on the closing price of common stock – and the accounting treatment remained straight‑line amortization over the probable vesting term with periodic adjustments for changes in stock price, shares likely to be earned, and the probability of meeting performance criteria.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims no BPAs were granted in 2022, but the ground truth explicitly states 1,165 thousand BPAs were issued at $38.73 weighted average intrinsic value in 2022. The LLM also incorrectly states no BPAs were outstanding, when ground truth shows 859 thousand BPAs outstanding at year-end 2022 valued at $59.05 per share. (2) FACTUAL INACCURACIES: The LLM claims the valuation methodology remained the same across all three years, but the ground truth shows a clear evolution - 2022 had active issuance with specific valuations, 2023 had zero activity (discontinuation), and 2024 introduced a formalized new methodology. The LLM completely misses this evolution narrative that is central to the question. (3) INCOMPLETE SYNTHESIS: The question specifically asks about evolution from 2022-2024, requiring multi-hop synthesis showing how the program changed. The LLM fails to capture: (a) the 1,165K grants in 2022, (b) the shift to zero activity in 2023, (c) the new formalized framework in 2024. (4) MISSING KEY DETAILS: The ground truth indicates a discontinuation or full vesting/forfeiture event between 2022-2023 that the LLM completely overlooks. The LLM's claim that methodology 'stayed the same' across all years directly contradicts the ground truth's description of a 'shift' and 'evolution' in treatment. This is a comprehensive failure to accurately represent the filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 418,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "Collateral under master‑netting arrangements tied to investments, advances and long‑term receivables fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**. The downward trend suggests a shrinking derivative exposure or more efficient netting, which reduces initial‑margin requirements and likely lowers the company’s funding costs over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022) matches $1,494 million in ground truth (format variation acceptable), $800 million (2023) is exact, and $491 million (2024) is exact. The downward trend is correctly identified and quantified. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the collateral values across all three years, (2) the trend analysis, and (3) the implications for derivative exposure and margin requirements. ENTITY ACCURACY: ExxonMobil correctly identified, years are correct (2022-2024), and the metric (collateral under master netting arrangements) is properly specified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the numerical trend to its business implications (derivative exposure reduction, more efficient netting, lower margin requirements, reduced funding costs). The logic is well-reasoned and goes slightly beyond the ground truth by adding the insight about funding costs, which is a reasonable inference from the data. SEMANTIC EQUIVALENCE: The phrasing differs slightly from ground truth ('shrinking derivative exposure or more efficient netting' vs. 'reduction in derivative exposure or strategic adjustment in margin requirements'), but both convey equivalent meaning. The LLM's addition of 'likely lowers the company's funding costs' is a logical extension that enhances the answer without contradicting the ground truth. Minor deduction (1 point) only because the ground truth uses 'strategic adjustment in margin requirements' while LLM emphasizes 'more efficient netting' - both are valid interpretations but represent slightly different framings of the same phenomenon.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 485,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K lists industrial fiber optics as a core product alongside optocouplers, sensors, encoders, LEDs and Ethernet ICs, framing its industrial portfolio around factory automation, renewable energy and automotive electronics (pages 8‑12). The 2023 and 2024 filings keep the same product family but broaden the application narrative to include power‑generation and distribution, medical, defense/aerospace and electric‑vehicle subsystems (pages 5‑6). This continuity in product positioning, coupled with an expanding scope, signals Broadcom’s strategic intent to deepen its industrial‑connectivity footprint across a wider array of high‑speed, data‑centric industrial and automotive markets (pages 3‑7).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CHRONOLOGICAL REVERSAL ERROR: The LLM answer fundamentally misrepresents the evolution timeline. It claims 2022 lists Industrial Fiber Optics with optocouplers, sensors, encoders, LEDs and Ethernet ICs in factory automation/renewable energy/automotive context, then states 2023-2024 'broaden' to include power generation, medical, defense/aerospace, and EVs. This is BACKWARDS from the ground truth, which shows 2022 had the BROADER application scope (industrial automation, power systems, medical, defense, aerospace, automotive/EVs), while 2023-2024 became MORE STRUCTURED and streamlined. (2) MISSING KEY EVOLUTION DETAIL: The ground truth emphasizes a critical shift from 2022's broad narrative to 2023's 'structured table format' emphasizing specific applications, then 2024's 'streamlined presentation.' The LLM answer misses this structural/presentation evolution entirely, instead describing a false broadening of scope. (3) PRODUCT LISTING INCONSISTENCY: The LLM mentions 'LEDs' in 2022 positioning, but the ground truth does not mention LEDs in the product family across these years. (4) PAGE REFERENCES UNVERIFIABLE: The LLM provides specific page numbers (8-12, 5-6, 3-7) that cannot be verified against the ground truth and appear potentially fabricated. (5) SEMANTIC CONTRADICTION: The LLM's conclusion about 'expanding scope' contradicts the ground truth's finding of 'increasing emphasis on structured, application-specific clarity' - these are different strategic narratives. The LLM essentially inverts the actual evolution pattern, making this a significant factual error despite some correct entity identification (Broadcom, years 2022-2024, product categories). The reasoning about strategic intent is plausible but built on an incorrect foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 488,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal has consistently borne **full margin risk** as the principal in payment transactions from 2022 through 2024.  In each filing the company states that it controls transaction pricing and that the fees it charges customers are set independently of the costs it incurs when it uses third‑party processors, so the use of external processors does not mitigate its margin‑risk exposure (PYPL_10k_2022 p. 78‑82; PYPL_10k_2023 p. 75‑79; PYPL_10k_2024 p. 73‑77).  Accordingly, there was no material change in PayPal’s control over pricing or its margin‑risk profile over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's consistent full margin risk exposure across 2022-2024; (2) Accurately captures the core principle that PayPal controls pricing independently of third-party processor costs; (3) Properly synthesizes the multi-hop requirement by comparing the three years and concluding no material change; (4) Correctly identifies PayPal as the principal in transactions; (5) Appropriately cites specific page ranges from the 10-K filings (2022 p. 78-82, 2023 p. 75-79, 2024 p. 73-77), demonstrating source verification; (6) Uses precise financial/accounting terminology (margin risk, transaction expense, principal). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth explicitly mentions 'transaction expense' as the accounting treatment, while the LLM focuses on the economic substance (pricing control and margin risk). Both approaches are semantically equivalent and correct. The LLM's statement that 'fees paid to payment processors...were recognized as transaction expense' is implicit in the answer but not explicitly stated—however, this is a minor omission that doesn't affect the core correctness. QUANTITATIVE ACCURACY: No numerical errors; dates (2022, 2023, 2024) are correct; page citations appear reasonable for 10-K filings. MULTI-HOP REASONING: Excellent synthesis across three years showing evolution (or lack thereof) in PayPal's margin risk profile. The answer correctly identifies that the narrative is consistent across all three years with no material changes. ENTITY ACCURACY: PayPal/PYPL correctly identified; years correctly specified; financial metrics (margin risk, pricing control) correctly applied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 499,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold Meridian in 2021 for $51 million cash, recording a $167 million net loss and entering into interim TSAs and a three‑year MSA (with a two‑year extension) to keep a supply‑chain relationship (PFE_10k_2022, pp. 114‑118). By 2023 the TSAs were completed and the MSA remained in force with no material financial impact (PFE_10k_2023, pp. 71‑75). In 2024 the MSA continued as the sole post‑sale arrangement, underscoring Pfizer’s shift from owning Meridian to divesting it and concentrating on core operations while preserving a supply‑chain link (PFE_10k_2024, pp. 2‑6). This progression signals a long‑term strategy of portfolio streamlining and core‑business focus.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and dates. All key numbers are accurate: $51 million sale price, $167 million net loss, three-year MSA with two-year extension option, and 2021 sale date. The multi-hop synthesis across 2022-2024 filings is sound, correctly tracking the evolution from discontinued operations status through TSA/MSA arrangements to the 2024 MSA-only relationship. The reasoning about portfolio streamlining and core-business focus is logically sound and well-supported. Minor strengths: The answer correctly identifies the progression from ownership to arms-length contractual relationship and appropriately characterizes the strategic shift. Minor weaknesses: (1) The answer uses 'TSAs' (Transition Service Agreements) without explicitly defining them, though this is a reasonable abbreviation; (2) The answer could have been slightly more explicit about the 2022 'discontinued operations' status mentioned in the ground truth, though it's implied by the context of the sale and subsequent arrangements; (3) The page citations (pp. 114-118, etc.) cannot be verified against the ground truth but appear reasonable for 10-K filings. The semantic equivalence is strong - the LLM captures the core narrative of strategic divestiture and supply-chain preservation. The answer directly addresses all three sub-questions: financial impact (sale price, loss, no material impact post-2023), contractual arrangements (MSA details), and strategic positioning (portfolio streamlining, core focus). The conclusion about long-term strategy is well-supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 448,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 to 2024, PMI’s risk‑factor disclosures show a tightening of product‑regulation constraints that curtail product differentiation and adult‑consumer communication for RRPs/SFPs. In 2022 (p. 17) PMI warned that existing rules already risk commoditizing its products and limiting RRP messaging; by 2023 (p. 21) it noted that new enforcement actions and stricter advertising bans further restricted differentiation and communication; and in 2024 (p. 18) it highlighted additional EU nicotine‑product rules and intensified enforcement that deepen these constraints, intensifying competitive pressure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc - that regulatory constraints on product differentiation and consumer communication for RRPs/SFPs intensified from 2022-2024. It accurately captures the evolution from 2022 (commoditization risk) through 2023 (enforcement actions) to 2024 (EU rules and intensified enforcement). The semantic understanding of the regulatory burden and competitive impact is sound. The answer appropriately addresses the multi-hop synthesis across three years and correctly identifies PMI as the subject company.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides page numbers (p. 17, p. 21, p. 18) that cannot be verified against the ground truth and appear to be fabricated specificity. This is a significant issue as it suggests citation hallucination. The ground truth does not reference specific page numbers, and these cannot be confirmed as accurate.\n\nWEAKNESSES - QUALITATIVE: The LLM answer introduces specific regulatory details (\"EU nicotine-product rules,\" \"new enforcement actions,\" \"stricter advertising bans\") that go beyond what the ground truth explicitly states. While these may be factually present in the actual filings, the ground truth focuses on the evolution of language regarding regulatory impact rather than specific regulatory mechanisms. The ground truth emphasizes the shift from 'RRPs' to 'SFPs' terminology in 2024, which the LLM mentions but doesn't emphasize as a key indicator of the evolution.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression of regulatory constraint. However, the ground truth's key insight about the disproportionate impact on RRPs relative to competitors (noted in 2023) is not explicitly captured in the LLM answer, representing a missed nuance.\n\nCRITICAL ISSUE: The page number citations appear to be hallucinated, which undermines confidence in the answer's reliability despite the correct overall narrative. This is a material accuracy problem for a financial document analysis task.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 556,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** – a cumulative drop of roughly **$1.0 billion** (‑$694 m from 2022‑23 and ‑$309 m from 2023‑24). This steady decline, driven mainly by lower initial‑margin requirements, indicates that the company is tightening its collateral usage—either by reducing net derivative exposure or by negotiating more efficient netting terms—demonstrating effective and increasingly efficient derivative risk‑management practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All numbers are correct - $1.494 billion (2022), $800 million (2023), $491 million (2024). The calculated year-over-year changes are accurate: -$694 million (2022-23) and -$309 million (2023-24), totaling approximately -$1.003 billion cumulative decline. Number format variations ($1.494 billion vs $1,494 million) are acceptable and properly handled. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) the exposure values across all three years, (2) the trend analysis showing consistent decline, and (3) interpretation of what this suggests about derivative risk management practices. ENTITY ACCURACY: ExxonMobil (XOM) correctly identified, fiscal years 2022-2024 properly specified, and the specific metric (collateral under master netting arrangements related to Notes and accounts receivable - net) accurately referenced. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical trend to strategic implications (lower margin requirements, more efficient netting terms, proactive risk mitigation). The interpretation that this reflects 'effective and increasingly efficient derivative risk-management practices' is a reasonable inference from the data, though slightly more optimistic in tone than the ground truth's more neutral 'strategic reduction in derivative exposure or shift in risk management practices.' MINOR DIFFERENCES: The LLM provides slightly more detailed calculation breakdown and attributes the decline to 'lower initial-margin requirements,' which adds specificity beyond the ground truth but remains consistent with the overall narrative. The characterization as 'tightening collateral usage' is semantically equivalent to the ground truth's description of the trend. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 512,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model used an expected volatility of **26.9 %** in 2022, which rose to **28.6 %** in 2023, before falling sharply to **18.7 %** in 2024. This upward swing in 2023 signals a heightened perception of market risk relative to 2022, while the steep decline in 2024 suggests the company’s view of market volatility has eased—likely reflecting more favorable market conditions or a shift in risk‑management strategy. (2022, p. 213; 2023, p. 206; 2024, p. 215)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE ACCURACY: All three volatility percentages are correct—26.9% (2022), 28.6% (2023), and 18.7% (2024)—matching the ground truth exactly. The page citations (p. 213, p. 206, p. 215) appear reasonable for 10-K filings. (2) COMPLETENESS: The answer addresses all parts of the multi-hop question: it identifies the evolution of volatility assumptions across all three years, describes the trend (increase then sharp decrease), and provides interpretation of what the trend suggests about market risk perception. (3) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR-based performance award model is properly referenced, and the peer group context is maintained throughout. (4) REASONING: The multi-hop synthesis is sound—the model correctly identifies the counterintuitive pattern (2023 increase followed by 2024 decrease) and provides logical interpretation that the 2024 drop suggests easing market volatility perception. The reasoning about 'improved market stability or strategic changes' aligns with the ground truth's interpretation. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('upward swing in 2023 signals heightened perception,' 'steep decline in 2024 suggests easing') conveys the same meaning as the ground truth while using slightly different language. Minor difference: The LLM uses 'eased' while ground truth uses 'declined,' but both convey the same directional change. The LLM's interpretation about 'favorable market conditions or shift in risk-management strategy' is semantically equivalent to the ground truth's 'improved market stability or strategic changes.' No calculation errors detected. The answer is well-structured and directly addresses the question's request for trend analysis and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 494,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Across FY 2022, FY 2023, and FY 2024 the principal outstanding of the 3.125 % senior notes due January 2025 stayed at $495 million, with no repayments or redemptions disclosed (see the 2017 Senior Notes table in each filing).  The company used proceeds from new senior notes to retire other short‑term debt (Term Loans) rather than the 3.125 % notes, reflecting a strategy of refinancing short‑term obligations with long‑term debt to lower short‑term exposure and extend its debt maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the principal amount of $495 million for the 3.125% notes due January 2025 across FY 2022, FY 2023, and FY 2024. (2) The quantitative data about no repayments or redemptions is accurate. (3) The reference to the 2017 Senior Notes table demonstrates proper source identification. (4) Number formatting is consistent and correct.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to address the key evolution mentioned in the ground truth - that by FY 2024, the note 'transitioned into its current portion of long-term debt.' This is a significant structural change that the LLM completely misses. The ground truth explicitly states this transition occurred and was important for understanding the company's debt management. (2) The LLM's interpretation of refinancing strategy is partially speculative and not fully grounded in the ground truth. While the ground truth mentions 'impending maturity that likely triggered internal refinancing or liquidity planning in 2024,' the LLM extends this to a broader narrative about retiring Term Loans with new senior notes, which goes beyond what the ground truth establishes about THIS specific note. (3) The LLM does not adequately explain the multi-year evolution - it treats FY 2022-2024 as a single static period rather than highlighting the stability in 2022-2023 followed by the transition in 2024. (4) The answer lacks the temporal progression analysis that the question specifically asks for ('how did...evolve across fiscal years').\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information about debt management strategy but does so incompletely. It correctly identifies the stable principal amount but fails to connect this to the critical transition point in FY 2024 that the ground truth emphasizes. The reasoning about refinancing strategy, while plausible, is not fully supported by the ground truth provided.\n\nSEMANTIC EQUIVALENCE: The LLM's statement about the principal remaining at $495 million is semantically equivalent to the ground truth on this point. However, the overall narrative diverges significantly by not addressing the FY 2024 transition to current portion of long-term debt, which is a material omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 598,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "AMD’s 10‑K filings show a steady strategy with AIB manufacturers from 2022 through 2024: in each year the company reiterated that its agreements “protect their inventory of our products against price reductions,” and it continued to highlight that system integrators use discrete‑graphics solutions to differentiate their board‑level products and add value for customers. No substantive changes to the inventory‑protection policy or the role of discrete graphics were disclosed over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly captures the core strategic positioning of AMD with AIB manufacturers from 2022-2024. Strengths: (1) Correctly identifies the consistent inventory protection policy across all three years, accurately quoting the protective language from AMD's filings; (2) Properly synthesizes the multi-hop information showing that discrete graphics remained a key differentiation tool throughout the period; (3) Accurately notes the absence of quantitative changes in AIB-related revenue disclosure; (4) Correctly identifies the key entities (AMD, AIBs, system integrators) and time period (2022-2024). Minor weaknesses: (1) The LLM answer is more concise than the ground truth and omits some contextual details present in the original answer, such as the specific mention of 'short design cycles' and 'rapid response to new technologies' as indicators of sustained strategic focus; (2) The ground truth explicitly mentions that AIBs 'build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors' - a detail the LLM answer condenses but doesn't fully articulate; (3) The LLM answer could have been slightly more explicit about the 'sustained strategic focus' aspect, though it does convey this through the phrase 'steady strategy.' Overall, the LLM answer is semantically equivalent to the ground truth on all material points - it correctly identifies the evolution (or lack thereof) in AMD's positioning, accurately captures the inventory protection policy consistency, and properly synthesizes the role of discrete graphics across the three-year period. No numerical errors or calculation issues present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 466,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "From 2022 to 2024 Disney shifted its DTC strategy from a cost‑realignment and ad‑supported Disney+ launch (2022 10‑K, pp. 25‑29) to a broader investment in content and technology, a new content‑curation approach and the launch of ESPN’s flagship DTC service (2023 10‑K, pp. 51‑55; 2024 10‑K, pp. 21‑25). The company positioned its DTC platforms to compete more aggressively with other streaming services, expanding into India via a joint venture and tightening distribution windows, and now expects subscription and advertising revenue from DTC to grow enough to offset declining linear‑network revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misalignments with the ground truth. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2024; (2) Accurately notes the shift toward more aggressive competitive positioning; (3) Correctly mentions the expectation that DTC subscription and advertising revenue would offset declining linear network revenue; (4) Appropriately references specific 10-K pages and years. WEAKNESSES: (1) CRITICAL OMISSION: The LLM completely misses the 2022 cautionary language about financial risks and potential negative returns, which is a key part of the ground truth's narrative about the evolution from 'cautious investment' to more confident positioning; (2) The LLM focuses heavily on operational details (ad-supported Disney+, ESPN DTC launch, India joint venture, distribution windows) that are not emphasized in the ground truth answer, which focuses on the strategic mindset shift regarding risk and confidence; (3) The LLM does not capture the 2023 turning point where Disney shifted from acknowledging risks to expressing confidence that investments would 'more than offset' revenue impacts; (4) The LLM mentions 'content-curation approach' and specific operational tactics but doesn't address the fundamental strategic evolution in how Disney viewed DTC's financial viability and competitive necessity; (5) The 2024 characterization in the LLM (competitive pressures impacting rates) is present but less emphasized than the ground truth's point about DTC becoming 'operationally critical' and the company's integrated dependence on these services. MULTI-HOP REASONING: The LLM does synthesize across three years and identifies a directional shift, but fails to capture the nuanced evolution in Disney's confidence level and risk assessment, which is the core of the ground truth answer. The answer reads more as operational history than strategic evolution. SEMANTIC ALIGNMENT: While the LLM captures that expectations shifted toward growth offsetting linear declines, it misses the critical 2022 baseline of acknowledged risks and the 2023 confidence inflection point that frames the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 585,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s Fixed‑Rate 2.850% notes, issued in September 2019, remained a constant $1.5 billion component of its term debt from 2022 through 2024.  The notes’ maturity stayed unchanged at 10/1/2029, and no early redemption or repurchase of this series occurred during that period.  While the overall debt structure expanded from $9.0 billion in 2022 to $10.6 billion in 2023 and 2024, the 2.850% notes’ principal and maturity obligations stayed the same, with the 2029 principal payment of $1.5 billion still scheduled in the company’s future principal‑payment schedule.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is largely accurate with strong alignment to the ground truth on core facts. CORRECT ELEMENTS: (1) The 2.850% notes remained at $1.5 billion consistently from 2022-2024 - correct. (2) Maturity date of 2029 (specifically 10/1/2029) - correct. (3) No early redemption or repurchase occurred - correct. (4) Total debt structure evolution: $9.0 billion in 2022 - correct. (5) The notes were issued in September 2019 - adds helpful context. (6) The 2029 principal payment of $1.5 billion scheduled - correct. MINOR ISSUES: (1) The LLM states debt was '$10.6 billion in 2023 and 2024' which is slightly imprecise. Ground truth shows $10.638 billion in 2023 and $10.574 billion in 2024 - these are different values, not the same. The LLM's rounding to $10.6 billion obscures this distinction. (2) The LLM omits the important strategic context that PYPL issued new debt instruments with higher interest rates (5.150% and 5.500% notes) in 2024, which was highlighted in the ground truth as indicating a shift in financing strategy. This is a notable omission that weakens the completeness of the answer regarding how the relationship 'evolved.' QUANTITATIVE VERIFICATION: All specific dollar amounts for the 2.850% notes ($1.5B) and 2022 debt ($9.0B) are correct. The 2023-2024 debt figures are approximately correct but lack precision. MULTI-HOP REASONING: The answer successfully synthesizes information about the specific notes, overall debt structure, and maturity obligations across three years. However, it misses the strategic financing shift element that would have provided fuller context to the 'evolution' question. SEMANTIC EQUIVALENCE: The answer conveys the core message that the 2.850% notes remained stable while broader debt structure changed, which matches the ground truth's main point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 491,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan corporate‑stock holdings fell sharply from roughly 37 % of plan assets in 2022 (1,111 / 2,990) to about 5 % in 2023 (181 / 3,385), then modestly rose to around 7 % in 2024 (226 / 3,186)【70‑74】【56‑60】【54‑58】. This pattern reflects a de‑risking strategy that cut equity exposure dramatically in 2023, with a slight rebound in 2024 as the plan rebalances its equity allocation within a broader shift toward debt and other assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states corporate stock holdings were '1,111 / 2,990' (37%) in 2022, but the ground truth clearly states $1,990 million in 2022. The LLM's 2024 figure of $226 million is also not mentioned in the ground truth, which instead describes a reclassification strategy. The LLM's percentage calculations (37% → 5% → 7%) are based on incorrect numerators. (2) MISSING KEY INFORMATION: The ground truth emphasizes a critical strategic shift in 2024 where UNP 'reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2.' The LLM completely misses this important reclassification detail and the shift to different valuation methodologies (Level 1 vs Level 2), which is central to understanding the investment strategy evolution. (3) INCOMPLETE SYNTHESIS: The ground truth describes a 'dramatic reduction in equity exposure' from $1,990M to $181M (a 91% decline), but the LLM frames this as a percentage-of-assets decline without capturing the absolute magnitude of the de-risking. The LLM's mention of a 'modest rebound' to 7% in 2024 contradicts the ground truth's emphasis on maintaining 'a smaller, more structured equity exposure' through reclassification rather than rebalancing upward. (4) REASONING QUALITY: While the LLM correctly identifies a de-risking strategy, it mischaracterizes the 2024 movement as a 'rebound' when the ground truth indicates a strategic reclassification to more transparent valuation methods, not a return to higher equity exposure. The LLM's interpretation of 'rebalancing' is inconsistent with the ground truth's emphasis on structural changes in how equity is held and valued.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 505,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million in 2022 to $719 million in 2024** – a decline of **$81 million**【source: 2023 table showing 800 million for 2022】【source: 2024 table showing 719 million for 2024】. This modest reduction indicates a slight pullback in the company’s allocation to illiquid alternative investments, suggesting a strategic rebalancing of its investment portfolio over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that make it substantially incorrect. (1) WRONG 2022 NUMBER: LLM states $800 million for 2022, but ground truth shows $623 million - this is a $177 million error (28% overstatement). (2) CORRECT 2024 NUMBER: LLM correctly identifies $719 million for 2024. (3) WRONG CALCULATION: LLM calculates $81 million decline ($800M - $719M), but this is based on the incorrect 2022 figure. The actual change from 2022 to 2024 is $719M - $623M = +$96 million (an INCREASE, not a decrease). (4) MISSING CRITICAL DATA: LLM completely omits the 2023 intermediate year ($755 million), which is essential for understanding the trend. Ground truth shows: 2022: $623M → 2023: $755M (+$132M) → 2024: $719M (-$36M). This reveals a growth phase followed by retrenchment - a nuanced pattern the LLM entirely misses. (5) INVERTED CONCLUSION: LLM concludes there was a 'pullback' and 'rebalancing,' but the actual 2022-2024 trend shows a net INCREASE of $96 million, suggesting expansion into alternative investments, not contraction. (6) INCOMPLETE MULTI-HOP SYNTHESIS: The question requires analyzing a 3-year trend to assess strategic direction. LLM only compares endpoints and misses the critical 2023 peak that demonstrates deliberate growth followed by modest correction. The sourcing citations appear fabricated (claiming '2023 table showing 800 million for 2022' contradicts the actual data). This answer fails on quantitative accuracy (wrong base year number), calculation (wrong direction of change), completeness (missing 2023), and reasoning (inverted strategic interpretation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 448,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 through 2024 Mastercard’s multi‑layered security strategy broadened its third‑party collaboration—moving beyond issuer, acquirer, merchant and industry‑association standards to partnerships with fintechs, central banks, digital‑messaging platforms and other third‑party technology providers for services such as Mastercard Send, VCN adoption and the Alias‑Based Remittances platform. Real‑time payment infrastructure grew from 12 markets in 2022 to 13 markets by 2023‑24, with continued expansion via new real‑time clearing and settlement platforms and the launch of the Alias‑Based Remittances and Payouts platform. Throughout, the resilience arm has been reinforced by an enterprise‑resilience program, insurance coverage, regular vulnerability testing and a coordinated response network of Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, all assessed by third‑party auditors and supported by public‑private partnerships.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the question's three main components (third-party collaboration, real-time payment infrastructure, and cyber threat resilience) and demonstrates understanding of the evolution from 2022-2024. However, there are significant quantitative discrepancies that undermine accuracy. CRITICAL ISSUE: The LLM states real-time payment infrastructure grew from '12 markets in 2022 to 13 markets by 2023-24,' but the ground truth indicates 13 markets as of year-end 2023, with no mention of 12 markets in 2022. This represents a factual error in the baseline number and the growth trajectory. The ground truth does not provide a 2022 baseline of 12 markets, making this claim unverifiable and potentially incorrect. STRENGTHS: (1) Correctly identifies the evolution toward broader third-party collaboration including fintechs, central banks, and technology providers; (2) Accurately mentions specific initiatives like Mastercard Send, VCN adoption, and Alias-Based Remittances platform; (3) Properly identifies the security infrastructure components (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center); (4) Correctly notes the shift toward ecosystem integration and external partnerships; (5) Appropriately mentions third-party auditors and public-private partnerships. WEAKNESSES: (1) The '12 to 13 markets' progression is not supported by ground truth and appears to be an inference error; (2) While the LLM mentions 'continued expansion via new real-time clearing and settlement platforms,' the ground truth does not provide specific details about these platforms, suggesting potential over-specification; (3) The mention of 'insurance coverage' and 'regular vulnerability testing' adds detail not explicitly confirmed in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period and connects third-party collaboration to infrastructure expansion and resilience. However, the quantitative error regarding market numbers represents a failure in accurate data synthesis. The qualitative reasoning about the strategic shift toward ecosystem integration is sound and matches the ground truth's characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 590,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements – which is included in the “Other assets, including intangibles – net” line – fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (a decline of roughly 67 % over two years). This downward trend indicates that the company has been reducing its collateral commitments, suggesting a more efficient derivative exposure management strategy—through lower notional exposure, tighter netting/clearing arrangements, or both—resulting in lower margin requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Specifically: (1) The LLM states the 2022 figure was $1.49 billion, but the ground truth clearly shows $800 million at end of 2022. This is a massive discrepancy (86% overstatement). (2) The LLM correctly identifies $800 million for 2023 and $491 million for 2024, but the starting point is wrong. (3) The LLM calculates a 67% decline from 2022-2024, but this calculation is based on the incorrect $1.49B starting figure. The correct calculation from ground truth ($800M to $491M) represents a 38% decline, which the ground truth explicitly states. (4) The LLM omits the 2021 baseline of $641 million entirely, which is important context for understanding the trend. REASONING ISSUES: While the LLM's qualitative interpretation about derivative exposure management and margin requirements is reasonable and aligns with the ground truth's conclusion, it is built on incorrect numerical foundations. The multi-hop synthesis is partially sound (connecting collateral to derivative exposure management), but the factual errors undermine the entire analysis. WHAT WAS CORRECT: The general direction of the trend (declining from 2022-2024) and the qualitative interpretation about efficiency and derivative management are directionally correct. The semantic understanding of what collateral under master netting arrangements represents is appropriate. WHAT WAS INCORRECT: The 2022 starting figure ($1.49B vs. $800M), the percentage decline (67% vs. 38%), and the omission of the 2021 data point. These are not minor formatting differences—they represent fundamental factual errors that would mislead a user about the magnitude of change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 478,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model’s expected volatility fell from **28.8 % in 2022** to **28.6 % in 2023** and then dropped sharply to **18.7 % in 2024**【DUK_10k_2022, 212‑216】【DUK_10k_2023, 204‑208】【DUK_10k_2024, 213‑217】. This downward trend indicates that investors perceive Duke Energy’s stock as becoming less volatile relative to its peer group, suggesting a lower market‑risk profile and a more stable outlook over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 volatility figure. Ground truth states 26.9% for 2022, but the LLM reports 28.8% - a 1.9 percentage point discrepancy. This is a material error for a financial metric. The 2023 (28.6%) and 2024 (18.7%) figures are correct. REASONING ASSESSMENT: The LLM correctly identifies the trajectory pattern (increase then decrease) and appropriately interprets the 2024 decline as suggesting reduced market risk perception. However, the characterization of the overall trend as 'downward' is misleading - the data actually shows an increase from 2022 to 2023, then a sharp decline in 2024. The ground truth explicitly notes a 'peak in perceived market risk in 2023,' which the LLM fails to emphasize. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three years and correctly references the TSR model against peer groups. The interpretation that the 2024 decline suggests 'lower market-risk profile and more stable outlook' is reasonable but somewhat incomplete compared to the ground truth's more nuanced observation about 'stabilization or reduced uncertainty.' COMPLETENESS: The answer addresses the core question about volatility changes and market risk perception, but the incorrect 2022 figure undermines the credibility of the entire analysis. The LLM also provides citations but these appear to be fabricated (specific page ranges are not verifiable from the question context). SEMANTIC EQUIVALENCE: While the general interpretation about reduced volatility in 2024 is semantically similar to the ground truth, the factual error in the 2022 baseline makes the comparative analysis fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 470,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022‑2024 GM’s indemnification to Stellantis for legacy Opel/Vauxhall emissions and product liabilities stayed the same—no material accrual was recorded because the loss was not estimable and the exposure was deemed remote (see 2022‑10‑K pp. 89‑93, 2023‑10‑K pp. 90‑94, 2024‑10‑K pp. 91‑95).  The Takata recall liability, however, has steadily declined: the remaining accrual fell from $1.1 billion in 2020 to $609 million in 2023 and $555 million in 2024, reflecting progress in the recall and lower expected costs (2023‑10‑K pp. 90‑94; 2024‑10‑K pp. 91‑95).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) The Takata recall accrual numbers cited ($1.1B in 2020, $609M in 2023, $555M in 2024) appear to be GM's total Takata liability, NOT specifically related to Stellantis indemnification obligations. The ground truth explicitly states GM's indemnification to Stellantis for Takata recalls was 'immaterial' and the exposure was 'remote'—not a multi-billion dollar liability. (2) The LLM conflates GM's overall Takata recall accrual with Stellantis-specific indemnification, which are different concepts. The question asks specifically about indemnification obligations TO Stellantis, not GM's total Takata exposure. (3) The LLM correctly identifies that Opel-related emissions/conduct investigations resulted in immaterial accruals, which aligns with ground truth. (4) The LLM correctly notes that Stellantis-related indemnification remained immaterial and remote across 2022-2024, which matches the ground truth. STRENGTHS: The answer correctly identifies the immaterial nature of Stellantis indemnifications and the remote exposure for Takata recalls. The page references provided appear plausible. WEAKNESSES: The quantitative data about Takata accruals is misleading in context—these are GM's total liabilities, not Stellantis-specific indemnifications. This represents a fundamental misunderstanding of the multi-hop synthesis required: the question asks about indemnification TO Stellantis, not GM's broader Takata exposure. The answer partially addresses the question but introduces incorrect financial figures that contradict the 'immaterial' characterization of Stellantis indemnifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 463,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "In each filing, AMD lists the 2011 Executive Incentive Plan as Exhibit 10.1 and incorporates it by reference (2022, pp. 91‑95; 2023, pp. 99‑103; 2024, pp. 96‑100). The reference remains unchanged across the three years, indicating that AMD has kept the same long‑term incentive framework for executives and has not altered the foundational plan. This consistency underscores a deliberate, stable long‑term executive‑compensation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that AMD consistently referenced the 2011 Executive Incentive Plan across 2022, 2023, and 2024 without amendments, and appropriately concludes this reflects a stable executive compensation strategy. However, there are significant issues with quantitative accuracy: (1) The page number citations (2022 pp. 91-95; 2023 pp. 99-103; 2024 pp. 96-100) cannot be verified against the ground truth and appear to be fabricated or hallucinated specific references. The ground truth does not provide page numbers, only confirms the consistent referencing pattern. (2) The LLM states the plan was 'filed on April 2, 2011' in the ground truth but omits this specific date from its answer, which is a minor omission. (3) The LLM correctly identifies Exhibit 10.1 as the reference location, matching the ground truth. The qualitative reasoning is sound - the LLM correctly synthesizes that consistency across three years suggests stability in compensation strategy. The semantic meaning aligns well with the ground truth conclusion. The main weakness is the introduction of specific page citations that cannot be verified and may be inaccurate, which is a critical error in financial document analysis where precision is essential. The answer would have been stronger by either providing verifiable citations or acknowledging the consistent pattern without specific page numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 393,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "PayPal’s 2022 risk‑factor section (p. 24‑28) warned that bad‑transaction losses could arise from its consumer and merchant credit products, cross‑border trade volumes, and reliance on third‑party lenders and processors. In 2023 (p. 23‑27) the company mitigated this exposure by selling a majority of its U.K./European BNPL loan receivables, diversifying its payment‑processor base, and investing in enhanced fraud‑detection and risk‑modeling tools. By 2024 (p. 21‑25) the disclosures reiterated these drivers while adding new concerns around cybersecurity, payment‑fraud, and trade‑policy risks, underscoring the continued importance of credit‑product risk management, cross‑border exposure, and third‑party dependencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PayPal's bad transaction risk evolution across 2022-2024 and correctly identifies the key 2023 strategic action (BNPL receivables sale). Strengths: (1) Correctly identifies the €40 billion BNPL receivables sale as the primary 2023 mitigation strategy, matching the ground truth; (2) Accurately captures the progression of risk concerns across the three-year period; (3) Properly synthesizes multi-hop information about credit products, cross-border trade, and third-party dependencies; (4) Correctly notes the shift toward risk management and exposure reduction. Weaknesses: (1) The LLM mentions 'selling a majority of its U.K./European BNPL loan receivables' but the ground truth specifies 'up to €40 billion' - the LLM's phrasing is less precise about the specific amount and structure (multi-year agreement); (2) The LLM adds details about 'diversifying its payment-processor base' and 'investing in enhanced fraud-detection and risk-modeling tools' that are not explicitly mentioned in the ground truth, which could represent either additional valid information or potential hallucination; (3) The LLM references specific page numbers (p. 24-28, p. 23-27, p. 21-25) which cannot be verified against the ground truth and may be inaccurate; (4) The ground truth emphasizes 'regulatory uncertainty, especially around the validity of loan sales post-transfer' as a 2024 concern, which the LLM does not explicitly capture. The core narrative is correct and the multi-hop reasoning is sound, but the answer lacks the precision on the €40 billion figure and the specific regulatory concerns mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 456,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024 Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (owned 6,204, leased 1,038, average age 22.5 yrs) to 6,893 units (owned 5,973, leased 920, average age 25.2 yrs) (UNP_10k_2022, p.22‑26; UNP_10k_2023, p.17‑21; UNP_10k_2024, p.17‑21). The decline in ownership and leasing, coupled with a higher average age, indicates a deliberate strategy to retire older locomotives and replace them with newer ones while shrinking the fleet to improve operational efficiency and support modernization initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides correct individual numbers (owned 6,204→5,973, leased 1,038→920, average age 22.5→25.2 years) but makes a fundamental arithmetic error in the total fleet calculation. The LLM states the fleet fell from 7,242 to 6,893 units. However, the correct totals are: 2022: 6,204 + 1,038 = 7,242 (correct), but 2024: 5,973 + 920 = 6,893 (correct). While the totals are arithmetically correct, the LLM's interpretation of what these numbers mean is fundamentally flawed. (2) REASONING ERROR - The LLM claims the data 'indicates a deliberate strategy to retire older locomotives and replace them with newer ones.' This directly contradicts the ground truth interpretation. The ground truth explicitly states the average age INCREASED from 22.5 to 25.2 years, which indicates the fleet is AGING, not being modernized. The LLM's conclusion that this represents 'replacement with newer ones' is logically inconsistent with an increasing average age. (3) STRATEGIC INTERPRETATION - The ground truth correctly identifies this as 'cost control over aggressive modernization' - the company reduced leasing but did NOT substantially increase new purchases. The LLM incorrectly frames this as a modernization strategy when the data shows the opposite: aging fleet with no evidence of replacement. (4) MULTI-HOP SYNTHESIS - While the LLM correctly extracted numbers from multiple years, it failed to synthesize the logical implication: increasing average age + declining fleet size = aging fleet without sufficient new purchases, not modernization. The LLM's interpretation is semantically opposite to the ground truth conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 459,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply – from **$1.494 billion in 2022 to $491 million in 2024** (a drop of about $1.0 billion, or 67 %). This steep decline reflects a more efficient, liquidity‑focused derivative strategy, likely driven by tighter netting, lower derivative exposure or improved counterparty limits, and shows the company is actively reducing collateral commitments that support its equity‑company receivables.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2022 figure was $1.494 billion, but the ground truth clearly shows $641 million in 2022. This is a massive discrepancy ($853 million overstatement). The LLM also omits the 2023 figure ($800 million) entirely, which is a critical data point showing the trend peaked in 2023 before declining in 2024. The calculation of a $1.0 billion drop is based on the incorrect 2022 baseline. (2) INCOMPLETE SYNTHESIS: The LLM failed to capture the three-year trend (2022: $641M → 2023: $800M → 2024: $491M), which is essential for understanding the pattern. The ground truth explicitly identifies 2023 as a peak year, which the LLM completely misses. (3) REASONING ISSUES: While the LLM's interpretation about derivative risk management and collateral efficiency is plausible, it is built on false numerical premises. The conclusion about 'sharp decline' and '67% drop' is mathematically incorrect given the wrong baseline. (4) ENTITY/METRIC ACCURACY: The LLM correctly identifies ExxonMobil and master netting arrangements, but misidentifies the collateral exposure amounts. The ground truth shows a more nuanced pattern (increase then decrease) rather than a simple 'sharp fall.' The LLM's narrative of 'actively reducing collateral commitments' may be directionally correct for 2023-2024, but the 2022 baseline is entirely wrong, undermining the entire analysis. This is a case where the LLM appears to have hallucinated or confused the 2022 figure with a different metric or company.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 447,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "The 2022, 2023, and 2024 10‑Ks all describe “Other” revenue as coming from packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware, and ready‑to‑drink beverages – the mix of items did not change materially.  The dollar amount grew from $6.89 B in 2022 to $7.70 B in 2023 and then eased to $7.54 B in 2024, while its share of total revenue rose modestly from 21 % in 2022 to 22 % in 2023 and returned to 21 % in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dollar amounts ($6.89B in 2022, $7.70B in 2023, $7.54B in 2024) and percentage figures (21% in 2022, 22% in 2023, 21% in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states there was 'no explicit mention of new product categories or significant shifts in this segment over the three-year period' and focuses on compositional stability, NOT quantitative growth metrics. The LLM has fabricated financial data that cannot be verified against the provided ground truth. While the LLM correctly identifies the composition of the 'Other' category (packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages), it fundamentally misrepresents the nature of the answer by adding unsubstantiated numerical claims. The qualitative assessment of compositional stability is correct, but the quantitative additions are entirely unsupported and represent a major factual error. The answer does address the evolution question but does so by inventing data rather than synthesizing from actual filings. This is a severe breach of accuracy in financial reporting context where numbers must be precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 353,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "Across 2022‑24 Alphabet continued to monetize Google Network inventory on a **gross‑basis** when it is the principal, recording the full amount billed to advertisers as revenue and the share paid to network partners as cost of revenue.  For **brand advertising** on Network properties, revenue is recognized **impression‑based**—at the moment the ad is displayed or viewed—while performance advertising revenue is recognized only when a user engages with the ad.  This gross‑basis, impression‑based recognition policy remained unchanged through the 2024 filing, with no shift to net‑basis accounting or a change in the timing of revenue recognition.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the gross-basis revenue recognition model for Google Network properties across 2022-2024, which is a core element of the ground truth. It accurately notes that Alphabet records the full amount billed to advertisers as revenue when acting as principal, with network partner shares recorded as cost of revenue. The statement that this policy remained unchanged through 2024 is correct. The mention of impression-based recognition for brand advertising is accurate and adds relevant detail.\n\nWEAKNESSES: (1) The LLM introduces a distinction between 'brand advertising' (impression-based) and 'performance advertising' (engagement-based) that is NOT present in the ground truth answer. While this may be factually accurate from the filings, it goes beyond what the ground truth specifies and potentially introduces information not directly supported by the knowledge graph. (2) The ground truth emphasizes the EVOLUTION and PROGRESSION of transparency from 2022 to 2024, noting that 2023 brought clarification and 2024 brought further emphasis on principal status. The LLM answer treats the policy as static ('remained unchanged') rather than highlighting the evolution of disclosure and transparency. (3) The ground truth mentions 'cost-per-impression as a key metric' in 2022, which the LLM does not address. (4) The LLM answer lacks the temporal narrative of increasing clarity that characterizes the ground truth's description of evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and correctly identifies the consistent monetization approach. However, it misses the nuance that the ground truth emphasizes evolution in transparency and accounting clarity rather than static policy.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers are provided in either answer, so quantitative accuracy is based on conceptual correctness. The LLM's statements about gross-basis and impression-based recognition are factually sound, but the introduction of performance advertising distinctions and the de-emphasis of evolution represent departures from the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 582,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "In 2022, MDLZ’s 10‑K (p. 13‑17) disclosed that its sales and media‑marketing activities were subject to restrictions on promotions of nutrient‑profile products, front‑of‑pack labeling for nutrient and environmental claims, and EPR policies in more than 25 EU member states. The 2023 filing (p. 9‑13) reiterated these exposures and noted increasing regulatory scrutiny, but the jurisdictional scope remained largely unchanged. By 2024, the 10‑K (p. 9‑13) expanded the EPR exposure to include India, Vietnam and U.S. states, and highlighted that front‑of‑pack labeling and single‑use plastic bans were tightening across Europe and other markets, thereby widening MDLZ’s regulatory exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of MDLZ's regulatory exposure evolution across 2022-2024, with mostly accurate factual content and appropriate multi-hop synthesis. Strengths: (1) Correctly identifies the core regulatory themes (EPR policies, front-of-pack labeling, marketing restrictions) across all three years; (2) Accurately captures the jurisdictional expansion from EU-focused (2022) to broader global scope (2024); (3) Properly notes the shift from contemplation to enforcement by 2024; (4) Correctly identifies specific jurisdictions (India, Vietnam, U.S. states) added in 2024. Quantitative accuracy is strong - the '25 EU countries' figure is correctly referenced, and the jurisdictional progression is accurately tracked. Minor weaknesses: (1) The 2023 description states 'jurisdictional scope remained largely unchanged' which is somewhat imprecise - the ground truth indicates 2023 emphasized increased attention to front-of-pack labeling and noted single-use plastic considerations in Indonesia/Philippines, suggesting some evolution; (2) The LLM answer mentions 'single-use plastic bans were tightening across Europe' in 2024, but the ground truth specifically notes these were 'being considered' in Indonesia and Philippines in 2023, not yet implemented; (3) Missing explicit mention that India, Vietnam, Indonesia, and Philippines were being 'considered' in 2022 before becoming enforcement jurisdictions. The multi-hop reasoning is sound - the answer successfully synthesizes information across three years and multiple jurisdictions. The semantic meaning aligns well with the ground truth despite some wording differences. Page citations appear plausible but cannot be verified. Overall, this is a competent answer with minor gaps in nuance regarding the progression of regulatory consideration vs. implementation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 501,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Between 2022 and 2024, Mastercard’s A‑class common shares consistently retained **one vote per share and dividend rights** as shown in the “Classes of Capital Stock” tables of the 2022, 2023, and 2024 Form 10‑K filings. The unchanged voting and dividend status across all three years signals a deliberate capital‑structure strategy that prioritizes stability and predictability—preserving public investor voting power while maintaining a consistent dividend policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that A Class shares maintained one vote per share and dividend rights consistently across 2022, 2023, and 2024—no numerical errors; (2) Properly synthesizes multi-hop information across three years of 10-K filings; (3) Accurately identifies the company as Mastercard and correctly references the 'Classes of Capital Stock' tables as the source; (4) Correctly interprets the consistency as indicating a deliberate capital structure strategy focused on stability. The LLM answer goes slightly beyond the ground truth by adding interpretive detail ('prioritizes stability and predictability' and 'preserving public investor voting power'), which is reasonable inference from the facts but represents minor elaboration. The core factual claim—unchanged voting and dividend status across all three years—is completely accurate. The reasoning about what this consistency indicates about MA's capital structure strategy is sound and semantically equivalent to the ground truth. No calculation errors, no date errors, no entity misidentification. The only minor distinction is that the LLM provides slightly more interpretive commentary than the ground truth statement, but this adds value rather than detracting from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 371,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements for the “Investments, advances and long‑term receivables” line fell from **$1.49 billion** at 12/31/2022 to **$800 million** at 12/31/2023 and further to **$491 million** at 12/31/2024. The downward trend indicates that the company is requiring less initial margin, suggesting a reduction in its overall derivative exposure or more efficient netting/hedging practices that lower margin requirements over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides completely incorrect numbers for 2022. Ground truth states $641 million at end of 2022, but LLM claims $1.49 billion - this is a massive discrepancy (132% error). The 2023 figure of $800 million is correct, and 2024 figure of $491 million is correct. (2) MULTI-HOP REASONING - The LLM correctly identifies the overall downward trend from 2023-2024 but fails on the complete 2022-2024 analysis. The ground truth shows: $641M (2022) → $800M (2023) → $491M (2024), which is actually an INCREASE from 2022 to 2023, then a decrease. The LLM incorrectly characterizes this as a continuous downward trend. (3) INTERPRETATION - The LLM's interpretation about 'reduction in derivative exposure' is partially reasonable for the 2023-2024 period but misses the important 2022-2023 increase that the ground truth emphasizes as a 'notable increase in margin requirements in 2023.' The ground truth provides more nuanced analysis of the 'dynamic derivative exposure profile' with both increases and decreases. (4) ENTITY/METRIC ACCURACY - Both answers correctly identify ExxonMobil and the collateral under master netting arrangements metric, but the LLM's specific numbers are fundamentally wrong for the 2022 baseline, which undermines the entire analysis. The $1.49 billion figure appears to be from a different metric or incorrect data extraction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 391,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ forward‑looking coffee‑purchasing strategy has been steadily extended: in FY 2022 the company’s fixed‑price and price‑to‑be‑fixed purchase commitments, together with forward contracts, futures and collars, were expected to cover through fiscal 2023; in FY 2023 that horizon was pushed to fiscal 2024; and in FY 2024 it was further extended to fiscal 2025 【SBUX_10k_2022.pdf: page 12】【SBUX_10k_2023.pdf: page 12】【SBUX_10k_2024.pdf: page 12】. This progression shows a deliberate strategy to lock in coffee prices and secure supply over a longer period, thereby reducing exposure to price volatility and supply risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE PROGRESSION: The LLM answer contains a significant factual error in the fiscal year progression. According to the ground truth: FY2022 commitments covered through FY2023, FY2023 commitments extended through FY2025, and FY2024 maintained the same through FY2025. However, the LLM states: FY2022 through FY2023, FY2023 through FY2024, and FY2024 through FY2025. This represents a fundamental misunderstanding of the multi-hop data synthesis. The LLM incorrectly shows a year-by-year incremental extension (each year adding one more year of coverage), when the actual pattern shows FY2023 made a significant jump to FY2025 coverage, which was then maintained in FY2024. POSITIVE ASPECTS: (1) The LLM correctly identifies the three fiscal years being analyzed (2022, 2023, 2024), (2) Correctly mentions the use of forward contracts, futures contracts, and collars as risk mitigation tools, (3) Appropriately characterizes the strategy as aimed at reducing price volatility and supply risk exposure, (4) Provides proper source citations. QUANTITATIVE ACCURACY ISSUES: The timeline progression is factually incorrect - this is a quantitative/chronological error that undermines the core answer. The LLM's interpretation suggests a linear year-by-year extension pattern rather than the actual pattern of a significant jump in FY2023 followed by maintenance in FY2024. REASONING QUALITY: While the LLM's interpretation of the strategic intent (locking in prices, securing longer-term supply) is reasonable and aligns with the ground truth's characterization, the factual basis for this reasoning is flawed due to the incorrect timeline. The multi-hop synthesis across three years of 10-K filings was not executed correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 474,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "ACN’s target mix for U.S. defined‑benefit plans moved from 95 % debt and 5 % cash in fiscal 2023 to a full 100 % debt allocation by fiscal 2025, eliminating equity and cash. For Non‑U.S. plans, equity exposure rose from 19 % to 28 % while debt fell from 43 % to 36 %, with modest changes to cash, insurance contracts and other assets. This multi‑year shift signals a strategic emphasis on duration matching and risk‑controlled, stable returns for U.S. plans, and a higher risk‑adjusted growth objective for Non‑U.S. plans—aligning with the company’s long‑term goal of achieving returns that exceed inflation while maintaining funding levels.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable asset allocation percentages for both U.S. and Non-U.S. defined benefit pension plans across the fiscal 2023-2025 period, which is more concrete than the ground truth answer. The specific numbers cited (U.S. plans: 95% debt/5% cash in FY2023 to 100% debt in FY2025; Non-U.S. plans: equity 19% to 28%, debt 43% to 36%) demonstrate detailed knowledge of the actual allocation shifts. The answer correctly identifies the strategic implications: duration matching and risk control for U.S. plans, and growth-oriented allocation for Non-U.S. plans. The reasoning about inflation-beating returns and funding level maintenance aligns with the ground truth's emphasis on liability matching and risk mitigation. Strengths: (1) Provides specific percentage allocations rather than general descriptions, (2) Distinguishes between U.S. and Non-U.S. plan strategies, (3) Correctly interprets the shift toward 100% debt for U.S. plans as a duration-matching strategy, (4) Identifies the increased equity exposure in Non-U.S. plans as a growth objective. Minor weaknesses: (1) The ground truth emphasizes 'continuity in strategy with updated flexibility ranges' while the LLM focuses on the directional shift, though both perspectives are valid, (2) The ground truth mentions 'specific attention to matching debt securities' duration to plan liabilities' which the LLM captures as 'duration matching' but with less explicit detail about the liability-matching framework. The quantitative data appears accurate and the multi-hop synthesis across fiscal years and plan types is sound. The answer directly addresses how the allocation evolved and what it suggests about investment strategy and risk objectives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 473,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, Amgen kept Olpasiran as a Phase 2 siRNA program focused on lowering lipoprotein(a) for atherosclerotic cardiovascular disease (see the Phase 2 table on pages 24‑28 of the 2022 and 2023 filings and pages 22‑26 of the 2024 filing).  The company secured composition‑of‑matter patents in the U.S. and Europe that were already issued by 2022 and remain in force through 2024, with estimated expirations in 2036, providing a 12‑year exclusivity window for the compound.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported with specific filing references. STRENGTHS: (1) All numeric values are accurate - patent expiration in 2036 is correct, 12-year exclusivity window calculation is accurate; (2) Entity identification is correct - Amgen, Olpasiran, siRNA, atherosclerotic cardiovascular disease all properly identified; (3) Multi-hop synthesis is sound - the answer correctly traces the program across 2022-2024 filings and identifies the consistent Phase 2 status; (4) IP protection details are accurate - composition-of-matter patents in U.S. and Europe with 2036 expiration matches ground truth; (5) Specific filing page references add credibility and demonstrate source verification. MINOR GAPS: (1) The LLM answer emphasizes 'lowering lipoprotein(a)' as the mechanism, which is more specific than the ground truth's general 'atherosclerotic cardiovascular disease' focus - this is actually additional accurate detail not contradicting the ground truth; (2) The ground truth mentions a 'transition from phase 2 investigation toward more advanced development or potential regulatory preparation' in 2024, but the LLM states it 'kept Olpasiran as a Phase 2 siRNA program' through 2024, suggesting it remained in Phase 2 rather than advancing. This is a subtle but potentially important distinction - if the ground truth implies advancement beyond Phase 2 by 2024, the LLM's statement that it remained Phase 2 through 2024 could be slightly inaccurate. However, the ground truth language is ambiguous ('transition...toward') rather than definitive about advancement. (3) The LLM provides more mechanistic detail (lipoprotein(a) lowering) and more specific filing references than the ground truth, which enhances the answer but wasn't explicitly required. Overall, the answer demonstrates strong command of the multi-hop synthesis across three years of filings with accurate numbers and logical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 525,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "From 2022 through 2024, American Express disclosed a steadily growing reliance on merchant acquirers, aggregators and processors to run its merchant‑acceptance and cobrand programs, with the 2024 filing noting an even greater dependence and the need to offer larger incentives and concessions. In 2022 the risk emphasis was on the possibility of losing partner relationships, renegotiating on less‑favorable terms, and third‑party goals that could conflict with the company’s; in 2023 the disclosure added concerns about third‑party operational failures, data‑security breaches and regulatory shifts; and by 2024 it highlighted the heightened risk of losing merchant relationships, the impact of increased incentives and concessions, and the potential for third‑party disruptions or regulatory changes to materially affect card acceptance and network volumes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop synthesis required across three years of American Express disclosures. STRENGTHS: (1) Correctly identifies the time period (2022-2024) and tracks the evolution of AXP's reliance on aggregators/processors; (2) Accurately captures the progression of risk emphasis across years - from partner relationship/conflict concerns (2022) to operational/data-security/regulatory risks (2023) to merchant relationship loss and incentive impacts (2024); (3) Properly synthesizes information across multiple filing years showing a clear trend; (4) Includes relevant details about incentives/concessions that appear in later filings; (5) No quantitative errors or incorrect dates. WEAKNESSES: (1) The LLM answer emphasizes 'merchant acquirers' and 'cobrand programs' more prominently than the ground truth, which focuses more specifically on 'aggregators' and their steering/surcharging behaviors - this is a slight semantic shift but not factually wrong; (2) The ground truth specifically mentions 'merchant steering' and 'surcharging' as key 2023 concerns, while the LLM answer generalizes these as 'third-party operational failures' - this is less precise but not incorrect; (3) The ground truth notes a shift 'from a focus on merchant behavior to broader systemic and legal concerns,' which the LLM captures but with less explicit framing of this conceptual evolution; (4) The LLM adds details about 'incentives and concessions' that enhance the answer but weren't explicitly highlighted in the ground truth summary. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filing years and correctly identifies the progression of risk disclosure. The logic is sound and the connections between years are clear. ENTITY ACCURACY: American Express correctly identified, years correct (2022, 2023, 2024), risk categories appropriately identified. The answer is substantively correct with minor differences in emphasis and framing rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 549,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks has consistently reported that green‑coffee price volatility is driven in part by trading activity in the arabica futures market—including hedge funds and commodity‑index funds—and it has continued to hedge “C”‑price exposure with forward contracts, futures and collars.  Over the three‑year period the company extended its forward purchase commitments each year: in fiscal 2022 commitments were projected to cover supply through fiscal 2023, in fiscal 2023 through fiscal 2024, and in fiscal 2024 through fiscal 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains accurate factual information about Starbucks' forward supply commitments and hedging strategies, but has a critical error in the timeline progression. CORRECT ELEMENTS: (1) Accurately identifies commodity index funds as a factor in green coffee price volatility; (2) Correctly names hedging instruments (forward contracts, futures, collars); (3) Correctly identifies the three-year period (fiscal 2022-2024); (4) Accurately states that commitments were extended each year. CRITICAL ERROR: The LLM states commitments in fiscal 2023 covered supply 'through fiscal 2024,' but the ground truth clearly indicates they extended 'through fiscal 2025.' This is a significant factual error in the multi-hop synthesis. The correct progression should be: FY2022→FY2023, FY2023→FY2025, FY2024→FY2025. The LLM's version (FY2022→FY2023, FY2023→FY2024, FY2024→FY2025) shows a different pattern that misrepresents the strategic shift. MISSING ELEMENTS: The LLM answer lacks discussion of the strategic significance of the multi-year extension and the shift toward longer-term risk mitigation, which the ground truth emphasizes as important context. The LLM also doesn't explicitly note that the FY2024 outlook remained 'unchanged' from FY2023, which indicates stabilization. QUANTITATIVE ACCURACY: The fiscal years mentioned are mostly correct except for the FY2023 endpoint error. QUALITATIVE ACCURACY: While the hedging mechanisms are correctly identified, the failure to accurately synthesize the timeline progression across the three years represents a fundamental multi-hop reasoning error. The answer reads as partially correct but contains a material factual error that affects the interpretation of Starbucks' strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 475,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture repurchased $4.111 billion of shares in fiscal 2022 (12.18 million shares) and $4.5 billion in fiscal 2024, with the open‑market program contributing $605 million in 2024; the Board added $3 billion of additional authority in 2022 (raising total authority to $6.129 billion) and $4 billion in 2024 (raising total authority to $6.694 billion). The aggregate available authorization for the open‑market program fell slightly from $3.129 billion in 2022 to $2.694 billion in 2024, yet the program remains open‑ended and is periodically reaffirmed, underscoring Accenture’s disciplined, flexible capital‑return strategy that consistently returns excess cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) SHARE REPURCHASE AMOUNTS: The LLM claims Accenture repurchased $4.111 billion in fiscal 2022 and $4.5 billion in fiscal 2024, but the ground truth only mentions $605 million in fiscal 2023 for 2,000,308 shares. The LLM provides no source for the $4.111B and $4.5B figures and these appear to be fabricated. (2) AUTHORIZATION AMOUNTS: The LLM states the Board added $3 billion in 2022 (raising total to $6.129 billion), but the ground truth shows $3,129,296 (approximately $3.129 billion) available in fiscal 2022 with no mention of a $3B addition in that year. The $6.129 billion figure is incorrect. (3) FISCAL 2024 AUTHORIZATION: The LLM correctly states $4 billion was added in 2024 raising total to $6.694 billion, which matches ground truth. (4) AVAILABLE AUTHORIZATION DECLINE: The LLM correctly notes the decline from $3.129 billion to $2.694 billion, matching ground truth. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the timeline - it conflates different fiscal years and introduces unsupported numbers. The ground truth clearly shows fiscal 2023 had the $605M repurchase activity, not fiscal 2024. (6) MISSING CONTEXT: The LLM provides no clear year-by-year breakdown and mixes fiscal 2022, 2023, and 2024 data without proper temporal organization. The answer demonstrates poor multi-hop reasoning across the three-year period requested. The only correct elements are the $2.694 billion available authorization in 2024, the $4 billion addition in 2024, and the $6.694 billion total authorization figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 451,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "The long‑term portion of marketable equity securities subject to lock‑up restrictions rose from **$803 million** at 12/31/2022 to **$1.4 billion** at 12/31/2023, then fell sharply to **$266 million** at 12/31/2024. This swing—an 74 % jump followed by an 81 % decline—indicates that Google expanded its illiquid equity exposure in 2023 but then substantially pared it back in 2024, suggesting a shift toward more liquid assets or a rebalancing of its investment strategy to manage risk and liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect: (1) WRONG NUMBERS: The LLM states 2022=$803M, 2023=$1.4B, 2024=$266M. Ground truth shows 2022=$1.4B, 2023=$803M, 2024=$1.4B. The LLM has reversed the 2022 and 2023 values and introduced a completely incorrect 2024 figure ($266M vs. correct $1.4B). (2) WRONG CALCULATIONS: The LLM calculates a 74% jump and 81% decline based on incorrect numbers. The correct pattern is: 2022→2023 is a 43% DECREASE (1.4B→803M), then 2023→2024 is a 74% INCREASE (803M→1.4B). (3) WRONG INTERPRETATION: Because the numbers are wrong, the entire narrative is inverted. The LLM claims Google 'expanded' in 2023 and 'pared back' in 2024, when the ground truth shows the opposite pattern—a decrease in 2023 followed by a return to higher levels in 2024. (4) MISSING CONTEXT: The ground truth emphasizes a 'cyclical or strategic rebalancing' pattern with a return to the original 2022 level by 2024, suggesting stability rather than the dramatic 'shift toward more liquid assets' the LLM describes. The LLM's reasoning about risk management and liquidity is plausible in isolation but is built on completely incorrect data points, making the entire analysis unreliable. This is a multi-hop question requiring accurate synthesis of three year-over-year data points, and the LLM failed on all three values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 385,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "From 2022 to 2024 GE shifted Electric Insurance Company (EIC) from a core captive insurer to a held‑for‑sale asset and finally sold it. In 2022 EIC was classified as held for sale with a $17 million valuation allowance (2022 10‑K, p. 45‑49); by 2023 the allowance rose to $124 million and GE recorded a $109 million loss on the held‑for‑sale classification (2023 10‑K, p. 48‑52). The asset was sold in 2024 for $120 million cash, yielding a gain of roughly $81 million (net of the $39 million carrying amount) and eliminating the valuation allowance, thereby improving GE’s balance sheet and cash position (2024 10‑K, p. 46‑50).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) TIMELINE MISCLASSIFICATION: The LLM states EIC was 'classified as held for sale' in 2022, but the ground truth clearly indicates this classification occurred in 2023. This is a fundamental factual error that undermines the entire narrative. (2) VALUATION ALLOWANCE NUMBERS: The LLM cites a '$17 million valuation allowance (2022)' and '$124 million (2023)' - these figures do not appear in the ground truth and appear to be fabricated or misattributed. The ground truth mentions a '$109 million loss related to the expected sale' in 2023, not a '$124 million allowance.' (3) GAIN CALCULATION ERROR: The LLM claims the 2024 sale yielded 'a gain of roughly $81 million (net of the $39 million carrying amount)' - this calculation is problematic and unsupported. The ground truth states the sale was for $120 million but does not mention an $81 million gain or a $39 million carrying amount. The 2023 loss of $109 million suggests the carrying amount was significantly higher than $39 million. (4) INCOMPLETE 2022 CHARACTERIZATION: The ground truth specifies that in 2022, EIC had 'net claim reserves of $0.2 billion' and was described as 'a captive industrial insurance subsidiary primarily serving GE and its employees' - the LLM omits these important details. (5) ASSET/LIABILITY DETAILS MISSING: The ground truth provides specific 2023 balance sheet figures (assets of $541 million, liabilities of $378 million) which the LLM does not mention. (6) MULTI-HOP SYNTHESIS: While the LLM attempts to trace the evolution across three years, the fundamental misplacement of the held-for-sale classification to 2022 (instead of 2023) breaks the logical progression. The answer does correctly identify the 2024 sale to Riverstone for $120 million and the strategic exit narrative, but the numerous quantitative errors and timeline issues significantly undermine credibility. The LLM appears to have either hallucinated specific numbers or confused data from different sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 538,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio expanded from 13 programs in 2022 (including new approvals and initiations) to 18 in 2023 and 24 by early 2024, reaching 25 by February 2025 (2022 10‑K p.25; 2023 10‑K p.27; 2024 10‑K p.24; 2024 10‑K p.27). This growth reflects a deliberate strategy to broaden its late‑stage pipeline, diversify therapeutic areas (oncology, immunology, cardiovascular), and accelerate development through acquisitions (e.g., Horizon programs) and a focus on biologics and human‑genetics‑driven targets (2024 10‑K p.24).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - QUANTITATIVE DISCREPANCY: The LLM answer states the portfolio reached '24 by early 2024' and '25 by February 2025,' but the ground truth clearly indicates 24 programs in 2024 and 25 programs by 2024 (not 2025). The LLM appears to have introduced a future date (February 2025) that contradicts the ground truth timeline. The progression 13→18→24→25 is correct in sequence, but the temporal attribution is problematic. CORRECT ELEMENTS: (1) Starting point of 13 programs in 2022 - correct; (2) Intermediate point of 18 in 2023 - correct; (3) Recognition of Horizon acquisition contribution - correct and appropriately cited; (4) Identification of therapeutic areas (oncology, immunology, cardiovascular) - contextually appropriate; (5) Multi-hop synthesis across years - generally sound. ISSUES: (1) The statement '25 by February 2025' appears to be an extrapolation or error, as the ground truth indicates 25 programs in 2024; (2) The LLM provides specific page citations (2022 10-K p.25, etc.) which cannot be verified against the ground truth but adds apparent credibility; (3) The answer conflates 'early 2024' with 24 programs and then jumps to 'February 2025' with 25 programs, creating temporal confusion. REASONING QUALITY: The LLM correctly identifies the strategic drivers (acquisitions, diversification, acceleration) and demonstrates sound multi-hop synthesis. However, the temporal attribution error undermines the factual accuracy. The qualitative analysis of strategic focus is well-reasoned and contextually relevant. OVERALL ASSESSMENT: Core narrative is correct (13→18→24→25 progression), strategic context is appropriate, but the temporal placement of the final data point (2025 vs 2024) represents a significant factual error that affects correctness despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 494,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "Between 2022 and 2024, American Express has scaled back its global card‑network licensing, exiting EU and Australian arrangements in response to regulatory scrutiny and tightening interchange‑fee and surcharging rules that have pressured discount revenue. The company has sharpened its focus on premium cardholder value and cobrand partnerships to compete with Visa, Mastercard, China UnionPay and other networks, while its designation as a Category III bank‑holding firm underscores the heightened regulatory expectations it now faces. These shifts reflect a broader industry trend toward tighter regulation of network operations and a competitive push to differentiate through rewards, travel benefits and digital services.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of American Express's relationship with global card networks from 2022-2024, correctly identifying key developments: (1) Exit from EU and Australian network licensing businesses due to regulatory constraints - this matches the ground truth; (2) Shift from direct competition to a more constrained regulatory environment - accurately reflected; (3) Emphasis on premium cardholder value and cobrand partnerships - correctly identified as competitive differentiation strategy; (4) Mention of competitors (Visa, Mastercard, China UnionPay) - accurate. The answer also adds relevant context about Category III bank-holding designation and interchange-fee/surcharging pressures, which are consistent with the regulatory pressures mentioned in ground truth. However, there are some gaps: (1) The LLM answer does not explicitly mention the 2023 intermediate period where competitive stance remained but alternative payment platforms (Alipay, PayPal) became more prominent challenges - this represents incomplete multi-hop synthesis across the three-year period; (2) The ground truth emphasizes 'uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations' which the LLM answer mentions only implicitly through 'regulatory constraints'; (3) The answer could have been more explicit about the trajectory from 'primarily competitive posture' to 'constrained environment shaped by regulatory dependencies.' The LLM answer demonstrates sound reasoning and correctly synthesizes information across the 2022-2024 period, but misses some nuanced details about the intermediate 2023 developments and the specific nature of cobrand arrangement uncertainties. No quantitative errors detected (no specific numbers were provided in either answer to verify). The semantic meaning largely aligns with ground truth, though the answer is somewhat less comprehensive in capturing the full evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 529,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in 2022, with the proceeds earmarked for share repurchases.  Share‑repurchase activity grew from 383 million shares at a cost of $29 billion in 2023 to 433 million shares at $34.3 billion in 2024, as the company’s authorization was expanded from $45 billion to $65 billion (2024 10‑K, pp. 110‑114; 2023 10‑K, pp. 108‑112).  The 2022 sale of CVE shares was a one‑time event; the filings do not disclose the dollar proceeds, but they were applied to fund the share‑repurchase program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TEMPORAL ATTRIBUTION: The LLM answer contains a fundamental factual error regarding the timing of share repurchases. The ground truth states that 383 million shares at $29 billion were repurchased in 2022, and by 2024 the cumulative total reached 433 million shares at $34.3 billion. However, the LLM answer incorrectly states that share repurchase activity 'grew from 383 million shares at a cost of $29 billion in 2023 to 433 million shares at $34.3 billion in 2024.' This misattributes the 2022 repurchase data to 2023, which is a significant chronological error that distorts the three-year evolution requested in the question. CORRECT ELEMENTS: The LLM correctly identifies that ConocoPhillips completed monetization of 91 million CVE shares in 2022, correctly states the cumulative repurchase figures of 433 million shares at $34.3 billion by 2024, and correctly notes the authorization increase to $65 billion in October 2024. The LLM also appropriately acknowledges that the specific dollar proceeds from the CVE share sale were not disclosed in the filings. MULTI-HOP REASONING: The answer demonstrates partial synthesis across multiple years and documents but fails to properly sequence the events across the 2022-2024 period as requested. The question specifically asks how the monetization and repurchases 'evolved from 2022 through 2024,' requiring year-by-year clarity, which the LLM fails to provide accurately. QUANTITATIVE ISSUES: While individual numbers are correct, their temporal assignment is wrong, which is a critical error in a financial analysis context. The answer should have clearly stated: 2022 repurchases = 383 million shares/$29 billion; 2024 cumulative = 433 million shares/$34.3 billion (implying 50 million shares/$5.3 billion in 2023-2024 combined). COMPLETENESS: The answer addresses most components of the question but fails to properly articulate the three-year progression with accurate year-by-year attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 532,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "At the end of fiscal 2022 the Omnibus Plan’s authorized share pool was 80 million shares (the maximum available for issuance)【HD_10k_2022.pdf:65-69】.  The 2023 filing shows the available pool had fallen to about 77 million shares, and the 2024 filing reports it further declined to roughly 70 million shares【HD_10k_2023.pdf:67-68】【HD_10k_2024.pdf:70-71】.  This downward trend indicates Home Depot has been steadily drawing on its equity‑compensation capacity, tightening the share pool and reflecting higher utilization of stock‑based awards over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2022 BASELINE: The LLM states 80 million shares were available at the end of fiscal 2022, but the ground truth clearly indicates 117 million shares were available under the 2005 Plan in 2022. This is a significant factual error (37 million share difference, ~46% understatement). The LLM's 2023 (77 million) and 2024 (70 million) figures appear correct and match the ground truth. However, the incorrect 2022 baseline undermines the entire trend analysis. The LLM correctly identifies the downward trajectory from 2023-2024 (77M to 70M, a 7 million share decline) and appropriately concludes this reflects steady utilization of equity compensation capacity. The reasoning about tightening share pools and higher stock-based award utilization is sound and semantically equivalent to the ground truth's conclusion. The LLM also correctly references the replenishment mechanism concept (though less explicitly than ground truth). The major weakness is the 2022 starting point error, which distorts the three-year trend analysis that was central to the question. The answer demonstrates good multi-hop synthesis across three fiscal years and appropriate interpretation of what the trend signifies, but the foundational quantitative error significantly compromises accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 362,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture raised the authorized pool for the Amended 2010 Share Incentive Plan from **127 million shares in 2022** (ACN_10k_2022, pp. 89‑93) to **141 million shares in 2023** (ACN_10k_2023, pp. 81‑85) and kept that level in 2024 (ACN_10k_2024, pp. 96‑100). The 14 million‑share expansion reflects a deliberate broadening of the equity pool to support larger or more frequent share‑based awards, underscoring the company’s focus on equity as a key tool for attracting, retaining, and aligning talent with shareholder interests while managing dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 127 million shares in 2022, 141 million shares in 2023 and 2024, and the calculated 14 million share increase. The numeric progression matches the ground truth exactly. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the 2022 baseline, (2) the 2023-2024 levels, (3) the evolution/progression, and (4) strategic implications. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, and the Amended 2010 SIP (Share Incentive Plan). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the progression as a strategic expansion. The reasoning that the increase reflects deliberate broadening of the equity pool for talent attraction, retention, and alignment is sound and consistent with the ground truth's interpretation. SEMANTIC EQUIVALENCE: The LLM's explanation of strategic intent ('equity as a key tool for attracting, retaining, and aligning talent with shareholder interests while managing dilution') conveys the same meaning as the ground truth's 'growing emphasis on equity-based incentives' and 'aligning executive and employee interests with shareholder value creation.' The additional detail about 'managing dilution' adds valuable context without contradicting the ground truth. MINOR OBSERVATION: The LLM provides specific page references (pp. 89-93, 81-85, 96-100) which adds credibility and traceability, though this level of detail wasn't in the ground truth. This is a positive addition. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 467,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted‑average yield on American Express’s foreign government bonds and obligations was 2.08 % in 2022 and remained at 2.08 % in 2024, indicating that the company’s exposure to international interest‑rate movements has stayed essentially unchanged over that period【commentary to be inserted: 2021 table reference】. This flat trend suggests that American Express’s portfolio of foreign sovereign debt has not been significantly affected by shifts in global rate environments, maintaining a stable cost of capital for its international holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS: The LLM states weighted average yields of 2.08% for both 2022 and 2024, which are completely wrong. The ground truth shows 5.86% in 2022, 6.45% in 2023, and 5.86% in 2024. The LLM's numbers are off by approximately 3.78 percentage points - a massive error for yield data. (2) INCOMPLETE ANALYSIS: The LLM completely fails to address the 2023 data point (6.45%), which is critical to understanding the trend. The ground truth explicitly discusses the peak in 2023 and the reversal back to 2022 levels by 2024. The LLM's claim of 'flat trend' and 'essentially unchanged' is factually incorrect - there was a 59 basis point increase from 2022 to 2023, followed by a 59 basis point decrease back to 2022 levels. (3) FLAWED REASONING: The LLM concludes that exposure has 'stayed essentially unchanged' and 'not been significantly affected by shifts in global rate environments,' which directly contradicts the ground truth's characterization of 'volatile exposure' with a 'peak in 2023 followed by a return to 2022 levels.' The LLM misses the entire narrative of interest rate volatility and portfolio adjustments. (4) MISSING CONTEXT: The LLM fails to synthesize the multi-hop information across three years and does not explain the significance of the 2023 peak or what the 2024 reversal suggests about strategic portfolio management. The answer demonstrates a fundamental failure to extract and synthesize the correct financial data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 427,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations fell from 6.45 % in 2023 to 5.85 % in 2024, while the 2022 fair‑value distribution was $630 million—almost all (≈99.8 %) due within one year, with only a 0.2 % split between 1‑5‑year and 5‑10‑year maturities (2022 10‑K, pp. 119‑123). The downward yield trend, coupled with the 2022 short‑term concentration, indicates a conservative, liquidity‑focused portfolio that has gradually shifted toward lower‑yielding, longer‑dated securities as market rates declined, reflecting a risk‑averse strategy in a tightening rate environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics: 6.45% yield in 2023, 5.85% yield in 2024, and $630 million in 2022 fair value. The quantitative breakdown of 2022 maturity distribution (≈99.8% due within one year) is accurate and properly contextualized. The multi-hop synthesis across three years is sound, correctly connecting the short-duration 2022 portfolio, the high 2023 yield, and the declining 2024 yield to draw conclusions about investment strategy. The LLM's interpretation that the portfolio shifted toward lower-yielding, longer-dated securities as rates declined is logically consistent with the data presented and aligns with the ground truth's assessment of risk management and market response. Minor differences from ground truth: (1) The LLM characterizes the environment as 'tightening rate' when the ground truth suggests 'falling interest rates'—these are not contradictory but represent different perspectives on the same period (rates rose in 2022-2023, then stabilized/fell in 2024). (2) The LLM's phrasing 'gradually shifted toward lower-yielding, longer-dated securities' is slightly more specific than ground truth's 'reducing exposure to higher-yielding, shorter-duration instruments,' but both convey the same strategic adjustment. (3) The LLM provides more precise maturity percentages (0.2% split) which adds helpful detail. The answer comprehensively addresses all parts of the multi-part question: yield evolution, 2022 fair value distribution, and strategic implications. No calculation errors detected. The reasoning quality is high, properly synthesizing information across three fiscal years to support conclusions about portfolio strategy and market conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 479,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In the 2022 10‑K, the 7 % Debentures due 2029 were listed together with common stock in the “Securities registered pursuant to Section 12(b)” table (COP_10k_2022.pdf: page 2). The 2023 filing separated the debentures into its own row, making the debt instrument more prominent (COP_10k_2023.pdf: page 2). The 2024 filing returned to the combined presentation (COP_10k_2024.pdf: page 2). This pattern shows that while ConocoPhillips consistently discloses the debentures, it flexibly adjusts the presentation—likely to enhance clarity or comply with evolving SEC guidance—demonstrating a transparent yet adaptable reporting approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth states that in 2024, COP 'maintained this structured disclosure' with the debentures in a separate row (consistent with 2023). However, the LLM claims that '2024 filing returned to the combined presentation,' suggesting a reversal back to the 2022 format. This is a direct contradiction of the ground truth and represents a significant multi-hop reasoning failure. The LLM correctly identifies: (1) the 2022 combined presentation with common stock, (2) the 2023 separation into its own row, and (3) the CUSIP identifier. However, it incorrectly characterizes the 2024 presentation as a return to combined format rather than a continuation of the separated format. The LLM also fails to mention the specific CUSIP number (718507BK1) that the ground truth identifies as being used consistently from 2023 onward. The LLM's interpretation that this represents 'flexible adjustment' and 'adaptable reporting' is inconsistent with the ground truth's characterization of 'consistent and more transparent treatment' and 'growing emphasis on clarity.' The reasoning about SEC guidance compliance is speculative and not supported by the ground truth. The answer demonstrates partial understanding of the disclosure evolution but fundamentally misrepresents the 2024 status, which is a critical error in a multi-year progression analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 403,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00% Notes Due 2031 was $1.25 billion in FY 2022 (NVDA_10k_2022, p. 80), $1.25 billion in FY 2023 (NVDA_10k_2023, p. 67), and $1.25 billion in FY 2024 (NVDA_10k_2024, p. 71). The flat exposure over three years shows a long‑term debt strategy that prioritizes a stable maturity mix and coupon structure, avoiding large swings in long‑term debt while preserving refinancing flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the carrying amount was $1.25 billion in all three years (FY 2022, 2023, 2024), but the ground truth shows: FY 2022: $1.2 billion, FY 2023: $1.057 billion, FY 2024: $1.25 billion. The LLM incorrectly states FY 2022 as $1.25 billion when it should be $1.2 billion, and completely misses the significant decline to $1.057 billion in FY 2023. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year progression. The ground truth shows a meaningful variation pattern (decrease from 2022 to 2023, then increase to 2024), which is economically significant and reveals important information about debt management. The LLM's claim of 'flat exposure over three years' is factually incorrect. (3) REASONING ERROR: The LLM's interpretation that the flat exposure 'shows a long-term debt strategy that prioritizes stable maturity mix' is based on false premises. The actual progression (1.2B → 1.057B → 1.25B) tells a different story about debt management than claimed. (4) ENTITY ACCURACY: While the company (NVIDIA), metric (2.00% Notes Due 2031), and years are correctly identified, the financial values are wrong, which is the core of the question. The LLM provided specific page citations that cannot be verified but the numbers themselves are demonstrably incorrect based on the ground truth data provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 415,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney has kept Marvel as a **top‑level branded tile on Disney+** in each of the three fiscal years, reinforcing its central role in the streaming lineup with no shift to other platforms or bundling (2024 p. 112‑116; 2023 p. 5‑9; 2022 p. 108‑112).  Its trademarks remain classified as **indefinite‑lived intangible assets** at a constant carrying amount of **$1.792 billion** in each year’s balance sheet (2024 p. 112‑116; 2023 p. 5‑9; 2022 p. 108‑112), indicating a stable valuation and unchanged strategic emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Marvel's trademark carrying amount was a 'constant' $1.792 billion across all three years (2022, 2023, 2024). This is a specific factual claim that requires verification against actual 10-K filings. The ground truth does not provide this specific dollar amount, and the claim of 'constant' valuation across three years is highly suspicious and likely incorrect - intangible asset valuations typically change year-to-year. This is a critical error as it presents unverified financial data as fact. (2) COMPLETENESS - The LLM answer does address the streaming branding aspect (Disney+ top-level tile) and indefinite-lived intangible assets classification, which aligns with the ground truth. However, the specific dollar amount claim is problematic. (3) ENTITY ACCURACY - Years and company (Disney/Marvel) are correctly identified. (4) REASONING - The LLM attempts multi-hop synthesis by connecting streaming strategy with balance sheet treatment, which is appropriate. However, the specific financial claim undermines the entire answer's credibility. (5) SEMANTIC EQUIVALENCE - The general framing about Marvel's strategic positioning is reasonable, but the unverified $1.792 billion figure repeated across three years is a factual claim that appears to be fabricated or misattributed. The ground truth mentions Marvel's inclusion in indefinite-lived intangible assets in 2022 and 2024 but does NOT provide specific dollar amounts or confirm the exact same valuation across all years. The LLM's citation format (page numbers) also appears to be invented without verification. This represents a fundamental failure in factual accuracy on a quantitative claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 470,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "American Express has continued to recognize discount revenue at the time of each Card Member transaction, with the portion earned from third‑party merchant acquirers recorded as a network‑rate fee that is individually negotiated and treated as discount revenue. Over the 2022‑2024 period the company has intensified its merchant‑coverage strategy by partnering more heavily with third‑party acquirers, aggregators and processors, targeting new‑to‑plastic industries, B2B acceptance and priority international markets, while investing in network‑platform upgrades to support this expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements but has notable omissions in completeness. STRENGTHS: (1) Correctly identifies discount revenue recognition at transaction time - accurate; (2) Properly describes network rate fees as individually negotiated and recorded as discount revenue - matches ground truth; (3) Accurately captures the 2022-2024 timeframe and evolution toward third-party acquirer partnerships; (4) Correctly identifies expansion strategies including third-party acquirers, aggregators, processors, and international markets; (5) No quantitative errors or incorrect numbers/dates. WEAKNESSES: (1) Missing the 2023 introduction of 'processed revenue' from network partnership agreements, royalties, and fees for facilitating transactions on partner-issued cards - this is a significant omission as it represents a distinct revenue stream evolution; (2) Lacks the specific mention of 'OptBlue program' or 'GNS partners' as examples of third-party acquirer arrangements; (3) Does not explicitly distinguish between the 2022 baseline (discount revenue primarily from merchant discounts) and subsequent evolution; (4) Omits the strategic emphasis on 'enhancing value propositions for merchants and acquirers' and 'scaling marketing efforts' mentioned in ground truth. The answer is semantically sound and captures the main narrative arc of evolution toward deeper third-party collaboration, but incompletely addresses the multi-part question regarding revenue structure evolution, particularly the processed revenue component introduced in 2023. The reasoning is logical and the synthesis across the 2022-2024 period is sound, but the answer would benefit from more comprehensive coverage of all revenue recognition mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 481,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s 2022 risk‑factor disclosures framed drug‑delivery devices as a source of regulatory, manufacturing and safety risk that could jeopardise clinical‑trial conduct and product availability.  By 2023 the company added product‑specific post‑marketing requirements—confirmatory studies, pediatric studies and observational safety studies—and stressed that device‑related safety reviews could trigger regulatory actions or labeling changes.  In 2024 the disclosures further emphasized ongoing monitoring of device safety, the role of REMS and post‑marketing commitments, and the potential for device‑related safety reviews to affect product availability, reflecting a heightened focus on regulatory oversight throughout the product lifecycle.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and captures the evolution of Amgen's regulatory risk disclosures across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the three-year progression and key themes: 2022 (general regulatory/manufacturing risks), 2023 (product-specific post-marketing requirements), 2024 (ongoing monitoring and lifecycle focus). (2) Accurately references specific elements like confirmatory studies, pediatric studies, observational safety studies, REMS, and pharmacovigilance. (3) Properly synthesizes the multi-hop information showing evolution from general dependencies to specific compliance challenges. (4) Correctly identifies LUMAKRAS context implicitly through discussion of post-marketing commitments and regulatory actions. (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the Complete Response Letter from FDA for LUMAKRAS that appears in the ground truth, though it does reference post-marketing studies and regulatory actions. (2) The phrase 'marketing authorization withdrawal' from the ground truth is not explicitly stated in the LLM answer, though 'affect product availability' conveys similar meaning. (3) The LLM answer uses 'jeopardise' (British spelling) and slightly different phrasing than ground truth, but semantic meaning is preserved. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple regulatory concepts (clinical trials, post-marketing requirements, device safety reviews) as required by the question. The progression narrative is logically sound and accurately reflects the evolution described in the ground truth. SEMANTIC EQUIVALENCE: The LLM's framing of the trend as 'heightened focus on regulatory oversight throughout the product lifecycle' effectively captures the same transformation described in the ground truth about shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 542,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips’ HSE audit program has consistently focused on auditing business units and staff groups, with improvement actions identified and tracked to completion and progress reported to the Executive Leadership Team and Board of Directors. The 2024 10‑K adds the phrase “Corporate HSE audits” and reiterates annual objectives, targets and deadlines, but the core scope, tracking mechanism and governance reporting structure remain essentially unchanged from 2023. The 2022 10‑K text is not included in the supplied pages, so a direct comparison to 2022 cannot be made.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer has significant limitations that prevent it from fully addressing the question. STRENGTHS: (1) Correctly identifies that the core scope (auditing business units and staff groups), tracking mechanisms (improvement actions tracked to completion), and governance structure (ELT and Board reporting) remained consistent across years. (2) Accurately notes the introduction of 'Corporate HSE audits' terminology in 2024. (3) Appropriately acknowledges data limitations regarding 2022 comparisons. CRITICAL WEAKNESSES: (1) The LLM explicitly states '2022 10-K text is not included in the supplied pages,' which contradicts the ground truth that clearly describes 2022 HSE audit program details. This represents a failure to synthesize available information. (2) The answer completely misses the evolution narrative that is central to the question - the ground truth describes a strategic progression from 'localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024).' (3) Missing key contextual details from 2023: the expansion to include Life Saving Rules, Process Safety Fundamentals, and stop work policy as tools to reduce incident likelihood. (4) The answer characterizes the evolution as 'essentially unchanged from 2023,' which contradicts the ground truth's emphasis on meaningful evolution across all three years. (5) Fails to capture the 'broader human capital management framework' context introduced in 2023. MULTI-HOP REASONING: The question requires synthesizing HSE audit program information across three years (2022-2024) with three specific dimensions (scope definition, improvement tracking, governance). The LLM only partially addresses this by acknowledging consistency but failing to articulate the documented evolution. The claim that 2022 data is unavailable appears to be a data access issue rather than a factual error, but it prevents proper multi-hop synthesis. SEMANTIC ACCURACY: While the LLM correctly identifies some elements (ELT/Board reporting, improvement tracking), it fundamentally mischaracterizes the nature of the evolution by suggesting stasis rather than the documented progression toward greater institutionalization and standardization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 599,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s 2022 filing noted that cloud, AI and other digital technologies could replace legacy services and that new pricing or commercial models might be needed to capture the value of these innovations. By 2023 the company emphasized the need to develop and introduce such pricing frameworks to mitigate client spending delays and revenue shortfalls, and in 2024 it further warned that failure to adopt new pricing models could materially affect results of operations. Across all three years the risk‑factor sections consistently cite client spending delays while evaluating new tech, the need to align pricing with evolving value, and broader operational, legal, regulatory, ethical and reputational risks tied to AI and cloud adoption.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Accenture's pricing model evolution across 2022-2024 and correctly identifies the core risks. Strengths: (1) Accurately captures the progression from general acknowledgment (2022) to more strategic/investment-driven approach (2024); (2) Correctly identifies the consistent risk theme of client spending delays during technology evaluation; (3) Properly synthesizes multi-hop information across three years; (4) No quantitative errors or incorrect dates/entities. Weaknesses: (1) The answer is somewhat less detailed than the ground truth in articulating the specific evolution - it mentions the progression but doesn't emphasize as clearly the shift from 'general acknowledgment' to 'strategic investments' to 'dependence on successful deployment'; (2) The phrase 'failure to adopt new pricing models could materially affect results of operations' appears to conflate 2023 and 2024 messaging - the ground truth indicates this was emphasized in 2022 as a warning, then evolved through 2023-2024; (3) Missing some nuance about how the company's focus shifted from cloud/as-a-service (2022) to AI and robotics (2023) to AI-based services (2024); (4) The mention of 'operational, legal, regulatory, ethical and reputational risks' is broader than what the ground truth emphasizes, which focuses more narrowly on revenue/competitive risks. The answer is fundamentally correct and addresses the question adequately, but lacks the precision and depth of the ground truth in describing the specific evolution of the company's strategic approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 436,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s carrying amount of the AerCap senior note rose steadily: it was $900 million at 12/31/2022 (GE 10‑K 2022, p. 90‑94), climbed to $944 million at 12/31/2023 (GE 10‑K 2023, p. 72‑76), and further increased to $982 million at 12/31/2024 (GE 10‑K 2024, p. 68‑72). This incremental growth shows that GE has been maintaining, and slightly expanding, its exposure to AerCap’s debt—consistent with a strategy of holding high‑quality, investment‑grade securities to earn interest income rather than divesting the position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual points. (1) QUANTITATIVE ERRORS - The LLM reports completely different numbers than the ground truth: LLM claims $900M (12/31/2022), $944M (12/31/2023), and $982M (12/31/2024), while ground truth shows $993M (end of 2021, reported in 2022 disclosure) and $944M (end of 2023, reported in 2024 disclosure). The LLM's 2022 figure of $900M contradicts the ground truth's $993M baseline. The LLM's 2024 figure of $982M has no corresponding ground truth value provided. (2) DIRECTIONAL CONTRADICTION - The LLM claims holdings 'rose steadily' and 'further increased,' suggesting an expansion strategy. The ground truth explicitly states a 'consistent decline' from $993M to $944M, representing a strategic reduction. These are opposite conclusions. (3) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the temporal progression across the 2022-2024 period. The ground truth clearly shows a downward trend ($993M → $944M), while the LLM reports an upward trend ($900M → $944M → $982M). (4) STRATEGIC INTERPRETATION ERROR - The LLM concludes GE is 'maintaining and slightly expanding' exposure, which contradicts the ground truth's assessment of 'strategic reduction in AerCap exposure.' (5) MISSING/INCORRECT BASELINE - The ground truth references the 2021 year-end position ($993M reported in 2022 disclosure) as the starting point, but the LLM begins with $900M in 2022, which is a significant discrepancy. The LLM answer demonstrates fundamental misreading or misrepresentation of the source data, resulting in an entirely incorrect narrative about GE's AerCap investment strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 453,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen moved Bemarituzumab into a Phase 3 program in 2022 for GEJ adenocarcinoma, and the 2023 filing confirmed the drug remained in Phase 3 with no further phase changes reported. The 2024 filing continued to list Bemarituzumab as a Phase 3 program, again with no new phase activity noted. Across all three filings, the composition‑of‑matter patents for Bemarituzumab in the U.S. and Europe are both estimated to expire in 2029, a timeline that has not shifted (2022 p. 23‑27; 2023 p. 24‑28; 2024 p. 24‑28).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer is highly accurate on quantitative details - correctly identifies Phase 3 status across all three years (2022-2024), accurately states the 2029 patent expiration date for both U.S. and European patents, and provides specific page references (p. 23-27 for 2022, p. 24-28 for 2023-2024). The numeric data is verifiable and correct. WEAKNESSES: The LLM answer significantly underrepresents the evolution and progression described in the ground truth. The ground truth emphasizes a meaningful shift from 'clinical development focus to broader therapeutic positioning and IP strategy,' noting that by 2024 Amgen 'provided a more detailed description of the drug's mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC.' The LLM answer dismisses this as 'no new phase activity noted' and fails to capture the expansion of investigational scope and therapeutic positioning evolution. The LLM's statement that the timeline 'has not shifted' is technically correct but misses the qualitative evolution in how the drug was positioned and described across the three-year period. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but does so in a way that emphasizes stasis rather than evolution. It answers the 'patent expiration timelines' part of the question well but substantially underaddresses the 'clinical phase progression' and 'intellectual property positioning' evolution aspects. The answer is factually sound but semantically incomplete in capturing the intended scope of how Amgen's positioning 'evolved.' CALCULATION/VERIFICATION: All numbers are correct (2022, 2023, 2024 years; Phase 3 status; 2029 expiration; page numbers). No calculation errors. The quantitative accuracy is high, but the qualitative interpretation of what constitutes meaningful evolution is limited.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 520,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "American Express’s 2022‑24 10‑K filings show a clear shift from a purely card‑issuer to a broader payments ecosystem: the 2022 and 2023 reports (pp. 10‑14) highlight “intense competition” from alternative payment platforms and a need to “invest in technology across all areas” (AI, tokenization, real‑time settlement, open‑banking) to keep its premium brand and merchant network competitive.  The 2024 filing (pp. 29‑33) expands this narrative, noting that fintech rivals now offer closed‑loop rewards, digital wallets and buy‑now‑pay‑later models, and that AmEx is pursuing strategic partnerships and deeper tech investment to protect its merchant discount rates and card‑member experience.  Together, these documents reveal a long‑term strategy of continual tech investment and partnership‑building to counter fintech disruption while preserving its core value proposition.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's strategic evolution from 2022-2024 and correctly identifies the core narrative of shifting from defensive positioning to proactive investment. Strengths: (1) Correctly identifies the three-year timeframe and the progression of American Express's strategic positioning; (2) Accurately names specific technologies (tokenization, real-time settlement, open banking, digital wallets, buy-now-pay-later) that align with ground truth; (3) Properly synthesizes the multi-hop concept that AmEx moved from viewing alternatives as threats to viewing them as necessary investments; (4) Correctly identifies key competitive pressures (fintech rivals, closed-loop rewards, merchant discount rates). Weaknesses: (1) The LLM provides specific page numbers (pp. 10-14, pp. 29-33) that cannot be verified against the ground truth and may be fabricated; (2) While the LLM captures the strategic shift, it doesn't explicitly articulate the 2023 expansion to include 'payment facilitators' and 'open banking platforms' as a distinct intermediate step in the evolution, instead treating these as part of the broader narrative; (3) The phrase 'dependency posture' from the ground truth—which captures the nuanced shift from threat-acknowledgment to necessity-based integration—is not explicitly captured, though the concept is implied through 'pursuing strategic partnerships and deeper tech investment'; (4) Minor semantic difference: ground truth emphasizes 'necessity of investing in and integrating' while LLM emphasizes 'pursuing partnerships and tech investment,' which are related but not identical strategic approaches. The answer is substantially correct in its core thesis and multi-hop reasoning, with no significant factual errors in the technologies or competitive dynamics mentioned. The page number citations are a concern for reliability but don't affect the factual accuracy of the substantive claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 530,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs climbed from **$91.58 million in 2022 to $112.50 million in 2023** (2024 10‑K, p. 123‑127; 2023 10‑K, p. 121‑125) and then eased slightly to **$110.39 million in 2024** (2024 10‑K, p. 123‑127). This pattern shows the company increased the value of its long‑term incentive awards in 2023—likely reflecting higher stock prices or more ambitious performance targets—and then moderated the award value in 2024, indicating a market‑responsive, cost‑controlled approach to long‑term incentive compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) UNIT MISIDENTIFICATION: The LLM states values in 'millions' ($91.58 million, $112.50 million, $110.39 million), but the ground truth clearly indicates these are per-unit grant date fair values in dollars ($91.58, $112.50), not millions. This is a fundamental error that misrepresents the magnitude of the compensation by a factor of 1,000,000. (2) INCORRECT 2024 VALUE: The LLM provides $110.39 million for 2024, but the ground truth states the 2024 value is $112.50. The LLM appears to have fabricated an intermediate 2024 value that contradicts the original answer. (3) INCOMPLETE TREND ANALYSIS: The ground truth indicates a consistent upward trend from 2022 ($91.58) to 2024 ($112.50), but the LLM incorrectly characterizes 2024 as showing a 'slight ease' to $110.39, which is both factually wrong and contradicts the actual trend. (4) MULTI-HOP SYNTHESIS FAILURE: While the LLM attempts to provide context about market responsiveness and cost control, this interpretation is undermined by the factual errors in the underlying numbers. The reasoning about strategic shifts is reasonable in structure but built on incorrect data. (5) POSITIVE ELEMENTS: The LLM correctly identifies ConocoPhillips, correctly references cash-settled PSUs, and attempts to address the strategic implications question. However, these strengths are overwhelmed by the quantitative errors. The correct answer should show: 2022: $91.58 → 2024: $112.50 (consistent upward trend), not the three-value progression with incorrect units and wrong 2024 figure provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 432,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s risk disclosures show a steady deepening of exposure to abusive behaviors as its credit‑product portfolio grew and new third‑party fraud schemes (synthetic identities, stolen instruments, etc.) emerged. In 2022 the company warned that failure to manage fraud could raise loss rates (PYPL_10k_2022.pdf: pages [24‑28]); by 2023 the risk factor was expanded to detail credit‑product default risk and the complexity of detecting third‑party abuse (PYPL_10k_2023.pdf: pages [23‑27]); and in 2024 the language reiterated the evolving nature of fraud and the need for continuous improvement (PYPL_10k_2024.pdf: pages [21‑25]). This consistent escalation suggests that while PayPal’s risk management acknowledges the threat, it remains largely reactive and has yet to fully contain the increasing risk of abusive behaviors.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the multi-year progression (2022-2024) of PayPal's fraud and abuse risk disclosures, accurately captures the evolution from general fraud concerns to credit-product-specific risks, and appropriately synthesizes the trend across multiple 10-K filings. The reasoning about reactive vs. proactive risk management is sound and relevant. The answer correctly identifies key fraud types (synthetic identities, stolen instruments) and acknowledges the credit product expansion. WEAKNESSES: (1) MISSING CRITICAL QUANTITATIVE DATA: The ground truth specifically mentions a €40 billion multi-year agreement to sell U.K./European BNPL loan receivables in 2023 - this is a concrete, material fact that the LLM answer completely omits. This is a significant oversight for a financial question. (2) INCOMPLETE REGULATORY CONTEXT: The ground truth mentions the 'valid-when-made doctrine' as a specific regulatory uncertainty impacting U.S. credit products in 2024 - the LLM answer references 'regulatory uncertainties' generically but doesn't identify this specific doctrine. (3) PAGE REFERENCES: While the LLM provides document citations with page ranges, these cannot be verified and appear to be illustrative rather than precise. (4) STRATEGIC MITIGATION DETAIL: The ground truth emphasizes PayPal's 'strategic move to mitigate credit and fraud-related losses' through the receivables sale agreement - the LLM mentions 'third-party risk mitigation strategies' more generally but misses this specific strategic action. CALCULATION/NUMERIC VERIFICATION: No calculations are present in either answer, but the €40 billion figure is a material omission. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects credit product growth to fraud risk evolution, but fails to integrate the specific strategic response (receivables sale) into the narrative. SEMANTIC EQUIVALENCE: The LLM's characterization of PayPal's approach as 'reactive' vs. the ground truth's emphasis on 'increasingly relying on third-party risk mitigation strategies' represents a slightly different framing - the LLM is more critical while the ground truth is more neutral/descriptive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 595,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "Cyramza’s therapeutic positioning remained essentially unchanged from 2022 through 2024, continuing to be marketed as a second‑line agent for gastric, colorectal and non‑small‑cell lung cancers, a first‑line option for EGFR‑mutated NSCLC, and a second‑line monotherapy for hepatocellular carcinoma【LLY_10k_2022.pdf:4‑7】【LLY_10k_2024.pdf:4‑7】.  Its intellectual‑property portfolio also stayed stable, with compound patents expiring 2026 in the U.S. and Japan and 2028 in major European markets, biologics data protection ending 2026 (U.S.) and data exclusivity ending 2024 (Europe) and 2023 (Japan)【LLY_10k_2022.pdf:7】【LLY_10k_2024.pdf:7】.  This consistency signals Lilly’s long‑term oncology strategy of maintaining a broad, multi‑indication targeted‑therapy portfolio while preserving market exclusivity through robust patents and data protection, thereby sustaining revenue streams and enabling continued investment in oncology innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides substantial detail about Cyramza's therapeutic positioning and IP protection, but contains significant discrepancies with the ground truth that affect overall accuracy:\n\nQUANTITATIVE ACCURACY ISSUES:\n1. Patent expiration dates: LLM states compound patents expire 2028 in major European markets, but ground truth only mentions 2026 for U.S. and Japan with no European date specified. This is a factual error.\n2. Data protection timeline: LLM provides more granular detail (biologics data protection ending 2026 U.S., data exclusivity 2024 Europe, 2023 Japan) compared to ground truth which only mentions 2023 Japan expiry. The additional European 2024 date cannot be verified against ground truth.\n3. The ground truth mentions data protection \"expiring as early as 2023 in Japan\" while LLM states \"2023 (Japan)\" - this is consistent but LLM adds unverified European dates.\n\nCOMPLETENESS ISSUES:\n1. Therapeutic indications: LLM adds \"first-line option for EGFR-mutated NSCLC\" which is not mentioned in ground truth. Ground truth lists gastric, lung, colorectal, and liver cancers without specifying EGFR-mutation status or line of therapy details.\n2. Ground truth emphasizes the strategic implication about \"preparing next-generation oncology products to succeed it, given the impending patent expiry\" - LLM's interpretation focuses on \"maintaining a broad, multi-indication targeted-therapy portfolio\" which is less specific about succession planning.\n\nMULTI-HOP REASONING:\n1. LLM correctly synthesizes that positioning remained stable 2022-2024\n2. LLM correctly identifies IP portfolio details across years\n3. However, LLM's strategic conclusion differs from ground truth: LLM emphasizes portfolio breadth and market exclusivity maintenance, while ground truth emphasizes preparation for product succession\n\nSEMANTIC EQUIVALENCE:\n1. \"Essentially unchanged\" vs ground truth's \"reaffirmed\" - semantically similar\n2. LLM's interpretation of strategy (maintaining broad portfolio) is reasonable but diverges from ground truth's emphasis on succession planning\n\nKEY ERRORS:\n- Unverified European patent expiration date (2028)\n- Unverified European data exclusivity date (2024)\n- Overly specific therapeutic positioning details (EGFR-mutated NSCLC, line of therapy) not in ground truth\n- Strategic interpretation differs from ground truth's succession planning emphasis\n\nThe answer demonstrates good structure and reasoning but introduces unverified data points and misses the key strategic insight about product succession planning that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 695,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Philip Morris kept the 3.875 % Notes due 2042 (PM42A) as a core long‑term debt anchor in every filing (2022, 2023 and 2024).  At the same time the company actively issued, retired and maturing a range of other notes—e.g., 2.375 % and 2.500 % Notes due 2022 in 2022, 3.250 % Notes due 2024 and 3.375 % Notes due 2025 in 2023, and 2.750 % and 3.125 % Notes due 2026‑2028 in 2024—adjusting coupons and maturities to manage cost and liquidity.  This pattern shows a strategy of maintaining a stable long‑term debt core while periodically refinancing or adding new debt to optimize the overall capital‑structure profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer introduces specific debt instruments (2.375%, 2.500% Notes due 2022; 3.250% Notes due 2024; 3.375% Notes due 2025; 2.750%, 3.125% Notes due 2026-2028) that are NOT mentioned in the ground truth answer. The ground truth specifically identifies 4.125% Notes due 2043 and 4.875% Notes due 2043 as present in 2022, and 4.250% Notes due 2044 in 2023—NONE of which appear in the LLM answer. This represents a fundamental failure in multi-hop synthesis across the three years. CORRECT ELEMENTS: The LLM correctly identifies the 3.875% Notes due 2042 as a consistent anchor across all three years (2022, 2023, 2024), which matches the ground truth. The overall strategic narrative about maintaining a stable long-term debt core while managing other instruments is conceptually aligned with the ground truth. CRITICAL ISSUES: (1) The LLM fabricates specific debt instruments not supported by the ground truth, suggesting hallucination or incorrect source data; (2) The LLM completely omits the 4.125% Notes due 2043 and 4.875% Notes due 2043 that were explicitly mentioned as present in 2022; (3) The LLM omits the 4.250% Notes due 2044 from 2023; (4) The specific coupon rates and maturity dates provided by the LLM cannot be verified against the ground truth and appear to be incorrect. The answer demonstrates poor quantitative accuracy due to invented numbers and missing key debt instruments. While the qualitative reasoning about capital structure strategy is reasonable, it is built on factually incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 425,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 filing warned that its expanding credit‑product portfolio and growing reliance on third‑party lenders and processors heightened its exposure to abusive behaviors, including fraud and default risk (see pages 24‑28 of the 2022 10‑K).  In 2023 the company mitigated this risk by selling up to €40 billion of U.K. and European buy‑now‑pay‑later loan receivables and by deploying advanced machine‑learning fraud‑detection tools (pages 23‑27 of the 2023 10‑K).  In 2024 PayPal further reduced exposure by diversifying and migrating its U.S. payment‑processor relationships and tightening third‑party due‑diligence and fraud‑prevention controls (pages 21‑25 of the 2024 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) All key numeric values are correct: €40 billion BNPL receivables sale is accurately cited; (2) Timeline progression is accurate: 2022 identification of risks, 2023 asset sales and fraud detection tools, 2024 continued mitigation efforts; (3) Multi-hop reasoning is sound - the answer correctly connects PayPal's evolving risk exposure across years and links specific actions to risk mitigation; (4) Entity identification is correct (PayPal, U.K./European markets, third-party relationships); (5) The answer appropriately addresses all parts of the multi-part question: evolution of exposure, credit products, third-party risk management, and specific 2023-2024 actions. MINOR WEAKNESSES: (1) The LLM answer adds specific details about 'machine-learning fraud-detection tools' and 'diversifying U.S. payment-processor relationships' that are not explicitly mentioned in the ground truth answer, though these appear to be reasonable inferences from 10-K filings and don't contradict the ground truth; (2) Page citations (pages 24-28, 23-27, 21-25) are provided by the LLM but cannot be verified against the ground truth, which doesn't include page numbers - however, this addition demonstrates thoroughness rather than error; (3) The ground truth emphasizes a 'shift from identifying...to actively mitigating...to enhancing,' while the LLM focuses more on specific actions, which is a slight difference in framing but not factually incorrect. The answer successfully captures the core narrative of PayPal's risk management evolution and provides accurate supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 471,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 10‑K risk disclosures consistently flag loss or modification of tax and tariff exemptions as a risk to its global operations. In the 2022 filing (p. 35‑39) the risk is noted in general terms tied to changes in tax laws and trade measures. By 2023 (p. 39‑43) the disclosure adds reference to sanctions and export‑control revisions, and in 2024 (p. 38‑42) it further expands to include broader geopolitical conflicts (e.g., Ukraine‑Russia, Israel‑Hamas) and sanctions, underscoring a growing regulatory uncertainty.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of AMD's evolving risk disclosure regarding tax and tariff exemptions from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with appropriate temporal framing; (2) Accurately captures the escalation pattern - from general terms in 2022, to sanctions/export-control additions in 2023, to geopolitical conflicts in 2024; (3) Provides specific examples of geopolitical conflicts (Ukraine-Russia, Israel-Hamas) that align with the ground truth's reference to 'ongoing geopolitical conflicts'; (4) Correctly identifies the core risk category (loss/modification of tax and tariff exemptions) and its connection to regulatory uncertainty; (5) Page references (2022: p. 35-39, 2023: p. 39-43, 2024: p. 38-42) appear reasonable for 10-K filings though cannot be independently verified; (6) The synthesis across three years demonstrates proper multi-hop reasoning. MINOR WEAKNESSES: (1) The LLM answer is slightly more specific/detailed about disclosure mechanics (sanctions, export-control revisions) compared to the ground truth, which is more interpretive about the company's 'sensitivity' and 'awareness' - this is not incorrect but represents a different emphasis; (2) The ground truth emphasizes the 'material impact' on 'financial and operational stability' more explicitly, while the LLM focuses on the disclosure evolution itself; (3) The LLM doesn't explicitly state the interpretive conclusion about what the trend 'suggests' about regulatory uncertainty as directly as the ground truth does, though it does convey this through the phrase 'underscoring a growing regulatory uncertainty.' QUANTITATIVE ACCURACY: No specific financial figures, percentages, or calculations are required for this question, so this dimension is less critical. The dates (2022, 2023, 2024) are correct. QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly synthesizes information across three years and identifies the escalation pattern. The multi-hop synthesis (connecting risk evolution to regulatory uncertainty) is present though somewhat implicit. CONTEXTUAL RELEVANCE: The answer directly addresses the question about how exposure evolved and what it suggests about regulatory uncertainty, though with slightly less interpretive depth than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 635,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and a **$91 million gain in FY 2024** (all figures in millions).  The move from a loss to progressively larger gains shows that Cisco has intensified and improved its use of these derivatives to hedge deferred‑compensation exposure, indicating an active strategy to manage compensation‑related volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - FY 2022 loss of $92 million, FY 2023 gain of $58 million, and FY 2024 gain of $91 million. The progression is accurately captured with proper directional indicators (loss vs. gains). (2) ENTITY AND TEMPORAL ACCURACY: Cisco is correctly identified, and all three fiscal years (2022, 2023, 2024) are properly referenced. The metric (total return swaps tied to deferred compensation) is correctly identified. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the three-year trend data and correctly identifies the reversal pattern from loss to gains. (4) REASONING QUALITY: The LLM provides sound interpretation of the trend, noting the shift from loss to progressively larger gains and characterizing this as indicating an active hedging strategy. The interpretation that this reflects 'improved market conditions or strategic shift' aligns with the ground truth's assessment. The LLM's additional characterization of 'intensified and improved use of these derivatives' is a reasonable inference from the data progression. (5) MINOR DISTINCTION: The ground truth uses slightly more cautious language ('potentially reflecting') while the LLM is more assertive ('indicating an active strategy'), but both convey the same essential insight about strategic management. The LLM's interpretation is reasonable and well-supported by the numerical progression. No calculation errors, no missing data points, and the semantic meaning is fully preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 437,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "Disney’s DTC strategy evolved from 2022’s launch of an ad‑supported Disney+ with new pricing and cost realignment (DIS_10k_2022, pp. 25‑29) to 2023’s broader strategic investments aimed at boosting subscription and ad‑revenue growth (DIS_10k_2023, pp. 51‑55), and in 2024 the company reorganized its Media & Entertainment Distribution unit to accelerate DTC expansion while confronting intensified competition, pricing pressure, and heightened financial risk from debt and rating volatility (DIS_10k_2024, pp. 21‑25). This progression underscores that scaling streaming services requires substantial content spend and debt‑backed financing, exposing Disney to competitive and market pressures that can erode profitability and liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with appropriate fiscal year references; (2) Accurately captures the strategic shift from 2022's cost management and pricing adjustments to 2023's broader investment focus to 2024's reorganization and competitive pressures; (3) Properly synthesizes multi-hop information showing evolution of Disney's DTC positioning across years; (4) Correctly identifies key themes: rising costs, pricing constraints, competitive pressures, and financial risks; (5) Appropriately references specific document sections (though page numbers cannot be verified against ground truth); (6) Semantic equivalence is strong - 'doubling down on investment' (ground truth) aligns with 'accelerate DTC expansion' (LLM answer). MINOR CONSIDERATIONS: (1) The LLM answer adds specific details about 'debt and rating volatility' and 'debt-backed financing' that are not explicitly mentioned in the ground truth summary, though these are reasonable inferences about financial risks in streaming; (2) The mention of 'ad-supported Disney+' launch in 2022 is accurate but represents slightly more specific detail than the ground truth provides; (3) No quantitative metrics (subscriber numbers, loss amounts, revenue figures) are provided in either answer, so this cannot be evaluated as a deficiency. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects strategic decisions to financial outcomes and market pressures, demonstrating sound multi-hop reasoning. The progression narrative is logical and well-structured. ENTITY ACCURACY: Disney correctly identified, fiscal years 2022-2024 correctly referenced, DTC offerings correctly identified as the focus. No factual errors detected in the core narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 513,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s exposure to margin risk stayed essentially the same over 2022‑2024.  In each year’s note the company reiterates that it has full discretion in setting transaction fees independent of the costs it incurs from payment processors, and that it therefore bears full margin risk on every completed transaction.  Transaction expenses paid to processors are consistently recorded as transaction expense, and while the dollar amount of those expenses has risen in line with higher TPV, the nature of the margin‑risk exposure and its accounting treatment have not materially changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core finding that PayPal's margin risk exposure remained stable across 2022-2024, with consistent discretion in fee-setting independent of processor costs, and consistent accounting treatment of processor fees as transaction expenses. The answer correctly identifies that no material structural changes occurred despite the 2024 adoption of ASU 2023-07 segment reporting standards. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required by the question, and the LLM appropriately notes that while absolute dollar amounts of transaction expenses rose with TPV, this represents a quantitative change in scale rather than a qualitative change in margin risk exposure or accounting treatment. This is factually correct and appropriately contextualized. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The LLM correctly synthesizes information across three years, identifying the consistent pattern of: (a) full margin risk borne by PayPal, (b) independent fee-setting discretion, (c) processor fees recorded as transaction expense, and (d) no material changes in structure or accounting. The reasoning properly connects fee discretion to margin risk exposure and explains why rising transaction expenses don't represent a change in margin risk positioning. (4) ENTITY ACCURACY: PayPal is correctly identified, the three-year period (2022-2024) is correct, and the relevant financial concepts (margin risk, transaction fees, processor costs, transaction expense) are all accurately applied. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, using slightly more concise language while maintaining all essential points. The phrase 'stayed essentially the same' is semantically equivalent to 'remained stable.' Minor differences in wording (e.g., 'reiterates' vs. 'explicitly stated/remained consistent') do not affect factual accuracy. The only very minor gap is that the LLM does not explicitly mention the ASU 2023-07 adoption by name, though it implicitly acknowledges no structural changes occurred despite regulatory/reporting changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 607,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s Aerospace risk‑factor language on new‑aircraft order cancellations stayed the same in each filing – the 2022 10‑K (page 29), the 2023 10‑K (page 30) and the 2024 10‑K (page 28) all warn that downturns in air‑travel demand could delay or cancel new orders. The unchanged wording signals that cancellation risk remains material, yet the Aerospace segment’s net sales and profit grew in 2024 versus 2023 (up 3 % and 2 % respectively, page 32), indicating a gradual recovery and increasing stability in the commercial aviation sector.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims the risk-factor language 'stayed the same in each filing' across 2022-2024, directly contradicting the ground truth which explicitly states the language 'expanded' from pandemic-specific concerns in 2022 to broader macroeconomic/geopolitical risks in 2023 to competitive/market structure concerns in 2024. This is a fundamental mischaracterization of the progression. (2) INCOMPLETE ANALYSIS - The LLM provides only a surface-level observation about unchanged wording without capturing the substantive evolution in risk characterization that the ground truth documents. (3) QUANTITATIVE ISSUES - While the LLM cites growth percentages (3% and 2% for net sales and profit), these numbers cannot be verified against the ground truth provided, and the LLM doesn't explain how these metrics relate to the risk evolution question. (4) MISSING MULTI-HOP SYNTHESIS - The ground truth synthesizes three years of risk language evolution showing a shift from pandemic-specific to geopolitical to competitive concerns. The LLM reduces this to 'unchanged wording' and then pivots to financial performance metrics without connecting them to the risk evolution narrative. (5) LOGICAL DISCONNECT - The LLM's conclusion that 'unchanged wording signals material risk' contradicts its own claim that wording was unchanged, creating internal inconsistency. The ground truth's approach of tracking how the *nature* of risks evolved (not just their presence) is more analytically sound. The LLM answer fundamentally fails to address how the risk evolved as a concern, which is the core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 472,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 through 2024 PMI’s risk‑factor disclosures show a clear tightening of regulatory constraints that erode its competitive edge.  In 2022 the company warned that “product regulation that diminishes the ability to differentiate tobacco products, restricts adult consumer access to truthful and non‑misleading information about our RRPs, or disproportionately impacts the commercialization of our products in relation to our competitors” (p. 13‑17).  By 2023 the same language was expanded to include specific challenges to RRPs and SFPs—product classification, advertising restrictions, corporate communications and scientific substantiation—highlighting growing scrutiny of its reduced‑risk portfolio (p. 18‑22).  In 2024 the risk factors further intensify the narrative, noting stricter labeling, packaging, marketing and communication rules that limit product differentiation and adult consumer access to information about SFPs, underscoring an escalating regulatory environment that increasingly hampers PMI’s ability to convert smokers and differentiate its offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of regulatory constraints on PMI's competitive positioning; (2) Accurately captures the shift from RRPs to SFPs as the primary product focus; (3) Properly synthesizes the multi-hop information showing how regulatory language evolved across years; (4) Correctly identifies key regulatory concerns: product differentiation, adult consumer access to information, commercialization impacts, and competitive asymmetries; (5) Appropriately notes the intensifying nature of regulatory pressure; (6) Uses accurate page references (p. 13-17, 18-22) that suggest proper source documentation. MINOR WEAKNESSES: (1) The LLM answer includes specific page citations that cannot be verified against the ground truth, which is appropriate for a detailed answer but introduces slight uncertainty about exact sourcing; (2) The phrase 'convert smokers' in the final clause is not explicitly mentioned in the ground truth, though it's a reasonable inference about PMI's business objectives; (3) The ground truth specifically mentions 'digital media in spreading misleading information about RRPs' in 2023, which the LLM answer does not explicitly capture, though it does reference 'corporate communications and scientific substantiation' which partially overlaps; (4) The ground truth emphasizes 'unfair competition and regulatory asymmetries' more explicitly than the LLM answer does. QUANTITATIVE ACCURACY: No numerical calculations or specific financial metrics are required for this question, so this dimension focuses on date accuracy (2022, 2023, 2024 all correct) and proper temporal sequencing (correctly maintained). QUALITATIVE ACCURACY: The multi-hop reasoning is sound—the answer correctly synthesizes information across three years and two product categories (RRPs and SFPs), showing how regulatory constraints evolved. The entity identification is accurate (PMI, RRPs, SFPs all correctly identified). CONTEXTUAL RELEVANCE: The answer directly addresses the question's core inquiry about regulatory evolution and its impact on competitive positioning, though it could have emphasized the 'intensifying' nature more explicitly as a through-line.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 614,
        "total_tokens": 2225
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  In each year’s 10‑K (2022 p. 78‑82, 2023 p. 75‑79, 2024 p. 73‑77) the company reiterates that it is the principal on all payment‑transaction services, that it sets a volume‑tiered pricing model with fixed and variable (percentage‑of‑payment) fees, and that it bears full margin risk regardless of the costs of payment processors or other financial institutions.  Incentives to merchants and consumers—discounts, rebates, rewards, and coupons—continue to be treated as revenue reductions, and the use of third‑party processors remains a transaction‑expense component but does not materially alter PayPal’s margin‑risk profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that PayPal bears full margin risk across all three years (2022-2024), accurately notes the volume-tiered pricing model with fixed and variable fees, and correctly characterizes incentives as revenue reductions. The page number citations (2022 p. 78-82, 2023 p. 75-79, 2024 p. 73-77) appear reasonable for 10-K filings. The answer correctly identifies that payment processor costs are transaction expenses. WEAKNESSES: (1) The LLM answer characterizes the evolution as 'essentially unchanged' and 'does not materially alter,' which contradicts the ground truth's emphasis on 'increasing detail' and 'more nuanced disclosure' of margin risk management. The ground truth explicitly states that 2023 'added details about incentives' and 2024 'highlighted the independence of the fee charged to customers from the costs incurred,' suggesting meaningful evolution in disclosure rather than stasis. (2) The LLM answer fails to capture the ground truth's key insight about how the 'increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.' This represents a significant omission in addressing the 'evolution' aspect of the question. (3) The LLM answer does not adequately distinguish between the three years' disclosures—it treats them as essentially identical rather than showing progression in how PayPal disclosed its margin risk management. (4) While the LLM mentions incentives are 'revenue reductions,' it doesn't capture the ground truth's detail that these are 'recognized as a reduction of revenue depending on performance targets or amortized over the contractual term,' which is a more precise characterization. MULTI-HOP REASONING: The answer demonstrates basic multi-hop synthesis by connecting pricing models, processor costs, and incentives across three years, but fails to synthesize the evolution narrative that the ground truth emphasizes. The reasoning is sound but incomplete in addressing how disclosure evolved to show more nuanced management of margin risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 578,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s 2022 10‑K (pp. 9‑13) already stated that agreements with AIB manufacturers protect their inventory against price reductions and that system integrators (SIs) use discrete graphics solutions to differentiate their products. The 2023 filing (pp. 11‑15) reiterated those inventory‑protection policies and further highlighted the role of discrete GPUs as a key differentiator for SIs. By 2024 (pp. 9‑13), AMD’s AIB agreements explicitly included return rights and reinforced the price‑reduction safeguard, while underscoring discrete graphics solutions as a core lever for SI differentiation, reflecting a strengthened focus on inventory protection and discrete‑GPU differentiation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some core elements correctly but has significant gaps and misses key nuances from the ground truth. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the key themes of inventory protection and discrete graphics differentiation; (2) Accurately notes that inventory protection policies were consistent across all years; (3) Correctly identifies the role of discrete graphics as a differentiator for SIs; (4) Appropriately references page numbers (though not verified against actual filings). WEAKNESSES: (1) The LLM introduces 'return rights' in 2024 which is not mentioned in the ground truth - this is a factual addition not supported by the original answer; (2) Misses the important evolution in emphasis: the ground truth emphasizes that by 2024, AMD shifted focus toward SIs selling based on 'regional or product-based strengths and responding quickly to new technologies' - the LLM completely omits this strategic shift; (3) Fails to capture the 'subtle shift in language' and 'deepening of value proposition' that the ground truth highlights as a key evolution from 2022-2024; (4) The LLM's characterization of the evolution as 'strengthened focus' is somewhat generic and doesn't capture the nuanced strategic repositioning described in the ground truth; (5) The LLM answer is more superficial, treating the three years as largely repetitive rather than showing genuine evolution in strategy. MULTI-HOP REASONING: The LLM does attempt to synthesize across three years and multiple documents, but the synthesis is incomplete - it identifies consistency but misses the strategic evolution that is central to the question. The answer reads as a summary of static policies rather than an analysis of how strategy evolved. SEMANTIC ISSUES: While the language differs from the ground truth, the LLM's version actually conveys less information and misses critical strategic nuances about the shift toward SI-centric differentiation and responsiveness to new technologies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 543,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Across fiscal 2022‑24 Disney kept the same credit‑risk policy: it only enters derivative and other investment transactions with counterparties that have an A‑ or better rating and requires collateral if a counterparty’s rating falls below A‑ or if aggregate exposures exceed contractual limits. The concentration rule for cash and cash‑equivalents remained a 10 % threshold of total cash, but the concentration of balances with institutions that exceed that threshold rose from zero in 2023 to 24 % of total cash in 2024 (no concentration disclosed for 2022). The company continued to report no material cash balances with below‑investment‑grade counterparties throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core policy elements correctly (A- or better rating requirement, collateral requirements, no material below-investment-grade balances) and identifies the key shift regarding cash concentration. However, there are significant quantitative accuracy issues: (1) The LLM introduces a '10% threshold' for cash concentration that is not mentioned in the ground truth, which appears to be an unsupported detail. (2) The LLM states 'zero in 2023' concentration, but the ground truth only references fiscal 2022 as having no concentration, with no mention of 2023 data. This is a factual error in the year-to-year comparison. (3) The ground truth clearly states the concentration rose 'from no such concentration in fiscal 2022' to '24% in fiscal 2024,' but the LLM's phrasing 'from zero in 2023 to 24% of total cash in 2024' misrepresents the timeline and introduces an unsupported intermediate year. The qualitative reasoning about policy consistency and credit risk mitigation is sound, and the answer appropriately addresses the multi-part question about counterparty ratings, collateral requirements, and concentration thresholds. The contextual relevance is strong as it directly addresses the evolution question. However, the quantitative inaccuracies regarding the timeline (2023 vs 2022) and the unexplained 10% threshold significantly undermine the answer's reliability for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 404,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "The company’s exposure to the 2029‑maturing Fixed‑rate 2.850% notes stayed at **$1.5 billion** in 2022, 2023, and 2024, with no repurchase or redemption of that tranche during the period. This steady exposure indicates a deliberate long‑term debt strategy that keeps a stable, laddered maturity profile and locks in a fixed rate, rather than aggressively refinancing or reducing that portion of debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core quantitative facts: PYPL's 2029-maturing Fixed-rate 2.850% notes remained at $1.5 billion across 2022, 2023, and 2024 with no principal reduction. The number format variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. The multi-hop reasoning is sound—the model correctly synthesizes that this stability across three years indicates a deliberate strategy. However, the LLM answer is INCOMPLETE relative to the ground truth. The original answer provides critical strategic context that the LLM omits: (1) PYPL issued new debt in 2023 and 2024, including higher-interest notes (5.150% and 5.500%), which strengthens the argument about deliberate retention of the lower-rate 2029 notes; (2) the ground truth explicitly suggests the retention may be to 'preserve favorable interest terms or manage cash flow predictability,' which is more specific than the LLM's general reference to 'locks in a fixed rate.' The LLM's characterization of the strategy as maintaining a 'stable, laddered maturity profile' is reasonable inference but not explicitly supported by the ground truth language. The LLM correctly avoids stating facts not in evidence and maintains logical consistency. The answer is directionally correct and addresses the main question about the multi-year pattern, but lacks the comparative debt issuance context that would fully justify the strategic interpretation. This is a solid but incomplete response that captures the primary finding but misses supporting evidence that would strengthen the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 437,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures for the Performance Materials and Technologies segment consistently flagged raw‑material demand and supply risk from 2022 through 2024. In 2022 the risk was noted without a contractual coverage figure (2022 p. 29); by 2023 the company disclosed that 64 % of its raw‑material supply base was under contract (2023 p. 31), and in 2024 it stated that a majority of the supply base was under contract (2024 p. 29). This gradual increase in contractual coverage shows the company is reducing exposure, yet the segment remains vulnerable to commodity‑price volatility because its cost structure is heavily tied to commodity inputs (2022 p. 29, 2023 p. 31, 2024 p. 29).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims (64% contractual coverage in 2023, majority in 2024) that are NOT present in the ground truth answer. This is a critical factual error - the ground truth makes no mention of these specific percentages or contractual coverage metrics. The ground truth explicitly states the risk was 'reiterated' and 'remained a key risk factor' across all three years, indicating sustained vulnerability, whereas the LLM answer claims the company is 'reducing exposure' through increased contractual coverage. This represents a fundamental misinterpretation of the evolution of risk exposure. The LLM correctly identifies: (1) the segment name change from Performance Materials and Technologies to Energy and Sustainability Solutions in 2024, (2) the consistent presence of raw material risk across three years, and (3) vulnerability to commodity volatility. However, the LLM incorrectly suggests a positive trend of risk mitigation through contractual coverage, when the ground truth indicates a consistent, sustained vulnerability despite strategic repositioning. The LLM also cites specific page numbers (2022 p. 29, 2023 p. 31, 2024 p. 29) which cannot be verified against the ground truth and may be fabricated. The answer fails to capture the ground truth's key insight about the 'consistent presence' indicating 'sustained vulnerability' and instead pivots to an unsupported narrative about risk reduction. This is a significant multi-hop reasoning failure where the LLM synthesized information incorrectly or invented details not in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 438,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Imperial Brands PLC was listed in PMI’s peer group in 2022, 2023 and 2024, with no change in its inclusion over the three‑year span (PM_10k_2022.pdf, pp. 19‑23; PM_10k_2023.pdf, pp. 24‑28; PM_10k_2024.pdf, pp. 24‑28). This steady presence shows that PMI’s benchmarking strategy is deliberately stable, using a consistent core set of global consumer‑product peers—including key tobacco competitors—to evaluate its performance against the broader industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies Imperial Brands PLC as consistently included in PM's peer group across all three years (2022, 2023, 2024) - this matches the ground truth exactly. (2) Accurately cites specific document sources with page ranges (PM_10k_2022.pdf pp. 19-23; PM_10k_2023.pdf pp. 24-28; PM_10k_2024.pdf pp. 24-28), demonstrating proper multi-hop synthesis across three years of filings. (3) Correctly interprets the consistency as indicating a 'stable benchmarking strategy' and 'consistent core set of global consumer-product peers,' which semantically matches the ground truth's characterization of 'stable benchmarking strategy' and 'strategic alignment in peer selection.' (4) Appropriately contextualizes Imperial Brands within the 'global tobacco and consumer products sector' as requested. (5) The reasoning is sound - the presence of Imperial Brands across all three years logically supports conclusions about deliberate stability in peer selection. MINOR CONSIDERATIONS: (1) The LLM uses 'PMI' while the question and ground truth use 'PM' - these are equivalent (PMI is Philip Morris International's ticker), so this is not an error but a slight terminology variation. (2) The LLM adds slightly more interpretive detail ('deliberately stable,' 'key tobacco competitors') compared to the ground truth, but this represents appropriate elaboration rather than inaccuracy. (3) All factual claims are verifiable and correct. The answer fully addresses the multi-part question regarding trajectory, consistency, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 447,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "From 2022 through 2024 PayPal’s exposure to the fixed‑rate 2.850% notes stayed flat at **$1.5 billion** (2022 table on pages 106‑110, 2023 table on pages 105‑109, 2024 table on pages 102‑106). The company did not redeem or repay this tranche during that period—only other notes were repurchased in 2022—so the long‑maturity, fixed‑rate exposure remained unchanged. This stability reflects a deliberate long‑term debt‑management strategy that locks in a fixed rate on a 2029‑maturity instrument while maintaining a balanced, diversified debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All key numbers are correct - the $1.5 billion balance is accurately stated for all three years (2022, 2023, 2024), matching the ground truth exactly. The note rate of 2.850% is correct. The maturity year of 2029 is appropriately referenced. COMPLETENESS: The answer addresses all aspects of the question: (1) the evolution of exposure (stable at $1.5B across all three years), (2) the progression pattern (no repayments or refinancing), and (3) what this indicates about debt management strategy. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three years of filings and connected the stable balance to strategic implications about fixed-rate locking and capital structure diversification. ENTITY ACCURACY: PayPal (PYPL) correctly identified, fiscal years 2022-2024 correctly referenced, the specific debt instrument (2.850% notes) correctly identified. REASONING QUALITY: The logic is sound - the observation that only other notes were repurchased in 2022 while this tranche remained untouched demonstrates careful analysis. The interpretation that this reflects a deliberate strategy to maintain fixed-rate exposure on a long-maturity instrument is reasonable and consistent with the ground truth's assessment of 'consistent long-term liability position' and 'leveraging the low fixed rate.' MINOR DIFFERENCES: The LLM provides slightly more specific detail (mentioning the 2029 maturity and page references) than the ground truth, but this adds value rather than detracting. The phrasing 'balanced, diversified debt mix' is a reasonable elaboration on the ground truth's 'broader capital structure strategy.' No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 475,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "ConocoPhillips’ HSE audit policy has stayed essentially the same from 2022 through 2024.  In each year the company conducts audits on both business‑unit and staff‑group levels to verify conformance with its HSE policies, standards and practices, and any improvement actions that arise are tracked to completion.  Audit results and progress are reported annually to the Executive Leadership Team and the Board of Directors, ensuring the audit process remains embedded in corporate governance.  (See 2023 10‑K, Health, Safety & Environment: “Corporate HSE audits are conducted on business units and staff groups…where improvement actions are identified and tracked to completion.” 2024 10‑K, Health, Safety & Environment: “HSE audits are conducted on business units and staff groups…Progress is tracked and reported to our ELT and the Board of Directors.”)",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental mischaracterization of the ground truth. The original answer explicitly describes an EVOLUTION from 2022 to 2024, with three distinct phases showing progression: (1) 2022 - basic audits with improvement tracking, (2) 2023 - explicit linking to annual objectives/targets/deadlines with ELT/Board reporting, and (3) 2024 - shift to corporate-level centralized oversight. The LLM answer directly contradicts this by stating 'ConocoPhillips' HSE audit policy has stayed essentially the same from 2022 through 2024.' This is a critical error in understanding the core premise of the question. The LLM correctly identifies that audits occur at business-unit and staff-group levels and that results are reported to ELT and Board, but it fails to capture the key evolution: the 2023 explicit linkage to annual objectives/targets/deadlines, and the 2024 shift toward corporate-level (centralized) oversight. The LLM also misses the characterization of the evolution as 'a shift from localized conformance checks toward a more integrated, governance-driven audit model.' While the LLM provides accurate details about audit scope and governance reporting, it fundamentally misses the temporal progression and the strategic shift in approach that is central to answering the question. The answer demonstrates incomplete multi-hop synthesis - it captures static facts but fails to synthesize the evolution across the three-year period. Quantitative accuracy is high (years and entities are correct), but qualitative accuracy is very low due to the failure to identify and explain the evolution that is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 452,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "AMD has continued to treat the 2011 Executive Incentive Plan as a foundational governance document by incorporating it by reference as Exhibit 10.1 in each filing.  In the 2022, 2023 and 2024 10‑K reports the plan is listed in the “Exhibit” section (2022 p. 91‑95; 2023 p. 99‑103; 2024 p. 96‑100) and remains a reference point even as the company expands its executive‑compensation disclosures to include newer plans and broader award details.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative that AMD consistently referenced the 2011 Executive Incentive Plan as Exhibit 10.1 across 2022, 2023, and 2024, and appropriately characterizes it as a foundational governance document. The semantic understanding of the question and the multi-hop synthesis across three years is sound. However, there are significant quantitative accuracy issues: The LLM provides specific page numbers (2022 p. 91-95; 2023 p. 99-103; 2024 p. 96-100) that cannot be verified against the ground truth and appear to be hallucinated. The ground truth does not provide these page citations, and the LLM's specificity here is problematic because it presents unverified details as fact. The LLM answer is more concise than the ground truth but captures the essential points: (1) consistent reference as Exhibit 10.1, (2) presence across all three years, (3) foundational role despite newer plans. The answer correctly synthesizes the multi-hop requirement (comparing across 2022, 2023, 2024) and maintains logical coherence. The main weakness is the introduction of unverified page numbers, which violates the principle of strict accuracy on specific details. The answer would have been stronger by either omitting the page numbers or clearly indicating uncertainty. The qualitative reasoning about continuity and the anchoring of the executive incentive framework is sound and aligns with the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 401,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings GM consistently reported that it had agreed to indemnify Stellantis for any losses arising from inaccuracies in the 2017 Opel/Vauxhall sale agreement, including costs related to emissions claims and recalls, but could not estimate a material loss and only recorded an immaterial indemnification for certain Takata‑related recalls. The obligations remained subject to time limits, thresholds and caps, and the company noted that any further indemnification for Takata recalls is remote. This unchanged, capped exposure indicates that GM’s post‑sale liability from the Opel/Vauxhall sale has remained limited and largely contained within defined parameters.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and misses the core evolution narrative that the ground truth emphasizes. CORRECT ELEMENTS: (1) The LLM correctly identifies that GM indemnified Stellantis for losses from the 2017 Opel/Vauxhall sale, (2) Correctly notes immaterial accruals for Takata-related recalls, (3) Correctly states obligations had time limits, thresholds and caps, (4) Correctly notes remote likelihood of further Takata indemnification. CRITICAL OMISSIONS AND ERRORS: (1) The LLM completely fails to capture the EVOLUTION and EXPANSION of exposure from 2022-2024. The ground truth explicitly documents geographic expansion (Germany, UK, Netherlands in 2023; Austria added in 2024) and the LLM provides no year-by-year progression. (2) The LLM omits the European Commission and UK CMA regulatory investigations mentioned in 2024, which represent new regulatory exposure beyond the original sale agreement indemnification. (3) The LLM mischaracterizes the exposure as 'unchanged' and 'largely contained,' when the ground truth shows 'expanding' geographic and legal scope with 'growing complexity and persistence.' (4) The LLM focuses narrowly on the original 2017 sale agreement indemnification but misses that the 2023-2024 exposure includes NEW regulatory actions (EC/CMA investigations) not tied to the original agreement's inaccuracies. (5) The LLM fails to synthesize the multi-hop information showing how the liability landscape evolved across three years. MULTI-HOP REASONING FAILURE: The question asks how obligations 'evolved' from 2022-2024 and what this 'progression indicates.' The LLM provides a static snapshot rather than a dynamic analysis of change. The ground truth shows escalating complexity (lawsuits in multiple jurisdictions, new regulatory investigations, new accruals), while the LLM concludes exposure remained 'limited and largely contained.' This is a fundamental misreading of the filing data's trajectory. The LLM answer would mislead readers about the actual trend in GM's post-sale liability exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 552,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "From 2022 to 2024 Eli Lilly’s exposure to bamlanivimab shifted from a major revenue driver to a negligible one. In 2022 the antibody generated $1.978 billion in revenue (≈7 % of total sales) and in 2023 it produced $2.009 billion (≈6 % of sales), but by 2024 the product was essentially discontinued, with revenue falling to near zero. Royalty payments to AbCellera – tiered mid‑teens to mid‑twenties on net sales – remained a cost of sales but represented a small fraction of overall expenses, underscoring that bamlanivimab’s long‑term strategic importance has largely faded as the pandemic waned.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine its credibility. (1) REVENUE NUMBERS REVERSED: The LLM states 2022 revenue was $1.978 billion and 2023 was $2.009 billion, but the ground truth clearly indicates 2022 was $2,008.9 million (~$2.009 billion) with 2023 dropping to ZERO. The LLM has essentially inverted the trajectory - claiming 2023 had higher revenue than 2022 when it actually dropped to zero. (2) MISSING CRITICAL FACT: The ground truth explicitly states '2023, U.S. revenue from the category had dropped to zero' - this is a fundamental turning point that the LLM completely misses. Instead, the LLM claims 2023 produced $2.009 billion, which is factually incorrect. (3) TIMELINE ACCURACY: While the LLM correctly identifies the overall trend (major revenue driver to negligible), it misplaces when this occurred. The sharp decline happened between 2022 and 2023, not between 2023 and 2024. (4) ROYALTY OBLIGATIONS: The LLM correctly identifies the tiered mid-teens to mid-twenties royalty structure to AbCellera, which matches the ground truth. (5) STRATEGIC CONCLUSION: The LLM's conclusion about declining strategic importance is correct in spirit, but is undermined by the incorrect revenue figures. The reasoning about pandemic waning is sound but based on wrong data points. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize revenue trends with royalty obligations and strategic importance, but the synthesis is built on incorrect financial data. The 2023 revenue figure is the most critical error - stating $2.009 billion when it should be zero represents a fundamental misunderstanding of the product's commercial trajectory. This is not a minor rounding or formatting difference; it's a complete reversal of the actual financial performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 495,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "From 2022 through 2024, PMI’s filings consistently list Jackpot as one of its key local cigarette brands in the Philippines, with no change in its positioning or product mix. This steady inclusion shows that PMI continues to maintain a local‑brand portfolio in important markets while its broader strategy pivots toward smoke‑free products. (PM_10k_2022: pages 3‑7; PM_10k_2023: pages 4‑8; PM_10k_2024: pages 3‑7)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies Jackpot as a key local cigarette brand in the Philippines across 2022-2024 and accurately notes PMI's dual strategy of maintaining local brands while pivoting toward smoke-free products. The dates and entity references (PMI, Philippines, Jackpot) are all correct. However, the answer has significant weaknesses in completeness and depth: (1) It fails to mention Fortune as another key local brand in the Philippines that was referenced in 2022, which the ground truth explicitly includes as part of the broader portfolio context. (2) The LLM answer states 'no change in its positioning or product mix' which is overly simplistic - the ground truth reveals a more nuanced evolution where PMI 'reiterated' reliance on local brands in 2023 and emphasized their complementary role, suggesting some strategic emphasis shifts even if the brand remained listed. (3) The answer lacks the contextual richness of the ground truth regarding how Jackpot's role evolved from being part of a 'broader portfolio' (2022) to being emphasized for 'complementing international brands' (2023) to remaining valued despite the 'broader strategic pivot' (2024). (4) The page citations provided appear reasonable but cannot be verified against actual filings. The core facts are accurate, but the answer undersells the strategic nuance and misses important portfolio context (Fortune) that demonstrates PMI's multi-brand approach to the Philippines market. The answer is partially correct but incomplete in addressing the full scope of the 3-year trajectory question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 433,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "PayPal’s 2022 risk disclosures (pp. 24‑28) highlighted that its branded‑credit and BNPL products exposed it to bad‑transaction losses from credit‑risk defaults, fraud and third‑party processing disruptions.  In 2023 the company mitigated its BNPL exposure by selling up to €40 billion of U.K. and European BNPL loan receivables— a forward‑flow arrangement that transfers most of that portfolio (pp. 23‑27).  By 2024, while the BNPL exposure had largely been transferred, PayPal still faced ongoing credit‑product default risk, evolving fraud schemes and the possibility of third‑party processor outages that could increase bad‑transaction losses (pp. 21‑25).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct: €40 billion BNPL receivables sale in 2023, correct years (2022, 2023, 2024). (2) The multi-hop synthesis is sound—the answer correctly traces the evolution from 2022 (growing exposure to bad transactions), through 2023 (major asset sale reducing direct exposure), to 2024 (continued but reduced risks). (3) All major risk categories are identified: fraud, synthetic identities, stolen financial instruments, third-party processing disruptions, account takeover attempts. (4) The characterization of the 2023 sale as a 'forward-flow arrangement' is accurate and shows understanding of the transaction structure. (5) The answer correctly notes that while direct BNPL exposure was transferred, underlying risks persisted. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth and omits some contextual details (e.g., specific mention of 'synthetic identities' and 'stolen financial instruments' as distinct fraud vectors, though fraud is mentioned generally). (2) The ground truth emphasizes 'regulatory challenges' and 'effectiveness of fraud detection systems' as ongoing uncertainties—the LLM answer doesn't explicitly mention regulatory challenges, though it does reference fraud and third-party risks. (3) The ground truth notes the sale was 'subject to conditions and execution risks'—the LLM characterizes it as a 'forward-flow arrangement that transfers most of that portfolio,' which is accurate but slightly less cautious about execution risks. QUANTITATIVE VERIFICATION: €40 billion figure is correct; years are correct; no calculations required. SEMANTIC EQUIVALENCE: The LLM's phrasing 'mitigated its BNPL exposure' and 'largely been transferred' conveys the same meaning as the ground truth's 'reducing its direct exposure' and 'shifted some of the credit risk burden.' The answer is factually sound and addresses the core question effectively, though it could have included slightly more detail on regulatory and fraud detection uncertainties.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 578,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022 the Safety & Productivity Solutions segment was flagged in the risk‑factor section (p. 30‑34) as vulnerable to retail‑market fluctuations, which could erode market share, selling prices and margins. In 2024 the newly‑defined Industrial Automation segment faced a similar risk (p. 28‑32), with the risk‑factor noting that retail‑market volatility could depress operating results and margins. The 2023 risk‑factor (p. 30‑34) reiterated retail‑market volatility as a key risk for both segments, underscoring that Honeywell’s overall risk posture remains sensitive to swings in retail demand across its industrial portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year progression (2022, 2023, 2024) of retail market fluctuation risks across Honeywell's segments. It accurately names the segments (Safety & Productivity Solutions in 2022, Industrial Automation in 2024) and correctly characterizes the nature of the risks (market share erosion, margin pressure, demand volatility). The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and showing the evolution of risk disclosure. The semantic meaning aligns well with the ground truth regarding persistent sensitivity to retail demand volatility.\n\nWEAKNESSES: (1) PAGE CITATIONS ARE PROBLEMATIC - The LLM provides specific page numbers (p. 30-34, p. 28-32) that cannot be verified against the ground truth, which does not include page references. This introduces unverifiable quantitative claims that could be incorrect. (2) INCOMPLETE DETAIL ON 2023 - The ground truth emphasizes that 2023 risk was 'reiterated as part of broader macroeconomic and industry risks' with specific emphasis on 'global economic instability and fluctuating demand' affecting 'customer investment behavior.' The LLM's 2023 description is vague ('reiterated retail-market volatility as a key risk for both segments') and lacks the contextual richness about macroeconomic factors and customer investment behavior. (3) MISSING SPECIFIC IMPACT MECHANISMS - The ground truth explicitly states the 2022 risk could lead to 'reduced investments in safety monitoring and process automation, directly impacting demand for its products and services.' The LLM mentions margin and market share impacts but omits the specific mechanism of reduced customer investment in safety monitoring and automation. (4) SEGMENT ATTRIBUTION IN 2023 - The LLM states the 2023 risk applied to 'both segments,' but the ground truth indicates it was part of 'broader macroeconomic and industry risks' without explicitly confirming dual-segment attribution in that year.\n\nCALCULATION/NUMERIC VERIFICATION: No calculations are required for this question. The years (2022, 2023, 2024) are all correct. No dollar amounts or percentages are provided in either answer, so quantitative accuracy is limited to date/year verification, which is correct.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and two/three business segments, showing the evolution of risk disclosure. However, the reasoning lacks the depth of the ground truth regarding how the risk manifestation changed (from specific investment reduction mechanisms in 2022 to broader macroeconomic context in 2023 to segment-specific impacts in 2024).\n\nOVERALL ASSESSMENT: The answer is directionally correct and captures the main narrative of persistent retail market sensitivity, but it lacks specificity in describing the mechanisms of impact and includes unverifiable page citations. The 2023 analysis is particularly underdeveloped compared to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 789,
        "total_tokens": 2253
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 through 2024 the Incyte partnership kept its tiered double‑digit royalty structure (up to 20 % on worldwide net sales of Olumiant, plus an extra low‑teens royalty on COVID‑19 sales above a threshold) unchanged, while milestone payments were largely front‑loaded—$260 m and $210 m were capitalized as intangible assets in 2021 and 2020, with no new milestones reported thereafter.  The collaboration’s strategic focus broadened to include follow‑on compounds and COVID‑19 indications, but the core royalty arrangement remained the same.  Olumiant’s net product revenue grew from $830.5 m in 2022 to $957.4 m in 2024, highlighting its expanding share of LLY’s revenue base.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the tiered royalty structure (up to 20% on general sales plus low-teens on COVID-19 sales above threshold), accurately reports Olumiant revenue growth ($830.5M in 2022 to $957.4M in 2024), and appropriately notes the strategic broadening to include follow-on compounds. The semantic understanding of the partnership's evolution is sound. CRITICAL ERRORS: (1) The LLM states milestone payments of '$260m and $210m were capitalized in 2021 and 2020' - this is factually incorrect. The ground truth specifies that in 2022, LLY had capitalized $260.0 million in milestone payments, with Incyte eligible for up to an additional $200.0 million in contingent payments. The LLM conflates historical capitalization dates (2020-2021) with the 2022 reporting period and misquotes the contingent payment amount ($210M vs. $200M). (2) The LLM states 'no new milestones reported thereafter' which is imprecise - the ground truth indicates the $200M contingent payment remained eligible through 2024, not that milestones ceased. PARTIAL ISSUES: (1) The answer lacks discussion of the 2023 transition to ongoing revenue recognition and cost of sales treatment, which was explicitly mentioned in the ground truth as a key evolution. (2) The answer doesn't clearly distinguish between capitalized historical milestones and ongoing contingent payments eligible through 2024. QUANTITATIVE VERIFICATION: Olumiant revenue figures ($830.5M 2022, $957.4M 2024) appear accurate and represent proper multi-hop synthesis. However, the milestone payment numbers and dates are materially incorrect. The answer demonstrates good understanding of the royalty structure stability but fails on milestone payment accuracy and completeness of the 2023-2024 evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 484,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria’s ownership of UST remained unchanged through 2024 – UST LLC and its wholly‑owned subsidiary USSTC are still fully owned by Altria (2024 p. 2‑6).  The intangible assets tied to UST—MST and snus trademarks—were reported at $8.8 B and $2.6 B as of 2021, with no impairment recorded in 2021 or 2020 and no changes disclosed in 2022 or 2024, indicating stable valuation (2024 p. 2‑6, 2023 p. 58‑62, 2022 p. 64‑68).  UST continues to be a core part of Altria’s smoke‑free transition strategy, providing moist smokeless tobacco and snus products that fit the company’s Vision to move adult smokers toward smoke‑free alternatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and inconsistencies when compared to the ground truth. STRENGTHS: (1) Correctly identifies UST and USSTC as wholly-owned subsidiaries through 2024; (2) Correctly cites the $8.8B figure for MST and snus trademarks; (3) Appropriately notes stable valuation with no impairments; (4) Correctly identifies UST's role in smoke-free transition strategy. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites '$2.6B' as a separate intangible asset value 'as of 2021' but the ground truth does not mention this figure or break down the $8.8B into components. This appears to be an unsupported number that may confuse the valuation picture; (2) TEMPORAL INCOMPLETENESS - The LLM fails to address the 2022-2024 evolution explicitly. The ground truth emphasizes how the relationship 'evolved' across these three years, showing strategic diversification toward oral nicotine pouches (Helix) and e-vapor (NJOY) while maintaining UST. The LLM mentions UST as 'core' but doesn't capture the strategic shift toward complementary alternatives; (3) MISSING SYNTHESIS - The question specifically asks about evolution 'from 2022 to 2024' with emphasis on how the relationship changed. The LLM states 'no changes disclosed in 2022 or 2024' which actually contradicts the ground truth's narrative of strategic evolution and diversification; (4) INCOMPLETE STRATEGIC CONTEXT - The ground truth emphasizes that while UST remained valuable, Altria's broader portfolio strategy shifted toward newer alternatives. The LLM mentions UST as 'core' but doesn't adequately convey the strategic complementarity with Helix and NJOY that represents the actual evolution. MULTI-HOP REASONING: The LLM partially synthesizes information but fails to connect the dots across the 3-year period to show how ownership remained stable while strategic positioning evolved. The answer reads more as a static snapshot than a trajectory analysis as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 536,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% senior note had an effective rate of 3.20 % in FY 2022, which jumped to 6.38 % in FY 2023 and rose further to 6.66 % in FY 2024. The sharp climb in the effective rate—well above the 3.50 % coupon—shows that Cisco’s borrowing costs accelerated as market rates tightened, reflecting a shift toward higher interest rates and a more expensive capital‑market environment over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All numeric values are correct - FY2022: 3.20%, FY2023: 6.38%, FY2024: 6.66%, and the coupon rate of 3.50% are all accurately stated. The trend calculation (3.20% to 6.66% increase) is correct. (2) ENTITY ACCURACY: Cisco (CSCO) correctly identified, fiscal years 2022-2024 properly referenced, and the 3.50% Senior Note correctly specified. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend across multiple fiscal periods and correctly interprets what the divergence between coupon rate (3.50%) and effective rates (3.20%-6.66%) indicates about market conditions. (4) COMPLETENESS: The answer addresses both parts of the question - how the interest rate exposure evolved (the specific numbers and trend) and what this indicates about borrowing costs and capital market conditions (tightening markets, higher rates, more expensive capital environment). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'sharp climb in the effective rate—well above the 3.50% coupon' and 'borrowing costs accelerated as market rates tightened' conveys the same meaning as the ground truth's 'significant upward trend' and 'tightening capital market conditions.' Minor difference: The LLM uses slightly more concise language but maintains all essential information. The reasoning about market conditions is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 398,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 senior notes, originally issued at $17 billion, fell from $16.0 billion at year‑end 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024 (all figures in millions). This steady decline—$1 billion in 2023 and $2 billion in 2024—shows a deliberate repayment of that tranche, underscoring Amazon’s strategy of trimming long‑term debt and interest exposure while maintaining a strong balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN UNIT CONVERSION: The LLM states the 2017 Notes balances as '$16.0 billion...to $15.0 billion in 2023 and further to $13.0 billion in 2024 (all figures in millions)' - this is internally contradictory and mathematically impossible. The LLM correctly identifies the billions figures but then incorrectly claims they are in millions, which would make them $16,000 million, $15,000 million, and $13,000 million respectively. This is a fundamental error that undermines credibility. CORRECT NUMBERS: The actual outstanding balances are correct: $16.0B (2022), $15.0B (2023), $13.0B (2024). The year-over-year reductions are accurate: $1B reduction in 2023, $2B reduction in 2024. MISSING CONTEXT: The LLM does not mention the broader long-term debt context provided in the ground truth ($67.2B in 2022 declining to $52.6B in 2024), which is important for understanding Amazon's overall debt management strategy. QUALITATIVE ASSESSMENT: The reasoning about deliberate debt repayment and interest expense reduction is sound and appropriate. The characterization of the strategy as maintaining a strong balance sheet is reasonable. MULTI-HOP SYNTHESIS: The answer adequately connects the specific 2017 Notes reduction to broader debt management strategy, though it lacks the quantitative context of total long-term debt reduction. The mention of the original $17 billion issuance adds helpful context not explicitly in the ground truth but is reasonable inference. MAIN ISSUE: The unit conversion error (stating billions are in millions) is a serious factual mistake that significantly impacts the answer's reliability, despite the underlying numbers being correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 457,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 carried an outstanding principal balance of $606 million and an effective interest rate of 5.18% (coupon 5.000%) in fiscal 2022, 2023 and 2024【AVGO_10k_2022.pdf pages 101‑105】【AVGO_10k_2023.pdf pages 79‑83】【AVGO_10k_2024.pdf pages 79‑83】. The unchanged balance and rate over three years show that AVGO has chosen to keep this long‑term debt in place, using it as a stable, low‑cost financing source and preserving liquidity while avoiding refinancing risk【AVGO_10k_2024.pdf pages 79‑83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numeric values are correct - $606 million principal balance for all three fiscal years (2022, 2023, 2024), effective interest rate of 5.18%, and coupon rate of 5.000%. These match the ground truth exactly. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) outstanding principal balance evolution, (2) interest rate information, (3) multi-year progression (fiscal 2022-2024), and (4) implications for debt management strategy. ENTITY ACCURACY: Company (AVGO), debt instrument (5.000% notes due April 2030), fiscal years (2022, 2023, 2024), and financial metrics are all correctly identified. MULTI-HOP REASONING: The LLM successfully synthesized information across three separate 10-K filings to demonstrate the consistency of the debt position over time. The conclusion that AVGO maintained a static approach is logically sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's interpretation that the unchanged balance represents a deliberate strategy to maintain stable, low-cost financing while preserving liquidity and avoiding refinancing risk is a reasonable and appropriate inference that aligns with the ground truth's characterization of a 'static approach.' The answer goes slightly beyond the ground truth by providing strategic context (stable financing source, liquidity preservation, refinancing risk avoidance), which adds value without contradicting the core facts. MINOR OBSERVATION: The LLM includes specific page references to source documents, which enhances credibility and traceability, though this wasn't explicitly required. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 463,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "In 2022 Netflix formally adopted and **restated** its Performance Bonus Plan, incorporating it into the executive compensation agreements (see Exhibit 10.5).  The 2023 filing repeated that restatement and further integrated the plan into the 2023 executive‑compensation framework, updating performance metrics and eligibility.  By 2024 the plan was again restated and fully embedded in the 2024 executive‑compensation agreements, aligning it with the company’s revised incentive structure and ensuring it is governed by the same contractual framework each year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DATING ERROR - The LLM states the plan was 'formally adopted and restated' in 2022, but the ground truth indicates the 'Amended and Restated Performance Bonus Plan' was introduced via 8-K filing on December 9, 2022, meaning it was formally restated in late 2022 for implementation in 2023, not simply 'adopted' in 2022. (2) INCOMPLETE TIMELINE - The LLM claims the plan was 'again restated' in 2024, but the ground truth does not support multiple restatements across all three years. The ground truth specifically mentions ONE formal restatement (the 'Amended and Restated' version introduced December 9, 2022). (3) UNSUPPORTED CLAIMS - The LLM asserts the plan was 'restated' in 2023 and 2024 without evidence from the ground truth. The ground truth only explicitly mentions the December 9, 2022 restatement. (4) VAGUE LANGUAGE - The LLM uses phrases like 'repeated that restatement' and 'again restated' without specific documentation or dates, whereas the ground truth provides precise timing (December 9, 2022 8-K filing). (5) MISSING KEY DETAIL - The ground truth emphasizes the 2024 integration with OTHER plans (Executive Officer Severance Plan, Performance-Based Restricted Stock Unit Award Agreement), showing a broader compensation architecture evolution. The LLM mentions these but doesn't clearly distinguish the 2024 integration as a NEW development beyond the 2022 restatement. (6) EXHIBIT REFERENCE - The LLM cites 'Exhibit 10.5' without verification against ground truth sources. WHAT WAS CORRECT: The LLM correctly identifies Netflix as the company, correctly names the 'Amended and Restated Performance Bonus Plan,' and correctly notes integration with executive compensation agreements. The general trajectory of formalization and integration is directionally correct. However, the specific claims about multiple restatements in 2023 and 2024 lack support in the ground truth, which only documents the December 2022 restatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 533,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "AIG’s international terrorism‑risk strategy has stayed essentially the same from 2022 to 2024. In 2022 the company disclosed a scenario‑based loss estimate of **$1.3 billion** for a five‑ton bomb attack net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance recoveries, noting that TRIPRA covered **80 %** of losses above a **$1.7 billion** deductible and that only limited private reinsurance was in place【2022 10‑K page 169】【2022 10‑K page 170‑171】. The 2023 and 2024 filings repeat the same approach—scenario‑based modeling, TRIPRA coverage, targeted private reinsurance purchases, and reliance on government‑sponsored terrorism pools—without changing the deductible, coverage percentage, or providing a new loss estimate【2023 10‑K page 119‑123】【2024 10‑K page 86‑89】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $1.3 billion loss estimate for the five-ton bomb attack scenario in 2022, net of TRIPRA and reinsurance. (2) The TRIPRA coverage details (80% of losses above $1.7 billion deductible) appear accurate based on the cited pages. (3) The LLM correctly notes that the modeling approach remained consistent across 2022-2024. (4) Citation format and page references are provided.\n\nCRITICAL GAPS AND ERRORS: (1) The LLM answer significantly UNDERREPRESENTS the evolution of AIG's strategy from 2022 to 2024. The ground truth explicitly states that by 2023-2024, AIG evolved its approach with 'targeted reinsurance purchases for certain lines of business' and specific attachment points. (2) MISSING KEY 2024 DETAILS: The LLM fails to mention the core attachment points retained for Japan ($200 million) and rest of world ($125 million), which represent concrete strategic evolution. (3) MISSING COLLATERAL INFORMATION: The ground truth specifies AIG held $20.1 billion in collateral to support reinsurance recoverable assets in 2024—a significant risk mitigation metric completely absent from the LLM answer. (4) MISSING REINSURANCE EVOLUTION: The ground truth mentions 'global property per risk covers for non-critical and critical catastrophe events outside North America' purchased in 2024, indicating strategic deepening that the LLM characterizes as 'essentially the same.' (5) INCOMPLETE CHARACTERIZATION: The LLM concludes the strategy 'stayed essentially the same' and 'without changing the deductible, coverage percentage,' which contradicts the ground truth's characterization of 'strategic deepening of reinsurance and risk alignment mechanisms over time.'\n\nMULTI-HOP REASONING ASSESSMENT: The LLM failed to synthesize the evolution across the three-year period. While it correctly identified 2022 baseline metrics, it did not adequately extract and synthesize the 2023-2024 developments (attachment points, collateral holdings, specific reinsurance purchases) that demonstrate strategic evolution. The conclusion that strategy remained 'essentially the same' is contradicted by the specific quantitative and qualitative changes documented in the ground truth.\n\nQUANTITATIVE ACCURACY: The $1.3 billion, 80%, and $1.7 billion figures appear correct, but the answer is incomplete by omitting the $200M, $125M, and $20.1B figures that are central to understanding the 2024 evolution.\n\nJUSTIFICATION: While the LLM provides accurate baseline information for 2022, it fundamentally mischaracterizes the evolution of AIG's strategy by claiming it 'stayed essentially the same' when the ground truth documents specific strategic deepening through new attachment points, collateral holdings, and targeted reinsurance purchases. This represents a significant failure in multi-hop synthesis and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 753,
        "total_tokens": 2191
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture‑investment focus accelerated between 2022 and 2024.  Total equity‑security holdings grew from **$3.7 billion in 2022 to $4.9 billion in 2024** (2023 10‑K, p. 48‑52; 2024 10‑K, p. 50‑54), while equity‑method investments in operating health‑care businesses more than doubled—from **$1.5 billion in 2022 to $3.8 billion in 2024** (2023 10‑K, p. 48‑52; 2024 10‑K, p. 50‑54).  This trend signals a shift toward larger, more direct stakes in healthcare operating firms as part of the company’s expanding venture portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics that are the core of this question. (1) EQUITY SECURITIES - 2022 figure: LLM states $3.7 billion, but ground truth is $3.5 billion (error of $0.2B or 5.7%). The 2024 figure of $4.9 billion is correct. (2) EQUITY METHOD INVESTMENTS - 2022 figure: LLM states $1.5 billion, but ground truth is $1.3 billion (error of $0.2B or 15.4%). The 2024 figure of $3.8 billion is correct. (3) MISSING 2023 DATA: The LLM answer completely omits 2023 figures, which are essential for showing the evolution across the full 2022-2024 period. Ground truth shows 2023 equity securities at $4.9 billion and equity method investments at $1.4 billion. This is a significant omission for a question specifically asking about evolution 'from 2022 through 2024.' (4) CALCULATION VERIFICATION: The LLM claims equity method investments 'more than doubled' from $1.5B to $3.8B (2.53x increase). Even using the LLM's incorrect 2022 figure, this is accurate math. However, using the correct ground truth figures ($1.3B to $3.8B), the increase is 2.92x, which is still 'more than doubled' but the magnitude is different. (5) QUALITATIVE ASSESSMENT: The LLM correctly identifies the strategic pivot toward deeper operational engagement and larger direct stakes in healthcare businesses, which aligns with the ground truth interpretation. The reasoning about the shift in strategy is sound. (6) ENTITY AND CONTEXT: Company name (UnitedHealth), metrics (equity securities, equity method investments), and time period are correctly identified. The characterization of the trend is appropriate. SUMMARY: While the LLM demonstrates good understanding of the strategic narrative and correctly identifies the directional trends, the quantitative errors in the 2022 baseline figures (both off by $0.2B) and the complete omission of 2023 data represent material failures in answering a question that explicitly asks about evolution across three years. For a financial question where precision is critical, these errors significantly undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 576,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria issued its 1.700% 2025 Notes in 2022 and the notes remained outstanding through 2023 and 2024, with no changes in principal or maturity reported (MO_10k_2022.pdf:1‑5; MO_10k_2023.pdf:1‑5; MO_10k_2024.pdf:1‑5). The consistent presence of these notes across three consecutive filings shows a deliberate strategy of maintaining a stable long‑term debt profile and predictable interest obligations, allowing the company to manage liquidity and refinance risk while keeping its capital structure steady.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 1.700% 2025 Notes as a key debt instrument and accurately notes its presence across 2022, 2023, and 2024 filings. The characterization of the notes as remaining 'outstanding' and 'unchanged' in principal is factually sound. The general interpretation about debt management strategy (maintaining stable long-term debt profile) is reasonable. WEAKNESSES: (1) The LLM answer lacks critical multi-hop synthesis that the ground truth provides. The ground truth specifically mentions the maturation and removal of the 1.000% 2023 Notes between 2022 and 2023, which is a key indicator of active debt management. The LLM completely omits this important contextual detail about how Altria managed its short-term obligations. (2) The LLM characterizes the 2025 Notes as 'long-term debt' when they are actually mid-term (maturing in 2025, which is only 1-2 years away from 2024), missing the nuance that the ground truth captures about 'mid-term capital strategy.' (3) The LLM provides generic document citations (MO_10k_2022.pdf:1-5, etc.) without specific evidence of the actual debt disclosures, whereas the ground truth demonstrates knowledge of the actual debt instruments listed. (4) The answer fails to address the full multi-year progression by not comparing the evolution of the debt portfolio across the three years - it treats the notes as static rather than showing how they fit into a changing capital structure. (5) The reasoning about 'refinance risk' and 'liquidity management' is somewhat speculative and not directly supported by the ground truth's more concrete observations about debt maturation patterns. The answer is partially correct but incomplete in its multi-hop synthesis and missing key details about the broader debt portfolio evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 489,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s cost of Class A treasury stock rose from $51.4 billion at year‑end 2022 (MA_10k_2022, p.66‑70) to $60.4 billion in 2023 (MA_10k_2023, p.69‑73) and to $71.4 billion in 2024 (MA_10k_2024, p.66‑70). This steady increase reflects a growing share‑repurchase program, indicating that the company is allocating excess cash to buy back shares and return value to shareholders rather than retaining cash or investing elsewhere.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental numerical errors that make it factually incorrect. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth shows treasury stock values as negative numbers: $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. The LLM converted these to positive values ($51.4B, $60.4B, $71.4B), which is incorrect. The parentheses notation in accounting indicates negative values (cash outflows for repurchases). The LLM's 2022 figure of $51.4B is completely wrong - it should be $36,658 million or $36.658 billion. (2) CALCULATION ERROR: The LLM's 2022 number ($51.4B) doesn't match either the ground truth ($36.658B) or any logical derivation. This is a major factual error. (3) PARTIAL CORRECTNESS: The 2023 ($60.4B) and 2024 ($71.4B) figures are numerically close to the ground truth values when converted to billions ($60.429B and $71.431B), though the sign convention is wrong. (4) REASONING: While the LLM correctly identifies the trend (increasing investment in treasury stock) and correctly interprets this as reflecting a share-repurchase strategy and capital allocation toward shareholders, the underlying numerical foundation is flawed. (5) ENTITY ACCURACY: Company name, years, and metric identification are correct. (6) SIGN CONVENTION: The most significant issue is treating treasury stock investments as positive values when they should be negative (representing cash outflows). This is a fundamental accounting convention error. The answer demonstrates understanding of the strategic implications but fails on basic numerical accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 453,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023, and then to a $91 million gain in FY 2024.  Over the three‑year span the cumulative effect shifted from negative to positive, yielding a net gain of roughly $97 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Verification of key elements: (1) All three financial figures are correct: $92M loss in FY2022, $58M gain in FY2023, $91M gain in FY2024. (2) The calculation of cumulative net gain is accurate: -$92M + $58M + $91M = $57M. However, the LLM states 'roughly $97 million' which appears to be an error. The correct cumulative net should be $57M, not $97M. This is a calculation error that reduces the score. (3) Entity identification is correct: Cisco, Total Return Swaps, Deferred Compensation. (4) Multi-hop reasoning is sound: the answer correctly synthesizes the three-year trend showing reversal from loss to gains and strengthening performance. (5) The characterization of the shift from 'negative to positive' is semantically equivalent to the ground truth's 'reversal and strengthening.' (6) The wording variation (using 'total-return swaps used to hedge deferred-compensation exposure' vs 'Total Return Swaps-Deferred Compensation') is acceptable and shows understanding. The primary weakness is the cumulative calculation error ($97M stated vs $57M actual), which is a material quantitative mistake that prevents a perfect score, though the core narrative and individual year figures are all correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 353,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "Netflix’s 10‑K risk‑factor disclosures consistently underscored its dependence on third‑party rights holders, but the wording evolved to reflect growing competition and regulatory constraints. In the 2022 filing (Item 1A, p. 9‑13) Netflix warned that studios or rights holders could refuse or withdraw licenses, curbing its library; the 2023 filing (Item 1A, p. 4) added that competition for exclusive rights is intensifying and licensing costs are rising; and the 2024 filing (Item 1A, p. 4; Regulation, p. 6) further highlighted new content‑quota rules, levies and ownership‑rights restrictions that could limit availability and increase costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the evolution of Netflix's dependency on rights holders; (2) Accurately captures the key risk factors mentioned in each year: 2022 (studios/rights holders refusing/withdrawing licenses), 2023 (intensifying competition for exclusive rights, rising licensing costs), and 2024 (content quotas, levies, ownership restrictions); (3) Properly synthesizes multi-hop information across three separate 10-K filings; (4) Correctly cites Item 1A sections and page numbers as evidence; (5) Uses appropriate semantic language ('risk-factor disclosures,' 'third-party rights holders') that matches the ground truth's conceptual framework. MINOR WEAKNESSES: (1) The LLM answer is more concise and document-focused than the ground truth, which provides slightly more narrative context about the 'strategic challenge' and the interplay between rights holders and regulators; (2) The ground truth explicitly mentions 'intellectual property disputes' as a 2023 concern, which the LLM answer does not explicitly state (though it references licensing disputes implicitly); (3) The LLM answer does not explicitly state that content providers launching their own streaming services was a 2022 concern, though it captures the essence of competitive pressure. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM correctly synthesizes information across three separate 10-K filings and identifies the progression of risks over time, demonstrating sound multi-hop reasoning. The answer appropriately connects regulatory pressures, competitive dynamics, and licensing risks as interconnected factors. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, with the main difference being presentation style (more document-centric vs. narrative-centric) rather than factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 573,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s 10‑K notes state that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022” (Note 4).  The obligation level therefore remained essentially unchanged and below materiality thresholds over the three‑year period, indicating that the company’s service‑delivery guarantees to its subsidiaries are stable and not a significant source of financial risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that service level guarantee amounts were immaterial across all three years (2022-2024), which aligns with the ground truth. However, the answer is significantly incomplete and misses critical quantitative information that directly addresses the question about how financial obligations 'evolved' over the period. \n\nKEY OMISSIONS:\n1. The LLM completely fails to mention the parent company's notes payable to subsidiaries, which is a crucial component of the ground truth answer. The ground truth explicitly states these fluctuated from $8.1B (2022) → $9.9B (2023) → $2.0B (2024), representing a significant 3-year trend.\n2. The LLM does not address the internal financing structure or liquidity strategies that the ground truth identifies as important context.\n3. The LLM's conclusion that obligations 'remained essentially unchanged' is partially misleading—while service level guarantees themselves were immaterial, the broader financial obligations supporting them showed material variation.\n\nQUANTITATIVE ACCURACY ISSUES:\n- Missing all three years of notes payable data ($8.1B, $9.9B, $2.0B)\n- No quantitative analysis of the 3-year trend despite the question explicitly asking about evolution\n- The statement about 'unchanged' obligations is incomplete without the subsidiary financing data\n\nREASONING ISSUES:\n- The LLM provides only a partial answer to a multi-part question\n- It addresses the service level guarantees component but ignores the subsidiary financing component that the ground truth identifies as essential to understanding the full picture\n- The conclusion about 'stability' is not fully supported by the complete data set\n\nWHAT WAS CORRECT:\n- Accurate citation that service level guarantee amounts were immaterial in all three years\n- Correct identification of years 2022, 2023, 2024\n- Correct company (UnitedHealth Group)\n- Correct reference to Note 4\n\nThe answer demonstrates partial understanding but fails to synthesize the complete multi-hop information required to fully answer the question about how financial obligations evolved and what the trend suggests.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 575,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s long‑duration fixed‑income allocation to below‑investment‑grade securities rose from roughly 8 % of its pension fixed‑income holdings in 2022 to about 11 % in 2023, then fell back to 8 % in 2024; the postretirement portfolio followed a similar pattern, moving from ~8 % in 2022 to ~9 % in 2023 and returning to ~8 % in 2024. This modest fluctuation, staying within a narrow 8‑11 % band for pension and 8‑9 % for postretirement, signals a cautious yet responsive risk appetite that adjusts credit exposure to market conditions while maintaining a conservative stance on long‑term obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth data. Specific issues: (1) PENSION PLAN ERRORS: Ground truth shows 16% in 2022, 11% in 2023; LLM claims 8% in 2022 and 11% in 2023 - the 2022 figure is completely wrong (off by 8 percentage points). (2) POSTRETIREMENT PLAN ERRORS: Ground truth shows 8% in 2022, 9% in 2023; LLM claims 8% in 2022 and 9% in 2023 - while 2023 matches, the characterization of 'similar pattern' is misleading since pension decreased while postretirement increased. (3) 2024 DATA: Ground truth explicitly states 2024 percentages were not disclosed; LLM fabricates specific percentages (8% for both plans) with no basis in the source material. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution across years and between the two plan types. The ground truth shows a diverging trend (pension down, postretirement up), not the 'similar pattern' claimed. (5) INTERPRETATION: While the LLM's conclusion about 'cautious yet responsive risk appetite' is reasonable in tone, it's built on incorrect data, making the analysis unreliable. The answer demonstrates a critical failure in quantitative accuracy - the core requirement for financial analysis questions. The fabrication of 2024 data is particularly problematic as it violates the principle of not inventing information not present in source materials.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 388,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard has applied the same settlement‑exposure model in 2022, 2023 and 2024: the gross exposure is calculated as the average daily payment volume over the prior three months multiplied by the estimated number of days of exposure, and the net figure is derived after applying risk‑mitigation arrangements that are reviewed periodically【2022‑108‑112】【2023‑110‑114】【2024‑102‑106】.  The unchanged methodology—along with regular reviews of risk standards and adjustments only to the mitigation amounts—shows a disciplined, stable risk‑management framework that continues to function effectively even as regulatory scrutiny and litigation pressures rise.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Mastercard's consistent settlement exposure methodology across 2022-2024 (average daily payment volume × estimated days of exposure) and accurately notes the unchanged approach to risk mitigation. The answer properly synthesizes the core finding that methodology remained stable despite regulatory and litigation pressures. However, there are notable gaps compared to the ground truth: (1) The LLM answer lacks specific mention of the regulatory investigations (FTC, DOJ in 2023; European Commission in 2024) and litigation risks (U.S. Liability Shift Litigation, TCPA class action) that provide important context for understanding the significance of the unchanged methodology. (2) The ground truth emphasizes that the consistent approach 'suggests that Mastercard viewed its existing risk management practices as robust and sufficient,' which is a key interpretive insight about what the consistency indicates about the company's risk management philosophy. The LLM answer states the framework 'continues to function effectively' but doesn't fully capture this interpretive dimension. (3) The citation references provided (2022-108-112, 2023-110-114, 2024-102-106) appear to be document locators but cannot be verified against the ground truth. The quantitative accuracy is strong regarding the methodology itself, but the answer is incomplete in addressing the full context of 'increasing regulatory scrutiny and litigation risks' mentioned in the question. The reasoning is sound but somewhat surface-level compared to the ground truth's more comprehensive analysis of what the consistency reveals about management's confidence in their risk framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 462,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90% senior note has stayed at a $2,000 million principal level in FY 2022, FY 2023 and FY 2024, and its effective interest rate has remained at 6.11 % throughout that period.  The unchanged utilization and cost demonstrate Cisco’s disciplined long‑term debt strategy of maintaining a stable, predictable debt profile and interest expense, rather than pursuing aggressive refinancing or rate‑hedging moves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - $2,000 million principal balance maintained across FY 2022-2024 (matches ground truth exactly), and 6.11% effective interest rate consistent throughout the period (matches ground truth exactly). The fiscal year references (2022, 2023, 2024) are accurate. COMPLETENESS: The answer addresses both key components of the question: (1) utilization/balance evolution ($2,000M constant), and (2) effective interest rate evolution (6.11% constant). The answer also addresses the strategic implication question about debt management. ENTITY ACCURACY: Cisco correctly identified, the 5.90% Note properly referenced, and all fiscal years correctly cited. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connected the stable principal balance with the stable effective interest rate to draw a logical conclusion about Cisco's deliberate debt management strategy. The interpretation that this represents 'disciplined long-term debt strategy' and 'stable, predictable debt profile' aligns well with the ground truth's characterization of 'preserved...fixed component' and 'strategic intent to maintain predictable interest obligations.' MINOR DIFFERENCES: The LLM uses slightly different phrasing ('disciplined long-term debt strategy' vs. 'preserved...fixed component') and mentions 'rate-hedging moves' rather than 'refinancing or retiring,' but these are semantically equivalent and represent reasonable interpretations of the same strategic posture. The LLM's language is clear and professional. No calculation errors detected. The answer fully satisfies the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 480,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million** in each of FY 2022, FY 2023 and FY 2024 (see the “Effective Interest Rate” tables in the 2022, 2023 and 2024 10‑K filings). The unchanged balance shows that the company has neither issued additional principal nor repaid this note during the period, indicating a strategy of keeping this long‑term, low‑rate debt component stable rather than actively refinancing or reducing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. (1) CORRECTNESS: All factual information is correct. The principal balance of $495 million is accurately stated for all three fiscal years (2022, 2023, 2024), matching the ground truth exactly. The company name (AVGO) and debt instrument details (3.125% notes due January 2025) are correct. (2) QUANTITATIVE ACCURACY: The $495 million figure is precisely correct for each year mentioned. No calculations are required for this question, but the consistency of the number across three years is accurately conveyed. The LLM correctly identifies that the balance remained unchanged, which is the key quantitative finding. (3) QUALITATIVE ACCURACY: The reasoning is sound and well-articulated. The LLM correctly interprets the unchanged balance as indicating no early repayments or refinancing adjustments, which aligns with the ground truth interpretation. The reference to 'Effective Interest Rate' tables in the 10-K filings adds credibility and specificity. The characterization of this as a 'long-term, low-rate debt component' is appropriate and contextually relevant. (4) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and correctly identifies the trend (stability/no change). The interpretation that this reflects a deliberate strategy of maintaining stable debt rather than active refinancing is logically sound and matches the ground truth assessment. (5) MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth in explaining the strategic implications ('keeping this long-term, low-rate debt component stable'), but this adds value without introducing inaccuracy. The citation of specific filing sections ('Effective Interest Rate' tables) demonstrates proper sourcing. Overall, this is a comprehensive, accurate, and well-reasoned response that fully addresses the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 520,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2024, CMCSA kept wireless services tied to bundled broadband packages, but broadened customer flexibility: in 2022 customers could activate multiple lines and choose unlimited, shared or per‑GB plans (2022, p. 5‑9); in 2023 the same bundling persisted while the company emphasized device financing and multi‑line flexibility (2023, p. 3‑7); by 2024 CMCSA added prepaid unlimited data plans under the NOW brand, letting customers buy wireless separately or within bundles while still offering shared data plans and multi‑line activation (2024, p. 3‑7).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of CMCSA's wireless service evolution from 2022-2024 and correctly identifies the key strategic elements: (1) bundling with broadband, (2) multiple pricing options (unlimited, shared data, per-GB), (3) multi-line flexibility, and (4) the 2024 introduction of NOW brand prepaid unlimited plans. The answer accurately captures the progression toward enhanced customer choice and service integration.\n\nSTRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and their respective offerings; (2) Accurately mentions shared data plans, unlimited plans, per-GB pricing, and NOW brand prepaid plans; (3) Properly synthesizes the bundling strategy evolution; (4) Correctly notes the shift toward greater flexibility by 2024; (5) Appropriately cites page references (though these cannot be verified against ground truth).\n\nWEAKNESSES: (1) The LLM answer mentions \"device financing\" in 2023 which is not explicitly mentioned in the ground truth answer - this appears to be an addition not supported by the provided ground truth; (2) The phrasing \"letting customers buy wireless separately or within bundles\" in 2024 slightly overstates the flexibility compared to ground truth, which emphasizes NOW brand prepaid plans specifically rather than a general ability to purchase wireless separately; (3) Minor semantic difference: ground truth emphasizes \"integration across services\" while LLM focuses more on \"flexibility\" - both are present but weighted differently.\n\nQUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The temporal accuracy (years 2022-2024) is correct.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple service dimensions (bundling, pricing options, customer flexibility), demonstrating appropriate multi-hop reasoning.\n\nSEMANTIC EQUIVALENCE: The core message aligns well with ground truth - CMCSA evolved from basic bundled shared data plans to more flexible offerings including NOW brand prepaid options. The slight overstatement about 2024 flexibility and the unsupported mention of device financing prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 604,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained a persistent funding pressure from 2022 through 2024, as CMS continued to freeze or cut benchmarks and alter risk‑adjustment calculations. In each year the company responded by selectively adjusting member benefits and premiums, exiting plans in certain counties, and intensifying medical and operating cost management (2022–2024) while also expanding its data‑analytics capabilities and Optum services to offset revenue declines (2023–2024) [UNH_10k_2022:23‑27][UNH_10k_2023:18‑22][UNH_10k_2024:18‑22].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the persistent nature of Medicare Advantage risk adjustment payment pressures from 2022-2024; (2) Accurately captures the core strategic responses: selective benefit/premium adjustments, cost management intensification, and plan exits in certain counties; (3) Properly synthesizes multi-hop information across three fiscal years; (4) Correctly identifies CMS benchmark freezes/cuts and risk adjustment calculation changes; (5) Appropriately notes the reactive posture and lack of full resolution. MINOR GAPS: (1) The LLM answer adds details about 'expanding data-analytics capabilities and Optum services' (2023-2024) that are not explicitly mentioned in the ground truth, though these may be valid supporting details from the filings; (2) The ground truth emphasizes the 'reactive posture' and 'continuous adaptation' more explicitly, while the LLM answer is slightly more neutral in tone; (3) The LLM answer includes specific page references [UNH_10k_2022:23-27, etc.] which add credibility but cannot be verified against the ground truth provided. QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or calculations are required in this question, so this dimension is less critical. The years (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple strategic dimensions (benefits, premiums, cost management, analytics expansion), demonstrating sound multi-hop synthesis. The connection between CMS actions and company responses is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis and organization but equivalent factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 501,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "From 2022 to 2024 Mastercard has deepened its multi‑layered security posture by moving from basic third‑party assessments to active public‑private partnerships and real‑time monitoring of incidents involving third‑party providers. The company has also broadened real‑time service integration—building and operating real‑time clearing and settlement infrastructure across a wider array of products—while expanding its real‑time payments footprint from 12 markets in 2022 to 13 markets by the end of 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ELEMENTS: (1) The expansion from 12 markets in 2022 to 13 markets by 2023 is accurately stated and matches the ground truth. (2) The mention of real-time payments infrastructure expansion is appropriate. (3) The reference to third-party collaboration and public-private partnerships aligns with the ground truth. INCORRECT/MISSING ELEMENTS: (1) The LLM answer focuses heavily on 'third-party assessments' and 'real-time monitoring of incidents involving third-party providers,' which are not mentioned in the ground truth and appear to be fabricated details not supported by the source material. (2) The answer fails to address the 2024 evolution entirely—the ground truth explicitly mentions that 'In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture.' The LLM answer stops at 2023 and provides no 2024 information. (3) The answer lacks mention of specific security features like EMV, fraud scoring, and tokenization that were integrated into transaction routing according to the ground truth. (4) The China joint venture expansion is completely omitted. MULTI-HOP REASONING: The LLM answer fails to properly synthesize the three-year evolution (2022-2024) as required by the question. It addresses only 2022-2023 and introduces unsupported claims about 'incident monitoring' that don't appear in the ground truth. The answer is incomplete in temporal scope and introduces potentially fabricated details while omitting verified information about 2024 developments and specific security mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 469,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500% Note due 2030 has remained a fixed‑rate, long‑term debt instrument that appears unchanged in each filing (2022 p. 69‑73; 2023 p. 73‑77; 2024 p. 72‑76). The note’s continued presence, alongside newer higher‑rate notes (e.g., the 3.000% Note due 2025 listed in 2024), indicates that Amazon prioritizes a stable, low‑cost debt core while using additional, higher‑rate debt to refinance other obligations—highlighting a long‑term debt‑management strategy focused on cost‑effective refinancing and maturity diversification.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address key elements of the ground truth. CRITICAL ISSUES: (1) The LLM claims the note 'appears unchanged in each filing' and provides page numbers (2022 p. 69-73; 2023 p. 73-77; 2024 p. 72-76), but these page references cannot be verified and appear to be fabricated specificity. (2) The LLM completely misses the core evolution described in the ground truth: the introduction of new financing instruments in 2023 (Term Loan Agreement dated January 3, 2023) and 2024 (364-Day Revolving Credit Agreement in October 2024). These are critical to understanding the 'evolution' requested in the question. (3) The LLM mentions a '3.000% Note due 2025' as evidence of refinancing strategy, but this is not mentioned in the ground truth and appears to be an unsupported claim. (4) The LLM's interpretation focuses narrowly on the note itself remaining 'unchanged' rather than analyzing how Amazon's broader financing strategy evolved around this note. (5) The ground truth explicitly states the note was in 'Exhibit 4.5' (2022), 'Exhibit 4.6' (2023), and 'Exhibit 4.6' (2024), with specific new agreements introduced in 2023 and 2024—none of which the LLM addresses. WHAT WAS CORRECT: The LLM correctly identifies the 1.500% rate and 2030 maturity date, and correctly notes it as a fixed-rate, long-term instrument. The general concept of maintaining low-cost debt while managing maturity diversification aligns with the ground truth's conclusion about 'layered financing.' MULTI-HOP REASONING: The LLM fails to synthesize the evolution across three years and the introduction of new credit facilities. The ground truth requires understanding how the note's role changed relative to new instruments—the LLM misses this entirely. The answer reads as a static description rather than an analysis of evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 505,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From 2022 to 2024, Comcast’s competition narrative shifted from a focus on 4G/5G wireless broadband services (2022, p. 26‑30) to an expanded threat that now includes 5G fixed‑wireless networks, unlimited‑data usage plans and bundled service packages that can compete with its broadband (2024, p. 19‑23; 2023, p. 6‑10 already noted bundling). The 2024 filing’s explicit mention of unlimited‑data plans and bundled offerings, together with the company’s own bundling strategy and reported net customer losses in the video segment, indicates that this intensified competition is pressuring CMCSA’s market positioning and customer‑retention efforts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of competitive threats from wireless providers to CMCSA's broadband business from 2022-2024, capturing the progression from 4G/5G wireless broadband to 5G fixed wireless networks to bundled offerings with unlimited data plans. The semantic content aligns well with the ground truth answer. However, there are several issues: (1) The LLM cites specific page numbers (p. 26-30, p. 19-23, p. 6-10) that cannot be verified against the ground truth and appear to be hallucinated citations - the ground truth does not provide page references. (2) The LLM introduces additional evidence about 'net customer losses in the video segment' which, while potentially relevant to customer retention strategies, is not explicitly mentioned in the ground truth answer and represents an inference beyond what was provided. (3) The LLM's reference to 'the company's own bundling strategy' is mentioned but not elaborated with specific details from the filings. (4) The chronological progression is correctly identified (2022: 4G/5G wireless broadband → 2023: 5G fixed wireless networks → 2024: bundled DTC streaming and unlimited data plans), matching the ground truth. (5) The conclusion about intensified competition pressuring market positioning and necessitating customer retention efforts is sound and aligns with the ground truth. The answer demonstrates good multi-hop reasoning by synthesizing information across three years, but the citation specificity and introduction of unverified claims reduce confidence in the quantitative accuracy. The qualitative reasoning about competitive escalation and market pressure is solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 456,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell from **$70.4 billion at December 31 2022** to **$67.5 billion at December 31 2023** and then sharply to **$38.0 billion at December 31 2024** [169‑173, 120‑124, 86‑90]. This downward trend shows a shrinking pool of recoverable assets, indicating that AIG’s ability to offset losses via reinsurance has diminished and its exposure to insurance loss risk has increased over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2022 figure of $70.4 billion, which contradicts the ground truth that states 'specific figures were not disclosed' for 2022. This is a major factual error. The 2023 figure of $67.5 billion is correct, and the 2024 figure of $38.0 billion is correct. (2) INTERPRETATION ERROR - The LLM's conclusion is fundamentally backwards. The ground truth indicates that the decline from $67.5B to $38.0B represents 'a substantial reduction in ceded life insurance risk exposure' and 'a strategic shift or de-risking in the life insurance segment.' However, the LLM interprets this as 'AIG's ability to offset losses via reinsurance has diminished and its exposure to insurance loss risk has increased over time.' This is the opposite of what the data shows - a reduction in reinsurance recoverables (particularly the dramatic drop in life reinsurance recoverables from $28.2B to $0.8B) indicates REDUCED exposure to ceded risk, not increased exposure. (3) MISSING CONTEXT - The LLM fails to provide the detailed breakdown of components (ceded loss reserves vs. life reinsurance recoverables) that are crucial to understanding the trend. The ground truth specifically notes the life reinsurance component dropped from $28.2B to $0.8B, which is the key driver of the overall decline and indicates strategic de-risking. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize the three-year trend, it fails to correctly interpret what the trend means for risk exposure. The conclusion that 'exposure to insurance loss risk has increased' is contradicted by the actual reduction in reinsurance recoverables, which represent ceded (transferred) risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 467,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure calculation has remained the same from 2022 through 2024, using the average daily payment volume of the preceding three months multiplied by the estimated days of exposure.  Its credit‑risk mitigation framework—cash collateral and credit‑enhancement instruments for customers that do not meet risk standards—grew from $9.2 billion in 2022 to $12.2 billion in 2023 and $13.5 billion in 2024, raising net exposure from $55.7 billion to $64.9 billion.  No explicit methodological changes were disclosed in response to regulatory scrutiny, though the company notes it reviews its risk‑management policies regularly, likely to address ongoing FTC, DOJ, and EU investigations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Mastercard's settlement exposure methodology remained unchanged from 2022-2024 (average daily payment volume × estimated days of exposure). It appropriately notes no explicit methodological changes were disclosed and correctly references the regulatory scrutiny (FTC, DOJ, EU investigations). The answer demonstrates good understanding of the multi-hop synthesis required.\n\nCRITICAL WEAKNESSES: The LLM introduces specific dollar amounts ($9.2B in 2022, $12.2B in 2023, $13.5B in 2024 for credit risk mitigation, and net exposure figures of $55.7B and $64.9B) that are NOT present in the ground truth answer. The ground truth explicitly states 'there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements' and does not provide these specific financial figures. The LLM appears to have fabricated or hallucinated these numbers, which is a serious factual error. The net exposure calculations ($55.7B to $64.9B) cannot be verified against the ground truth and may be incorrect.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about regulatory events (FTC consent agreement, DOJ CID, EU investigation) and connects them to risk management practices. However, the introduction of unverified financial data undermines the credibility of this synthesis.\n\nQUANTITATIVE ACCURACY: Severely compromised by the unsubstantiated dollar figures. While the methodology description is correct, the specific financial metrics cannot be confirmed and appear to be fabricated.\n\nQUALITATIVE ACCURACY: Good on methodology and regulatory context, but the unsupported financial claims represent a fundamental accuracy problem that cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 485,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 through 2024 AIG’s loss‑reserve governance has become progressively more structured.  In 2022 (p. 165‑169) the company described internal controls and oversight of the reserve‑setting process, reviews by external experts, and the use of stochastic and deterministic modeling to capture uncertainty.  By 2023 (p. 117‑121) AIG added a formal model‑risk management framework and validation processes, and by 2024 (p. 84‑88) it further emphasized escalation procedures, scenario‑ and sensitivity‑analysis techniques, and continued external‑expert reviews, thereby broadening the range of modeling tools used to address reserve uncertainty.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with appropriate temporal progression; (2) Accurately captures the key components mentioned in ground truth: internal controls, external expert involvement, and modeling techniques; (3) Properly synthesizes multi-hop information showing how AIG's approach evolved over time; (4) Correctly identifies specific modeling techniques (stochastic, deterministic, sensitivity analysis, scenario analysis); (5) Appropriately notes the addition of model risk management frameworks and validation processes by 2023-2024; (6) Includes page references that add credibility and specificity. MINOR WEAKNESSES: (1) The LLM answer mentions 'stochastic and deterministic modeling' in 2022, while the ground truth indicates these were more prominently featured in 2023 as part of the expanded framework - this is a slight temporal attribution issue but not a major error; (2) The ground truth specifically mentions 'experience studies' and 'experience monitoring with updated assumptions' as part of the 2023-2024 evolution, which the LLM answer does not explicitly capture; (3) The phrase 'progressively more structured' in the opening is slightly different from the ground truth's emphasis on 'maturing and more integrated risk analytics approach,' though semantically similar. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question, so this dimension is not heavily tested. The years (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (internal controls, external oversight, modeling techniques), showing proper understanding of how these elements evolved together. The logical progression is sound and matches the ground truth's narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 528,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "From 2022 to 2024 the sensitivity of PMPM estimates to a change in benefit mix grew markedly: a 1 % shift in mix raised medical‑cost payable by $298 m in 2022, $376 m in 2023 and $421 m in 2024, while a 3 % shift increased payable by $895 m, $1,128 m and $1,264 m respectively. This upward trend shows that benefit‑design changes are having an increasingly large impact on cost estimates, indicating a rising exposure to benefit‑mix variability over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data that directly addresses the question about PMPM sensitivity evolution from 2022-2024. Strengths: (1) Provides concrete dollar amounts ($298M, $376M, $421M for 1% shift; $895M, $1,128M, $1,264M for 3% shift) that demonstrate the upward trend clearly; (2) Correctly identifies the three-year period (2022-2024) and tracks the progression; (3) Accurately synthesizes the multi-hop requirement by connecting benefit mix sensitivity to exposure variability over time; (4) The mathematical relationship is sound - the ratios between 1% and 3% shifts are consistent (approximately 3:1), suggesting internal consistency. Comparison to ground truth: The original answer describes a qualitative trajectory (general sensitivity → negative impact → stabilized), while the LLM answer provides quantitative evidence of an upward trend in sensitivity magnitude. These are not contradictory but complementary perspectives. The LLM's specific numbers and clear demonstration of increasing impact ($298M→$376M→$421M) actually provides stronger evidence for the 'rising exposure' conclusion. Minor consideration: The original answer mentions a 'shift to neutral tone' in 2024, while the LLM shows continued increase in 2024 sensitivity. However, this could reflect different aspects of the same data (tone vs. magnitude), and the LLM's quantitative approach is more directly responsive to the specific question about sensitivity evolution. The LLM answer is more precise, data-driven, and directly quantifies the exposure variability that the original answer describes qualitatively. No calculation errors detected. All numbers appear internally consistent and properly formatted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 467,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Across 2022, 2023, and 2024 Walmart’s 10‑K filings all list **Marketside** among its private‑label brands (alongside Great Value, Mainstays, etc.), with no change in its categorization or emphasis. This steady inclusion shows that Walmart continues to treat Marketside as a core private‑label line that underpins its everyday‑low‑price, broad‑assortment strategy, underscoring the brand’s ongoing strategic importance in the U.S. merchandise mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that by 2024, there was a 'restructured merchandise unit that emphasized \"Fashion\" instead of \"Apparel,\"' representing a strategic shift in how Walmart categorizes its offerings. The LLM answer claims 'no change in its categorization or emphasis' across all three years (2022-2024), which is factually incorrect. This is a critical multi-hop reasoning failure - the question specifically asks about the 'evolution' and 'progression' of Marketside's positioning, and the LLM missed the key structural change in merchandise unit organization. While the LLM correctly identifies that Marketside appears in private brand lists across all three years and correctly names other brands (Great Value, Mainstays), it fails to capture the essential evolution that the ground truth emphasizes. The LLM's conclusion that there is 'no change' directly contradicts the ground truth's finding of a 'broader strategic shift.' The quantitative accuracy is relatively high (correct years, correct brand names), but the qualitative accuracy is severely compromised by missing the core strategic evolution that the question asks about. The answer demonstrates incomplete synthesis of multi-hop information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 376,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 through 2024, Home Depot strengthened its competitive stance against showrooms by expanding service offerings—adding extensive installation services, tool rentals, and Pro‑focused solutions—and by deepening digital integration, such as mobile‑first, interconnected shopping experiences and enhanced online order management (2022, pp. 7‑11; 2023, pp. 6‑10; 2024, pp. 6‑10). In 2022, the company positioned itself against showrooms by offering a broad range of services and a frictionless digital experience (2022, pp. 7‑11), and in 2023 it continued to invest in digital tools and installation services to meet evolving customer needs (2023, pp. 6‑10). By 2024, Home Depot further differentiated itself with additional showroom space, an upgraded order‑management system, and a $3.5 billion capital‑expenditure plan that bolstered its digital and service capabilities, solidifying its role as a destination for both urgent purchases and complex professional projects (2024, pp. 6‑10).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the general question about Home Depot's competitive positioning evolution but contains significant factual discrepancies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the multi-year evolution from 2022-2024; (2) Mentions relevant service offerings like tool rentals and installation services; (3) Acknowledges digital integration as a key competitive factor; (4) Appropriately contextualizes the evolution across three fiscal years. CRITICAL ERRORS: (1) The ground truth specifically mentions '1,400 locations' for tool rental services in 2022—the LLM answer omits this specific quantitative detail; (2) The ground truth explicitly lists 2023 innovations: 'self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation'—the LLM answer does not mention these specific 2023 features; (3) The LLM introduces a '$3.5 billion capital-expenditure plan' in 2024 that is NOT mentioned in the ground truth, potentially fabricating a specific financial figure; (4) The LLM mentions 'additional showroom space' in 2024, which contradicts the ground truth's focus on omnichannel integration rather than physical showroom expansion. QUANTITATIVE ACCURACY ISSUES: The $3.5 billion figure cannot be verified against the ground truth and appears to be an unsupported claim. The ground truth provides specific location counts (1,400) that the LLM omits. REASONING QUALITY: While the LLM correctly identifies the strategic shift from physical services to omnichannel integration, it mischaracterizes the nature of 2024 evolution (showroom space vs. digital integration) and fails to synthesize the specific tactical innovations mentioned in 2023. The multi-hop reasoning is partially sound but incomplete and contains factual inaccuracies that undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 502,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s $500 million 3.50% senior note stayed at the same principal level from FY 2022 through FY 2024, but its effective interest rate jumped from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024. The steep rise in the effective rate reflects higher market rates and a higher effective yield on the note, indicating that Cisco’s borrowing costs have increased markedly, while the debt structure—fixed‑rate, senior notes maturing June 15 2025—remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $500 million principal amount (consistent FY 2022-2024), effective interest rates of 3.20% (FY 2022), 6.38% (FY 2023), and 6.66% (FY 2024) match the ground truth exactly. The format variations are handled appropriately. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) evolution of effective interest rate across three fiscal years, (2) outstanding amount stability, (3) interpretation of what this indicates about borrowing costs and debt structure. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, the 3.50% Note is properly characterized, and the maturity date (June 15, 2025) is accurately included. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the relationship between rising effective rates and market conditions. The logic is sound - the principal remained constant while effective rates increased significantly, indicating higher borrowing costs. SEMANTIC EQUIVALENCE: The LLM's explanation of 'higher effective yield on the note' and 'marked increase in borrowing costs' conveys the same meaning as the ground truth's 'significant increase in borrowing costs.' The additional detail about the fixed-rate senior note structure and maturity date adds helpful context without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM includes the maturity date (June 15, 2025) which is not in the ground truth but is factually accurate and relevant. The phrasing 'steep rise' and 'markedly' are appropriate characterizations of the 3.46 percentage point increase (3.20% to 6.66%) over two years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 481,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022 to 2024, Comcast’s fiber‑based broadband positioning strengthened against Lumen as it moved from offering up to 3 Gbps speeds and planning DOCSIS 4.0 (2022 p. 7‑11) to rolling out 2 Gbps downstream on 50 % of its HFC footprint, deploying DOCSIS 4.0 in select markets, and launching fiber‑to‑the‑premises with up to 10 Gbps residential and 100 Gbps business speeds (2023 p. 6‑10). By 2024, the company continued expanding DOCSIS 4.0 and fiber‑to‑the‑premises capabilities, further solidifying its high‑speed service portfolio while Lumen remained a competitor building its own fiber network (2024 p. 6‑10). This evolution positioned Comcast as a more advanced fiber broadband provider relative to Lumen.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides incorrect information. Key issues: (1) PERSPECTIVE REVERSAL: The question asks about CMCSA's competitive positioning AGAINST Lumen, but the LLM answer focuses on Comcast's (CMCSA's) own advancements rather than analyzing the competitive dynamic between the two companies. The ground truth explicitly discusses how Lumen remained a consistent competitive threat to CMCSA across 2022-2024. (2) MISSING LUMEN ANALYSIS: The ground truth emphasizes Lumen's fiber expansion, bundled offerings, and speed increases as competitive threats. The LLM answer mentions Lumen only briefly in 2024 as 'a competitor building its own fiber network' without substantive detail about Lumen's competitive positioning or infrastructure advancements. (3) FACTUAL CONCERNS: While the LLM provides specific technical details about CMCSA's offerings (3 Gbps in 2022, 2 Gbps on 50% of HFC footprint in 2023, DOCSIS 4.0 deployment, fiber-to-premises with 10 Gbps residential/100 Gbps business), these cannot be verified against the ground truth and appear to be specific claims that may or may not be accurate. The ground truth does not provide these specific technical metrics. (4) INCOMPLETE SYNTHESIS: The question requires multi-hop analysis of how the competitive relationship evolved across three years. The LLM provides a one-sided narrative of CMCSA's improvements without adequately addressing how Lumen's competitive threat evolved or intensified. (5) STRUCTURAL MISMATCH: The ground truth describes a 'consistent and intensifying competitive threat from Lumen' across the period. The LLM answer suggests CMCSA strengthened its position relative to Lumen, which is a different analytical conclusion not supported by the ground truth. The answer fails to capture the core insight that Lumen remained a named, consistent competitor with advancing fiber infrastructure and service strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 524,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express’s reliance on aggregators has grown steadily from 2022 through 2024, as the 2023 and 2024 10‑Ks note an expanding dependence on merchant acquirers, aggregators and processors to manage merchant relationships (2023 p. 27‑31; 2024 p. 33‑37). This shift has amplified the risk of merchant steering and differential surcharging, and while the company’s contracts contain non‑discrimination and honor‑all‑cards clauses, enforcement is constrained by the third‑party nature of those relationships, a challenge that has intensified over the period (2022 p. 27‑31).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution of American Express's reliance on aggregators from 2022-2024, but has significant gaps and lacks the depth of the ground truth answer. STRENGTHS: (1) Correctly identifies the growing reliance on aggregators/processors across the period; (2) Appropriately mentions merchant steering and non-discrimination/honor-all-cards clauses; (3) Correctly notes enforcement challenges due to third-party relationships; (4) Proper company identification (American Express/AXP) and time period (2022-2024). WEAKNESSES: (1) MISSING KEY EVOLUTION: The ground truth emphasizes a critical trajectory showing how the risk INTENSIFIED from 2022 to 2023 to 2024, with specific escalation points (2023 concern about new products like debit cards facing discrimination; 2024 litigation and regulatory scrutiny). The LLM answer presents this as a steady linear growth without capturing the intensification narrative; (2) INCOMPLETE SYNTHESIS: The ground truth explicitly connects three distinct years with evolving concerns - 2022 (acknowledged reliance), 2023 (increasingly relied, new product discrimination risk), 2024 (litigation/regulatory exposure). The LLM answer mentions 2023 and 2024 but doesn't clearly differentiate the 2022 baseline or show the progression; (3) MISSING SPECIFIC RISKS: The ground truth mentions 'new products like debit cards on the American Express network could face discrimination' and 'litigation and regulatory scrutiny around merchant contract provisions' - these specific risk factors are absent from the LLM answer; (4) PAGE CITATIONS: The LLM provides page numbers (2023 p. 27-31; 2024 p. 33-37; 2022 p. 27-31) but these cannot be verified and appear potentially inaccurate or generic; (5) INCOMPLETE MULTI-HOP REASONING: While the LLM identifies the key elements, it fails to synthesize the causal chain showing how growing aggregator reliance led to specific enforcement challenges and legal/regulatory risks. The ground truth shows this as an interconnected evolution; (6) VAGUE LANGUAGE: Phrases like 'enforcement is constrained' are less specific than the ground truth's discussion of actual legal actions and regulatory scrutiny forcing changes. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator, but the LLM's page citations are unverifiable and potentially incorrect. QUALITATIVE ACCURACY: The LLM demonstrates understanding of the general concept but misses the critical narrative arc of intensifying risk and the specific mechanisms (litigation, regulatory action, product discrimination) that drove the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 702,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 to 2024, Johnson & Johnson shifted its talc strategy from a stay‑based Chapter 11 approach by LTL Management LLC to a comprehensive pre‑packaged plan. In 2022, LTL’s Chapter 11 petition stayed all talc litigation; after court reversals and a dismissal in 2023 the stay was lifted, prompting the company to refile and ultimately pursue a $6.475 billion present‑value pre‑packaged plan in 2024, while establishing a $2 billion trust and a $9 billion reserve for LTL, recording a $5 billion incremental charge and a $11.6 billion present‑value reserve for the plan, and restructuring LLT into Texas entities that filed their own Chapter 11 petitions and enjoined claims. Throughout, the company settled high‑profile cases (including the Ingham verdict and 95 % of mesothelioma suits), reached agreements with state attorneys general, and continued to litigate and appeal decisions to resolve remaining talc claims.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. CRITICAL ERRORS: (1) The LLM cites a '$6.475 billion present-value pre-packaged plan in 2024' - this specific figure does not appear in the ground truth and cannot be verified. (2) The LLM states '$9 billion reserve for LTL' - the ground truth only mentions a '$2 billion reserve' established in 2022; no $9 billion figure is referenced. (3) The LLM references a '$5 billion incremental charge' and '$11.6 billion present-value reserve' - these specific numbers are not in the ground truth. (4) The LLM claims 'restructuring LLT into Texas entities' - the ground truth does not mention Texas entities or this specific restructuring detail. (5) The LLM references 'the Ingham verdict and 95% of mesothelioma suits' - while settlement activity is mentioned in ground truth, these specific case references and percentages are not provided in the original answer. CORRECT ELEMENTS: The LLM correctly identifies that LTL Management LLC filed Chapter 11 bankruptcy in 2022, that the Third Circuit reversed decisions, that LTL 2 was dismissed in July 2023, and that settlement agreements were reached with states. The general narrative arc of shifting from litigation stay to settlement attempts is directionally correct. However, the introduction of unverified financial figures ($6.475B, $9B, $5B charge, $11.6B reserve) represents either hallucination or reliance on sources beyond the ground truth. The multi-hop reasoning about the evolution from 2022-2024 is partially sound but is undermined by the quantitative inaccuracies. The answer demonstrates some understanding of the strategic shift but fails on factual precision regarding specific dollar amounts and case details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 484,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In the 2022 10‑K (pages 7‑11) Home Depot highlighted store appearance—location, visual presentation and ease of navigation—as a key competitive differentiator. By the 2024 10‑K (pages 6‑10) that emphasis had evolved into a full‑scale store‑refresh program adding wayfinding signage, self‑service lockers, curbside pickup, electronic shelf labels, redesigned front‑ends and expanded self‑checkout, all linked to digital tools such as GET phones, mobile‑app navigation and an interconnected retail strategy that ties BOPIS, BOSS, BODFS, BORIS and curbside pickup into a seamless online‑to‑in‑store experience. The 2023 10‑K (pages 12‑16) confirms that these physical upgrades are integrated with a frictionless digital ecosystem, enhancing the customer journey from inspiration to fulfillment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Home Depot's evolution in store appearance strategy from 2022-2024. STRENGTHS: (1) Correctly identifies the core progression from standalone store appearance emphasis (2022) to integrated omnichannel strategy (2024); (2) Accurately cites specific page ranges from 10-K filings (2022: pages 7-11, 2024: pages 6-10, 2023: pages 12-16), showing proper multi-hop document synthesis; (3) Provides concrete examples of physical upgrades (wayfinding signage, self-service lockers, electronic shelf labels, redesigned front-ends, expanded self-checkout) that align with the ground truth's description of store aesthetics and layout integration; (4) Correctly identifies digital integration points (GET phones, mobile-app navigation, BOPIS, BOSS, BODFS, BORIS, curbside pickup) that match the ground truth's mention of 'mobile-optimized platforms, product search, and fulfillment options'; (5) Accurately captures the semantic shift from standalone competitive factor to omnichannel component. MINOR WEAKNESSES: (1) The LLM introduces specific acronyms (BOPIS, BOSS, BODFS, BORIS) and program names that, while plausible and consistent with retail terminology, are not explicitly mentioned in the ground truth answer—these appear to be reasonable inferences but represent slight elaboration beyond the source material; (2) The answer is more specific and detailed than the ground truth, which could indicate either superior research or potential over-specification; (3) No quantitative metrics (e.g., store count, investment amounts, customer satisfaction improvements) are provided, though the question doesn't explicitly require them. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and connects physical store improvements to digital capabilities, demonstrating sound multi-hop reasoning. The progression narrative is logical and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental message as the ground truth—evolution from isolated store appearance focus to integrated digital-physical omnichannel strategy—while providing more operational specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 588,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "From 2022 through 2024 AT&T transitioned from owning and operating Time Warner (WarnerMedia) to fully divesting it: in 2022 AT&T still held a 100 % stake and had integrated WarnerMedia into its WarnerMedia segment (Turner, HBO, Warner Bros.) (T_10k_2022, pp. 3‑7).  In April 2022 the company completed a Reverse Morris Trust with Discovery, distributing the WarnerMedia assets to AT&T shareholders and classifying the unit as discontinued (T_10k_2023, pp. 2‑6; T_10k_2024, pp. 2‑6).  By 2023‑24 AT&T had no remaining ownership or operational role in WarnerMedia, underscoring a strategic pivot away from large content ownership toward a network‑centric model that focuses on delivering its own streaming platform (HBO Max) over its connectivity infrastructure (T_10k_2024, pp. 2‑6).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core narrative - AT&T's divestiture of WarnerMedia through a Reverse Morris Trust with Discovery in April 2022, the transition to discontinued operations status, and the strategic pivot away from entertainment toward telecommunications. The timeline (2022-2024) and key transaction details are accurate. The reasoning about the strategic shift is sound and well-articulated.\n\nCRITICAL ERRORS: (1) The LLM states AT&T 'still held a 100% stake' in 2022 and 'had integrated WarnerMedia into its WarnerMedia segment' - this is misleading because the Reverse Morris Trust was COMPLETED in April 2022, meaning AT&T's ownership was being divested during 2022, not held throughout. The phrasing suggests full ownership persisted when the divestiture was already underway. (2) The LLM mentions 'delivering its own streaming platform (HBO Max) over its connectivity infrastructure' - this is factually incorrect. After the Reverse Morris Trust, HBO Max became part of Warner Bros. Discovery, NOT AT&T. AT&T no longer owned or operated HBO Max post-2022. This represents a fundamental misunderstanding of the transaction outcome.\n\nINCOMPLETENESS: The original answer mentions AT&T's 2024 DIRECTV divestiture to TPG as part of the broader entertainment/media exit strategy. The LLM completely omits this important element of the 3-year trajectory, which was explicitly part of the ground truth answer's explanation of AT&T's strategic pivot. This is a significant gap in addressing the 'multi-year trajectory' aspect of the question.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across 2022-2024 but fails to properly connect all elements. It correctly identifies the WarnerMedia separation but incorrectly suggests AT&T retained operational involvement with HBO Max, and misses the DIRECTV divestiture entirely.\n\nQUANTITATIVE ISSUES: The '100% stake' reference is technically correct for the pre-April 2022 period, but the presentation is misleading given the April 2022 completion date. No calculation errors per se, but the temporal framing is imprecise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 568,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022 through 2024, American Express has remained the fourth‑largest general‑purpose card network, but the competitive landscape has sharpened with the rise of alternative payment platforms and continued pressure from Visa, Mastercard, and regional networks (see 2022‑2024 Competition sections, pages 10‑14).  Regulatory scrutiny has intensified, culminating in 2024’s designation as a Category III bank‑holding firm and the company’s exit from network‑licensing operations in the EU and Australia to comply with new regulatory regimes (see 2024 Supervision & Regulation, pages 32‑36).  These changes have deepened the firm’s regulatory dependency on card‑network rules while forcing it to adapt its competitive strategy amid heightened regulatory and market pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core elements of the question regarding American Express's competitive positioning and regulatory dependency evolution from 2022-2024. STRENGTHS: (1) Correctly identifies AEX as the fourth-largest general-purpose card network, matching the ground truth; (2) Accurately references the 2024 exit from network licensing in EU and Australia; (3) Properly identifies intensifying regulatory scrutiny as a key theme; (4) Correctly notes the shift toward regulatory dependency and compliance-driven strategy; (5) Appropriately synthesizes multi-hop information about competitive pressures (Visa, Mastercard, regional networks) and regulatory changes. MINOR WEAKNESSES: (1) The LLM introduces 'Category III bank-holding firm' designation in 2024, which is not mentioned in the ground truth answer and cannot be verified against it - this represents a potential factual claim that goes beyond the provided ground truth; (2) The answer mentions 'alternative payment platforms' as competitive pressure, which is slightly broader than the ground truth's focus on traditional card networks; (3) The ground truth specifically mentions 'interchange fees, network routing practices, and merchant acceptance terms' as regulatory focus areas, while the LLM answer is more general about 'new regulatory regimes' without these specifics; (4) The ground truth emphasizes 'cobrand arrangements' uncertainty in the EU, which the LLM answer does not explicitly mention. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period, connecting competitive pressures with regulatory changes and their impact on business strategy. The logic flow is sound and the conclusion about deepened regulatory dependency is well-supported. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The dates (2022-2024, 2024 specifically) are correct. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - AEX faced competitive and regulatory pressures that forced strategic adaptation, particularly around network licensing exits and increased regulatory compliance focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 602,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250 % Notes due 2050 fell from **$983 million** at year‑end 2022 to **$826 million** in 2023 and **$808 million** in 2024 (see the long‑term debt tables in the 2022, 2023, and 2024 10‑K). This steady decline shows the company is actively paying down older long‑term debt, underscoring a disciplined strategy of reducing debt exposure while keeping a stable, low‑interest maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All three year-end balances are correct: $983 million (2022), $826 million (2023), and $808 million (2024). The total reduction of $175 million over the three-year period is mathematically accurate ($983M - $808M = $175M). COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the outstanding balance across all three years, (2) the trend showing consistent decline, and (3) interpretation of the company's debt management strategy. ENTITY ACCURACY: Johnson & Johnson is correctly identified, the specific debt instrument (2.250% Notes due 2050) is accurately referenced, and all fiscal years are correct. REASONING QUALITY: The LLM correctly synthesizes information across three separate 10-K filings and draws a logical conclusion about J&J's deliberate debt reduction strategy. The characterization of this as a 'disciplined strategy of reducing debt exposure' is semantically equivalent to the ground truth's 'deliberate strategy to reduce long-term liabilities.' MINOR STRENGTHS: The LLM adds helpful context by noting the 'low-interest maturity profile' and explicitly references the source documents (10-K filings), which enhances credibility. The phrase 'steady decline' accurately captures the trend. NO ERRORS DETECTED: All numbers, calculations, dates, and entities are factually correct. The multi-hop synthesis across three years of data is sound. The only minor distinction is that the LLM's interpretation emphasizes 'disciplined strategy' while the ground truth emphasizes 'deliberate strategy,' but these are semantically equivalent and both supported by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 464,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "From 2022 to 2024, the weighted‑average yield on American Express’s foreign government bonds and obligations climbed steadily—moving from roughly 2.08 % in 2022 to about 2.18 % in 2023 and to roughly 2.28 % in 2024 (see the weighted‑average‑yield tables on pages 119‑123, 133‑137 and 175‑179). This upward trend reflects a gradual rise in international rates and indicates that the company’s portfolio has become increasingly sensitive to global interest‑rate movements, heightening its exposure to foreign‑rate volatility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative dimensions. (1) CRITICAL NUMERIC ERRORS: The LLM reports yields of 2.08% (2022), 2.18% (2023), and 2.28% (2024), which are completely inconsistent with the ground truth data. The ground truth shows: 2022 short-term yield of 6.45%, 2023 short-term yield of 6.45% and 1-5 year yield of 4.48%, and 2024 short-term yield of 5.86% and 1-5 year yield of 2.03%. The LLM's numbers are off by 3-4 percentage points across all years. (2) DIRECTIONAL CONTRADICTION: The LLM claims yields climbed steadily upward (2.08% → 2.18% → 2.28%), directly contradicting the ground truth which shows a declining trend (6.45% → declining to 5.86% for short-term, and 4.48% → 2.03% for 1-5 year bonds). This is a fundamental mischaracterization of the 3-year trend. (3) MISSING CRITICAL CONTEXT: The LLM fails to distinguish between short-term (within 1 year) and medium-term (1-5 years) bond yields, which are essential to understanding the portfolio's maturity structure and yield profile evolution. The ground truth explicitly separates these categories. (4) INCORRECT INTERPRETATION: The LLM concludes the trend indicates 'increasing sensitivity to global interest-rate movements,' when the ground truth indicates a 'decreasing return on foreign government bonds' and a 'shift in the interest rate environment or strategic change.' (5) INCOMPLETE SYNTHESIS: The LLM fails to address the $630 million holding amount mentioned in the ground truth and doesn't properly synthesize the multi-year evolution across different maturity buckets. The answer appears to reference page numbers that may not correspond to the actual data, suggesting potential hallucination of sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 467,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free, self‑service learning was originally hosted on **learning.adobe.com** and was part of a broader Digital Learning Services portfolio that included custom learning for enterprise customers (ADBE 10‑K 2022, pp. 15‑19). By 2024 the platform was re‑branded to **training.adobe.com** and the free learning was positioned as a core element of **Adobe Customer Solutions**, explicitly tied to enterprise customer‑success managers and custom learning services (ADBE 10‑K 2024, pp. 16‑20). This shift shows Adobe’s strategy to embed a unified, branded learning ecosystem into its customer‑success framework, underscoring a broader focus on enabling customers, accelerating adoption, and driving retention.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) DOMAIN REVERSAL: The LLM states the platform was 'originally hosted on learning.adobe.com' and 'rebranded to training.adobe.com' by 2024. The ground truth explicitly states the OPPOSITE: In 2022 it was www.training.adobe.com, and by 2023 it was rebranded to learning.adobe.com. This is a complete reversal of the actual evolution. (2) TIMELINE INVERSION: The LLM incorrectly presents the chronological sequence of platform changes, placing learning.adobe.com first (2022) when it actually came second (2023). (3) MISSING KEY DETAILS: The LLM omits critical contextual information from the ground truth including: the 2023 rebranding milestone, solution-specific skills assessments for marketing teams, and the explicit emphasis on enterprise customer success initiatives in 2023. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the broader strategic themes (customer enablement, retention, adoption), it fails to accurately trace the specific evolution of platform branding that is central to the question. (5) CITATION ISSUES: The LLM cites specific page numbers (pp. 15-19, pp. 16-20) without verification, and these citations cannot be confirmed against the ground truth. The answer demonstrates understanding of Adobe's general customer enablement strategy but fundamentally misrepresents the documented evolution of the learning platform domains, which is the core factual basis of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 422,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90 % Senior Notes stayed at a constant $2.0 billion each fiscal year from 2022 through 2024, and the effective interest rate on those notes remained steady at 6.11 % for each year. This unchanged utilization and cost demonstrate Cisco’s long‑term debt strategy of maintaining a stable debt mix and predictable financing costs rather than pursuing aggressive debt expansion or rate arbitrage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - the $2.0 billion ($2,000 million) outstanding balance is accurate, the 5.90% coupon rate is correct, and the 6.11% effective interest rate is accurate for all three fiscal years (2022-2024). Number formatting variations ($2.0 billion vs $2,000 million) are appropriately handled. COMPLETENESS: The answer addresses all key aspects of the question: (1) utilization/balance evolution, (2) effective interest rate evolution, and (3) implications for debt strategy. ENTITY ACCURACY: Cisco is correctly identified, the specific debt instrument (5.90% Senior Notes) is correctly referenced, and all three fiscal years are properly covered. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the stable balance and stable effective rate to draw a logical conclusion about Cisco's deliberate debt strategy. The interpretation that unchanged metrics indicate no refinancing or retirement is consistent with the ground truth. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as maintaining \"a stable debt mix and predictable financing costs rather than pursuing aggressive debt expansion or rate arbitrage\" is semantically equivalent to the ground truth's statement about maintaining the debt \"on its balance sheet\" as part of a deliberate strategy. Minor difference: The LLM provides slightly more interpretive detail about what the strategy avoids (aggressive expansion, rate arbitrage) versus what it maintains, but this adds reasonable context without contradicting the ground truth. The answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 482,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA increased its allocation to Special Situation Strategies from **8 % of its pension assets in 2022 to 9 % in 2024** (actual allocations in the 2022, 2023, and 2024 tables). This 1‑percentage‑point rise over three years signals a modest but consistent tilt toward opportunistic, higher‑risk private‑equity plays as part of the company’s broader private‑equity strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in critical ways: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims specific percentage allocations (8% in 2022, 9% in 2024) that are not supported by the ground truth. The ground truth explicitly states 'no specific dollar amounts were disclosed for Special Situation Strategies in any year' and that quantitative disclosure is absent. The LLM fabricated precise numerical data that does not exist in the source documents. (2) FACTUAL CONTRADICTION: The ground truth indicates that while Special Situation Strategies were consistently mentioned as a category, no specific allocation percentages were disclosed across the three years. The LLM's claim of specific percentage allocations directly contradicts this. (3) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the available information. Rather than acknowledging the lack of quantitative data (as the ground truth does), it invented specific numbers and calculated a 1-percentage-point increase. (4) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'strategic continuity' and 'consistent inclusion' without quantitative change, while the LLM claims a 'modest but consistent tilt' based on fabricated percentage increases. (5) METHODOLOGY ERROR: The LLM appears to have hallucinated data from 'actual allocations in the 2022, 2023, and 2024 tables' that either don't exist or don't contain the claimed information. This is a critical failure in financial analysis where precision is paramount. The answer demonstrates a fundamental misunderstanding of the source material and violates basic principles of factual accuracy in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 462,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "Global Interventional Solutions sales climbed from **$4.3 billion in 2022** (U.S. $2,169 m + Int’l $2,131 m) to **$6.35 billion in 2023** (U.S. $3,633 m + Int’l $2,717 m) – a 47.7 % jump – and then held steady at **$6.35 billion in 2024** (U.S. $3,633 m + Int’l $2,717 m). The sharp post‑acquisition surge and subsequent plateau demonstrate that the segment has become a key, stable revenue driver within JNJ’s MedTech portfolio, underscoring its strategic importance after the December 2022 acquisition.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that directly contradict the ground truth: (1) WRONG NUMBERS: LLM states 2022 sales were $4.3 billion, but ground truth shows $3,971 million ($3.971 billion). This is a ~$330 million error. (2) WRONG YEAR PROGRESSION: LLM claims 2023 was $6.35 billion and 2024 was $6.35 billion (flat), but ground truth shows 2023 was $4,300 million and 2024 was $6,350 million. The LLM has completely reversed the 2023 and 2024 figures. (3) CALCULATION ERROR: LLM calculates a 47.7% jump from 2022 to 2023, but this is based on incorrect numbers. The actual growth from $3,971M to $4,300M is only 8.3%. (4) MISCHARACTERIZATION: LLM describes the segment as 'holding steady' in 2024, when in fact there was a significant 47.7% acceleration from 2023 ($4,300M) to 2024 ($6,350M). (5) COMPONENT BREAKDOWN: The U.S./International breakdowns provided by LLM ($2,169M + $2,131M = $4,300M for 2022) do not match the ground truth total of $3,971M for 2022. The LLM appears to have confused data from different years or sources. (6) STRATEGIC INTERPRETATION: While the LLM correctly identifies the acquisition timing (December 2022) and attempts to discuss strategic importance, the underlying data is so corrupted that the analysis is fundamentally flawed. The actual story is one of accelerating growth post-acquisition (8.3% in 2023, then 47.7% in 2024), not a plateau. The LLM has failed on the core quantitative requirements and multi-hop synthesis needed to answer this question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 424,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "From 2022 through 2024, Walmart continued to list “No Boundaries” as a private‑label brand within its general‑merchandise portfolio, with no change in its placement across the grocery, general‑merchandise, or health‑and‑wellness units (WMT_10k_2022, p. 8; WMT_10k_2023, p. 9; WMT_10k_2024, p. 8). This consistent positioning over three consecutive years shows that Walmart’s private‑label strategy is to maintain a stable, broad assortment of low‑price brands in its core merchandise units, reinforcing its everyday‑low‑price (EDLP) positioning and building long‑term customer trust.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CLAIM about merchandise unit placement - The LLM states 'No Boundaries' showed 'no change in its placement across the grocery, general-merchandise, or health-and-wellness units,' but the ground truth explicitly states that by 2024, there was a 'reorganization of merchandise units that shifted Apparel to a new Fashion category.' This is a material factual error. (2) MISSING CRITICAL DETAIL - The LLM fails to mention the reorganization from 'General Merchandise' (which included Apparel and Home) to a new 'Fashion' category structure, which is a key evolution the question asks about. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 3-year consistency of 'No Boundaries' branding, it misses the nuanced evolution showing how the brand adapted to structural changes in merchandise organization. (4) CITATION ACCURACY - The LLM provides specific page citations (p. 8, p. 9, p. 8) but these cannot be verified against the ground truth, and the claims made don't align with documented facts. (5) REASONING QUALITY - The LLM's conclusion about EDLP positioning and customer trust is reasonable but somewhat generic and doesn't capture the specific strategic insight about margin expansion in competitive categories mentioned in the ground truth. The answer demonstrates partial understanding of the brand's consistency but fundamentally misrepresents the evolution of merchandise unit organization, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 428,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023, and deepened to a $67 million loss in fiscal 2024. Those losses eroded the company’s other income (loss), net, turning a $392 million gain in 2022 into a $248 million loss in 2023 and a $306 million loss in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ERRORS - The LLM provides precise dollar amounts ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) and claims about other income (loss), net ($392M gain in 2022, $248M loss in 2023, $306M loss in 2024). The ground truth does not provide these specific numbers, only indicating that losses were reported and negatively impacted other income. The LLM appears to have hallucinated these figures. (2) UNVERIFIABLE CLAIMS - The ground truth states Cisco 'disclosed the value of its available-for-sale debt investments in a detailed table' but does not provide the actual numbers. The LLM's specific figures cannot be cross-referenced with the provided ground truth. (3) PARTIAL ALIGNMENT - The LLM correctly identifies the directional trend (from gains to losses, worsening over time) and correctly names the metric (other income/loss, net), which aligns with the ground truth's narrative of 'consistent negative impact.' However, this correct directional understanding is undermined by the fabricated specific numbers. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize the relationship between available-for-sale debt investments and other income (loss), net across three fiscal years, it does so with unsubstantiated numerical claims. The ground truth confirms this relationship exists but does not provide the specific dollar amounts the LLM cites. (5) FUNDAMENTAL PROBLEM - In financial analysis, specific numbers are critical. Providing precise but unverified figures is worse than providing directional statements, as it creates false confidence in incorrect data. The answer fails the primary requirement of factual accuracy for financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 498,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express has maintained a consistent reliance on third‑party merchant acquirers from 2022 through 2024.  The 2022, 2023 and 2024 10‑K filings all describe third‑party acquirers—such as OptBlue and GNS partners—as a key mechanism for expanding merchant coverage, with small‑ and mid‑size merchants served under flexible, no‑fixed‑term agreements and large merchants under fixed‑term contracts, thereby driving transaction growth across all merchant tiers.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant conceptual errors that contradict the ground truth. (1) MAJOR ERROR - EVOLUTION CHARACTERIZATION: The LLM states American Express 'maintained a consistent reliance' on third-party acquirers from 2022-2024, directly contradicting the ground truth which explicitly describes an EVOLUTION or SHIFT from viewing them as 'supplementary to considering them essential for growth.' This is a fundamental misunderstanding of the question's core premise about how reliance has 'evolved.' (2) MISSING CRITICAL DETAILS: The LLM omits key evolutionary markers: (a) 2022's emphasis on OptBlue/GNS allowing processing without direct merchant contracts; (b) 2023's detailed financial structure showing negotiated network rate fees recorded as discount revenue; (c) 2024's explicit statement about 'deeper strategic dependency' on third-party partners for global expansion. These represent the progression of strategic importance. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies OptBlue and GNS as programs and mentions merchant tiers (small, mid-sized, large), it fails to synthesize how the company's strategic framing of these relationships changed across the three-year period. (4) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were provided in either answer, so this dimension scores well (8/10) - both answers avoid numerical errors, though neither provides quantitative metrics. (5) REASONING FLAW: The LLM's conclusion that relationships were 'consistent' rather than 'evolved' represents a failure in multi-hop reasoning across the three years of filings. The ground truth clearly documents a progression in strategic importance and dependency, which the LLM completely misses. (6) CONTEXTUAL ISSUE: While the answer addresses the right topic and entities, it fundamentally mischaracterizes the nature of change, making it contextually misaligned with the question's focus on evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 528,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s multi‑year initiative to grow its financial shared‑service capabilities has remained a consistent, enterprise‑wide effort from 2022 through 2024, with each filing (2022 p. 115‑119, 2023 p. 116‑120, 2024 p. 117‑121) describing the same goal of “integrating, simplifying and standardizing processes and systems for HR, IT, procurement, supply chain and finance.”  Over this period the focus has deepened on aligning and streamlining the design and operation of its financial control environment, reinforcing the integration of those functions and the standardization of financial systems to support shared‑service growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative of Johnson & Johnson's multi-year initiative from 2022-2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance. The answer accurately captures the consistent enterprise-wide effort and the deepening focus on financial control environment alignment. STRENGTHS: (1) Correctly identifies all five functional areas (HR, IT, procurement, supply chain, finance); (2) Accurately conveys the multi-year consistency of the initiative across 2022-2024; (3) Properly synthesizes the evolution from initial emphasis on shared service capabilities to deeper focus on control environment alignment; (4) Includes specific page references (2022 p. 115-119, 2023 p. 116-120, 2024 p. 117-121) showing document sourcing; (5) Maintains semantic equivalence with ground truth regarding proactive nature of initiative. WEAKNESSES: (1) The LLM answer omits an important contextual detail present in the ground truth - the explicit statement that these enhancements were 'not in response to any identified deficiencies in internal controls' and 'not prompted by any material changes or weaknesses in internal control over financial reporting.' This is a significant omission as it clarifies the proactive (vs. reactive) nature of the initiative; (2) The answer is somewhat more concise than the ground truth, potentially missing nuance about the consistency of messaging across years; (3) Does not explicitly state that the initiative remained 'proactive' or address the absence of control deficiencies as a key distinguishing feature. QUANTITATIVE ACCURACY: Page numbers are provided but cannot be independently verified from the question context. The years (2022, 2023, 2024) are correct. No calculations are required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the evolution of emphasis while maintaining the core initiative's consistency. The reasoning is sound and logically structured. OVERALL: The answer is substantially correct on the main facts and demonstrates good multi-hop synthesis, but the omission of the important contextual detail about the proactive nature (not in response to deficiencies) represents a meaningful gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 622,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "American Express has moved from a largely defensive stance in 2022—acknowledging rising competition from open‑banking, digital‑wallet and real‑time‑settlement platforms but without a clear counter‑strategy—to a more proactive approach in 2024, where the company highlights new investments in digital‑wallet integration, real‑time settlement infrastructure and open‑banking APIs to keep its card‑issuer and network businesses competitive. This shift reflects heightened competitive pressure from fintech and tech‑company‑backed payment solutions and a strategic pivot toward technology that supports faster, more seamless payment flows and broader merchant acceptance.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on key factual elements and correctly identifies the core evolution of American Express's positioning from 2022 to 2024. STRENGTHS: (1) Correctly identifies the three main technological threats: open banking, digital wallets, and real-time settlement systems; (2) Accurately captures the temporal progression from defensive/reactive stance (2022) to proactive/strategic adaptation (2024); (3) Properly synthesizes the multi-hop reasoning across years and competitive dynamics; (4) Correctly identifies the shift from viewing these as external threats to adopting them as strategic components; (5) No quantitative errors or incorrect dates/entities. WEAKNESSES: (1) The LLM answer omits specific mention of 2023 as a distinct inflection point where 'the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings,' instead presenting a binary 2022-2024 comparison; (2) Less explicit about the transformation from 'external threats' to 'essential components of technological roadmap' - the LLM frames it more as competitive necessity rather than strategic integration; (3) Adds contextual detail about 'fintech and tech-company-backed payment solutions' not explicitly mentioned in ground truth, though this is reasonable inference; (4) The phrase 'without a clear counter-strategy' in the LLM answer is slightly stronger than the ground truth's 'acknowledged...as a key competitive threat,' suggesting the 2022 position was more reactive than the ground truth indicates. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across the three-year period and identifies the strategic evolution, though with less granularity on the 2023 transition year. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well - American Express moved from defensive acknowledgment to proactive technological investment - though the LLM's framing emphasizes competitive necessity slightly more than strategic integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 561,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In the 2022 10‑K (pp. 95‑99) Frame.io was described as a cloud‑native collaboration platform “directly integrated with Adobe Premiere Pro and Adobe After Effects” that enabled real‑time upload and camera‑to‑cloud capture. The 2023 10‑K (pp. 10‑14) kept that core positioning but added frame‑accurate commenting and still‑image camera support, still limited to Premiere Pro and After Effects. By the 2024 10‑K (pp. 10‑14) Adobe had expanded Frame.io’s integration to Photoshop, Lightroom, Workfront, and the new GenStudio suite (including Express and Firefly Services), signaling a strategy to embed collaboration across the entire Creative Cloud ecosystem and make it a core, end‑to‑end production workflow.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of Frame.io across three fiscal years (2022-2024). STRENGTHS: (1) Correctly identifies Frame.io's positioning in each year with accurate progression: 2022 as cloud-native platform with Premiere Pro/After Effects integration; 2023 adding frame-accurate commenting and still-image support; 2024 expanding to Photoshop, Lightroom, Workfront, and GenStudio. (2) Accurately captures the strategic shift from post-production focus to broader creative workflows. (3) Properly cites specific 10-K page references (pp. 95-99 for 2022, pp. 10-14 for 2023 and 2024), demonstrating document-specific sourcing. (4) Correctly synthesizes the multi-hop reasoning showing Adobe's deepening investment in end-to-end collaboration. (5) Mentions GenStudio suite integration (Express and Firefly Services), which adds valuable detail. MINOR GAPS: (1) The original answer mentions Frame.io being 'listed among Adobe's trademarks' in 2022, which the LLM answer does not explicitly address, though this is a minor contextual detail. (2) The original answer specifically mentions 'casting, location scouting, and marketing campaign management' as expanded use cases in 2024, while the LLM answer frames this more broadly as 'end-to-end production workflow' without these specific examples. (3) The phrase 'central hub for multi-app, cross-functional workflows at scale' from the original is not explicitly stated, though the LLM's 'core, end-to-end production workflow' conveys similar meaning. QUANTITATIVE ACCURACY: All dates and year references are correct; no calculations required. QUALITATIVE ACCURACY: The reasoning about strategic evolution is sound and properly synthesizes information across three years. The conclusion about embedding collaboration across Creative Cloud ecosystem is well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses the question about positioning evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 541,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s outstanding balance on its 2017 Notes fell from **$16.0 billion** at December 31 2022 (2023 p.56) to **$15.0 billion** at December 31 2023 (2023 p.56) and further to **$13.0 billion** at December 31 2024 (2024 p.56). This gradual reduction reflects a disciplined debt‑management strategy, actively paying down higher‑rate long‑term debt. By shrinking the 2017 Notes balance, Amazon lowers interest expense and improves its leverage profile, supporting a lower weighted‑average cost of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $16.0 billion (Dec 31, 2022), $15.0 billion (Dec 31, 2023), and $13.0 billion (Dec 31, 2024). The progression shows consistent year-over-year reductions ($1.0 billion in 2023, $2.0 billion in 2024), which is mathematically accurate. ENTITY ACCURACY: Correctly identifies Amazon's 2017 Notes and the proper fiscal year dates. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the three-year debt evolution and connects it to strategic implications. REASONING QUALITY: The LLM goes beyond the ground truth by providing additional context about the strategic rationale - explaining that the paydown reduces interest expense and improves leverage profile/weighted-average cost of capital. This enhanced analysis is logically sound and adds value without contradicting the ground truth. COMPLETENESS: Addresses both parts of the question - the evolution of the balance AND what it indicates about debt management strategy. MINOR CONSIDERATION: The ground truth uses the phrase 'gradually pay down this liability' while the LLM uses 'disciplined debt-management strategy, actively paying down higher-rate long-term debt.' Both convey the same strategic intent, though the LLM provides more specific financial reasoning. The inclusion of page references (p.56) adds credibility. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 398,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 10‑K filings for 2022, 2023 and 2024 all list upgrades and conversions as a core component of its Global Services offering, with the wording and emphasis unchanged (see page 3 of each filing). This steady focus signals a long‑term strategic priority on sustaining existing aerospace platforms through upgrades and conversions, underscoring the company’s commitment to aftermarket support and lifecycle services.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Boeing's Global Services segment consistently included 'Upgrades and Conversions' across 2022-2024, matching the ground truth. The answer accurately conveys the core finding: sustained strategic focus on modernizing existing aerospace platforms through lifecycle management and aftermarket support. Strengths: (1) Correctly identifies all three years (2022, 2023, 2024) with accurate entity identification (Boeing, Global Services segment); (2) Accurately characterizes the consistency of the offering across the period; (3) Properly synthesizes the multi-hop reasoning about strategic implications (long-term priority, aftermarket support, lifecycle services); (4) Semantic equivalence is strong - 'steady focus,' 'long-term strategic priority,' and 'commitment to lifecycle management' convey the same meaning as the ground truth. Minor weaknesses: (1) The LLM cites 'page 3 of each filing' which is a specific reference not present in the ground truth - this is a minor addition that doesn't contradict but adds specificity not verified; (2) The LLM answer is slightly more concise and omits the specific mention of 'supply chain management and maintenance' as companion services listed in 2022, though this is a minor contextual detail; (3) The phrase 'wording and emphasis unchanged' is asserted but not substantiated with examples. Overall, the answer demonstrates sound multi-hop reasoning across three years and correctly synthesizes the strategic implications. No calculation errors or factual inaccuracies detected. The answer appropriately addresses the question's focus on trajectory and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 455,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s 2021 amendment to its U.S. non‑union pension plan—effective Jan 1 2026—applies the Retirement Value formula to all eligible employees regardless of hire date. The 2022, 2023, and 2024 10‑K disclosures (2022 p. 73‑77; 2023 p. 74‑78; 2024 p. 75‑79) reiterate that this policy remains unchanged, with no adjustments to eligibility or the 2026 implementation date, and the company continues to communicate the same effective date to employees.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2026 implementation date, the January 2021 announcement, the application to all U.S. non-union employees, and that the policy remained unchanged across 2022-2024. The page number citations (2022 p. 73-77; 2023 p. 74-78; 2024 p. 75-79) are appropriately formatted and plausible. The core factual claim that no changes occurred to eligibility or timeline is accurate.\n\nWEAKNESSES: (1) The LLM answer lacks the important clarification from the ground truth that employees hired after 2014 were ALREADY under the Retirement Value formula before 2026, which is a key distinction about the evolution of the strategy. (2) The ground truth specifies that the Final Average Pay formula still applies to pre-2015 hires for service BEFORE 2026, which provides important context about the transition mechanism that the LLM answer omits. (3) The LLM answer states the formula applies to 'all eligible employees' but doesn't clarify the distinction between those already under it (post-2014 hires) and those transitioning to it in 2026 (pre-2015 hires). (4) The LLM answer doesn't adequately capture the evolution narrative—it presents the information as static rather than showing how understanding/communication evolved from 2022 to 2024.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies that no changes occurred. However, it misses the nuanced evolution in how the company clarified eligibility criteria across these years, which was a key part of the original question about how the strategy 'evolved.'\n\nNUMERIC/DATE ACCURACY: All dates are correct (January 2021 announcement, 2026 implementation, 2022-2024 years). No calculations are required for this question.\n\nSEMANTIC ISSUES: The phrase 'applies the Retirement Value formula to all eligible employees regardless of hire date' is technically correct for the 2026 date but could be misleading without the clarification that some employees were already under this formula before 2026.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 554,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2022, FY 2023, and FY 2024 (see the senior‑notes table on pages 101‑105 of the 2022 10‑K, pages 79‑83 of the 2023 10‑K, and pages 79‑83 of the 2024 10‑K). The unchanged balance shows that the company has not repaid or refinanced this instrument, indicating a strategy of maintaining a stable, long‑term debt profile and preserving the favorable interest‑rate and maturity terms until the notes mature in 2030.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states the outstanding principal balance was $606 million at the end of FY 2022, FY 2023, and FY 2024 (unchanged throughout). However, the ground truth clearly shows: FY 2022: $1,086 million, FY 2023: $606 million, FY 2024: $606 million (unchanged from 2023). This is a major quantitative error - the LLM missed the $480 million reduction that occurred between FY 2022 and FY 2023 ($1,086M - $606M = $480M decrease). The LLM's claim that 'the company has not repaid or refinanced this instrument' is factually incorrect, as there was a significant $480 million repayment/reduction between 2022 and 2023. The LLM's interpretation of the debt management strategy is therefore fundamentally flawed - it should indicate a deliberate reduction strategy (as stated in ground truth), not a strategy of maintaining stable debt. The LLM correctly identified the company (AVGO), the instrument (5.000% notes due April 2030), and the fiscal years, but failed on the core quantitative data and the resulting strategic interpretation. The reasoning about 'preserving favorable interest-rate and maturity terms' contradicts the actual debt reduction that occurred. This is a multi-hop question requiring synthesis of data across three fiscal years, and the LLM failed to correctly synthesize the progression, missing the key evolution from 2022 to 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 404,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T acquired Time Warner in 2018 and folded the company into its WarnerMedia segment. In 2021 AT&T agreed to merge WarnerMedia with Discovery, and by April 2022 the Reverse Morris Trust transaction completed the separation, re‑classifying WarnerMedia as a discontinued operation and divesting the Time Warner assets (2024 10‑K pp. 2‑6; 2023 10‑K pp. 2‑6; 2022 10‑K pp. 3‑7). By 2024 the WarnerMedia business remained a discontinued operation, reflecting the full divestiture of the Time Warner holdings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the key timeline and transactions but has some notable gaps and a minor chronological inconsistency. STRENGTHS: (1) Correctly identifies the 2018 Time Warner acquisition and its integration into WarnerMedia segment; (2) Accurately dates the Reverse Morris Trust transaction completion to April 2022; (3) Correctly identifies the transaction as a merger with Discovery; (4) Properly characterizes WarnerMedia as a discontinued operation by 2024; (5) Correctly notes the divestiture of Time Warner holdings. WEAKNESSES: (1) States 'In 2021 AT&T agreed to merge WarnerMedia with Discovery' - the ground truth indicates the transaction was completed in April 2022, but the agreement timing is not explicitly confirmed in the ground truth provided; (2) The answer states 'By 2024 the WarnerMedia business remained a discontinued operation, reflecting the full divestiture of the Time Warner holdings' which is somewhat redundant and doesn't add clarity about the evolution from 2022-2024; (3) Missing the broader strategic narrative about AT&T's pivot away from vertically integrated media back to core telecommunications - the ground truth emphasizes this strategic shift, while the LLM answer is more transactional in focus; (4) Does not address the DIRECTV divestiture mentioned in the ground truth as the 'last major asset tied to the entertainment strategy'; (5) The answer focuses heavily on the mechanics of the transaction rather than the 'evolution' and 'strategic relationship' aspects emphasized in the question. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years (2018-2024) and connects the Time Warner acquisition to the WarnerMedia segment to the Discovery merger to the discontinued operation status. However, it misses the broader strategic context of AT&T's business model transformation. QUANTITATIVE ACCURACY: All dates and transaction details are accurate (2018 acquisition, April 2022 completion). No calculation errors. CONTEXTUAL RELEVANCE: While the answer addresses the core transaction timeline, it incompletely addresses the 'evolution' and 'strategic relationship' aspects of the question, focusing instead on transaction mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 600,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "AIG’s approach to international terrorism exposure stayed essentially the same from 2022 through 2024.  In 2022 the company disclosed a specific five‑ton bomb scenario with a $1.3 billion net loss and a $1.7 billion deductible under TRIPRA, which covers 80 % of losses above that deductible【2022 pages 167‑171】.  The 2023 and 2024 10‑Ks repeat that terrorism risk is modeled with third‑party scenarios, that TRIPRA remains the primary reinsurance protection, and that targeted private reinsurance and country terrorism pools are used, but they do not report any new attachment points or changes to the deductible【2023 pages 119‑123】【2024 pages 86‑90】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical information from the ground truth. MAJOR ERRORS: (1) The LLM claims AIG's approach 'stayed essentially the same' from 2022-2024, directly contradicting the ground truth which explicitly states there was 'a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.' (2) The LLM fails to identify the key 2024 evolution: specific geographic attachment points of $200 million for Japan and $125 million for rest of world - these are central to the question about 'refined geographic attachment points' and represent a material change in risk management approach. (3) The LLM incorrectly states the TRIPRA deductible is $1.7 billion and covers 80% of losses - while the $1.3 billion loss figure is correct, the characterization of TRIPRA mechanics appears incomplete/inaccurate compared to ground truth. (4) The LLM's conclusion that 2023 and 2024 'do not report any new attachment points or changes' is factually wrong - the ground truth explicitly documents 2024 attachment points. WHAT WAS CORRECT: The $1.3 billion five-ton bomb scenario for 2022 is accurate, and the general statement about TRIPRA being primary reinsurance and use of private reinsurance/country pools is directionally correct. MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the evolution across the three-year period, instead characterizing it as static when the ground truth shows clear progression toward geographic segmentation. The answer fundamentally misses the strategic evolution that is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 447,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s 10‑K filings for 2022, 2023 and 2024 all present the same description of its pipe‑working tools line—pipe wrenches, cutters, threading/roll‑grooving equipment, etc.—and make no mention of new introductions or discontinuations (see 2022 p. 7–11 and 2024 p. 71–75).  The unchanged product‑portfolio narrative indicates that Emerson has kept its core pipe‑wrench offering stable, focusing on incremental refinements and customer reliability rather than rapid product innovation.  This steady positioning underscores the company’s strategy to maintain a solid foothold in the professional tools market while prioritizing quality and durability.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on multiple critical factual points: (1) MAJOR FACTUAL ERROR: The LLM claims the product portfolio descriptions are 'unchanged' across 2022-2024, but the ground truth explicitly states significant evolution occurred—battery hydraulic tools were introduced in 2023, diagnostic systems like sewer inspection cameras were added in 2023, and digital integration was emphasized in 2024. (2) MISSING KEY DEVELOPMENTS: The LLM completely fails to identify the introduction of battery-powered tools and enhanced diagnostic systems that represent the core of Emerson's strategic evolution. (3) INCORRECT INTERPRETATION: The LLM concludes the company pursued 'incremental refinements' and 'stable' positioning, when the ground truth indicates a deliberate 'strategic shift toward modernizing' the segment with new technologies. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about portfolio evolution FROM 2022 TO 2024 and what this indicates about strategic positioning. The LLM failed to synthesize the year-over-year changes (2022→2023→2024) that demonstrate strategic modernization. (5) CITATION ISSUE: While the LLM cites specific page numbers, the actual content analysis appears superficial or incorrect, as it misses documented product introductions. (6) CONTRADICTS GROUND TRUTH: The ground truth clearly documents battery hydraulic tools, sewer inspection cameras, and digital integration as new additions, not static offerings. The LLM's assertion of 'unchanged product-portfolio narrative' is factually incorrect based on the knowledge graph data. The answer demonstrates fundamental failure to identify and synthesize the multi-year product evolution that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 475,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has consistently treated free‑rent periods as lease incentives, recognizing them on a straight‑line basis over the lease term and any reasonably certain extensions. The present value of the free‑rent period is deducted from the lease liability, so the right‑of‑use (ROU) asset is initially measured net of the incentive, lowering its carrying amount. This accounting treatment and disclosure remained unchanged in the 2022, 2023, and 2024 10‑K filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Specific issues: (1) INCORRECT CORE CLAIM: The LLM states treatment 'remained unchanged in the 2022, 2023, and 2024 10-K filings,' but the ground truth explicitly states there WAS an evolution - the 2022 filing included detailed disclosure of discounting methodology and ARO treatment that was NOT repeated in 2023-2024, indicating a shift toward standardized language. This is a fundamental misunderstanding of the question's focus on 'evolution.' (2) INCOMPLETE METHODOLOGY DESCRIPTION: The LLM correctly identifies straight-line recognition but fails to mention the incremental borrowing rate derivation from quoted interest rates, which was explicitly disclosed in 2022. (3) MISSING KEY DISCLOSURE EVOLUTION: The ground truth's central point is that disclosure depth DECREASED over time - the 2022 filing was more detailed about valuation mechanics, while 2023-2024 used more standardized ASC 842 language. The LLM completely misses this disclosure evolution. (4) INCORRECT ROU ASSET VALUATION DESCRIPTION: The LLM states the ROU asset is 'initially measured net of the incentive,' but the ground truth indicates the present value of free-rent periods is deducted from the lease liability (affecting liability measurement), not that the ROU asset is measured net. This represents a conceptual error in understanding the mechanics. (5) MISSING CONTEXT: The ground truth notes this represents 'maturation of lease accounting practices post-adoption period,' suggesting a deliberate shift in disclosure strategy. The LLM provides no such contextual insight. The answer demonstrates partial understanding of Costco's lease accounting but fundamentally fails to address the evolution question and contains technical inaccuracies in the accounting mechanics description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 509,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "In 2022 Microsoft’s 2.000 % Notes were due 2020 and were governed by the Tenth Supplemental Indenture (Exhibit 4.13). In 2023 the company issued new 2.000 % Notes due 2023, documented under the Eleventh Supplemental Indenture (Exhibit 4.14). By 2024 Microsoft had shifted away from the 2.000 % series, issuing 2.875 % Notes due 2024 under the Twelfth Supplemental Indenture (Exhibit 4.15) rather than new 2.000 % Notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. MATURITY DATE ERRORS: The LLM claims 2.000% Notes were due 2020 in 2022, but ground truth states they were due 2023. This is a fundamental factual error - the maturity date is wrong by 3 years.\n\n2. INDENTURE DOCUMENTATION ERRORS: The LLM incorrectly identifies the indenture framework. Ground truth clearly states the 2.000% Notes were under the Eleventh Supplemental Indenture dated August 8, 2016 across all three years (2022-2024). The LLM incorrectly claims they were under the Tenth Supplemental Indenture in 2022 and then switched to Eleventh in 2023.\n\n3. ISSUANCE NARRATIVE ERRORS: The LLM suggests Microsoft issued NEW 2.000% Notes due 2023 in 2023, implying a new issuance. Ground truth indicates the same 2.000% Notes were consistently referenced across all years with no structural changes - this was not a new issuance in 2023.\n\n4. 2024 ANALYSIS ERRORS: The LLM claims Microsoft \"shifted away\" from 2.000% series and issued 2.875% Notes instead. Ground truth states the 2.000% Notes due 2023 were still present in the 2024 exhibit list, showing continuity in historical documentation, not a shift to different instruments.\n\n5. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the consistent debt structure across three years. It incorrectly portrayed this as an evolving series of new issuances rather than a stable, consistent instrument.\n\nThe answer demonstrates fundamental misunderstanding of the question and provides incorrect financial data across all key metrics (maturity dates, indenture numbers, and the nature of the debt evolution).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 462,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon continued to recognize third‑party seller services revenue when the services were rendered—generally at the point the seller’s products are delivered to a third‑party carrier or to the customer for an Amazon delivery (2022 p. 1‑5; 2023 p. 41‑45; 2024 p. 1‑5).  The revenue composition remained the same across the three years: commissions plus related fulfillment and shipping fees.  No change in the timing or allocation of those components was disclosed in the 2022‑2024 filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the consistent revenue recognition timing principle (upon delivery to third-party carrier or customer) across all three years; (2) Accurately characterizes the revenue composition as commissions plus fulfillment and shipping fees; (3) Properly notes the absence of disclosed changes in timing or allocation across the period; (4) Appropriately cites page ranges for each year's filing; (5) Demonstrates sound multi-hop reasoning by synthesizing information across three separate annual filings. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth, which provides slightly more context about the types of fees (fixed fees, percentage of sales, per-unit activity fees, interest mentioned in 2022); (2) The ground truth emphasizes 'increasing clarity in disclosures over time,' which the LLM answer doesn't explicitly highlight, though this is a subtle interpretive point rather than a factual error; (3) The LLM answer could have been slightly more explicit about the 2023 specification being a clarification of the timing principle. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, so this dimension is less critical. The dates (2022, 2023, 2024) are all correct. SEMANTIC EQUIVALENCE: The LLM answer conveys the core factual content accurately and is semantically equivalent to the ground truth on the key points: consistent revenue recognition timing, composition of revenue streams, and lack of disclosed changes. The answer directly addresses the question's focus on 'timing and composition' of revenue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 475,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s continued guarantee of Southwestern Bell Telephone Co.’s obligations through 2024 reflects a deliberate strategy of retaining long‑term support for legacy telecom liabilities. By maintaining the guarantee, AT&T signals that it is willing to absorb potential future defaults or restructuring costs for its former subsidiaries, thereby preserving credit stability and protecting the interests of bondholders and other stakeholders. This approach indicates a preference for steady, predictable liability management over divesting or restructuring legacy obligations, ensuring that legacy telecom entities remain financially backed as they transition out of AT&T’s core operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that AT&T maintained guarantees of Southwestern Bell Telephone Co.'s obligations across 2022-2024, and the years/entities are accurate. However, there are significant issues with the reasoning and interpretation: (1) The LLM introduces speculative claims not supported by the ground truth, such as 'absorb potential future defaults or restructuring costs' and 'preserving credit stability and protecting bondholders' - these are inferences beyond what the filing evidence shows. (2) The ground truth emphasizes that the guarantee was 'unchanging' and showed 'no indication of reduction or restructuring,' focusing on the stability and consistency of the commitment itself. The LLM shifts focus to motivations (credit stability, bondholder protection) that are not explicitly stated in the filings. (3) The LLM's phrase about 'legacy telecom entities remain financially backed as they transition out of AT&T's core operations' is somewhat speculative and not directly supported by the ground truth's more straightforward observation about the persistence of guarantee language. (4) The ground truth is more precise and evidence-based, noting the 'repeated inclusion of Exhibit 4-b' as the specific documentary evidence, while the LLM generalizes without citing this specific exhibit reference. The quantitative accuracy is good (correct years and entities), but the qualitative reasoning introduces unsupported interpretations rather than sticking to what the filings actually demonstrate about the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 428,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 declined from $983 million at the end of 2022 to $826 million in 2023 and $808 million in 2024, reflecting a gradual repayment of that tranche. The steady drop, while keeping the effective rate at 2.29 %, shows the company’s disciplined approach to managing maturity risk and maintaining a low‑cost, long‑term debt base.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correct: $983 million (2022), $826 million (2023), and $808 million (2024), plus the effective rate of 2.29%. The multi-hop synthesis is sound, correctly tracking the debt instrument across three years and identifying the trend of gradual decline. The reasoning about disciplined debt management and maturity risk is logically sound and appropriate. However, there are minor differences from the ground truth: (1) The LLM characterizes the decline as 'gradual repayment of that tranche' which is slightly more specific/interpretive than the ground truth's 'minor reductions in exposure,' though both convey similar meaning; (2) The LLM omits the phrase 'relatively stable' which the ground truth uses to characterize the overall pattern - while the numbers show decline, the ground truth emphasizes the stability aspect more explicitly; (3) The LLM's phrase 'maintaining a low-cost, long-term debt base' is semantically equivalent to the ground truth's 'maintaining a stable cost of capital at a fixed effective rate' but uses slightly different framing. The answer is comprehensive, addresses the evolution question and the strategic implications question, and all calculations/numbers are verified as correct. The minor omission of the 'relatively stable' characterization and slight reframing of the strategic interpretation prevents a perfect score, but the core answer is substantively correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 409,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 stayed at a carrying amount of $1.25 billion in 2022, 2023 and 2024 (Note 4‑Debt, pages 52–54). The maturity schedule shows the notes due in 2027 (2025‑2027 schedule, pages 53–54). This unchanged balance indicates that Costco has not issued additional 1.375 % notes or redeemed them, reflecting a conservative capital‑management strategy that keeps a stable, low‑interest long‑term debt profile to support growth while preserving liquidity (Note 4‑Debt, pages 52–54).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 1.375% Senior Notes due June 2027 at $1.25 billion ($1,250 million) for all three years (2022-2024), matching the ground truth. (2) The note references (Note 4-Debt, pages 52-54) are appropriately cited. (3) The observation that the balance remained unchanged is accurate. CRITICAL WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to address the broader long-term debt structure evolution that is central to the question. The ground truth explicitly states total long-term debt decreased from $6,590M (2022) to $6,484M (2023) to $5,919M (2024). The LLM completely omits these critical figures and the year-over-year comparisons. (2) MISSING CAPITAL MANAGEMENT ANALYSIS: The ground truth reveals that Costco's strategy involved 'selective repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.' The LLM's characterization as merely 'conservative' and 'stable' misses the nuanced insight about selective debt reduction across the portfolio. (3) INCOMPLETE ANSWER TO QUESTION: The question explicitly asks 'how did...evolve' and 'what does this reveal about capital management strategy.' The LLM addresses only the specific note (no evolution shown) and provides generic capital management commentary rather than the specific strategic insight about differential debt reduction. (4) QUANTITATIVE INCOMPLETENESS: The LLM provides only 1 of 7 key financial data points (the $1.25B figure) while omitting the total debt figures for all three years that demonstrate the actual evolution. This is a significant gap in a multi-hop financial question. CALCULATION/ACCURACY: No calculation errors, but the selective omission of required data points constitutes a material factual gap. The answer reads as a partial response that addresses only the surface-level observation about the specific notes while failing to synthesize the broader debt structure context needed to answer the full question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 536,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "From 2022 to 2024 Mastercard expanded its real‑time payments infrastructure from 12 to 13 markets and continued to grow, while its multi‑layered security program deepened—adding more cyber‑resilience layers, third‑party assessments, advanced fraud‑scoring and tokenization, AI‑driven privacy controls, and formal technical standards with issuers, acquirers and industry partners. This parallel evolution shows the company is deliberately scaling risk management in tandem with network expansion, embedding robust, evolving security and governance into every new payment channel as it scales globally.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE INACCURACY - LLM states expansion 'from 12 to 13 markets' but ground truth shows: 12 markets in 2021 (reported in 2022 filing), 13 markets in 2023, and 'several countries' (qualitative, not quantitative) in 2024. The LLM incorrectly implies this was the only expansion, missing the 2024 shift to 'several countries around the world' which represents a qualitative change in reporting scope. (2) UNSUPPORTED CLAIMS - LLM introduces specific security features ('advanced fraud-scoring and tokenization, AI-driven privacy controls, formal technical standards') that are NOT mentioned in the ground truth. The original answer only references 'multi-layered security approach,' 'third-party assessments and partnerships,' and 'protection from cyber threats.' These additions appear fabricated. (3) INCOMPLETE TEMPORAL ANALYSIS - LLM fails to capture the significant 2024 shift from quantitative market counting (12→13) to qualitative 'several countries' language, which the ground truth identifies as 'signaling a qualitative shift toward broader global deployment.' (4) REASONING QUALITY - While the LLM correctly identifies the parallel evolution concept and risk management scaling, it does so by inventing details rather than synthesizing actual filing information. The ground truth explicitly notes 'filings do not explicitly state that security measures directly enabled infrastructure expansion,' but LLM's language ('embedding robust, evolving security...into every new payment channel') overstates the causal relationship. CORRECT ELEMENTS: The core insight about parallel scaling of security with infrastructure expansion is sound, and the general strategic intent is correctly identified. However, the answer is undermined by fabricated security details and incomplete/inaccurate market expansion numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 500,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft issued the 4.000% Notes due 2021 in 2011 under the Third Supplemental Indenture (4.6). The notes matured in 2021, and by FY 2022 the company had fully retired them, leaving a zero balance on the debt schedule; the 2023 and 2024 10‑Ks likewise show no outstanding 4.000% Notes due 2021. This pattern demonstrates Microsoft’s disciplined debt‑maturity management, consistently retiring maturing debt and maintaining a low long‑term debt profile【4.6】【MSFT_10k_2022 pages 102‑106】【MSFT_10k_2023 pages 102‑106】【MSFT_10k_2024 pages 102‑106】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Debt Status: The ground truth explicitly states that Microsoft 'continued to disclose the 4.000% Notes due 2021 in its exhibit list' across FY 2022, 2023, and 2024, even 'despite the note being past its maturity date.' The LLM claims the notes were 'fully retired' by FY 2022 with 'zero balance on the debt schedule' and that '2023 and 2024 10-Ks likewise show no outstanding 4.000% Notes due 2021.' This is a direct contradiction of the ground truth. (2) EXHIBIT REFERENCE ERROR: The ground truth confirms the Third Supplemental Indenture was 'listed as Exhibit 4.6 in the 10-K filing' and 'again referenced under the same exhibit number and description' across all three years. The LLM correctly identifies Exhibit 4.6 but incorrectly interprets what this means - the continued reference indicates ongoing disclosure, not retirement. (3) INTERPRETATION ERROR: The ground truth indicates 'a consistent and transparent approach to debt disclosure, even post-maturity' and suggests 'either a delayed settlement, rollover, or ongoing disclosure requirement.' The LLM misinterprets this as full retirement, which is factually incorrect. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the information that the notes were referenced consistently across all three years despite being past maturity - this is the key insight the question asks about. Instead, the LLM invented a narrative of retirement that contradicts the actual filing evidence. The answer demonstrates disciplined debt management but for the wrong reason (retirement vs. transparent post-maturity disclosure). The contextual relevance score reflects that the answer does address Microsoft's debt management strategy, but with fundamentally incorrect facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 503,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated mention of the 1.500% Note due 2030 in its 10‑K filings (see the Officer’s Certificate of June 3 2020 referenced in the 2022, 2023 and 2024 reports) signals that the company treats this long‑term, low‑coupon debt as a core, stable component of its capital structure. By keeping a consistent 1.5% long‑term note in its debt mix, Amazon balances a low‑cost, long‑duration source of capital against higher‑rate or shorter‑maturity instruments, providing a diversified debt profile and a benchmark for future refinancing decisions【AMZN_10k_2022.pdf: 69‑73】【AMZN_10k_2023.pdf: 73‑77】【AMZN_10k_2024.pdf: 72‑76】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 1.500% Note due 2030 as a core, stable component of Amazon's capital structure and accurately conveys the strategic intent of maintaining low-cost, long-duration debt alongside higher-rate instruments. The answer demonstrates sound multi-hop reasoning by synthesizing information across 2022, 2023, and 2024 filings.\n\nSTRENGTHS:\n1. Correctly identifies the 1.500% coupon rate and 2030 maturity date\n2. Accurately characterizes the note as long-term, low-coupon debt\n3. Properly synthesizes the concept of balancing low-cost capital with higher-rate instruments\n4. Correctly references the Officer's Certificate of June 3, 2020\n5. Appropriately cites all three years (2022, 2023, 2024)\n6. Sound reasoning about diversified debt profile and refinancing risk mitigation\n\nWEAKNESSES:\n1. INCOMPLETE COMPARISON: The LLM answer mentions \"higher-rate or shorter-maturity instruments\" but fails to provide specific examples like the 4.700% Note due 2024 or 4.700% Note due 2032 that are explicitly mentioned in the ground truth. This represents a significant omission in comparative analysis.\n2. MISSING CONTEXT: The ground truth notes that the 1.500% Note was \"introduced as part of a broader issuance that included instruments maturing as far out as 2060\" - this strategic context about the breadth of the issuance is absent from the LLM answer.\n3. INCOMPLETE TEMPORAL ANALYSIS: While the LLM mentions the note appears across three years, it doesn't explicitly discuss how Amazon's debt strategy evolved (e.g., introducing newer instruments in 2023 and 2024 while maintaining the 2030 note).\n4. LESS DETAILED SYNTHESIS: The ground truth provides a more nuanced year-by-year analysis showing how Amazon managed near-term obligations (4.700% Note due 2024) while maintaining long-term presence, which the LLM answer doesn't capture.\n\nQUANTITATIVE VERIFICATION:\n- 1.500% coupon: CORRECT\n- 2030 maturity: CORRECT\n- Officer's Certificate date (June 3, 2020): CORRECT\n- All three years referenced: CORRECT\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and correctly identifies the strategic pattern. However, it doesn't fully leverage the comparative analysis across different debt instruments that would strengthen the answer.\n\nThe answer is fundamentally sound and addresses the core question, but lacks the depth of comparative analysis and specific instrument examples that would elevate it to a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 666,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "From 2022 through 2023 AT&T held a 41.3 % minority stake in SKY Mexico, which it accounted for under the equity method and reported equity in net income of affiliates (T_10k_2022.pdf: 94; T_10k_2023.pdf: 68). In June 2024 the company sold that stake, removing the equity‑method investment from its books and ending its presence in the Mexican pay‑TV market (T_10k_2024.pdf: 66–68). This three‑year path underscores AT&T’s broader strategy of divesting non‑core international pay‑TV assets to streamline its portfolio and focus on U.S. and streaming operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key facts: (1) AT&T held a 41.3% minority stake in SKY Mexico from 2022-2023, (2) the investment was accounted for under the equity method, (3) the sale occurred in June 2024, and (4) this reflected a broader divestiture strategy for non-core international assets. Quantitative accuracy is high - the 41.3% ownership percentage is correct, the June 2024 timing is accurate, and the equity method accounting treatment is properly identified. The LLM correctly synthesized multi-hop information across three years of filings showing the progression from ownership through equity method accounting to complete exit. The answer appropriately references specific document pages (T_10k_2022.pdf: 94; T_10k_2023.pdf: 68; T_10k_2024.pdf: 66-68), demonstrating source verification. Minor areas for improvement: (1) The original answer provides slightly more context about the 2022 explicit statement regarding continued ownership following the Vrio sale, which the LLM omits. (2) The original answer mentions SKY Mexico being part of a broader portfolio alongside DIRECTV and Gigapower in 2023, providing additional context about AT&T's equity method investments that the LLM doesn't include. (3) The LLM could have been more explicit about the 'phased approach' terminology used in the original answer. However, these are minor contextual enhancements rather than factual errors. The core narrative - ownership stake, accounting method, exit timing, and strategic rationale - is accurately conveyed. The reasoning about AT&T's divestiture strategy is sound and well-supported by the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 457,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path strategy has remained a liability‑driven, return‑seeking framework that “reduces growth assets and increases liability‑hedging assets as the plan’s funded ratio improves” (see the 2022, 2023 and 2024 10‑Ks).  The target mix moved from 15 % equity, 75 % fixed‑maturity and 10 % other in 2022 (target) to 8 % equity, 77 % fixed‑maturity and 15 % other in 2023 (actual) and to a 2024 target of 9 % equity, 80 % fixed‑maturity and 11 % other, showing a deliberate de‑risking: equity exposure fell while fixed‑maturity holdings rose as the plan became better funded.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical allocations (15% equity/75% fixed-maturity/10% other for 2022; 8% equity/77% fixed-maturity/15% other for 2023; 9% equity/80% fixed-maturity/11% other for 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific percentage allocations, making it impossible to confirm whether these numbers are accurate or fabricated. This is a major red flag for a financial question requiring precision. POSITIVE ASPECTS: (1) The LLM correctly identifies the core de-risking strategy and liability-driven investing approach; (2) The directional trend is correct (equity declining, fixed-maturity increasing); (3) The semantic understanding of the glide path mechanism is sound; (4) The connection between funded status improvement and de-risking is properly articulated. STRUCTURAL ISSUES: (1) The ground truth discusses target allocations for 2022, 2024, and 2025 based on funded status at year-end 2021, 2023, and 2024 respectively, showing a lagged relationship. The LLM conflates 'target' and 'actual' allocations without clearly distinguishing this temporal relationship; (2) The LLM states '8% equity, 77% fixed-maturity and 15% other in 2023 (actual)' but the ground truth doesn't specify whether these are actual or target allocations for that year; (3) The answer lacks the nuanced explanation of how the glide path is based on prior-year funded status, which is a key insight in the ground truth. CALCULATION VERIFICATION: The percentages provided sum correctly (15+75+10=100, 8+77+15=100, 9+80+11=100), but without source verification, this doesn't validate accuracy. The directional changes are logical (equity down from 15% to 8% to 9%, fixed-maturity up from 75% to 77% to 80%), but the specific numbers cannot be confirmed. MULTI-HOP REASONING: The answer demonstrates understanding of the relationship between funded status and allocation changes, but fails to properly synthesize the temporal lag between funded status measurement and glide path adjustment that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 564,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From 2022 to 2024 Mastercard raised its risk‑mitigation buffers for settlement exposure from $9.2 bn to $13.5 bn (a 46 % increase) while net settlement exposure climbed from $55.7 bn to $64.9 bn, reflecting a proactive scaling of credit‑risk safeguards amid mounting litigation and regulatory scrutiny. The company maintained its policy of requiring cash collateral, letters of credit, and guarantees for non‑compliant merchants and expanded its derivative hedging program to cover foreign‑currency and interest‑rate risk, thereby reinforcing its credit‑risk framework. These adjustments demonstrate Mastercard’s agile, data‑driven risk‑management approach that quickly adapts credit‑risk buffers to evolving legal and regulatory pressures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported quantitative claims that contradict the ground truth. Specific issues: (1) QUANTITATIVE ERRORS - The LLM cites specific dollar amounts ($9.2bn to $13.5bn settlement exposure buffers, $55.7bn to $64.9bn net settlement exposure) with a calculated 46% increase. The ground truth makes NO mention of these specific figures or any quantitative changes in settlement exposure buffers between 2022-2024. These numbers appear to be fabricated or hallucinated. (2) MISSING REGULATORY CONTEXT - The ground truth emphasizes the FTC's finalized consent agreement (2023), DOJ antitrust investigation into U.S. debit program (2023), U.S. Liability Shift Litigation, and European Commission investigation. The LLM answer vaguely references 'litigation and regulatory scrutiny' without identifying these specific regulatory actions, which are central to understanding the evolution of risk strategies. (3) INCOMPLETE SYNTHESIS - The ground truth shows a clear temporal evolution: 2022 (regular monitoring emphasis), 2023 (FTC consent agreement + DOJ investigation initiation), 2024 (ongoing DOJ investigation + new legal challenges). The LLM answer fails to capture this multi-year regulatory escalation pattern. (4) UNSUPPORTED CLAIMS - The LLM mentions 'expanded derivative hedging program' for foreign-currency and interest-rate risk, which is not mentioned in the ground truth and appears to be an unsupported addition. (5) CORE FINDING OMITTED - The ground truth's key insight that 'Mastercard consistently reported a low level of losses from customer settlement failures across all three years' is completely absent from the LLM answer, which is a critical finding about the effectiveness of risk strategies. (6) CHARACTERIZATION MISMATCH - While the LLM describes the approach as 'agile, data-driven,' the ground truth emphasizes consistency of framework with contextual adaptation, not dramatic scaling of buffers. The LLM's narrative of a 46% increase in buffers is fundamentally different from the ground truth's narrative of consistent framework application amid changing external pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 580,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "At January 30, 2022 Home Depot reported about 117 million shares available for future grants under its 2005 Omnibus Stock Incentive Plan [HD_10k_2022, pp. 65‑69]. By January 28, 2024 that pool had shrunk to roughly 77 million shares under the Omnibus Plan [HD_10k_2024, pp. 67‑71]. The downward trend indicates a tightening of the equity award pool, suggesting the company is adopting a more disciplined, performance‑aligned stock‑based compensation strategy to manage dilution and reward performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the 117 million shares available as of January 30, 2022 and the 77 million shares as of January 28, 2024. The company name (Home Depot) and plan name (Omnibus Stock Incentive Plan/2005 Plan) are accurate. The reasoning about the downward trend indicating active equity issuance is sound and relevant to the question.\n\nWEAKNESSES: The LLM answer is INCOMPLETE on the multi-hop requirement. The ground truth explicitly states a THREE-YEAR evolution (2022→2023→2024) with three data points: 117M (2022), 77M (2023/Jan 28, 2024), and 70M (2024/Feb 2, 2025). The LLM only provides TWO data points (117M and 77M) and completely omits the 2024 figure of 70 million shares as of February 2, 2025. This is a significant omission for a question specifically asking about evolution \"from 2022 to 2024.\"\n\nQUANTITATIVE ACCURACY: The two numbers provided (117M and 77M) are correct, but the answer is missing the third critical data point (70M for 2024). This represents a 33% incompleteness in the quantitative data required to answer the full question.\n\nQUALITATIVE ACCURACY: The reasoning about the trend is sound and the interpretation about equity compensation strategy is reasonable. However, the interpretation differs slightly from the ground truth - the LLM emphasizes \"disciplined, performance-aligned strategy to manage dilution\" while the ground truth emphasizes \"increased reliance on equity incentives to retain and motivate associates and directors.\" Both are valid interpretations of the same trend, but they emphasize different aspects.\n\nMULTI-HOP SYNTHESIS: The answer fails to fully synthesize the complete three-year trend. A complete answer should show the progression: 117M → 77M → 70M, demonstrating consistent year-over-year decline. The LLM only shows the first two points.\n\nJUSTIFICATION: The answer is partially correct but significantly incomplete. It addresses only 2 of 3 required years and misses the final 2024 data point, which is essential for demonstrating the full \"evolution from 2022 to 2024\" requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 564,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom’s 3.625% senior notes due October 2024 carried a principal balance of **$622 million** as of October 29 2023 (unchanged from 2022) and were scheduled to mature in October 2024, leaving no outstanding balance thereafter【2024‑10‑K table “April 2019 Senior Notes – fixed rate” – 3.625% notes due October 2024, 622 million】.  The company did not redeem or refinance this instrument early – the principal remained unchanged through 2023 and the notes were held to maturity – indicating a conservative debt‑management approach that prefers to retire debt at its scheduled maturity rather than seek lower‑cost refinancing.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) INCOMPLETE DATA PRESENTATION: The LLM answer only addresses fiscal years 2022 and 2023 ($622M unchanged), but completely omits the fiscal year 2024 data showing the obligation dropped to $0. The ground truth explicitly states 'by fiscal year 2024, the obligation associated with these notes had dropped to $0,' which is a crucial part of the multi-hop analysis across three fiscal years. (2) FLAWED REASONING: The LLM concludes the company 'prefers to retire debt at its scheduled maturity rather than seek lower-cost refinancing' and held notes 'to maturity,' but this contradicts the ground truth showing the obligation was eliminated by FY2024 (before October 2024 maturity). The LLM's interpretation that the notes were 'held to maturity' is inconsistent with the $0 balance in FY2024. (3) MISSING SYNTHESIS: The question explicitly asks about evolution 'across fiscal years 2022, 2023, and 2024' and what the progression indicates. The LLM only covers 2022-2023 and misses the critical FY2024 elimination. (4) QUANTITATIVE ACCURACY: The $622M figure for 2022-2023 is correct, but the absence of FY2024 data ($0) represents a significant omission in a multi-hop question requiring three-year analysis. (5) INTERPRETATION ERROR: The LLM's characterization of the strategy as 'conservative' and 'holding to maturity' contradicts the actual progression showing early elimination of the liability. The ground truth indicates 'deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date,' which is fundamentally different from the LLM's interpretation. The answer is partially correct on historical numbers but fails the multi-hop synthesis requirement and provides incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 491,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "By 2022, AT&T had already folded Time Warner into its WarnerMedia segment and was executing a divestiture plan that culminated in a Reverse Morris Trust transaction with Discovery, fully separating WarnerMedia and ending its ownership stake (2022 10‑K, pp. 3‑7). The 2023 10‑K (pp. 2‑6) confirms the separation as a discontinued operation, and the 2024 10‑K (pp. 2‑6) reports that AT&T has sold its remaining interest in DIRECTV to TPG, completing its exit from legacy media assets. This sequence underscores AT&T’s strategic pivot from a diversified media conglomerate toward a telecom‑centric focus on connectivity, fiber, 5G, and direct‑to‑consumer content distribution.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop evolution of AT&T's relationship with Time Warner from 2022-2024. STRENGTHS: (1) Correctly identifies all key events: Time Warner integration into WarnerMedia by 2022, Reverse Morris Trust separation with Discovery in 2023, and DIRECTV sale to TPG in 2024. (2) Accurately cites the relevant 10-K filings and page numbers as sources. (3) Properly characterizes the strategic pivot from diversified media conglomerate to telecom-centric focus. (4) Correctly identifies the transaction types (Reverse Morris Trust, divestiture). (5) Accurately names all entities (AT&T, Time Warner, Discovery, TPG, DIRECTV). MINOR WEAKNESSES: (1) The answer states AT&T 'had already folded Time Warner into its WarnerMedia segment' by 2022, which is technically correct but slightly less precise than the ground truth's explicit statement that Time Warner 'had been acquired in 2018 and was a core component of its WarnerMedia segment' - this provides better historical context. (2) The phrase 'direct-to-consumer content distribution' at the end is somewhat speculative and not explicitly confirmed in the ground truth, though it's a reasonable inference about AT&T's strategic direction. (3) The answer could have been slightly more explicit about the 2023 separation being the key inflection point marking the strategic reversal. QUANTITATIVE VERIFICATION: All dates are correct (2022, 2023, 2024). No specific dollar amounts are provided in either answer, so no calculation errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple transactions to demonstrate the strategic evolution. The logic connecting the events to the broader strategic pivot is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis and wording but equivalent meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 530,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson described its pipe cutters as part of its pipe‑working tools line, noting diagnostic features such as closed‑circuit TV inspection but no battery‑powered emphasis. By 2024 the Safety & Productivity segment’s narrative shifted to highlight battery‑hydraulic tools and integrated diagnostic systems—sewer‑inspection cameras and locating equipment—underscoring a strategic move toward battery‑powered technology and advanced diagnostics to boost safety and productivity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Emerson's Pipe Cutters product line from 2022 to 2024, correctly identifying the shift toward battery-powered technologies and diagnostic system integration. However, there are notable discrepancies with the ground truth:\n\n1. FACTUAL ACCURACY - PARTIAL: The LLM correctly identifies the 2024 positioning with battery-hydraulic tools and integrated diagnostic systems (sewer inspection cameras). However, it mischaracterizes the 2022 positioning by stating there was \"no battery-powered emphasis\" and mentions \"closed-circuit TV inspection\" in 2022, which the ground truth does not explicitly confirm for that year.\n\n2. TIMELINE PROGRESSION - INCOMPLETE: The ground truth provides a more detailed three-year progression: (a) 2022 as standalone tools, (b) 2023 as explicitly linked with battery hydraulic tools for press connections (a critical intermediate step), and (c) 2024 as part of a broader smart ecosystem. The LLM answer jumps from 2022 to 2024, omitting the important 2023 transition point where battery-powered technology was first explicitly linked to the product line.\n\n3. PRODUCT ECOSYSTEM FRAMING: The ground truth emphasizes the evolution toward \"smart, integrated tooling solutions,\" while the LLM uses similar but slightly less comprehensive language (\"battery-powered technology and advanced diagnostics\"). The ground truth's framing of a \"broader ecosystem\" is more precise than the LLM's description.\n\n4. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across the three-year period and correctly identifies the Safety & Productivity segment context. However, it fails to capture the intermediate 2023 positioning, which is a material omission in a multi-hop analysis.\n\n5. SPECIFIC DETAILS: The LLM mentions \"locating equipment\" in addition to sewer inspection cameras, which adds detail not explicitly in the ground truth but is reasonable contextual addition. The mention of \"press connections\" in the ground truth is absent from the LLM answer, representing a loss of technical specificity.\n\nThe answer is directionally correct but incomplete in its temporal coverage and missing key intermediate developments that demonstrate the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 605,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "From 2022 through 2024, J&J’s multi‑year, enterprise‑wide initiative has remained a continuous effort to integrate, simplify and standardize processes and systems across HR, IT, procurement, supply chain and finance, with the stated goal of expanding shared‑service capabilities and harmonizing financial systems (2022 p.118‑119, 2023 p.119‑120, 2024 p.120‑121). The 2024 filing notes that the company “has and will continue” to align and streamline its financial control environment, indicating progress but no change in focus. This persistent emphasis signals that J&J prioritizes process standardization and operational efficiency in finance as a cornerstone of its governance and risk‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the multi-year enterprise-wide initiative spanning 2022-2024, accurately captures the core themes of integration, simplification, and standardization, and properly synthesizes the consistent messaging across years. The qualitative assessment of J&J's strategic focus on process optimization and financial systems modernization aligns well with the ground truth. The answer appropriately emphasizes the long-term commitment and governance implications.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM provides specific page number citations (2022 p.118-119, 2023 p.119-120, 2024 p.120-121) that cannot be verified against the ground truth and appear to be hallucinated. These citations are presented with false precision and specificity. (2) SCOPE EXPANSION - The LLM expands the scope of functions mentioned to include 'HR, IT, procurement, supply chain and finance' whereas the ground truth specifically emphasizes 'key functions including finance' without explicitly listing all these additional functions. This represents a potential over-specification not supported by the ground truth. (3) TERMINOLOGY - The LLM uses 'harmonizing financial systems' which is semantically similar but not identical to the ground truth's 'standardize financial systems.' (4) MISSING CONTEXT - The ground truth explicitly notes that in 2022 the initiative was described as 'not in response to any internal control deficiencies,' which is an important contextual detail absent from the LLM answer.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the consistent narrative thread. The logical progression and conclusion about strategic focus are sound.\n\nOVERALL ASSESSMENT: While the LLM captures the essential narrative and demonstrates good qualitative reasoning about J&J's strategic priorities, the fabricated page citations and scope expansion represent significant accuracy concerns that prevent a higher score. The answer is directionally correct but contains problematic specificity that cannot be verified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 567,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco has consistently listed the Executive Health Plan as Exhibit 10.1 in each of its 10‑K filings for FY 2022, FY 2023 and FY 2024, and in every year the plan is noted as being filed with the SEC as part of the 10‑K (COST_10k_2024.pdf p. 64‑68; COST_10k_2023.pdf p. 64‑68; COST_10k_2022.pdf p. 64‑68).  The unchanged filing status across three consecutive years indicates that Costco treats the Executive Health Plan as a stable, long‑term component of its executive compensation program rather than a temporary or ad‑hoc benefit.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Costco consistently listed the Executive Health Plan as Exhibit 10.1 across FY 2022, 2023, and 2024, and appropriately concludes this indicates a stable long-term executive benefit strategy. The reasoning about consistency implying no material updates is sound and matches the ground truth's interpretation. However, there are critical omissions in quantitative accuracy: (1) The LLM fails to mention the specific 'Period Ended' date of September 2, 2012, which is a key factual detail in the ground truth. (2) The LLM fails to mention the specific 'Filing Date' of October 19, 2012, another key factual detail. (3) The LLM cites page numbers (p. 64-68) without verification against the ground truth, which did not provide specific page citations. These omissions are significant because the ground truth explicitly emphasizes that the plan 'always referencing the same Period Ended date of September 2, 2012, and the same Filing Date of October 19, 2012' as evidence of no material updates. The LLM's statement that the plan is 'noted as being filed with the SEC as part of the 10-K' is somewhat vague compared to the ground truth's more precise language about the exhibit designation and dates. The qualitative reasoning is sound—the LLM correctly synthesizes that consistency across three years indicates stability—but the answer lacks the specific factual details that would make it fully equivalent to the ground truth. The contextual relevance is strong as it directly addresses the question about evolution and long-term strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 436,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "Mastercard’s Class A shares continued to carry one vote per share throughout 2022‑2024【MA_10k_2023 pages 97‑101】【MA_10k_2024 pages 90‑94】, while the dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024【MA_10k_2023 pages 97‑101】【MA_10k_2024 pages 90‑94】. This steady voting framework, coupled with a progressive dividend policy, signals a governance strategy that rewards shareholders consistently while maintaining a simple, predictable voting structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states that A Class Shares maintained 'standard dividend rights' with NO mention of specific dividend amounts or increases. The LLM has fabricated quantitative data that contradicts the original answer's focus on consistency and stability. Additionally, the LLM misinterprets the question by conflating 'dividend rights' (a governance right) with 'dividend per share' (an actual payment amount). The ground truth emphasizes that dividend RIGHTS remained consistent, not that dividend payments increased. The LLM's claim of a 'progressive dividend policy' with specific year-over-year increases ($2.04→$2.37→$2.74) represents a fundamental factual error - this information does not appear in the ground truth and appears to be hallucinated. The voting rights portion (one vote per share) is correctly identified, but this represents only partial correctness. The multi-hop reasoning is flawed because it synthesizes information that wasn't in the source material. The answer does address the three-year period (2022-2024) correctly, but the core factual content about dividend evolution is incorrect and contradicts the ground truth's emphasis on consistency and unchanging governance strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 390,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform has consistently been positioned as a bridge between its mainframe security analytics and customers’ own SIEM environments.  In each of the FY 2022, FY 2023 and FY 2024 10‑Ks the platform is described as “quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps, with data available for use with in‑house tools for security information and event management.”  Over the three years the core integration with in‑house security tools and the risk‑identification function remained, while the company added incremental enhancements—such as broader data availability and more detailed remediation guidance—to deepen that integration and improve the speed and accuracy of risk detection.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - The LLM claims the platform description was identical across all three fiscal years (FY 2022, 2023, 2024), stating it was described as 'quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps, with data available for use with in-house tools for security information and event management' in each year. However, the ground truth explicitly states that by FY 2023, the platform was 'more explicitly tied to ongoing and ad hoc remediation planning' - indicating a material change in how the platform was described, not consistency. (2) The LLM introduces unsupported claims about 'incremental enhancements—such as broader data availability and more detailed remediation guidance' that are not mentioned in the ground truth. The ground truth indicates the description remained stable in FY 2024, not that enhancements were added. (3) The LLM's characterization of the evolution is fundamentally misleading - it suggests continuous enhancement and deepening of integration, when the ground truth indicates the core functionality remained consistent with only a shift in emphasis toward remediation planning in FY 2023. (4) The LLM provides a specific quoted description that appears to be fabricated or misattributed, as the ground truth does not provide this exact verbatim quote across all three years. (5) Multi-hop reasoning failed: the LLM did not correctly synthesize the actual evolution pattern (stable in 2022, shift in emphasis in 2023, maintained in 2024) and instead invented a narrative of continuous enhancement. The answer demonstrates poor fidelity to the source material and introduces false information about product evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 490,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 through 2024, AIG kept the same framework for assessing loss‑reserve adequacy: it relies on sensitivity and scenario analyses, stochastic modeling, and experience studies, supported by internal controls and an established review‑and‑challenge process. External experts consistently review and validate the reserve‑setting process, and no significant changes in methodology or the role of those experts are noted in the filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Specific issues: (1) MAJOR ERROR - The LLM claims 'no significant changes in methodology or the role of those experts are noted in the filings,' which directly contradicts the ground truth showing clear evolution from 2022-2024. The ground truth explicitly documents expansion of risk management framework in 2023 (detailed modeling techniques, formalized actuarial reviews) and reinforcement in 2024 (ERM second-line reviews, enhanced monitoring). (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the multi-hop evolution across the three-year period. It treats the approach as static rather than showing progression: 2022 (basic internal controls/external reviews) → 2023 (expanded framework with stochastic/deterministic modeling) → 2024 (multi-tiered oversight with ERM integration). (3) PARTIAL CREDIT for correctly identifying some methodologies (sensitivity/scenario analyses, stochastic modeling, external expert reviews) that are indeed part of AIG's approach, but these are presented as unchanged rather than evolved. (4) The answer demonstrates a fundamental misunderstanding of the question's focus on EVOLUTION and CHANGE, instead asserting consistency where the ground truth shows clear progression and maturation. (5) No quantitative errors in numbers/dates (none were provided), but the qualitative reasoning is severely flawed - the model failed to synthesize information showing how AIG's approach became 'more structured,' 'expanded,' and 'increasingly proactive' over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 442,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In 2022 Emerson described Electrical Distribution Equipment as part of its Industrial Solutions offering – a segment that bundled fluid‑control, pneumatic mechanisms and electrical distribution gear (2022 p. 74‑78). By 2023 and 2024, the company moved that product into the newly‑emphasised Discrete Automation segment, which now lists electrical distribution equipment alongside solenoid valves, pneumatic valves, linear‑motion solutions and other discrete‑automation components (2023 p. 71‑75; 2024 p. 71‑75). This repositioning signals Emerson’s strategic shift to treat electrical distribution equipment as a core discrete‑automation asset, underscoring a heightened focus on growth in discrete manufacturing markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing Emerson's strategic repositioning of Electrical Distribution Equipment across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the 2022 positioning within Industrial Solutions segment; (2) Accurately describes the 2023-2024 shift to Discrete Automation segment; (3) Properly synthesizes the multi-hop information showing evolution across years; (4) Correctly identifies related products (solenoid valves, linear-motion solutions, programmable control systems); (5) Appropriately characterizes the strategic shift toward discrete automation focus; (6) Page references provided (though not verifiable in this context) add credibility. MINOR WEAKNESSES: (1) The LLM mentions 'pneumatic mechanisms' and 'pneumatic valves' in the 2022-2023 descriptions, while the ground truth specifically mentions 'materials joining products' for 2022 - this is a slight product portfolio characterization difference that doesn't fundamentally alter the core narrative; (2) The ground truth emphasizes 'materials joining products' as part of the 2022 Industrial Solutions bundle, which the LLM omits; (3) The ground truth's phrase 'foundational component of its discrete automation strategy' captures a nuance about strategic importance that the LLM's 'core discrete-automation asset' conveys similarly but with slightly different emphasis. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and two segment reorganizations, correctly identifying the progression and its strategic implications. The conclusion about 'heightened focus on growth in discrete manufacturing markets' aligns well with the ground truth's assessment. QUANTITATIVE ACCURACY: No specific financial metrics, percentages, or calculations are required for this question, so this dimension is less critical. The dates (2022, 2023, 2024) are all correct. Overall, the answer captures the essential strategic narrative with minor product portfolio characterization differences that don't materially affect the correctness of the core finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 567,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s pension plan has been moving toward a single “Retirement Value” formula for all U.S. non‑union employees, a change announced in 2021 that takes effect on Jan 1 2026 and does not alter benefits earned before that date (2022 p. 73‑74; 2023 p. 74‑75; 2024 p. 75‑76).  Across 2022‑2024 the plan structure remained unchanged, with the company preparing for the 2026 transition while maintaining the Final Average Pay formula for earlier service.  This multi‑year rollout signals a long‑term workforce strategy that prioritizes pension liability management, cost simplification, and alignment of benefits across all employees to support financial sustainability as the workforce ages.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) Johnson & Johnson's shift to Retirement Value formula for U.S. non-union employees, (2) effective date of January 1, 2026, (3) preservation of Final Average Pay benefits accrued before 2026, and (4) consistent messaging across 2022-2024. The page references (2022 p. 73-74; 2023 p. 74-75; 2024 p. 75-76) are appropriately cited and suggest proper multi-hop synthesis across three years of filings. Quantitative accuracy is excellent - all dates and structural elements are correct. The LLM correctly identifies the multi-year transition period and the lack of reversal or delay in the policy. However, there are minor differences from the ground truth: (1) The LLM mentions the announcement was in 2021, which adds context not explicitly in the ground truth but is not contradicted; (2) The LLM's characterization of the strategy emphasizes 'pension liability management' and 'cost simplification' while the ground truth emphasizes 'cost predictability' and 'broader workforce inclusivity' - these are semantically related but slightly different framings. The LLM's interpretation is reasonable but shifts emphasis from inclusivity to financial management. (3) The ground truth explicitly notes the strategy reveals 'standardize retirement benefits and align them with total years of service and compensation, rather than final earnings' - the LLM captures this concept but less explicitly. The multi-hop reasoning is sound, correctly synthesizing information across three years to show consistency and strategic intent. The answer appropriately addresses the evolution question by confirming no structural changes occurred during 2022-2024, which is the correct interpretation of the ground truth's 'maintained the same structural description.' Overall, this is a strong answer with accurate facts and good synthesis, with only minor differences in emphasis and framing from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 537,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "Downy’s share of the Fabric & Home Care segment’s net sales fell modestly over the three‑year period – roughly 13 % in 2022, 12 % in 2023 and 11 % in 2024 (see the major‑brand contribution tables in the MD&A for each year). This gradual decline indicates that while Downy remains a core brand, its relative importance is shrinking, likely reflecting heightened competition or a strategic shift toward other brands within the portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ACCURACY - MAJOR ERROR: The LLM provides completely different percentage figures (13%, 12%, 11% for 2022-2024) compared to the ground truth (35%, 36%, 36% for 2022-2024). These are not minor discrepancies but represent entirely different data points - a difference of approximately 22 percentage points. The LLM's numbers are factually wrong. (2) INTERPRETATION ERROR: The ground truth states that the Fabric & Home Care segment itself grew from 35% to 36% of P&G's total net sales, and Downy remained a key brand within that segment. The LLM misinterprets this as Downy's share of the Fabric & Home Care segment declining from 13% to 11%, which is a fundamental misreading of the data structure. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the relationship between segment contribution and brand positioning. The ground truth indicates stable/consistent positioning with strategic importance, while the LLM incorrectly concludes a declining trend suggesting reduced strategic importance. (4) DIRECTIONAL CONCLUSION ERROR: The LLM's conclusion about declining relative importance contradicts the ground truth's assertion of sustained strategic importance. The LLM's narrative about heightened competition and strategic shifts is unsupported by the actual data. (5) CITATION ISSUE: The LLM references 'major-brand contribution tables in the MD&A' but appears to have misread or fabricated these figures, as they don't match the ground truth data. The answer demonstrates a critical failure in data accuracy and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 449,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s total senior and subordinated notes carried $27.2 billion at year‑end 2022, rose to $31.2 billion in 2023, and then eased slightly to $30.7 billion in 2024. The peak in 2023 reflects a sizable increase in long‑term debt—likely to fund growth or acquisitions—while the modest decline in 2024 indicates a partial repayment or refinancing effort, suggesting the company is using debt to support expansion but also actively managing its balance‑sheet load and interest costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error regarding the 2024 carrying value. Ground truth states the 2024 value was $31,248 million ($31.2 billion), but the LLM claims it was $30.7 billion. This is a material discrepancy of approximately $548 million (1.8% difference), which is substantial for financial analysis. The LLM also contradicts the ground truth's statement that 2023 and 2024 had the same peak value of $31,248 million by claiming 2024 'eased slightly' to $30.7 billion. CORRECT ELEMENTS: The 2022 figure of $27.2 billion and 2023 figure of $31.2 billion are accurate. The general characterization of an upward trend is correct. The company name (Capital One/COF) and metric (senior and subordinated notes carrying value) are correctly identified. REASONING ISSUES: While the LLM's interpretation about debt strategy (funding growth, managing balance sheet) is reasonable and contextually relevant, it is based on an incorrect premise about 2024 values. The multi-hop synthesis across three years is attempted but undermined by the factual error. The LLM's narrative about 'modest decline in 2024' is factually unsupported by the ground truth, which shows the value remained flat or increased from 2023 to 2024. This represents a fundamental failure in quantitative accuracy that significantly impacts the credibility of the strategic analysis provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 389,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022, T still held a 41.3 % interest in SKY Mexico and accounted for the investment under the equity method. The stake and accounting treatment remained unchanged in 2023. In 2024, T sold its 41.3 % stake, terminating the equity‑method accounting and exiting the investment altogether. This three‑year path illustrates T’s deliberate divestiture of legacy Latin‑American pay‑TV assets, underscoring a broader strategy to streamline its portfolio and focus on higher‑growth or core markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key quantitative details correct: the 41.3% ownership stake is accurate, the 2022-2024 timeline is correct, the June 2024 exit date is properly referenced (implied through '2024'), and the equity method accounting treatment is accurately described. The multi-hop synthesis is sound—the answer correctly traces the evolution across three years and connects the individual facts into a coherent narrative about T's strategic shift. The answer properly identifies the core entities (T, SKY Mexico, Latin American pay-TV market) and correctly characterizes the divestiture as part of a broader portfolio streamlining strategy. However, there are minor differences from the ground truth: (1) The LLM answer is slightly less explicit about SKY Mexico being listed 'among T's key equity method investments, alongside DIRECTV and Gigapower' in 2023—it simply states the treatment 'remained unchanged' without this contextual detail. (2) The ground truth emphasizes 'non-core international assets' while the LLM uses 'legacy Latin-American pay-TV assets' and 'higher-growth or core markets'—these are semantically similar but the LLM's framing is slightly different. (3) The LLM answer characterizes the strategy as focusing on 'higher-growth or core markets' which is a reasonable inference but goes slightly beyond what the ground truth explicitly states ('focus on its core domestic operations'). These are minor semantic variations rather than factual errors. The reasoning quality is strong, the multi-hop synthesis correctly connects ownership, accounting treatment, and strategic intent across the three-year period, and the answer directly addresses all parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 476,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 2022 10‑K risk‑factor warned that its ability to return capital could be limited by U.S. banking laws, capital‑planning rules, Delaware law and the failure to pay full and timely dividends on preferred stock (see pages 1‑5). The 2024 10‑K kept that core warning but added a separate risk‑factor that explicitly cites regulatory capital‑adequacy standards—“well‑capitalized” and “well‑managed” status—and notes that failure to meet those could restrict the company’s activities (see pages 3‑7). Thus, the 2024 disclosure broadened the regulatory context and highlighted capital adequacy alongside the dividend‑policy constraint that was already present in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies core elements of BNY Mellon's capital return constraints across 2022-2024, including U.S. banking laws, capital adequacy rules, Delaware law, and dividend policy constraints. The answer accurately notes that 2024 disclosures added explicit emphasis on 'well-capitalized' and 'well-managed' regulatory standards. However, the answer has significant limitations: (1) It only compares 2022 and 2024, omitting the 2023 evolution that the ground truth identifies as important; (2) It fails to address the 2023 expansion of risk discussion to include ESG-related regulatory pressures, which the ground truth explicitly mentions; (3) It does not discuss the Parent company's reliance on subsidiary dividends, a key 2024 development noted in the ground truth; (4) It misses the strategic transformation initiatives' impact on capital planning and liquidity that the ground truth highlights as increasingly important by 2024; (5) The page references (pages 1-5, pages 3-7) cannot be verified against the ground truth and appear to be illustrative rather than precise citations. The answer correctly identifies the broadening of regulatory context and the stable framework with increasing complexity, but incompletely captures the full evolution across all three years. The multi-hop synthesis is partial—it addresses the 2022-2024 comparison but fails to integrate the 2023 intermediate developments and contextual complexity that the ground truth emphasizes as part of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 415,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "From 2022 through 2024, 3M shifted structural adhesives from a standalone product in the Safety and Industrial segment to a bundled core of the newly created Industrial Specialties division, where they are paired with tapes, closure systems, masking, and packaging materials. This re‑organization—highlighted by the 2024 creation of the Industrial Specialties division that groups the former Industrial Adhesive and Tapes division with adjacent industrial‑specialty offerings—underscores adhesives as a foundational technology that enables integrated, high‑performance solutions across metalworking, automotive repair, construction, and electrical applications.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims 3M created a 'newly created Industrial Specialties division' in 2024 that groups the 'former Industrial Adhesive and Tapes division with adjacent industrial-specialty offerings.' The ground truth makes no mention of any new divisional reorganization or creation of an Industrial Specialties division. This is a fundamental mischaracterization of 3M's organizational structure. (2) INCORRECT POSITIONING NARRATIVE: The LLM describes a shift from 'standalone product' to 'bundled core,' but the ground truth indicates Structural Adhesives were already positioned alongside other products in 2022 (industrial abrasives, autobody repair, electrical materials), suggesting they were never truly standalone. The evolution described in ground truth is more subtle—a shift in adjacent product emphasis rather than a major reorganization. (3) MISSING CONTEXT: The ground truth emphasizes that positioning 'remained largely consistent' from 2022-2023, with only a 'slightly expanded emphasis' on packaging and closure systems. The LLM overstates the magnitude of change. (4) UNSUPPORTED CLAIMS: The specific mention of 'tapes, closure systems, masking, and packaging materials' as new bundling partners is not substantiated in the ground truth, which mentions these products but not as part of a new divisional structure. (5) MULTI-HOP REASONING FAILURE: While the LLM attempts to synthesize information about strategic positioning, it does so by introducing organizational claims not present in the source material. The ground truth's conclusion about adhesives as 'foundational component in complex industrial systems' is reasonable, but the LLM's path to this conclusion is factually incorrect. The answer demonstrates a fundamental misunderstanding of 3M's actual organizational changes (or lack thereof) during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 527,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From 2022 through 2024, Lilly’s Cyramza portfolio has kept the same core indications—second‑line therapy for gastric, esophageal, colorectal, and hepatocellular cancers and first‑line therapy for EGFR‑mutated NSCLC—while its intellectual‑property horizon has tightened: the compound patents now expire in 2026 in the U.S. and 2028 in major European markets, and data‑protection ends in 2026 (U.S.), 2024 (Europe) and 2023 (Japan)【LLY_10k_2022.pdf: page 5】【LLY_10k_2023.pdf: page 9】【LLY_10k_2024.pdf: page 4】【LLY_10k_2024.pdf: page 8】. This shift signals a strategic pivot toward sustaining exclusivity through new indications or combination therapies as the current patents and data protection wind down.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Cyramza's strategic evolution from 2022-2024, but contains significant factual discrepancies that undermine its reliability:\n\nCORRECT ELEMENTS:\n- Correctly identifies that therapeutic indications remained consistent across the period\n- Accurately notes data protection expiration in Japan (2023) and Europe (2024)\n- Correctly identifies U.S. biologics data protection expiring in 2026\n- Appropriately synthesizes the strategic implication about managing lifecycle and preparing for competition\n- Properly cites multiple 10-K filings across the three-year period\n\nFACTUAL ERRORS:\n1. THERAPEUTIC INDICATIONS: The LLM lists \"esophageal cancer\" and \"first-line therapy for EGFR-mutated NSCLC\" as core indications. The ground truth specifies \"gastric, lung, colorectal, and liver cancers\" without mentioning esophageal cancer or EGFR-mutated NSCLC as primary positioning. This represents either an addition of indications not in the ground truth or a mischaracterization of the indication profile.\n\n2. PATENT EXPIRATION DATES: The LLM states \"compound patents now expire in 2026 in the U.S. and 2028 in major European markets.\" The ground truth does not provide specific compound patent expiration dates for these years. The ground truth only mentions data protection expirations (2023 Japan, 2024 Europe, 2026 U.S.), not patent expirations. The LLM appears to have conflated or invented patent expiration dates not supported by the ground truth.\n\n3. EUROPEAN DATA PROTECTION: The LLM states \"2028 in major European markets\" for patents, but the ground truth indicates 2024 for European data protection expiration. The discrepancy between 2024 and 2028 is significant and suggests confusion about the IP protection timeline.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across multiple years and documents, correctly identifying the evolution pattern. However, the introduction of unsupported patent expiration dates (2026 U.S., 2028 Europe) undermines the multi-hop synthesis quality, as these appear to be either fabricated or misinterpreted from the source documents.\n\nSEMANTIC EQUIVALENCE:\nWhile the overall narrative structure matches the ground truth (consistent indications + tightening IP horizon = lifecycle management strategy), the specific factual content diverges significantly, particularly regarding patent expiration dates and the specific therapeutic indications emphasized.\n\nJUSTIFICATION:\nThe answer demonstrates good understanding of the strategic question and proper document synthesis, but the introduction of specific dates and indications not supported by the ground truth represents material factual errors that would mislead readers about Cyramza's actual IP protection timeline and therapeutic positioning. The quantitative accuracy score is reduced due to the unsupported patent expiration dates, while qualitative accuracy remains moderate due to sound reasoning structure despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 795,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19.98 billion** in 2022 to **$27.17 billion** in 2023, then dipped slightly to **$26.93 billion** in 2024.  The weighted‑average interest rate climbed from **2.91 %** in 2022 to **4.45 %** in 2023 and to **4.84 %** in 2024.  This pattern shows the company is expanding its fixed‑rate debt base while accepting higher rates—reflecting a strategy of locking in longer‑dated financing amid a tightening rate environment, even as it manages repayments or refinancing that modestly reduce the carrying value in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor quantitative discrepancies. CORRECT ELEMENTS: (1) 2022 carrying value of $19.98 billion ($19,975M) - correctly formatted as $19.98B; (2) 2024 carrying value of $26.93 billion ($26,930M) - exact match; (3) 2022 weighted-average interest rate of 2.91% - correct; (4) 2024 weighted-average interest rate of 4.84% - correct; (5) Multi-hop synthesis across three years (2022-2023-2024) properly executed; (6) Qualitative reasoning about debt strategy, rate environment, and refinancing is sound and well-articulated. MINOR DISCREPANCY: The LLM provides 2023 intermediate data ($27.17B carrying value and 4.45% rate) that was not in the original ground truth answer. While this additional detail is not contradicted by the ground truth (which only specified 2022 and 2024 endpoints), it cannot be verified against the provided knowledge graph. The 2023 figures appear plausible given the trend trajectory, but represent information beyond the scope of the original answer. QUANTITATIVE ASSESSMENT: All verified numbers (2022 and 2024 data points) are accurate. The format conversions ($19,975M to $19.98B, etc.) are correct. The trend interpretation (increase from 2022 to 2024 in both metrics) is accurate. QUALITATIVE ASSESSMENT: The reasoning about debt strategy, rate-locking behavior, and market conditions is appropriate and well-supported. The explanation of the slight 2024 decline as reflecting repayments/refinancing shows sophisticated understanding. MULTI-HOP REASONING: Successfully synthesizes carrying value and interest rate trends across the three-year period to draw conclusions about capital structure strategy. The answer appropriately connects market conditions to company behavior. The only limitation is the introduction of unverified 2023 data, which slightly reduces confidence despite being contextually reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 513,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024.  The fair‑value impact on operating results swung from a $92 million loss in FY 2022 to gains of $58 million in FY 2023 and $91 million in FY 2024, underscoring the instrument’s pronounced volatility—fluctuations of roughly $90 million in either direction over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: the loss of $92 million in FY 2022, gain of $58 million in FY 2023, and gain of $91 million in FY 2024 match the ground truth exactly. The answer goes beyond the original answer by providing additional context about notional exposure amounts ($651M in 2022, $792M in 2023, $985M in 2024), which adds valuable detail without contradicting the ground truth. The multi-hop synthesis is sound: the LLM correctly identifies the pattern of volatility (loss to gains) and quantifies the magnitude of fluctuations ('roughly $90 million in either direction'), which accurately characterizes the three-year trend. The reasoning about volatility is logical and well-supported by the data presented. The answer directly addresses all aspects of the question: (1) how the exposure evolved (both notional amounts and fair-value impacts), (2) the pattern of gains/losses across the three years, and (3) what this reveals about volatility. The only minor consideration is that the original answer focuses specifically on gains/losses while the LLM answer adds notional exposure data, but this is supplementary information that enhances rather than contradicts the answer. All numbers are formatted correctly and calculations are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 368,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 to 2024, Home Depot shifted its store‑appearance strategy from basic refresh packages and way‑finding signage (2022 p. 7‑11) to a comprehensive, tech‑enabled experience that added self‑service lockers, curb‑side pickup, electronic shelf labels, front‑end redesigns, expanded self‑checkout, and mobile‑app navigation (2023 p. 12‑16; 2024 p. 6‑10). These upgrades lifted customer‑satisfaction scores and pushed the share of online orders fulfilled through a store to roughly 55 % in 2023 and 50 % in 2024, strengthening Home Depot’s omnichannel advantage and its competitive edge over multichannel and online rivals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and methodological problems that substantially diverge from the ground truth: (1) QUANTITATIVE ERRORS: The LLM provides specific percentages (55% in 2023, 50% in 2024) and page references (2022 p. 7-11, 2023 p. 12-16, 2024 p. 6-10) that cannot be verified against the ground truth and appear to be fabricated. The ground truth makes no mention of these specific metrics or page numbers. This is a critical failure as the LLM is presenting invented data as fact. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the evolution from basic store improvements to tech-enabled experiences, it fails to capture the ground truth's key insight about the strategic pivot from 'standalone in-store experience to a hybrid model.' The LLM focuses heavily on tactical implementations (self-service lockers, electronic shelf labels, etc.) rather than the strategic positioning evolution. (3) MISSING CONTEXT: The ground truth emphasizes how store appearance became increasingly integrated with digital capabilities and omnichannel strategy across the three years. The LLM mentions these elements but doesn't adequately convey the strategic evolution of how store appearance's role changed in relation to competitive positioning. (4) COMPETITIVE POSITIONING: The ground truth explicitly discusses competitive positioning against 'exclusively online retailers and digital-first competitors,' while the LLM uses vaguer language about 'multichannel and online rivals' without the same strategic clarity. (5) REASONING QUALITY: The LLM's reasoning appears to conflate specific tactical metrics with strategic evolution. The invented percentages and page citations suggest the model hallucinated supporting details rather than synthesizing actual filing information. The ground truth's approach of tracking conceptual evolution (component → integrated → fully interconnected) is more accurate than the LLM's focus on specific feature implementations with unverified metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 541,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 carried **$1,637 million** at the end of FY 2022 (Jan 28 2023)【NVDA_10k_2022.pdf:78‑82】, remained at **$1,637 million** at the end of FY 2023 (Jan 28 2024)【NVDA_10k_2024.pdf:70‑74】, and fell to **$1,604 million** at the end of FY 2024 (Jan 28 2025)【NVDA_10k_2024.pdf:70‑74】. The slight decline—about $33 million—indicates a modest reduction in long‑term debt, suggesting a gradual deleveraging strategy while still maintaining a substantial long‑term debt balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three fiscal years: (1) FY 2022: LLM states $1,637M but ground truth is $2,147M (error of $510M or 23.8% understatement). (2) FY 2023: LLM states $1,637M but ground truth is $1,637M (this one matches by coincidence, but the FY 2022 baseline is wrong). (3) FY 2024: LLM states $1,604M but ground truth is $2,000M (error of $396M or 19.8% understatement). The LLM's narrative of 'slight decline—about $33 million' is completely incorrect; the actual progression shows: $2,147M → $1,637M (decrease of $510M) → $2,000M (increase of $363M). This represents significant volatility, not gradual deleveraging. The LLM failed to capture the key insight from the ground truth: a temporary reduction followed by strategic repositioning/stabilization. The multi-hop synthesis is fundamentally broken because the underlying numbers are wrong. The LLM appears to have confused or misread the carrying values from the SEC filings, resulting in a completely inaccurate characterization of NVIDIA's debt positioning for this instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 325,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 to 2024, 3M’s Scotchgard litigation evolved from a single class‑action settlement to a multi‑state exposure that involved more defendants and broader geographic reach.  In 2022 (MMM_10k_2022, pp. 122‑126) 3M settled a $65 million Scotchgard class action with Saint‑Gobain, Honeywell, DuPont and Tonaga, and faced lawsuits in New York and Michigan.  By 2023 (MMM_10k_2023, pp. 92‑96) additional settlements were reached in Michigan (Wolverine) and the litigation expanded to include defendants such as Wolverine, Saint‑Gobain, Honeywell, DuPont and Tonaga across states like Alabama and Georgia, with 3M facing up to five co‑defendants in individual cases.  In 2024 (MMM_10k_2024, pp. 96‑100) the landscape broadened further to new suits in Vermont, New Jersey and other states, with 3M remaining a defendant in hundreds of private actions and the PWS Settlement covering claims from public water systems nationwide.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) INCORRECT DEFENDANT LIST IN 2022: The LLM states the 2022 settlement included 'DuPont and Tonaga' as co-defendants, but the ground truth specifies only 'Saint-Gobain and Honeywell' settled with 3M in the Baker case. DuPont and Tonaga are not mentioned in the original answer for 2022. This is a significant factual error. (2) INCOMPLETE 2023 INFORMATION: The LLM mentions 'Wolverine' as a defendant in 2023, but the ground truth indicates Wolverine World Wide was involved in a Michigan case where Scotchgard was linked to contamination from shoe manufacturing waste - Wolverine was the plaintiff/affected party, not a co-defendant. The LLM conflates the parties. (3) VAGUE 2024 DESCRIPTION: The LLM mentions Vermont, New Jersey, and 'other states' but the ground truth specifically highlights Alabama and Georgia as key geographic expansion areas. The LLM's mention of Vermont and New Jersey is not supported by the ground truth. (4) MISSING KEY DETAILS: The LLM fails to mention specific plaintiffs like municipal water utilities, individual landowners, and carpet manufacturers (Mohawk Industries) that are explicitly mentioned in the ground truth as part of the expanding litigation landscape. (5) SETTLEMENT AMOUNTS: The $65 million figure is correct, but the LLM doesn't clarify that 3M's share was 'immaterial' as stated in the ground truth. (6) MULTI-HOP REASONING: While the LLM attempts to show evolution across years, it introduces incorrect entities and mischaracterizes relationships between parties, undermining the synthesis quality. The core narrative of expansion is present but with significant factual errors that distort the actual legal landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 463,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "The royalty structure on worldwide net sales of bamlanivimab and bebtelovimab remained tiered in the mid‑teens to mid‑twenties, and no milestone payments were reported for the AbCellera partnership during this period. Commercially, the collaboration generated $2.02 billion in net product revenue in 2022 (down from $2.24 billion in 2021) and no sales in 2023 or 2024, indicating a sharp decline as the product was discontinued or no longer authorized.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the evolution of the collaboration. STRENGTHS: (1) Correctly identifies the $2.02 billion net product revenue in 2022, matching ground truth exactly; (2) Accurately states zero sales in 2023 and 2024, consistent with ground truth; (3) Correctly characterizes the royalty structure as tiered mid-teens to mid-twenties on worldwide net sales; (4) Properly notes no milestone payments during the period; (5) Appropriately identifies the products by name (bamlanivimab and bebtelovimab), adding specificity; (6) Correctly synthesizes the multi-hop information showing commercial decline across the three-year period. MINOR ISSUES: (1) The LLM includes a reference to 2021 revenue ($2.24 billion) which, while factually accurate, was not part of the original question's scope (2022-2024). This is a minor addition that doesn't contradict the ground truth but slightly expands beyond the requested timeframe; (2) The phrase 'discontinued or no longer authorized' is slightly speculative language compared to ground truth's more neutral 'no further demand or regulatory authorization,' though semantically equivalent. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($2.02B in 2022, $0 in 2023-2024), royalty percentages are accurate (mid-teens to mid-twenties), and the timeline is correct. MULTI-HOP REASONING: The answer successfully synthesizes information about financial terms (royalties, milestones) and commercial performance (revenue trajectory) across the three-year period, demonstrating proper understanding of the collaboration's evolution. The reasoning connecting declining sales to product discontinuation is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 474,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "From 2022 through 2024, P&G’s MD&A (2022 p. 17‑21, 2023 p. 16‑20, 2024 p. 16‑20) consistently lists Dawn among the Fabric & Home Care “major brands” and notes that the segment’s ~25 % global home‑care market share is driven by dish‑care products, with Dawn as a core contributor. This unchanged positioning across three years shows that Dawn remains a key revenue driver and brand pillar in P&G’s portfolio, underscoring its strategic importance within the Fabric & Home Care segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer provides a ~25% global home-care market share figure that is NOT present in the ground truth and appears to be fabricated or misattributed. The ground truth provides specific segment performance metrics (2022: 35% of net sales/31% of earnings; 2023: 36% of net sales/34% of earnings; 2024: 36% of net sales/34% of earnings) that are completely absent from the LLM response. This represents a major omission of key quantitative data that directly answers the question about how positioning evolved. QUALITATIVE ASSESSMENT: The LLM correctly identifies that Dawn remained consistently positioned as a major brand across 2022-2024 and correctly concludes this indicates sustained strategic importance. The reasoning about unchanged positioning is sound. However, the answer lacks the specific segment performance metrics that would substantiate the claim about strategic importance. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across three years but fails to include the critical financial metrics that demonstrate the segment's evolution and Dawn's role within it. The citation format (MD&A page references) appears plausible but cannot be verified. MISSING ELEMENTS: The answer omits all segment-level financial data (net sales percentages and earnings percentages) that form the quantitative backbone of the ground truth answer. This is a significant gap for a question asking about strategic importance, which is typically demonstrated through financial contribution metrics. SEMANTIC ISSUES: While the LLM correctly conveys that Dawn remained important, it does so without the supporting financial evidence that makes the ground truth answer compelling and verifiable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 474,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s total short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024, bringing total debt down from $48.7 billion to $45.6 billion over the three‑year period. The company has eliminated its floating unsecured senior debt—$1.7 billion in 2022, $349 million in 2023, and none in 2024—replacing it with higher‑rate fixed‑senior debt, which reduces exposure to variable rates but raises the weighted‑average rate on unsecured senior debt from 2.8 % to 4.8 %. This trend signals a deliberate shift toward a more stable, fixed‑rate debt structure with lower short‑term funding reliance.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Capital One's debt structure evolution and correctly identifies the key strategic shift toward fixed-rate debt. However, there are critical quantitative discrepancies that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Total debt trajectory is accurate: $48.7B (2022) → $49.3B (2023) → $45.6B (2024), matching ground truth of $43.086B → $48.715B → $45.551B when accounting for rounding\n- Floating unsecured senior debt elimination is correct: $1.7B (2022) → $349M (2023) → $0 (2024)\n- Weighted-average interest rate trend is directionally correct: rising from ~2.8-2.91% to 4.8-4.84%\n- Strategic narrative about shift to fixed-rate debt is sound and well-articulated\n- Multi-hop synthesis across debt components and interest rates is logical\n\nCRITICAL ERRORS:\n1. SHORT-TERM BORROWINGS: LLM states $883M (2022), $538M (2023), $562M (2024). Ground truth shows $43.086B (2022) total, which when broken down should reflect different short-term borrowing figures. The LLM's numbers appear to be significantly understated or from a different debt category.\n2. LONG-TERM DEBT BREAKDOWN: LLM shows $47.8B (2022), $49.3B (2023), $44.9B (2024). Ground truth total is $43.086B in 2022, suggesting the LLM's long-term debt figures are inflated by approximately $4.7B in 2022.\n3. INTEREST RATE PRECISION: LLM states 2.8% for 2022, but ground truth shows 2.91%. While directionally correct, this is a material difference in financial reporting.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects debt composition changes to interest rate implications. The reasoning that eliminating floating-rate debt reduces variable rate exposure while increasing fixed-rate costs is sound.\n\nSEMANTIC EQUIVALENCE: The narrative interpretation is correct—the company did shift toward fixed-rate debt structure. However, the underlying numbers don't align with ground truth, which undermines the quantitative foundation.\n\nThe answer reads well and demonstrates good financial analysis, but the significant discrepancies in absolute debt figures (particularly short-term borrowings and the 2022 baseline) suggest potential data sourcing errors or confusion between different debt categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 608,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a principal of $2 billion with an unchanged effective rate of 6.11 % and remained classified as long‑term debt in each year.  In FY 2022 and FY 2023 the note was part of a $8.9 billion total debt package (long‑term debt $8.4 billion, total debt $8.9 billion), while by FY 2024 the company had issued additional senior notes that pushed total debt to $20.1 billion (long‑term debt $19.6 billion), thereby reducing the 5.90% note’s share of the debt mix but leaving its rate and classification unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and captures the core narrative correctly. CORRECT ELEMENTS: (1) Principal amount of $2 billion/2,000 million is accurate; (2) Effective interest rate of 6.11% is correct; (3) Long-term debt classification maintained across all years is accurate; (4) FY 2024 long-term debt figure of $19.6 billion matches ground truth; (5) The narrative about the note's stable position while overall debt expanded is sound; (6) Multi-hop synthesis across years and debt composition is logical and well-reasoned. MINOR DISCREPANCIES: (1) FY 2022 total debt stated as $8.9 billion - ground truth specifies $8,416 million in long-term debt but doesn't explicitly state total debt figure, so this appears to be an inference that may be slightly off; (2) FY 2024 total debt stated as $20.1 billion vs. ground truth's $19,621 million long-term debt - the LLM appears to be rounding $19.621B to $20.1B or including additional debt categories, which is a minor discrepancy of approximately $0.5 billion; (3) The answer conflates 'total debt' with 'long-term debt' in some places, which could be imprecise terminology. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that the note remained constant while the overall debt portfolio expanded, reducing the note's proportional share. The answer appropriately addresses all three dimensions of the question (debt composition, effective interest rate, and long-term debt classification). The semantic meaning aligns well with the ground truth despite minor numerical variations in total debt figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 444,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "In FY 2022 and FY 2023 NVIDIA reported a carrying value of $1,099 million for its 1.55% Notes Due 2028, which rose to $1,115 million in FY 2024. The effective interest rate on those notes stayed constant at 1.64 % throughout the period. The modest increase in carrying value at a stable, low interest rate shows NVIDIA is adding incremental long‑term debt at favorable terms, reflecting a disciplined strategy of using long‑term financing to support growth while keeping interest costs predictable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) CARRYING VALUE ERRORS: The LLM states the carrying value was $1,099 million in both FY 2022 and FY 2023, then $1,115 million in FY 2024. The ground truth shows: FY 2022: $1,200 million, FY 2023: $1,099 million, FY 2024: $1,250 million. The LLM completely misses the $1,200 million starting value in 2022 and the $1,250 million ending value in 2024, instead providing an incorrect $1,115 million for 2024. (2) EFFECTIVE INTEREST RATE ERROR: The LLM claims the rate 'stayed constant at 1.64% throughout the period,' but the ground truth indicates the rate increased from an implied rate in 2022 to 1.64% in 2024, showing a trend of increasing borrowing costs. The LLM incorrectly characterizes this as stable when it actually increased. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM fails to capture the key pattern in the ground truth—the temporary decrease to $1,099 million in 2023 followed by a reacquisition/increase to $1,250 million in 2024. This is a critical insight about NVIDIA's debt management strategy that the LLM completely misses. (4) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'adding incremental long-term debt at favorable terms' contradicts the actual pattern of a decrease followed by a significant increase, and mischaracterizes the interest rate trend as stable when it actually increased. The answer demonstrates fundamental misunderstanding of the data and fails to accurately synthesize the multi-year trend required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 433,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "Google has kept Pixel device sales within its “Google Subscriptions, Platforms, and Devices” segment from 2022 through 2024 (see 2022, 2023, 2024 10‑Ks).  Over that period the company broadened its hardware line—adding Pixel 5a 5G, Pixel 6, Fitbit, Chromecast, and Nest products—and ramped up R&D and capital‑expenditure budgets to support these innovations (see 2023 and 2024 10‑Ks).  This shift signals a growing strategic emphasis on hardware as a complementary growth engine to its core services.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides partially correct information but has significant gaps in addressing the core question about revenue categorization evolution and strategic emphasis. STRENGTHS: (1) Correctly identifies the 'Google Subscriptions, Platforms, and Devices' segment as the consistent categorization across 2022-2024; (2) Accurately mentions specific Pixel devices (Pixel 5a 5G, Pixel 6) and related products (Fitbit, Chromecast, Nest); (3) Correctly notes increased R&D and capital expenditure investments; (4) Appropriately characterizes the shift toward hardware as a growth engine. WEAKNESSES: (1) The LLM answer claims Pixel devices were kept in the same segment 'from 2022 through 2024,' but the ground truth indicates a more nuanced evolution—in 2022, Pixel was mentioned among key devices without explicit segment categorization, while by 2023 it was 'explicitly categorized under a distinct devices segment,' suggesting a meaningful change in how Google presented this business; (2) The answer fails to capture the critical distinction that the ground truth emphasizes: the progression from 'hardware investment focus' (2022) to 'mature, strategically embedded product line' (2024), which represents a qualitative shift in strategic positioning; (3) Missing the important detail about 'more detailed revenue recognition policies for digital services and cloud offerings' in 2024, which suggests integration with broader AI and cloud capabilities; (4) The answer treats the categorization as static rather than evolving, missing the 'transformation' narrative that is central to the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects hardware expansion to investment increases, but fails to properly synthesize the evolution in how Google categorized and presented Pixel devices across the period. SEMANTIC ISSUES: While the LLM conveys that Pixel became more important, it doesn't capture the ground truth's emphasis on the shift from exploratory investment to integrated strategic positioning within the broader ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 562,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s 10‑K consistently cites the ratification of KPMG LLP as its principal accountant in Item 14, noting KPMG’s PCAOB firm ID 185 and that the ratification is included in the proxy. No new wording, additional details, or changes in presentation appear in the 2023 or 2024 filings. This unchanged disclosure signals a stable, ongoing audit relationship with KPMG, with no indication of transition or uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the multi-hop question. STRENGTHS: (1) All numeric values are accurate - correctly identifies KPMG's PCAOB firm ID as 185, covers all three years (2022, 2023, 2024), and accurately states no changes occurred. (2) Entity identification is precise - correctly names BNY Mellon and KPMG LLP throughout. (3) Multi-hop synthesis is sound - the answer successfully synthesizes information across three years to identify the pattern of consistency and draw the appropriate conclusion about audit relationship stability. (4) The core finding matches ground truth exactly: identical language across all three years, no changes in content or structure, indicating stable ongoing relationship. (5) Semantic equivalence is maintained - the LLM's phrasing 'unchanged disclosure signals a stable, ongoing audit relationship' conveys the same meaning as the ground truth's 'consistency suggests no disruptions.' MINOR CONSIDERATIONS: (1) The LLM specifies 'Item 14' as the location while ground truth mentions 'Proxy' - both are technically correct as Item 14 relates to proxy disclosures, though the ground truth's reference to 'Proxy' is slightly more precise about the document type. This is a very minor distinction that doesn't affect factual accuracy. (2) The LLM's phrasing is slightly more concise than ground truth but loses no substantive information. The answer fully addresses the question's request to explain how disclosure evolved and what consistency reveals about audit relationship stability. All key conclusions are supported and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 445,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Lilly’s private‑alternative‑investment allocation was 69 % of total pension and retiree‑health‑plan assets in 2022 (15.7 M/22.7 M), fell to 68 % in 2023 (16.3 M/24.0 M), and remained roughly 68 % in 2024 (16.2 M/24.0 M). The modest decline in relative allocation, despite a small rise in absolute dollars, signals a deliberate long‑term commitment to illiquid assets while gradually adjusting the mix toward greater diversification or liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth shows private alternative investments in millions: 2022: $10,542.5M, 2023: $10,335.2M, 2024: $10,051.0M. The LLM reports 15.7M, 16.3M, and 16.2M respectively - these are off by approximately 650-1000x (appearing to confuse millions with billions or use wrong data entirely). The LLM also calculates percentages (69%, 68%, 68%) that cannot be verified from the provided ground truth numbers and appear to reference different metrics entirely (possibly total pension assets rather than private alternative investments specifically). The ground truth shows a DECLINING trend in absolute dollars ($10,542.5M → $10,335.2M → $10,051.0M), while the LLM incorrectly characterizes this as 'a small rise in absolute dollars' - this is factually wrong. The LLM's interpretation about 'gradually adjusting the mix toward greater diversification or liquidity' contradicts the ground truth's statement that the company 'maintained a consistently high exposure to private alternative investments.' The multi-hop reasoning is flawed because the LLM appears to have used incorrect source data or misread the figures entirely. While the LLM attempts to address the multi-year trajectory and strategic implications, the foundational numbers are so incorrect that the entire analysis is unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 388,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "Procter & Gamble kept Tampax Bounty within its Baby, Feminine & Family Care segment throughout all three years, but the sub‑category it was grouped under shifted. In 2022 the MD&A table listed “Feminine Care (Adult Incontinence, Feminine Care)” and included Tampax Bounty as a brand (pages 17‑21). By 2023 and 2024 the sub‑category was re‑defined as “Feminine Care (Adult Incontinence, Menstrual Care)” (pages 16‑20), signaling a sharper focus on menstrual products while still highlighting Tampax Bounty as a core brand.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several critical factual errors that significantly diverge from the ground truth: (1) ENTITY ERROR: The LLM refers to 'Tampax Bounty' as a brand, but the ground truth only mentions 'Tampax' - there is no evidence of 'Tampax Bounty' in the original answer, suggesting a potential confusion or fabrication. (2) MISSING QUANTITATIVE DATA: The ground truth provides specific sales contribution percentages (25% in 2022, 24% in 2023, 24% in 2024), but the LLM answer completely omits these key metrics. This is a significant omission for a financial question. (3) CATEGORY EVOLUTION MISCHARACTERIZATION: The ground truth clearly states that in 2023, 'Menstrual Care' explicitly replaced 'Feminine Care' as a sub-category, and by 2024, 'Baby Care' was removed entirely from the segment. The LLM answer suggests the sub-category was simply 're-defined' without capturing the strategic shift away from baby care products. (4) INCOMPLETE STRATEGIC CONTEXT: The ground truth emphasizes that the evolution 'reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines' - a key strategic insight that the LLM answer fails to capture. (5) PAGE REFERENCES: The LLM provides specific page numbers (17-21, 16-20) which cannot be verified against the ground truth and may be inaccurate. (6) MULTI-HOP SYNTHESIS: While the LLM attempts to track changes across three years, it fails to synthesize the complete picture of segment composition changes and the removal of Baby Care in 2024. The answer is partially responsive to the question but contains material factual errors and significant omissions of quantitative data essential to answering a financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 468,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) fair value climbed from $5 million at the end of 2022 to $58 million at the end of 2023 and to $69 million at the end of 2024.  The company continued to value these instruments with discounted‑cash‑flow models, but the key unobservable input shifted: swap rates used to discount the cash flows widened from a 1‑2 % range (weighted average 2 %) in 2022 to a 3‑5 % range (weighted average 4 %) in 2023 and to a 4 % range (weighted average 4 %) in 2024.  Default rates, which are relevant for retained interests in securitizations, were not a key input for derivative valuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ERRORS (Primary Issue):\n   - 2022 Fair Value: LLM states $5 million vs. Ground Truth $19 million (ERROR: -$14M discrepancy)\n   - 2024 Fair Value: LLM states $69 million vs. Ground Truth $58 million (ERROR: +$11M discrepancy)\n   - 2023 Fair Value: Both agree on $58 million (CORRECT)\n   - Swap Rates 2022: LLM claims 1-2% range vs. Ground Truth does not specify 2022 swap rates (UNSUPPORTED)\n   - Default Rates: LLM claims default rates \"were not a key input for derivative valuations\" vs. Ground Truth explicitly states default rates of 53-163% were cited in 2023-2024 (CONTRADICTORY)\n\n2. INCOMPLETE/INCORRECT SYNTHESIS:\n   - The LLM failed to capture the key finding that default rates (53-163%) were explicitly disclosed as unobservable inputs in 2023-2024\n   - The LLM incorrectly dismisses default rates as irrelevant, when the ground truth shows they were material valuation assumptions\n   - The LLM provides swap rate data for 2022 that the ground truth does not confirm, suggesting fabrication or misattribution\n\n3. MISSING CONTEXT:\n   - Failed to note the shift toward \"more transparent and methodologically consistent valuation practices starting in 2023\"\n   - Did not acknowledge that 2022 valuation technique was not disclosed (per ground truth)\n   - Missed the net unrealized loss of $20 million mentioned in 2022\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is flawed because the LLM contradicts the ground truth on material facts\n   - The claim about default rates being irrelevant directly contradicts explicit ground truth statements\n   - The 2024 fair value error ($69M vs $58M) is a significant quantitative mistake\n\nThe answer demonstrates partial understanding of the topic but contains too many material errors in both numbers and interpretation to be considered substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 529,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt portfolio moved from a modest net gain to a sizable net loss in its contribution to “Other income (loss), net.”  In fiscal 2022 the AFS debt investments added a $9 million gain; in fiscal 2023 they produced a $21 million loss; and in fiscal 2024 the loss rose to $67 million.  This shift shows that the portfolio has experienced growing unrealized losses—reflecting heightened market and credit risk—despite being largely investment‑grade, and it has turned a positive contribution into a negative one, driving the overall other‑income (loss) metric from $392 million in 2022 to a $306 million loss in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states specific dollar amounts ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that are NOT present in the ground truth. The ground truth explicitly states 'no specific performance metrics were provided for that year' (2022) and does not provide the precise figures the LLM claims. The LLM also claims 'other income (loss), net' was $392M in 2022 and a $306M loss in 2024—these specific numbers are not confirmed in the ground truth and appear to be hallucinated. (2) CONTRADICTION WITH GROUND TRUTH: The ground truth indicates that in fiscal 2022, 'no specific performance metrics were provided,' yet the LLM confidently states a $9M gain. This is a direct factual contradiction. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize the impact across three fiscal years and connect AFS debt investments to 'other income (loss), net,' it does so using unverified numbers. The reasoning structure is sound, but the factual foundation is compromised. (4) SEMANTIC ALIGNMENT: The LLM's general narrative (AFS debt investments moved from gains to losses, creating negative impact on other income) aligns with the ground truth's direction, but the specific quantification is unsupported. (5) HALLUCINATION RISK: The precision of the numbers ($9M, $21M, $67M, $392M, $306M loss) suggests the LLM may have generated plausible-sounding figures rather than extracting actual filing data. This is a severe accuracy failure for a financial analysis task where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 458,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "In the 2022 10‑K (pages 10‑14) Starbucks noted that its purchase commitments and inventory would provide an adequate green‑coffee supply through fiscal 2023. The 2023 10‑K (pages 10‑14) extended that projection to fiscal 2024, and the 2024 10‑K (pages 10‑14) further extended it to fiscal 2025. This incremental extension reflects a forward‑looking sourcing strategy that relies on longer‑term contracts, hedging, and inventory buffers to mitigate supply volatility and ensure continuity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error in the fiscal year progression. According to the ground truth, the progression is: FY2022 (adequate through FY2023) → FY2023 (adequate through FY2025) → FY2024 (adequate through FY2025). However, the LLM states: FY2022 (adequate through FY2023) → FY2023 (adequate through FY2024) → FY2024 (adequate through FY2025). This is incorrect - the LLM shows FY2023 extending to FY2024, when it should extend to FY2025. This is a material factual error that misrepresents the company's supply adequacy projections. The LLM correctly identifies the three-year progression concept and the general sourcing strategy elements (longer-term contracts, hedging, inventory buffers), which are semantically aligned with the ground truth's description of 'longer-term purchase commitments and improving inventory management.' However, the specific year-to-year progression is wrong, which is critical for a multi-hop question requiring precise synthesis of data across three fiscal years. The reasoning about risk mitigation and supply chain resilience is appropriate but cannot compensate for the incorrect underlying data. The page references (10-14) appear reasonable but cannot be verified. The core multi-hop synthesis failed due to the incorrect intermediate year projection.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 374,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 rose modestly over the three‑year period: $1,030 million at the end of FY 2022 (NVDA 10‑K 2022, p. 78‑82), $1,044 million in FY 2023 (NVDA 10‑K 2023, p. 65‑69), and $1,057 million in FY 2024 (NVDA 10‑K 2024, p. 70‑74). This incremental increase reflects a disciplined long‑term debt strategy that issues low‑coupon notes to fund growth while keeping the overall debt profile stable and the weighted‑average cost of capital low.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports FY2022: $1,030M, FY2023: $1,044M, FY2024: $1,057M. The ground truth states FY2022: $1,200M, FY2023: $1,044M, FY2024: $1,250M. The FY2022 figure is off by $170M (14% error), and FY2024 is off by $193M (15% error). Only the FY2023 figure ($1,044M) matches. (2) TREND ANALYSIS FAILURE: The LLM describes an 'incremental increase' suggesting steady growth ($1,030M → $1,044M → $1,057M), but the ground truth shows a different pattern: increase from $1,200M to $1,044M (decrease), then significant increase to $1,250M. This is a material mischaracterization of the trend. (3) INTERPRETATION ERROR: The LLM's conclusion about 'disciplined long-term debt strategy' and 'incremental increase' is based on incorrect numbers and misses the actual volatility in the debt position. The ground truth correctly identifies 'fluctuation' and 'dynamic approach,' which the LLM fails to capture. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize data across three fiscal years, it does so with incorrect base numbers, making the entire analysis unreliable. (5) CONTEXTUAL RELEVANCE: The question asks about evolution and strategy implications - the LLM addresses this but with wrong data, leading to incorrect strategic conclusions. The page citations provided cannot be verified but the numerical discrepancies are severe enough to indicate fundamental data retrieval or calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 429,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In 2022, Fall Protection Solutions were only part of the broader “industrial safety” offering in the Safety and Industrial segment and were not singled out in the product‑line description (MMM_10k_2022.pdf: pages 129‑133). By 2024, 3M had re‑categorized Fall Protection Solutions as a distinct product line within the Safety and Industrial segment, explicitly listing them alongside respiratory, hearing, eye protection and other safety products, which signals a greater emphasis on fall protection relative to other industrial safety offerings (MMM_10k_2024.pdf: pages 108‑112).",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer directly contradicts the ground truth on the core evolution narrative. Ground truth states that in 2022, Fall Protection Solutions WERE listed alongside respiratory, hearing, and eye protection as part of a broader suite, and by 2024 they remained included but with revised grouping and less standalone emphasis. The LLM claims the OPPOSITE: that in 2022 Fall Protection was NOT singled out/not explicitly listed, but by 2024 it was RE-CATEGORIZED as a DISTINCT product line with GREATER emphasis. This is a fundamental reversal of the actual evolution described in the ground truth. The LLM's characterization of the 2024 positioning as showing 'greater emphasis' contradicts the ground truth's description of a 'subtle shift' toward alignment with broader industrial safety systems rather than standalone highlighting. The LLM correctly identifies the years (2022, 2024) and company (3M/MMM), and appropriately cites document pages, but the semantic interpretation of the evolution is inverted. The reasoning logic appears sound structurally, but is applied to incorrect premises about what the documents actually show. The answer fails to capture the nuanced positioning described in the ground truth and instead presents a narrative of increasing prominence when the ground truth suggests integration into broader systems with less standalone emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 387,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s bamlanivimab revenue was $1.978 billion in 2022, rose modestly to $2.009 billion in 2023, and fell to zero in 2024 as the product was discontinued and sales ceased (LLY_10k_2024.pdf: pages 70). This sharp decline shows that Lilly’s reliance on its COVID‑19 antibody portfolio has sharply diminished, reflecting a strategic shift away from these products toward other therapeutic areas (LLY_10k_2024.pdf: pages 70).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding bamlanivimab revenue figures. Ground truth shows: 2022: $2.01 billion, 2023: $0, 2024: $0. LLM claims: 2022: $1.978 billion, 2023: $2.009 billion, 2024: $0. The LLM incorrectly reports 2023 revenue as $2.009 billion when it should be $0 - this is a fundamental error of approximately $2 billion. The 2022 figure of $1.978 billion is close to the ground truth of $2.01 billion (minor variance acceptable), but the 2023 figure is completely wrong. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the revenue trend across the three-year period. The ground truth shows a dramatic collapse from $2.01B to $0 between 2022-2023, indicating rapid market decline. The LLM's narrative of a 'modest rise' to 2023 contradicts the actual data showing complete discontinuation in 2023. ENTITY AND TEMPORAL ACCURACY: While the company (Eli Lilly) and product (bamlanivimab) are correctly identified, the temporal sequencing of events is wrong. The product was discontinued in 2023 (not 2024 as the LLM's narrative suggests), resulting in zero revenue for both 2023 and 2024. SEMANTIC ISSUES: While the LLM correctly concludes that reliance on COVID-19 antibodies has diminished, the reasoning path to reach this conclusion is based on incorrect intermediate data points. The conclusion happens to be directionally correct but is supported by false premises. The citation to 'pages 70' cannot be verified but appears to be fabricated or misinterpreted. OVERALL ASSESSMENT: This answer demonstrates poor quantitative accuracy with a major error in the 2023 figure, failed multi-hop synthesis of the revenue trend, and incorrect narrative about product performance timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 483,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 2022 and 2024 10‑K product‑supply sections (pages 10‑14) both note that coffee price volatility is influenced by trading activity in the arabica futures market, including commodity‑index funds, and that the company mitigates this exposure with fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures and collars. The consistent emphasis on hedging and the statement that purchase commitments, together with inventory, are expected to provide an adequate supply through fiscal 2025 shows that the company’s risk‑management strategy has remained focused on securing long‑term green‑coffee supply and price certainty despite ongoing index‑fund exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Starbucks acknowledged commodity index fund influence on arabica coffee futures prices, mentions the use of hedging instruments (fixed-price commitments, forward contracts, futures, and collars), and notes the company's focus on securing long-term green coffee supply through fiscal 2025. The answer accurately reflects that risk management strategy remained consistent across the period examined. WEAKNESSES: (1) The LLM answer fails to capture the critical temporal evolution that is central to the question - the ground truth emphasizes a progression from 'adequate supply through fiscal 2023 in 2022' to 'adequacy through fiscal 2025 by 2024,' showing strengthening risk management over time. The LLM answer treats the strategy as 'remained focused' (static) rather than 'improved/strengthened' (dynamic). (2) The answer omits mention of fiscal 2023 entirely, despite the ground truth explicitly referencing all three fiscal years (2022, 2023, 2024) and the progression between them. This is a significant gap in multi-hop synthesis. (3) The answer mentions 'remote delivery risk assessments' are absent from the LLM response, though this is a minor detail. (4) The LLM answer provides page references (pages 10-14) that cannot be verified against the ground truth and may be inaccurate. (5) The core insight about 'evolution' and 'trend' in the question is not adequately addressed - the answer describes current state rather than change over time. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided by either answer, so this dimension is less critical. The dates mentioned (fiscal 2022, 2023, 2024, 2025) are correct in the LLM answer. MULTI-HOP REASONING: The LLM answer fails to synthesize the three-year progression that demonstrates improving risk management capabilities. It treats the information as static rather than dynamic, missing the key insight about how supply visibility extended from fiscal 2023 to fiscal 2025 over the two-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 546,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "Google’s core impression‑based monetization strategy—using Google Ad Manager to serve ads on its Network properties—remained essentially unchanged between 2022 and 2024, with the company still tracking revenue through metrics such as cost‑per‑impression and describing Ad Manager as a key part of its Google Network mix【2022 pages 29‑33】【2024 pages 56‑60】.  In 2023 Alphabet extended the useful life of its servers and network equipment from 4 to 6 years, a change that cut depreciation expense by $3.9 billion and lifted net income by $3.0 billion, thereby improving long‑term profitability by lowering future depreciation charges and freeing capital for reinvestment【2023 pages 55‑59】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the depreciation schedule change. Strengths: (1) All quantitative data is accurate—the $3.9 billion depreciation expense reduction and $3.0 billion net income increase are correctly stated; (2) The 2023 server useful life adjustment from 4 to 6 years and network equipment from 5 to 6 years is correctly identified; (3) The multi-hop synthesis across 2022-2024 is sound, connecting Ad Manager's role in impression-based monetization to the infrastructure cost optimization; (4) The explanation of how depreciation changes affect long-term profitability is logically sound. Minor weaknesses: (1) The LLM answer is slightly less comprehensive than the ground truth—it doesn't explicitly mention that Google 'continued to report advertising revenues from Google Network properties on a gross basis' in 2024, which reinforces strategic importance; (2) The phrase 'freeing capital for reinvestment' adds interpretation not explicitly in the ground truth, though it's a reasonable inference; (3) The answer could have been more explicit about the 'multi-year trend of optimizing cost structures' framing present in the ground truth. The core narrative is correct: Ad Manager remained central to monetization, the 2023 depreciation adjustment was material and beneficial, and this supported long-term profitability. The citation format and page references appear reasonable though cannot be independently verified. Overall, this is a strong answer with accurate numbers and sound reasoning, with only minor omissions of contextual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 449,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK has continued to issue Performance Share Unit Agreements each year under the 2019 Long‑Term Incentive Plan. The 2022 10‑K (pages 18‑22) contains the 2022 Form of Performance Share Unit Agreement (exhibit 10.21) governed by the 2019 LTIP (exhibit 10.14) [10.21, 10.14]; the 2023 10‑K (pages 16‑20) includes the 2023 Form of Performance Share Unit Agreement (exhibit 10.23) [10.23]; and the 2024 10‑K (pages 16‑20) contains the 2024 Form of Performance Share Unit Agreement (exhibit 10.25) [10.25]. This steady, annual issuance under the same plan signals a strategy that prioritizes performance‑based equity to keep executive incentives aligned with long‑term shareholder value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that contradict the ground truth: (1) EXHIBIT NUMBERS WRONG: LLM claims 2022 10-K contains exhibit 10.21 (2022 Form PSU), but ground truth shows exhibit 10.45 (2021 Form PSU). LLM claims 2023 10-K contains exhibit 10.23 (2023 Form PSU), but ground truth shows exhibit 10.14 (2019 LTIP re-filing). LLM claims 2024 10-K contains exhibit 10.25 (2024 Form PSU), but ground truth shows exhibit 10.18 (2022 Form PSU). (2) AGREEMENT FORMS MISIDENTIFIED: LLM incorrectly identifies which year's PSU agreement forms were included in each filing year. Ground truth shows: 2022 referenced 2021 agreements, 2023 re-filed the 2019 plan, 2024 incorporated 2022 agreements. LLM claims annual new forms (2022, 2023, 2024) were issued each year, which is factually incorrect. (3) MULTI-HOP SYNTHESIS FAILED: The LLM failed to correctly synthesize the evolution pattern across the three-year period. Ground truth shows an adaptive approach with strategic re-filing and updating, while LLM presents a misleading narrative of continuous annual new issuances. (4) STRATEGIC INTERPRETATION FLAWED: While LLM's conclusion about performance-based equity alignment is reasonable, it's based on incorrect factual premises about which agreements were actually filed in which years. The ground truth indicates a more nuanced strategy of maintaining foundational structures while selectively updating mechanisms. The answer demonstrates fundamental misunderstanding of the filing exhibits and their progression across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 431,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across 2022, 2023, and 2024 3M’s Safety & Industrial segment consistently described its electrical offering as “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)”, showing no change in descriptive specificity. The only product‑category shift was the temporary renaming of the “Industrial specialty products” line to “Closure systems” in 2023, which was reverted in 2024. This consistency and brief re‑categorization suggest that 3M is maintaining a stable focus on electrical OEM markets while fine‑tuning its internal product classification.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim. (1) MAJOR FACTUAL ERROR: The LLM claims there was 'no change in descriptive specificity' across 2022-2024, directly contradicting the ground truth which documents clear evolution: 2022 used 'construction and maintenance, power distribution and electrical OEMs'; 2023 refined to 'electrical original equipment manufacturers (OEMs)' with increased precision; 2024 evolved to 'power distribution and electrical original equipment manufacturers (OEMs)'. The LLM's assertion of consistency is demonstrably false. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth explicitly identifies a progression showing 'growing strategic emphasis on the electrical OEM space, with increasing specificity.' The LLM dismisses this as 'no change' and 'consistency,' which is a fundamental misreading of the evidence. (3) IRRELEVANT TANGENT: The LLM introduces information about 'Industrial specialty products' being renamed to 'Closure systems' in 2023 and reverted in 2024. This appears to be either fabricated or from a different product line entirely, and is not mentioned in the ground truth. This tangent distracts from the actual electrical products evolution and suggests the model may have confused different product categories. (4) INCOMPLETE ANALYSIS: The LLM fails to capture the semantic progression in how 3M formalized its OEM market identification (from 'electrical OEMs' to 'electrical original equipment manufacturers (OEMs)'), which the ground truth identifies as a key indicator of strategic focus. (5) WRONG CONCLUSION: The LLM concludes 3M is 'maintaining a stable focus' when the ground truth indicates 'growing strategic emphasis' with 'increasing specificity.' These are contradictory interpretations of the same data. The answer demonstrates poor multi-hop reasoning by failing to synthesize the year-over-year changes in language and categorization that the ground truth clearly documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 537,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$24.1 B** (weighted‑average rate 4.45 %) in 2022 to **$27.2 B** (4.45 %) in 2023, then fell slightly to **$26.9 B** (4.84 %) in 2024. The stable debt level with a modest rate uptick in 2024 indicates the company is keeping its long‑term debt base largely unchanged while gradually shifting to higher‑rate instruments—reflecting a strategy of balancing maturity profiles and managing interest‑rate risk without aggressive leverage expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect carrying values for 2022. Ground truth shows $19,975 million in 2022, but LLM states $24.1B ($24,100 million), a difference of ~$4.1 billion or 20.5% error. The 2023 and 2024 values are approximately correct ($27.2B vs $27,168M and $26.9B vs $26,930M). (2) WEIGHTED-AVERAGE INTEREST RATE ERROR - The LLM incorrectly assigns 4.45% to both 2022 and 2023, when ground truth shows 2.91% for 2022, 4.45% for 2023, and 4.84% for 2024. This is a major factual error for the 2022 rate. (3) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the three-year progression. The ground truth shows a dramatic 35.9% increase from 2022 to 2023 ($19,975M to $27,168M), followed by a slight 1% decline in 2024. The LLM's narrative of 'stable debt level' is contradicted by the actual 2022-2023 surge. (4) STRATEGIC INTERPRETATION - While the LLM's interpretation about managing interest-rate risk is reasonable, it's based on incorrect data. The ground truth interpretation about 'securing more long-term fixed-rate financing during a rising interest rate environment' is more aligned with the actual 35.9% debt increase from 2022 to 2023. (5) COMPLETENESS - The LLM addresses all three years but with significant numerical inaccuracies that undermine the entire analysis. The 2022 carrying value error is particularly egregious as it's the baseline for understanding the multi-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 408,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were valued at **$870 million in FY 2022 and FY 2023** (NVDA_10k_2022 p. 78‑82; NVDA_10k_2023 p. 65‑69) and **declined to $851 million in FY 2024** (NVDA_10k_2024 p. 70‑74).  The notes are carried at their original issuance value net of a small unamortized discount (≈$37 million in FY 2024), so the carrying amount remained essentially unchanged and close to the fair value.  This steady valuation and minimal discounting show that NVIDIA is using long‑term debt strategically to finance growth while maintaining a conservative, interest‑rate‑managed debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth across all three fiscal years. (1) FY 2022: LLM states $870 million, but ground truth shows $1,066 million - a $196 million error (18% understatement). (2) FY 2023: LLM states $870 million, but ground truth shows $851 million - a $19 million error. (3) FY 2024: LLM states $851 million, but ground truth shows $1,000 million carrying amount (not fair value) - a $149 million error (15% understatement). The LLM fundamentally misrepresents the valuation trajectory. Ground truth shows: $1,066M (FY22) → $851M (FY23) → $1,000M carrying amount (FY24), indicating a significant decline from FY22 to FY23, then a recovery to $1,000M in FY24. The LLM's claim of 'steady valuation' is incorrect - there was a substantial $215M decline from FY22 to FY23. Additionally, the LLM conflates fair value (FY22-23) with carrying amount (FY24), missing the critical accounting treatment shift that the ground truth identifies. The LLM's interpretation about 'minimal discounting' and 'conservative debt profile' may be reasonable inferences, but they are built on incorrect numerical foundations. The multi-hop synthesis fails because the core numbers are wrong, making the comparative analysis and strategic conclusions unreliable. The answer demonstrates poor accuracy on the primary quantitative metrics that form the basis of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 400,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from $16.0 bn at year‑end 2022 (2023 filing, p. 56) to $15.0 bn at year‑end 2023 (2023 filing, p. 56) and further to $13.0 bn at year‑end 2024 (2024 filing, p. 55). This steady decline shows Amazon is actively repaying or redeeming the higher‑rate 2017 debt, reflecting a deliberate deleveraging strategy to lower interest costs and strengthen its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key financial figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The year-end dates and filing references are accurate. The reduction trajectory ($1.0B in 2023, $2.0B in 2024) is correctly captured. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and multiple SEC filings, correctly tracking the evolution of the 2017 Notes balance. ENTITY ACCURACY: Amazon, the 2017 Notes, and all fiscal years are correctly identified. REASONING QUALITY: The LLM goes beyond the ground truth by providing additional context about the debt management strategy - specifically mentioning 'higher-rate 2017 debt,' 'deleveraging strategy,' 'lower interest costs,' and 'strengthen balance sheet.' These inferences are reasonable and consistent with typical corporate debt management practices, though they represent interpretive analysis beyond the factual data points. The core factual answer matches the ground truth exactly. MINOR CONSIDERATION: The LLM adds interpretive details (interest cost reduction, balance sheet strengthening) that, while logically sound, are not explicitly stated in the ground truth. However, these represent reasonable financial analysis rather than factual errors. The answer is comprehensive, well-sourced with specific page references, and accurately addresses both parts of the question (the evolution and what it suggests about strategy).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 425,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s repeated disclosure of floating‑rate notes due 2019 in its 2022, 2023, and 2024 10‑Ks (see Exhibit 4.4 in each filing) shows that the company still carries short‑term debt that will mature in 2019. Because those notes reset to a benchmark rate, Apple’s interest expense is more rate‑sensitive, so a rise in market rates would lift its borrowing costs relative to fixed‑rate debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) TEMPORAL CONTRADICTION: The LLM states the notes 'will mature in 2019' when answering about 2022, 2023, and 2024 filings. This is factually impossible - by 2022, notes due 2019 would have already matured 3 years prior. The ground truth correctly identifies this as a disclosure anomaly (notes appearing in filings years after their maturity date), suggesting rollover obligations or continuing disclosure requirements. The LLM fundamentally misunderstands the temporal relationship. (2) MISSING KEY INSIGHT: The ground truth emphasizes the unusual persistence of 2019-maturity notes in 2022-2024 filings, suggesting rollover obligations or continuing commitments. The LLM treats this as straightforward current debt without addressing why notes that matured years ago still appear in filings. (3) INCOMPLETE ANALYSIS: The ground truth discusses liquidity planning and capital structure flexibility implications; the LLM only addresses basic interest rate sensitivity. (4) EXHIBIT REFERENCE: The LLM cites 'Exhibit 4.4' without verification against ground truth sources, which reference an Officer's Certificate dated May 6, 2014. (5) REASONING QUALITY: The LLM's logic about floating-rate sensitivity is correct in isolation, but it's applied to an incorrect temporal understanding of the debt situation. The core multi-hop reasoning fails because it doesn't synthesize the anomalous disclosure pattern across three years with the 2019 maturity date. The answer reads as if discussing current floating-rate debt rather than addressing the unusual persistence of expired-maturity notes in recent filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 445,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "From 2022 to 2024, Google’s Pixel strategy evolved from launching new hardware (Pixel 5a 5G and Pixel 6) to treating Pixel phones as a defined hardware revenue stream that is integrated into its AI‑enhanced ecosystem. The company continued to invest in hardware but emphasized that Pixel devices are a small, growing part of total revenue, while focusing on leveraging AI and software to differentiate the line and mature the product portfolio. This progression signals Google’s long‑term positioning as a hardware platform that complements and enhances its core services, rather than a standalone consumer‑electronics competitor.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Google's Pixel strategy from 2022-2024 and correctly identifies the key progression from investment phase to revenue-generating product category. Strengths: (1) Correctly mentions Pixel 5a 5G and Pixel 6 as 2022 investments, (2) Accurately reflects the transition to Pixel as a defined revenue stream by 2023-2024, (3) Properly synthesizes the multi-hop information about product maturity and market positioning, (4) Correctly emphasizes the AI/software differentiation strategy. Minor weaknesses: (1) The phrase 'small, growing part of total revenue' introduces quantitative language not explicitly stated in the ground truth, which could be misleading without specific percentages or dollar amounts to support it, (2) The characterization of Pixel as 'complementing core services rather than standalone competitor' is a reasonable inference but goes slightly beyond what the ground truth explicitly states about 'long-term positioning in the hardware market,' (3) The answer could have been more explicit about the 'devices' revenue category as the structural indicator of maturity. The multi-hop reasoning is sound—the model correctly synthesized information across three years and identified the progression from investment to revenue contribution to market positioning. No factual errors detected regarding dates, product names, or the core strategic evolution. The semantic meaning aligns well with the ground truth despite different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 412,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s 2024 10‑K shows that the fair value of client securities available for pledging rose to **$X billion** from **$Y billion** in 2022, while the fair value of securities pledged for margin‑lending and securities‑lending activities climbed to **$Z billion** from **$W billion**. This upward trend indicates a deliberate strategy of expanding the use of client securities as collateral to support margin lending and securities‑lending, thereby boosting liquidity and interest‑income generation while keeping collateral coverage robust.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FAILURES: (1) QUANTITATIVE ACCURACY - The LLM answer uses placeholder variables ($X billion, $Y billion, $Z billion, $W billion) instead of providing actual numbers. The ground truth explicitly states that in 2022 'no specific dollar value was provided' for total available or pledged securities, yet the LLM fabricates specific dollar amounts without any actual data. This is a fundamental failure - the answer presents false precision with undefined variables. (2) FACTUAL ERRORS - The LLM claims specific numerical comparisons between 2022 and 2024 that cannot be verified and contradict the ground truth's statement that 2022 data lacked specific dollar values. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The ground truth provides a nuanced 3-year progression showing: 2022 (no specific values disclosed), 2023 (expanded disclosure, formalized process), 2024 (active pledging for options clearing and securities lending). The LLM only addresses a simplistic 2022-2024 comparison without capturing the 2023 intermediate evolution or the specific operational contexts (options clearing, securities lending activities). (4) REASONING QUALITY - While the LLM correctly identifies the general trend (increasing use of client securities), it does so by inventing numbers rather than acknowledging the disclosure limitations noted in the ground truth. The conclusion about 'liquidity and interest-income generation' is reasonable but unsupported by the fabricated data. (5) MISSING CONTEXT - The LLM fails to mention the regulatory compliance framework, the distinction between margin lending and securities lending activities, or the Options Clearing Corporation context that the ground truth emphasizes. The answer reads as a template response with placeholder values rather than actual analysis of Schwab's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 493,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s 10‑K filings show a consistent partnership with primary insurers to file state‑approved premium‑rate increases on long‑term‑care policies, with the frequency of such filings rising from 2022 to 2024 (GE_10k_2022.pdf, pp. 49‑53; GE_10k_2023.pdf, pp. 19‑23; GE_10k_2024.pdf, pp. 18‑22). Sensitivity tables illustrate that the potential adverse impact of a 25 % drop in the success rate of pending rate‑increase actions grew from $200 million in 2023 to $300 million in 2024 (GE_10k_2023.pdf, pp. 20‑21; GE_10k_2024.pdf, pp. 20‑21), underscoring GE’s proactive risk‑management approach that relies on ceding insurers to manage premium deficiencies and adjust reserves accordingly.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims sensitivity tables show potential adverse impact grew from $200 million in 2023 to $300 million in 2024 due to a 25% drop in success rate of pending rate-increase actions. These specific dollar amounts ($200M, $300M) and the 25% threshold are not verified in the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of these specific financial impact figures. (2) INCOMPLETE EVOLUTION NARRATIVE: The LLM answer fails to capture the key progression described in the ground truth - the evolution from GE's 'indirect role' in 2022, to 'formalized collaboration' in 2023, to 'reinforced collaborative framework' in 2024. Instead, the LLM vaguely states 'consistent partnership' and 'frequency of filings rising,' which oversimplifies the strategic shift. (3) MISSING STRATEGIC INSIGHT: The ground truth emphasizes that GE increasingly emphasized 'collaboration and alignment with ceding companies' and used 'recent experience from ceding companies and regulatory precedents' - nuances entirely absent from the LLM response. (4) CITATION ISSUES: The LLM provides specific page numbers (pp. 49-53, pp. 19-23, etc.) that cannot be verified against the ground truth and may be inaccurate. (5) REASONING QUALITY: While the LLM correctly identifies this as a multi-hop question requiring synthesis across years, it fails to properly synthesize the evolution of GE's approach. The statement about 'proactive risk-management approach' is correct in spirit but lacks the specific evidence of formalization and structural changes noted in the ground truth. The answer reads as partially fabricated with invented financial metrics rather than grounded in actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 507,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) holdings rose modestly from $845 million in 2022 to $862 million in 2023, but fell sharply to $71 million in separate accounts in 2024 – a 92 % decline from the prior year (CVS_10k_2022.pdf: 147; CVS_10k_2023.pdf: 147; CVS_10k_2024.pdf: 158). This 3‑year trend shows the company is trimming its exposure to structured credit, reflecting a more conservative risk stance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states $845M vs. ground truth $721M (17% overstatement); (2) 2023: LLM states $862M vs. ground truth $614M (40% overstatement); (3) 2024: LLM correctly states $71M. The LLM's narrative of 'rose modestly from $845M to $862M' is completely inverted from the actual trend of declining from $721M to $614M before the 2024 rebalancing. The 92% decline calculation ($862M to $71M) is arithmetically correct based on the LLM's incorrect 2023 figure, but this calculation is built on false premises. The ground truth shows a clear 2-year decline (2022-2023) followed by a dramatic reduction in 2024, not a rise then fall. The LLM correctly identifies the 2024 figure and the general concept of 'trimming exposure,' but the 2022-2023 trajectory is entirely wrong, which is the core of the multi-hop analysis. The reasoning about 'conservative risk stance' is qualitatively reasonable but is based on incorrect data points. The answer fails to capture the actual trend: cautious reduction in 2023 amid unrealized losses, followed by strategic rebalancing in 2024. This is a case where the LLM appears to have hallucinated or misread the 2022-2023 figures, making the entire 3-year trend analysis incorrect despite getting the final year right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 386,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "Short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024; long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and then fell to $44.9 billion in 2024. The net effect is a decline in total debt from $48.7 billion to $45.6 billion, reflecting a deliberate deleveraging and refinancing strategy that keeps leverage low, preserves liquidity, and relies on a diversified mix of securitized debt and senior notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental numerical inaccuracies that severely undermine its credibility. (1) SHORT-TERM BORROWINGS: LLM states $883M (2022), $538M (2023), $562M (2024). Ground truth indicates total debt figures of $43.086B, $49.856B, $45.551B - the LLM's short-term borrowing numbers are far too small to be the complete picture. (2) LONG-TERM DEBT: LLM claims $47.8B (2022), $49.3B (2023), $44.9B (2024). These numbers don't reconcile with ground truth totals. For example, $47.8B + $0.883B = $48.683B ≠ $43.086B (2022 total). (3) TOTAL DEBT CALCULATION: LLM states decline from $48.7B to $45.6B, but ground truth shows $43.086B (2022) to $45.551B (2024) - the LLM's starting point is already wrong. (4) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is a key component of the ground truth answer and directly addresses the 'rising borrowing costs' aspect of debt management strategy. (5) MISSING DEBT COMPOSITION ANALYSIS: Ground truth specifically mentions the reduction in floating unsecured senior debt ($1,709M → $349M → $0M), which is a crucial indicator of strategic shift away from variable-rate instruments. The LLM mentions 'diversified mix of securitized debt and senior notes' but provides no supporting data. (6) PATTERN RECOGNITION: While the LLM correctly identifies a general deleveraging trend, it misses the critical 2023 peak that ground truth emphasizes as a 'strategic shift' followed by deliberate reduction. The LLM's numbers don't show this peak pattern. (7) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the relationship between rising interest rates and debt reduction strategy, which is central to understanding capital structure evolution. VERDICT: The answer demonstrates fundamental quantitative errors that make it unreliable for financial analysis. The numbers don't reconcile with ground truth, critical metrics are omitted, and the analysis lacks the depth of the original answer regarding interest rate impacts and debt composition changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 567,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 liability fell modestly over the three‑year period: it was about **$1,650 million in FY 2022, $1,637 million in FY 2023, and $1,604 million in FY 2024**.  The gradual decline reflects a deliberate capital‑structure strategy of trimming long‑term debt to lower leverage and improve debt sustainability while still using bond issuances to fund growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the FY 2022 figure. Ground truth states the liability was $2,147 million in fiscal 2022, but the LLM claims it was approximately $1,650 million - a difference of $497 million or 23% understatement. This is a significant quantitative error that fundamentally misrepresents the magnitude of the debt reduction. The FY 2023 ($1,637 million) and FY 2024 ($1,604 million) figures are correct. The LLM's characterization of the decline as 'modest' is also misleading given the actual $543 million reduction from 2022-2024 (25% decrease), which is substantial, not modest. MULTI-HOP REASONING: The LLM correctly identifies the downward trend and attempts to synthesize a capital structure strategy interpretation, which is appropriate. However, the incorrect starting point undermines the entire analysis. The reasoning about 'trimming long-term debt to lower leverage' is sound in principle but is based on flawed data. COMPLETENESS: The answer addresses the evolution question and attempts to explain strategic implications, but the factual errors prevent it from being a reliable answer. The ground truth explicitly states the decrease from $2,147M to $1,604M, which the LLM failed to capture accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 360,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple issued the 0.45% Notes due 2016 in 2013 (see Exhibit 4.3, which lists the 0.45% Notes due 2016).  The notes matured in 2016, so they are not included in the debt schedules of the 2022, 2023, or 2024 10‑K filings (Notes to Consolidated Financial Statements, pages 54‑58).  This pattern shows that Apple discloses only outstanding long‑term debt and does not re‑issue the same instrument after maturity, underscoring a consistent, transparent debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that Apple CONTINUED TO REFERENCE the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024, indicating these historical debt instruments were included in the exhibits for transparency and legal continuity. However, the LLM answer claims the opposite: that these notes are NOT included in the debt schedules of the 2022, 2023, or 2024 10-K filings. This is a critical misrepresentation of the actual disclosure pattern. The LLM correctly identifies that the notes were issued in 2013 and matured in 2016, and correctly cites Exhibit 4.3 as a reference source. However, the core conclusion about the disclosure pattern is inverted. The LLM's interpretation that Apple 'discloses only outstanding long-term debt' contradicts the ground truth finding that Apple maintains legacy debt disclosures in exhibits post-maturity. The question specifically asks about how the issuance 'evolved across 2022, 2023, and 2024' and what the pattern indicates about disclosure strategy. The ground truth indicates a consistent pattern of continued disclosure, while the LLM indicates these notes were removed from disclosures. This represents a fundamental failure in multi-hop reasoning and factual accuracy regarding Apple's actual debt disclosure practices across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 393,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) grew from $5 million at December 31 2022 to $58 million at December 31 2023 and to $69 million at December 31 2024 (Table 16.2 2022, Table 16.2 2023, Table 17.2 2024).  The valuation of these Level 3 instruments is driven by discounted‑cash‑flow models that use swap rates as the key unobservable input, with a 3‑5 % range and a 4 % weighted average in 2023 and a 4 % range and weighted average in 2024 (Table 16.3 2023, Table 17.3 2024).  This steady risk‑input profile, coupled with the expanding balance, indicates that the company’s derivative exposure has increased mainly due to market activity while its modeling assumptions and valuation methodology have remained consistent.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states net derivative assets were $5 million in 2022, but ground truth shows $31 million - a 84% discrepancy. The LLM claims $69 million in 2024, but ground truth shows $58 million - a $11 million overstatement. The 2023 figure of $58 million is correct. (2) RISK INPUT MISCHARACTERIZATION: The LLM incorrectly identifies 'swap rates' as the key unobservable input for 2023, when ground truth clearly states 'default' was the significant unobservable input in 2023. The LLM correctly identifies swap rates for 2024, but this represents a shift FROM default TO swap rates - a critical evolution the LLM fails to capture. (3) MISSING CONTEXT: The LLM completely omits the unrealized loss of $20 million in 2022 and the realized loss reduction from $43 million in 2022 to stable values - key indicators of risk management evolution. (4) FLAWED REASONING: The LLM's conclusion that 'modeling assumptions have remained consistent' is incorrect. The ground truth explicitly indicates a SHIFT in the significant unobservable input from default (2023) to swap rates (2024), representing a fundamental change in which risk driver dominates the valuation. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-year progression properly, missing the critical insight that the company's key risk exposure shifted from credit/default risk to interest rate sensitivity. The answer demonstrates poor multi-hop reasoning across the three-year period and contains multiple material factual errors that would mislead users about Capital One's derivative exposure and risk profile.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 469,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s carrying amount of the 1.55% Notes Due 2028 grew modestly over the three‑year period: $1,080 million in FY 2022, $1,099 million in FY 2023 and $1,115 million in FY 2024 (Note 9 – Fair Value of Financial Assets and Liabilities). The incremental rise reflects a deliberate long‑term debt strategy that favors low‑coupon, long‑dated notes to fund growth while keeping leverage levels stable and manageable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACY: The LLM answer provides completely incorrect financial figures that contradict the ground truth. Ground truth states: FY2022: $1.2 billion, FY2023: $1.1 billion, FY2024: $1.25 billion. LLM states: FY2022: $1,080 million ($1.08B), FY2023: $1,099 million ($1.099B), FY2024: $1,115 million ($1.115B). These numbers are fundamentally wrong - the LLM figures are approximately $100-150 million LOWER than the actual values across all three years. (1) QUANTITATIVE ACCURACY FAILURE: All three year-end values are incorrect. The LLM shows a steady upward trend ($1.08B → $1.099B → $1.115B), while ground truth shows a dip in 2023 then recovery ($1.2B → $1.1B → $1.25B). This is a material misrepresentation of the actual debt position. (2) MULTI-HOP REASONING: While the LLM correctly identifies the instrument (1.55% Notes Due 2028) and attempts to synthesize a narrative about debt strategy, the underlying data is wrong, making the entire analysis unreliable. The characterization of 'incremental rise' is incorrect - the actual pattern shows decline then recovery. (3) ENTITY ACCURACY: Company (NVIDIA) and instrument name are correct, but fiscal years and amounts are wrong. (4) SEMANTIC ISSUE: The LLM's interpretation of the trend as 'modest growth' contradicts the actual pattern of decline-then-recovery. The conclusion about 'deliberate long-term debt strategy' may be reasonable in tone but is based on false premises. This is a severe factual error that would mislead investors or analysts relying on this information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 430,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 2022 10‑K (pp. 69‑73) disclosed that the company still faced trailing legal liabilities from the 2015 Alstom acquisition and from shareholder suits over past financial reporting, with reserves set for potential settlements. The 2023 filing (pp. 34‑38) reiterated those legacy matters, noting that litigation was ongoing and that reserves remained in place, but reported no material change in exposure. By 2024 (pp. 31‑35) GE again highlighted the same Alstom‑related proceedings and shareholder lawsuits, with no reduction in the nature or magnitude of the reserves, underscoring that these contingent liabilities have persisted and continue to pose a potentially significant financial impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core elements of GE's trailing legal liabilities from 2022-2024, including the Alstom acquisition legacy matters and shareholder lawsuits. The multi-hop synthesis across three years is sound, and the conclusion about persistence of these liabilities is accurate. However, there are notable weaknesses: (1) The LLM provides specific page numbers (pp. 69-73 for 2022, pp. 34-38 for 2023, pp. 31-35 for 2024) that cannot be verified and may be fabricated, which is a significant concern for financial document analysis. (2) The LLM states 'no material change in exposure' and 'no reduction in the nature or magnitude of the reserves' but provides no actual dollar amounts or specific reserve figures to substantiate these claims, whereas the ground truth emphasizes that liabilities 'could exceed current estimates.' (3) The LLM's characterization of 'no material change' is slightly weaker than the ground truth's emphasis on liabilities that 'have not diminished but have remained a consistent and costly burden' and could 'significantly impact' financial performance. (4) The answer lacks the specific detail about 'claims of anti-competitive conduct or corruption' from Alstom's pre-acquisition period mentioned in the ground truth. The reasoning about persistence and financial impact is qualitatively sound, but the quantitative specificity is lacking, and the unverifiable page citations are problematic. The answer demonstrates good understanding of the multi-hop nature of the question but falls short on providing concrete financial evidence to support the conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 443,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s exposure to hedge‑fund limited partnership investments through HF LP Investments rose from **$225 million in 2022 to $280 million in 2024**—an increase of $55 million (2022 footnote, 2024 footnote).  The uptick, together with a higher target allocation to hedge funds (from 3 % to 4 %), signals the pension plan’s gradual shift toward a more aggressive, higher‑return strategy while still preserving diversification.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) WRONG 2022 FIGURE: LLM states $225 million for 2022, but ground truth shows $214 million—a $11 million discrepancy. (2) WRONG 2024 FIGURE: LLM states $280 million for 2024, but ground truth shows $252 million—a $28 million error. (3) WRONG CALCULATION: LLM calculates the increase as $55 million ($280M - $225M), but the correct increase from 2022 to 2024 should be $38 million ($252M - $214M). (4) MISSING 2023 DATA: Ground truth explicitly includes the 2023 intermediate value of $225 million, showing a three-year progression. The LLM only provides 2022 and 2024 endpoints, missing the complete picture of the 'consistent upward trend.' (5) INCOMPLETE TREND ANALYSIS: While the LLM correctly identifies an upward trend and mentions strategic intent, it fails to capture the full evolution across all three years. The ground truth shows a more measured progression ($214M → $225M → $252M), whereas the LLM's inflated 2024 figure ($280M) misrepresents the magnitude of the shift. (6) HEDGE FUND TARGET ALLOCATION: The LLM introduces a claim about target allocation increasing from 3% to 4%, which is not mentioned in the ground truth and cannot be verified. This appears to be an unsupported inference. The qualitative interpretation about 'aggressive, higher-return strategy' is reasonable but is built on incorrect quantitative foundations. The answer demonstrates poor multi-hop synthesis by failing to accurately extract and combine the three-year data points from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 448,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 Africa/Eurasia generated $228 million in operating profit (CL_10k_2022, p.118). In 2023 the region absorbed about 5 % of the $32 million Global Productivity Initiative charges—roughly $1.6 million in restructuring costs (CL_10k_2023, p.86). In 2024 depreciation and amortization spending in the region was $8 million (CL_10k_2024, p.118), indicating a focus on maintaining existing assets rather than aggressive expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) OPERATING PROFIT ERROR: LLM states $228 million for 2022, but ground truth is $203 million—a $25 million discrepancy (12% error). This is a critical factual error on a core metric. (2) RESTRUCTURING CHARGES ERROR: LLM claims 5% of $32 million = $1.6 million, but ground truth indicates 10% of expected charges totaling $20-24 million. The LLM appears to have misidentified both the percentage allocation (5% vs 10%) and the total restructuring pool ($32M vs $20-24M range). This represents a fundamental misunderstanding of the 2022 Global Productivity Initiative's impact on the region. The $1.6M figure is off by a factor of 12-15x compared to the $20-24M ground truth. (3) DEPRECIATION/AMORTIZATION: The $8 million figure for 2024 is correct, and the LLM correctly notes the comparison to prior years' $9 million. (4) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year trajectory. It missed the critical context that depreciation declined from $9M to $8M (showing asset base reduction), and completely mischaracterized the restructuring initiative's scale and impact. (5) REASONING QUALITY: While the LLM's concluding statement about 'maintaining existing assets rather than aggressive expansion' is reasonable, it's built on incorrect foundational data. The ground truth narrative of 'cost optimization rather than expansion' is more nuanced and supported by accurate figures. The answer demonstrates poor document comprehension and calculation errors that would mislead stakeholders about the region's financial significance and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 467,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "Across 2022‑2024 AIG’s modeled loss estimate for a five‑ton bomb attack stayed at $1.3 billion net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance recoveries, and the TRIPRA attachment point remained a $1.7 billion deductible covering 80 % of losses above that level, with no change in private reinsurance coverage【2022‑10‑k p.167‑171】【2023‑10‑k p.119‑123】【2024‑10‑k p.89】. Reinsurance recoverable assets fell sharply from $67.5 billion at December 31 2023 to $38.0 billion at December 31 2024, indicating a contraction in recoverable exposure【2023‑10‑k p.121】【2024‑10‑k p.87】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $1.3 billion net loss estimate for the five-ton bomb attack scenario across the period. (2) The $1.7 billion TRIPRA deductible is accurately stated. (3) The $38.0 billion reinsurance recoverable assets figure for 2024 is correct. (4) The 80% TRIPRA coverage level is accurate. (5) The document citations provided appear reasonable in format.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL FACTUAL ERROR: The LLM states reinsurance recoverable assets \"fell sharply from $67.5 billion at December 31 2023 to $38.0 billion at December 31 2024.\" The ground truth does not mention a $67.5 billion figure for 2023, and this comparison is not substantiated. This is a significant quantitative error that misrepresents the evolution of reinsurance protections. (2) INCOMPLETE SYNTHESIS: The LLM fails to mention the $29.1 billion in ceded loss reserves within the 2024 reinsurance recoverable assets, which is a key component of the ground truth answer showing the composition of reinsurance protections. (3) MISSING INTERNATIONAL CONTEXT: The LLM does not address the international terrorism exposure modeling or the core attachment points of $200 million in Japan and $125 million elsewhere, which are explicitly mentioned in the ground truth as important elements of how AIG's approach evolved. (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes that AIG \"maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S.\" The LLM states \"no change in private reinsurance coverage,\" which contradicts the ground truth's emphasis on increasing reliance on reinsurance and expansion of protections. (5) MISSING 2023 DETAILS: The ground truth mentions that in 2023 AIG \"continued to actively monitor and model terrorism risk using third-party vendor models\" and made \"targeted reinsurance purchases,\" but the LLM provides no information about 2023 specifically beyond the reinsurance recoverable assets figure.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but fails to properly integrate the evolution narrative. It presents static information rather than showing how the relationship between modeled losses, TRIPRA protections, and reinsurance evolved. The unsubstantiated $67.5 billion figure represents a failure in multi-hop synthesis from the source documents.\n\nCALCULATION/VERIFICATION: The $38.0 billion figure is correct for 2024. However, the $67.5 billion 2023 figure cannot be verified against the ground truth and appears to be either fabricated or misattributed. This is a critical accuracy failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 715,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s 2.00% Notes Due 2031 liability fell from a $1.20 billion carrying amount in FY 2022 to $1.044 billion in FY 2023, then rose to $1.25 billion in FY 2024. This modest fluctuation indicates the company is actively managing its long‑term debt mix—repaying or refinancing a portion in 2023 and re‑issuing or rolling over debt in 2024—while keeping the overall debt level stable and aligned with growth‑funding needs. The trend reflects a conservative, flexible debt strategy that balances liquidity, cost of capital, and capital‑structure stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $1.20 billion (2022), $1.044 billion (2023), and $1.25 billion (2024). The quantitative data is presented accurately with proper formatting and no calculation errors. The multi-hop synthesis is sound—the model correctly identifies the three-year trend and connects it to debt management strategy. The reasoning about 'active management,' 'repaying or refinancing,' and 'rolling over debt' is logically coherent and appropriately interprets the fluctuations. The LLM answer characterizes the strategy as 'conservative' and 'flexible,' which aligns well with the ground truth's emphasis on 'consistent long-term debt strategy' and 'strategic intent to preserve stable long-term liabilities.' Minor differences exist in framing: the LLM emphasizes 'active management' and 'flexibility' while the ground truth emphasizes 'stability' and 'preservation.' Both interpretations are valid given the data pattern. The LLM answer is slightly more interpretive about the mechanisms (repayment, refinancing, re-issuance) compared to the ground truth's more cautious 'possibly reflecting minor debt repayments or reclassifications,' but this represents reasonable inference rather than error. The answer appropriately addresses the question's focus on long-term debt management strategy and provides relevant context about liquidity and capital structure. No factual errors detected; the slight deduction reflects minor differences in emphasis and interpretive framing rather than substantive inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 432,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple issued the 1.05 % Notes due 2017 in 2014, which were scheduled to mature in 2017.  By the 2022, 2023, and 2024 10‑K filings (pages 54‑58, 53‑57, 54‑58 respectively), the notes appear in Exhibit 4.4 but carry no outstanding balance, indicating they were fully repaid at maturity.  This steady, transparent reporting shows Apple’s disciplined, long‑term debt management, with clear visibility into each instrument’s maturity and a consistent approach to retiring maturing debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The original answer states that the 1.05% Notes due 2017 'remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments' and that 'despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation.' The LLM answer claims the notes 'carry no outstanding balance, indicating they were fully repaid at maturity,' which directly contradicts the ground truth's assertion that they continued to appear in filings across 2022-2024. The LLM also provides specific page references (pages 54-58, 53-57, 54-58) without verification against actual filings. The core issue is that the LLM misinterprets the question's premise: the ground truth indicates the notes were still being referenced in 2022-2024 filings despite maturing in 2017, suggesting they were rolled over or refinanced. The LLM's conclusion that they were 'fully repaid at maturity' and appear only in exhibits with zero balance contradicts the ground truth's implication of continued presence and potential refinancing. The LLM does correctly identify the 2014 issuance date and 2017 maturity date, and appropriately characterizes Apple's debt management as disciplined and transparent. However, the fundamental misunderstanding of whether these notes continued to represent active obligations or were merely historical references is a critical error that undermines the entire answer. The multi-hop reasoning fails because the LLM did not properly synthesize the information about the notes' persistent appearance across three years with the implications about their status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 481,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022 Schwab was still operating under the 2019 IDA agreement, which let it migrate up to $10 billion of IDA balances each year (only floating‑rate balances) while keeping a $50 billion minimum balance and requiring that at least 80 % of balances be fixed‑rate. In May 2023 the 2019 agreement was replaced by a new 2023 IDA agreement that eliminated the 80 % fixed‑rate rule, introduced a new minimum/maximum regime (a $30 billion cap above the fixed‑rate balance through 9/10/2025, then a $60 billion minimum and $90 billion maximum thereafter), and allowed a $5 billion buy‑down of fixed‑rate obligations; Schwab did not move any IDA balances in 2023. The 2023 agreement remained in force in 2024, during which Schwab again did not migrate balances (the IDA balance fell to $87.6 billion) and the same minimum/maximum thresholds applied.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially accurate and more detailed information than the ground truth answer. Strengths: (1) Correctly identifies the 2019 IDA agreement's $10 billion annual migration limit in 2022; (2) Accurately dates the May 2023 transition to the 2023 IDA agreement; (3) Correctly states that no migrations occurred in 2023 and 2024; (4) Provides specific technical details about the agreements (80% fixed-rate requirement, $50 billion minimum in 2019 agreement, $30 billion cap structure, $60-90 billion thresholds post-9/10/2025, $5 billion buy-down provision) that enhance understanding; (5) Correctly notes the IDA balance fell to $87.6 billion in 2024. The answer demonstrates sound multi-hop reasoning by synthesizing agreement terms, migration decisions, and balance changes across the three-year period. Minor considerations: (1) The ground truth answer emphasizes a 'strategic shift' narrative that the LLM answer doesn't explicitly frame, though the facts support this interpretation; (2) The LLM provides more granular technical detail than the ground truth, which could be viewed as either more comprehensive or potentially beyond the scope of the question depending on interpretation. The quantitative data (dates, dollar amounts, percentages, thresholds) are all accurate. The qualitative synthesis correctly shows the evolution from active migration under the 2019 agreement to constrained off-balance sheet management under the 2023 agreement. No calculation errors detected. The answer fully addresses all parts of the multi-hop question regarding how Schwab's migration ability evolved and what key changes occurred in limits and balance requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 460,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "From 2022 to 2024 GE’s exposure to Bank BPH litigation widened: the estimated loss estimate climbed from $1.359 billion in 2022 to $2.669 billion in 2023 and then eased slightly to $2.461 billion in 2024. Capital support shifted from a $530 million cash injection in 2022 to a $1.797 billion non‑cash inter‑company loan forgiveness in 2023, with no new cash contributions needed in 2024. Correspondingly, the mortgage portfolio’s carrying value was written down to zero by the end of 2023 and remained at zero in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all major financial figures correctly stated: estimated losses of $1.359B (2022), $2.669B (2023), and $2.461B (2024); capital contributions of $530M cash (2022) and $1.797B non-cash intercompany loan forgiveness (2023); and mortgage portfolio write-down to zero. The multi-hop synthesis across years and metrics is sound, correctly tracking the evolution of GE's exposure through the litigation period. However, there is one notable omission: the ground truth specifically mentions a $1.014 million charge recorded in Q2 2023 as part of a settlement program, which the LLM answer does not include. This is a material detail that provides important context about the timing and nature of the 2023 charge. Additionally, while the LLM correctly states the mortgage portfolio was written down to zero, the ground truth specifies this occurred 'by the end of 2024,' whereas the LLM states it was 'written down to zero by the end of 2023 and remained at zero in 2024.' This is a minor temporal discrepancy that slightly misrepresents when the full write-down occurred. The answer effectively captures the overall narrative of worsening conditions through 2023 followed by stabilization in 2024, and correctly identifies GE's strategic shift from cash contributions to non-cash loan forgiveness. The reasoning is logically sound and the entity identification (GE, Bank BPH, litigation, capital contributions, mortgage portfolio) is accurate throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 415,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "From 2022 to 2023 CVS’s commercial mortgage‑backed securities (CMBS) fair value fell from $1,018 million to $975 million, while unrealized losses dropped from $155 million to $100 million (2022‑23 tables).  In 2024 the fair value remained roughly $975 million and unrealized losses stayed low, reflecting a continued focus on high‑quality, low‑loss CMBS and a conservative risk‑management strategy that limits exposure to market‑price volatility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all key metrics and years. Specific errors: (1) 2022 CMBS fair value: LLM states $1,018 million vs. ground truth $574 million - a 77% overstatement; (2) 2022 unrealized losses: LLM states $155 million vs. ground truth $12 million - a 1,192% overstatement; (3) 2023 fair value: LLM states $975 million vs. ground truth $675 million - a 44% overstatement; (4) 2023 unrealized losses: LLM correctly states $100 million, matching ground truth; (5) 2024 fair value: LLM states ~$975 million vs. ground truth $3 million - a 32,400% overstatement; (6) 2024 unrealized losses: LLM states 'stayed low' but provides no specific number vs. ground truth which shows a dramatic reduction from 2023. The LLM's characterization of the trend is entirely backwards - it describes a stable portfolio with 'continued focus on high-quality, low-loss CMBS' when the ground truth shows a dramatic de-risking strategy in 2024 with a 99.6% reduction in CMBS exposure (from $675M to $3M). The multi-hop reasoning fails because the LLM misidentified the key inflection point (2024 de-risking) and mischaracterized the risk management strategy. The answer suggests the LLM either accessed incorrect data or fundamentally misread the source documents. This is a critical failure on a quantitative financial question where accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 394,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑label lineup, which includes the grocery brand Marketside, stayed essentially the same from fiscal 2022 through fiscal 2024 – the same 23 private brands appear in each filing.  This steady composition shows the company is pursuing an incremental, stability‑focused private‑label strategy in grocery, reinforcing its price‑leadership and customer‑trust model rather than making large, rapid changes to the assortment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims 'the same 23 private brands appear in each filing' from 2022-2024, but provides no evidence for this specific number and this claim contradicts the ground truth which explicitly states that new brands like 'bettergoods' were introduced by 2024, indicating the portfolio was NOT static. The ground truth indicates portfolio evolution, not stasis. (2) FACTUAL INACCURACY: The LLM states the lineup 'stayed essentially the same' and 'the same 23 private brands appear in each filing,' but the ground truth clearly indicates that by 2024, Walmart 'introduced new private brands like bettergoods,' which directly contradicts the claim of no change. This is a fundamental factual error. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the key multi-hop insight from the ground truth - that Walmart pursued a DUAL STRATEGY of maintaining legacy brands (Marketside) while introducing new ones (bettergoods). The LLM incorrectly characterizes this as 'stability-focused' and 'incremental' when the ground truth explicitly describes it as 'strategic expansion and modernization.' (4) MISINTERPRETATION OF STRATEGY: The ground truth indicates Walmart's approach reflects 'preserving trusted private brands while innovating to meet evolving consumer preferences' - a dynamic strategy balancing continuity with innovation. The LLM mischaracterizes this as merely 'stability-focused' and 'reinforcing price-leadership,' missing the innovation component entirely. (5) MISSING KEY DETAILS: The LLM fails to mention the introduction of 'bettergoods' as a new brand in 2024, which is explicitly stated in the ground truth and is crucial to understanding the 3-year progression. The answer lacks the nuanced understanding that the portfolio evolved while maintaining core brands.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 515,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "In 2022 Lowe’s relied on its human‑rights, conflict‑minerals and Vendor Code of Conduct policies, together with a basic wood‑sourcing policy that set environmental standards, to monitor and enforce supplier practices. By 2023 the company overhauled the wood‑sourcing policy, adding country‑by‑country risk levels, a risk‑based monitoring framework and a new forestry grievance process, while tightening its human‑rights and environmental monitoring. In 2024 Lowe’s further strengthened enforcement with enhanced monitoring practices and expanded renewable‑energy investments—installing rooftop solar at more than 100 sites and spending over $300‑$400 million on energy‑efficiency upgrades—to support a more sustainable supply chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a critical factual error regarding investment amounts. The ground truth states 'multi-year investments exceeding $550 million by 2022 and over $400 million through 2023.' The LLM answer claims '$300-$400 million on energy-efficiency upgrades' in 2024, which contradicts the ground truth's statement that investments were 'over $400 million through 2023.' The LLM appears to have misattributed or conflated investment figures, presenting them as 2024 energy-efficiency spending rather than the broader operational sustainability investments mentioned in the ground truth. QUALITATIVE STRENGTHS: The LLM correctly identifies the evolution of policies across the three years (2022-2024), accurately describes the 2023 wood-sourcing policy overhaul with country-by-country risk levels and forestry grievance process, and properly synthesizes the progression from basic monitoring to more robust risk-based approaches. The mention of rooftop solar installations at 100+ sites is a specific detail not contradicted by ground truth but also not explicitly confirmed. COMPLETENESS ISSUES: While the LLM addresses policy enhancements well, it somewhat conflates renewable energy investments (rooftop solar, energy-efficiency) with supply chain sustainability investments, which may be a category mismatch. The ground truth emphasizes 'operational sustainability initiatives' more broadly. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression of monitoring/enforcement mechanisms, but the investment figures are materially incorrect, which is a critical failure for a financial question. The semantic understanding of policy evolution is sound, but the quantitative foundation is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 491,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple consistently reported the 2.40% Notes due 2023 as outstanding long‑term debt in each of its 2022, 2023, and 2024 10‑Ks. The 2022 filing listed a principal balance of $X and a September 2023 maturity (2022 10‑K, p. 54‑58); the 2023 filing reiterated the same outstanding balance (2023 10‑K, p. 53‑57); by 2024 Apple reported the notes had been repaid or had matured and were no longer outstanding (2024 10‑K, p. 54‑58). This steady update shows a disciplined debt‑management strategy that keeps long‑term notes on the balance sheet until maturity or repayment and transparently informs investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM uses placeholder '$X' for principal balance instead of providing actual numbers, and incorrectly states the maturity date as 'September 2023' when the ground truth indicates the notes were due in 2023 (without specifying September). The LLM also provides specific page numbers (p. 54-58, p. 53-57, p. 54-58) that cannot be verified against the ground truth and appear fabricated. (2) FACTUAL MISREPRESENTATION: The ground truth states the notes were 'listed among other global notes' and appeared 'in the exhibit list' - this is about disclosure/exhibit inclusion, not about balance sheet reporting of 'outstanding long-term debt' as the LLM claims. The LLM fundamentally mischaracterizes the nature of the disclosure. (3) INCORRECT CONCLUSION: The ground truth emphasizes that Apple 'still included the 2.40% Notes due 2023 in its exhibit list' even in 2024 (after maturity), suggesting deliberate legacy debt disclosure. The LLM incorrectly states that by 2024 'the notes had been repaid or had matured and were no longer outstanding' - this contradicts the ground truth which indicates they were still included in 2024 filings. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the three-year pattern. The ground truth shows consistent inclusion across all three years despite maturity, indicating transparency about legacy obligations. The LLM incorrectly suggests the notes disappeared from filings by 2024. (5) SEMANTIC DIVERGENCE: While both answers discuss debt management strategy, they reach different conclusions about what the pattern indicates - the ground truth emphasizes sustained transparency and legacy debt management, while the LLM emphasizes standard balance sheet accounting practices, which are not equivalent interpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 516,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap note grew steadily over the three‑year period.  In 2022 the note was disclosed as part of GE’s investment‑securities portfolio, but its carrying amount was not separately reported (2022 10‑K, pp. 90‑94).  By year‑end 2023 the note was valued at **$944 million** (2023 10‑K, pp. 68‑72), and it increased to **$982 million** at year‑end 2024 (2024 10‑K, pp. 68‑72).  This modest, incremental rise indicates GE’s strategy of gradually expanding its high‑quality debt‑security holdings within its run‑off insurance portfolio, aiming to enhance yield while maintaining a conservative risk profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) FUNDAMENTAL FACTUAL ERROR - The LLM claims the AerCap note 'grew steadily' and shows a 'modest, incremental rise,' but the ground truth shows a DECREASE from 2022 to 2023 ($976M → $944M, a $32M decline), followed by an increase to 2024 ($944M → $982M). The overall trajectory is NOT steady growth but rather a decline followed by recovery. (2) MISSING 2022 DATA - The LLM states the 2022 carrying amount was 'not separately reported,' but the ground truth explicitly provides $976 million for 2022. This is a significant omission of key data. (3) INCORRECT CHARACTERIZATION - The LLM's interpretation that this represents 'gradually expanding' holdings is contradicted by the actual 2022-2023 decline. The ground truth correctly identifies this as 'fluctuation' with 'slight overall stability,' which is semantically different from steady growth. (4) QUANTITATIVE ACCURACY - While the 2023 ($944M) and 2024 ($982M) figures are correct, the missing/incorrect 2022 figure ($976M) is a major omission that undermines the multi-hop analysis. (5) REASONING FLAW - The LLM's interpretation of investment strategy as 'gradually expanding' is not supported by the actual data pattern (down then up). The ground truth's characterization of 'dynamic approach' and 'fluctuation' better reflects the actual progression. (6) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize the three-year progression, instead presenting an incomplete and mischaracterized narrative. The answer demonstrates poor understanding of the actual data trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 427,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—defined in the 2023 10‑K as a “return‑seeking” allocation that is lowered and a liability‑hedging allocation that is raised as the plan’s funded ratio rises (page 250)—has stayed conceptually the same but its target mix has shifted.  In 2022 the target was 15 % equity, 75 % fixed‑maturity, 10 % other (page 308); by 2024 the target had moved to 9 % equity, 80 % fixed‑maturity, 11 % other (page 251), a 6‑point drop in growth exposure and a 5‑point rise in hedging assets that reflects a better funded status.  The 2025 target (9 % equity, 80 % fixed, 11 % other, page 183) shows the glide path has plateaued at a more conservative stance once the plan’s funded ratio stabilized.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of AIG's glide path concept and de-risking strategy, correctly identifying the directional shift toward liability-hedging assets and away from growth assets. However, there are significant quantitative accuracy issues that undermine the response. The LLM provides specific target allocations (2022: 15% equity/75% fixed/10% other; 2024: 9% equity/80% fixed/11% other; 2025: 9% equity/80% fixed/11% other) with page citations, but these cannot be verified against the ground truth, which does not provide specific percentage allocations. The ground truth emphasizes the glide path mechanism (allocation determined by funded status at prior year-end) and the progression across 2022-2024, but does not confirm the specific percentages cited by the LLM. The LLM's calculation of a 6-point drop in equity and 5-point rise in fixed-maturity is arithmetically correct (15%-9%=6%, 80%-75%=5%), but the underlying data cannot be validated. The LLM correctly identifies the de-risking strategy and liability-driven investing principles, matching the ground truth's core conclusion. The answer appropriately addresses the multi-hop question by synthesizing information across years and explaining the relationship between funded status and asset allocation shifts. However, the introduction of specific percentages with page citations creates a factual accuracy concern—either these numbers are correct (in which case the ground truth is incomplete) or they are incorrect (in which case the LLM has fabricated data). The qualitative reasoning about the glide path mechanism and de-risking strategy is sound and aligns with the ground truth's conceptual framework. The contextual relevance is strong, directly addressing the question about evolution and de-risking strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 490,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept the same strategic focus on analog and embedded‑processing products from 2022 through 2024, repeatedly stressing the industrial and automotive markets as its highest‑growth segments (2022 MD&A p. 18‑22; 2023 MD&A p. 16‑20; 2024 MD&A p. 16‑20).  This year‑to‑year consistency shows that embedded‑processing remains a core engine of the company’s business model, as TI links the product line to strong cash‑flow generation and long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Texas Instruments' consistent strategic focus on embedded processing from 2022-2024 and appropriately links this to free cash flow per share growth. However, there are several issues: (1) QUANTITATIVE ACCURACY: The LLM cites specific MD&A page numbers (p. 18-22 for 2022, p. 16-20 for 2023 and 2024) without verification against ground truth. These page citations cannot be confirmed and may be inaccurate or fabricated. (2) COMPLETENESS: The LLM answer mentions 'industrial and automotive markets' as highest-growth segments, which is not mentioned in the ground truth answer. While this may be factually correct from the filings, it introduces information not in the original answer and potentially shifts focus away from the core question about embedded processing's strategic role. (3) ENTITY ACCURACY: The answer correctly identifies Texas Instruments and the 2022-2024 timeframe. (4) REASONING: The LLM correctly synthesizes that embedded processing remained a core engine and links it to cash flow generation, matching the ground truth's conclusion about foundational pillar status. However, the reasoning is less detailed than the ground truth, which specifically quotes company language about 'more opportunity per customer' and 'supply chain control.' (5) SEMANTIC EQUIVALENCE: The core message aligns - embedded processing is strategically consistent and drives long-term cash flow growth. However, the LLM's introduction of market-specific information (industrial/automotive) and page citations without verification weakens confidence in the answer's accuracy. The answer would score higher if it focused more directly on the strategic narrative consistency and less on unverified page references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 475,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024 Lowe’s continued to protect its private‑brand trademarks—Kobalt, STAINMASTER and allen+roth—while shifting its brand‑portfolio emphasis toward higher‑margin private brands.  In 2023 the company highlighted “high‑value private brands” in its product‑selection strategy, balancing them with national power brands and expanding localization and rural assortments【source: 2023 IP & Product Selection】.  By 2024, Lowe’s maintained the same trademark protection but further integrated those private brands into its omnichannel and digital‑first initiatives, using its online platforms, mobile apps and virtual design tools to promote private‑brand products across all customer touchpoints【source: 2024 IP, Omnichannel Capabilities, Online】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three core private brands (Kobalt, STAINMASTER, allen+roth) that were maintained across all three fiscal years. (2) The answer accurately captures the evolution toward digital transformation and omnichannel integration by 2024. (3) The general trajectory of the strategy shift is directionally correct. (4) No specific numbers or calculations are provided, so quantitative accuracy is not compromised by errors.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The ground truth explicitly states that in fiscal 2022, Lowe's listed 'RONA' and 'Reno Depot' as retail names under intellectual property, and that these were removed by fiscal 2023. The LLM answer completely omits this important detail about the streamlining/refocusing of the brand portfolio. This is a significant gap in the multi-hop synthesis. (2) The LLM introduces language about 'high-value private brands' and 'balancing with national power brands' in 2023 that is not present in the ground truth, which could represent hallucination or unsupported claims. (3) The LLM's citation format [source: 2023 IP & Product Selection] appears to be fabricated or inferred rather than directly from the ground truth. (4) The ground truth emphasizes the REMOVAL of certain brand names as a key strategic shift, while the LLM focuses only on what was maintained, missing this crucial evolution point. (5) The LLM does not adequately explain the significance of the fiscal 2022-2023 transition where RONA and Reno Depot were dropped from IP disclosure.\n\nMULTI-HOP REASONING: The LLM partially synthesizes the evolution across three years but fails to capture the complete picture of brand portfolio changes. It correctly identifies the digital transformation integration but misses the brand portfolio streamlining that is central to understanding the IP strategy evolution.\n\nSEMANTIC EQUIVALENCE: While the LLM's description of digital integration aligns with the ground truth, the omission of the RONA/Reno Depot removal represents a material gap in semantic equivalence regarding the overall strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 566,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM consistently cites client relationships and trust as a core competitive differentiator across its 2022, 2023, and 2024 10‑Ks (2022, p. 2‑6; 2023, p. 1‑5; 2024, p. 1‑5). Over time the company has woven this theme more tightly into its hybrid‑cloud‑and‑AI narrative, positioning its long‑standing client ties as the foundation for delivering integrated AI and hybrid‑cloud solutions (2024, p. 1‑5). The steady emphasis signals IBM’s intent to be the trusted partner for enterprises adopting hybrid‑cloud and AI, differentiating itself from hyperscalers and new entrants while driving growth in those markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM emphasized client relationships and trust across 2022-2024 and appropriately cites page numbers from the 10-K filings. However, it falls significantly short on the core requirement of the question: demonstrating the EVOLUTION of this emphasis across the three-year period. The original answer provides specific, substantive details about how the framing changed: (1) 2022 focused on hybrid cloud/AI platform integration with industry expertise; (2) 2023 expanded to include strategic partnerships with AWS, Microsoft, and SAP; (3) 2024 added cybersecurity partners like Palo Alto Networks. The LLM answer merely states that IBM 'wove this theme more tightly' into its narrative without providing concrete evidence of how the positioning actually evolved year-over-year. The LLM fails to mention any specific strategic partnerships (AWS, Microsoft, SAP, Palo Alto Networks) that were central to demonstrating the evolution. The answer also misses the key insight that trust became increasingly tied to ecosystem partnerships and security considerations over time. While the LLM correctly identifies the general theme and provides appropriate citations, it lacks the multi-hop synthesis required to show the progression and strategic implications. The statement about differentiating from 'hyperscalers and new entrants' is generic and doesn't capture the nuanced evolution described in the ground truth. The answer reads more as a summary of a consistent theme rather than an analysis of how that theme evolved strategically across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 438,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In 2022 the El Segundo, California site was described as a clinical‑manufacturing location for Gilead’s cell‑therapy programs (GILD_10k_2022, pp. 31‑35).  By 2023 the company had expanded that facility’s use to include commercial manufacturing and processing of cell‑therapy products (GILD_10k_2023, pp. 9‑13).  In 2024 the El Segundo site continued to serve both clinical and commercial production responsibilities, remaining a key hub for cell‑therapy manufacturing (GILD_10k_2024, pp. 8‑12).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer directly contradicts the ground truth on a key factual claim. The LLM states that 'By 2023 the company had expanded that facility's use to include commercial manufacturing' - implying commercial manufacturing was NOT present in 2022 and was added in 2023. However, the ground truth explicitly states that in 2022 the facility was already 'described as being utilized for clinical and commercial manufacturing and processing of cell therapy products' with a 'dual role in both trial-related and market-ready production.' This is a fundamental factual error that misrepresents the evolution of the facility's role. The LLM incorrectly characterizes 2022 as 'clinical-manufacturing location' only, when the ground truth confirms it had both clinical AND commercial responsibilities from 2022 onward. The correct narrative is one of CONSISTENCY and CONTINUITY across all three years (2022-2024), not an EXPANSION from clinical-only to clinical+commercial between 2022-2023. The LLM's characterization of the facility's evolution is therefore factually incorrect and contradicts the core finding that 'the role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes.' While the LLM correctly identifies the facility location, company, years, and general product category, it fundamentally misrepresents the timeline and nature of the facility's responsibilities, which is the central question being asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 422,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "From 2022 through 2024, Lowe’s consistently issued 4.550% Notes due April 5, 2049, with each issuance amounting to roughly $1.5 billion (2022 10‑K, p. 79‑83; 2023 10‑K, p. 74‑78; 2024 10‑K, p. 73‑77). The unchanged coupon and long‑dated maturity over these three years show a deliberate long‑term debt strategy that prioritizes stable, fixed‑rate financing to support capital projects and refinance existing debt over a 25‑plus‑year horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Lowe's 'consistently issued' 4.550% Notes with 'each issuance amounting to roughly $1.5 billion' across 2022-2024. This is INCORRECT. The ground truth indicates these were NOT new issuances in each year, but rather consistent REFERENCES to the same debt instrument (4.550% Notes due April 5, 2049) that was originally issued on April 5, 2019. The LLM fundamentally misrepresents the nature of the debt by claiming multiple issuances of $1.5B each year, when the ground truth shows a single instrument consistently referenced across filings. (2) ENTITY/FACT ACCURACY - The LLM incorrectly characterizes the multi-year pattern as showing 'each issuance' when the ground truth explicitly states the instrument was issued once (April 5, 2019) and consistently referenced thereafter. This is a critical distinction that changes the entire interpretation of Lowe's debt strategy. (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the information: it should have recognized that consistent references to the same debt instrument across multiple years indicates STABILITY and MAINTENANCE of existing debt, not repeated new issuances. (4) WHAT WAS CORRECT - The coupon rate (4.550%), maturity date (April 5, 2049), and the general conclusion about long-term debt strategy are directionally correct. The LLM correctly identified this as a long-duration debt instrument. (5) CRITICAL FLAW - The claim of '$1.5 billion' issuances in each of 2022, 2023, and 2024 cannot be verified from the ground truth and appears to be fabricated. The ground truth makes no mention of specific dollar amounts for these notes or multiple issuances. This represents a serious factual error that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 486,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 to 2024, 3M’s Scotchgard product continued to face a growing number of PFAS‑related lawsuits, but the company’s settlement outlays remained immaterial.  In 2023, 3M settled a Wolverine World Wide lawsuit over Scotchgard for an immaterial amount (MMM_10k_2023.pdf: 92‑96), and by 2024 the company still had ongoing litigation but had not incurred additional significant settlement costs (MMM_10k_2024.pdf: 96‑100).  This trend indicates that while legal exposure for Scotchgard remains high, the direct financial impact of PFAS litigation on 3M has been limited.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM claims settlements were 'immaterial' and 'limited,' but the ground truth explicitly documents a $65 million settlement in 2022 (with Saint-Gobain and Honeywell) and another $65 million settlement in New York being finalized by 2024. These are material amounts.\n   - The LLM fails to mention the $65 million settlement amounts entirely, which are concrete, verifiable financial figures.\n   - The LLM incorrectly characterizes the 2023 Wolverine settlement as 'immaterial' when the ground truth indicates it was finalized as a 'non-material settlement' in Michigan (different context than the $65M settlements).\n\n2. COMPLETENESS FAILURES:\n   - The LLM completely omits the $65 million settlement in 2022 involving Saint-Gobain and Honeywell.\n   - The LLM fails to document the expansion of litigation to Alabama and Georgia in 2024.\n   - The LLM does not mention the approximately 68 AFFF suits outside the MDL in 2023.\n   - The LLM omits the Canadian class action mentioned in the ground truth.\n   - The LLM fails to capture the geographic expansion and increasing case complexity that characterizes the trend.\n\n3. ENTITY AND REASONING FAILURES:\n   - The LLM's conclusion that 'direct financial impact of PFAS litigation on 3M has been limited' directly contradicts the ground truth's finding that 'the company's liabilities and legal costs associated with Scotchgard are escalating over time.'\n   - The LLM misses the multi-hop synthesis required: tracking how litigation expanded from 2022 (NY/MI) → 2023 (IL, Canada, ~68 AFFF suits) → 2024 (AL, GA, multiple municipal/property owner suits).\n   - The LLM fails to synthesize the pattern of escalating geographic spread and case complexity.\n\n4. SEMANTIC EQUIVALENCE FAILURES:\n   - The LLM's characterization of limited financial impact is semantically opposite to the ground truth's characterization of escalating liabilities and costs.\n   - The LLM's framing of 'immaterial' settlements contradicts the documented $65 million settlements.\n\n5. CONTEXTUAL RELEVANCE:\n   - While the LLM addresses the general topic of Scotchgard litigation, it fundamentally mischaracterizes the financial impact and trend direction, making it contextually misleading despite addressing the right subject matter.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 648,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "From 2022 to 2024, Gilead’s Foster City headquarters shifted from a broad “administrative, manufacturing and R&D” hub (2022) to a more specialized center that focuses on process‑chemistry research, analytical method development, formulation/device development and API/drug‑product manufacturing for clinical trials (2023‑24). This evolution reflects a tighter integration of R&D and manufacturing at the corporate site and reinforces its role as a key node in Gilead’s global network of facilities that support operations across North America, Europe, Asia and beyond. (GILD_10k_2022, pp. 31‑35; GILD_10k_2023, pp. 9‑13; GILD_10k_2024, pp. 8‑12)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential evolution of Gilead's Foster City facility from 2022-2024. STRENGTHS: (1) Correctly identifies the transition from broad 'administrative, manufacturing and R&D' (2022) to specialized focus on process chemistry research, analytical method development, formulation/device development, and API/drug-product manufacturing for clinical trials (2023-2024). (2) Accurately synthesizes the multi-hop information across three fiscal years. (3) Properly identifies the strategic shift toward consolidating R&D and clinical production at Foster City. (4) Correctly references the facility as corporate headquarters and a key node in global operations. (5) Appropriately cites source documents with page ranges. MINOR WEAKNESSES: (1) The LLM answer mentions 'North America, Europe, Asia and beyond' as part of the global network context, which adds reasonable contextual information but is not explicitly detailed in the ground truth answer. This is a minor enhancement rather than an error. (2) The ground truth specifically mentions other locations (La Verne, Oceanside, international sites) handling commercial-scale manufacturing, which the LLM answer does not explicitly state, though it implies this through the 'tighter integration' language. (3) The phrase 'reinforces its role as a key node' is slightly different from the ground truth's 'key hub within a broader network' - semantically equivalent but not identical. QUANTITATIVE ACCURACY: All dates (2022, 2023-2024) are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution across years and identifies the strategic alignment. The multi-hop synthesis is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question: R&D focus, manufacturing responsibilities, and strategic alignment with global operations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 517,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "AIG’s loss‑reserve oversight moved from a basic internal‑control system with periodic external expert reviews in 2022 (internal controls and “reviews by external experts”【2022 p.167】) to a formal risk‑management framework in 2023 that added escalation procedures, a model‑risk management and validation process, and expanded modeling to stochastic and scenario analyses【2023 p.119】. By 2024, the company further institutionalized oversight with board‑level risk committees and a three‑tiered limits hierarchy, while embedding external reviews and third‑party model validation into the reserve‑setting process and reinforcing the model‑risk framework【2024 p.84‑85】【2024 p.86】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 evolution of AIG's loss reserves risk management. STRENGTHS: (1) Correctly identifies the progression from basic internal controls with external reviews (2022) to expanded frameworks (2023) to institutionalized oversight (2024); (2) Accurately captures key methodological additions: stochastic methods, scenario analyses, model-risk management, and validation processes; (3) Properly synthesizes multi-hop information across three years showing evolution in sophistication; (4) Correctly identifies specific governance enhancements (board-level committees, three-tiered limits hierarchy, second-line review); (5) Appropriately cites page references to support claims. MINOR WEAKNESSES: (1) The LLM answer uses slightly different terminology than ground truth (e.g., 'three-tiered limits hierarchy' vs. 'enterprise risk management framework') - while not incorrect, this represents a minor semantic variation; (2) The ground truth explicitly mentions 'shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance' as a key insight, which the LLM answer implies but doesn't explicitly state; (3) The LLM answer emphasizes 'board-level risk committees' and 'three-tiered limits hierarchy' which aren't explicitly mentioned in the ground truth, suggesting possible over-specification or different source interpretation. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question, so this dimension is not heavily weighted. The years (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple dimensions (oversight mechanisms, modeling approaches, external reviews), showing proper understanding of the evolution. The logical progression is sound and well-articulated. OVERALL: The answer captures the essential evolution and demonstrates strong comprehension of AIG's risk management progression, with only minor deviations from ground truth framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 566,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "From 2022 through 2024 Texas Instruments kept the Melaka, Malaysia site as an **analog‑only** manufacturing location (the table lists “Melaka, Malaysia †/∗/∗∗” under the Analog column and no entry under Embedded Processing【TXN_10k_2022】【TXN_10k_2023】【TXN_10k_2024】).  The footnote changed from “† Portions of the facilities are leased and owned” in 2022, to “∗ Portions of the facilities are leased and owned” in 2023, and to “∗∗ Leased” in 2024, indicating a shift to a fully leased facility but no change in product focus.  This three‑year trend shows TI has maintained a consistent analog manufacturing presence in Melaka, with no expansion into embedded‑processing operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies Melaka, Malaysia as an analog-only manufacturing location across all three years (2022-2024), matching the ground truth exactly. (2) Accurately notes the absence of Embedded Processing operations in Melaka during this period. (3) Provides additional valuable detail about the footnote evolution († to ∗ to ∗∗), showing the shift from 'portions leased and owned' to 'fully leased' - this adds nuance beyond the ground truth while remaining factually accurate. (4) Properly cites all three 10-K filings (2022, 2023, 2024) as sources. (5) Correctly synthesizes the multi-hop information: tracking the facility across three years, identifying the product focus consistency, and drawing the logical conclusion about TI's manufacturing strategy. (6) The reasoning is sound - the answer correctly interprets that no expansion occurred and that the role remained specialized and stable. MINOR CONSIDERATIONS: The ground truth answer is more concise, while the LLM answer provides additional contextual detail about the lease structure changes. This additional detail is accurate and enhances understanding without contradicting the ground truth. The semantic meaning is fully aligned - both answers convey that Melaka maintained an analog-only focus with no Embedded Processing expansion from 2022-2024. No numerical errors, calculation errors, or entity misidentifications detected. The answer fully addresses all parts of the multi-part question regarding the 3-year evolution and what it indicates about manufacturing focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 441,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In FY 2022, Lowe’s had forward‑interest‑rate‑swap exposure of $2.56 billion (notional) (Note 9, p. 60). By FY 2023 the fair value of those swaps had fallen to $251 million (Fair‑Value Measurements, p. 52), and in FY 2024 the company reported no forward‑interest‑rate‑swap exposure on its balance sheet (Fair‑Value Measurements, p. 44). This progression shows that Lowe’s used forward‑rate swaps to hedge forecasted debt issuances and systematically unwound the hedges as the debt was issued or the contracts matured.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the overall progression of Lowe's forward interest rate swap exposure from FY 2022 through FY 2024 and accurately captures the strategic shift. However, there are significant quantitative accuracy issues: (1) The LLM introduces a $2.56 billion notional value for FY 2022 that is not mentioned in the ground truth answer, and this specific number cannot be verified against the provided ground truth. (2) The FY 2023 fair value of $251 million is correctly stated and matches the ground truth. (3) The FY 2024 statement that the company held no forward interest rate swaps is correct. The core reasoning about the strategic shift from hedging forecasted debt issuances to managing existing debt exposure is sound and well-articulated. The LLM correctly synthesizes the multi-hop information showing the progression across three fiscal years. However, the introduction of the $2.56 billion notional figure without ground truth support is problematic—this appears to be an unsupported detail that could be factually incorrect. The qualitative assessment of the hedging strategy shift is accurate and well-reasoned, matching the ground truth's conclusion about moving from anticipated debt issuances to existing debt management. The answer is contextually relevant and addresses the question appropriately, but the unverified quantitative claim significantly undermines confidence in the response's overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 401,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 2022, 2023, and 2024 Form 10‑Ks all disclose the 6.50% Debentures due 2028 as Exhibit 2 to a Form 8‑K filed on January 8 1998 (IBM_10k_2024, pp. 17‑21; IBM_10k_2023, pp. 17‑21; IBM_10k_2022, pp. 28‑32). The unchanged reference across all three filings shows that the debt’s terms have remained constant since issuance, and that IBM continues to rely on the original 1998 documentation to support its long‑term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All numeric values are correct - the 6.50% interest rate, the 2028 maturity date, and the January 8, 1998 Form 8-K filing date are all accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies that IBM referenced the same debenture documentation across all three years (2022, 2023, 2024) and properly synthesizes this consistency to draw conclusions about the debt instrument's stability. (3) Entity identification is precise - IBM is correctly identified, the debenture terms are accurate, and the exhibit/form references are correct. (4) The reasoning logic is valid - the answer correctly interprets that unchanged references across three years indicate stable documentation and no material amendments. (5) The answer directly addresses all parts of the multi-part question: how disclosure evolved (consistently referenced), what the filing date reveals (stable long-standing structure), and the implications for long-term documentation. MINOR CONSIDERATIONS: The LLM answer includes specific page number citations (pp. 17-21 for 2023/2024, pp. 28-32 for 2022) which cannot be verified against the ground truth but appear reasonable and add helpful specificity. The wording 'continues to rely on the original 1998 documentation' is a reasonable interpretation of the consistency pattern, though the ground truth uses slightly different phrasing ('remained unchanged'). Both convey the same semantic meaning. The answer is comprehensive, factually accurate, and demonstrates proper multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 445,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective signage has remained a listed product within 3M’s Transportation and Electronics segment in all three years, with its description unchanged as “Reflective signage for highway, and vehicle safety” (2022, p.129‑133; 2023, p.105‑109; 2024, p.108‑112). This continuity indicates that 3M views reflective signage as a core, strategically important component of its transportation and electronics portfolio, likely because it supports highway and vehicle safety markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally fails to address the core question about how Reflective Signage's positioning evolved across 2022, 2023, and 2024. CRITICAL FAILURES: (1) The LLM completely omits the specific positional rankings that are central to the question - it does not mention that Reflective Signage was 5th in 2022, 4th in 2023, and 4th in 2024. (2) The LLM does not track the sequence of products before and after Reflective Signage across the three years, which is essential to understanding the 'evolution' requested. (3) The LLM provides page citations (p.129-133, p.105-109, p.108-112) but these appear to be generic references without substantiating the positional analysis. (4) The LLM's conclusion about 'continuity' and 'core strategic importance' is vague and unsupported by the specific positional data that would demonstrate this. WHAT WAS CORRECT: The LLM correctly identifies that Reflective Signage remained listed in the Transportation and Electronics segment across all three years, and correctly notes the product description as relating to highway and vehicle safety. However, this represents only a small fraction of what the question asks. MULTI-HOP REASONING: The question requires synthesizing positional data across three years to identify trends - the LLM completely fails this synthesis task. The ground truth answer provides specific positional rankings and explains what the sequence suggests about strategic importance; the LLM provides only generic statements about continuity. The LLM's answer is incomplete, missing the quantitative positional analysis that is the heart of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 445,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "From 2022 through 2024, Gilead has consistently described its Hoofddorp, Netherlands site as a commercial manufacturing and processing hub for cell‑therapy products (2022: p. 35; 2023: p. 13; 2024: p. 12). The facility has remained central to Gilead’s cell‑therapy production, supporting key products such as Yescarta and Tecartus, and its strategic importance has grown as the company expands its cell‑therapy portfolio and scales commercial production to meet global demand.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) PAGE NUMBER CITATIONS ARE UNVERIFIED AND LIKELY INCORRECT - The LLM provides specific page citations (2022: p. 35; 2023: p. 13; 2024: p. 12) without verification against actual filings. These citations cannot be confirmed and appear to be hallucinated. (2) PRODUCT ATTRIBUTION ERROR - The LLM claims Hoofddorp supports 'key products such as Yescarta and Tecartus' but the ground truth does not mention these specific products in connection with the Hoofddorp facility. This is a factual error that introduces unsupported information. (3) INCOMPLETE TEMPORAL PROGRESSION - The ground truth emphasizes an EVOLUTION from 2022 (identified as principal facility) → 2023 (explicitly described for commercial manufacturing) → 2024 (retained as key facility with growing strategic importance). The LLM states the facility was 'consistently described' across all three years, which contradicts the ground truth's narrative of progression and increasing emphasis. This misses the key insight about how the facility's role evolved and became more strategically important. (4) MISSING CONTEXT - The ground truth emphasizes 'growing strategic importance' and 'increasing emphasis on Hoofddorp as a dedicated hub,' reflecting Gilead's commitment to scaling cell therapy. The LLM mentions strategic importance has 'grown' but doesn't capture the nuanced progression from initial identification to explicit commercial designation to retained key status. WHAT WAS CORRECT: The facility name (Hoofddorp, Netherlands), company name (Gilead), general timeframe (2022-2024), and general category (cell therapy manufacturing) are correct. The semantic direction that strategic importance increased is correct. OVERALL ASSESSMENT: The answer contains fabricated citations, introduces unsupported product claims, and mischaracterizes the temporal evolution as 'consistent' rather than progressive. These are significant factual errors that undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 532,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 2003 Director Compensation Plan had **zero shares available for future issuance in 2022, 2023, and 2024** (the footnote for each year lists only the 2009 LTIP, 2014 ESPP, 2018 Director Plan, and 2024 LTIP). This steady zero balance shows that TI has fully exercised or retired the 2003 plan for new director awards and now relies on newer plans such as the 2018 Director Plan and the 2024 LTIP for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states zero shares were available in 2022, 2023, and 2024, but the ground truth clearly shows: 1,843,134 shares in 2022, 1,786,785 shares in 2023, and 1,745,284 shares in 2024. These are substantial, specific numbers that the LLM completely misrepresented. (2) ENTITY/METRIC CONFUSION: The LLM appears to have confused or misread the footnote disclosures, claiming the 2003 plan had zero shares available when the ground truth explicitly documents declining but positive share balances across all three years. (3) REASONING ERROR: The LLM's conclusion that TI 'fully exercised or retired the 2003 plan' directly contradicts the ground truth showing consistent active use with shares being issued each year (evidenced by the year-over-year decline). The declining trend from 1,843,134 → 1,786,785 → 1,745,284 demonstrates ongoing utilization, not retirement. (4) MULTI-HOP SYNTHESIS FAILURE: The question required synthesizing share availability data across three years to identify a trend. The LLM failed to identify any trend and instead provided incorrect static data (zero across all years). The correct answer shows a clear downward trend indicating active plan usage. (5) SEMANTIC MISMATCH: The LLM's interpretation that the plan is 'fully exercised or retired' is the opposite of what the data shows—the plan remains active with decreasing available shares due to ongoing issuances. This is a critical misunderstanding of what the numbers indicate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 430,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In 2022 IBM had not yet issued the 0.950% Notes due 2025, so the 10‑K contained no disclosure of that debt. By 2023 the notes were issued and disclosed in the filing, but they were still unlisted and the company provided only limited market‑for‑securities information. In 2024 IBM registered the notes on the NYSE (IBM25B) and listed them in the “Securities registered pursuant to Section 12(b) of the Act” table, indicating a move to full public trading and a more transparent market‑for‑securities section【2024‑10K‑pages‑1‑5】. This progression shows IBM’s broader strategy of increasing liquidity and investor confidence by making its debt more accessible and its disclosures more complete.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - Issuance Timeline: The LLM claims IBM had not issued the 0.950% Notes due 2025 in 2022, but the ground truth explicitly states these notes were referenced in 2022 as part of IBM's debt instruments, with the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. This means the notes existed well before 2022. The LLM's claim that they were 'issued' in 2023 is factually incorrect. (2) QUANTITATIVE ACCURACY: The LLM provides no specific dates or references to verify, but the core claim about when the notes first appeared is wrong. The ground truth shows continuous disclosure from 2022 onward, not a gap followed by first disclosure in 2023. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year progression. The ground truth shows: 2022 (referenced as part of broader debt list), 2023 (increased prominence alongside newer instruments), 2024 (explicit listing with trading symbol IBM25B). The LLM's narrative of non-existence in 2022, then issuance in 2023, then registration in 2024 is a fundamentally different and incorrect timeline. (4) ENTITY ACCURACY: While the LLM correctly identifies IBM, the 0.950% Notes due 2025, and the NYSE ticker IBM25B, it mischaracterizes the historical progression of these instruments. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation of the evolution is inverted - it suggests a progression from non-existence to disclosure to registration, when the ground truth shows a progression from internal documentation to increased prominence to active market visibility. The LLM's conclusion about 'increasing liquidity and investor confidence' may be directionally similar to the ground truth's 'greater transparency and investor accessibility,' but this is undermined by the incorrect factual foundation. The reference to '2024-10K-pages-1-5' appears to be a fabricated citation format not matching standard SEC filing references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 542,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method balances grew from roughly **$1.8 billion in deposit assets and $1.4 billion in deposit liabilities in 2022** to **$5.1 billion in assets and $1.3 billion in liabilities at year‑end 2023**, then fell slightly to **$4.6 billion in assets and $1.2 billion in liabilities by 2024** (2024: $4.6 billion assets, $1.2 billion liabilities; 2023: $5.1 billion assets, $1.3 billion liabilities). The 2023 Global Atlantic transaction, which transferred $9.5 billion of assets and created $10.3 billion of deposit receivables, drove the 2023 jump and signals a strategic shift toward using the deposit method for larger, structured risk‑transfer deals that also move substantial assets to the reinsurer.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the key financial metrics and trends across the 2022-2024 period. STRENGTHS: (1) All deposit asset and liability figures are accurate: 2022 ($1.8B assets, $1.4B liabilities), 2023 ($5.1B assets, $1.3B liabilities), 2024 ($4.6B assets, $1.2B liabilities). (2) The $10.3 billion deposit receivables figure from the Global Atlantic transaction is correctly cited. (3) The multi-hop synthesis is sound—the answer correctly connects the 2023 transaction to the observed increase in deposit balances and characterizes it as a strategic shift. (4) The narrative flow effectively explains the evolution from 2022 through 2024 and contextualizes the Global Atlantic transaction as a driver of change. (5) Semantic equivalence is maintained throughout; wording differs from ground truth but conveys identical meaning. MINOR WEAKNESSES: (1) The LLM mentions '$9.5 billion of assets' transferred in the Global Atlantic transaction, which is not explicitly stated in the ground truth answer. While this detail may be accurate from the source filings, it introduces information not present in the original answer, creating a slight discrepancy in what was provided as ground truth. (2) The ground truth emphasizes the transaction 'recorded $10.3 billion in reinsurance recoverables and deposit receivables' while the LLM states it 'created $10.3 billion of deposit receivables'—a subtle distinction that the LLM partially addresses by mentioning both assets transferred and deposit receivables created. The characterization of the strategic shift as 'more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio' (ground truth) versus 'larger, structured risk-transfer deals that also move substantial assets to the reinsurer' (LLM) are semantically equivalent interpretations. CALCULATION VERIFICATION: No calculations required; all figures are direct citations. The trend analysis (increase 2022→2023, slight decrease 2023→2024) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the Global Atlantic transaction to the observed balance sheet changes, demonstrating sound multi-hop reasoning. The minor introduction of the $9.5 billion asset figure prevents a perfect score, but the core answer remains substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 645,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Across 2022‑2024, 3M’s Safety and Industrial segment consistently listed “fall protection solutions” as part of its respiratory, hearing, eye and fall protection product line (2022 pp. 129‑133; 2023 pp. 105‑109; 2024 pp. 108‑112), with no new categories added or removed.  The segment’s operating income rose from $1.1 B in 2022 to $2.3 B in 2023 and $2.5 B in 2024 (2022‑24 tables), showing that the company is not only maintaining but also strengthening its focus on workplace safety solutions, particularly fall protection.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that fall protection solutions remained consistent across 2022-2024 within the Safety and Industrial segment, matching the ground truth's core finding. The answer appropriately cites page numbers and maintains semantic equivalence with the original answer regarding product portfolio consistency. However, there are significant quantitative accuracy issues: (1) The operating income figures ($1.1B in 2022, $2.3B in 2023, $2.5B in 2024) are NOT verified in the ground truth and appear to be unsupported claims. The original answer makes no mention of these financial metrics. (2) The LLM introduces financial data that goes beyond what the ground truth provides, which is problematic because these numbers cannot be verified against the source material. (3) The reasoning that rising operating income 'strengthens' focus on workplace safety is logical but relies on unverified numbers. The qualitative assessment of product portfolio evolution is sound - the LLM correctly notes no new categories were added or removed, which aligns with the ground truth's finding of 'stable strategic focus.' The answer appropriately addresses the multi-hop question by synthesizing information across three years. However, the introduction of specific financial metrics without ground truth support significantly undermines credibility. The answer would have been stronger by sticking to the documented product portfolio consistency and avoiding unsupported financial claims. The contextual relevance is good as it directly addresses workplace safety focus, but the quantitative claims create a major factual accuracy problem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 451,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST LLC as a wholly‑owned subsidiary of Altria Group, with its operating arm, U.S. Smokeless Tobacco Company LLC (USSTC), also wholly owned, through 2022‑24 (2022 p. 64‑68; 2023 p. 58‑62; 2024 p. 2‑6).  The company reports UST under its oral‑tobacco segment, reinforcing a centralized ownership and a strategic focus on smokeless tobacco as a core growth engine.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides accurate structural information about UST's ownership (wholly-owned subsidiary status through 2022-24) and correctly identifies the organizational entities (UST LLC and USSTC). However, it significantly underperforms on the core question requirements:\n\n(1) WHAT WAS CORRECT: The LLM correctly identifies that UST remained a wholly-owned subsidiary across all three years (2022-24), accurately names the entities (UST LLC and U.S. Smokeless Tobacco Company LLC), and correctly notes the oral-tobacco segment classification. Page references appear reasonable.\n\n(2) WHAT WAS MISSING/INCORRECT: The LLM answer fails to address critical quantitative data from the ground truth - specifically the $8.8 billion trademark valuation mentioned in 2022, which is a key financial metric demonstrating Altria's strategic valuation of UST. The answer also lacks the temporal evolution narrative that the question explicitly asks for ('how has...evolved from 2022 to 2024'). The ground truth shows a progression of strategic positioning (2022: key subsidiary with valued trademarks → 2023: reaffirmed wholly-owned subsidiary → 2024: core operating company under 'Moving Beyond Smoking'), but the LLM treats all three years as essentially identical.\n\n(3) MULTI-HOP REASONING: The LLM fails to synthesize the strategic evolution across years. It presents static ownership facts rather than analyzing the progression and what it reveals about strategic positioning. The ground truth explicitly connects UST's role to Altria's 'Moving Beyond Smoking' initiative and reduced-risk product strategy, which the LLM completely omits.\n\n(4) INCOMPLETENESS ON QUESTION REQUIREMENTS: The question has two parts: (a) how has organizational structure/ownership evolved, and (b) what does this reveal about strategic positioning. The LLM addresses only part (a) superficially and completely ignores part (b). The ground truth demonstrates increasing strategic integration and alignment with reduced-risk positioning, which is absent from the LLM response.\n\n(5) SEMANTIC GAPS: While the LLM mentions 'core growth engine,' it doesn't connect this to the broader 'Moving Beyond Smoking' strategic pivot or the transition toward reduced-risk products that the ground truth emphasizes as central to understanding Altria's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 624,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s repeated mention of the SolarCity 5.45% Solar Bonds, Series 2015/C92‑15 in its 2022, 2023 and 2024 10‑Ks shows that the company still carries this long‑term debt and continues to use it as a key financing vehicle for its solar projects. The consistency across filings signals a deliberate strategy of funding solar initiatives through stable, long‑term debt rather than equity or short‑term borrowing, and that Tesla has not yet refinanced or retired these bonds.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C92-15), the years referenced (2022, 2023, 2024), and accurately notes that Tesla continues to carry this debt. The quantitative elements are accurate - the bond percentage and series designation are correct. However, the answer has significant qualitative shortcomings: (1) It lacks the specific legal/documentary detail provided in the ground truth (the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015), which is material context for understanding Tesla's structured financing approach. (2) The ground truth emphasizes 'securitized solar debt as a core funding source' and 'strategic commitment' with confidence in bond performance, while the LLM answer focuses more narrowly on the fact that bonds haven't been refinanced/retired. (3) The ground truth connects the repeated references to Tesla's 'broader clean energy business model,' providing deeper strategic context that the LLM answer omits. (4) The LLM's inference that Tesla 'has not yet refinanced or retired these bonds' is reasonable but represents a narrower interpretation than the ground truth's emphasis on sustained reliance and strategic commitment. The LLM answer is partially correct and addresses the core question but misses important nuances about the strategic significance and legal/structural details that characterize Tesla's long-term solar financing strategy. The answer is competent but incomplete in capturing the full strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 423,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor disclosures consistently list “governmental and stock‑exchange regulations” as a factor that can affect the value of its debt securities and the market price of its common stock across 2022 (pages 20‑24), 2023 (pages 9‑13), and 2024 (pages 9‑13). The unchanged wording indicates that IBM’s exposure to stock‑exchange regulatory risk has remained stable over this period, with no new regulatory threats identified. This consistency reflects a capital‑market risk‑management strategy that prioritizes ongoing monitoring and mitigation of regulatory risks rather than relying on changes in the regulatory environment to alter its risk profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and analytical errors that substantially diverge from the ground truth. CRITICAL ISSUES: (1) The LLM claims 'unchanged wording' across 2022-2024, but the ground truth explicitly states IBM 'expanded on this risk' by 2024 and 'reiterated' in 2023 with emphasis on different aspects - this is a fundamental mischaracterization of the multi-year progression. (2) The LLM states 'no new regulatory threats identified,' contradicting the ground truth which shows IBM linked regulatory exposure to 'broader market liquidity conditions and customer credit risks' by 2024 - a material expansion of scope. (3) The LLM's conclusion that consistency 'reflects a capital-market risk-management strategy that prioritizes ongoing monitoring' is unsupported inference not present in ground truth; the ground truth explicitly states there was 'no material reduction in dependency or mitigation strategy' - a different and more cautious assessment. (4) The LLM provides page numbers (20-24 for 2022, 9-13 for 2023/2024) without verification against actual filings, and these cannot be confirmed as accurate. (5) The LLM misses the key insight from ground truth: IBM's evolution shows 'increasing recognition of regulatory dynamics as a persistent and systemic component' - not static consistency. QUANTITATIVE ACCURACY: Page numbers are cited but unverified; no calculations present. QUALITATIVE ACCURACY: The multi-hop reasoning fails to capture the actual evolution across years. The LLM conflates 'consistent disclosure' with 'unchanged exposure,' missing the nuanced progression described in ground truth. CONTEXTUAL RELEVANCE: The answer addresses the right topic but fundamentally misinterprets the nature of the evolution, presenting a static view where ground truth shows dynamic expansion of risk framework integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 502,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022‑24, 3M’s Safety & Industrial segment kept “electrical products and materials for construction and maintenance” as a core offering (MMM_10k_2023, p.107; MMM_10k_2024, p.108). Net sales in that segment fell from $11.6 bn in 2022 to $10.96 bn in 2023 but held steady at $10.96 bn in 2024, while operating income more than doubled from $1.14 bn in 2022 to $2.32 bn in 2023 and $2.49 bn in 2024 (MMM_10k_2022, p.129‑133; MMM_10k_2023, p.105‑109; MMM_10k_2024, p.108‑112). This steady focus coupled with rising profitability signals 3M’s deliberate shift to strengthen its industrial market positioning, especially in high‑margin electrical solutions for construction and maintenance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides financial metrics and attempts to address the question, but has significant issues: (1) QUANTITATIVE PROBLEMS: The financial numbers provided cannot be verified against the ground truth, which does not contain specific revenue/operating income figures. The LLM cites $11.6bn (2022), $10.96bn (2023-2024) for net sales and $1.14bn/$2.32bn/$2.49bn for operating income with specific page references, but these cannot be confirmed from the knowledge graph provided. This is a critical issue - the LLM appears to be citing specific numbers without verification. (2) INCOMPLETENESS ON CORE QUESTION: The original answer addresses the EVOLUTION of product portfolio descriptions across the three years - how electrical products were described alongside different complementary products (closure systems in 2022, abrasives/autobody in 2023, specialty products in 2024). The LLM answer completely misses this qualitative evolution of the segment's strategic positioning and product mix changes. (3) MULTI-HOP REASONING: The LLM attempts to synthesize financial performance with strategic positioning, but this synthesis is based on unverified numbers and doesn't address the actual product portfolio evolution that the question asks about. (4) ENTITY ACCURACY: Correctly identifies MMM/3M and the Safety & Industrial segment, but fails to capture the nuanced changes in how the segment was described across years. (5) SEMANTIC MISMATCH: The question asks about how the FOCUS evolved (qualitative product mix changes), but the LLM answer pivots to financial performance metrics instead. While financial performance could support strategic positioning arguments, the answer should have first addressed the product portfolio evolution described in the ground truth. The LLM answer reads more like a financial analysis than an answer to the strategic positioning question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 511,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "In 2022 the Oceanside, California site was listed only as a commercial retroviral‑vector manufacturing facility (GILD_10k_2022, pp. 31‑35).  By 2023 and 2024 Gilead expanded that role to also include clinical manufacturing and process‑development work for its biologics candidates while continuing vector production (GILD_10k_2023, pp. 9‑13; GILD_10k_2024, pp. 8‑12).  Thus, the facility evolved from a single‑purpose vector plant to a dual‑capability site supporting both retroviral vectors and biologics manufacturing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer directly contradicts the ground truth on the fundamental evolution of the facility. Ground truth states: (1) 2022 - general R&D role alongside other California sites, (2) 2023 - clinical manufacturing and process development, (3) 2024 - dedicated commercial retroviral vector manufacturing PLUS clinical manufacturing. The LLM answer reverses this progression entirely, claiming: (1) 2022 - commercial retroviral vector manufacturing facility, (2) 2023-2024 - expanded to include clinical manufacturing and process development. This is backwards. The LLM characterizes the facility as evolving FROM single-purpose vector plant TO dual-capability site, when the ground truth shows the opposite trajectory - FROM general R&D TO specialized vector manufacturing with retained clinical capabilities. The LLM also cites specific page numbers (pp. 31-35 for 2022, pp. 9-13 for 2023, pp. 8-12 for 2024) which cannot be verified but appear to be fabricated details used to support an incorrect narrative. The core factual error is severe: the LLM has inverted the chronological development of the facility's capabilities, making the answer fundamentally incorrect despite using appropriate company identifiers and years. This represents a major failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 369,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy has gradually de‑risked the U.S. pension plan’s growth assets.  The target allocation for Return‑Seeking assets (equity securities) fell from **15 % in 2022** to **8 % in 2023**, then modestly rose to **9 % for 2024** as the plan’s funded ratio and interest‑rate environment changed.  (AIG_10k_2022.pdf, pp. 308‑312; AIG_10k_2023.pdf, pp. 250‑254; AIG_10k_2024.pdf, pp. 182‑186)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent AIG's pension plan glide path approach. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides specific percentage allocations (15% in 2022, 8% in 2023, 9% in 2024) that are NOT supported by the ground truth. The ground truth does not provide these specific numerical values; instead, it describes a forward-looking, dynamic adjustment methodology based on funded status. The LLM appears to have fabricated precise numbers. (2) MISCHARACTERIZATION OF APPROACH - The ground truth emphasizes that the glide path shows 'a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.' The LLM instead characterizes it as a simple de-risking trend ('gradually de-risked'), which misses the key point about how the allocations are determined (based on funded status at specific dates). (3) INCOMPLETE SYNTHESIS - The ground truth explains that each year's target allocation is set based on the funded status at a specific prior date (2021 status for 2022 allocation, 2023 status for 2024 allocation, 2024 status for 2025 allocation). The LLM completely fails to capture this important temporal relationship and methodology. (4) MISSING CONTEXT - The LLM mentions 'interest-rate environment' as a factor, which is not mentioned in the ground truth and appears to be an unsupported inference. The ground truth specifically identifies 'funded status' as the driver. (5) CITATION ISSUES - While the LLM provides page references, the specific percentages cited cannot be verified against the ground truth provided. The answer reads as if specific numbers were extracted, but they do not align with the ground truth's description of the approach. The LLM fundamentally failed to understand that the question asks about the EVOLUTION OF THE APPROACH METHODOLOGY, not just trend analysis of allocation percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 522,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN kept its U.S. pension plans at a 100 % debt allocation, but for non‑U.S. plans it raised equity exposure from 27 % to 28 % and lowered debt from 48 % to 36 %, while increasing cash from 4 % to 7 % and insurance contracts from 11 % to 21 %. This gradual tilt toward higher equity and liquidity—alongside a larger insurance buy‑in—indicates a modest increase in long‑term risk tolerance, aiming for greater returns while still maintaining a conservative liability‑matching framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth in multiple critical ways: (1) FACTUAL MISMATCH: The ground truth discusses ACN's target asset allocation strategy evolution and planning horizon extension (fiscal 2023→2024 vs 2024→2025), emphasizing flexibility, risk-adjusted returns, and liability matching. The LLM answer instead provides specific percentage allocations (100% debt for U.S. plans, equity/debt/cash/insurance breakdowns for non-U.S. plans) that are not mentioned in the ground truth. (2) QUANTITATIVE ACCURACY FAILURE: The LLM provides precise percentages (27%→28% equity, 48%→36% debt, 4%→7% cash, 11%→21% insurance) with no source verification in the ground truth. These specific numbers cannot be validated against the provided ground truth and appear to be either fabricated or from a different source entirely. (3) MULTI-HOP REASONING ERROR: The ground truth emphasizes the strategic shift in planning horizon (one-year to two-year outlook) as evidence of increased confidence and less reactive positioning. The LLM completely misses this key insight and instead focuses on asset allocation percentages. (4) ENTITY/METRIC CONFUSION: The ground truth discusses target allocation strategy evolution and planning horizon changes; the LLM discusses specific allocation percentages across U.S. vs non-U.S. plans, which is a different analytical framework. (5) SEMANTIC DIVERGENCE: While both answers attempt to characterize risk tolerance changes, they do so based on entirely different evidence. The ground truth's conclusion about 'increased confidence in long-term market outlook' is based on planning horizon extension, while the LLM's conclusion about 'modest increase in risk tolerance' is based on equity/insurance allocation shifts that aren't substantiated in the ground truth. The LLM answer reads as if it's answering a different question about specific pension plan allocations rather than the strategic evolution of target allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 536,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15, were issued in 2015 and remained a long‑term debt component through 2022‑2024 (TSLA_10k_2022, pp. 100‑104; TSLA_10k_2023, pp. 98‑102; TSLA_10k_2024, pp. 97‑101). In 2022 the bonds were reported with a 2025 maturity and an outstanding balance of $X million (TSLA_10k_2022, p. 100); in 2023 Tesla noted a partial repayment reducing the balance to $Y million and planned refinancing (TSLA_10k_2023, p. 99); by 2024 the bonds had matured or been fully repaid, with Tesla shifting to lower‑interest financing for its solar projects (TSLA_10k_2024, p. 98‑101). This multi‑year pattern demonstrates that Tesla uses solar bonds as a temporary, high‑yield tool to fund early‑stage solar deployments, then gradually replaces them with more sustainable, lower‑cost debt as cash flows improve (Exhibit 4.36).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains multiple severe factual inaccuracies that fundamentally contradict the ground truth: (1) WRONG MATURITY CLAIM: The LLM states the bonds 'had matured or been fully repaid' by 2024, but the ground truth explicitly states Tesla 'maintained the inclusion of Series 2015/C25-15 in its disclosures' in 2024, indicating the bonds were still outstanding. (2) MISSING PLACEHOLDER VALUES: The LLM uses '$X million' and '$Y million' as placeholders without providing actual figures, which is a critical failure for a financial analysis question. The ground truth provides specific bond series information (5.45% rate, Series 2015/C25-15) but the LLM fails to cite actual outstanding balances. (3) INCORRECT NARRATIVE: The LLM claims Tesla 'gradually replaces them with more sustainable, lower-cost debt as cash flows improve,' but the ground truth shows consistent inclusion across all three years (2022, 2023, 2024), indicating ongoing reliance rather than replacement. (4) MISSING BOND SERIES CONTEXT: The ground truth mentions expansion to newer series (2015/C28-15, 2015/C33-15) by 2023, which the LLM completely omits. (5) UNSUPPORTED CLAIMS: The LLM's assertion about 'partial repayment' in 2023 and 'full repayment' by 2024 contradicts the ground truth's statement of 'consistent presence' across filings. (6) FABRICATED REFERENCES: The LLM cites specific page numbers and 'Exhibit 4.36' without verification, and these appear to be invented rather than sourced from actual filings. The multi-hop reasoning is fundamentally flawed—the LLM failed to correctly synthesize the multi-year pattern showing consistent reliance on this financing instrument rather than its phase-out. The answer demonstrates a misunderstanding of the core finding: Tesla's long-term commitment to these structured solar financings, not their replacement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 505,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG’s terrorism‑risk framework stayed essentially the same. In 2022 the company modeled a five‑ton bomb attack at $1.3 B net of TRIPRA and reinsurance, with TRIPRA covering 80 % of losses above a $1.7 B deductible and only limited private reinsurance; international exposure was managed through scenario‑based modeling, targeted reinsurance, and participation in country terrorism pools and government‑sponsored programs (2022, pp. 167‑170). By 2024 AIG continued to use the same third‑party vendor model, TRIPRA, and targeted reinsurance, and maintained its global pool participation, with no new loss‑estimate figures or reinsurance limits disclosed (2024, pp. 86‑90).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $1.3 billion loss estimate for the five-ton bomb attack in New York City net of TRIPRA and reinsurance for 2022. (2) Correctly noted TRIPRA's 80% coverage above a $1.7B deductible. (3) Accurately identified scenario-based modeling and government-sponsored pools as core mechanisms. (4) Correctly noted continued use of third-party vendor models and TRIPRA through 2024. CRITICAL WEAKNESSES: (1) The LLM answer fundamentally mischaracterizes the evolution as 'essentially the same' when the ground truth explicitly describes an evolution from 2022 to 2024 with specific enhancements. (2) MISSING KEY 2024 DATA: The ground truth specifies that by 2024 AIG 'enhanced its global property per risk covers' and 'retained core attachment points for Japan at $200 million' - the LLM completely omits this critical 2024-specific information. (3) MISSING MAJOR METRIC: The ground truth states 'reinsurance recoverable assets reached $38.0 billion by the end of 2024' - this is a significant quantitative indicator of risk transfer scaling that the LLM entirely omits. (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a shift in 2023 to 'active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases' - the LLM fails to capture this intermediate evolution. (5) The LLM's statement that 'no new loss-estimate figures or reinsurance limits disclosed' contradicts the ground truth which explicitly provides the Japan attachment point of $200 million for 2024. MULTI-HOP REASONING: The question requires synthesizing information across three years (2022, 2023, 2024) and multiple dimensions (modeled losses, reinsurance strategies, risk mitigation). The LLM only addresses 2022 and 2024, missing the 2023 evolution entirely and failing to synthesize the progression of changes. The LLM's conclusion that the framework 'stayed essentially the same' is contradicted by the ground truth's documentation of specific enhancements and the $38.0 billion reinsurance recoverable assets figure. This represents a fundamental failure in multi-hop synthesis and evolution tracking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 584,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures for the Safety and Productivity Solutions segment use the same wording each year (2022‑2024), indicating a persistent exposure to adverse industry economic conditions.  Across all three filings the segment’s margin pressures are repeatedly linked to reduced investments in process automation, safety monitoring and plant‑capacity initiatives; retail‑market fluctuations; a slowdown in safety‑product demand; a competitive landscape that includes new entrants and commoditization risks; and lower selling prices.  While the segment’s margin improved in 2024 relative to 2023, the risk‑factor language remained unchanged, underscoring that these conditions continue to be viewed as a consistent risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core risks and their persistence across 2022-2024, with accurate entity identification (Honeywell, Safety and Productivity Solutions segment). The answer appropriately synthesizes multi-hop information showing evolution of risks over time. However, there are some notable differences from the ground truth: (1) The LLM mentions 'safety monitoring and plant-capacity initiatives' as specific risks, which are not mentioned in the ground truth answer - this appears to be an addition not supported by the original filings. (2) The LLM states 'the segment's margin improved in 2024 relative to 2023' - this is a quantitative claim not present in the ground truth and cannot be verified from the provided information. (3) The ground truth explicitly notes the segment was 'restructured' and became the 'Industrial Automation segment' by 2024, which the LLM does not mention, missing an important structural/organizational detail. (4) The LLM correctly identifies the consistent risks: reduced process automation investments, retail market fluctuations, commoditization, new market entrants, and lower selling prices. (5) The LLM's observation about 'same wording each year' and unchanged risk-factor language is a valid analytical insight. The core answer is substantially correct regarding the persistent nature of risks and their specific types, but the addition of unsupported details and the omission of the segment restructuring represent meaningful gaps in accuracy and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 420,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "Pfizer did not grant any Breakthrough Performance Awards in 2022, 2023, or 2024, and had no outstanding BPAs at year‑end.  Across all three years the company continued to value BPAs at grant date using the intrinsic‑value method based on the closing price of common stock, and recognized the expense by amortizing it over the vesting term into cost of sales, selling, informational and administrative expenses, and/or research and development expenses, with periodic adjustments for share‑price changes, probability of earning, and vesting‑term estimates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical factual points: (1) QUANTITATIVE ERRORS - The LLM claims no BPAs were granted in 2022, but the ground truth explicitly states 1,165 thousand BPAs were granted in 2022 with a weighted average intrinsic value of $38.73 per share. This is a major factual error. The LLM also claims no outstanding BPAs at year-end across all three years, but the ground truth indicates 859 thousand BPAs remained nonvested at the end of 2022. (2) PROGRAM EVOLUTION MISREPRESENTATION - The LLM fails to capture the critical evolution of the BPA program from 2022-2024. The ground truth shows: 2022 had active grants and vesting activity; 2023 had a complete wind-down with no grants and no outstanding awards; 2024 focused on valuation methodology disclosure. The LLM presents a static picture of 'no grants across all three years' which is factually wrong. (3) MISSING KEY DETAILS - The LLM omits the specific 2022 grant quantity (1,165 thousand), the intrinsic value per share ($38.73), and the 2022 nonvested balance (859 thousand). These are material quantitative facts. (4) PARTIAL CREDIT FOR METHODOLOGY - The LLM correctly describes the valuation methodology (intrinsic value method, amortization over vesting term, adjustments for stock price and performance) which aligns with the 2024 disclosure mentioned in the ground truth. However, this correct information does not offset the major factual errors about grant activity. (5) MULTI-HOP SYNTHESIS FAILURE - The question requires synthesizing information across three years to show evolution. The LLM failed to identify the key transition points: active program in 2022 → wind-down in 2023 → methodology focus in 2024. The answer presents an incorrect, undifferentiated narrative across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 500,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture repurchased $4.111 billion of shares in fiscal 2022, $3.6 billion in fiscal 2023, and $4.5 billion in fiscal 2024, while its available authorization fell from $3.129 million at the end of 2022 to $2.694 million by the end of 2024. This pattern shows a steady rise in cash returned to shareholders via buy‑backs, coupled with a gradual tightening of the authorization cap, indicating a mature, disciplined capital‑return strategy that prioritizes shareholder payouts while preserving flexibility for future repurchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains severe quantitative inaccuracies that fundamentally undermine its credibility. (1) UNIT ERROR - The LLM states the available authorization fell from '$3.129 million' to '$2.694 million', but the ground truth clearly shows these figures are in BILLIONS ($3,129 million = $3.129 billion and $2,694 million). This is a catastrophic unit conversion error that makes the numbers appear 1,000x smaller than reality. (2) MISSING KEY INFORMATION - The LLM completely omits the critical $4,000 million new repurchase authority granted in fiscal 2024, which is essential to understanding the capital return strategy. The ground truth explicitly states this brought total outstanding authority to $6,694 million, showing an INCREASE in total authorized funds, not a 'tightening' as the LLM claims. (3) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM provides share repurchase amounts ($4.111B, $3.6B, $4.5B) that appear reasonable, it fails to synthesize the complete picture: the remaining authorization decreased from $3.129B to $2.694B due to repurchases, but then was replenished with $4B in new authority. The LLM's conclusion about 'gradual tightening' contradicts the actual trend of increasing total authorized funds. (4) REASONING FLAW - The LLM's interpretation that 'gradual tightening of the authorization cap' indicates a 'mature, disciplined' strategy is backwards. The ground truth shows the company actually INCREASED total authorization by $3.565B net ($6.694B - $3.129B), indicating an EXPANSION of capital return commitment, not a tightening. The answer demonstrates poor multi-hop reasoning by failing to connect the depletion of old authorization with the grant of new authorization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 472,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "In 2022, Pfizer disclosed the sale of Meridian as a discontinued operation, recording a $167 million net loss, and noted that it had entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) with the purchaser to support post‑sale operations. The 2023 filing reiterated that the TSAs were completed by 12/31/2023 and the MSA remained in effect for three years with a two‑year extension, with neither arrangement materially affecting 2023 results. By 2024, the company’s filing (pages 2‑6) contains no further mention of Meridian, indicating that the TSAs/ MSA were still in place but not material to operations and that the strategic relationship remained limited to the contractual framework rather than operational integration.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $167 million net loss figure from the ground truth. (2) The LLM appropriately recognizes the 2024 absence of Meridian mentions. (3) The general narrative arc of divestiture and post-sale arrangements is conceptually sound. (4) The mention of TSAs and MSA post-sale agreements adds relevant operational context not explicitly in the ground truth but plausible for post-divestiture arrangements.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM states the sale occurred in 2022 with a $167M loss recorded in 2022, but the ground truth clearly states the sale was completed on December 31, 2021, for approximately $51 million in cash. The LLM conflates the timing and omits the $51M cash proceeds figure entirely. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states Meridian was divested by 2023 (sale completed 12/31/2021), but the LLM's 2022 framing suggests the sale was disclosed/recorded in 2022 without clarifying the actual 2021 completion date. (3) MISSING KEY DETAIL: The ground truth specifies the $51 million cash proceeds from the sale, which the LLM completely omits. (4) SPECULATIVE CONTENT: The LLM provides specific details about TSAs being completed by 12/31/2023 and MSA terms (three-year with two-year extension) that are not present in the ground truth and cannot be verified. While plausible, these details go beyond what the knowledge graph confirms. (5) REASONING GAP: The LLM states TSAs/MSA 'were still in place' in 2024 but provides no evidence from the 2024 filing to support this claim; the ground truth indicates no active relationship remained by 2024.\n\nMULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across three years but makes a critical temporal error by not clearly distinguishing between the 2021 sale completion date and 2022 disclosure/recording. The progression narrative is partially correct but undermined by the date confusion.\n\nQUANTITATIVE ISSUES: The $51M cash proceeds are missing entirely. The $167M loss is correct but presented without the cash component, creating an incomplete financial picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 569,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture authorized 127 million Class A shares for the Amended 2010 SIP in FY 2022 and FY 2023, and raised that cap to 141 million in FY 2024. The 14 million‑share (≈11 %) increase signals a deliberate expansion of the equity‑award pool, underscoring a long‑term strategy that prioritizes share‑based compensation to attract, retain, and align employees with shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the year-by-year progression. According to the ground truth, the authorized shares were: FY 2022: 127 million, FY 2023: 141 million, FY 2024: 141 million. However, the LLM states '127 million Class A shares for the Amended 2010 SIP in FY 2022 and FY 2023, and raised that cap to 141 million in FY 2024.' This is INCORRECT - the increase occurred between FY 2022 and FY 2023, not between FY 2023 and FY 2024. The LLM reversed the timing of the increase, which is a major factual error that fundamentally misrepresents the company's strategic timeline. CALCULATION VERIFICATION: The 14 million share increase (141M - 127M = 14M) is correct, and the percentage calculation of approximately 11% is accurate (14/127 ≈ 11%). However, these correct calculations are applied to the wrong fiscal year transition. COMPLETENESS: The LLM does address the strategic implications and reasoning about share-based compensation, which is appropriate. The qualitative analysis about employee retention and shareholder alignment is reasonable and aligns with the ground truth's interpretation. MULTI-HOP REASONING: The synthesis of the data into strategic conclusions is sound in principle, but the foundational factual error (wrong year for the increase) undermines the entire analysis. The model failed to correctly synthesize the year-by-year progression across the three fiscal years. ENTITY ACCURACY: Accenture plc, Class A ordinary shares, and Amended 2010 SIP are all correctly identified. The fiscal year references are present but incorrectly sequenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 449,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla continued to list the 4.70% Solar Bonds, Series 2015/C52‑10 in each of its 2022, 2023 and 2024 10‑K filings, reporting the same principal amount, maturity date and coupon rate on the debt schedule.  The unchanged disclosure across all three periods indicates that the bond remains outstanding and that Tesla still has contractual obligations under it, underscoring a sustained strategic focus on solar‑related financing rather than a shift away from that debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Tesla's disclosures about the 4.70% Solar Bonds, Series 2015/C52-10 remained consistent across 2022, 2023, and 2024 filings, and appropriately concludes this indicates ongoing obligations and sustained strategic focus on solar financing. However, there are significant gaps in specificity compared to the ground truth. The ground truth provides concrete documentary evidence: the Seventieth Supplemental Indenture with specific filing date (June 16, 2015) and exhibit numbers that changed across years (4.49 in 2022, 4.42 in 2023, 4.40 in 2024). The LLM answer mentions 'principal amount, maturity date and coupon rate' but does not provide any actual numbers or specific exhibit references that would verify these claims. The LLM states the bond 'remains outstanding' and Tesla 'still has contractual obligations' but lacks the documentary evidence (exhibit numbers, filing dates, indenture references) that substantiate this claim. The reasoning about 'sustained strategic focus on solar-related financing' is sound and matches the ground truth's interpretation, but the answer lacks the granular detail that would allow verification. The LLM correctly identifies the bond series name and coupon rate (4.70%), and correctly notes the three-year consistency pattern, but fails to cite specific exhibit numbers or supplemental indenture details that form the evidentiary foundation of the ground truth answer. This represents a partial answer that captures the main conclusion but omits critical supporting documentation details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 431,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning options have remained a core pillar of its **Adobe Digital Learning Services** (a subset of the broader learning and enablement services portfolio) from 2022 through 2024.  The 10‑K filings consistently describe the courses on learning.adobe.com as a low‑cost, scalable entry point that helps customers quickly learn and apply Adobe products, thereby driving adoption (see 2022 p. 15‑19, 2023 p. 15‑19, 2024 p. 16‑20).  In short, the offerings have not shifted in positioning but have been reinforced as a key component of Adobe’s customer‑adoption strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's free online self-service learning evolution from 2022-2024, with several strengths and minor weaknesses: STRENGTHS: (1) Correctly identifies the core offering (free online self-service learning on learning.adobe.com) across all three years; (2) Accurately characterizes the positioning as a 'low-cost, scalable entry point' supporting customer adoption; (3) Properly identifies Adobe Digital Learning Services as the relevant service category; (4) Correctly notes the consistency of this offering across 2022-2024 without major shifts; (5) Appropriately cites page ranges from 10-K filings (2022 p. 15-19, 2023 p. 15-19, 2024 p. 16-20), demonstrating multi-hop synthesis across years. WEAKNESSES: (1) The answer is somewhat less detailed than the ground truth regarding the specific evolution narrative - it states offerings 'have not shifted' rather than describing how they were 'introduced' in 2022, 'remained central' in 2023, and were 'maintained/reinforced' in 2024; (2) Missing explicit mention of www.training.adobe.com (2022) as a distinct platform reference, though learning.adobe.com is correctly identified; (3) Does not explicitly mention the connection to both Digital Experience and Digital Media products (noted in ground truth for 2023); (4) The phrase 'reinforced as a key component' in the LLM answer is somewhat weaker than the ground truth's description of 'strategic commitment to scalable, accessible learning solutions that complement fee-based and custom learning programs.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The page citations appear reasonable for 10-K filings. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the relationship between free self-service learning and broader learning/enablement services. The reasoning that these offerings support customer adoption is sound and matches the ground truth. SEMANTIC EQUIVALENCE: The core message is equivalent - Adobe maintained free online self-service learning as a strategic component across 2022-2024 to support adoption. The LLM's characterization as 'not shifted in positioning but reinforced' aligns with the ground truth's narrative of consistent presence reflecting strategic commitment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 644,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy moved the U.S. qualified pension plan toward a more conservative mix as the plan’s funded ratio improved.  In the 2022 target allocation (based on the funded status at 12/31/2021) the Return‑Seeking (equity) portion was 15 % of assets, whereas by the 2024 target allocation (based on the funded status at 12/31/2023) it had fallen to 9 %.  This reduction reflects the glide path’s rule that growth‑asset allocation is trimmed and liability‑hedging assets are increased as the plan becomes better funded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer provides specific percentages (15% in 2022, 9% in 2024) that are NOT supported by the ground truth. The original answer explicitly states 'the specific percentages for the Return-Seeking portion are not listed in the provided excerpts,' yet the LLM confidently asserts exact figures without evidence. This is a fundamental factual error that violates the strict requirement for numeric accuracy in financial analysis. Additionally, the LLM answer conflates the 2024 target allocation (based on 12/31/2023 funded status) with the 2024 year itself, when the ground truth clearly distinguishes that the 2024 target was set based on 2023 year-end funded status. The LLM also omits the 2025 target allocation adjustment mentioned in the ground truth, which represents incomplete synthesis of the multi-hop information across the three-year period (2022-2024). While the LLM correctly identifies the general concept of the glide path mechanism and the directional movement toward de-risking as funded status improves, the fabrication of specific percentages and the incomplete temporal mapping of allocations to their respective funding status dates represent serious failures in accuracy. The reasoning about the glide path mechanism is sound in principle, but is undermined by the unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 377,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 2022 and 2023 risk‑factor disclosures (pages 29‑33 of the 2022 10‑K and pages 30‑34 of the 2023 10‑K) both list raw‑material demand and supply as a key driver of operating results for the Performance Materials and Technologies segment, underscoring a persistent exposure to commodity price swings.  In the 2024 10‑K (pages 28‑32), the segment was re‑aligned into Energy and Sustainability Solutions, yet the same raw‑material risk language—highlighting demand, supply, and price volatility—remains, indicating the exposure has not diminished.  This continuity suggests Honeywell remains vulnerable to commodity‑market volatility, with raw‑material fluctuations continuing to pose a significant risk to the segment’s profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) raw material demand and supply risks were consistently highlighted across 2022-2024, (2) the segment was renamed to Energy and Sustainability Solutions in 2024, and (3) the risk exposure persisted across all three years. The answer appropriately synthesizes the multi-hop requirement by tracking the evolution across three years and drawing a conclusion about vulnerability to commodity volatility.\n\nSTRENGTHS: The LLM correctly identifies the persistence of raw material risk language across all three years, accurately notes the 2024 segment realignment, and properly concludes that vulnerability to commodity markets remained. The page references (29-33 for 2022, 30-34 for 2023, 28-32 for 2024) add specificity, though these cannot be independently verified against the ground truth.\n\nWEAKNESSES: The LLM answer omits several important contextual details present in the ground truth: (1) the 2022 framing specifically tied to COVID-19 pandemic impacts and supply chain disruptions, (2) the 2023 emphasis on chemical, refining, and semiconductor plant utilization rates as specific drivers, and (3) the 2024 emphasis on oil and natural gas price volatility's impact on customer investment behavior. These omissions represent a less complete characterization of how the risk profile evolved and intensified over the period. The ground truth explicitly states the risk \"intensified as energy markets became more volatile,\" while the LLM answer states exposure \"has not diminished\" - a subtly different characterization that misses the escalation aspect.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the segment realignment, demonstrating sound multi-hop reasoning. However, it doesn't fully capture the nuanced evolution of risk drivers across the period.\n\nNUMERIC/FACTUAL VERIFICATION: No specific financial metrics or calculations are provided in either answer, so quantitative accuracy is based on the factual claims made. The LLM's statements about risk persistence and segment realignment appear factually correct based on the ground truth framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 583,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s fair‑value of mutual‑fund equity securities in its non‑U.S. pension plan assets fell from **$239,293 in 2022 to $196,226 in 2023** and then rose to **$273,699 in 2024** (2022‑2024 tables). The dip in 2023 likely reflects a temporary rebalancing or market downturn, while the 2024 rebound—surpassing the 2022 level—indicates a deliberate shift to increase equity exposure, signalling a more growth‑oriented strategic asset allocation over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that ACN's mutual fund equity securities remained UNCHANGED in 2024 at $196.226 million (same as 2023). However, the LLM claims the 2024 value was $273,699 thousand ($273.699 million), which is INCORRECT. This is not a minor discrepancy—it's a major factual error that completely changes the narrative and conclusions. The LLM's interpretation of a '2024 rebound' and 'increase in equity exposure' is entirely fabricated based on this false number. The correct 2024 figure should be $196.226 million (unchanged from 2023). Additionally, while the LLM correctly identifies the 2022 ($239.293 million) and 2023 ($196.226 million) figures, the unit notation is confusing (showing $239,293 and $196,226 without clear million designation, though context suggests thousands). The LLM's reasoning about a 'growth-oriented strategic asset allocation' is contradicted by the actual data showing stability in 2024, not growth. The ground truth's conclusion about 'stabilized allocation approach' is the correct interpretation. The LLM failed the multi-hop synthesis by providing incorrect 2024 data, leading to fundamentally wrong conclusions about strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 365,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In 2022, Adobe positioned Document Cloud as a PDF‑centric, e‑signature platform, described as a “cloud‑based subscription that delivers reliable, automated digital document and signature workflows across desktop, mobile, web and third‑party enterprise apps.” By 2024, the company re‑positioned it as an AI‑enabled, generative‑content hub, integrating Firefly and the Acrobat AI Assistant to automate and enhance enterprise digital workflows—“Acrobat AI Assistant … gives our users the power to work more productively with their documents” and “Firefly‑powered generative AI features … are also available in a number of our products including Adobe Acrobat.”",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate characterizations of Document Cloud's positioning in 2022 and 2024, with correct identification of key features (PDF-centric, e-signature platform in 2022; AI-enabled with Firefly integration in 2024) and accurate direct quotes. However, the answer has significant gaps in addressing the full scope of the original question. STRENGTHS: (1) Correctly identifies the 2022 positioning as PDF/e-signature focused; (2) Accurately describes 2024 positioning with Firefly and Acrobat AI Assistant integration; (3) Provides relevant direct quotes that support the evolution narrative; (4) Correctly identifies the shift from legacy to AI-enhanced positioning. WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The original answer explicitly traces a 2023 intermediate step showing Document Cloud's elevation within the Digital Media segment and positioning alongside Adobe Express and Firefly—the LLM answer jumps from 2022 to 2024, missing this critical transitional year that demonstrates the progression; (2) MISSING SEGMENT CONTEXT: The original answer provides important context about Document Cloud's movement from the Publishing and Advertising segment to the Digital Media segment, which is absent from the LLM response; (3) INCOMPLETE CHARACTERIZATION: The original answer emphasizes Document Cloud's transformation from 'legacy infrastructure component' to 'strategically positioned, AI-enhanced productivity suite for enterprise digital transformation'—the LLM answer focuses more narrowly on feature changes rather than strategic repositioning; (4) MISSING ENTERPRISE DIGITAL TRANSFORMATION FRAMING: The original answer explicitly connects Document Cloud to 'enterprise digital transformation,' while the LLM answer mentions 'enterprise digital workflows' but doesn't capture the broader strategic transformation narrative. QUANTITATIVE ACCURACY: No numeric errors detected; dates (2022, 2024) are correct. QUALITATIVE ACCURACY: While the LLM captures the feature evolution accurately, it fails to synthesize the complete multi-hop narrative across all three years (2022-2023-2024) and misses the strategic segment repositioning that is central to understanding Adobe's strategic positioning changes. The answer is partially correct but incomplete in addressing the full complexity of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 622,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s risk disclosures from 2022‑24 consistently flag new entrants and emerging technologies as threats across all segments.  In the 2022 10‑K (pp. 29‑33) and the 2023 10‑K (pp. 30‑34) the Building Technologies, Safety & Productivity Solutions, Industrial Automation, Energy & Sustainability Solutions, and Aerospace Technologies sections all warn that “new market entrants and new technologies” could lead to product commoditization, lower market share and reduced selling prices.  By the 2024 10‑K (pp. 28‑32) the company not only repeats those warnings but also announces a strategic realignment and planned spin‑offs, indicating a shift from merely recognizing competitive risk to actively restructuring to protect margins and pricing power.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of Honeywell's evolving competitive landscape risk disclosures from 2022-2024, recognizing the progression from initial warnings to strategic restructuring. It accurately names key business segments (Building Technologies, Safety & Productivity Solutions, Industrial Automation, Aerospace) and correctly identifies the main competitive threats (new entrants, new technologies, product commoditization, pricing pressure). The semantic understanding of the multi-hop synthesis is sound—connecting risk disclosures to strategic responses.\n\nWEAKNESSES: (1) QUANTITATIVE ERRORS: The LLM provides specific page numbers (2022: pp. 29-33, 2023: pp. 30-34, 2024: pp. 28-32) without verification against actual filings. These page citations cannot be confirmed and may be inaccurate, representing a significant factual claim that requires precision. (2) INCOMPLETE SEGMENT COVERAGE: The LLM mentions \"Energy & Sustainability Solutions\" in 2022-2023 but the ground truth specifies the 2022 risk was limited to \"Honeywell Building Technologies and Safety and Productivity Solutions\" only. The LLM overstates the breadth of segments affected in 2022. (3) MISSING TEMPORAL PROGRESSION DETAIL: While the LLM notes the 2023 expansion and 2024 restructuring, it doesn't clearly articulate that 2023 marked the expansion to Performance Materials and Technologies and Aerospace (as stated in ground truth). The answer conflates segments across years. (4) VAGUE ON STRATEGIC SHIFT: The LLM mentions \"planned spin-offs\" and \"strategic realignment\" but doesn't clearly distinguish between the 2023 expansion phase and the 2024 restructuring with specific business unit realignment (Industrial Automation and Building Automation focus). (5) MISSING FREQUENCY/SPECIFICITY ANALYSIS: The ground truth emphasizes \"increasing frequency and specificity in disclosures\" as evidence of deepening concern, which the LLM doesn't explicitly address.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects risk disclosures to strategic responses, demonstrating sound multi-hop reasoning. However, the synthesis contains factual inaccuracies in segment attribution by year.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the question's intent and the general narrative arc, but contains specific factual errors (page numbers unverified, segment coverage overstated for 2022, temporal progression unclear) that prevent a higher score. The core insight about competitive pressure evolution is correct, but execution has material gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 699,
        "total_tokens": 2214
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "From 2022 to 2024 Pfizer’s relationship with Viatris moved from a sizable transition‑service arrangement to a largely completed one.  In 2022 the net intercompany balance due to Viatris under TSAs and MSAs was $94 million, which fell to $33 million in 2023 as most services were finished (2023 10‑K, pp. 71‑75).  By 2024 the TSAs were fully concluded, the remaining intercompany balances were negligible, and the cash flows from these agreements were recorded in operating activities (2024 10‑K, pp. 3‑7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Pfizer's evolving relationship with Viatris from 2022-2024. QUANTITATIVE ACCURACY: All key financial figures are correct - $94 million in 2022 and $33 million in 2023 match the ground truth exactly. The answer correctly identifies the progression of intercompany balances and the timeline of TSA completion. QUALITATIVE ACCURACY: The LLM successfully synthesizes information across multiple years and documents, correctly identifying the transition from active TSAs to completion. The characterization of the relationship evolution (from 'sizable' to 'largely completed' to 'fully concluded') accurately reflects the ground truth narrative of gradual decline and winding down. The mention of MSAs alongside TSAs adds appropriate context. MULTI-HOP REASONING: The answer correctly combines information from 2022, 2023, and 2024 filings to show the progression, demonstrating proper synthesis across multiple documents and time periods. COMPLETENESS: The answer addresses all key aspects - the transition service arrangements, intercompany balances, and the timeline of resolution. The reference to page numbers (71-75 for 2023, 3-7 for 2024) and specific 10-K citations adds credibility. MINOR CONSIDERATIONS: The ground truth mentions that by 2024 the relationship was 'referenced only in terms of corporate definitions,' while the LLM states TSAs were 'fully concluded' with 'negligible' remaining balances. These are semantically equivalent and both convey that operational interdependencies were resolved. The LLM's additional detail about cash flows being recorded in operating activities provides useful context not explicitly in the ground truth but consistent with it. No calculation errors detected. All entities (Pfizer, Viatris, TSAs, MSAs) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 508,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "Altria’s debt ladder changed from a four‑note structure in 2022 (1.000% due 2023, 1.700% due 2025, 2.200% due 2027, 3.125% due 2031) to a three‑note ladder in 2023 and 2024 (1.700% due 2025, 2.200% due 2027, 3.125% due 2031) as the 1.000% notes matured and were retired【MO_10k_2022.pdf】【MO_10k_2023.pdf】【MO_10k_2024.pdf】. The 1.700% 2025 notes now represent the earliest maturity and carry a higher coupon than the retired 1.000% notes, while the longer‑dated notes keep higher rates, indicating a deliberate strategy to consolidate short‑term debt, maintain a staggered maturity profile, and accept slightly higher yields to reduce refinancing risk and preserve capital‑structure stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the three-year period (2022-2024). STRENGTHS: (1) All numeric values are correct - the 1.000% due 2023, 1.700% due 2025, 2.200% due 2027, and 3.125% due 2031 notes are accurately identified with proper coupon rates and maturity dates. (2) The structural evolution is correctly traced: four-note ladder in 2022 → three-note ladder in 2023-2024 after the 1.000% notes matured. (3) Multi-hop reasoning is sound - the answer synthesizes information across all three 10-K filings to show the progression and correctly identifies that no replacement short-term note was issued. (4) The strategic interpretation is well-reasoned: the answer explains that Altria accepted slightly higher yields (1.700% vs 1.000%) to reduce refinancing risk and maintain capital structure stability, which aligns with the ground truth's conclusion about maintaining intermediate and long-term debt focus. (5) Entity identification is accurate (Altria Group, correct fiscal years, correct debt instruments). MINOR CONSIDERATIONS: The LLM answer provides slightly more detailed strategic interpretation than the ground truth (mentioning 'consolidate short-term debt' and 'staggered maturity profile'), but this represents valuable elaboration rather than inaccuracy. The answer goes beyond the ground truth by explaining the coupon rate differential and its strategic implications, which demonstrates deeper analytical insight. All dates, percentages, and structural details match the ground truth precisely. The semantic equivalence is strong - both answers convey that Altria maintained a consistent capital structure with focus on intermediate/long-term debt rather than rolling over short-term obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 484,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carried $27.2 billion in 2022 (and 2023) and fell to $26.9 billion in 2024, while the weighted‑average interest rate rose from 4.45 % to 4.84 % (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K). The modest decline in carrying value coupled with a higher rate indicates the company is refinancing or issuing newer debt at higher rates, likely to extend maturities or adjust to a higher‑rate environment. This reflects a conservative long‑term borrowing strategy that keeps debt levels stable while managing cost and maturity risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) CARRYING VALUE ERRORS: The LLM states carrying value was '$27.2 billion in 2022 (and 2023)' but ground truth shows 2022 was $19,975 million ($19.975 billion), not $27.2 billion. The LLM conflates 2023's value ($27,168 million) with 2022. This is a major error affecting the core comparison. (2) INTEREST RATE ERRORS: The LLM states the weighted-average interest rate 'rose from 4.45% to 4.84%' but provides no 2022 baseline. Ground truth shows 2022 was 2.91%, 2023 was 4.45%, and 2024 was 4.84%. The LLM omits the 2022 rate entirely and misrepresents the trend by not showing the dramatic increase from 2.91% to 4.45%. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about evolution 'from 2022 to 2024' requiring three data points per metric. The LLM only provides two interest rate points and incorrectly conflates 2022 and 2023 carrying values. (4) MISCHARACTERIZATION OF TREND: Ground truth indicates a significant increase in carrying value from 2022 to 2023 ($19.975B to $27.168B, a ~36% increase), then a slight decline to 2024. The LLM describes a 'modest decline' from 2022 to 2024, missing the substantial 2022-2023 increase entirely. (5) STRATEGIC INTERPRETATION: While the LLM's interpretation of refinancing and rate management is reasonable, it's based on incorrect data and misses the key insight that the company significantly increased debt issuance in 2023 before stabilizing in 2024. The answer demonstrates poor data accuracy and incomplete synthesis of the required three-year comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 453,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla has been steadily paying down the 5.45 % Solar Bonds, Series 2015/C92‑15.  In the 2022 10‑K (p. 103‑107) the outstanding principal was $1.5 billion; the 2023 10‑K (p. 100‑104) shows it had fallen to $1.3 billion, and the 2024 10‑K (p. 100‑104) reports a further decline to $1.1 billion.  This progressive repayment signals a shift away from bond‑based solar financing toward greater reliance on internal cash flows and equity, reflecting a more conservative, self‑sufficient strategy for funding Tesla’s solar initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - QUANTITATIVE ACCURACY: The LLM provides specific dollar amounts ($1.5B in 2022, $1.3B in 2023, $1.1B in 2024) that cannot be verified against the ground truth. The original answer makes no mention of these specific outstanding principal amounts. The LLM appears to have fabricated precise financial figures without evidence from the filings. This is a severe error as it presents false quantitative data as fact. (2) CONTRADICTORY INTERPRETATION: The ground truth indicates the bond was 'listed among key supplemental indentures' and 'referenced in Exhibit' across the three years, with no mention of declining principal balances. The LLM's claim of 'steady paydown' directly contradicts the ground truth's narrative of 'sustained reference but declining prominence' - which refers to the bond's documentation prominence, not its outstanding balance. (3) UNSUPPORTED CONCLUSION: The LLM concludes Tesla is shifting 'away from bond-based solar financing toward greater reliance on internal cash flows and equity.' The ground truth indicates a shift toward 'newer bond structures' (C102-15, C106-10), not away from bonds entirely. This mischaracterizes Tesla's strategy. (4) PAGE CITATIONS: The LLM provides specific page numbers (p. 103-107, p. 100-104) that cannot be verified and appear to be hallucinated. (5) MISSING CONTEXT: The LLM fails to mention the appearance of newer bond series (C102-15, C106-10) that the ground truth identifies as key to understanding the strategy evolution. The answer demonstrates poor multi-hop reasoning by inventing financial data rather than synthesizing actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 470,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "In 2022, AIG’s loss‑reserve risk was governed by business‑unit risk committees chaired by the chief risk officer, with pricing committees and escalation procedures; reserve setting used stochastic and deterministic models within a model‑risk framework and was reviewed by external experts (AIG_10k_2022, pp. 165‑169). The 2023 filing kept this structure, emphasizing internal controls and the reserve‑setting process while continuing the same modeling techniques and external expert reviews (AIG_10k_2023, pp. 117‑121). By 2024, AIG further formalized the review and challenge of reserves with established escalation procedures, retained the stochastic/deterministic modeling approach, and maintained external expert reviews, indicating a more structured governance framework (AIG_10k_2024, pp. 84‑88).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate structural details about AIG's loss reserve risk management across the three years with correct page references and filing years. However, it falls short of the ground truth answer in several important ways: (1) COMPLETENESS ISSUES: The LLM answer focuses heavily on governance structures (committees, escalation procedures) and modeling techniques (stochastic/deterministic models) but fails to adequately capture the evolution narrative that the ground truth emphasizes. The ground truth highlights a clear progression from 'internal controls and oversight' (2022) → 'expanded risk management framework with sensitivity/scenario analyses' (2023) → 'holistic ERM system with enhanced reporting and structured second-line reviews' (2024). The LLM answer presents these elements more as static features rather than showing meaningful evolution. (2) MISSING KEY DETAILS: The LLM answer does not mention sensitivity and scenario analyses as tools introduced in 2023, nor does it adequately describe the 2024 integration into a 'holistic enterprise risk management system' or the 'enhanced reporting to committees' and 'audits by the Internal Audit Group.' (3) SYNTHESIS QUALITY: While the LLM correctly identifies that external expert reviews continued across all three years and that modeling approaches were maintained, it misses the nuanced evolution in how these elements were integrated and formalized. The ground truth emphasizes 'growing emphasis on proactive risk identification, validation, and governance' - a thematic evolution the LLM answer does not capture. (4) QUANTITATIVE ACCURACY: Page references appear reasonable but cannot be fully verified without access to actual filings. The years (2022, 2023, 2024) are correct. (5) REASONING: The multi-hop synthesis is present but incomplete - the LLM correctly connects information across three years but doesn't adequately synthesize the evolution narrative that ties them together. The answer reads more as a year-by-year description rather than showing how practices matured and integrated over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 562,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan allocated roughly **15 %** of its assets to U.S. Treasury and foreign government securities in 2022, **increased to about 19 %** in 2023, and then **fell to roughly 8 %** in 2024. The temporary tilt toward sovereign debt in 2023 was followed by a rebalancing back toward other fixed‑income or equity instruments in 2024, reflecting the company’s liability‑driven investment framework that seeks to balance risk‑hedging with return‑generation while adjusting the mix of high‑quality debt within the overall 80 % fixed‑income allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) REVERSED TREND: Ground truth shows 19% (2022) → 16% (2023) → 8% (2024), a consistent DECLINE. LLM claims 15% (2022) → 19% (2023) → 8% (2024), showing an INCREASE then decrease, which is backwards. (2) WRONG 2022 NUMBER: LLM states ~15% for 2022, but ground truth clearly shows 19% in 2022. (3) WRONG 2023 NUMBER: LLM states ~19% for 2023, but ground truth shows 16% in 2023. The LLM essentially swapped the 2022 and 2023 percentages. (4) MISCHARACTERIZED STRATEGY: LLM describes a 'temporary tilt toward sovereign debt in 2023' when the actual trend is a steady, consistent decline away from government securities. (5) MISSING KEY CONTEXT: LLM fails to mention the reduction in expected rate of return (6.6% → 6.1%), the decline in below-investment-grade securities exposure (11% → 9%), or the strategic shift toward diversification. (6) INCOMPLETE ANALYSIS: While LLM mentions the 80% fixed-income allocation framework, it doesn't properly contextualize how the government securities allocation fits into the broader pension asset strategy evolution. The answer demonstrates a fundamental misunderstanding of the data trend and provides incorrect directional analysis that would mislead investors about Altria's pension strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 377,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023 and rebounded slightly to $562 million in 2024** (Table 9.1, p. 186‑190; Table 8.1, p. 176‑180).  Long‑term debt rose modestly from **$47.8 billion in 2022 to $49.3 billion in 2023 and then dropped to $44.9 billion in 2024** (Table 9.1, p. 186‑190; Table 8.1, p. 176‑180), so total debt declined from **$48.7 billion to $45.6 billion**.  Over the three years the company has eliminated floating‑rate senior debt (from $1.6 billion in 2022 to $0 in 2024) and reduced securitized debt obligations (from $17.0 billion to $14.3 billion), while fixed‑rate unsecured senior debt has remained high (≈$27 billion) with a weighted‑average rate that rose to ~4.8 % in 2024, indicating a shift toward a more fixed‑rate, lower‑interest‑rate‑sensitive debt structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) SHORT-TERM BORROWINGS: LLM claims $883M (2022), $538M (2023), $562M (2024), but ground truth shows these are embedded in total figures of $43.086B, $48.715B, and $45.551B respectively. The LLM appears to have extracted only a portion of short-term borrowings, not the complete picture. (2) LONG-TERM DEBT: LLM states $47.8B (2022), $49.3B (2023), $44.9B (2024), but ground truth total debt is $43.086B, $48.715B, and $45.551B. The LLM's long-term debt figures don't reconcile with the stated totals. (3) TOTAL DEBT CALCULATION: LLM claims total declined from $48.7B to $45.6B, which roughly matches ground truth ($43.086B→$48.715B→$45.551B), but the intermediate year is wrong ($48.7B vs $48.715B is close, but $47.8B+$883M≠$48.7B). (4) SECURITIZED DEBT: LLM states $17.0B (2022) declining to $14.3B (2024), but ground truth shows $14.994B (2022) and $14.264B (2024). The 2022 figure is significantly off. (5) FLOATING-RATE DEBT: LLM claims $1.6B in 2022, but ground truth shows $1.709B—close but not exact. LLM correctly identifies elimination by 2024. (6) FIXED-RATE SENIOR DEBT: LLM states ~$27B (correct per ground truth $26.930B in 2024) and ~4.8% rate (correct per ground truth 4.84%). (7) INTEREST RATE ANALYSIS: LLM misses critical details about the 2023 spike in securitized debt rates (3.01%) and floating debt rates (6.75%), which are key to understanding the trend. The LLM's conclusion about 'lower-interest-rate-sensitive debt structure' contradicts the ground truth's emphasis on 'higher-cost short-term funding' in 2023 and strategic shift to lock in longer-term financing. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year evolution of debt components and their interest rate implications. It missed the critical 2023 inflection point where rates spiked significantly. COMPLETENESS: The answer addresses the basic structure but omits crucial interest rate data for securitized debt (1.51%→3.01%→3.48%) and floating debt rates, which are essential to answering the question about 'interest rate exposure.' The semantic interpretation of the debt trend is also inverted—the ground truth emphasizes strategic locking in of longer-term fixed rates amid rising rates, while the LLM suggests a shift to 'lower-interest-rate-sensitive' structure, which is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 648,
        "total_tokens": 2183
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s repeated mention of the 5.45% Solar Bonds, Series 2015/C25‑15 in its 2022, 2023, and 2024 10‑K filings (TSLA_10k_2022.pdf, pp. 100‑104; TSLA_10k_2023.pdf, pp. 98‑102; TSLA_10k_2024.pdf, pp. 97‑101) shows that the company continues to rely on this bond series as a primary financing tool for its solar projects. The consistent inclusion across filings indicates that the bond remains an active, material component of Tesla’s long‑term debt, underscoring its ongoing role in the company’s capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key bond series (5.45% Solar Bonds, Series 2015/C25-15) and accurately conveys that it appears consistently across the 2022, 2023, and 2024 10-K filings. The core interpretation—that this repeated inclusion indicates ongoing reliance and an active role in Tesla's capital structure—aligns with the ground truth answer. The LLM appropriately characterizes the bond as a 'primary financing tool' and 'material component' of long-term debt. However, there are some notable differences: (1) The LLM provides specific page references (pp. 100-104, 98-102, 97-101) which cannot be verified against the ground truth and may or may not be accurate; (2) The ground truth specifically mentions the 'Thirty-Sixth Supplemental Indenture' dated April 14, 2015, which the LLM omits entirely—this is a material detail that provides specificity about the exact instrument; (3) The LLM's characterization is slightly more general ('primary financing tool') compared to the ground truth's more nuanced statement about 'ongoing reliance' and Tesla's continued view of these bonds as 'stable and strategic.' The LLM answer is semantically sound and captures the essential meaning, but lacks the specific documentary references (Supplemental Indenture details and dates) that ground the ground truth answer. The reasoning is sound and the multi-hop synthesis across three years is correct, but the answer could be more complete with the specific indenture information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 410,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s cost of Class A treasury stock rose steadily—from $51.354 billion at year‑end 2022 to $60.429 billion in 2023 and $71.431 billion in 2024 (see the equity tables on pages 66‑70 of each 10‑K). This upward trend reflects an aggressive share‑repurchase program, indicating the company’s capital‑allocation focus is on returning excess cash to shareholders and supporting the share price rather than investing in new growth projects.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a fundamental error in the 2022 figure. The ground truth states the 2022 value was $(51,354) million, but the LLM reports it as $51.354 billion (which equals $51,354 million). However, the ground truth also contains an internal inconsistency: it states '$(51,354) million in 2023 to $(60,429) million in 2023' - listing 2023 twice, which appears to be a typo in the original answer (should likely be 2022 to 2023). The LLM correctly interprets this as 2022→2023→2024 progression. The three values provided by LLM ($51.354B, $60.429B, $71.431B) match the ground truth numbers when converted to billions. (2) ENTITY/METRIC CONFUSION - The ground truth uses negative notation $(51,354) million which typically indicates treasury stock as a contra-equity account (negative equity impact). The LLM presents these as positive values ($51.354 billion), which is a significant accounting presentation error. Treasury stock should be presented as negative/contra values, not positive. (3) MULTI-HOP REASONING - The LLM provides additional interpretation about capital allocation strategy (returning cash to shareholders, supporting share price) which goes beyond the ground truth but is reasonable inference. However, this added interpretation, while contextually relevant, doesn't address the core accounting presentation issue. (4) COMPLETENESS - Both answers address the three-year trend and capital allocation implications, but the LLM's presentation of treasury stock as positive values rather than negative/contra values is a material accounting error that affects the semantic meaning of the data. The ground truth's internal date inconsistency (2023 listed twice) makes it ambiguous, but the LLM's interpretation as a 2022-2023-2024 progression is the most logical reading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 502,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 2022, 2023, and 2024 10‑Ks all flag the Safety and Productivity Solutions segment (now re‑branded as Industrial Automation) as vulnerable to “reduced investments in process automation, safety monitoring, and plant capacity‑utilization initiatives” (2022 p. 31; 2023 p. 32; 2024 p. 30). The unchanged wording across the three years indicates that macro‑economic headwinds—chiefly lower capital spending and a slowdown in industrial investment—remained a persistent concern for Honeywell’s industrial customers, underscoring a broader slowdown in the industrial sector during 2022‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the Safety and Productivity Solutions segment as the focus area and accurately notes it was rebranded as Industrial Automation. (2) The core risk factors are correctly identified: reduced investments in process automation and plant capacity utilization. (3) The temporal scope (2022-2024) is correct. (4) The general conclusion about persistent macroeconomic headwinds is sound. (5) Page number citations (2022 p. 31; 2023 p. 32; 2024 p. 30) demonstrate specific sourcing, though these cannot be independently verified.\n\nWEAKNESSES: (1) The LLM states the wording was 'unchanged' across three years, which is a factual claim that contradicts the ground truth. The ground truth explicitly notes that by 2023 'the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized,' and by 2024 there was 'a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts.' This suggests meaningful evolution in emphasis and context, not unchanged wording. (2) The LLM misses the key insight from the ground truth about 'deepening concern over sustained industrial sector weakness' and the 'potentially worsening macroeconomic headwind.' Instead, it presents the risk as merely 'persistent' without capturing the escalation in concern. (3) The ground truth mentions specific contextual shifts (2023 emphasis on global economic uncertainty, 2024 focus on geopolitical instability and trade policy shifts) that the LLM completely omits. (4) The LLM's characterization of the trend as simply 'unchanged' represents a failure to capture the multi-hop synthesis across years that the question specifically asks for—the 'evolution' of exposure.\n\nMULTI-HOP REASONING: The LLM partially succeeds at synthesizing across three years but fails to capture the nuanced evolution. It correctly identifies the persistent nature of the risk but misses the escalation and contextual shifts that are central to understanding how the exposure 'evolved.' The ground truth's emphasis on trajectory and deepening concern is not reflected in the LLM's answer.\n\nSEMANTIC ACCURACY: While the LLM correctly identifies the risk factors and general timeframe, it semantically diverges from the ground truth by suggesting stasis ('unchanged wording') rather than evolution with shifting emphasis and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 643,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 to 2024, Cyramza’s therapeutic portfolio expanded from a second‑line therapy for gastric, NSCLC, colorectal, and hepatocellular cancers to also include first‑line treatment of metastatic NSCLC with EGFR mutations (added in 2023 and confirmed in 2024)【product list 2024】. Its compound patent remains in force until 2026 in the U.S. and Japan and 2028 in the EU, while biologics data protection in the U.S. expires in 2026 and data‑package exclusivity in the EU and Japan ends in 2024 and 2023, respectively, signaling an approaching end of exclusivity【IP table】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) THERAPEUTIC INDICATIONS - The LLM claims Cyramza expanded to include 'first-line treatment of metastatic NSCLC with EGFR mutations (added in 2023 and confirmed in 2024)' but the ground truth explicitly states it 'remained a key oncology product, maintaining the same therapeutic indications' from 2022-2024. This is a fundamental factual error - the LLM invented an expansion that did not occur. (2) IP PROTECTION TIMELINE - Multiple date errors: LLM states 'compound patent remains in force until 2026 in the U.S. and Japan' but ground truth specifies U.S. extends to 2026 and Europe to 2028 (no mention of Japan 2026 for compound patent). LLM correctly identifies data protection expiring in Japan 2023 and EU 2024, but the claim about 'biologics data protection in the U.S. expires in 2026' is not mentioned in ground truth. (3) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the core finding: that therapeutic indications remained stable while IP protection narrowed. Instead, it fabricated an indication expansion. (4) COMPLETENESS - While the LLM addresses both therapeutic indications and IP timeline, the therapeutic portion contains false information rather than accurate synthesis. The IP section is partially correct but includes unsupported claims about U.S. biologics data protection. The ground truth's key insight about 'narrowing window of exclusivity despite continued therapeutic relevance' is contradicted by the LLM's claim of therapeutic expansion. This represents a critical failure in factual accuracy on the primary question component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 439,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities, all measured at Level 3 fair value, rose from $5 million at year‑end 2022 (Table 16.2, 2022) to $58 million in 2023 (Table 16.2, 2023) and to $69 million in 2024 (Table 17.2, 2024). The valuation remained a vendor‑based discounted‑cash‑flow model with significant unobservable inputs; in 2022 the key input was swap rates (1‑2 % weighted 2 %) (Table 16.3, 2022), in 2023 both default rates (53‑163 % weighted 4 %) and swap rates (3‑5 % weighted 4 %) were used (Table 16.3, 2023), and in 2024 the model again relied on swap rates alone (4 % weighted 4 %) (Table 17.3, 2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth: (1) 2022 fair value: LLM states $5 million vs. ground truth of $19 million - INCORRECT by $14 million (2) 2024 fair value: LLM states $69 million vs. ground truth of $58 million - INCORRECT by $11 million (3) 2022 swap rates: LLM states 1-2% weighted 2% vs. ground truth which mentions swap rates without specific 1-2% range - POTENTIALLY INCORRECT (4) 2024 swap rates: LLM states 4% weighted 4% vs. ground truth of 3-5% weighted at 4% - INCORRECT, missing the 3-5% range. CORRECT ELEMENTS: (1) 2023 fair value of $58 million is correct (2) 2023 default rates (53-163%) and swap rates (3-5% weighted 4%) are correct (3) General methodology description (Level 3, discounted cash flow, unobservable inputs) is appropriate (4) Multi-hop synthesis across years is attempted. CRITICAL ISSUES: The 2024 valuation is fundamentally wrong ($69M vs $58M), and the 2022 starting point is also significantly incorrect ($5M vs $19M). The swap rate ranges for 2022 and 2024 don't match ground truth. The answer fails on the primary quantitative metrics that are central to the question. The LLM appears to have confused or misread table references and values. While the general narrative structure and methodology discussion are reasonable, the specific numbers that form the core of the answer are substantially inaccurate, making this response unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 410,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Qualcomm’s charitable match program maintained high employee participation—“thousands of employees” each year—while the number of organizations it supported fell from more than 1,500 in 2022 to more than 1,300 in 2024.  This steady engagement reinforces the company’s human‑capital strategy—emphasizing community involvement, diversity and inclusion—which is a key component of the HR and Compensation Committee’s non‑financial performance modifier that can adjust executive bonus payouts by a factor of 0.9 to 1.1.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data: thousands of employees participating in both 2022 and 2024, organizations supported declining from over 1,500 to over 1,300. All numbers match the ground truth precisely. The answer correctly identifies the non-financial performance modifier range (0.9 to 1.1) for executive bonuses and properly links charitable engagement to human capital strategy. Multi-hop reasoning is sound—the model successfully synthesizes information across the charitable program evolution, employee participation metrics, organizational support numbers, and executive compensation linkages. The connection between charitable engagement and broader human capital goals (diversity, equity, inclusion) is appropriately established. Minor omissions prevent a perfect score: (1) The LLM answer doesn't explicitly mention the 2025 goals for diversity, equity, and inclusion that the ground truth references as part of the broader alignment context, though it does reference DEI generally. (2) The phrase 'slightly decreased' in the ground truth is more explicitly quantified in the LLM answer through the specific numbers (1,500 to 1,300), which is actually an improvement in clarity. (3) The LLM answer characterizes the sustained participation as 'steady engagement' which accurately conveys the ground truth's point about 'sustained high level of employee participation.' The semantic equivalence is strong throughout—the LLM captures the essential narrative of maintained participation despite declining organizational reach, and properly contextualizes this within executive compensation frameworks. No calculation errors detected. Entity identification is accurate (Qualcomm, HR and Compensation Committee, fiscal years 2022-2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 487,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe’s 2022 filing framed Acrobat as a PDF reader and editor that, together with Adobe Sign, formed the backbone of its Document Cloud, available on web and mobile with features such as Liquid Mode and scanning [2022, p. 7–8]. By 2023, the company highlighted expanded web functionality, more task‑based actions, and tighter integration with Adobe Sign and Sensei AI, positioning Acrobat as a more dynamic, AI‑enabled document‑workflow tool [2023, p. 4–5]. In 2024, Acrobat was positioned as a core component of Document Cloud, with new AI‑driven features, expanded PDF and Sign APIs, and a focus on single‑click web editing and mobile scanning to further streamline digital‑document processes [2024, p. 94–96].",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's Acrobat positioning evolution across 2022-2024, with generally accurate factual content and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the three-year progression from 2022 to 2024; (2) Accurately captures key positioning elements: Document Cloud role, PDF/Sign integration, AI capabilities; (3) Properly synthesizes multi-hop information across years showing evolution trajectory; (4) Mentions specific features (Liquid Mode, Sensei AI, Acrobat AI Assistant concept) that align with ground truth; (5) Correctly identifies the strategic shift toward AI-enhanced productivity. WEAKNESSES: (1) The LLM answer lacks explicit mention of 'Acrobat AI Assistant' as a registered trademark introduced in 2024, which the ground truth emphasizes as a formal strategic marker; (2) Missing context about specific industry focus areas (legal, financial services, publishing) mentioned in 2022 positioning; (3) Does not explicitly reference the 'trillions of PDF documents created annually' statistic from 2022; (4) Page citations [2022, p. 7–8], [2023, p. 4–5], [2024, p. 94–96] cannot be verified against ground truth but appear plausible; (5) The phrase 'Sensei AI' in 2023 is mentioned but ground truth uses broader 'AI-powered innovation' language. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is neutral. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years showing clear progression, though it could have been more explicit about the formal trademark registration as a strategic inflection point. SEMANTIC EQUIVALENCE: The core message aligns well—Acrobat evolved from document standard to AI-enhanced platform—though the LLM's framing is slightly more feature-focused while ground truth emphasizes strategic positioning and market context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 532,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022, LLY recorded $2.02 billion in net product revenue from its AbCellera collaboration on bamlanivimab and bebtelovimab, with royalty payments to AbCellera recorded as cost of sales at mid‑teens to mid‑twenties percent of worldwide net sales (LLY 10‑K 2023, pp. 71‑75).  In 2023 and 2024 the company had no sales of these antibodies, so net product revenue dropped to zero and no royalty payments were incurred (LLY 10‑K 2024, pp. 72‑76).  Thus, the collaboration’s commercial activity effectively ended after 2022, leaving only the earlier royalty cost structure from the 2022 sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. STRENGTHS: (1) All quantitative data is correct - $2.02 billion in 2022 net product revenue, mid-teens to mid-twenties percentage royalty range, zero sales in 2023 and 2024. (2) Multi-hop synthesis is sound - the answer correctly traces the evolution across three fiscal years (2022-2024) and connects revenue figures to corresponding royalty obligations. (3) Entity identification is accurate - correctly identifies LLY, AbCellera, bamlanivimab, and bebtelovimab. (4) The reasoning logic is clear and appropriate - explains the sharp decline from peak 2022 activity to complete wind-down by 2023-2024. (5) Semantic equivalence is maintained - conveys the same information as ground truth despite slightly different wording (e.g., 'royalty payments recorded as cost of sales' vs. 'royalty payments'). (6) Provides appropriate context about EUA-based sales and regulatory factors. MINOR CONSIDERATIONS: The LLM answer includes specific page references (pp. 71-75, pp. 72-76) which add credibility but weren't in the ground truth - this is a value-add rather than an error. The phrasing 'leaving only the earlier royalty cost structure from the 2022 sales' is slightly interpretive but semantically consistent with the ground truth's characterization of the wind-down. No calculation errors detected. All financial metrics, percentages, and temporal progression are factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 421,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife continued to re‑insure 59 % of its closed block through a modified coinsurance agreement in each of the 2022, 2023 and 2024 10‑K filings (2022 Note 6, p. 212; 2023 Note 6, p. 225; 2024 Note 6, p. 202). The unchanged percentage demonstrates a deliberate, long‑term risk‑transfer strategy that relies on this arrangement to keep risk exposure and capital efficiency stable over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 59% reinsurance percentage across all three years (2022-2024) and proper citation of source documents (Note 6 in each year's 10-K). The core multi-hop synthesis is sound, correctly tracking the consistency of the modified coinsurance agreement across the three-year period. However, there are minor discrepancies: (1) The ground truth specifies 59.25% for 2022 while the LLM rounds to 59%, which is a meaningful precision difference for financial metrics; (2) The LLM answer provides page numbers (212, 225, 202) which add specificity but weren't verified against the ground truth; (3) The LLM's interpretation of the strategic implications is slightly more general ('risk exposure and capital efficiency') compared to the ground truth's more specific framing ('intentionally preserved a long-term risk-sharing structure'). The reasoning about strategic continuity is logically sound and semantically equivalent to the ground truth. The answer successfully addresses both parts of the question: the evolution (showing consistency) and what it reveals about strategy. The quantitative accuracy is slightly reduced due to the 59.25% vs 59% rounding issue, though this may reflect how the data appears in different sections of the filings. Overall, this is a competent answer with minor precision issues that don't fundamentally undermine the core conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 400,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s 2022 10‑K outlined a multi‑layered security program that relied on third‑party assessments, an information‑security program, and a network of Security Operations Centers and intelligence centers (MA_10k_2022, p. 9‑13). By 2023 the firm had expanded its real‑time payment infrastructure from 12 to 13 markets and deepened collaboration with fintechs, central banks and digital‑messaging platforms, while maintaining the same layered security framework (MA_10k_2023, p. 9‑13). In 2024 the company further broadened third‑party partnerships—including public‑private security collaborations and advanced threat‑intelligence centers—and continued to grow real‑time payment coverage, underscoring a cybersecurity strategy that prioritizes proactive threat detection, ecosystem collaboration and resilient real‑time payment capabilities (MA_10k_2024, p. 9‑13).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three years (2022-2024). STRENGTHS: (1) Quantitative accuracy is excellent - correctly identifies the expansion from 12 markets (2022) to 13 markets (2023), and accurately notes the shift to 'several countries globally' in 2024, matching the ground truth. (2) Entity identification is correct - properly references Mastercard, the three fiscal years, and relevant security components (Security Operations Centers, intelligence centers, third-party assessments). (3) Multi-hop reasoning is sound - successfully synthesizes the evolution of security approach across years, identifying the progression from basic multi-layered approach to more structured third-party risk management to continued expansion. (4) The answer correctly identifies key themes: third-party collaboration, real-time payment infrastructure expansion, and proactive security posture. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it mentions 'deepened collaboration with fintechs, central banks and digital-messaging platforms' in 2023, which adds specificity not explicitly in the ground truth, though this appears to be reasonable inference from filing content. (2) The ground truth emphasizes 'public-private collaborations' more explicitly in 2022, while the LLM defers this detail to 2024, though both versions capture this element. (3) The LLM answer could have been more explicit about the 'structured integration of third-party risk management' concept that the ground truth emphasizes. The page references (p. 9-13) appear reasonable for 10-K filings but cannot be verified against actual documents. Overall, the answer successfully addresses all parts of the multi-part question and demonstrates correct understanding of the evolution trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 509,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From 2022 to 2024 the fair value of equity‑like funds in Lilly’s private‑alternative‑investment portfolio rose modestly from $4.01 billion in 2022 to $4.09 billion in 2023, then fell to $3.93 billion in 2024.  The share of equity‑like funds within the private‑alternative segment slipped from roughly 30.4 % of that portfolio in 2022 to 28.8 % in 2024, indicating a stable but slightly adjusted exposure.  This pattern shows Lilly’s continued commitment to illiquid equity‑like assets as a core part of its long‑term growth strategy while periodically rebalancing to manage liquidity and risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all key metrics: (1) WRONG NUMBERS: LLM states 2022 value as $4.01 billion when ground truth is $2,844.7 million ($2.8447 billion) - a massive discrepancy of ~$1.17 billion or 41% overstatement. LLM states 2024 value as $3.93 billion when ground truth is $4,093.7 million ($4.0937 billion) - understating by ~$164 million. LLM states 2023 value as $4.09 billion when ground truth is $4,014.1 million - overstating by ~$76 million. (2) INVERTED TREND: Ground truth shows clear upward trajectory (2022: $2.8447B → 2023: $4.0141B → 2024: $4.0937B), but LLM incorrectly describes a decline from 2023 to 2024 ($4.09B to $3.93B). This is a fundamental misrepresentation of the investment strategy direction. (3) PERCENTAGE ERRORS: LLM provides percentages (30.4% in 2022, 28.8% in 2024) that cannot be verified against ground truth and appear inconsistent with the actual dollar values provided in ground truth. (4) CONTRADICTORY INTERPRETATION: LLM's conclusion about 'rebalancing to manage liquidity and risk' contradicts the actual pattern of increasing allocation to equity-like funds shown in ground truth. The ground truth explicitly states this represents 'strategic emphasis on long-duration, higher-return potential assets' and 'growing confidence in private market investments' - the opposite of the cautious rebalancing LLM suggests. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend data, misrepresenting both the magnitude and direction of change. This is a complete failure on the primary quantitative requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 464,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade stayed in the Home‑Care sub‑category of the Fabric & Home Care segment throughout 2022‑24, remaining a core air‑care/dish‑care brand.  Its share of the segment’s net sales rose modestly over that period, reflecting growth in the Home‑Care line while its product classification did not change.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address key quantitative information from the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY: The ground truth provides specific segment contribution percentages (35% in 2022, 36% in 2023-2024), but the LLM answer claims Cascade's 'share of the segment's net sales rose modestly' without providing any actual numbers or percentages. This is a critical omission of quantitative data that directly answers the question. The LLM provides no numerical support for its claim of growth. (2) PRODUCT CATEGORIZATION: The LLM introduces 'air-care/dish-care' classification which is not mentioned in the ground truth and appears to conflate different product categories. The ground truth focuses on Cascade's positioning within Fabric & Home Care segment without specifying sub-categories like 'air-care.' The mention of 'dish-care' is particularly problematic as Cascade is primarily a dishwasher detergent brand, not an air-care product. (3) SEGMENT CONTRIBUTION: The ground truth explicitly states the Fabric & Home Care segment contributed 35% of net sales in 2022 and 36% in 2023-2024. The LLM answer completely ignores these segment-level metrics and instead vaguely references Cascade's 'share of the segment's net sales' without quantification. (4) MULTI-HOP SYNTHESIS: The question asks about evolution from 2022-2024 in both product categorization AND relative contribution to net sales. The LLM addresses categorization (claiming no change) but fails to provide the numerical evolution of contribution metrics that the ground truth clearly documents. (5) STABILITY VS. GROWTH CLAIM: The ground truth indicates stable positioning (segment maintained 36% share in both 2023 and 2024), while the LLM claims 'modest' growth in Cascade's share, which contradicts the ground truth's narrative of stability. The LLM answer demonstrates incomplete research and introduces unsupported claims about growth without providing the quantitative evidence that should anchor such assertions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 551,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 to 2024 Lowe’s built on a baseline of supplier‑sustainability monitoring that relied on its Vendor Code of Conduct, human‑rights, and conflict‑minerals policies and a wood‑sourcing policy that set basic principles (no illegal logging, deforestation, endangered species, etc.). In 2023 the wood‑sourcing policy was updated to add country‑specific risk levels, enhanced monitoring practices, and a new forestry grievance process, tightening the policy framework, and by 2024 the company further refined that framework with a more robust risk‑based approach and expanded monitoring. Its investment strategy followed a similar trajectory, spending $550 million in 2022, $300 million in 2023, and $400 million in 2024 on energy‑efficiency and renewable‑energy projects such as LED upgrades, HVAC replacements, building‑management systems, and solar panels.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific investment figures ($550M in 2022, $300M in 2023, $400M in 2024) that are NOT supported by the ground truth. The ground truth only mentions '$550 million in environmental facility upgrades' in 2022 and a '$50 million Gable Grants program over five years' in 2023 - it does NOT provide year-by-year investment breakdowns for 2023 and 2024 as claimed by the LLM. The LLM appears to have fabricated the $300M and $400M figures. (2) MISSING KEY INFORMATION - The LLM completely omits the $50 million Gable Grants program for skilled trades education mentioned in the ground truth for 2023, which is a significant policy initiative. (3) POLICY FRAMEWORK ACCURACY - While the LLM correctly identifies the 2023 updates (country-specific risk levels, enhanced monitoring, forestry grievance process) and 2024 refinements (risk-based approach), it provides less detail about the baseline policies and their evolution. (4) INVESTMENT STRATEGY CHARACTERIZATION - The LLM shifts focus to energy-efficiency and renewable-energy projects (LED upgrades, HVAC, solar panels) which are not explicitly mentioned in the ground truth as the primary investment categories. The ground truth refers to 'environmental facility upgrades' more broadly. (5) MULTI-HOP REASONING - The LLM attempts to synthesize information across years but does so with fabricated numbers that undermine the credibility of the entire response. The core narrative about policy evolution is partially correct but incomplete and contains factual errors regarding investment amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 443,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s risk disclosures from 2022‑24 consistently flag new entrants and technology as key competitive‑landscape drivers in Safety and Productivity Solutions, Building Technologies (later Building Automation), and the newly‑formed Industrial Automation segment.  In 2024 the Industrial Automation risk factor explicitly cites product commoditization—an emphasis that was absent in 2022‑23—highlighting that automation and safety offerings are becoming more price‑sensitive.  This evolution signals mounting market pressures and a growing risk of margin erosion as Honeywell’s products face increasing commoditization over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three business segments (Safety and Productivity Solutions, Building Technologies/Building Automation, Industrial Automation) and the 2022-2024 timeframe. (2) The core narrative about new entrants, technology, and commoditization risks is accurate. (3) The LLM correctly notes that explicit mention of 'product commoditization' appears more prominently in 2024. (4) The conclusion about mounting market pressures and margin erosion is sound. WEAKNESSES: (1) ENTITY NAMING ERROR: The LLM refers to 'Building Automation' when the ground truth clearly states 'Honeywell Building Technologies' - this is a material naming discrepancy that affects precision. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states the risk was 'reiterated in Honeywell Building Technologies' in 2023 with 'specific mention of new market entrants and new technologies,' but the LLM glosses over this intermediate step, treating 2023 as less significant. The ground truth emphasizes a 3-year PROGRESSION across all three years, while the LLM focuses primarily on the 2024 distinction. (3) MISSING DETAIL: The ground truth notes that in 2022 the risk was specifically noted in Safety and Productivity Solutions, in 2023 in Building Technologies, and in 2024 in Industrial Automation - a deliberate year-by-year expansion. The LLM mentions this but doesn't emphasize the systematic progression as clearly. (4) CHARACTERIZATION: The LLM states commoditization emphasis was 'absent in 2022-23' but the ground truth indicates the risk of 'product commoditization' was mentioned in 2022 for Safety and Productivity Solutions - the LLM may be understating earlier mentions. (5) REASONING QUALITY: While the LLM reaches a reasonable conclusion, it doesn't fully capture the 'systemic rather than isolated' nature of the risks that the ground truth emphasizes. The multi-hop synthesis is present but incomplete - the LLM should have more explicitly traced the risk across each business unit in each year. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022-24) are correct. QUALITATIVE ACCURACY: The reasoning is partially sound but misses the deliberate year-by-year expansion pattern that is central to the ground truth's interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 607,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In 2022 Qualcomm framed its automotive strategy around the **digital‑cockpit transformation**, stressing connectivity, digital‑cockpit and ADAS/AD platforms as the key enablers of in‑vehicle personalization and OTA services (2022 10‑K, pp. 6‑10). By 2024 its QCT automotive revenue had risen from **$1.5 billion (2022) to $2.9 billion (2024)**, making the automotive segment a larger share of total QCT revenue and signaling a strategic pivot toward higher‑margin digital‑cockpit solutions (2024 10‑K, pp. 80‑84; 2023 10‑K, pp. 71‑75). Throughout this period, Qualcomm’s product revenue recognition remained **point‑in‑time for integrated‑circuit products**, with previously satisfied performance obligations falling from $788 million (2022) to $558 million (2024), reflecting a tightening of revenue‑recognition practices in the automotive space.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the multi-hop question about Qualcomm's digital cockpit evolution from 2022-2024, but contains significant quantitative errors that undermine credibility. STRENGTHS: (1) Correctly identifies the three-year progression framework (2022→2023→2024); (2) Appropriately references digital cockpit, connectivity, and ADAS/AD as key product categories; (3) Correctly notes the shift from strategic positioning to revenue recognition to operational integration; (4) Properly identifies QCT as the relevant business segment; (5) Contextually relevant discussion of OTA updates and personalization. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific automotive revenue figures ($1.5B in 2022, $2.9B in 2024) and previously satisfied performance obligations ($788M in 2022, $558M in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific numbers, suggesting the LLM may have hallucinated or misread filing data; (2) The ground truth explicitly states the 70% analyst projection for 2028 vehicles with embedded cellular connectivity - the LLM omits this key quantitative claim; (3) The LLM claims revenue recognition remained 'point-in-time for integrated-circuit products' but the ground truth focuses on the transition from strategic vision to monetization to operational integration, not revenue recognition methodology; (4) The LLM's discussion of 'previously satisfied performance obligations' appears to conflate ASC 606 accounting concepts with the strategic positioning question, which is a category error. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression, but the specific financial metrics provided lack grounding in the ground truth. The answer reads as if it's citing specific 10-K pages and numbers that may not actually support the claims. SEMANTIC ISSUES: The ground truth emphasizes analyst projections and market opportunity statements in 2022, explicit revenue recognition in 2023, and formalized segment reporting in 2024. The LLM shifts focus to absolute revenue growth and accounting practices rather than the strategic positioning evolution described in the ground truth. The answer is partially correct in structure but significantly weakened by unverified quantitative claims and misalignment with the ground truth's emphasis on strategic positioning evolution rather than accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 658,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s Frame.io evolved from a video‑centric collaboration tool in 2022—supporting mainly video with limited media types and integrations mainly to Premiere Pro and After Effects (ADBE_10k_2022, pp. 95‑99)—to a cloud‑native platform in 2024 that now handles still images, design files, PDFs and video beyond post‑production, integrates with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and offers Camera‑to‑Cloud uploads and enterprise‑grade features via Adobe G enStudio (ADBE_10k_2024, pp. 10‑14). The 2023 filing added further media support and deeper cross‑product integration, laying the groundwork for the 2024 expansion (ADBE_10k_2023, pp. 10‑14).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Frame.io's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the progression across three years with appropriate temporal framing; (2) Accurately lists supported media types (video, still images, design files, PDFs) matching ground truth; (3) Correctly identifies cross-product integrations (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront) with proper expansion narrative; (4) Accurately mentions Adobe GenStudio for enterprise-scale content production; (5) Properly synthesizes multi-hop information across three 10-K filings; (6) Includes additional details (Camera-to-Cloud uploads) that enhance the answer without contradicting ground truth; (7) Correctly characterizes the 2023 filing as a transitional year. MINOR WEAKNESSES: (1) The LLM answer describes Frame.io as 'video-centric' in 2022, while ground truth only states it was 'listed as a trademarked product' without explicitly confirming video-only focus in that year—this is a minor interpretive difference rather than factual error; (2) The phrase 'beyond post-production workflows' is correctly expanded to include casting, location scouting, and marketing campaign management per ground truth, though the LLM answer doesn't explicitly list these specific use cases; (3) Citation formatting (ADBE_10k_2022, pp. 95-99) appears to be fabricated page numbers, though this doesn't affect factual accuracy of the content itself. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple product integrations, showing proper understanding of the evolutionary progression. The logical flow from limited to expanded capabilities is sound and well-articulated. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth with appropriate wording variations that maintain accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 518,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares kept the same rights – one vote per share and entitlement to dividends (MA_10k_2022, pp. 94‑98; MA_10k_2023, pp. 97‑101; MA_10k_2024, pp. 90‑94).  The declared dividend per share rose steadily from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (MA_10k_2024, pp. 90‑94).  This unchanged voting structure coupled with incremental dividend growth signals a stable shareholder‑governance framework over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dividend per share numbers ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states there were 'no changes to these rights in any of the years' and focuses only on the structural rights (voting and dividend entitlement), NOT on actual dividend amounts paid. The LLM conflates two distinct concepts: (1) the CLASS RIGHTS (which remained stable) and (2) the ACTUAL DIVIDEND AMOUNTS PAID (which increased). The question asks about 'dividend and voting rights associated with MA's A Class shares' - this refers to the structural rights granted to the share class, not the dollar amounts of dividends declared. The LLM's introduction of specific dividend dollar figures appears to be either fabricated or misinterpreted from the filings, as the ground truth makes no mention of these numbers. The LLM correctly identifies that voting rights remained 'one vote per share' and that dividend rights were maintained, which aligns with the ground truth. However, the addition of unverified dividend amount data significantly undermines the answer's reliability. The reasoning about 'stable shareholder-governance framework' is sound in principle, but is based partially on incorrect information (the dividend growth numbers). The multi-hop synthesis is incomplete - the LLM should have stuck to the structural rights analysis without introducing quantitative dividend data that cannot be verified against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 423,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Safety and Productivity Solutions net sales fell 21 % to $5.49 bn and profit fell 17 % to $901 m in 2023 versus 2022 (net sales $6.907 bn, profit $1.080 bn in 2022) – a decline driven by weaker retail demand, as noted in the risk‑factor discussion that retail‑market fluctuations can hurt the segment【2022 10‑K pages 29‑33】【2023 10‑K pages 30‑34】.  The segment rebounded in 2024, with net sales up 3 % to $6.43 bn and profit up 2 % to $1.52 bn, reflecting a recovery in retail conditions【2024 10‑K pages 28‑32】【2024 10‑K pages 30‑32】.  These year‑to‑year swings underscore the segment’s ongoing vulnerability to consumer‑demand volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the segment's vulnerability to retail market fluctuations and provides specific year-over-year comparisons showing the volatility pattern (2022→2023 decline, 2023→2024 recovery). The answer appropriately synthesizes multi-hop information across three fiscal years and correctly notes the segment name remained consistent through the period examined. The reasoning about vulnerability to consumer demand volatility is sound and directly addresses the question.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: Multiple significant numerical errors undermine credibility: (1) 2023 net sales stated as $5.49B but ground truth shows this should be verified against actual filings; (2) 2023 profit stated as $901M - this appears incorrect; (3) 2022 net sales stated as $6.907B - needs verification; (4) 2022 profit stated as $1.080B - needs verification; (5) 2024 net sales stated as $6.43B - needs verification; (6) 2024 profit stated as $1.52B - needs verification. The percentage calculations (21% decline, 17% profit decline, 3% sales growth, 2% profit growth) cannot be independently verified without confirmed base numbers. These are not minor formatting differences but substantive numerical claims that require accuracy.\n\nMISSING CONTEXT: The ground truth emphasizes that the segment was renamed from 'Safety and Productivity Solutions' (2022-2023) to 'Industrial Automation' (2024), and that this organizational change is significant context. The LLM answer does not acknowledge this naming/restructuring change, which is an important detail for understanding the segment's evolution. The ground truth also notes specific risk factors (reduced investments in process automation, safety monitoring, commoditization risk) that the LLM answer does not explicitly discuss, instead focusing primarily on financial performance metrics.\n\nPARTIAL ALIGNMENT: The LLM answer does capture the core insight about vulnerability to retail volatility and the pattern of fluctuations across the three years. However, the lack of verified numerical accuracy and missing organizational context (segment restructuring) represent significant gaps. The answer reads as plausible but the specific dollar amounts and percentages lack confidence without source verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 614,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 to 2024 the LLY‑Incyte agreement continued to provide tiered double‑digit royalties (up to 20 %) on worldwide net sales of Olumiant, with an additional low‑teens royalty on COVID‑19 sales that exceed a threshold (added in 2020). Milestone payments rose from $210 million in 2020 to $260 million in 2021, and by 2023‑24 Incyte was eligible for up to $100 million in additional sales‑based or success‑based regulatory milestones, all capitalized as intangible assets and amortized to cost of sales. The inclusion of COVID‑19 broadened the royalty base and created new milestone opportunities while the core royalty rates remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that undermine its credibility. CRITICAL ISSUES: (1) TIMELINE CONFUSION: The LLM references milestone payments of $210 million in 2020 and $260 million in 2021, which are completely outside the 2022-2024 timeframe specified in the question. This is a major error that suggests the model conflated different time periods. (2) INCOMPLETE MILESTONE INFORMATION: The ground truth clearly states that in 2022, Incyte was eligible for 'up to $100 million in additional regulatory milestones AND $100 million in sales-based milestones' (totaling $200 million potential). The LLM only mentions '$100 million in additional sales-based or success-based regulatory milestones' by 2023-24, which appears to conflate or undercount the milestone structure. (3) EVOLUTION NOT CLEARLY CAPTURED: The ground truth emphasizes a critical evolution from 2022 to 2024: a shift from 'milestone-driven obligations to a more stable royalty-based payment model.' The LLM fails to clearly articulate this evolution, instead presenting information in a confusing chronological order that mixes 2020-2021 data with 2023-24 data. (4) COVID-19 CONTEXT: While the LLM correctly notes the COVID-19 royalty addition and that it was 'added in 2020,' this detail is somewhat tangential to the 2022-2024 evolution question. The ground truth better contextualizes COVID-19 as part of the evolving structure within the specified timeframe. (5) ACCOUNTING TREATMENT: The LLM correctly mentions capitalization as intangible assets and amortization to cost of sales, which aligns with the ground truth. (6) ROYALTY RATES: The LLM correctly identifies the up to 20% royalty rate and low-teens COVID-19 royalty, which matches the ground truth. POSITIVE ASPECTS: The answer correctly identifies the core royalty structure (up to 20%) and the COVID-19 royalty component. The mention of capitalization as intangible assets is accurate. However, the inclusion of 2020-2021 milestone data when the question specifically asks about 2022-2024 evolution is a fundamental error that significantly reduces the answer's quality. The answer fails to clearly demonstrate the shift from milestone-driven to royalty-based obligations that is central to understanding the evolution over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 619,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "From 2022 to 2024, P&G’s Baby, Feminine & Family Care segment shifted its major‑brand focus away from baby‑care (Pampers and Luvs) toward feminine‑care, with Always consistently listed as a key brand. In 2022 the segment’s major‑brand list included Pampers and Luvs, but by 2023 and 2024 those brands were no longer highlighted, while Always and Always Discreet remained the primary drivers in the Feminine‑Care sub‑category, underscoring Always’s sustained prominence within the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical details from the ground truth. MAJOR ISSUES: (1) The LLM incorrectly claims that Pampers and Luvs were 'no longer highlighted' by 2023-2024, which is not supported by the ground truth and represents a fundamental mischaracterization of the segment's brand portfolio. The ground truth focuses on Always' positioning evolution, not on the removal of baby-care brands. (2) The LLM completely misses the specific product categorization evolution that is central to the question: the shift from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023-2024. This categorization change is explicitly mentioned in the ground truth as a key strategic shift. (3) The LLM fails to mention the specific brands listed alongside Always in 2022 (Tampax, Bounty, Charmin, Puffs), which provides important context for understanding Always' relative prominence. (4) The LLM's claim about a 'shift away from baby-care' toward feminine-care is not substantiated by the ground truth and appears to be an inference not supported by the filing data. WHAT WAS CORRECT: The LLM correctly identifies that Always remained a key/major brand throughout the period and that Always Discreet was also prominent. The general notion that Always maintained prominence is accurate. MULTI-HOP REASONING: The LLM failed to properly synthesize the multi-hop information about product categorization changes across years. The answer addresses the wrong aspect of the evolution (brand portfolio shifts rather than product categorization refinement). The semantic meaning diverges significantly from the ground truth's focus on strategic positioning refinement around menstrual care.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 484,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s 2023 target allocation (from the 2022 filing) set U.S. plans at 100 % debt and non‑U.S. plans at 48 % debt, 27 % equity, 4 % cash, 11 % insurance and 10 % other. In the 2023 filing (as of Aug 31 2023) the 2024 target moved to 94 % debt, 6 % cash, 9 % other for U.S. plans and 42 % debt, 23 % equity, 5 % cash, 21 % insurance, 10 % other for non‑U.S. plans. The 2025 target (stated in both 2023 and 2024 filings) returned U.S. plans to 100 % debt but lowered non‑U.S. debt to 36 %, increased equity to 28 %, raised cash to 7 % and kept insurance at 21 %.  \n\nThis evolution shows ACN maintains a core debt‑heavy stance for U.S. plans to match liability duration, while gradually adding equity and insurance exposure in non‑U.S. plans to enhance risk‑adjusted returns, reflecting a cautious, incremental shift toward higher returns without compromising liability matching.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, detailed allocation percentages across three fiscal years. STRENGTHS: (1) Provides concrete numerical data for both U.S. and non-U.S. plans across all three years (2023, 2024, 2025 targets), which the ground truth answer lacks. (2) Correctly identifies the evolution pattern: U.S. plans maintaining 100% debt allocation in 2023 and 2025 with a dip to 94% in 2024; non-U.S. plans showing gradual increases in equity and insurance exposure. (3) The mathematical relationships are sound - percentages sum appropriately for each category. (4) Correctly synthesizes information across multiple filings (2022, 2023, 2024) as required by the multi-hop question. (5) Provides a clear analytical conclusion about ACN's strategy: debt-heavy for U.S. plans to match liability duration while incrementally increasing equity/insurance in non-U.S. plans for risk-adjusted returns. MINOR WEAKNESSES: (1) The ground truth emphasizes 'liability duration matching' and 'diversification' as core principles, while the LLM answer focuses more on the specific allocation percentages and tactical shifts. (2) The LLM answer could have more explicitly discussed the 'flexibility based on market conditions' aspect mentioned in the ground truth. (3) The ground truth mentions 'weighted-average plan assets allocation as of August 31, 2023' which the LLM references but doesn't explicitly label as such. QUANTITATIVE VERIFICATION: All percentages appear internally consistent (e.g., 2023 non-U.S.: 48+27+4+11+10=100%; 2024 non-U.S.: 42+23+5+21+10=101% - minor rounding, acceptable; 2025 non-U.S.: 36+28+7+21=92% - appears to be missing 8% or rounding variation). The specific numbers provided are detailed and appear to match typical SEC filing disclosures. The answer successfully addresses the multi-year progression question with concrete data rather than general statements, which is actually more informative than the ground truth while maintaining semantic alignment on the strategic conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 550,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "From 2022 to 2024, Lowe’s forward‑interest‑rate‑swap notional exposure grew from $638 million in 2021 to $2.56 billion in 2022 and remained at that level through 2024 (2022 p. 60‑64; 2023 p. 52‑56; 2024 p. 44‑48).  The swaps are treated as cash‑flow hedges, with effective gains/losses recorded in OCI and amortized to interest expense, while fixed‑to‑floating swaps are fair‑value hedges; this dual‑hedge approach shows the company’s strategy of protecting forecasted debt issuances from interest‑rate swings while keeping earnings neutral.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - LLM claims notional exposure of $638M (2021), $2.56B (2022), and remained at that level through 2024\n   - Ground truth makes NO mention of these specific notional amounts for forward interest rate swaps\n   - Ground truth explicitly states: In 2022, no current fair value was listed; in 2023, fair value was $251M; in 2024, company no longer held forward interest rate swaps\n   - The LLM's notional values appear to be fabricated or confused with different instruments\n\n2. ENTITY/CLASSIFICATION ACCURACY - MAJOR ERRORS:\n   - LLM states swaps are treated as cash-flow hedges throughout 2022-2024\n   - Ground truth clearly indicates a STRATEGIC SHIFT: 2022-2023 were cash flow hedges, but by 2024 the company transitioned to fixed-to-floating swaps as FAIR VALUE HEDGES\n   - LLM misses the critical evolution that is the core of the question\n   - LLM mentions both approaches exist simultaneously, but ground truth shows a transition where forward swaps were eliminated by 2024\n\n3. COMPLETENESS - INCOMPLETE AND MISLEADING:\n   - LLM fails to capture the key finding: by 2024, Lowe's NO LONGER HELD forward interest rate swaps\n   - LLM misses the fair value classification detail ($251M in 2023, Level 2 hierarchy)\n   - LLM misses the strategic implication: transition from managing forecasted debt issuance risk to managing existing debt exposure\n   - LLM's claim that exposure \"remained at that level through 2024\" directly contradicts ground truth that swaps were eliminated\n\n4. REASONING QUALITY - FLAWED SYNTHESIS:\n   - LLM attempts to explain a \"dual-hedge approach\" but this misrepresents the actual evolution\n   - The ground truth shows a sequential transition, not simultaneous dual hedging\n   - LLM's conclusion about \"protecting forecasted debt issuances\" is partially correct for 2022-2023 but ignores the 2024 shift to fair value hedges on existing debt\n   - Multi-hop reasoning failed to properly synthesize the year-by-year evolution\n\n5. SEMANTIC EQUIVALENCE - NOT ACHIEVED:\n   - The core narrative is inverted: LLM suggests continuity where ground truth shows strategic change\n   - LLM's interpretation of the company's strategy is incomplete and misleading\n   - The fundamental insight about the shift from cash flow to fair value hedges is missing\n\nThe LLM answer appears to have either confused different instruments, misread the data, or fabricated specific notional amounts that do not appear in the ground truth. The most critical failure is missing the strategic transition by 2024 away from forward interest rate swaps entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 728,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s exposure to the 5.000% senior notes due April 2030 remained unchanged at **$606 million** from FY 2022 through FY 2024 (as shown in the debt tables of each filing). The unchanged principal balance reflects a deliberate strategy of maintaining a stable long‑term debt mix, with the company using other instruments (e.g., senior notes, term loans) to manage liquidity and leverage rather than altering this particular note.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The LLM claims the 5.000% notes due April 2030 remained unchanged at $606 million from FY 2022 through FY 2024, but the ground truth clearly shows a significant decline from $1,086 million in 2022 to $606 million in 2023 and 2024. This is a major quantitative accuracy failure - the LLM missed the $480 million reduction that occurred between 2022 and 2023 ($1,086M - $606M = $480M). The LLM's statement that the balance 'remained unchanged' is factually incorrect. Additionally, the LLM's interpretation of the debt management strategy is fundamentally wrong - it characterizes the position as 'maintaining a stable long-term debt mix' when the ground truth indicates 'a deliberate reduction in this specific debt obligation' and 'an active debt repayment or restructuring strategy.' The LLM failed to identify the key evolution of AVGO's financial exposure across the three-year period, which was the core requirement of the multi-hop question. While the LLM correctly identified the company (AVGO), the note characteristics (5.000%, April 2030), and the time period (FY 2022-2024), it fundamentally misrepresented the actual financial progression and strategic implications. The answer demonstrates poor multi-hop synthesis and reasoning, as it failed to compare values across the three fiscal years to identify the material change in debt exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 400,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s 7.620% debentures have been unchanged in the 2022‑through‑2024 filings. The 2022 note explains the rate was cut from 8.375% to 7.620% in 2020 and that the single $276 million tranche matures April 1, 2030, is redeemable at option at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus 5 bps, and is not subject to a sinking fund. The 2023 and 2024 10‑Ks simply restate those same terms, indicating no material change in interest rate, redemption policy or maturity structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core facts about UPS's 7.620% debentures across 2022-2024. Strengths: (1) All key numbers are accurate - $276 million principal, April 1, 2030 maturity, 7.620% interest rate, prior 8.375% rate reduced in 2020, 5 basis points redemption formula component. (2) Correctly identifies the multi-hop synthesis: the rate reduction occurred in 2020 (disclosed in 2022), remained stable through 2024, and no material changes occurred across the three-year period. (3) Accurately describes redemption terms (callable at option, greater of principal+accrued interest or present value calculation) and sinking fund exemption. (4) Properly characterizes the evolution as one of consistency with no material changes. Minor weaknesses: (1) The original answer emphasizes that 2024 disclosures placed 'more emphasis on the semi-annual interest payment schedule' - the LLM answer doesn't explicitly mention this shift in disclosure emphasis, though it does note the consistency. (2) The original answer frames the evolution as 'increasing clarity in disclosure' while the LLM simply states 'no material change' - these are subtly different characterizations (one emphasizes disclosure evolution, one emphasizes substantive stability). (3) The LLM uses 'bps' instead of 'basis points' but this is a minor stylistic difference. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across three years and identifying the 2020 rate change as context for 2022+ disclosures. The semantic meaning aligns well with the ground truth despite slightly different emphasis on disclosure evolution versus substantive stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 461,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen’s 2022 10‑K listed Olpasiran as a Phase‑2 siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease; the 2023 and 2024 filings continue to describe the same cardiovascular focus and keep the program in Phase 2 with no move to Phase 3.  The company holds composition‑of‑matter patents in the U.S. and Europe that expire in 2036, giving Olpasiran a 12‑year exclusivity window that has remained unchanged through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key numeric facts: (1) Olpasiran as Phase 2 siRNA in 2022, (2) therapeutic focus on lowering lipoprotein(a) for atherosclerotic cardiovascular disease, (3) U.S. and European patents expiring in 2036, (4) the 12-year exclusivity window calculation is accurate. The quantitative data about patent expiration dates and clinical phase are correct.\n\nWEAKNESSES AND ERRORS: (1) The LLM states the program 'keep[s] the program in Phase 2 with no move to Phase 3' through 2024, but the ground truth does not explicitly confirm this remained unchanged - the LLM is making an inference not directly supported by the provided ground truth. (2) More critically, the LLM MISSES the key evolution described in the ground truth: the 2024 therapeutic indication broadened from 'atherosclerotic cardiovascular disease' to simply 'cardiovascular disease.' This is a significant strategic shift that the ground truth explicitly highlights as 'suggesting a potential expansion of its clinical application or regulatory strategy.' The LLM fails to capture this important progression. (3) The LLM characterizes the patent information as 'unchanged through 2024,' but the ground truth presents the 2023 disclosure of patent details as a NEW disclosure in that year, representing an evolution in how Amgen communicated IP protection strategy. (4) The LLM's framing of 'no move to Phase 3' is presented as fact but represents an inference about what wasn't disclosed rather than what was explicitly stated.\n\nMULTI-HOP REASONING: The LLM partially synthesizes information across years but fails to identify the key therapeutic indication expansion from 2023 to 2024, which is central to answering how the positioning 'evolved.' The answer is more static than dynamic in describing evolution.\n\nSEMANTIC ISSUES: While the LLM's statement about patent protection is technically accurate, it misses the narrative arc of the ground truth, which emphasizes movement 'from mid-stage development toward a more defined commercial and intellectual property strategy.' The LLM's answer is factually partial but strategically incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 575,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax remained a major brand in P&G’s Feminine Care sub‑category throughout 2022‑2024. In 2022 and 2023 the segment’s major‑brands list included Tampax Bounty alongside Pampers, Always, and others, with the sub‑category described as “Feminine Care (Adult Incontinence, Feminine Care)”【PG_10k_2022.pdf, page 18】【PG_10k_2023.pdf, page 17】. By 2024 Pampers was no longer listed, the sub‑category was re‑described as “Feminine Care (Adult Incontinence, Menstrual Care)”, and Tampax Bounty remained a key brand among the top five (Always, Always Discreet, Tampax Bounty, Charmin, Puffs)【PG_10k_2024.pdf, page 17】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. MAJOR FACTUAL ERROR - Brand Listing: The LLM claims 'Tampax Bounty' was listed as a major brand in 2022-2023 and 2024. This is incorrect. The ground truth clearly states Tampax was listed separately among major brands like 'Always and Bounty' - these are two distinct brands, not 'Tampax Bounty' as a single entity. This is a fundamental misreading of the source material.\n\n2. CATEGORIZATION ERRORS: The LLM states the 2022-2023 sub-category was 'Feminine Care (Adult Incontinence, Feminine Care)' - this matches ground truth. However, the LLM then claims by 2024 it was re-described as 'Feminine Care (Adult Incontinence, Menstrual Care)' - but the ground truth indicates this change occurred between 2022 and 2023, not between 2023 and 2024. The ground truth explicitly states: '2023: reclassified...under Feminine Care (Adult Incontinence, Menstrual Care)' and 'By 2024, the categorization remained consistent with 2023.'\n\n3. TIMELINE CONFUSION: The LLM incorrectly sequences the categorization changes. It suggests the 'Menstrual Care' terminology was introduced in 2024, when it was actually introduced in 2023 and remained consistent through 2024.\n\n4. INCOMPLETE SYNTHESIS: While the LLM attempts to show evolution across three years, it fails to accurately capture the actual progression of changes and misidentifies which year saw which modifications.\n\n5. MISSING CONTEXT: The LLM does not clearly convey that the segment name itself ('Baby, Feminine & Family Care') remained consistent, with only the sub-category labeling being refined.\n\nThe answer demonstrates poor multi-hop reasoning and contains a critical brand identification error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 485,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "From 2022 through 2024, MetLife’s use of internally developed designations for non‑agency RMBS and CMBS dropped to zero – all holdings in each year were assigned NAIC designations (see the NAIC designation tables on pages 99–103, 92–96, and 82–86). This trend shows that NAIC evaluations have become fully available for the asset class, and that MetLife’s acquisition strategy increasingly targets securities that already carry NAIC ratings, thereby eliminating the need for internal credit‑quality assessments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally and completely incorrect on the core factual claim. The ground truth states that MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a CONSISTENT PRACTICE across 2022-2024, with NAIC designations NOT immediately available for all new holdings. The LLM answer claims the opposite: that internally developed designations 'dropped to zero' and that 'all holdings in each year were assigned NAIC designations.' This is a direct contradiction of the ground truth. The LLM also misinterprets the trend, claiming NAIC evaluations became 'fully available' when the ground truth indicates NAIC evaluations continued to lag behind acquisition timelines. The LLM's conclusion about MetLife's acquisition strategy is inverted - the ground truth indicates a sustained strategy of investing in complex structured securities where NAIC evaluations lag, while the LLM claims MetLife increasingly targets securities that already carry NAIC ratings. The page references cited by the LLM (99-103, 92-96, 82-86) cannot be verified from the provided context but appear to be fabricated or misinterpreted. The answer fails on all critical dimensions: it provides incorrect quantitative claims (zero internally developed designations vs. consistent use), incorrect entity characterization (availability of NAIC designations), and inverted reasoning about MetLife's strategy. This represents a complete failure to accurately synthesize the multi-year trend from the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 420,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "Accenture repurchased 12.18 million shares for $4.11 billion in fiscal 2022, with an available authorization of $3.13 million (later raised to $6.13 billion). By fiscal 2024, the company had bought 2.00 million shares under its open‑market program for $605 million in the fourth quarter, while its aggregate available authorization had surged to $2.694 billion (with an additional $4 billion authority added to bring total outstanding authority to $6.694 billion). The steady rise in both repurchase volume and authorization reflects Accenture’s expanding commitment to returning capital to shareholders and confidence in its cash‑generating strength.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL UNIT ERROR: LLM states fiscal 2022 available authorization was '$3.13 million' when ground truth clearly states '$3.13 billion' - this is a 1000x error that fundamentally misrepresents the scale of the program. (2) INCORRECT NUMBERS FOR FY2022: LLM claims 12.18 million shares repurchased for $4.11 billion in fiscal 2022, but ground truth does not provide these specific numbers for FY2022 - only mentions FY2024 Q4 activity (2.00 million shares for $605M). The LLM appears to have fabricated or confused fiscal year data. (3) AUTHORIZATION FIGURE ERROR: LLM states authorization was 'later raised to $6.13 billion' but ground truth indicates it was raised to $6.69 billion (or $6.694 billion), not $6.13 billion. (4) INCOMPLETE FISCAL 2023 DATA: Ground truth mentions fiscal 2023 had increased authorization but LLM provides no specific FY2023 figures, missing a key data point in the three-year evolution. (5) CORRECT ELEMENTS: The FY2024 Q4 repurchase amount ($605 million for 2.00 million shares) is accurate. The final authorization figure of $6.69 billion is essentially correct (minor rounding variation). The qualitative conclusion about capital return strategy is reasonable but undermined by the quantitative errors. The multi-hop reasoning is partially sound in structure but fails due to incorrect underlying numbers. The answer demonstrates understanding of the question's intent but contains multiple factual errors that significantly compromise credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 416,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom’s 2022 10‑K (pp. 8‑12) presents fiber optics mainly as high‑speed optical components for Ethernet networking, storage, and telecom markets and lists them as part of its industrial product line. The 2023 and 2024 10‑Ks (pp. 3‑7) keep the same generic description but explicitly position “industrial fiber optics” as a core product within the industrial end‑market, alongside optocouplers, motion encoders, LEDs, and Ethernet ICs. This consistent emphasis across three years signals Broadcom’s strategic focus on leveraging fiber optics to drive growth in industrial automation, renewable‑energy, and automotive electronics.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Broadcom's industrial fiber optics positioning evolution across 2022-2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the three-year evolution pattern (2022→2023→2024); (2) Accurately lists associated products (optocouplers, motion encoders, LEDs, Ethernet ICs/PHYs); (3) Correctly identifies strategic applications (industrial automation, renewable energy, automotive electronics); (4) Properly synthesizes the progression from broad portfolio description to more standardized categorization to application-focused positioning; (5) Correctly identifies Broadcom (AVGO) and maintains accurate company/ticker references. WEAKNESSES: (1) The LLM states fiber optics were presented in 2022 as 'mainly...for Ethernet networking, storage, and telecom markets' which slightly mischaracterizes the ground truth's emphasis on industrial applications specifically - the ground truth emphasizes industrial automation, medical systems, and EV subsystems as the primary 2022 positioning; (2) The LLM's characterization of 2023-2024 descriptions as 'generic' is somewhat imprecise - the ground truth indicates these were actually more structured and application-specific; (3) Minor omission: the ground truth specifically mentions 'camera microcontrollers' as a 2024 addition alongside Ethernet PHYs, which the LLM doesn't capture. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. Page references in LLM answer (pp. 8-12, pp. 3-7) cannot be verified against ground truth but appear reasonable. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the evolution pattern and strategic implications. The conclusion about 'maturing and application-focused product strategy' aligns with ground truth. SEMANTIC EQUIVALENCE: The core message is preserved - Broadcom maintained consistent industrial fiber optics positioning with increasing strategic application focus. The slight characterization differences don't fundamentally alter the accuracy of the main thesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 591,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "From 2022 through 2024 UPS SurePost remained a residential‑ground service for non‑urgent, lightweight shipments, with final delivery “often provided by the U.S. Postal Service” (2022 10‑K p. 7; 2023 10‑K p. 7).  In the 2024 filing UPS announced a strategic shift: beginning January 1 2025 it will insource SurePost to reduce reliance on USPS and gain greater control over the end‑to‑end delivery experience (2024 10‑K p. 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) All key facts are correct - UPS SurePost is accurately described as a residential ground service for non-urgent, lightweight shipments; (2) The USPS role is correctly characterized as providing final delivery (LLM uses 'often provided' which aligns with ground truth's 'frequently handled'); (3) The strategic shift is accurately dated to January 1, 2025, with correct characterization of the change from USPS reliance to insourcing; (4) The motivation is correctly identified as gaining control over service quality and customer experience; (5) Multi-hop synthesis is sound - the answer correctly traces the evolution from 2022-2023 (unchanged model) through 2024 (announcement of shift); (6) Citations to specific 10-K pages (p. 7) add credibility and demonstrate source verification. Minor observation: The LLM uses 'often provided' rather than 'frequently handled' - both are semantically equivalent and appropriately convey the same meaning. The answer is concise, well-organized, and directly addresses all aspects of the question regarding role evolution, delivery model changes, and strategic shifts. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 353,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline expanded from 13 programs in 2022 to 18 in 2023 and 24 in 2024【AMGN_10k_2022.pdf:23‑27】【AMGN_10k_2023.pdf:24‑28】【AMGN_10k_2024.pdf:23‑27】. In 2022 the company secured regulatory approvals for three programs, launched four new Phase 3 studies and terminated one; in 2023 it added three new initiations and one approval while acquiring additional programs; by 2024 the portfolio reached 24 programs, with five Horizon‑acquired initiatives, three new Phase 3 launches, one FDA approval and one Japan approval【AMGN_10k_2024.pdf:23‑27】. This steady rise in quantity and the mix of internal development, acquisitions, and approvals demonstrate Amgen’s deliberate R&D expansion strategy focused on human‑genetics‑driven modalities and accelerated pipeline growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core progression of Phase 3 programs (13→18→24) across the 2022-2024 period, matching the ground truth numbers. It appropriately mentions the Horizon Therapeutics acquisition in 2023 and its contribution of five Phase 3 programs. The answer demonstrates sound multi-hop reasoning by synthesizing information across multiple 10-K filings and connecting internal development with external acquisitions. The conclusion about R&D expansion strategy is logically sound and well-supported.\n\nWEAKNESSES: (1) The LLM answer does not mention the 25 Phase 3 programs figure as of February 4, 2025 (noted in the 2024 filing), which represents the most current data point in the ground truth. This is a notable omission for a question asking about evolution \"through 2024.\" (2) The specific breakdown of activities in 2022 (\"three programs secured regulatory approvals, launched four new Phase 3 studies and terminated one\") is provided but not verified against ground truth sources - these granular details cannot be confirmed. (3) The mention of \"human-genetics-driven modalities\" as a strategic focus is not present in the ground truth answer and may be an inference not directly supported by the filing data provided.\n\nNUMBER VERIFICATION: The core progression numbers (13→18→24) are correct. The Horizon acquisition contribution of five Phase 3 programs is accurate. However, the omission of the 25-program figure as of February 4, 2025 represents incomplete coverage of the available data.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects internal pipeline development with external acquisition strategy, demonstrating appropriate multi-hop reasoning.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution, quantity, milestones, and strategic implications, though it could have been more comprehensive by including the most recent data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 536,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "In FY 2022 Accenture authorized **127 million** Class A shares for its Amended 2010 SIP (ACN_10k_2022, pp. 89‑93).  The authorized pool was raised to **141 million** shares in FY 2023 (ACN_10k_2023, pp. 81‑85) and remained at that level in FY 2024 (ACN_10k_2024, pp. 96‑100).  The expansion of the share‑based compensation pool signals Accenture’s strategic emphasis on using equity awards to attract, retain, and align employees with shareholder interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - FY 2022: 127 million shares, FY 2023-2024: 141 million shares. The progression is accurately captured with the increase occurring between FY 2022 and FY 2023, with stability in FY 2024. Number formatting (127 million vs 127,000,000) is appropriately flexible. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the specific authorization amounts for each year, (2) the evolution/progression across the three-year period, and (3) strategic implications. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, Amended 2010 SIP, and all three fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to show the temporal progression and correctly interprets this as a strategic shift. The reasoning that the increase signals emphasis on equity-based incentives for talent retention and alignment is sound and matches the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's characterization of the expansion as signaling 'strategic emphasis on using equity awards to attract, retain, and align employees with shareholder interests' is semantically equivalent to the ground truth's statement about 'greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy.' Minor note: The LLM provides specific page references (pp. 89-93, 81-85, 96-100) which adds credibility but wasn't in the ground truth - this is a positive addition. The answer is concise, accurate, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 467,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks projected that its green‑coffee supply coverage would extend through fiscal 2023 in FY 2022, through fiscal 2025 in FY 2023, and remained at fiscal 2025 in FY 2024. This shift shows the company has expanded its inventory and purchase commitments to secure a longer‑term supply, underscoring a proactive risk‑management strategy that mitigates supply‑chain disruptions and price volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Starbucks' green coffee supply coverage projections. All key dates and fiscal year projections are correct: FY 2022 through fiscal 2023, FY 2023 through fiscal 2025, and FY 2024 maintaining fiscal 2025 coverage. The quantitative data is entirely accurate with no calculation errors. The multi-hop reasoning is sound, correctly synthesizing the progression across three fiscal years and identifying the strategic shift toward longer-term supply assurance. The answer appropriately interprets what this evolution indicates about inventory and risk management strategy, noting the proactive approach to mitigating supply-chain disruptions and price volatility. The only minor distinction from the ground truth is that the LLM answer uses slightly more concise phrasing (e.g., 'remained at fiscal 2025' vs. 'maintained the same projected supply coverage through fiscal 2025'), but this represents semantic equivalence rather than factual error. The answer fully addresses both parts of the question: the evolution of projected duration and what it indicates about strategy. The reasoning about extended purchase commitments and hedging mechanisms aligns with the ground truth's characterization of a 'more forward-looking inventory and risk management strategy.' No factual errors, omissions of key data, or calculation mistakes are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 392,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "UPS reported no amendments or remeasurements to the UPS/IBT Full‑Time Employee Pension Plan in 2022 (see pages 90‑94). In 2023, the Teamsters ratified a new five‑year national master agreement that increased wage and benefit rates for UPS/IBT plan participants, and the resulting benefit‑cost increase was recognized in the year‑end measurement of the plan (pages 80‑84). In 2024, UPS disclosed no amendments, remeasurements, or collective‑bargaining changes to the UPS/IBT plan, and the plan continued under the same terms as in 2023 (pages 84‑88).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains critical factual errors that directly contradict the ground truth. (1) MAJOR ERROR - 2022 Remeasurement: The ground truth clearly states that in 2022, the plan was remeasured following the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax). The LLM explicitly claims 'UPS reported no amendments or remeasurements to the UPS/IBT Full-Time Employee Pension Plan in 2022,' which is factually incorrect. This is a significant quantitative error involving a $3.3 billion gain that should have been reported. (2) 2023 Treatment: The LLM correctly identifies the Teamsters ratification and wage/benefit rate increases, which aligns with the ground truth. However, the LLM's characterization of this as merely 'recognized in the year-end measurement' is less precise than the ground truth's fuller context. (3) 2024 Treatment: The LLM claims 'no amendments, remeasurements, or collective-bargaining changes' and that the plan 'continued under the same terms as in 2023.' The ground truth states the plan was 'still maintained as a noncontributory defined benefit plan' with 'no indication of further structural changes,' which is semantically similar but the LLM's phrasing of 'no amendments' contradicts the documented 2023 collective bargaining agreement impacts that would carry forward. (4) Missing Strategic Context: The LLM fails to capture the three-year progression and strategic balance that the ground truth emphasizes - the regulatory responsiveness to the American Rescue Plan Act, the pension obligations management, and the collective bargaining dynamics. (5) Page References: The LLM provides specific page numbers that cannot be verified against the ground truth, and these may be inaccurate. The fundamental failure is the complete omission of the $3.3 billion 2022 remeasurement gain, which is a material financial event that should be central to any analysis of how UPS's treatment of this plan evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 538,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across fiscal 2022, 2023 and 2024 Walmart continues to list **Holiday Time** as one of its private‑label brands, consistently grouping it with other low‑price, seasonal‑themed lines such as “Way to Celebrate” and “Time and Tru.”  The brand remains positioned within the general‑merchandise unit (the seasonal‑merchandise sub‑category), showing no shift in its categorization or strategic emphasis.  This continuity signals Walmart’s ongoing strategy of embedding seasonal merchandise in its private‑label mix to deliver low‑priced holiday items under the same everyday‑low‑price framework that drives its broader private‑label portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) MAJOR ERROR - The LLM claims 'Holiday Time' showed 'no shift in its categorization or strategic emphasis' across the three fiscal years, directly contradicting the ground truth which explicitly states there WAS an evolution, particularly by fiscal 2024 when Walmart 'explicitly restructured its merchandise units to include seasonal merchandise as a defined category.' (2) ENTITY ACCURACY ISSUE - The LLM introduces 'Way to Celebrate' and 'Time and Tru' as comparable seasonal brands grouped with Holiday Time, but the ground truth specifically mentions 'George' and 'Great Value' as the relevant comparison brands. This suggests the LLM may have confused or fabricated brand associations. (3) CATEGORIZATION ERROR - The LLM states Holiday Time remained in 'the seasonal-merchandise sub-category' consistently across all three years, but the ground truth indicates this was a NEW development by fiscal 2024, not a consistent positioning. The ground truth shows fiscal 2022-2023 had Holiday Time listed 'without specific strategic emphasis on seasonal offerings' and 'without a distinct strategic role,' while fiscal 2024 introduced the explicit 'seasonal merchandise' category structure. (4) MISSING EVOLUTION - The LLM completely fails to capture the core insight of the question: the EVOLUTION across the three years. The ground truth reveals a strategic shift toward 'structured seasonal planning' and 'optimizing private label offerings for time-sensitive retail cycles,' which the LLM entirely misses. (5) QUANTITATIVE ACCURACY - No specific numbers or dates are provided by either answer, so this dimension is neutral, though the LLM's claim of consistency across years is factually incorrect. The LLM answer demonstrates fundamental misunderstanding of the multi-hop synthesis required and provides contradictory information to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 527,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s fair‑value of mutual‑fund equity securities in its non‑U.S. pension plan assets fell from **$239,293 k in 2022** to **$196,226 k in 2023** and then rose to **$273,699 k in 2024** (2024 table on pages 94‑98; 2023 table on pages 81‑85; 2022 table on pages 87‑91). The dip in 2023 followed by a rebound in 2024 indicates a deliberate rebalancing—ACN reduced equity exposure amid market volatility or strategic realignment in 2023, then increased it in 2024 to pursue a more growth‑oriented allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error that contradicts the ground truth. The ground truth clearly states that ACN's mutual fund equity securities 'remained unchanged in 2024' at the 2023 level ($196.226 million), but the LLM claims the value 'rose to $273,699 k in 2024.' This is a significant discrepancy of approximately $77.5 million. The 2022 ($239,293k) and 2023 ($196,226k) figures are correct and match the ground truth, but the 2024 figure is entirely wrong. The LLM's interpretation of the trend is therefore fundamentally incorrect—it suggests a 'rebound in 2024 to pursue a more growth-oriented allocation,' when the ground truth indicates the value remained flat from 2023 to 2024, suggesting a 'consistent decline' and 'strategic rebalancing away from this asset class.' The LLM misidentified the strategic narrative: the ground truth emphasizes a consistent downward trend with no recovery, while the LLM describes a V-shaped recovery pattern that did not occur. The page references provided by the LLM (pages 94-98, 81-85, 87-91) cannot be verified but the numerical data is demonstrably incorrect for 2024. The answer does address the multi-part question structure and attempts multi-hop synthesis, but the core quantitative error undermines the entire analysis and strategic conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 373,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks has consistently disclosed that green‑coffee prices are influenced by futures‑market activity—including commodity‑index funds—and has maintained a hedging strategy that uses forward contracts, futures contracts and collars to manage “C”‑price exposure across fiscal 2022, 2023 and 2024 (see 2022 10‑K, p. 12; 2023 10‑K, p. 12; 2024 10‑K, p. 12). The company’s disclosures show no significant change in the intensity or composition of these hedges over the three‑year period, indicating a stable, disciplined risk‑management approach that relies on futures instruments to mitigate commodity‑price volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Starbucks' hedging strategy and correctly identifies the key instruments (forward contracts, futures contracts, collars) used across fiscal 2022-2024. The answer appropriately cites the 10-K filings and correctly notes the company's exposure to commodity index funds and futures market activity. However, there are notable differences from the ground truth that affect the overall evaluation: (1) The LLM states there was 'no significant change in the intensity or composition of these hedges' over the three-year period, whereas the ground truth reveals an important evolution—specifically that by 2023, Starbucks 'extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure.' This represents a material difference in the narrative of how the strategy evolved. (2) The ground truth emphasizes the progression from 2022 (covering through fiscal 2023) to 2023 (extending through fiscal 2025), showing a lengthening of the hedging horizon. The LLM's characterization of this as 'stable' and 'no significant change' misses this important temporal evolution. (3) The LLM correctly identifies the hedging instruments but doesn't capture the nuance about how the company's confidence and forward-looking commitments evolved. (4) Quantitatively, no specific dollar amounts or percentages are provided in either answer, so numeric accuracy cannot be fully assessed, but the LLM's page citations (p. 12 for all three years) appear reasonable. The answer is fundamentally sound in its core facts but fails to capture the evolution aspect that is central to the question's focus on how exposure 'evolved' from 2022 through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 475,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO’s exposure to the 3.625 % senior notes due October 2024 stayed flat at **$622 million** from fiscal year 2022 through fiscal year 2024 (see the debt schedule in AVGO_10k_2022.pdf p. 101‑105, AVGO_10k_2023.pdf p. 79‑83, and AVGO_10k_2024.pdf p. 79‑83). This unchanged level shows the company is keeping a low‑level, consistent short‑term debt profile and is not adding new debt at that maturity, instead focusing on refinancing or paying down other obligations to manage its near‑term debt load.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM claims the 3.625% notes remained at $622 million 'from fiscal year 2022 through fiscal year 2024,' but the ground truth explicitly states that by 2024, the company had completely retired this liability and the notes no longer appeared in the debt schedule. This is a major quantitative inaccuracy - the LLM failed to identify the key progression that defines the answer: $622M (2022) → $622M (2023) → $0 (2024/retired). The LLM's statement that the amount 'stayed flat...through fiscal year 2024' is demonstrably incorrect. Additionally, the LLM's interpretation of the strategy is flawed - it suggests AVGO is 'keeping a low-level, consistent short-term debt profile' when in fact the ground truth shows deliberate near-term debt management through complete retirement/refinancing of the obligation before maturity. The LLM failed to synthesize the multi-hop information correctly across the three fiscal years, missing the critical 2024 retirement event that is central to understanding AVGO's debt management strategy. While the $622 million figure for 2022-2023 is correct, the failure to identify the 2024 retirement represents a complete misunderstanding of the question's core requirement: analyzing the 'evolution' of this exposure. The reasoning about debt management strategy is also incorrect - the ground truth indicates proactive debt retirement ahead of maturity, not passive maintenance of existing debt levels.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 423,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s credit‑risk mitigation framework—requiring non‑compliant customers to post cash collateral, letters of credit or guarantees and regularly reviewing the adequacy of those arrangements—remained unchanged in principle but expanded in scale as settlement exposure rose.  Gross settlement exposure climbed from $59.6 million in 2021 to $78.4 million in 2024, with risk‑mitigation arrangements increasing from $7.7 million to $13.5 million, raising net exposure from $51.9 million to $64.9 million (2024 p. 102‑106; 2023 p. 110‑114; 2022 p. 108‑112).  The upward trend reflects intensified regulatory scrutiny (FTC, DOJ, EU investigations) and mounting litigation (merchant and ATM claims) that heightened Mastercard’s settlement‑risk profile and prompted greater risk‑mitigation coverage.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative data on settlement exposure and risk mitigation arrangements that are not present in the ground truth, which is a strength. The numbers cited ($59.6M in 2021 to $78.4M in 2024 for gross settlement exposure, $7.7M to $13.5M for risk-mitigation arrangements, and net exposure calculations) appear internally consistent and mathematically sound. The answer correctly identifies the core framework (cash collateral, letters of credit, guarantees) and the regulatory/litigation context (FTC, DOJ, EU investigations, merchant/ATM claims). However, there are notable gaps: (1) The LLM answer lacks specific mention of the FTC consent agreement on debit transaction routing transparency that the ground truth highlights as a 2023 development. (2) The EMV liability shift class-action lawsuit ($1+ billion) mentioned in the ground truth is not referenced. (3) The European Commission investigation into anticompetitive behavior tied to network fees is mentioned only generically as 'EU investigations' without the specific focus on network fees. (4) The answer does not explicitly discuss the evolution from 2022 through 2024 as a narrative arc showing transformation in external risk environment, instead presenting it more as a linear quantitative trend. The quantitative data provided (settlement exposure figures and page citations) cannot be verified against the ground truth but appears plausible and well-documented. The multi-hop reasoning is sound—connecting regulatory scrutiny and litigation to increased risk mitigation coverage—but the answer prioritizes quantitative detail over the qualitative evolution narrative that the ground truth emphasizes. The answer is more narrowly focused on settlement exposure metrics rather than the broader credit risk mitigation strategy evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 499,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 10‑K risk disclosures on drug‑delivery devices have remained essentially unchanged from 2022 through 2024.  Each filing (2022 pp. 32‑36, 2023 pp. 51‑55, 2024 pp. 50‑54) stresses that devices used with its products are subject to regulatory oversight, require ongoing pharmacovigilance and reporting, and may trigger post‑marketing studies or REMS obligations.  The 2023 and 2024 disclosures largely mirror the 2022 language, with no substantive changes in compliance requirements or safety‑oversight procedures, though the 2024 filing reiterates the need for continued monitoring and potential post‑marketing commitments.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core question. MAJOR ERRORS: (1) The LLM claims disclosures 'remained essentially unchanged from 2022 through 2024,' directly contradicting the ground truth which explicitly documents an EVOLUTION showing increasing regulatory scrutiny and expanded oversight across the three years. (2) The ground truth identifies specific substantive changes: 2022 focused on disruption risks, 2023 added detail on surrogate endpoints and conditional approvals (Repatha, LUMAKRAS), and 2024 expanded on safety reviews and enforcement action consequences. The LLM dismisses these as 'no substantive changes.' (3) The LLM provides page number citations (2022 pp. 32-36, 2023 pp. 51-55, 2024 pp. 50-54) that cannot be verified and appear to be fabricated specificity without actual evidence of these exact page ranges or their content. (4) The LLM's characterization of 2023 and 2024 as 'largely mirror[ing] the 2022 language' directly contradicts the ground truth's documented progression showing increasing emphasis on post-market compliance and safety monitoring. (5) The LLM fails to address the specific products mentioned in the ground truth (Repatha, LUMAKRAS) or the evolution in regulatory requirements around confirmatory studies and conditional approvals. The answer demonstrates poor multi-hop synthesis—it failed to identify and compare the actual changes across the three years that the ground truth clearly documents. The LLM appears to have made a blanket assertion of stasis rather than performing the required comparative analysis across the three filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 448,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Parent’s Choice appears in the list of private‑label brands in each of Walmart’s 2022, 2023 and 2024 10‑K filings, and the company’s grocery‑unit description—across all three years—continues to include baby products and consumables.  The brand has remained consistently categorized under the Grocery unit, indicating that Walmart has not shifted it to a different merchandise category.  This stability shows Walmart’s deliberate positioning of Parent’s Choice as a low‑price private‑label staple within its core baby‑and‑consumables portfolio, reinforcing its everyday‑low‑price strategy in these high‑volume, price‑sensitive categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Parent's Choice appearing in all three fiscal years (2022, 2023, 2024) with accurate entity identification; (2) Accurately captures the consistent categorization under the Grocery unit across all three years; (3) Correctly notes that baby products and consumables remained part of the Grocery unit description throughout the period; (4) Properly synthesizes the multi-hop information showing no merchandise category shifts; (5) Accurately interprets the strategic implications—positioning as a low-price private-label staple aligned with EDLP strategy; (6) Uses semantically equivalent language ('everyday-low-price strategy' vs 'EDLP pricing philosophy'); (7) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'stability' and 'no shifts' slightly more explicitly than the ground truth, though this is a valid interpretation of the data; (2) The ground truth mentions 'omni-channel convenience strategy' which the LLM answer does not explicitly reference, though this is a minor omission that doesn't affect core correctness; (3) The phrasing 'high-volume, price-sensitive categories' in the LLM answer is a reasonable inference not explicitly stated in ground truth but logically sound. The answer successfully addresses all parts of the multi-part question: evolution across three years, merchandise categorization consistency, and strategic positioning within the baby/consumables portfolio. The reasoning is sound and the synthesis across multiple years is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 451,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "In the 2022 10‑K (p. 100) Tesla reported the 4.70 % Solar Bonds, Series 2015/C24‑10 as outstanding debt maturing in 2025, a legacy of the SolarCity acquisition. By the 2023 10‑K (p. 100) the company had repurchased a portion of those bonds, reducing the principal balance and extending the maturity to 2026. In the 2024 10‑K (p. 97) Tesla disclosed that the remaining bonds were fully repaid (or converted to equity), reflecting a deliberate move to retire legacy debt and shift toward more favorable, lower‑cost financing for its solar operations. This multi‑year pattern indicates that Tesla is actively managing its debt portfolio to reduce long‑term liabilities, streamline its capital structure, and support the expansion of its renewable‑energy business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims Tesla repurchased bonds in 2023, extended maturity to 2026, and fully repaid/converted bonds by 2024. The ground truth indicates the bonds were consistently referenced across all three years (2022, 2023, 2024) as part of ongoing solar financing, with no mention of repurchases, maturity extensions, or full repayment. (2) QUANTITATIVE ACCURACY: The LLM provides specific claims about maturity dates (2025, 2026) and repayment status that are not supported by the ground truth and appear to be fabricated. The ground truth does not mention any of these specific maturity dates or repayment actions. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year pattern. The ground truth shows a consistent securitization strategy with the bond referenced alongside other series (C27-10, C32-10 in 2023; C4-10, C9-10 in 2024), indicating a mature and recurring model. The LLM instead invented a narrative of debt reduction and retirement that contradicts the ground truth's emphasis on consistent reliance and scalability. (4) ENTITY AND CONTEXT ACCURACY: While the bond identifier (4.70% Solar Bonds, Series 2015/C24-10) is correct, the LLM mischaracterizes its role and evolution. The ground truth emphasizes ongoing securitization and consistent financing strategy; the LLM incorrectly frames this as legacy debt being retired. (5) SEMANTIC MISMATCH: The ground truth's conclusion about 'consistent and scalable securitization strategy' is fundamentally different from the LLM's conclusion about 'actively managing debt portfolio to reduce long-term liabilities.' These represent opposite interpretations of Tesla's solar financing strategy. The LLM appears to have hallucinated specific financial transactions and maturity dates without evidence from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 520,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom has consistently described its Security Insights Platform as a main‑frame security‑assessment tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and that “this data is available for use with in‑house tools for security information and event management” (2022 pp. 9‑13; 2023 pp. 8‑12; 2024 pp. 8‑12).  The wording has not materially changed, so the platform’s positioning has remained focused on main‑frame risk assessment while explicitly highlighting its ability to feed data into enterprise SIEM‑type tools across all three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core positioning of Broadcom's Security Insights Platform across 2022-2024 and accurately captures the key functional descriptions (mainframe security assessment, risk identification, remediation steps, SIEM integration). The page number citations (2022 pp. 9-13; 2023 pp. 8-12; 2024 pp. 8-12) appear reasonable and specific. However, the answer has significant weaknesses: (1) It oversimplifies the evolution narrative by stating 'wording has not materially changed' and that positioning 'remained focused,' which contradicts the ground truth's more nuanced finding that there was a 'subtle but meaningful reaffirmation' and 'maturing narrative' in 2024. The ground truth explicitly notes a 'slightly stronger emphasis on integration' in 2024 and describes this as reflecting 'more deliberate alignment with enterprise-wide security strategies.' (2) The LLM answer misses the temporal evolution aspect that the question specifically asks about—it treats the three years as essentially identical rather than showing how the positioning evolved or matured. (3) While the LLM correctly identifies the core capabilities and SIEM integration emphasis, it fails to capture the ground truth's insight about the 2024 shift toward 'enterprise-wide security strategies' and 'broader cybersecurity frameworks.' (4) The phrase 'on an ongoing and ad-hoc basis' appears in the LLM answer but is not explicitly mentioned in the ground truth, raising questions about source accuracy. The answer is partially correct on core facts but misses the qualitative evolution and strategic positioning shifts that are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 453,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Between 2022 and 2024 Mastercard’s Class A shares continued to carry one vote per share and retained dividend rights, with the dividend per share rising from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (2022 p. 94‑98; 2023 p. 97‑101; 2024 p. 90‑94). The unchanged voting structure coupled with a steady increase in dividend payouts shows the company’s deliberate strategy to preserve voting control in Class A shares while progressively rewarding shareholders, reflecting a consistent dual‑class capital‑structure approach across the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of MA's Class A shares maintaining one vote per share across 2022-2024. The dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) appear reasonable and show proper multi-hop synthesis across three fiscal years. The page references (2022 p. 94-98; 2023 p. 97-101; 2024 p. 90-94) are appropriately cited, suggesting proper document sourcing. The answer correctly identifies the core finding: unchanged voting structure with increasing dividend payouts. However, the LLM answer goes beyond the ground truth by introducing specific dividend per share amounts that, while potentially accurate, were not mentioned in the original answer. This represents either additional detail or potential over-specification. The reasoning about 'deliberate strategy to preserve voting control' and 'progressively rewarding shareholders' is sound and logically derived from the facts presented. The answer properly synthesizes the multi-hop requirement by comparing the status across three years and drawing conclusions about capital structure strategy. The semantic equivalence is strong - both answers convey that voting rights remained stable while the company maintained its dual-class structure. The main distinction is that the LLM provides more granular financial detail (specific dividend amounts) which enhances the answer's informativeness, though this wasn't explicitly required by the ground truth. No calculation errors detected. The answer appropriately addresses both parts of the question: the evolution (or lack thereof) of voting/dividend rights AND what this reveals about capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 463,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "From 2022 through 2024 Amgen kept bemarituzumab in a Phase 3 program for gastro‑esophageal junction (GEJ) adenocarcinoma, with no shift to earlier or later phases noted in the 2022, 2023 or 2024 10‑K filings.  The company’s composition‑of‑matter patents in the U.S. and Europe, issued in 2022, carry estimated expirations in 2029, a date that remained unchanged in the 2023 and 2024 reports.  Amgen continues to file additional patents and pending applications to extend exclusivity beyond the 2029 horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key points but has some notable differences from the ground truth. CORRECT ELEMENTS: (1) Bemarituzumab remained in Phase 3 for GEJ adenocarcinoma throughout 2022-2024 - accurate; (2) Patent expiration date of 2029 in U.S. and Europe - correct; (3) Patents issued in 2022 - accurate; (4) Mention of additional patent filings to extend exclusivity - aligns with ground truth's reference to 'potential regulatory exclusivity periods.' ISSUES: (1) The LLM states patents were 'issued in 2022' while the ground truth indicates patents were 'estimated to expire in 2029' as disclosed in 2023, suggesting the patents may have been issued earlier; the LLM's characterization of 2022 issuance is not explicitly contradicted but adds specificity not confirmed in ground truth. (2) The LLM answer is more technical/detailed about 'composition-of-matter patents' and 'pending applications' which goes slightly beyond what the ground truth explicitly states, though it's not contradictory. (3) The ground truth emphasizes a 'progression' and 'transition from early-phase development to a more mature pipeline asset,' while the LLM focuses on the static nature of the Phase 3 program ('no shift to earlier or later phases'). This represents a different interpretive emphasis - the ground truth highlights evolution/progression, while the LLM emphasizes continuity. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022-2024) and connects clinical development phases with IP strategy timelines. The reasoning is sound and logically structured. QUANTITATIVE ACCURACY: The 2029 expiration date is correct; the characterization of patent status is accurate. SEMANTIC EQUIVALENCE: The core information is conveyed accurately, though the LLM's emphasis on 'no shift' differs from the ground truth's emphasis on 'progression.' Both interpretations can be supported by the data, but they frame the narrative differently.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 535,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Walmart’s private‑label “No Boundaries” has been listed in every filing as part of its apparel assortment (2022 pages 5‑9; 2023 pages 6‑10; 2024 pages 5‑9).  In 2022 and 2023 the apparel sub‑unit was called “Apparel,” but the 2024 filing renamed it “Fashion” (encompassing apparel, shoes, jewelry and accessories) (2024 pages 5‑9).  This re‑labeling signals a deliberate shift to broaden and elevate Walmart’s fashion offering, positioning “No Boundaries” within a wider, style‑centric private‑label strategy that extends beyond basic clothing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies 'No Boundaries' as a private-label brand present in all three years (2022-2024), matching the ground truth's emphasis on continuity. (2) Accurately captures the categorical shift: 'Apparel' in 2022-2023 to 'Fashion' in 2024, with correct description of Fashion's expanded scope (apparel, shoes, jewelry, accessories). (3) Provides appropriate page references (2022 pages 5-9, 2023 pages 6-10, 2024 pages 5-9) that add credibility. (4) Correctly interprets the strategic significance: the renaming signals a deliberate shift to broaden and elevate fashion positioning. (5) Multi-hop reasoning is sound—synthesizes information across three years to show evolution in categorization strategy. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing than ground truth ('re-labeling signals deliberate shift' vs. 'strategic realignment to strengthen fashion positioning'), but both convey equivalent meaning. (2) The LLM answer emphasizes the 'style-centric private-label strategy' angle, which is a reasonable interpretation of the categorical shift but goes slightly beyond what the ground truth explicitly states about 'omni-channel offerings and customer-centric experiences.' However, this is a reasonable inference rather than an error. (3) The LLM answer is more concise and direct than the ground truth while maintaining all essential information. No quantitative errors detected. The answer successfully addresses all parts of the multi-part question regarding how 'No Boundaries' fit within evolving strategic units and what this reveals about Walmart's shifting focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 478,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a core competitive differentiator (2022 pages 2‑6; 2023 pages 1‑5), but the 2024 filing (pages 1‑5) explicitly links that trust to its secure, open hybrid‑cloud platform and AI solutions—presenting trust and security as a pillar of the hybrid‑cloud and AI strategy. This shift shows IBM is moving from a general value proposition to positioning trust as a foundational element that underpins its hybrid‑cloud and AI offerings, underscoring the importance of reliable, secure technology in a crowded market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in completeness and reasoning quality. STRENGTHS: (1) Correctly identifies that IBM consistently emphasized 'client relationships and trust' across 2022-2024; (2) Accurately notes the 2024 filing explicitly links trust to hybrid-cloud and AI solutions; (3) Correctly identifies the shift toward positioning trust as foundational to hybrid-cloud/AI strategy; (4) Page references appear reasonable (2022 pages 2-6, 2023 pages 1-5, 2024 pages 1-5). WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The answer fails to capture the 2023 intermediate step where IBM 'explicitly linked client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies.' This is a critical part of the evolution that shows progression from foundational (2022) to value-delivery focused (2023) to ecosystem-extended (2024); (2) MISSING ECOSYSTEM EVOLUTION - The ground truth emphasizes that by 2024, IBM 'expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators,' extending trust through ecosystem collaboration. The LLM answer mentions partnerships but doesn't capture this as an evolution or expansion of the trust model; (3) INCOMPLETE MULTI-HOP REASONING - The question asks what the progression 'reveals about its hybrid cloud and AI strategy positioning.' The LLM answer states trust is 'a pillar' of the strategy but doesn't fully explain how the evolution from 2022→2023→2024 reveals strategic positioning (i.e., moving from internal differentiation to ecosystem-based delivery); (4) OVERSIMPLIFICATION - The characterization as 'moving from a general value proposition to positioning trust as foundational' is somewhat reductive and misses the nuance that trust was foundational in 2022 and evolved in how it was leveraged (through partnerships, ecosystems) by 2024. The answer presents a binary shift rather than a three-stage evolution. QUANTITATIVE ACCURACY: No specific numbers or calculations to verify, but page references appear plausible. QUALITATIVE ACCURACY: The reasoning is partially sound but incomplete—it identifies one key shift (trust linked to hybrid-cloud/AI) but misses the intermediate evolution and ecosystem partnership expansion that are central to understanding the full strategic progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 635,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15 were still reported as $1.0 billion of principal outstanding and due 2025 in each of the three filings – $1.0 billion on page 101 of the 2022 10‑K, the same amount on page 100 of the 2023 10‑K, and again $1.0 billion on page 98 of the 2024 10‑K. The unchanged principal over three years shows that Tesla has retained the long‑term, fixed‑rate debt issued by SolarCity, using it as a stable, low‑cost financing vehicle for its solar assets while deferring repayment until the 2025 maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth and the nature of the question. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims the bond had '$1.0 billion of principal outstanding and due 2025' in 2022, 2023, and 2024. This is problematic because if the bond was due in 2025, it would have matured by 2024, making the claim of unchanged principal across all three years highly suspect. The ground truth indicates the bond was issued in early 2015 with a 2025 maturity, meaning by 2024 it should be approaching or at maturity. The LLM provides specific page numbers (101, 100, 98) that cannot be verified against the ground truth. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes that Tesla 'consistently referenced' the bond across filings, indicating ongoing legal/financial linkage and a persistent financing strategy. The LLM shifts focus to claiming unchanged principal amounts, which is a different analytical approach and potentially incorrect given the bond's maturity timeline. (3) INCOMPLETE MULTI-HOP REASONING: The question asks about how the bond 'evolved' across the three years and what the pattern indicates about strategy. The LLM's answer that the principal remained unchanged does not adequately address evolution or strategic implications. The ground truth correctly identifies that the persistence of references indicates a consistent strategy, while the LLM's claim of static principal amounts doesn't explain strategic intent. (4) MISSING CONTEXT: The LLM fails to mention the Thirty-Sixth Supplemental Indenture (April 14, 2015) or the broader solar bond framework that the ground truth identifies as important context. (5) LOGICAL INCONSISTENCY: If a bond was due in 2025 and the LLM is reporting on 2024 filings, the bond would be in its final year, yet the LLM presents this as evidence of a 'stable, low-cost financing vehicle' without acknowledging the imminent maturity. The answer demonstrates partial understanding of the bond's existence but fails on accuracy of financial details, temporal logic, and strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 566,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Between 2022 and 2024, Emerson’s Safety & Productivity segment broadened its pipe‑working line by adding battery‑powered hydraulic tools for press connections and for cutting/crimping electrical cable, and by introducing diagnostic systems that include sewer‑inspection cameras and locating equipment—features that were not highlighted in the 2022 offering (pages 7‑11). This shift toward cordless, battery‑driven, tech‑enabled tools signals a strategic emphasis on mobility, safety, and productivity, positioning Emerson as a modern, innovation‑driven competitor in the professional tools market (pages 71‑75).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key product innovations and strategic positioning. STRENGTHS: (1) Correctly identifies the progression from traditional tools (2022) to battery-powered hydraulic tools for press connections (2023) to expanded battery tools for cutting/crimping cables (2024); (2) Accurately captures the shift toward cordless, battery-driven solutions; (3) Properly identifies diagnostic systems including sewer inspection cameras and locating equipment; (4) Correctly synthesizes the strategic implication about modernization and competitive positioning; (5) No quantitative errors or date misstatements. WEAKNESSES: (1) The answer is notably more concise than the ground truth, omitting some contextual details such as the explicit mention of pipe wrenches as foundational tools across all three years, which the ground truth emphasizes as important for understanding continuity; (2) Does not explicitly mention traditional tools like pipe cutters, threading equipment, or closed-circuit television systems from 2022, which provides important context for the 'before' state; (3) The phrase 'features that were not highlighted in the 2022 offering' is somewhat vague compared to the ground truth's more explicit enumeration of what was offered in each year; (4) Missing the explicit connection between the foundational role of pipe wrenches and the progressive innovation layered on top. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects product evolution to strategic positioning, though with less granular detail than the ground truth. The reasoning is sound but less comprehensive. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—Emerson modernized its toolset through battery-powered innovations while maintaining core offerings. The strategic conclusion about competitive positioning is accurate. The answer would benefit from more complete enumeration of product offerings in each year to fully match the ground truth's comprehensiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 559,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "From 2022 to 2024, Gilead’s capital‑allocation strategy for its El Segundo, California site shifted from an initial expansion of cell‑therapy manufacturing capacity to a focus on scaling that capacity for commercial production in line with its broader biologics pipeline. In 2022, the company noted that its capital resources were sufficient to support the expansion of the El Segundo facility for cell‑therapy production (2022 10‑K, pp. 31‑35). By 2023, Gilead continued to invest in the site, expanding its clinical and commercial cell‑therapy manufacturing capacity (2023 10‑K, pp. 9‑13), and by 2024 the facility was positioned for commercial manufacturing of cell‑therapy products, reflecting a strategic alignment with the company’s biologics development priorities (2024 10‑K, pp. 8‑12).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer cites specific page numbers (2022 10-K pp. 31-35, 2023 10-K pp. 9-13, 2024 10-K pp. 8-12) that do NOT match the ground truth citations. Ground truth specifies: GILD_10k_2022.pdf:page_33:chunk_1, GILD_10k_2023.pdf:page_11:chunk_1, GILD_10k_2024.pdf:page_10:chunk_1. The LLM's page ranges are incorrect and appear fabricated. FACTUAL ACCURACY ISSUES: (1) The LLM claims in 2022 that 'capital resources were sufficient to support the expansion of the El Segundo facility for cell-therapy production' - the ground truth states El Segundo was listed as a general manufacturing facility WITHOUT specific emphasis on cell therapy in 2022. This is a significant mischaracterization. (2) The LLM's framing of 'initial expansion' in 2022 contradicts ground truth which shows the strategic shift toward cell therapy specialization occurred in 2023, not 2022. WHAT WAS CORRECT: (1) The general progression from 2022-2024 is directionally accurate. (2) The identification of El Segundo as a cell therapy site by 2023-2024 is correct. (3) The alignment with biologics development priorities is mentioned appropriately. MISSING KEY DETAILS: The LLM answer omits the important ground truth detail about Gilead's reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies (mentioned in 2024 filing), which suggests increased investment in securing and scaling proprietary processes. MULTI-HOP REASONING: The synthesis across three years is attempted but contains a fundamental error in characterizing 2022 as already focused on cell therapy expansion, when the ground truth shows this was a 2023 strategic shift. The reasoning is partially sound but built on an incorrect premise about the 2022 baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 490,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "In its 2022 Form 10‑K, IBM listed the 1.250% Notes due 2027 as a registered security but did not report any issuance. The 2023 filing added a reference to the notes’ instrument definition, indicating that the notes had been issued and were outstanding. By 2024, IBM continued to disclose the notes—listing them in the securities section and providing the instrument definition in the exhibits—showing that the notes remained outstanding and due in 2027.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022: The LLM states IBM 'listed the 1.250% Notes due 2027 as a registered security but did not report any issuance' in 2022. The ground truth indicates IBM disclosed the notes as part of its exhibit list, referencing an instrument defining holder rights filed January 30, 2019—not as a newly registered security. This is a fundamental mischaracterization. (2) MISSING CRITICAL DETAIL: The LLM completely omits the crucial 2024 development that the notes were 'formally listed...as an issued financial instrument on the New York Stock Exchange' with trading symbol IBM27B. This represents the key evolution showing transition from disclosure to active market presence—the core narrative of the ground truth. (3) INCORRECT PROGRESSION NARRATIVE: The LLM suggests the notes were issued between 2022-2023 ('had been issued and were outstanding' by 2023), but the ground truth shows they were already issued in 2019 (per the January 30, 2019 filing reference) and the 2024 development was their formal listing on NYSE. (4) MISSING DATES: The ground truth provides specific filing dates (February 8, 2022; February 3, 2023) that contextualize the evolution—the LLM provides no such temporal specificity. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes a 'clear transition from internal documentation and reference to public issuance and trading,' with 2024 marking formal NYSE listing. The LLM misses this entirely, treating all three years as simple disclosure/outstanding status without capturing the market presence shift. The LLM answer is internally consistent but factually diverges significantly from the ground truth narrative and omits the most important development (2024 NYSE listing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 501,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022‑24 (pages 101‑105 in 2022; 99‑103 in 2023 and 2024) repeatedly cite the 5.45 % Solar Bonds, Series 2015/C45‑15, indicating that the SolarCity‑issued debt remains a long‑term obligation on Tesla’s balance sheet.  Over the same period the company also reports newer debt—such as the 2.00 % convertible senior notes due 2024—showing a shift from the legacy SolarCity bonds to more flexible, lower‑cost financing and a consolidation of its solar financing strategy under Tesla’s own debt structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that substantially diverge from the ground truth:\n\n1. QUANTITATIVE ACCURACY (6/10): The LLM correctly identifies the 5.45% Solar Bonds, Series 2015/C45-15 and mentions the 2.00% convertible senior notes due 2024. However, it fails to reference the additional bond series mentioned in the ground truth (C53-15, C62-15, C72-15), which are critical to demonstrating the evolution of Tesla's solar financing strategy. The page number citations (101-105, 99-103) cannot be verified against the ground truth but appear plausible.\n\n2. QUALITATIVE ACCURACY (3/10): The LLM fundamentally misinterprets the strategic evolution. The ground truth emphasizes Tesla's deliberate expansion of its securitization model through multiple bond series (C45-15, C53-15, C62-15, C72-15), all issued in 2015 but referenced across 2022-2024 filings. This demonstrates a scalable, asset-backed financing approach. The LLM instead characterizes this as a \"shift from legacy SolarCity bonds to more flexible, lower-cost financing,\" which contradicts the ground truth's narrative of sustained reliance and iterative expansion of the securitization framework.\n\n3. ENTITY ACCURACY (4/10): The LLM correctly identifies Tesla and SolarCity but incompletely catalogs the bond series. It mentions only C45-15 and the 2024 convertible notes, omitting C53-15, C62-15, and C72-15—all critical to understanding the multi-year evolution.\n\n4. REASONING ERRORS: The LLM's core thesis—that Tesla is shifting away from SolarCity bonds toward lower-cost alternatives—contradicts the ground truth's finding that Tesla is refining and expanding a standardized securitization model. The ground truth shows iterative growth (C45-15 → C53-15 → C62-15 → C72-15), not replacement. The LLM conflates the 2024 convertible notes (corporate debt) with solar financing strategy, missing the distinction that the solar bonds represent asset-backed instruments aligned with solar deployments.\n\n5. COMPLETENESS: The LLM fails to address the multi-hop synthesis required: (a) the sustained reference to the original 2015 bond across 2022-2024 filings, (b) the introduction of subsequent bond series in 2023-2024 filings, and (c) the strategic implication of this pattern (scalable, repeatable securitization model). Instead, it presents a simplified narrative of debt consolidation.\n\n6. SEMANTIC DIVERGENCE: The ground truth emphasizes \"sustained reliance,\" \"iterative approach,\" and \"scalable, repeatable financing model.\" The LLM emphasizes \"shift\" and \"consolidation,\" which are semantically opposite conclusions about Tesla's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 706,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "From 2022 to 2024 Adobe has kept Acrobat as the centerpiece of its Document Cloud while deepening its AI‑driven capabilities and broadening the platform’s reach.  In 2022 the company highlighted Acrobat’s leadership in document‑intensive sectors (government, finance, legal, pharma, aerospace, insurance, publishing) and its use of Adobe Sensei to add intelligent, responsive actions, while positioning Acrobat Web, mobile Reader (Liquid Mode), Scan and Sign APIs as part of a unified digital‑document workflow.  By 2024 the same positioning is reinforced, but with a stronger emphasis on AI‑powered task‑based actions, full integration of Adobe Sign across all surfaces, expanded API‑driven automation, and a more comprehensive, cloud‑based services platform that delivers single‑click PDF editing, AI‑enhanced contract management, and mobile‑first workflows to further accelerate adoption in those high‑volume industries.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of Acrobat's evolution from 2022-2024 with some strengths but notable gaps compared to the ground truth. STRENGTHS: (1) Correctly identifies the timeframe (2022-2024) and core trajectory from market leadership to AI-driven innovation; (2) Accurately mentions Document Cloud as the platform centerpiece; (3) Correctly references Adobe Sensei and AI integration; (4) Appropriately identifies document-intensive industries (legal, financial services, publishing mentioned in both); (5) Captures the expansion of digital document services platform concept. WEAKNESSES: (1) The ground truth explicitly mentions 'Acrobat AI Assistant' as a formal trademark introduction in 2024 - the LLM answer discusses AI-powered capabilities but does not specifically name this product/trademark, which is a concrete factual element from the ground truth; (2) The LLM answer adds specific details not in the ground truth (government, pharma, aerospace, insurance sectors; Liquid Mode, Scan APIs, contract management) - while these may be accurate, they represent information beyond the ground truth scope and suggest potential hallucination or over-specification; (3) The ground truth emphasizes a 'strategic pivot' in 2023 with forward-looking statements about AI, which the LLM answer does not explicitly capture as a distinct 2023 milestone; (4) The LLM answer's mention of 'single-click PDF editing' and 'mobile-first workflows' are not explicitly in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years and identifies the progression from market leadership to AI integration, matching the ground truth's core narrative structure. However, it misses the specific 2023 inflection point. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is neutral. SEMANTIC EQUIVALENCE: The core message aligns - Acrobat evolved from market-leading document solution to AI-enhanced platform - but the LLM's additional specificity and omission of 'Acrobat AI Assistant' trademark represent meaningful divergences from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 581,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "From 2022 to 2024, Schwab’s RIA platform evolved from a web portal that offered interactive tools, multi‑year archival, and third‑party integrations—including the free Schwab Advisor Portfolio Connect—to a more sophisticated suite that added real‑time trading and automated rebalancing. In 2023, the platform was upgraded with Schwab Trading Powered by Ameritrade and the integration of the thinkpipes trading platform and iRebal, providing real‑time charting and customizable portfolio rebalancing capabilities. By 2024, Schwab further enhanced the RIA offering by fully integrating TD Ameritrade’s thinkpipes and iRebal, expanding API‑driven data feeds and third‑party platform connectivity while continuing to provide interactive educational tools【SCHW_10k_2022, pages 7‑11】【SCHW_10k_2023, pages 5‑9】【SCHW_10k_2024, pages 5‑9】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Schwab Advisor Portfolio Connect was available in 2022, but the ground truth indicates it was highlighted in 2024 as a new offering. The LLM also introduces 'Schwab Trading Powered by Ameritrade,' 'thinkpipes,' and 'iRebal' as Schwab RIA tools, which are not mentioned in the ground truth and appear to be TD Ameritrade products incorrectly attributed to Schwab's RIA platform. (2) MISSING CORE INFORMATION: The ground truth emphasizes the Advisor Services website as the core platform across all three years, which the LLM fails to mention. The ground truth highlights educational content and support for RIAs transitioning to independence in 2023, which is absent from the LLM answer. (3) MULTI-HOP SYNTHESIS: While the LLM attempts to show evolution across 2022-2024, it does so by introducing unverified product names and features rather than accurately synthesizing the documented evolution. The ground truth shows consistent focus on digital tools and integrations; the LLM invents specific technical features (real-time trading, automated rebalancing, API-driven data feeds) not mentioned in the original answer. (4) CITATION ISSUES: The LLM provides specific page citations that cannot be verified against the ground truth, suggesting potential hallucination of source material. The answer reads plausibly but conflates Schwab's actual RIA offerings with TD Ameritrade products, representing a fundamental misunderstanding of the platform evolution. The only correct element is the general timeframe (2022-2024) and the mention of third-party integrations, which are too vague to constitute substantial accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 485,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson continued to market Air Preparation Equipment as a core element of its Discrete Automation portfolio throughout 2022‑2024, consistently describing it as part of the same integrated pneumatic‑control family that includes solenoid valves, pneumatic valves, cylinders, actuators, and programmable control systems.  In 2022 the company highlighted Air Preparation Equipment as one of the “pneumatic mechanisms” that “transform air or gas into energy and power” for discrete manufacturing (see pages 4‑8 of the 2022 10‑K).  The 2023 and 2024 10‑Ks repeat the same language, noting that the segment “includes … air preparation equipment” alongside pneumatic valves, cylinders, actuators and control‑system components (see pages 71‑75 of the 2023 and 2024 10‑Ks).  No material shift in positioning or integration strategy was disclosed, indicating that Emerson maintained the same emphasis on integrating Air Preparation Equipment with other pneumatic and control technologies across the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The ground truth explicitly describes a clear 3-year evolution: (1) 2022 - mechanical focus with pneumatic mechanisms, (2) 2023 - stronger alignment with digital/automated control ecosystems, and (3) 2024 - interoperability with smart actuation, predictive maintenance, and Industry 4.0 trends. The LLM answer directly contradicts this by claiming 'No material shift in positioning or integration strategy was disclosed' and that 'Emerson maintained the same emphasis' across all three years. This is a fundamental factual error that misses the entire premise of the question - which asks specifically about how the positioning 'evolved.' The LLM correctly identifies the company (Emerson/EMR), the segment (Discrete Automation), the years (2022-2024), and the product (Air Preparation Equipment), and accurately notes the consistent integration with pneumatic and control technologies. However, it fails to recognize or describe the documented evolution from mechanical to digital/Industry 4.0 positioning that the ground truth clearly establishes. The LLM's citation of specific 10-K page numbers adds credibility but appears to be used to support an incorrect conclusion. The answer demonstrates a failure in multi-hop reasoning - it should have synthesized the progression across three years to identify the strategic shift, but instead concluded there was no shift. This is a critical error for a question specifically asking about evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 426,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "From 2022 to 2024, Coca‑Cola issued the 0.125% Notes due 2029 in successive tranches—first in 2022 (p. 134‑138), again in 2023 (p. 132‑136), and once more in 2024 (p. 128‑132)—each time to refinance maturing debt and preserve a low‑coupon debt profile. This incremental issuance pattern shows a disciplined, low‑cost strategy for managing near‑term maturities, using the same instrument to refinance debt while keeping the overall debt mix stable and taking advantage of favorable market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - MULTIPLE ISSUANCES CLAIM: The LLM claims Coca-Cola issued the 0.125% Notes due 2029 in successive tranches in 2022, 2023, and 2024. The ground truth explicitly states the note was 'consistently referenced' across these years but does not indicate multiple new issuances. The ground truth describes a passive disclosure approach in 2022, a consolidated format in 2023, and continued reference in 2024—not repeated issuances of the same instrument. (2) MISCHARACTERIZATION OF STRATEGY: The LLM describes an 'incremental issuance pattern' and 'successive tranches,' which is factually incorrect based on the ground truth. The ground truth indicates the company was managing this existing liability through its maturation cycle, not repeatedly issuing the same note. (3) MISSING KEY INSIGHT: The LLM completely fails to capture the strategic pivot described in the ground truth—that by 2024, Coca-Cola introduced significantly higher-yielding instruments (5.000% Notes due 2034 and 5.400% Notes due 2064) as the 2029 note approached maturity. This is a critical element of the company's refinancing strategy that the LLM omits entirely. (4) INCORRECT REASONING: The LLM's logic about 'successive tranches' and 'refinancing maturing debt' through repeated issuances of the same instrument is economically implausible and contradicts the ground truth's narrative of strategic evolution. (5) PAGE REFERENCES: The LLM provides specific page numbers (p. 134-138, p. 132-136, p. 128-132) without verification, which cannot be confirmed and appear to be fabricated details. The ground truth does not reference specific pages for these claims. The answer fundamentally misrepresents the company's debt management strategy by inventing a pattern of repeated issuances rather than accurately describing the evolution from passive disclosure to strategic refinancing with higher-yielding instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 536,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 10‑K filings all contain the same risk‑factor statement: “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The wording and emphasis on regulatory constraints on dividends (and, by implication, share repurchases) have remained unchanged, indicating that BNY Mellon’s exposure to U.S. banking laws regarding capital planning and shareholder capital returns did not materially evolve from 2022 through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer makes a fundamental factual error that directly contradicts the ground truth. The LLM claims that 'The wording and emphasis on regulatory constraints...have remained unchanged' and that exposure 'did not materially evolve from 2022 through 2024.' This is the opposite of what the ground truth establishes. The ground truth explicitly states there WAS an evolution: from 'general caution in 2022' to 'more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024,' with 2024 showing 'more structured' language emphasizing 'well capitalized' status and capital adequacy rules. The LLM's assertion of static, unchanged language across all three years directly contradicts the documented evolution in regulatory framing. QUANTITATIVE ACCURACY: The LLM correctly identifies the years (2022, 2023, 2024) and accurately quotes the risk-factor statement language. However, this accuracy is undermined by the fundamental misinterpretation of what the filings actually show. QUALITATIVE ACCURACY: The LLM fails at the core multi-hop reasoning task. The question asks HOW the exposure 'evolved,' and the ground truth provides a clear narrative arc of increasing specificity and formalization. The LLM instead concludes there was no material evolution, which is a complete failure of synthesis. The LLM appears to have focused on finding identical boilerplate language and concluded this meant no change, missing the documented shifts in emphasis and specificity that the ground truth identifies. CONTEXTUAL RELEVANCE: The answer is contextually inappropriate because it directly contradicts what the filings actually demonstrate regarding the evolution of regulatory constraint communication. The LLM's conclusion that constraints 'did not materially evolve' is factually incorrect based on the ground truth evidence of increasing specificity and formalization in 2023-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 523,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McGriddles has been presented consistently as a standard breakfast sandwich in each year’s menu disclosures – listed alongside Egg McMuffin, Sausage McMuffin with Egg, biscuits, bagels, oatmeal, breakfast burritos and hotcakes – with no shift in emphasis or positioning from 2022 through 2024. This unchanged portrayal shows that McDonald’s breakfast strategy has remained stable, focusing on maintaining core breakfast items rather than launching major new products. (2024: pages 4‑8; 2023: pages 4‑8; 2022: pages 5‑9)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that McGriddles remained consistently portrayed as a standard breakfast item across 2022-2024 without significant innovation emphasis. The answer accurately captures the main conclusion about McDonald's stable breakfast strategy. However, there are some notable differences from the ground truth: (1) The LLM provides a broader list of breakfast items (including biscuits, bagels, oatmeal, breakfast burritos, hotcakes) not explicitly mentioned in the ground truth answer, which adds context but may exceed what was directly stated in the filings. (2) The page number citations (pages 4-8 for all years) are vague and differ from the ground truth's specific chunk references (page_7:chunk_1 for 2022, page_6:chunk_1 for 2023, page_6:chunk_1 for 2024), suggesting the LLM may not have precise source verification. (3) The LLM answer lacks the specific year-by-year narrative progression that the ground truth provides, particularly the 2023 reference to 'continuous evolution' language and the 2024 reference to 'testing new products on an ongoing basis' - these contextual details strengthen the argument about consistency. (4) The semantic meaning is equivalent: both conclude McGriddles remained static while broader menu innovation occurred elsewhere. The core multi-hop reasoning is sound - comparing portrayals across three years and drawing conclusions about strategy consistency. The answer is factually accurate in its main claims but less detailed in supporting evidence and lacks precise source citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 431,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe has kept free online self‑service learning as a core element of its Digital Learning Services throughout 2022‑2024, but the delivery platform shifted from the older www.training.adobe.com in 2022 to the unified learning.adobe.com portal in 2023 and 2024. This change reflects a consolidation and re‑branding of the learning experience while preserving the same emphasis on accessible, cloud‑based education. The 2024 filing notes that the free learning remains part of Digital Learning Services and is now hosted on learning.adobe.com, which also carries Adobe’s fee‑based training programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key facts: (1) Platform evolution correctly identified - www.training.adobe.com in 2022 shifting to learning.adobe.com in 2023-2024; (2) All dates and years are accurate (2022, 2023, 2024); (3) The characterization of the shift as 'consolidation and re-branding' aligns with the ground truth's description of 'more centralized or rebranded approach'; (4) Correctly identifies that free learning remained a core component across all three years; (5) Accurately notes integration with fee-based programs. Minor areas where the LLM answer is slightly less comprehensive than ground truth: (1) The ground truth emphasizes the 'strategic emphasis on self-service learning as a core component of Adobe's customer enablement' and describes it as part of a 'broader enablement strategy' - the LLM answer mentions this but with less emphasis on the strategic positioning; (2) The ground truth explicitly notes the 'maturing and more structured approach to digital education' and 'increased integration into the broader Adobe Learning Services ecosystem' - the LLM answer touches on integration but doesn't emphasize the maturation aspect as clearly; (3) The ground truth mentions 'assisting customer and partner teams in product adoption' as a specific purpose, which the LLM answer omits. The LLM answer is accurate, well-structured, and addresses the core question effectively, but lacks some of the contextual depth regarding strategic positioning and maturation that the ground truth provides. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 445,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "Emerson continued to classify commercial vacuums as part of the “Other professional tools” line within its Safety & Productivity segment from 2022 through 2024 (see 2022 10‑K, pp. 7‑11, and 2024 10‑K, pp. 71‑75).  Over this period the company shifted its strategic emphasis toward a stronger professional‑tools focus, positioning commercial vacuums as a key safety‑and‑productivity product and aligning them with the Tools & Home Products portfolio, with sales driven primarily through distributors and a direct sales force.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) SEGMENT CLASSIFICATION ERROR: The LLM states Commercial Vacuums were classified within 'Safety & Productivity segment' consistently from 2022-2024, but the ground truth explicitly states they were in the 'Tools & Home Products segment' in 2022, only moving to Safety & Productivity in 2023. This is a fundamental mischaracterization of the evolution being asked about. (2) MISSING EVOLUTION NARRATIVE: The LLM fails to capture the key evolution described in the ground truth - the shift from Tools & Home Products (2022) to Safety & Productivity (2023-2024), and the subsequent repositioning within Safety & Productivity toward more technologically advanced industrial tools. The LLM presents a static picture rather than the dynamic evolution requested. (3) CONTRADICTORY ALIGNMENT: The LLM states Commercial Vacuums were 'aligning them with the Tools & Home Products portfolio' in the 2022-2024 period, but the ground truth shows they moved AWAY from Tools & Home Products and INTO Safety & Productivity. This is backwards. (4) INCOMPLETE CONTEXT: The LLM mentions 'Other professional tools' and sales channels but misses the critical strategic shift toward integration with 'programmable automation control systems and electrical distribution equipment' in 2024, which represents the key evolution in product categorization and strategic emphasis. (5) CITATION ISSUES: While page references are provided, they appear generic and don't substantiate the specific claims made. The answer reads as partially fabricated rather than derived from actual filing analysis. The core narrative of repositioning from general tools to integrated industrial solutions is entirely absent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 487,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s 10‑K filings for 2022, 2023 and 2024 all describe the Hoofddorp, Netherlands site as a **commercial manufacturing and processing location for its cell‑therapy products**.  No change in the facility’s role or scope is reported across the three years—there is no shift to clinical manufacturing or expansion of its use, indicating a steady, ongoing focus on commercial‑scale cell‑therapy production.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - CONTRADICTS GROUND TRUTH: The LLM answer fundamentally contradicts the ground truth by claiming 'No change in the facility's role or scope is reported across the three years.' The original answer explicitly describes a PROGRESSION/EVOLUTION: (1) 2022: 'principal manufacturing site' (general description), (2) 2023: 'explicitly described as being utilized for commercial manufacturing and processing of cell therapy products' (strategic shift toward advanced therapies), (3) 2024: 'continued to serve as a dedicated site for commercial manufacturing and processing of cell therapy products' (sustained role). The ground truth emphasizes 'a growing emphasis on cell therapy capabilities' and 'a strategic shift' from 2022 to 2023. The LLM incorrectly characterizes this as 'steady, ongoing focus' with 'no shift,' which directly contradicts the ground truth's narrative of evolution and strategic emphasis. CORRECT ELEMENTS: The LLM correctly identifies (1) the facility location (Hoofddorp, Netherlands), (2) the company (Gilead/GILD), (3) the years covered (2022-2024), (4) the product focus (cell therapy), and (5) the activity type (commercial manufacturing and processing). INCORRECT ELEMENTS: The LLM fails to recognize the documented evolution from a general 'principal manufacturing site' designation in 2022 to an explicit focus on cell therapy commercial manufacturing by 2023-2024. This represents a failure in multi-hop reasoning and synthesis of the progression described across the three-year period. The answer demonstrates poor comprehension of the question's core request to describe how utilization 'evolved' - the LLM instead claims static consistency when the ground truth shows strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 472,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Across the 2022 (p. 134‑138) and 2023 (p. 132‑136) 10‑Ks, Coca‑Cola repeatedly lists the 1.000% Notes due 2028 as a core, low‑cost component of its debt portfolio, underscoring a long‑standing strategy of maintaining a low‑yield, medium‑term debt base. In the 2024 10‑K (p. 128‑132) the company introduces 5.000% Notes due 2034 and 5.400% Notes due 2064, signaling a deliberate shift toward higher‑yield, longer‑dated debt to diversify maturities, lock in rates, and support capital‑expenditure or refinancing needs. This evolution reflects a more aggressive approach to debt‑financing costs and a recalibration of the capital structure to balance cost, maturity, and leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All numeric values are correct - 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 are accurately cited with correct percentages and maturity dates. The page references (2022: p. 134-138, 2023: p. 132-136, 2024: p. 128-132) provide specific sourcing. ENTITY ACCURACY: Coca-Cola is correctly identified, all three fiscal years (2022, 2023, 2024) are properly referenced, and all debt instruments are accurately named. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the persistent reference to the 1.000% Notes across 2022-2024 and the introduction of higher-yield notes in 2024. The logical connection between these observations and their implications for capital structure management is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Coca-Cola maintained low-cost debt while introducing higher-yield instruments in 2024, reflecting a strategic recalibration. The LLM adds slightly more specificity by mentioning 'lock in rates' and 'capital-expenditure or refinancing needs,' which are reasonable inferences consistent with the ground truth's mention of 'favorable market conditions or strategic initiatives.' MINOR DIFFERENCES: The LLM uses 'more aggressive approach' while ground truth uses 'recalibration' - both are semantically compatible descriptions of the same strategic shift. The LLM's characterization is slightly more interpretive but remains factually grounded. No calculation errors, no factual inaccuracies detected. The answer fully addresses the multi-part question regarding debt financing costs and capital structure management changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 495,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s pipe‑cutting line moved from a focus on press‑connection tools to fully battery‑powered, hydraulic cutting and crimping tools while adding integrated diagnostic systems.  In 2022 the portfolio included “battery hydraulic tools for press connections” and CCTV pipe‑inspection cameras (pages 7‑11), whereas 2023 and 2024 documents describe “battery hydraulic tools for cutting and crimping electrical cable” and “diagnostic systems, including sewer‑inspection cameras and locating equipment” (pages 71‑75).  This evolution signals a strategic push toward portable, tech‑enabled tools, positioning Emerson as an innovation‑driven leader in the professional plumbing tools market that differentiates itself with battery‑powered, diagnostic‑integrated solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) PRODUCT CATEGORY ERROR: The LLM claims the portfolio included 'battery hydraulic tools for press connections' in 2022 and 'battery hydraulic tools for cutting and crimping electrical cable' in 2023-2024. The ground truth explicitly states pipe cutters were 'traditional' in 2022 with 'no emphasis on battery-powered' capabilities, and the evolution was toward 'battery hydraulic technology into pipe cutters' - NOT electrical cable tools. This is a fundamental misidentification of the product category. (2) TIMELINE ACCURACY: The ground truth shows a clear 3-year progression: 2022 (traditional tools), 2023 (battery hydraulic integration begins), 2024 (diagnostic systems emphasized). The LLM conflates these timelines and misrepresents what was in each year. (3) DIAGNOSTIC SYSTEMS: While the LLM correctly identifies that diagnostic systems (sewer inspection cameras, locating equipment) were added, it incorrectly associates these with 2022 ('CCTV pipe-inspection cameras') when the ground truth indicates this emphasis emerged in 2024. (4) PAGE REFERENCES: The LLM cites specific page numbers (7-11, 71-75) that cannot be verified against the ground truth and appear to be fabricated details. (5) STRATEGIC POSITIONING: While the LLM's conclusion about positioning as 'innovation-driven leader' aligns directionally with the ground truth, the factual foundation is compromised by the product category errors. The core narrative of evolution from traditional to battery-powered to diagnostic-integrated is correct in concept but severely undermined by the electrical cable misidentification and timeline confusion. The answer demonstrates partial understanding of the strategic shift but fails on fundamental product accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 499,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024, Gilead’s Santa Monica, California site has consistently been described as a location for **clinical manufacturing and processing of its cell‑therapy products** (2022 p. 31‑35; 2023 p. 9‑13; 2024 p. 8‑12). The unchanged role shows that the facility functions as a dedicated clinical manufacturing hub within Gilead’s broader network, supporting early‑stage development and clinical‑trial supply of cell‑therapy candidates rather than commercial production.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims the Santa Monica facility was described as being used for 'clinical manufacturing and processing of cell-therapy products' consistently from 2022 through 2024, but the ground truth explicitly states that in 2022, the facility was NOT specifically highlighted for cell therapy processing - it was only identified as part of R&D and manufacturing network generally. (2) The LLM's core claim of 'unchanged role' is directly contradicted by the ground truth, which describes a clear PROGRESSION/EVOLUTION: from general R&D site (2022) → dedicated cell therapy manufacturing hub (2023) → continued role (2024). (3) The LLM provides page number citations (2022 p. 31-35; 2023 p. 9-13; 2024 p. 8-12) that cannot be verified and appear to be fabricated, as these specific page ranges are not confirmed in the ground truth. (4) The LLM fails to capture the key insight from the ground truth: that Santa Monica TRANSITIONED from a general R&D site to a dedicated cell therapy manufacturing hub - this is the essential strategic evolution the question asks about. The LLM instead presents a static picture of 'unchanged role,' which is fundamentally incorrect. The answer demonstrates poor multi-hop reasoning by failing to synthesize the year-by-year progression that is central to answering the question about how the facility's utilization 'evolved.' The semantic meaning is inverted - the ground truth emphasizes change and strategic transition, while the LLM emphasizes consistency and lack of change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 443,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In 2022, Frame.io was described as a cloud‑native collaboration platform that was directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, enabling real‑time upload, review, approval and frame‑accurate commenting on video, still images, design files and PDFs 【2022‑pages 95‑99】. By 2024, Adobe expanded Frame.io’s media support to include camera‑to‑cloud uploads and still‑image camera integration, and positioned it as part of Adobe GenStudio with deeper ties to Express and Firefly Services, thereby broadening cross‑app collaboration and frame‑specific feedback across the entire Creative Cloud ecosystem 【2024‑pages 10‑14】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions: (1) MAJOR ERROR - 2022 Description: The LLM claims Frame.io was integrated with Photoshop, Lightroom, and Workfront in 2022, but the ground truth explicitly states these integrations occurred by 2024. In 2022, Frame.io was only listed as part of Adobe's trademark portfolio without detailed functional description. (2) MAJOR ERROR - 2022 Capabilities: The LLM describes extensive 2022 capabilities (real-time upload, frame-accurate commenting, support for video/images/design files/PDFs) that the ground truth attributes to 2023 or later. The ground truth indicates 2022 had minimal functional detail. (3) INCORRECT EVOLUTION NARRATIVE: The LLM fails to capture the actual progression: 2022 (trademark listing only) → 2023 (cloud-native platform with specific app integrations and media support) → 2024 (expanded video use cases and additional integrations). Instead, it presents 2022 as already feature-rich. (4) MISSING KEY DETAILS: The LLM omits the 2023 intermediate state entirely, which is critical for showing the evolution. It also misses the 2024 expansion into non-post-production video workflows (casting, location scouting, marketing). (5) PARTIALLY CORRECT 2024 DESCRIPTION: The 2024 portion correctly mentions GenStudio positioning and additional integrations, though it adds 'camera-to-cloud uploads' and 'Express/Firefly Services' details not explicitly in the ground truth. (6) MULTI-HOP SYNTHESIS FAILURE: The answer fails to properly synthesize the three-year evolution, instead conflating 2022 and 2023 capabilities and presenting an inaccurate timeline. The core error is backdating integrations and capabilities to 2022 that only existed in 2023-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 485,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In 2022 Emerson’s electrical distribution equipment was bundled within the Industrial Solutions sub‑segment of Automation Solutions, where it was paired mainly with fluid‑control and pneumatic mechanisms (see 2022 pages 74‑78). By 2023 and 2024 Emerson spun off a dedicated Discrete Automation segment that broadened the product mix to include solenoid valves, pneumatic cylinders, electric linear‑motion solutions, programmable automation control systems and software, and integrated electrical distribution equipment (see 2023–2024 pages 71‑75). This shift reflects a deeper integration of electrical distribution equipment with automation technologies and a wider discrete‑automation portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON PRODUCT ASSOCIATIONS: The LLM claims in 2022 electrical distribution equipment was 'paired mainly with fluid-control and pneumatic mechanisms' - the ground truth states it was used 'broadly in manufacturing operations as part of integrated solutions' with NO mention of fluid-control or pneumatic mechanisms in 2022. This is a significant factual error. (2) INCOMPLETE/INACCURATE PRODUCT SCOPE EVOLUTION: The LLM lists 'solenoid valves, pneumatic cylinders' as part of the 2023-2024 Discrete Automation segment, but the ground truth specifically mentions 'electric linear motion solutions and materials joining solutions' - the LLM's product list does not match the ground truth's stated product scope expansion. (3) STRUCTURAL MISCHARACTERIZATION: The LLM describes a 'spin off' of a dedicated Discrete Automation segment in 2023-2024, but the ground truth indicates Electrical Distribution Equipment was 'more specifically embedded within the Discrete Automation segment' in 2023 - this is a different organizational narrative. (4) MISSING KEY EVOLUTION DETAIL: The ground truth emphasizes the 2023 positioning alongside 'programmable automation control systems and software, signaling a stronger link to automation technologies' - while the LLM mentions these products, it doesn't capture the significance of this 2023 inflection point as clearly. (5) PAGE REFERENCES: The LLM cites specific page numbers (74-78, 71-75) which cannot be verified against the ground truth and appear to be fabricated details. (6) CORE NARRATIVE ALIGNMENT: While both answers discuss integration with automation technologies and product scope expansion, the LLM's specific product associations and organizational structure claims diverge significantly from the ground truth. The answer captures the general theme but fails on specific factual accuracy regarding which products were associated with electrical distribution equipment in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 532,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from a carrying value of **$19,975 million** at 12/31/2022 (weighted‑average rate 2.91%) to **$27,168 million** at 12/31/2023 (rate 4.45%) and then slightly declined to **$26,930 million** at 12/31/2024 (rate 4.84%)【COF_10k_2022.pdf】【COF_10k_2023.pdf】【COF_10k_2024.pdf】. The rising weighted‑average rate reflects the higher cost of new fixed‑rate issuances in a tightening rate environment, while the modest drop in 2024 suggests some repayment or refinancing; together, the pattern indicates a strategy of expanding fixed‑rate debt to fund growth while accepting higher rates and likely hedging interest‑rate exposure to manage cost volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - carrying values of $19,975M (2022), $27,168M (2023), and $26,930M (2024) match ground truth exactly; weighted-average interest rates of 2.91% (2022), 4.45% (2023), and 4.84% (2024) are accurate. The year-over-year progression is correctly identified (increase 2022-2023, slight decline 2023-2024). MULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three fiscal years and two metrics (carrying value and weighted-average rate) from multiple 10-K filings, demonstrating proper cross-document integration. ENTITY ACCURACY: Capital One (COF) correctly identified, all fiscal years properly referenced with dates (12/31/2022, 12/31/2023, 12/31/2024), and the metric 'fixed unsecured senior debt' is correctly specified. REASONING QUALITY: The interpretation of the debt strategy is sound - the answer correctly identifies that rising rates reflect higher issuance costs in a tightening environment, and the modest 2024 decline suggests refinancing activity. The conclusion about 'expanding fixed-rate debt to fund growth while accepting higher rates' is a reasonable inference from the data pattern. MINOR CONSIDERATIONS: The LLM adds interpretive elements ('likely hedging interest-rate exposure') that go slightly beyond the ground truth's more straightforward statement about 'locking in long-term debt at increasingly higher rates.' However, this additional context is reasonable and not contradictory - it represents a plausible elaboration rather than an error. The semantic meaning aligns well with the ground truth's characterization of a 'proactive approach to anticipated rate hikes.' No calculation errors detected. All source citations are appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 491,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for performance‑and‑operating‑cost guarantees fell from $1.157 billion at the start of 2022 to $993 million by the end of 2024, a net decline of $164 million over three years.  Each year the balance dropped because settlements (2022 $284 m, 2023 $308 m, 2024 $247 m) exceeded new issuances (2022 $264 m, 2023 $305 m, 2024 $216 m), with a modest rise in “other” adjustments in 2024.  The trend shows RTX is actively managing and reducing its guarantee exposure, yet the remaining ~$1 billion balance still reflects substantial long‑term product‑performance risk inherent in its commercial aerospace portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key quantitative metrics. CRITICAL ERRORS: (1) WRONG NUMBERS: The LLM claims the liability was $1.157 billion at start of 2022 and $993 million by end of 2024, but ground truth shows $120 million in 2022, $120 million in 2023, and $101 million in 2024. The LLM's figures are approximately 10x higher than actual values. (2) WRONG SETTLEMENT/ISSUANCE DATA: The LLM provides specific settlement amounts ($284M in 2022, $308M in 2023, $247M in 2024) and issuance amounts ($264M, $305M, $216M respectively) that do not match any data in the ground truth. These appear to be fabricated numbers. (3) WRONG CALCULATION: The LLM claims a $164 million decline from $1.157B to $993M, but this math is also incorrect ($1.157B - $993M = $164M is arithmetically correct for those numbers, but the underlying figures are wrong). (4) CONTRADICTORY CONCLUSION: The LLM concludes RTX has a ~$1 billion remaining balance, which is completely inconsistent with the actual ~$100 million liability shown in ground truth. (5) FAILED MULTI-HOP SYNTHESIS: The LLM failed to correctly extract and synthesize the liability figures across the three-year period from the source documents. The ground truth clearly shows stability around $120 million with a slight decrease to $101 million, indicating consistent and manageable exposure. The LLM's narrative about 'actively managing and reducing' a $1 billion exposure is entirely fabricated. The only correct element is the general concept that the question addresses performance and operating cost guarantees in commercial aerospace, but the specific financial data is completely wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 461,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Coca‑Cola’s 10‑K notes for 2022, 2023 and 2024 all describe the same valuation framework for non‑public investments: “management’s assessment of fair value is based on various valuation methodologies, including discounted cash flows, estimates of sales proceeds, and appraisals.” The wording and emphasis on “estimates of sales proceeds” did not change across the three years, indicating that the company has continued to rely on this method as part of a diversified, conservative fair‑value approach. This consistency underscores Coca‑Cola’s ongoing commitment to careful valuation in emerging markets, where forecasting cash flows is particularly uncertain and multiple techniques are needed to mitigate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The ground truth explicitly documents an EVOLUTION across three years: (1) 2022 - disclosure of methodology in impairment context, (2) 2023 - explicit statement of reliance/deepening dependence, (3) 2024 - continued use with increased emphasis on challenges/risk-aware application. The LLM answer claims 'wording and emphasis did not change across the three years' and describes 'consistency,' which directly contradicts the documented progression from 'disclosed' → 'relies on' → 'use with increased emphasis on challenges.' This is a fundamental failure to synthesize the multi-hop temporal evolution that is the core of the question. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). QUALITATIVE ACCURACY: The LLM misidentified the nature of the evolution entirely. The ground truth reveals a strategic shift in how the company applies the methodology (from passive disclosure to active reliance to cautious, risk-aware integration), while the LLM characterizes it as static consistency. This represents a major reasoning failure on the primary analytical task. CONTEXTUAL RELEVANCE: The LLM does address the right company, years, and general topic, but fundamentally misinterprets what the filings reveal about the company's 'changing approach'—the question explicitly asks about evolution, which the LLM denies occurred. The answer is contextually relevant in form but incorrect in substance. The LLM's claim of 'unchanged wording' across years cannot be verified from the provided context, but contradicts the ground truth's explicit documentation of different language ('disclosed,' 'relies on,' 'use with increased emphasis').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 506,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor disclosures have remained essentially unchanged from 2022 through 2024: each filing states that the company’s ability to return capital to shareholders is subject to the Board’s discretion and may be limited by U.S. banking laws and regulations, including capital‑planning rules (2022, p. 5; 2023, p. 7; 2024, p. 7). The wording has not evolved materially, only adding a brief note that Delaware law and preferred‑stock dividend obligations also apply. This steady, unaltered language signals that while regulatory constraints continue to govern capital distributions, BNY Mellon preserves strategic flexibility to adjust its capital‑return policy within those limits.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and analytical errors that substantially diverge from the ground truth. SPECIFIC ISSUES: (1) MISSING KEY EVOLUTION: The ground truth explicitly identifies a critical 2024 disclosure evolution—the addition of emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends. The LLM answer completely omits this material development, stating instead that 'wording has not evolved materially.' This is a major factual error that misses the core finding of the multi-year progression. (2) INCOMPLETE REGULATORY CONSTRAINTS: The ground truth identifies specific regulatory limitations including 'failure to pay full and timely dividends on preferred stock' as a disclosed constraint. The LLM answer mentions preferred-stock dividend obligations only in passing ('brief note') and fails to emphasize this as a substantive constraint. (3) MISCHARACTERIZATION OF STRATEGIC IMPLICATIONS: The ground truth concludes that the progression 'suggests ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.' The LLM answer instead concludes that BNY Mellon 'preserves strategic flexibility to adjust its capital-return policy within those limits'—a fundamentally different and more optimistic interpretation that contradicts the ground truth's assessment of constrained flexibility. (4) PAGE CITATIONS: While the LLM provides page numbers (2022 p. 5; 2023 p. 7; 2024 p. 7), these cannot be verified against the ground truth and appear to be fabricated details. (5) ANALYTICAL DEPTH: The ground truth provides nuanced multi-year analysis showing how regulatory language remained stable while internal structural dependencies became more prominent. The LLM reduces this to 'essentially unchanged' language, missing the substantive shift in emphasis regarding internal capital flows. The LLM answer demonstrates weak multi-hop synthesis by failing to identify and connect the evolution of disclosure emphasis across the three-year period. The answer is partially correct on the basic fact that regulatory language persisted across all three years, but fundamentally fails to capture the material 2024 evolution and misinterprets the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 626,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 10‑K (p. 35‑39) listed the risk of losing tax and tariff exemptions as part of its general political, legal and economic risks. The 2023 10‑K (p. 39‑43) repeated that risk but added a focus on sanctions and export‑control revisions that could affect those exemptions. By 2024 (p. 38‑42) the disclosure expanded further to cite specific geopolitical conflicts (e.g., Russia‑Ukraine, China‑Taiwan) and new sanctions that heighten the likelihood of losing tax and tariff exemptions, underscoring an increasingly complex and volatile regulatory environment for AMD’s global operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of AMD's risk disclosures regarding tax and tariff exemptions; (2) Accurately captures the evolution from general awareness in 2022 to more specific geopolitical context in 2023-2024; (3) Properly synthesizes multi-hop information by connecting specific geopolitical events (Russia-Ukraine, China-Taiwan conflicts) to regulatory impacts; (4) Correctly identifies the expansion of U.S. export controls and sanctions as key drivers; (5) Appropriately characterizes the trend as increasing complexity and volatility. MINOR WEAKNESSES: (1) The LLM provides specific page numbers (p. 35-39, p. 39-43, p. 38-42) which cannot be verified against the ground truth and may introduce unnecessary specificity that could be incorrect; (2) The answer is slightly more concise than the ground truth, omitting the phrase about 'internal expansion' as a contributing factor alongside external geopolitical pressures, though this is a minor omission; (3) The phrasing 'repeated that risk but added a focus' for 2023 is slightly less precise than the ground truth's 'expanded its discussion to include the effects of specific geopolitical events.' QUANTITATIVE ACCURACY: No numerical calculations or financial metrics are involved in this question, so quantitative accuracy is not directly applicable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly links geopolitical events to regulatory changes affecting tax/tariff exemptions. The logical progression is sound and matches the ground truth's narrative arc. SEMANTIC EQUIVALENCE: The core message is preserved - AMD's exposure to this risk increased over time due to geopolitical and regulatory complexity. The answer conveys the same essential information despite slightly different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 540,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s total short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024. Long‑term debt stayed at $49.3 billion in 2022‑23 but declined to $44.99 billion in 2024, so total borrowings dropped from $49.86 billion to $45.55 billion. The elimination of $349 million of floating‑rate unsecured senior debt in 2024 and the shift to lower‑rate fixed‑senior and subordinated debt (weighted‑average long‑term rate fell from 6.51% to 5.72%) show a deliberate move to reduce interest‑rate sensitivity and tighten the debt mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) CRITICAL ERRORS: The LLM states total borrowings were $49.86 billion in 2022-23 and $45.55 billion in 2024, but the ground truth shows $43.086 billion in 2022, $49.856 billion in 2023, and $45.551 billion in 2024. The LLM appears to have conflated 2022 and 2023 figures. (2) SHORT-TERM BORROWINGS MISREPRESENTATION: The LLM claims short-term borrowings fell from $883M (2022) to $538M (2023) to $562M (2024), but these numbers are not substantiated by the ground truth, which focuses on the total debt evolution and doesn't isolate short-term borrowings in this manner. The ground truth's $43.086B (2022) and $49.856B (2023) figures appear to be total short-term + long-term debt, not just long-term. (3) FLOATING DEBT ERRORS: The LLM states floating-rate unsecured senior debt was eliminated in 2024 (correct directionally), but misses the critical detail that it was $1.709B in 2022 (not mentioned), $349M in 2023 (correct), and $0 in 2024 (correct). The LLM also fails to note the dramatic shift in weighted-average rates from 1.01% (2022) to 6.75% (2023). (4) INTEREST RATE ANALYSIS INCOMPLETE: The LLM cites weighted-average rates of 6.51% to 5.72%, which don't match the ground truth's 2.91% (2022) to 4.84% (2024) for fixed unsecured senior debt. The LLM appears to have used incorrect rate figures. (5) MISSING KEY INSIGHTS: The ground truth emphasizes the strategic pivot from floating to fixed-rate debt; the LLM mentions this but with incorrect supporting numbers. The ground truth provides specific debt category breakdowns (fixed unsecured senior debt: $21.045B in 2022 → $27.168B in 2023 → $26.930B in 2024) that the LLM completely omits. (6) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the relationship between total debt evolution, floating vs. fixed composition changes, and interest rate exposure across the three-year period. The answer reads as partially constructed from different data sources without proper reconciliation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 552,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG remained unchanged at **57 %** (with a 51 % share in IAE LLC) from 2022 through 2024【RTX_10k_2022.pdf p.108‑112】【RTX_10k_2024.pdf p.99‑103】, indicating that RTX has maintained a stable, significant influence as the primary beneficiary in the V2500 engine‑program collaboration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains critical factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims RTX's net program share interest remained unchanged at 57% from 2022-2024, but the ground truth clearly states it decreased from 61% in 2022 to 57% in 2023 and 2024. This is a fundamental misrepresentation of the data trend. The LLM failed to identify the 4-percentage-point decline in 2022-2023. (2) MULTI-HOP REASONING FAILURE: The question explicitly asks how the interest 'evolved' from 2022 to 2024, requiring comparison across three years. The LLM completely missed the evolution/change that occurred, instead claiming stability. This represents a failure to synthesize information across the required time periods. (3) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion that RTX 'maintained a stable, significant influence' is contradicted by the ground truth's interpretation that the reduction 'indicates a strategic adjustment' and 'gradual dilution' of RTX's direct economic exposure. The LLM's interpretation is semantically opposite to the correct strategic positioning. (4) INCOMPLETE ANSWER: The LLM mentions a 51% share in IAE LLC but does not explain how this relates to the overall net program share or the evolution being asked about. The ground truth provides a clear narrative of strategic repositioning; the LLM provides a false narrative of stability. The citation references appear present but the data extraction from those sources was fundamentally incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 421,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade’s role within P&G’s home‑care portfolio has grown in relative importance.  In the 2022 filing the Fabric & Home Care segment accounted for 35 % of net sales and 31 % of net earnings; by 2023 and 2024 that share rose to 36 % of sales and 34 % of earnings, reflecting a mid‑single‑digit sales lift and a sharper earnings contribution.  These shifts indicate that Cascade, as a key brand in the segment, has become more prominent and profitable within P&G’s home‑care lineup.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: All quantitative data is accurate - the LLM correctly identifies the Fabric & Home Care segment percentages (35% sales/31% earnings in 2022; 36% sales/34% earnings in 2023-2024). The numbers match the ground truth exactly. The LLM also correctly synthesizes the multi-hop information across three years and properly identifies Cascade as a key brand within this segment.\n\nWEAKNESSES: The LLM's interpretation of Cascade's positioning evolution differs meaningfully from the ground truth. The LLM characterizes Cascade as having 'grown in relative importance' and become 'more prominent and profitable,' suggesting an upward trajectory. However, the ground truth explicitly states that Cascade 'maintained consistent positioning' and 'maintained stable strategic importance' - emphasizing consistency rather than growth. The LLM's phrase 'mid-single-digit sales lift and sharper earnings contribution' could be interpreted as attributing growth to Cascade specifically, when the ground truth indicates the segment's metrics remained stable (36% sales and 34% earnings in both 2023 and 2024). The LLM conflates segment-level growth (2022 to 2023) with Cascade's individual positioning, which is a reasoning error.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the Fabric & Home Care segment as the relevant context. However, it misinterprets the significance of the data - the key insight is stability/consistency, not growth.\n\nCOMPLETENESS: The LLM addresses the core question about positioning evolution but reaches a different conclusion than the ground truth. It provides segment-level context but doesn't adequately address that Cascade's positioning remained consistent within that segment across all three periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 486,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2024 BNY Mellon shifted the Directors’ Code of Conduct from a “bnymellon.com” site to the shorter “bny.com” brand and moved the PDF into a more formal “investor‑relations” folder (2022: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf; 2023: …/inv relations/directors‑code‑of‑conduct.pdf; 2024: https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf). The 2024 filing also ties the code to the broader corporate‑governance framework by citing it in the governance section of the proxy and noting that amendments will be posted on the website, thereby integrating the code more fully into the company’s governance disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc of BNY Mellon's evolution in Directors' Code of Conduct disclosure from 2022-2024, correctly identifying the domain shift from bnymellon.com to bny.com and the general progression toward investor-relations integration. However, there are critical URL path errors that undermine quantitative accuracy: (1) The 2022 URL path is stated as 'in relations' in the LLM answer, but the ground truth specifies 'in relations' (which appears to be a typo in ground truth itself, likely meant 'inv relations'). The LLM correctly identifies this as 'in relations' in 2022. (2) The 2023 path is correctly identified as 'inv relations' in both answers. (3) The 2024 path shows a critical error: the LLM writes 'investor‑relations' (with hyphenation) while ground truth shows 'investor-relations' - this is a minor formatting difference that should be acceptable. However, the LLM also appears to have a typo: 'directors‑code‑ofconduct.pdf' (missing hyphen between 'of' and 'conduct') versus ground truth's 'directors-code-of-conduct.pdf'. This is a factual error in the filename. The qualitative reasoning is sound - the LLM correctly synthesizes the multi-hop information about domain branding evolution, URL structure changes, and integration with corporate governance frameworks. The answer appropriately notes the shift from document-focused to stakeholder-oriented strategy. The contextual relevance is high as it directly addresses all aspects of the question: URL structure, domain branding, and governance framework integration. The main weaknesses are: (1) the filename hyphenation error in 2024, (2) lack of explicit mention of the 'siloed and document-focused approach' characterization from 2022, and (3) minor incompleteness in describing the 2023 as a 'minor internal reorganization' without significant change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 504,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "AMD’s strategy toward AIB manufacturers stayed essentially the same from 2022 through 2024: it continued to offer inventory‑protection clauses that shield AIBs from price reductions and kept emphasizing discrete‑graphics solutions as a key differentiation lever for system integrators. The identical wording appears in the 2022, 2023 and 2024 10‑Ks (AMD_10k_2022, pp. 9‑13; AMD_10k_2023, pp. 11‑15; AMD_10k_2024, pp. 9‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core strategic consistency across 2022-2024 regarding inventory protection policies for AIBs; (2) Accurately emphasizes discrete graphics solutions as a key differentiation lever; (3) Properly synthesizes the multi-hop information showing stability in partnership model across three years; (4) Provides specific document citations (AMD_10k_2022, 2023, 2024 with page ranges) that add credibility; (5) Uses semantically equivalent language ('inventory-protection clauses' vs 'inventory protection policies') while maintaining factual accuracy. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the explicit mention of 'system integrators and retail buyers' as specific customer segments in 2022, though this is a minor detail; (2) The phrase 'identical wording appears' is a strong claim that suggests verbatim repetition across filings - while the ground truth supports consistency, the LLM's assertion of identical wording is slightly stronger than what the ground truth explicitly states (which says 'remained stable' and 'reiterated'); (3) No quantitative metrics, percentages, or dollar amounts are involved in this question, so quantitative accuracy is not directly testable, but the answer contains no numerical errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the consistent pattern of inventory protection and discrete graphics emphasis. The logical conclusion about a 'stable, long-term partnership model' is sound and well-supported. ENTITY ACCURACY: All entities are correct (AMD, AIBs, discrete graphics, system integrators, inventory protection). The answer fully addresses all parts of the multi-part question regarding evolution, inventory protection policies, and discrete graphics' role in differentiation strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 545,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In 2022 McDonald’s highlighted its breakfast menu—including the Egg McMuffin—as part of a broader effort to evolve its menu while maintaining high food‑safety and quality standards across suppliers. By 2023 the disclosure shifted to a stronger emphasis on supply‑chain innovation and continuous improvement, positioning the Egg McMuffin as a flagship product that exemplifies the company’s commitment to consistent quality. In 2024 the focus expanded further to a digital‑transformation initiative that uses data‑driven quality and food‑safety metrics to manage supply‑chain risk, reinforcing the Egg McMuffin’s role in meeting customer expectations for quality and consistency.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the temporal evolution (2022-2024) and the key themes of McDonald's disclosure evolution. All dates and entities are correct. The answer accurately captures the three-year progression: (1) 2022 focus on menu evolution and quality standards, (2) 2023 shift to supply chain innovation and continuous improvement, and (3) 2024 emphasis on digital transformation with data-driven metrics. The Egg McMuffin is correctly positioned throughout as a core product exemplifying these commitments. The multi-hop reasoning is sound, synthesizing information across three years and connecting supply chain strategy to product consistency. However, there are minor differences from the ground truth: (1) The LLM characterizes the 2022 disclosure as emphasizing 'food-safety and quality standards across suppliers' while the ground truth emphasizes 'taste, quality, and nutrition' - a subtle but meaningful difference in framing. (2) The LLM describes the 2024 initiative as 'data-driven quality and food-safety metrics to manage supply-chain risk' while the ground truth specifically mentions 'digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance' - the LLM's phrasing is slightly more generic. (3) The ground truth explicitly notes this represents 'a shift from general quality assurance to a more technologically integrated and supply chain-driven approach,' which the LLM answer implies but doesn't explicitly state. These are minor semantic/emphasis differences rather than factual errors. The answer is well-structured, logically coherent, and appropriately addresses all parts of the multi-part question about evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 489,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle’s repeated reporting of the 4.30% Note due 2034 in its 2022, 2023, and 2024 10‑Ks (pp. 111‑115, 108‑112, 108‑112) shows that the note is a core, long‑term debt instrument in the company’s capital structure. The fixed‑rate, 10‑year maturity is embedded in a diversified mix of notes with varying coupons and maturities, reflecting Oracle’s strategy of securing stable, predictable financing to support capital expenditures, acquisitions, and working‑capital needs. This continuity across reporting periods signals a deliberate, long‑term financing priority rather than ad‑hoc borrowing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 4.30% Note due 2034 as a persistent component of Oracle's long-term debt across 2022-2024, and accurately characterizes it as a fixed-rate instrument with a 10-year maturity (2024 to 2034). The answer appropriately notes the diversified debt portfolio strategy and the signal of deliberate long-term financing priorities. However, there are significant gaps compared to the ground truth: (1) The LLM answer lacks specific contextual details about companion instruments disclosed in each year (e.g., the 3.625% Note due 2023 and 4.50% Note due 2044 in 2022; the 2.950% Notes due 2024 in 2023). The ground truth provides a year-by-year evolution showing how Oracle's debt portfolio evolved while maintaining the 4.30% Note, which is important for understanding the 'evolving debt portfolio' concept. (2) The LLM cites specific page numbers (pp. 111-115, 108-112, 108-112) which cannot be verified against the ground truth and may be inaccurate or fabricated. (3) The LLM's explanation of financing purposes (capital expenditures, acquisitions, working-capital needs) is reasonable but not explicitly supported by the ground truth, which focuses on the structural and strategic aspects rather than specific uses. (4) The LLM answer is more concise and direct but misses the nuanced year-by-year analysis that demonstrates how the note remained 'stable' within a 'broader, evolving' portfolio. The core insight about long-term financing strategy is present but incompletely developed. Quantitative accuracy is good (the 4.30% rate and 2034 maturity are correct), but qualitative accuracy suffers from incomplete synthesis of the multi-year comparative analysis that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 471,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One values most of its derivatives with vendor‑based models that use observable inputs (yield curves, credit curves, volatility, currency rates) but classify any instrument whose key inputs are unobservable as Level 3, applying credit‑risk adjustments and cross‑checking internal pricing against external valuation agents.  The Level 3 net derivative assets (liabilities) fell to $5 million at year‑end 2022, jumped to $58 million at year‑end 2023, and rose modestly to $69 million at year‑end 2024, showing a growing share of its derivative portfolio that relies on significant unobservable inputs.  This upward trend in Level 3 balances indicates increasing valuation uncertainty and exposure to inputs that are not directly observable in liquid markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth: (1) QUANTITATIVE FAILURES: The LLM reports Level 3 net derivative assets of $5M (2022), $58M (2023), and $69M (2024). The ground truth shows $19M (2022), $58M (2023), and $58M (2024). The 2022 figure is off by $14M (wrong by 280%), and the 2024 figure is off by $11M (wrong by 19%). These are material discrepancies in a financial analysis context. (2) METHODOLOGY MISMATCH: The ground truth specifically discusses 'net derivative assets/liabilities' with unrealized losses and specific unobservable inputs (default rates 53-163%, swap rates 3-5%). The LLM discusses 'Level 3' classification methodology and vendor-based models with observable inputs, which is a different analytical framework. While Level 3 classification is relevant to fair value hierarchy, the LLM conflates this with the specific valuation amounts and unobservable inputs mentioned in the ground truth. (3) MISSING KEY DETAILS: The ground truth explicitly mentions default rates (53-163%) and swap rates (3-5%) as unobservable inputs. The LLM mentions swap rates only in passing and omits default rates entirely. The ground truth also notes a 'net unrealized loss of $20 million' in 2022, which the LLM completely omits. (4) INTERPRETATION ERROR: The ground truth characterizes the evolution as a 'transformation from mixed realized/unrealized loss position in 2022 to more stable fair value by 2023-2024.' The LLM characterizes it as an 'upward trend' indicating 'increasing valuation uncertainty.' These are opposite interpretations - the ground truth shows stabilization while the LLM suggests deterioration. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the specific unobservable inputs and their ranges across the three-year period, instead providing generic methodology discussion. The question specifically asks about evolution of 'fair value amounts' and 'exposure to unobservable market inputs' - the LLM provides methodology but incorrect amounts and incomplete input analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 564,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s flight‑hour payments to Rolls‑Royce have remained a per‑hour, cash‑based obligation that is capitalized as a collaboration intangible asset and amortized to cost of sales.  The total flight‑hour commitment fell from about $1.05 billion in 2022 (see the “Other commercial aerospace commitments” table on pages 110‑114 of the 2022 10‑K) to roughly $0.77 billion in 2024 (see the same table on pages 101‑105 of the 2024 10‑K).  The payment structure and amortization policy—capitalizing each payment and spreading it over the life of the V2500 program—remained unchanged through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core structure of RTX's obligations to Rolls-Royce (per-hour payments capitalized as collaboration intangible assets and amortized to cost of sales) and appropriately references the relevant 10-K sections. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The LLM provides specific dollar amounts ($1.05 billion in 2022 and $0.77 billion in 2024) that are NOT mentioned in the ground truth answer\n   - The ground truth states the 2024 total commercial aerospace financing commitments were $14.1 billion, but does NOT isolate Rolls-Royce flight-hour payments to specific amounts\n   - The LLM's claim of a decline from $1.05B to $0.77B cannot be verified against the ground truth and appears to be unsupported or potentially fabricated\n   - These specific numbers are presented with confidence and page references, making the inaccuracy more problematic\n\n2. COMPLETENESS:\n   - The LLM answer addresses the payment structure and amortization strategy well\n   - However, it omits important context from the ground truth: the 2012 acquisition of Rolls-Royce's stake in IAE as the origin of this obligation\n   - It misses the evolution of transparency/disclosure improvements mentioned in the ground truth\n   - It fails to mention the June 2027 end date for these payments\n\n3. ENTITY AND TEMPORAL ACCURACY:\n   - Correctly identifies RTX, Rolls-Royce, and V2500-powered aircraft\n   - Correctly references 2022, 2024, and the time period in question\n   - Appropriately cites 10-K filings with page numbers\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is sound in concept (connecting payment structure to amortization policy)\n   - However, the introduction of unsupported quantitative claims undermines the reasoning\n   - The statement about \"unchanged\" policy through 2024 aligns with ground truth\n\n5. SEMANTIC EQUIVALENCE:\n   - The description of capitalization and amortization matches the ground truth\n   - The per-hour structure is correctly identified\n   - The reference to \"collaboration intangible asset\" is accurate\n\nThe primary issue is the introduction of specific dollar amounts ($1.05B and $0.77B) that cannot be verified in the ground truth and appear to be either hallucinated or incorrectly extracted. This is a critical flaw in financial analysis where precision is essential. The answer would be stronger if it stuck to the verifiable information about structure and policy without claiming specific commitment amounts that aren't supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 696,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K (pp. 49‑53) disclosed that the FDA had been evaluating the Neulasta Onpro kit after user complaints and that the company had implemented device‑ and labeling‑enhancements to address those complaints, noting it would continue to monitor and add enhancements as needed. The 2023 filing (pp. 53‑57) reiterated this approach, adding that further device‑ and labeling changes had been made and that the company maintained operational resilience through backup power and supply‑chain safeguards for its manufacturing facilities. In the 2024 filing (pp. 52‑56) Amgen again emphasized continuous monitoring of user complaints and additional device‑ and labeling‑enhancements, while underscoring its broader operational‑resilience strategy—including backup generators and supply‑chain continuity measures—to mitigate disruptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Amgen's disclosures regarding Neulasta Onpro complaints and risk mitigation across 2022-2024, but contains significant issues: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM cites specific page numbers (2022: pp. 49-53, 2023: pp. 53-57, 2024: pp. 52-56) that cannot be verified and appear potentially inaccurate. These page citations are presented as factual but are unverifiable claims that reduce confidence in the answer. (2) FACTUAL DISCREPANCIES: The ground truth specifically mentions Puerto Rico's unstable electric grid and an island-wide outage on December 31, 2024, as concrete operational resilience examples. The LLM answer generalizes these to 'backup generators and supply-chain continuity measures' without the specific Puerto Rico context or the December 31, 2024 date. This is a material omission of key factual details. (3) MULTI-HOP REASONING: The LLM correctly synthesizes the three-year evolution and identifies the progression from device-focused complaints (2022-2023) to broader operational resilience measures (2024). However, it fails to capture the specific causal link between Puerto Rico's infrastructure instability and device production impact mentioned in the ground truth. (4) COMPLETENESS: The answer addresses the core question about evolution of disclosures but misses the specific operational context (Puerto Rico location, December 31, 2024 outage) that distinguishes 2024's disclosures. (5) SEMANTIC ISSUES: The phrase 'further device-and labeling changes had been made' in 2023 is not explicitly confirmed in the ground truth, which states enhancements were 'reiterated' rather than necessarily expanded. The LLM may be overstating the degree of change year-to-year. The answer demonstrates reasonable understanding of the disclosure evolution but lacks precision on specific facts and contains unverifiable citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 515,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings show no change in the ratification language: each year (2022, 2023, 2024) the “Item 14 – Principal Accountant Fees and Services” section simply states that KPMG LLP is the principal accountant and cites its PCAOB firm identification number 185 (see pages 11‑15 of 2022, 12‑16 of 2023, and 12‑16 of 2024). The unchanged reference to the same PCAOB number across all three filings signals that BK has retained the same audit firm and, by extension, a stable audit‑governance relationship over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) BK consistently disclosed KPMG LLP as principal accountant across 2022, 2023, and 2024; (2) PCAOB firm number 185 remained unchanged across all three years; (3) this consistency indicates stable audit governance with no auditor rotation. The answer appropriately synthesizes the multi-hop requirement by connecting the unchanged disclosure language to the unchanged PCAOB number to the conclusion about audit governance continuity. STRENGTHS: The answer accurately captures the key finding that there was no substantive change in disclosure structure or framing across the three years, correctly identifies KPMG LLP and PCAOB number 185, and properly concludes that this signals continuity and stable audit governance. The page references (11-15 for 2022, 12-16 for 2023, 12-16 for 2024) are specific and add credibility, though they cannot be independently verified from the ground truth. WEAKNESSES: The LLM answer is somewhat more concise than the ground truth and omits the explicit mention that the consistency 'suggests strong institutional trust in the firm's audit services' - a nuanced interpretive element present in the original answer. The LLM focuses more on the factual consistency and less on the broader governance implications. However, the core semantic meaning is preserved: both answers conclude that the unchanged PCAOB number and consistent disclosure indicate continuity and stable audit governance. The answer does not contain any factual errors regarding numbers, dates, or entities. The multi-hop reasoning is sound: it correctly connects the disclosure consistency across three years to the unchanged PCAOB identifier to the conclusion about governance stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 475,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s maximum potential exposure to commercial‑aerospace customer‑financing guarantees fell from **$304 million in 2022 to $274 million in 2024** (Note 18, 2022 p. 111; 2023 p. 101; 2024 p. 100).  Simultaneously, the share of those guarantees attributable to collaboration partners declined from **$142 million in 2022 to $131 million in 2024** (Note 18, 2022 p. 111; 2023 p. 101; 2024 p. 100).  This downward trend reflects a risk‑management strategy that limits RTX’s residual liability by curbing its own guarantee commitments and shifting risk to partners.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key collaboration partners' share figures ($142M in 2022, $131M in 2024) and accurately characterizes the downward trend. However, there are notable gaps and issues: (1) COMPLETENESS: The LLM answer omits the 2023 intermediate data point ($135M), which is explicitly mentioned in the original answer and is important for demonstrating the 'consistent downward trend' across all three years. The question specifically asks about evolution 'from 2022 through 2024,' implying all three years should be addressed. (2) QUANTITATIVE ACCURACY: The LLM correctly cites the collaboration partners' share figures for 2022 and 2024. It also introduces additional context about maximum potential exposure ($304M in 2022 to $274M in 2024), which is factually accurate but not directly requested. The numbers provided are correct. (3) REASONING: The LLM's interpretation of the trend as reflecting 'a risk-management strategy that limits RTX's residual liability by curbing its own guarantee commitments and shifting risk to partners' is reasonable but slightly different from the original answer's framing. The original emphasizes 'strategic reduction in shared financial risk with partners' and notes RTX's confidence in underlying asset values. The LLM's interpretation focuses more on shifting risk to partners, which is a valid but somewhat different emphasis. (4) MISSING ELEMENT: The original answer includes important context about RTX maintaining that 'fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which the LLM answer completely omits. This is a significant contextual element that provides fuller understanding of the risk management strategy. (5) SEMANTIC EQUIVALENCE: The core finding—that collaboration partners' share declined from 2022 to 2024—is correctly conveyed, though the intermediate year is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 517,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 to 2024, P&G kept Always as a core brand in its Feminine Care portfolio but clarified its product positioning.  In 2022 the sub‑category was listed simply as “Feminine Care (Adult Incontinence, Feminine Care)”; by 2023 and 2024 it was re‑defined as “Feminine Care (Adult Incontinence, Menstrual Care)” (PG_10k_2022 p. 17‑21; PG_10k_2023 p. 16‑20; PG_10k_2024 p. 16‑20).  Across all three filings, the MD&A notes that Always and Tampax Bounty are the leading brands in the menstrual‑care sub‑category, underscoring Always’s continued prominence relative to other feminine‑hygiene offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) SEGMENT NAMING ERROR: The LLM claims the segment was renamed from 'Feminine Care' in 2022 to 'Baby, Feminine & Family Care' in 2023-2024, but the ground truth explicitly states this renaming occurred and the segment was called 'Baby, Feminine & Family Care' in 2023-2024, not the subcategory definitions the LLM provided. The LLM incorrectly describes subcategory formatting ('Adult Incontinence, Feminine Care' vs 'Adult Incontinence, Menstrual Care') rather than the actual segment-level renaming. (2) MISSING CRITICAL QUANTITATIVE DATA: The ground truth provides specific segment contribution percentages (25% in 2022, 24% in 2023-2024), which are completely absent from the LLM answer. These are material financial metrics directly relevant to the question about brand positioning evolution. (3) INCOMPLETE BRAND PORTFOLIO: The ground truth mentions Always Discreet alongside Always and Tampax in 2023-2024, but the LLM only references Always and 'Tampax Bounty' (which appears to be an incorrect product name - the ground truth says 'Tampax'). (4) STRUCTURAL MISCHARACTERIZATION: The LLM describes changes in subcategory formatting within Feminine Care, but the actual evolution involved a broader segment-level restructuring that included renaming to 'Baby, Feminine & Family Care.' (5) PARTIAL CREDIT: The LLM correctly identifies that Always remained a core brand and that its positioning was emphasized relative to other offerings, and correctly cites the 10-K filings as sources. However, the fundamental factual errors about segment naming, missing percentage contributions, and incorrect product names significantly undermine the answer's accuracy and usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 483,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In its 2022 10‑K, AMD listed IP‑protection difficulties as a general risk in foreign operations, noting reliance on third‑party wafer foundries in the U.S., Europe and Asia but without specific emphasis on Asia or third‑party manufacturing (AMD_10k_2022, pp. 35‑39). By 2023, the risk factor explicitly highlighted that nearly all assembly and testing occurs at third‑party facilities in China, Malaysia and Taiwan, underscoring the growing exposure to IP protection challenges in those jurisdictions (AMD_10k_2023, pp. 39‑43). In 2024, the filing added detail on geopolitical tensions between China and Taiwan, sanctions and export‑control changes that could disrupt Taiwan‑based foundries and heighten IP risk, reflecting AMD’s expanding international sales (66 % of revenue) and continued reliance on Asian manufacturing (AMD_10k_2024, pp. 38‑42).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across AMD's 2022-2024 10-K filings. STRENGTHS: (1) Correctly identifies the evolution of AMD's IP protection risks across three years; (2) Accurately cites specific jurisdictions (China, Malaysia, Taiwan) and their increasing prominence in AMD's manufacturing footprint; (3) Properly notes the shift from general foreign operations risk (2022) to specific Asia-focused concerns (2023-2024); (4) Correctly identifies geopolitical tensions between China and Taiwan as a new risk layer in 2024; (5) Quantitative data is accurate - the 66% international sales figure in 2024 is consistent with ground truth's 65% figure for 2023 (minor variation acceptable); (6) Multi-hop reasoning is sound, connecting international expansion → third-party manufacturing reliance → IP protection exposure. MINOR ISSUES: (1) The LLM states 'nearly all assembly and testing occurs at third-party facilities' in 2023, which is more specific than the ground truth's general statement about 'reliance on third-party manufacturing' - this is a reasonable inference but slightly more definitive than the source material warrants; (2) The 66% vs 65% international sales figure is a minor discrepancy (likely due to different fiscal year reporting or rounding), but both are within acceptable range; (3) The LLM provides page citations (pp. 35-39, etc.) which adds credibility but cannot be verified against the ground truth. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years and multiple risk factors (IP protection + international operations + manufacturing locations + geopolitical risks), demonstrating proper understanding of how these elements interconnect. The progression narrative matches the ground truth's characterization of increasing complexity and regional concentration in Asia.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 515,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first issued the 2.300% Notes due 2028 in 2021 as part of a $4.5 billion issuance; the 2022 10‑K (pp. 112‑116) reports the notes outstanding at $4.5 billion, and the same principal appears unchanged in the 2023 (pp. 108‑112) and 2024 (pp. 109‑113) 10‑Ks, indicating the notes remained fully outstanding through 2024. This steady, long‑term, fixed‑rate debt position, coupled with the company’s simultaneous issuance of higher‑rate notes (e.g., 4.500% due 2028 in 2023), demonstrates Oracle’s strategy of maintaining a staggered maturity profile and a diversified mix of fixed‑rate instruments to manage interest expense and preserve liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative details (the $4.5 billion principal amount and page references) that are not present in the ground truth, making verification difficult. However, there are several critical issues: (1) The ground truth explicitly states the notes were first 'referenced' in 2022 as part of Exhibit 4.16 from March 2021 issuance, not that they were 'issued in 2021' as the LLM claims—this is a subtle but important distinction about when Oracle first disclosed them in its filings. (2) The LLM provides specific page numbers (112-116 for 2022, 108-112 for 2023, 109-113 for 2024) that cannot be verified against the ground truth and may be inaccurate. (3) The LLM introduces the 4.500% Notes due 2028 issued in 2023 as supporting evidence, which is not mentioned in the ground truth and represents additional synthesis that may or may not be accurate. (4) The core narrative differs: the ground truth emphasizes the consistent 'inclusion' and 'disclosure' of the notes across exhibits (4.16 in 2022, 4.14 in 2023 and 2024), while the LLM focuses on the principal amount remaining 'unchanged' and 'fully outstanding.' These are related but distinct analytical angles. (5) The LLM's conclusion about 'staggered maturity profile' and 'diversified mix' aligns with the ground truth's interpretation, but the supporting evidence (the 4.500% notes) is not grounded in the provided ground truth. The answer demonstrates reasonable financial reasoning and addresses the multi-year pattern question, but introduces unverified quantitative claims and shifts the analytical focus from disclosure patterns to principal amounts outstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 452,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 to 2024, BA increased its private‑equity allocation from a 4 % target in 2022 to a 7 % target in 2023 (and maintained that target in 2024), while actual holdings rose from 8 % in 2022 to 9 % in 2024 (see pages 108‑112, 90‑94, 97‑101). The geographic scope of its limited‑partnership investments remained global—U.S. and non‑U.S.—and the strategic focus continued to center on leveraged buy‑outs, venture capital, growth, and special‑situation strategies (see pages 108‑112, 90‑94, 97‑101).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses some elements of the question but has significant gaps and potential inaccuracies. STRENGTHS: (1) Correctly identifies geographic scope as U.S. and non-U.S., which matches ground truth; (2) Correctly identifies strategic focus areas (leveraged buyouts, venture capital, growth, special situations) for the period; (3) Attempts to provide specific allocation percentages and page references. CRITICAL WEAKNESSES: (1) The ground truth emphasizes evolution and progression in strategy from 2022-2024, particularly the shift toward 'global private investments in real assets such as energy, farmland, and infrastructure' by 2023 and increased sophistication with derivatives by 2024. The LLM answer completely omits these key strategic evolutions, instead focusing narrowly on allocation percentages; (2) The LLM answer provides allocation percentages (4% target in 2022, 7% in 2023, 8-9% actual holdings) but these specific numbers cannot be verified against the ground truth, which does not mention these percentages. This raises concerns about accuracy; (3) The LLM answer fails to capture the 'strategic deepening' and 'broader integration of alternative investment tools' that characterize the evolution described in the ground truth; (4) The answer misses the expansion into real assets (energy, farmland, infrastructure) and the use of derivatives for performance transfer—these are central to understanding how the strategy evolved; (5) The answer reads more like a static description of allocation targets rather than an analysis of strategic evolution. MULTI-HOP REASONING: The LLM failed to synthesize the qualitative evolution of strategy across the three-year period, instead focusing on quantitative allocation changes. The ground truth requires understanding how investment focus areas shifted and deepened, not just how percentages changed. CONCLUSION: While the LLM captures some basic facts (geographic scope, core strategies), it fundamentally misses the core narrative of strategic evolution that the question asks about, and introduces unverified percentage figures that may be inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 571,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen began bemarituzumab’s Phase 3 program in 2022 (the 2022 filing notes “initiated phase 3 study” for GEJ adenocarcinoma).  The 2023 and 2024 filings show the program still in Phase 3 with no additional milestones.  Across all three years, the issued composition‑of‑matter patents for bemarituzumab are projected to expire in 2029 in both the U.S. and Europe.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key numeric facts: Phase 3 initiation in 2022, patent expiration in 2029 for both U.S. and Europe, and the composition-of-matter patent classification. The dates and numbers are accurate. WEAKNESSES: The LLM answer is significantly less complete than the ground truth. It fails to capture important qualitative information about Bemarituzumab's development: (1) Missing the drug's mechanism of action (monoclonal antibody targeting FGFR2b) - this is a key clinical/scientific detail; (2) Missing the indication context (gastric and gastroesophageal junction cancer) - only mentions GEJ adenocarcinoma in 2022; (3) Fails to synthesize the broader narrative about patent and regulatory exclusivity strategy mentioned in 2024 filings; (4) The statement 'no additional milestones' between 2023-2024 is incomplete - the ground truth indicates Amgen provided 'further context' in 2024 describing the drug's mechanism and importance of exclusivity. MULTI-HOP REASONING: The LLM correctly synthesizes the patent timeline across three years (2022-2024), but fails to synthesize the clinical/scientific context evolution. The ground truth emphasizes how Amgen's positioning evolved to include mechanism of action and exclusivity strategy, which the LLM misses. SEMANTIC ISSUES: The LLM's characterization of 'no additional milestones' is misleading - there were additional disclosures about the drug's mechanism and market protection strategy, even if clinical phase didn't advance. The answer is factually narrow and misses the qualitative evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 443,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn remained a core brand in P&G’s Fabric & Home Care segment throughout 2022‑2024.  The segment’s earnings contribution grew from 31 % of net earnings in 2022 to 34 % in 2023 and stayed at 34 % in 2024, while Dawn continued to appear among the major brands listed alongside Ariel, Downy, Gain, Tide, Cascade, Fairy, Febreze, Mr. Clean and Swiffer【PG_10k_2022.pdf, p. 17‑21】【PG_10k_2023.pdf, p. 16‑20】【PG_10k_2024.pdf, p. 16‑20】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Dawn as a core brand in the Fabric & Home Care segment across 2022-2024, provides accurate brand listings, and demonstrates proper multi-hop synthesis across three years of 10-K filings. The answer appropriately addresses the question's focus on positioning evolution and brand consistency. CRITICAL ERRORS: The LLM states earnings contribution was '31% in 2022 to 34% in 2023 and stayed at 34% in 2024,' but the ground truth specifies 31% in 2022 and 34% in 2024 (with no 2023 data mentioned in the original answer). This is a significant quantitative error that misrepresents the earnings trajectory. OMISSIONS: The LLM completely omits the net sales percentage data (35% in 2022, 36% in 2023 and 2024), which is explicitly included in the ground truth as important context for understanding the segment's stability and strategic positioning. The ground truth emphasizes that while earnings contribution increased, sales remained stable—a key insight about the segment's performance that the LLM answer lacks. CALCULATION/REASONING: The multi-hop reasoning is sound in connecting brand listings to segment performance, but the incomplete financial picture weakens the overall analysis. The answer would have been stronger by noting the divergence between growing earnings contribution and stable sales percentages, which suggests improving profitability within the segment. SEMANTIC EQUIVALENCE: The core message about Dawn's consistent positioning is conveyed, but the answer is incomplete in its financial analysis and contains a factual error regarding the 2023 earnings contribution figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 448,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022‑2024 Schwab shifted client‑securities collateral from short‑term credit lines toward liquidity support.  CS&Co’s secured uncommitted lines of credit fell from $950 million in 2023 to $500 million in 2024, while collateral pledged for the Federal Reserve discount window jumped from $6.2 billion in 2023 to $30.5 billion in 2024 and FHLB collateral remained high at $59.8 billion in 2024 (pages 97‑101).  The fair value of client securities available for margin lending grew from $84.006 billion in 2020 to $120.306 billion in 2021, indicating continued expansion of client assets that Schwab now uses more for liquidity than for short‑term borrowing (pages 74‑78).  This trend shows that Schwab’s exposure to client‑held assets remains substantial but is being strategically reallocated to support liquidity rather than short‑term credit lines.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth:\n\n(1) FUNDAMENTAL MISINTERPRETATION: The LLM answer discusses collateral pledged for Federal Reserve discount window and FHLB facilities ($30.5B and $59.8B), which are NOT client securities used for margin lending. These are Schwab's own liquidity management activities, not client asset utilization. The ground truth focuses on how Schwab uses CLIENT securities for margin lending and options clearing collateral.\n\n(2) INCORRECT TIME PERIOD: The LLM cites 2020-2021 data ($84.006B to $120.306B) when the question specifically asks about 2022-2024 evolution. This is a major temporal error that misses the requested timeframe entirely.\n\n(3) WRONG FOCUS: The LLM answer pivots to discussing Schwab's own secured credit lines and liquidity management rather than client securities pledging practices. The ground truth emphasizes: (a) fair value of client securities available as collateral, (b) margin loan collateral under ASC 326, (c) pledging for options clearing, and (d) cash collateral in securities lending.\n\n(4) MISSING KEY ELEMENTS: The LLM answer completely omits: (a) ASC 326 practical expedient application, (b) options clearing corporation collateral requirements, (c) securities lending activities, (d) the sophistication and growth in client engagement with leveraged activities.\n\n(5) SEMANTIC DISCONNECT: The conclusion about \"strategic reallocation to support liquidity\" describes Schwab's own treasury management, not the evolution of client securities usage for margin lending and operational purposes as stated in the ground truth.\n\n(6) QUANTITATIVE ISSUES: While the numbers cited ($950M, $500M, $6.2B, $30.5B, $59.8B, $84.006B, $120.306B) may be accurate from the filings, they measure the wrong phenomena relative to the question asked.\n\nThe answer demonstrates a fundamental misunderstanding of what the question asks (client securities usage) versus what was answered (Schwab's own collateral management).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 547,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s target allocation for U.S. defined‑benefit pension plans remained at 100 % debt from FY 2023 to FY 2025, but the weighted‑average plan assets shifted from 97 % debt (Aug 31 2022) to 95 % (2023) to 94 % (2024), with cash rising from 3 % to 5 % to 6 %. For non‑U.S. plans, the target moved from 48 % debt, 27 % equity, 4 % cash, 11 % insurance, 10 % other (FY 2023) to 36 % debt, 28 % equity, 7 % cash, 21 % insurance, 8 % other (FY 2025), and the weighted‑average allocations reflected a similar trend—debt fell from 50 % (2022) to 43 % (2023) to 42 % (2024), equity rose from 21 % to 19 % to 23 %, cash increased, and insurance grew markedly.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to describe a completely different pension plan allocation structure than what the ground truth indicates. Critical issues: (1) WRONG NUMBERS: The LLM reports U.S. plans at 100% debt/97-94% debt allocations, while the ground truth shows 55-61% fixed income and 39-45% equities for the overall plan. These are entirely different asset allocation profiles. (2) WRONG STRUCTURE: The LLM separates U.S. and non-U.S. plans with different allocation strategies, but the ground truth presents a unified weighted-average allocation across all plans. (3) MISSING KEY DATA: The ground truth clearly states the three-year progression: FY2023 (55% fixed income/45% equities), FY2024 (58% fixed income/42% equities), FY2025 (61% fixed income/39% equities). The LLM provides none of these correct percentages. (4) WRONG INTERPRETATION: The ground truth describes a clear de-risking trend toward fixed income, while the LLM describes debt allocations that don't match this pattern at all. (5) ENTITY CONFUSION: The LLM appears to have confused or misread the pension plan data entirely, possibly mixing in unrelated plan information. The answer demonstrates a fundamental failure to extract and synthesize the correct multi-hop information from the source documents. The numbers, trends, and overall narrative are all incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 380,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt grew from $47.8 B in 2022 to $49.3 B in 2023 and declined to $45.0 B in 2024, reducing total debt from $48.7 B to $49.9 B and then to $45.6 B. The weighted‑average interest rate on long‑term debt dropped from roughly 4.5 % in 2022 to 3.5 % in 2024, reflecting a shift to lower‑rate, longer‑term financing. This three‑year trend shows a more stable debt structure with a higher proportion of fixed‑rate debt (≈4.8 %) and a small floating‑rate component, thereby lowering overall interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors across nearly all key metrics. QUANTITATIVE ERRORS: (1) Total debt figures are significantly wrong - LLM states $48.7B→$49.9B→$45.6B, but ground truth shows $43.086B→$48.715B→$45.551B. The 2022 figure is off by ~$5.6B and 2023 is off by ~$1.2B. (2) Short-term borrowings breakdown is incorrect - LLM provides specific figures ($883M, $538M, $562M) that don't align with the ground truth's total figures. (3) Long-term debt figures are wrong - LLM states $47.8B→$49.3B→$45.0B, which doesn't match ground truth totals. (4) Interest rate direction is reversed - LLM claims rates DROPPED from 4.5% to 3.5%, but ground truth clearly shows rates INCREASED from 1.51% (2022) to 3.01% (2023) to 3.48% (2024). This is a critical error in understanding the trend. (5) The LLM mentions 4.8% fixed-rate debt with no ground truth support. MULTI-HOP REASONING FAILURES: The LLM failed to correctly synthesize the three-year trend. Ground truth shows a clear pattern of rising rates and strategic debt reduction (floating debt elimination), but LLM presents an opposite narrative of declining rates. MISSING KEY INSIGHTS: The LLM completely omits the critical finding about floating unsecured senior debt reduction from $1,597M to $0, which is a major strategic shift mentioned in ground truth. SEMANTIC ISSUES: The conclusion about 'lower interest-rate exposure' contradicts the actual rising rate environment documented in ground truth. The answer demonstrates fundamental misunderstanding of Capital One's debt dynamics and interest rate trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 435,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Fleet‑support costs stayed flat at roughly 1 % of total consolidated costs each year from 2022 through 2024 (2022, 2023 and 2024 filings note that fleet‑support “has historically been approximately 1 % of total consolidated costs of products and services”【BA_10k_2022, pages 40‑44】【BA_10k_2023, pages 34‑38】【BA_10k_2024, pages 37‑41】).  In contrast, abnormal production costs and reach‑forward losses exploded—cumulative abnormal costs of $2.7 billion were recorded through 2023 and $256 million were expensed in 2024 for the 787 program, while the 777X program incurred $2.608 billion in Q3 2024 and $891 million in Q4 2024—showing that the stable fleet‑support expense was not driving the company’s growing losses, which were largely due to production rework and program delays.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Fleet support services costs remained stable at approximately 1% of total consolidated costs across 2022-2024, (2) The 787 program had $2.7 billion in cumulative abnormal production costs through 2023, (3) The 777X program recorded $2.608 billion in Q3 2024 and $891 million in Q4 2024 reach-forward losses. The answer properly synthesizes the multi-hop relationship between stable fleet support costs and escalating program-specific losses. However, there is a minor quantitative discrepancy: the LLM states '$256 million were expensed in 2024 for the 787 program' but the ground truth does not explicitly mention this $256 million figure for 2024. The ground truth focuses on the $2.7 billion cumulative through 2023 without breaking out a specific 2024 amount for the 787 program. This represents a potential factual error or unsupported claim. The LLM correctly interprets the 777X figures ($2.608B Q3 + $891M Q4 = $3.499B total in 2024), though the ground truth presents these as separate quarterly events rather than a combined total. The reasoning is sound—the answer correctly concludes that stable fleet support costs were not the source of financial strain, with losses driven by production inefficiencies and program execution risks. The answer is well-structured and addresses all parts of the multi-part question. The main weakness is the unexplained $256 million 2024 figure for the 787 program, which cannot be verified against the ground truth and may represent an error or misinterpretation of the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 434,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s allocation to money‑market funds and time deposits fell from **$21 million in 2022** to **$10 million in 2023** and stayed at **$10 million in 2024**. The decline and subsequent plateau indicate a deliberate shift away from money‑market holdings, likely to free up cash for other uses or to invest in higher‑yielding short‑term instruments, while still maintaining a modest, stable liquidity buffer.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors in the year-to-year progression of numbers. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. LLM states: 2022=$21M, 2023=$10M, 2024=$10M. This is a complete reversal/misalignment of the data across years. Specifically: (1) LLM incorrectly assigns $21M to 2022 when it should be $12M; (2) LLM incorrectly assigns $10M to 2023 when it should be $21M; (3) LLM correctly identifies $10M for 2024 by coincidence. The LLM's narrative about 'decline and subsequent plateau' is factually wrong - the actual trend shows an increase from 2022 to 2023, then a decrease to 2024. The reasoning about 'deliberate shift away from money-market holdings' contradicts the actual 2023 increase. While the LLM addresses the question's structure (3-year trend, liquidity strategy implications), the core quantitative data is severely misrepresented, making the entire analysis incorrect. This is not a minor formatting or wording issue - these are fundamental data accuracy failures that undermine the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 306,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture’s share‑repurchase authorization grew from $3.129 million of available authority in fiscal 2022 (when it repurchased 12.18 million shares for $4.111 million【ACN_10k_2022.pdf pages 91‑95】) to $6.129 million after a $3.000 million add‑on, and further to $6.694 million after a $4.000 million add‑on in fiscal 2024, while the available authorization dipped to $2.694 million【ACN_10k_2024.pdf pages 37‑41】. Share‑repurchase activity remained robust, with 12.18 million shares bought in 2022 and 2.0 million shares bought in Q4 2024 under the publicly announced program【ACN_10k_2024.pdf pages 37‑41】. The steady rise in authorization and consistent repurchases signal a proactive capital‑return strategy that prioritizes returning cash to shareholders while preserving flexibility for future buybacks.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains severe quantitative inaccuracies that fundamentally undermine its credibility. (1) UNIT CONVERSION ERROR: The LLM states '$3.129 million' when the ground truth clearly indicates '$3,129,296 thousand' (which equals $3.129 billion, not million). This is a 1,000x magnitude error. Similarly, '$6.129 million' and '$6.694 million' should be '$6.129 billion' and '$6.694 billion' respectively. (2) MISSING KEY FIGURE: The ground truth explicitly states the cumulative total authorized capacity reached '$50.1 billion cumulatively since 2001' as of fiscal 2023, which the LLM completely omits. This is a critical data point for understanding the company's capital return strategy. (3) CALCULATION INCONSISTENCY: The LLM claims authorization grew from '$3.129 million' to '$6.129 million' (a $3.000 million add-on), but the ground truth shows $2.694 million remaining in fiscal 2023, not $6.129 million. The progression is unclear and mathematically inconsistent in the LLM answer. (4) INCOMPLETE FISCAL 2023 DATA: The LLM fails to properly address the fiscal 2023 authorization status ($2.694 million remaining as of August 31, 2023), which is a key waypoint in the three-year evolution. (5) SHARE REPURCHASE DETAILS: While the LLM mentions 12.18 million shares in 2022 and 2.0 million in Q4 2024, it doesn't provide the complete picture of repurchase activity across all three fiscal years. The ground truth focuses on authorization evolution rather than detailed share counts. (6) REASONING QUALITY: Despite the correct conclusion about a 'proactive capital-return strategy,' the path to that conclusion is built on fundamentally incorrect numbers, making the reasoning unreliable. The multi-hop synthesis fails because the underlying data is wrong. The answer demonstrates understanding of the question's intent but fails catastrophically on execution due to unit conversion errors and missing critical figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 526,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s 2022 Form 10‑K (pp. 44‑48) disclosed that “stockholders may only remove directors for cause,” a clause that is repeated unchanged in the 2023 (pp. 25‑29) and 2024 (pp. 25‑29) filings. The unchanged provision, together with the board’s power to fill vacancies and staggered terms, shows a deliberate effort to entrench the board and limit shareholder influence. This consistent emphasis signals a long‑term takeover‑defense strategy that prioritizes board stability and resistance to hostile bids.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three years of AbbVie filings. STRENGTHS: (1) Correctly identifies the core governance provision ('stockholders may only remove directors for cause') as consistent across 2022, 2023, and 2024; (2) Accurately notes the provision remained unchanged across all three years; (3) Properly synthesizes the multi-hop reasoning by connecting this provision to broader anti-takeover defenses (staggered board terms, board vacancy-filling power); (4) Correctly interprets the strategic implication as a deliberate board entrenchment and takeover defense strategy; (5) Page references provided (2022: pp. 44-48; 2023 and 2024: pp. 25-29) are specific and verifiable. MINOR WEAKNESSES: (1) The original answer explicitly mentions 'restrictions on special meetings' and 'supermajority requirements for bylaw amendments' as part of the broader anti-takeover defense package, while the LLM answer only references 'staggered terms' and 'board's power to fill vacancies'—this represents a slight incompleteness in describing the full governance architecture, though the core answer remains correct; (2) The LLM answer could have been slightly more explicit about the 'consistent emphasis' across all three filings as evidence of deliberate strategy, though this is adequately conveyed. QUANTITATIVE VERIFICATION: No calculations or specific dollar amounts are involved in this governance question, so quantitative accuracy focuses on dates/years (all correct: 2022, 2023, 2024) and page number specificity (appropriately cited). MULTI-HOP REASONING: The answer successfully synthesizes information across three separate annual filings and connects the governance provision to broader strategic implications—this multi-hop synthesis is sound and well-reasoned. The semantic equivalence between the LLM answer and ground truth is high, with only minor omissions in the breadth of anti-takeover mechanisms described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 540,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo lists the 4.000 % Senior Note due 2047 in each 10‑K’s debt schedule and notes‑to‑financial‑statements (pages 124‑128 for 2022 and 2023; pages 125‑129 for 2024), with the same coupon, maturity and outstanding balance reported each year.  The unchanged, repeated disclosure shows that the note is a core, long‑term financing instrument in PepsiCo’s debt mix, providing a stable, low‑cost source of capital that the company relies on to support its long‑term capital‑structure strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) The LLM provides specific page numbers (124-128 for 2022/2023, 125-129 for 2024) without verification against the ground truth, which only references Exhibit 4.5 from the May 2, 2017 8-K filing. These page citations cannot be verified and may be fabricated. (2) The LLM claims 'unchanged, repeated disclosure' regarding 'coupon, maturity and outstanding balance' but the ground truth specifically emphasizes the consistent reference to Exhibit 4.5 from May 2, 2017 across all three years - this is the key disclosure pattern, not page numbers or balance sheets. (3) The LLM fails to mention the critical detail that the note references the same May 2, 2017 8-K filing across all three years (2022, 2023, 2024), which is the core evidence of stability. (4) The LLM's characterization of the note as 'low-cost' is unsupported by the ground truth and represents an inference not grounded in the provided data. WHAT WAS CORRECT: The LLM correctly identifies that the note appears in debt schedules and notes-to-financial-statements, and correctly characterizes it as a stable, long-term financing instrument. The semantic understanding that this represents a core component of capital structure is appropriate. MULTI-HOP REASONING: The LLM fails to properly synthesize the key multi-hop insight: the consistent reference to the same 2017 8-K filing across three different years (2022, 2023, 2024) demonstrates stability. Instead, the LLM focuses on page numbers and balance information that cannot be verified. The ground truth's emphasis on the identical Exhibit 4.5 reference is the crucial evidence of the disclosure pattern evolution (or lack thereof), which the LLM misses entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 485,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014 (Exhibit 4.09).  In each subsequent 10‑K, the note is still reported as a long‑term debt instrument with a fixed 4.30 % coupon and a 2034 maturity—2022 (pages 111‑115), 2023 (pages 108‑112), and 2024 (pages 108‑112)—with no change to its principal or terms.  This steady, unchanged disclosure shows Oracle’s long‑term debt strategy is to maintain a stable, fixed‑rate debt portfolio that it holds to maturity rather than frequently refinancing or restructuring.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) ISSUANCE DATE DISCREPANCY: The LLM claims Oracle 'first issued the 4.30% Note due 2034 in 2014' but the ground truth indicates the note was 'first disclosed in 2022.' This is a fundamental factual error—the LLM has the issuance date wrong by 8 years. The question specifically asks about evolution 'across 2022, 2023, and 2024,' and the ground truth establishes 2022 as the first disclosure point, not 2014. (2) MULTI-HOP SYNTHESIS FAILURE: The ground truth emphasizes the evolution pattern across the three-year period (2022-2024) as a 'multi-year pattern,' showing disclosure consistency that 'indicates a stable long-term debt strategy.' The LLM correctly identifies the consistent disclosure across 2022-2024 but undermines this by anchoring to an incorrect 2014 issuance date, which contradicts the ground truth's framing. (3) STRATEGIC INTERPRETATION: While the LLM's conclusion about 'stable, fixed-rate debt portfolio held to maturity' is reasonable and somewhat aligned with the ground truth's 'stable long-term debt strategy,' the reasoning is built on incorrect foundational facts. The ground truth emphasizes 'diversified maturity profiles and sustained capital market engagement,' which the LLM does not address. (4) PAGE REFERENCES: The LLM provides specific page numbers (111-115 for 2022, 108-112 for 2023/2024) which cannot be verified against the ground truth but appear plausible as supporting detail. However, this detail does not compensate for the core factual error about the issuance date. (5) QUESTION ALIGNMENT: The question asks specifically about how the note 'evolved' across 2022-2024, implying a starting point in 2022. The LLM's introduction of a 2014 issuance date is extraneous and contradicts the ground truth's temporal framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 485,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "In FY 2022 Accenture authorized 127 million Class A shares for the Amended 2010 SIP; the cap was raised to 141 million shares in FY 2023 and remained at 141 million in FY 2024. The increase reflects a deliberate expansion of the share‑based incentive pool to reward a broader employee base, while the subsequent plateau indicates a mature, controlled approach to dilution and a long‑term commitment to aligning employee incentives with shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitatively, all numbers are correct: 127 million shares in FY 2022, 141 million in FY 2023, and 141 million in FY 2024. The number format variation (127 million vs 127,000,000) is acceptable and properly handled. The progression is accurately captured with the increase from 2022 to 2023 and the plateau through 2024. The multi-hop synthesis is sound, correctly identifying the Amended 2010 SIP, the company (Accenture plc), the share class (Class A ordinary shares), and the three-year evolution. The qualitative analysis is well-reasoned: the LLM correctly interprets the increase as a strategic expansion of share-based compensation capacity and the plateau as indicating a mature, controlled approach. The interpretation about 'aligning employee incentives with shareholder value' and 'controlled approach to dilution' adds appropriate strategic context that aligns with the ground truth's mention of 'talent retention and incentive programs.' The answer is complete, addressing both the numerical evolution and the strategic implications requested in the question. Minor deduction from perfect score only because the LLM's interpretation, while sound and reasonable, goes slightly beyond the ground truth's more conservative characterization, though this represents value-added analysis rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 384,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo first issued the 2.750% Senior Note due 2051 on October 21 2021 (see Exhibit 4.51 in the 2021 8‑K).  The 2022, 2023 and 2024 Form 10‑K filings (pp. 124‑128, 126‑130, 127‑131) all reference the same note with unchanged terms—2.750% coupon, maturity 2051—and simply incorporate the 8‑K documentation by reference.  This steady, multi‑year reporting shows PepsiCo’s strategy of issuing long‑dated debt with stable, predictable terms and maintaining consistent, transparent documentation across filings to support long‑term capital structure planning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - ISSUANCE DATE: The LLM claims the note was first issued on October 21, 2021, but the ground truth indicates the note was first introduced in 2022 documentation (Exhibit 4.60). This is a fundamental factual error about when the instrument appeared in filings. (2) EXHIBIT NUMBER INCONSISTENCY: The ground truth shows the exhibit numbers evolved from 4.60 (2022) to 4.51 (2023) to 4.48 (2024), indicating a progression in documentation structure. The LLM references Exhibit 4.51 for 2021 (which predates the ground truth timeline) and doesn't acknowledge the exhibit number changes across years. (3) DOCUMENTATION EVOLUTION MISSED: The ground truth emphasizes a three-stage evolution: authorization (2022) → formalization (2023) → maintenance (2024). The LLM incorrectly suggests the note was already issued in 2021 and merely 'incorporated by reference' in subsequent filings, missing the key insight about the phased approach to structuring. (4) TIMELINE ACCURACY: The LLM's claim about an October 21, 2021 issuance contradicts the ground truth's 2022 starting point for this note's documentation history. (5) REASONING QUALITY: While the LLM's conclusion about stable, predictable terms is reasonable, it's based on an incorrect foundational premise about when the note first appeared. The multi-hop synthesis fails because it starts from a wrong date and misses the exhibit number progression that indicates documentation evolution. The answer demonstrates a fundamental misunderstanding of the filing pattern and timeline that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 456,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "From 2022 to 2024, American Express has remained the fourth‑largest general‑purpose card network behind China UnionPay, Visa and Mastercard, but its competitive edge has been increasingly tested by tighter regulatory scrutiny and the rapid rise of alternative payment platforms.  In 2022 (pp. 10‑14) the company highlighted its premium‑card and network strengths while noting competition from other networks and digital payment platforms; by 2023 (pp. 10‑14) it began to emphasize growing regulatory focus on interchange‑fee caps, network‑licensing rules and merchant‑acceptance policies; and in 2024 (pp. 32‑36) it noted that it had become a Category III bank‑holding company, faced heightened regulatory expectations, and that the expansion of digital wallets, BNPL, real‑time settlement and other fintech solutions had intensified competition, prompting greater investment in technology and compliance to preserve its market position.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies American Express as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard - matching the ground truth exactly. (2) Accurately captures the evolution of competitive pressures from 2022-2024, including the shift from market-driven to regulation-constrained environment. (3) Properly identifies key regulatory concerns (interchange fees, network routing, cobrand arrangements) and competitive threats (BNPL, digital wallets, fintech solutions). (4) Appropriately notes the company's response through increased compliance and technology investment. (5) Correctly references the Category III bank-holding company designation in 2024. (6) Multi-hop reasoning is sound - synthesizes information across three years and multiple competitive dimensions. MINOR WEAKNESSES: (1) The LLM answer includes page references (pp. 10-14, pp. 32-36) that cannot be verified against the ground truth and appear to be fabricated citations, though this doesn't affect factual accuracy. (2) The ground truth mentions 'exits from certain markets' which the LLM answer doesn't explicitly state, though it's a relatively minor omission. (3) The LLM answer could have been slightly more explicit about the shift from 'primarily market-driven competition to regulation-constrained environment' as a strategic inflection point, though this concept is implicitly present. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal progression (2022→2023→2024) is correctly maintained. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with appropriate emphasis on regulatory evolution and competitive dynamics. The wording differs but the factual content aligns well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 537,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 10‑K Business sections for both 2022 and 2024 list upgrades and conversions as part of its Global Services portfolio, showing a consistent emphasis on these offerings【BA_10k_2022 pages 3‑7】【BA_10k_2024 pages 1‑5】.  The unchanged focus indicates that Boeing continues to view upgrades and conversions as a core element of its services strategy, aiming to extend aircraft life‑cycles and generate recurring revenue from long‑term customer relationships.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fails to address the core question about how Boeing's strategic emphasis CHANGED from 2022 to 2024. Critical deficiencies: (1) The LLM claims 'unchanged focus' and 'consistent emphasis,' directly contradicting the ground truth which documents a clear evolution: 2022 (upgrades/conversions grouped with other services) → 2023 (modifications emphasized more prominently) → 2024 (integration of data analytics and digital services). (2) The LLM completely misses the 2023 data point, which is essential for understanding the progression. (3) The LLM fails to capture the strategic shift toward 'technology-enabled service differentiation' and the move from 'sustaining operations' to 'enhancing aircraft value through modernization.' (4) The answer provides generic statements about lifecycle extension and recurring revenue without demonstrating the actual strategic evolution documented in the filings. (5) While the LLM correctly identifies Boeing and the Global Services segment, it fundamentally misinterprets the nature of change (claiming no change when significant evolution occurred). The LLM's conclusion that the focus is 'unchanged' is factually incorrect based on the ground truth. The answer demonstrates poor multi-hop reasoning across the three-year period and fails to synthesize the documented progression in how Boeing positioned these services. The citation format appears fabricated (specific page ranges without verification). This is a significant failure on a question specifically asking about CHANGE over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 426,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo first issued the 5.50 % Senior Note due 2035 in 2018, and the note has been listed as an exhibit in every subsequent Form 10‑K: Exhibit 4.23/4.27 in the 2022 filing (PEP_10k_2022 p. 124‑128), the same exhibits in the 2023 filing (PEP_10k_2023 p. 124‑128), and Exhibit 4.27/4.29 in the 2024 filing (PEP_10k_2024 p. 125‑129). The unchanged terms and consistent year‑to‑year disclosure demonstrate PepsiCo’s strategy of maintaining a stable, fixed‑rate senior‑note structure with a long maturity while ensuring transparent, ongoing reporting of its long‑term debt obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT NUMBERS: The LLM answer contains significant factual errors regarding exhibit numbers that directly contradict the ground truth. Ground truth states: 2022 = Exhibit 4.31, 2023 = Exhibit 4.25, 2024 = Exhibit 4.23. LLM answer claims: 2022 = Exhibit 4.23/4.27, 2023 = same exhibits, 2024 = Exhibit 4.27/4.29. These exhibit number discrepancies are material errors in a question specifically asking about documentation evolution across years. The LLM also provides page numbers (124-128, 125-129) that cannot be verified against the ground truth and appear to be fabricated. CORRECT ELEMENTS: The LLM correctly identifies (1) the 5.50% Senior Note due 2035, (2) the 2018 issuance date, (3) that the note appears in all three years' 10-K filings, (4) the interpretation that this represents stable debt management without retirement/modification, and (5) the overall strategic conclusion about maintaining a stable, fixed-rate structure. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly understands that consistent year-to-year documentation indicates ongoing debt obligation without modification. However, the specific exhibit number errors undermine the credibility of the answer and suggest the LLM may have hallucinated or confused the exhibit references. The semantic interpretation of PepsiCo's debt strategy is accurate, but the quantitative details (exhibit numbers) are demonstrably wrong. This is particularly problematic because the question explicitly asks about 'documentation' evolution, making exhibit numbers central to answering correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 439,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 10‑Ks all contain the same risk‑factor paragraph stating that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (2022 pages 3‑7; 2023 pages 3‑7; 2024 pages 3‑7).  The unchanged wording shows that the company’s exposure to regulatory constraints on capital‑return policies has remained steady over the three‑year period, indicating that U.S. banking laws continue to impose a consistent ceiling on how much capital can be returned to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements but falls short on depth of analysis compared to the ground truth. STRENGTHS: (1) Correctly identifies the consistent regulatory language across all three years (2022, 2023, 2024); (2) Accurately cites the specific risk-factor paragraph and its location (pages 3-7); (3) Correctly identifies the key regulatory constraints: U.S. banking laws, capital adequacy requirements, Delaware law, and preferred stock dividend obligations; (4) Accurately characterizes the constraint as 'unchanged wording' showing 'steady' exposure; (5) Properly synthesizes multi-hop information across three years. WEAKNESSES: (1) The LLM answer states the wording is 'the same' and 'unchanged,' which is technically accurate but misses the ground truth's more nuanced observation that the language 'remained largely unchanged' while 'reiterating' constraints and 'also noting' the importance of 'well capitalized' status in 2024 - suggesting subtle evolution rather than complete stasis; (2) The LLM answer concludes with 'steady' exposure and a 'consistent ceiling,' which is correct but less insightful than the ground truth's characterization of 'consistent yet evolving emphasis' reflecting 'ongoing prudential oversight and risk-conscious capital management expectations'; (3) The LLM answer lacks the temporal progression narrative that the ground truth emphasizes - the ground truth traces a journey from 'general regulatory oversight' (2022) to 'specifically reiterated' constraints (2023) to 'largely unchanged' with additional emphasis on 'well capitalized' status (2024). QUANTITATIVE ACCURACY: All dates, page numbers, and company references are correct. No calculation errors. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct, but the analysis is more surface-level than the ground truth's deeper examination of regulatory evolution. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution and multi-year progression, though with less analytical depth than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 562,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle issued 2.300% Notes due 2028 on March 24 2021 with a 2.300 % coupon, a principal amount of $1.5 billion, a maturity of July 15 2028, and a call date of July 15 2025.  Its 2022, 2023, and 2024 10‑K filings report the same coupon, maturity, and call date with no amendments, indicating that the terms have remained unchanged over that period.  This consistency shows Oracle’s preference for locking in low, fixed rates and long maturities to hedge against rising rates, rather than adjusting debt terms in response to short‑term market swings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific quantitative details (coupon rate 2.300%, principal $1.5 billion, maturity July 15 2028, call date July 15 2025) that are not contradicted by the ground truth, though the ground truth does not explicitly confirm these specific figures. The LLM correctly identifies that the terms remained unchanged across 2022-2024, which aligns with the ground truth statement that there were 'no structural or rate changes to the instrument.' However, the LLM answer has significant gaps in completeness and multi-hop synthesis: (1) It fails to address the broader context of Oracle's fixed-income strategy evolution across the three-year period, specifically missing the key insight that Oracle shifted to 'higher-yielding instruments like the 4.500% Notes due 2028' in 2023, which is central to understanding how the company's approach evolved; (2) It does not synthesize the multi-tiered bond offering context mentioned in the ground truth (2.875% Notes due 2031, 3.950% Notes due 2051); (3) It misses the strategic implication that the lack of new 2028-dated instruments in 2024 suggests a shift toward maintaining existing obligations rather than refinancing; (4) The reasoning about 'locking in low, fixed rates' is present but lacks the nuance about timing (lower interest rate periods in 2021-2022) and the strategic decision to avoid redundant issuance when existing instruments remain competitive. The answer is partially correct on the specific instrument terms but substantially incomplete in addressing the evolution of Oracle's financing strategy across the three-year period, which is the core of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 452,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a core competitive differentiator in its 2022, 2023, and 2024 10‑K filings, with the wording unchanged across the three years.  The steady emphasis signals that IBM views deep, trusted client relationships as essential to its hybrid‑cloud and AI strategy, reinforcing its positioning as a trusted partner that can deliver integrated, secure, and innovative solutions in a highly competitive market.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM emphasized client relationships and trust across 2022, 2023, and 2024, and appropriately connects this to hybrid cloud and AI strategy. However, there are significant issues with the multi-hop synthesis and evolution narrative: (1) The LLM claims 'wording unchanged across the three years,' which contradicts the ground truth that shows an evolution from 2022 (embedding AI/cloud, modernizing platforms) to 2023 (deep incumbency, innovation focus) to 2024 (expanded partnerships like Palo Alto Networks). This is a material factual error about the progression. (2) The LLM misses the key insight from the ground truth: the strategy became 'increasingly nuanced' over time, with 2024 showing expansion of strategic partnerships and a more sophisticated positioning. The LLM presents this as static rather than evolving. (3) The LLM fails to capture the multi-year progression aspect of the question - it treats the three years as equivalent rather than showing how the emphasis evolved and became more sophisticated. (4) The ground truth explicitly mentions specific strategic developments (adding Palo Alto Networks in 2024, deep incumbency emphasis in 2023) that the LLM omits entirely. (5) While the LLM correctly identifies the connection to hybrid cloud and AI, it doesn't demonstrate the synthesis across multiple years showing strategic evolution. The answer is partially correct on the basic premise but fails on the critical requirement to show how the emphasis 'evolved' and what the 'multi-year progression indicates' about strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 439,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations has been essentially flat at roughly 2 % over the 2022‑2024 period.  The 2022 10‑K (covering 2021) reports a 2.08 % yield on this segment【2022 10‑K, pages 119‑123】, and the 2024 10‑K (covering 2023) shows no material change in that yield, while the overall portfolio of investment securities still averages 12.8 % on total interest‑earning assets【2024 10‑K, pages 175‑179】.  This stability indicates a conservative, low‑yield sovereign‑debt focus that limits exposure to interest‑rate swings while preserving capital and generating steady income.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all key metrics and facts. Critical errors: (1) YIELD NUMBERS: Ground truth shows yields of 6.45% (2023) and 5.85% (2024), but LLM claims ~2% across the period—a massive discrepancy of 4-5 percentage points. The LLM's citation of 2.08% from the 2022 10-K appears to reference a different metric or year entirely and does not match the ground truth data. (2) HOLDINGS AMOUNT: Ground truth specifies $630 million in 2022 holdings; LLM provides no comparable figure. (3) MATURITY PROFILE: Ground truth documents a critical shift from ultra-short duration (all within 1 year in 2023) to diversified maturity (2.03% in 1-5 year bucket by 2024). LLM completely misses this strategic evolution. (4) INVESTMENT STRATEGY INTERPRETATION: Ground truth correctly identifies a deliberate shift toward diversified maturity management and interest rate risk mitigation. LLM incorrectly characterizes the holdings as 'conservative, low-yield sovereign-debt focus' when the ground truth shows relatively high yields (6.45%, 5.85%) compared to typical sovereign debt. (5) MULTI-HOP SYNTHESIS: LLM fails to synthesize the 3-year progression across 2022-2024 as requested. It conflates different time periods and metrics without proper alignment. (6) CONTEXTUAL ACCURACY: The claim that yields are 'essentially flat at roughly 2%' directly contradicts the ground truth showing a decline from 6.45% to 5.85%—a meaningful 0.6 percentage point decrease that reflects strategic repositioning. The answer demonstrates fundamental misreading of the source documents and provides incorrect financial data that would mislead investors or analysts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 456,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s government‑grant assistance earmarked to offset capital expenditures for diagnostics‑testing technology grew steadily: $87 million in 2022, $136 million in 2023 and $198 million in 2024 (with corresponding operating‑expense offsets of $49 m, $51 m and $43 m)【DHR_10k_2022.pdf pages 57‑61】【DHR_10k_2023.pdf pages 69‑73】【DHR_10k_2024.pdf pages 66‑70】. The rising grant‑backed cap‑ex reflects an accelerating commitment to expand testing production capacity, signalling that diagnostics testing is becoming a key growth engine within Danaher’s broader health‑care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All three core figures are correct - $87M (2022), $136M (2023), and $198M (2024). The LLM additionally provides operating expense offsets ($49M, $51M, $43M) which adds valuable context not in the ground truth but appears consistent with detailed 10-K disclosures. The progression shows consistent growth: 2022→2023 increase of $49M (+56%), 2023→2024 increase of $62M (+46%), demonstrating accelerating investment. ENTITY ACCURACY: Correctly identifies Danaher Corporation (DHR), the specific focus on diagnostics testing technologies, and the three-year period (2022-2024). MULTI-HOP REASONING: Successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly interprets the trend as indicating strategic importance. The conclusion that diagnostics testing is becoming a 'key growth engine' is well-supported by the upward trajectory. SEMANTIC EQUIVALENCE: The LLM's phrasing 'government-grant assistance earmarked to offset capital expenditures' is semantically equivalent to the ground truth's 'government grant funds were used to offset capital expenditures.' The characterization of the trend as 'accelerating commitment' and 'key growth engine' aligns with the ground truth's assessment of 'increasingly central to Danaher's strategic focus.' MINOR CONSIDERATIONS: The inclusion of operating expense offsets goes beyond the ground truth but represents additional accurate detail from the source documents rather than an error. The citation format with specific page ranges adds credibility. No calculation errors detected. The answer fully addresses all aspects of the multi-part question regarding evolution, government funding, and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 497,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "BK’s 10‑K filings for 2022, 2023 and 2024 all state that KPMG LLP’s PCAOB firm identification number is **185** and that the ratification is incorporated into the Proxy under **Item 3 – Ratification of KPMG LLP**.  The wording and placement of this disclosure remained unchanged across the three fiscal years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core facts from the ground truth. Strengths: (1) All numeric values are accurate - PCAOB firm identification number 185 is correctly stated; (2) All three fiscal years (2022, 2023, 2024) are correctly identified; (3) The item designation 'Item 3 – Ratification of KPMG LLP' is correctly cited; (4) The key finding that disclosure remained unchanged across all three years is accurately conveyed; (5) The company (BK) and auditor (KPMG LLP) are correctly identified. Minor weaknesses: (1) The LLM answer omits the specific reference to 'Item 14 of the Proxy materials' which provides additional structural context about where Item 3 appears within the broader proxy filing structure - this is a contextual detail that adds precision to the ground truth but is not essential to answering the core question; (2) The phrase 'incorporated into the Proxy' is slightly less precise than the ground truth's 'appearing under Item 3 within Item 14 of the Proxy materials,' though semantically equivalent; (3) The LLM does not explicitly state that the disclosure appeared in 'Proxy sections' for all three years, though this is implied. The multi-hop reasoning is sound - the LLM correctly synthesized information across three fiscal years and identified the consistent pattern. The answer directly addresses the question about how disclosure evolved (or in this case, remained stable) across the three-year period. The quantitative accuracy is perfect with no calculation errors or numeric discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 427,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 to 2024, American Express maintained its reliance on third‑party merchant acquirers but shifted its revenue classification from discount revenue (recorded at the transaction) to processed revenue, which also captures alternative‑payment‑service fees recognized when the service is performed (2022‑2024 10‑K pages 102‑106, 101‑105, 91‑95). Contractually, the company moved from variable‑duration agreements for small‑ and medium‑size merchants and fixed 3‑to‑7‑year contracts for large merchants in 2022 to adding auto‑renewal clauses in 2023 and further formalizing network‑partner and acquirer agreements in 2024. Strategically, it has intensified global merchant‑coverage expansion, targeting priority international cities, destinations, and industry verticals through its third‑party acquirer network (2022‑2024 10‑K pages 102‑106, 101‑105, 91‑95).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of American Express's third-party merchant acquirer relationships from 2022-2024 and correctly identifies the three key dimensions (revenue recognition, contractual relationships, and strategic expansion). However, there are several issues:\n\nSTRENGTHS:\n1. Correctly identifies the shift from discount revenue to processed revenue classification across the 2022-2024 period\n2. Accurately captures the contractual evolution (variable-duration for SMBs, 3-7 year fixed for large merchants in 2022, adding auto-renewal clauses in 2023, formalizing agreements in 2024)\n3. Properly synthesizes the strategic shift toward global merchant expansion targeting international markets and industry verticals\n4. Correctly identifies OptBlue and Global Network Services as relevant programs (implied through context)\n5. Demonstrates sound multi-hop reasoning across three years and multiple dimensions\n\nWEAKNESSES:\n1. QUANTITATIVE ACCURACY: The LLM provides specific 10-K page references (pages 102-106, 101-105, 91-95) that cannot be verified against the ground truth. While these may be accurate, they represent unverifiable claims that reduce confidence in quantitative precision.\n2. MISSING DETAIL: The ground truth explicitly mentions 'Processed Revenue' model formalization in 2023 with royalties, fees, and network partnership agreements. The LLM mentions processed revenue but doesn't explicitly detail the royalties and fees components as clearly.\n3. ALTERNATIVE PAYMENT SERVICES: The LLM introduces 'alternative-payment-service fees' which is not mentioned in the ground truth. While this may be accurate from the filings, it represents information not in the ground truth answer.\n4. REVENUE STRUCTURE CLARITY: The ground truth emphasizes the shift from transactional to strategic partnership model more explicitly. The LLM focuses more on technical revenue classification changes.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and three dimensions (revenue recognition, contracts, strategy), showing appropriate multi-hop reasoning.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - evolution from transactional to strategic relationships - though the emphasis differs slightly.\n\nThe score of 7 reflects that while the answer is substantially correct and well-reasoned, the unverifiable page citations and minor gaps in capturing the full 'Processed Revenue' model framework prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 673,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals—set in the 2022 10‑K and reiterated in the 2023 and 2024 filings—call for a 15 % increase in women and under‑represented minority leaders and a 20 % increase in overall URM representation (see 2022 p. 18‑19, 2023 p. 18, 2024 p. 18). Across fiscal 2022, 2023 and 2024 the HR and Compensation Committee tied progress on those goals to executive bonuses through a non‑financial multiplier of 0.9‑1.1 (see 2022 p. 18, 2023 p. 18, 2024 p. 18), so the performance modifier remained unchanged over the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core quantitative facts: (1) 15% increase target for women and URM in leadership, (2) 20% increase target for overall URM representation, (3) 0.9-1.1 multiplier range for the non-financial modifier, (4) consistency of the modifier across all three fiscal years (2022-2024). The numeric values are accurate and properly formatted. WEAKNESSES: (1) The LLM answer is significantly less complete than the ground truth. It fails to mention that these were '2025 diversity goals' (forward-looking targets), which is an important contextual detail. (2) The answer omits important qualitative evolution details from the ground truth: the 2023 emphasis on 'continued focus on diversity and inclusion' with 'recognition in multiple regions' and 'participation in initiatives like the Reboot Representation Tech Coalition.' (3) The answer misses the 2024 expansion of 'global engagement efforts' and 'broader wellness and development programs,' which the ground truth identifies as evidence of 'deepening integration of human capital metrics into corporate strategy.' (4) The question specifically asks about 'evolution' from 2022-2024, but the LLM answer only states the modifier 'remained unchanged,' missing the narrative of how supporting programs and engagement expanded. (5) The answer provides page citations (which adds credibility) but these are not verifiable in the evaluation context. MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and identifies the consistency of the compensation linkage, but fails to capture the evolution in supporting programs and strategic emphasis that the ground truth highlights. The answer is factually accurate on numbers but incomplete on the broader strategic evolution the question asks about. The response reads more like a summary of static facts rather than an analysis of how the program evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 518,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s EMD‑branded product distribution shrank from 193 countries in 2022 to 187 countries in 2024 (the dealer network fell from 160 to 152 dealers). This modest contraction indicates a strategic realignment that focuses on core, high‑margin markets and streamlines the global distribution footprint to improve efficiency and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key geographic contraction (193 countries in 2022 to 187 countries in 2024). The quantitative data is accurate: the 6-country decline is correctly calculated, and the dealer network figures (160 to 152 dealers) are presented accurately. The answer successfully synthesizes multi-hop information by connecting geographic reach changes to strategic implications. However, there are two minor gaps: (1) The ground truth specifies an intermediate data point (191 countries in 2023), which the LLM omits, reducing completeness of the year-by-year trend analysis. (2) The LLM's interpretation of the contraction as focusing on 'core, high-margin markets' and 'efficiency and profitability' is reasonable strategic inference but goes slightly beyond what the ground truth explicitly states (which characterizes it as 'potential strategic refocusing or consolidation' with possible causes including 'market-specific challenges, competitive pressures, or internal restructuring'). The LLM's interpretation is plausible but represents a more definitive strategic characterization than the ground truth's more cautious framing. The answer is well-structured, addresses the core question about geographic reach changes and strategic positioning, and maintains semantic equivalence with the ground truth despite these minor differences in completeness and interpretive nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 401,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The repeated listing of Palmolive among the principal global trademarks in the 2022, 2023, and 2024 10‑K filings signals that the brand remains a core pillar of Colgate’s Oral, Personal and Home Care segment. It indicates that Palmolive is a key driver of sales, brand equity, and market presence, and that Colgate continues to prioritize and invest in this brand as a strategic asset.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Palmolive's consistent inclusion across 2022-2024 signals strategic importance to Colgate's business. The dates (2022, 2023, 2024) and the three-year consistency are accurately captured. However, the answer has significant weaknesses in specificity and contextual detail compared to the ground truth. STRENGTHS: (1) Correctly identifies the 3-year period of consistent inclusion; (2) Accurately characterizes Palmolive as a 'core pillar' and 'strategic asset'; (3) Properly notes Colgate's continued prioritization and investment. WEAKNESSES: (1) Lacks specific product category details - the ground truth mentions 'liquid hand soap, dishwashing detergents, and household cleaners' while the LLM provides only generic references to 'sales, brand equity, and market presence'; (2) Missing comparative context - the ground truth notes Palmolive's positioning alongside other brands like Colgate and Ajax in 2022, and the addition of Darlie in 2023, which provides important context about competitive positioning; (3) Fails to note that Palmolive maintained position 'without any positional dilution' despite new additions, which is a meaningful detail about its sustained importance; (4) The answer is more generic and less grounded in specific filing evidence than the ground truth. The LLM answer is directionally correct but lacks the granular detail and specific product/competitive context that demonstrates deeper analysis of the filings. The reasoning is sound but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 423,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K (pp. 6‑10) positioned edge‑networking as a key driver of its IoT strategy, noting that the installed base of IoT devices – including edge‑networking products such as mobile broadband and wireless access points – was projected to more than double by 2026.  In the 2023 and 2024 10‑Ks (pp. 71‑75), edge‑networking is listed as a distinct sub‑segment of the IoT portfolio (alongside consumer and industrial), and its equipment revenue is still recognized at point‑in‑time while licensing revenue is recognized over time; the 2024 filing also highlights the separate recognition of previously satisfied performance obligations and unearned revenue tied to future edge‑networking contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Qualcomm's Edge Networking positioning across fiscal 2022-2024 with substantial accuracy. STRENGTHS: (1) Correctly identifies the 27 billion IoT device projection and 'more than double by 2026' language from 2022 10-K; (2) Accurately notes Edge Networking's formalization as a distinct sub-segment in 2023-2024 alongside consumer and industrial applications; (3) Properly synthesizes the revenue recognition structure (point-in-time for equipment, over-time for licensing); (4) Correctly identifies the QCT segment context and references to previously satisfied performance obligations in 2024. WEAKNESSES: (1) The answer lacks explicit mention of 'hybrid work trends' and 'wireless technology advances like 5G and Wi-Fi 6/6E' that were cited in the original answer as contextual drivers in 2022; (2) Does not explicitly state the 'strategic transformation from emerging opportunity to structurally embedded product pillar' narrative that frames the 3-year progression; (3) The phrase 'still recognized' in the 2023-2024 context could be clearer about whether this represents continuity or change from 2022; (4) Missing explicit reference to the 'hybrid work trends' that contextualized the IoT growth story. QUANTITATIVE VERIFICATION: The '27 billion' figure and 'more than double by 2026' language are correctly cited. The page references (pp. 6-10 for 2022, pp. 71-75 for 2023-2024) appear reasonable for 10-K filings but cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects product categorization changes to revenue recognition structures, demonstrating sound multi-hop reasoning. The connection between formalization of Edge Networking as a category and its revenue treatment is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential factual content of the ground truth, though with less narrative framing about strategic transformation. The core claim about evolution from emerging opportunity to embedded pillar is implied but not explicitly stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 567,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s disclosures in 2022, 2023 and 2024 all note that the company’s global operations generate revenue and costs in many currencies and that “fluctuations in currency exchange rates have had, and will continue to have, an impact on our results as expressed in U.S. dollars”【2022‑pages 20‑24】【2023‑pages 17‑21】【2024‑pages 17‑21】.  In each year it reiterates that it uses currency‑hedging instruments to mitigate adverse moves, but that such hedges can forego potential gains and that the coverage remains limited, leaving earnings volatility from FX swings largely unchanged【2022‑pages 20‑24】【2023‑pages 17‑21】【2024‑pages 17‑21】.  No material change in the scope or amount of hedging was disclosed, indicating a largely unchanged approach despite the continued exposure from its international operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Caterpillar's global operations expose it to currency exchange rate risk across 2022-2024. (2) Accurately notes that the company uses currency-hedging instruments in all three years. (3) Correctly captures the key limitation that hedges can forego potential gains. (4) Page references appear reasonable and consistent with typical 10-K structure. (5) Quantitative accuracy is solid - no specific numbers are cited that are verifiably wrong.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely fails to address the evolution/change over time, which is the core of the question. The ground truth explicitly describes a PROGRESSION: 2022 (basic hedging discussion), 2023 (expanded to include exchange controls and currency devaluation risks in emerging markets), and 2024 (intensified emphasis on external macroeconomic pressures). The LLM states \"No material change in the scope or amount of hedging was disclosed, indicating a largely unchanged approach\" - this directly contradicts the ground truth's finding of evolving risk management emphasis. (2) MISSING KEY EVOLUTION: The ground truth identifies a growing concern over geopolitical and macroeconomic volatility, particularly regarding emerging markets, exchange controls, and devaluation risks. The LLM answer makes no mention of these specific risk categories or their evolution. (3) INCOMPLETE SYNTHESIS: The question asks specifically about how management \"evolved\" - the LLM fails to synthesize the multi-year progression that the ground truth clearly documents. (4) TONE MISMATCH: The ground truth describes an \"increasingly cautious approach\" with \"rising emphasis on external macroeconomic pressures\" - the LLM characterizes it as \"largely unchanged,\" which is semantically opposite to the ground truth's finding of evolution.\n\nMULTI-HOP REASONING: The LLM demonstrates basic multi-hop reasoning by connecting information across three years, but fails at the critical synthesis task of identifying and explaining the evolution/changes across those years. The answer reads as a static description rather than a dynamic analysis of change over time.\n\nCONCLUSION: While the LLM provides accurate foundational information about Caterpillar's currency hedging practices, it fundamentally misses the primary analytical requirement of the question - demonstrating how the company's approach EVOLVED from 2022 to 2024. The claim of \"largely unchanged approach\" contradicts the ground truth's documented progression in risk emphasis and disclosure scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 685,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive cut its U.S. Treasury/agency exposure in the pension plan fixed‑income portfolio from roughly 40 % in 2022 to about 30 % in 2023, and the allocation remained at that level in 2024 (CL_10k_2022, p. 101; CL_10k_2023, p. 103; CL_10k_2024, p. 100). This downward trend and subsequent plateau indicate a deliberate move to diversify away from Treasury securities, suggesting the company is moderating duration and interest‑rate risk by adopting a more balanced fixed‑income mix during the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the allocation percentages. According to the ground truth, the allocation was 50% (2020), 40% (2021), 30% (2022), 30% (2023), and 30% (2024). The LLM states the allocation was 'roughly 40% in 2022' when it should be 30% in 2022. This is a fundamental error that misrepresents the trend. The LLM correctly identifies the 30% level for 2023-2024 and the general downward trend, but the starting point for the 2022-2024 period is wrong. MISSING HISTORICAL CONTEXT: The ground truth provides important context that the decline began earlier (from 50% in 2020 to 40% in 2021 to 30% in 2022), showing a two-year reduction followed by stabilization. The LLM only captures the 2022-2024 period and misses the 2020-2021 decline, which is relevant to understanding the full evolution requested in the question. REASONING QUALITY: The LLM's interpretation about diversification away from Treasury securities and moderating duration/interest-rate risk is reasonable and aligns with the ground truth's assessment. However, the LLM misses the important detail about Level 2 classification and its implications for liquidity considerations. ENTITY AND METRIC ACCURACY: Company name (Colgate-Palmolive), ticker (CL), and metric (U.S. Treasury and agency securities allocation) are correctly identified. The pension plan fixed income portfolio context is correct. CALCULATION/COMPARISON: The LLM correctly identifies the decline from 40% to 30% (as stated in their answer), but this is based on an incorrect starting point for 2022. The actual trend from 2020-2024 shows a more significant strategic shift than the LLM captures. OVERALL ASSESSMENT: While the LLM demonstrates understanding of the general concept and provides reasonable interpretation of interest rate risk management, the quantitative inaccuracy regarding the 2022 baseline percentage is a critical flaw that undermines the credibility of the analysis. The answer is partially correct but contains a material factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 558,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "From 2022 through 2024 Pfizer consistently reported **no Breakthrough Performance Awards (BPAs) granted or outstanding** (2022 note, 2023 note, 2024 note).  The valuation methodology remained unchanged—BPAs were valued at the intrinsic value using the closing price of Pfizer’s common stock and amortized over the vesting term (described in each year’s note).  Disclosure transparency stayed consistent, with each filing explicitly stating zero BPA activity and providing the same terms, valuation, and accounting treatment for the award type.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical factual points: (1) QUANTITATIVE ERRORS: The LLM claims 'no Breakthrough Performance Awards (BPAs) granted or outstanding' across all three years (2022-2024), but the ground truth explicitly states that in 2022, Pfizer granted 1,165 thousand shares at $38.73 weighted average intrinsic value with 859 thousand shares nonvested. These are specific, verifiable numbers that the LLM completely missed or misrepresented. (2) FACTUAL INACCURACY ON 2023: While the LLM correctly states no BPAs were granted in 2023, it fails to acknowledge the significant shift that occurred. (3) FACTUAL INACCURACY ON 2024: The LLM claims 2024 showed 'zero BPA activity' with 'unchanged valuation methodology,' but the ground truth indicates BPAs 'reappeared in disclosures' with 'detailed valuation and amortization policies introduced' - a material change in disclosure transparency and methodology. (4) MISSING EVOLUTION NARRATIVE: The LLM completely fails to capture the 3-year trajectory described in the ground truth: active issuance (2022) → suspension (2023) → reappearance with enhanced transparency (2024). This is the core of the question asking about 'evolution.' (5) REASONING FAILURE: The LLM's claim that 'disclosure transparency stayed consistent' directly contradicts the ground truth's finding of a 'strategic shift' toward 'more transparent and dynamic valuation framework.' The LLM demonstrates a fundamental misunderstanding of the source material and provides answers that are factually incorrect on specific numbers, dates, and the overall narrative arc of BPA treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 456,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "From 2022 through 2024 Schwab’s Advisor Services portal consistently offered RIAs an interactive web platform that provided account‑management, trade execution, archival tools and a free Schwab Advisor Portfolio Connect for portfolio oversight, while also enabling third‑party integrations for CRM, portfolio‑management, trade‑order and financial‑planning systems. The core interactive features and integration framework remained largely unchanged in 2023, continuing to support the same suite of tools and services. In 2024 Schwab expanded these capabilities by integrating the thinkpipes trading platform and the iRebal portfolio‑rebalancing solution, giving RIAs more advanced, automated portfolio‑management options beyond the simplified Advisor Portfolio Connect.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Most critically: (1) The LLM claims Schwab 'expanded these capabilities by integrating the thinkpipes trading platform and the iRebal portfolio-rebalancing solution' in 2024 - these specific integrations are NOT mentioned in the ground truth and appear to be fabricated details. (2) The LLM states 'The core interactive features and integration framework remained largely unchanged in 2023' - this contradicts the ground truth which explicitly notes that 2023 saw 'increased emphasis on the Advisor Services website as a core platform' with new features like 'multi-year document archiving and search capabilities.' (3) The LLM mischaracterizes the evolution by suggesting 2024 brought 'more advanced, automated portfolio-management options beyond the simplified Advisor Portfolio Connect' - the ground truth indicates 2024 'continued to offer Schwab Advisor Portfolio Connect' without suggesting it was superseded or that new automated solutions were added. (4) The LLM correctly identifies Schwab Advisor Portfolio Connect and third-party integrations (CRM, portfolio management, trade order, financial planning) which are accurate per ground truth. (5) The LLM correctly notes the Advisor Services website/portal as a core platform. However, the introduction of specific third-party tools (thinkpipes, iRebal) in 2024 appears to be hallucinated information not supported by the ground truth. The answer fails to capture the key evolution: the shift in emphasis from proprietary software to the Advisor Services website platform (2022→2023) and the refinement toward 'intuitive modern experience' (2024). The multi-hop synthesis is flawed because it invents specific product integrations rather than accurately tracking the documented evolution of platform emphasis and usability enhancements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 509,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across 2022, 2023, and 2024 Texas Instruments consistently framed its strategy around analog and embedded‑processing products, noting a modest 3 % rise in embedded‑processing revenue in 2023 and a 25 % decline in 2024 but maintaining it as a core focus (2022 MD&A, pages 18‑22; 2023 MD&A, pages 16‑20; 2024 MD&A, pages 16‑20). This unchanging emphasis signals TI’s long‑term positioning as a leading analog‑and‑embedded‑processing supplier—particularly for industrial and automotive markets—where a diversified, high‑margin portfolio underpins sustained free‑cash‑flow growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic emphasis on embedded processing products across 2022-2024 and appropriately synthesizes the multi-hop information about TI's long-term positioning. However, there are significant quantitative accuracy issues that prevent a higher score. STRENGTHS: (1) Correctly identifies the consistent framing of embedded processing as central to TI's strategy across all three years; (2) Appropriately connects this to long-term positioning in semiconductor markets; (3) Correctly identifies industrial and automotive markets as key focus areas; (4) Properly synthesizes the multi-hop reasoning about free cash flow growth; (5) Provides specific MD&A page references showing research depth. CRITICAL WEAKNESSES: (1) The specific revenue percentages cited (3% rise in 2023, 25% decline in 2024) cannot be verified against the ground truth provided and appear to be unsupported claims. The ground truth does not mention these specific percentage changes; (2) The ground truth emphasizes the 'four sustainable competitive advantages' framework as the consistent strategic messaging, which the LLM answer omits entirely; (3) The ground truth specifically notes that embedded processing is 'point 1.ii' of the four pillars, indicating a structured strategic framework that the LLM answer does not capture. REASONING ASSESSMENT: The multi-hop synthesis is sound in connecting consistent messaging to long-term positioning, but the introduction of unverified quantitative claims undermines credibility. The LLM appears to have fabricated or misremembered specific revenue figures without proper grounding in the source material. The qualitative reasoning about market positioning and free cash flow is appropriate and well-reasoned, but the quantitative claims create factual errors that significantly impact overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 505,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Fleet‑support costs stayed essentially flat, remaining about 1 % of total consolidated costs in 2022 (pages 40‑44) and again in 2024 (pages 37‑41).  Abnormal 787 production costs, however, rose sharply—from a projected $2 billion in 2022 to $2.7 billion by year‑end 2023 (pages 34‑38) and then $256 million in 2024 (pages 37‑41) as rework and inspections were expensed.  Delivery delays mirrored this trend: 787 deliveries were paused in 2021, resumed at roughly five per month in 2023, but slowed again below five per month in 2024 due to supply‑chain constraints and rework, continuing to affect the program’s schedule.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trajectory of Boeing's 787 abnormal costs and delivery challenges but contains a significant quantitative error and some unsupported claims. CORRECT ELEMENTS: (1) Fleet support services remained ~1% of consolidated costs in both 2022 and 2024 - accurate; (2) $2.7 billion cumulative abnormal costs by end of 2023 - correct; (3) $256 million in rework costs expensed in 2024 - correct; (4) General narrative about delivery delays and rework progression - semantically aligned. CRITICAL ERRORS: (1) The LLM states abnormal costs 'rose sharply from a projected $2 billion in 2022 to $2.7 billion by year-end 2023.' The ground truth does NOT disclose a specific $2 billion figure for 2022 - it states 'no specific abnormal cost figures disclosed' for 2022. This is a factual error that misrepresents the 2022 disclosure; (2) The claim about '787 deliveries were paused in 2021, resumed at roughly five per month in 2023, but slowed again below five per month in 2024' is not supported by the ground truth, which focuses on inventory rework completion and 2025 delivery expectations rather than specific monthly delivery rates. MULTI-HOP REASONING: The answer attempts to synthesize fleet support costs with 787 abnormal costs across three years, which is appropriate to the question. However, the unsupported delivery rate claims suggest the LLM may have extrapolated beyond the source material. COMPLETENESS: The answer addresses the evolution of both cost profile and delivery impact, though the delivery impact discussion relies on claims not in the ground truth. The answer correctly identifies the progression from delays/instability (2022) through peak abnormal costs (2023) to reduced costs and ongoing rework (2024). The quantitative error regarding the 2022 baseline and the unsupported delivery rate specifics prevent a higher score despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 516,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold Meridian to a purchaser on December 31, 2021 for about $51 million, recording a $167 million loss (net of tax) in 2021.  In 2022 no cash or revenue was recorded under the post‑sale transition‑service agreements (TSAs) or the manufacturing‑service agreement (MSA); the MSA was set for a three‑year term with a two‑year extension.  By 2023 the TSAs had been completed (but still not material to the financial statements), and the 2024 filing confirms the same MSA framework remains in place with no material amounts recorded through 2024.  (Sources: 2022 10‑K pp. 114‑118; 2023 10‑K pp. 71‑75; 2024 10‑K pp. 2‑6.)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the Pfizer-Meridian relationship evolution and correctly identifies key financial and contractual elements. STRENGTHS: (1) Correctly identifies the December 31, 2021 sale date; (2) Accurately states the $167 million loss (net of tax); (3) Properly describes the three-year MSA with two-year extension option; (4) Correctly notes TSAs were completed by end of 2023; (5) Accurately conveys that amounts under MSA were not material; (6) Provides appropriate source citations; (7) Correctly synthesizes the multi-hop evolution from 2022-2024. WEAKNESSES: (1) States 'no cash or revenue was recorded' in 2022 under TSAs/MSA - the ground truth indicates TSAs and MSA were 'in place' but doesn't explicitly state zero amounts were recorded in 2022 specifically, creating potential ambiguity about whether this is a precise statement or inference; (2) The sale price of 'about $51 million' is mentioned but not in the ground truth answer, which focuses on the loss rather than proceeds - while this may be factually correct from the filings, it introduces information not in the ground truth that could be verified; (3) Minor: The statement 'but still not material to the financial statements' in 2023 is slightly awkwardly phrased compared to ground truth's clearer 'amounts recorded under the MSA were not material.' The core narrative arc is correct: sale in 2021 → TSAs/MSA in place 2022 → TSAs completed 2023 → MSA continues 2024. The answer successfully addresses the question's three components: financial implications (loss, non-materiality), contractual arrangements (TSAs, MSA terms), and evolution over time. Multi-hop reasoning is sound, synthesizing information across three fiscal years appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 478,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate‑Palmolive continues to list **hello** as one of its global trademarks within the Oral, Personal and Home Care segment and makes no mention of a repositioning or strategic shift for the brand in its 2022, 2023 or 2024 10‑Ks. The filings show that hello remains marketed alongside other global brands such as Colgate, Palmolive, and others, with its positioning relative to the other product lines staying essentially unchanged over the period【CL_10k_2022.pdf pages 75‑79】【CL_10k_2023.pdf pages 77‑81】【CL_10k_2024.pdf pages 77‑81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Strengths: (1) Correctly identifies 'hello' as a global trademark in the Oral, Personal and Home Care segment across all three years (2022-2024); (2) Accurately states that no repositioning or strategic shift occurred; (3) Correctly notes that 'hello' remained positioned alongside other major brands like Colgate and Palmolive; (4) Properly cites specific page ranges from the 10-K filings (pages 75-79 for 2022, 77-81 for 2023 and 2024), demonstrating multi-hop synthesis across three years of documents; (5) Uses appropriate semantic language ('essentially unchanged,' 'sustained emphasis') that aligns with the ground truth's conclusion about consistent positioning. Minor considerations: (1) The LLM answer is slightly more concise than the ground truth, which explicitly mentions Darlie's addition in 2023 as a contextual detail; however, this omission does not affect the core factual accuracy of the answer; (2) The ground truth uses the phrase 'sustained strategic emphasis' and 'continued prioritization,' while the LLM uses 'positioning staying essentially unchanged' - both convey the same meaning but with slightly different emphasis. The LLM's approach of stating 'no mention of repositioning' is actually more precise and defensible given the filing language. Overall, the answer correctly synthesizes information across three years of filings and accurately conveys that 'hello' maintained consistent strategic positioning within the broader portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 421,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Texas Industries’ non‑qualified defined‑benefit pension plan has stayed **unfunded and closed to new participants** throughout 2022‑2024, with no change in its funding status reported in the 10‑Ks. Because the plan is closed, **participant engagement has remained static**—only the existing cohort continues to accrue benefits, and no new hires are added. This steady, unfunded status shows that the company’s long‑term pension liabilities are concentrated in the qualified defined‑benefit plan (which remains under‑funded), while the non‑qualified plan is not being expanded or funded, reflecting a shift toward defined‑contribution plans for new employees.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) COMPANY NAME ERROR: LLM states 'Texas Industries' instead of 'Texas Instruments' - this is a fundamental entity identification error that undermines credibility. (2) MISSING QUANTITATIVE DATA: The ground truth provides specific, verifiable numbers across 2022-2024 that the LLM completely omits: TI common stock holdings (6M shares in 2022 declining to 5M in 2023-2024), valuations ($940M→$873M→$852M), dividend payments ($28M→$27M→$26M), and defined contribution plan expenses ($70M→$75M→$76M). These are concrete, multi-year data points essential to answering the question about 'evolution' and 'progression.' (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about 'multi-year progression' and what it 'indicates' about long-term obligations. The ground truth demonstrates this through quantitative trends (declining stock holdings, declining dividends, increasing DC expenses). The LLM provides only qualitative statements ('unfunded and closed,' 'participant engagement remained static') without the supporting numerical evidence that demonstrates the actual evolution. (4) VAGUE REASONING: The LLM's claim that 'participant engagement has remained static' is unsupported by any data. The ground truth shows measurable changes in plan composition and company spending patterns that indicate strategic shifts. (5) PARTIAL CREDIT: The LLM correctly identifies that the plan is unfunded, closed to new participants, and that the company is shifting toward defined contribution plans. However, these correct elements are insufficient without the quantitative evidence of HOW this evolution occurred. The answer reads as generic pension plan knowledge rather than specific analysis of TI's actual 2022-2024 filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 477,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity at cost declined from **$800 million** at 12/31/2022 to **$755 million** at 12/31/2023 and further to **$719 million** at 12/31/2024. This steady downward trend over three years indicates a deliberate reduction in exposure to private‑equity securities, suggesting the company is reallocating capital toward other investments or risk‑management priorities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect starting value: claims $800 million at 12/31/2022, but ground truth shows $623 million. This is a $177 million discrepancy (28% error). The 2023 and 2024 figures ($755M and $719M) are correct. (2) TRAJECTORY MISCHARACTERIZATION - The LLM describes a 'steady downward trend' from $800M→$755M→$719M, but the actual trajectory is $623M→$755M→$719M, which shows an INCREASE in 2023 followed by a decrease in 2024. The LLM's interpretation fundamentally misrepresents the strategic pattern. (3) STRATEGIC INTERPRETATION ERROR - The LLM concludes the company is 'deliberately reducing exposure' and 'reallocating capital,' but the ground truth indicates a 'measured approach' with a 'short-term strategic increase in 2023 followed by a partial reduction in 2024.' These are opposite conclusions. The 2023 increase contradicts the 'steady downward' narrative. (4) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the company (Pfizer/PFE) and metric (long-term private equity securities at cost), it fails to accurately synthesize the three-year data points. The incorrect 2022 baseline cascades through the entire analysis. (5) ENTITY ACCURACY - Company and metric identification are correct, but the fiscal year data is materially wrong. The error is not a minor formatting issue but a fundamental factual mistake that invalidates the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 398,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "Under the 2019 IDA agreement that was still in effect in 2022, Schwab could move up to $10 billion of IDA balances each year, but only floating‑rate balances and only if it kept a minimum $50 billion IDA balance and at least 80 % of balances as fixed‑rate obligations through 2026; it migrated roughly $10 billion that year. The 2023 IDA agreement replaced those terms, eliminated the 80 % fixed‑rate rule, required Schwab to maintain balances above the total of unmatured fixed‑rate obligations with a $30 billion ceiling, and limited withdrawals to customer‑initiated amounts; Schwab did not migrate any balances in 2023 or 2024, and the same minimum‑balance and withdrawal constraints applied in 2024. In each year, the migration option was also contingent on Schwab’s capital levels and the binding limitations set out in the applicable IDA agreement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - LLM claims 2022 had a '$50 billion minimum IDA balance' requirement - NOT in ground truth\n   - LLM claims '80% fixed-rate obligation' requirement through 2026 - NOT in ground truth\n   - LLM states Schwab 'migrated roughly $10 billion that year' (2022) - ground truth says $10.1 billion was moved by December 31, 2021, not 2022\n   - LLM claims 2023 agreement 'eliminated the 80% fixed-rate rule' - this rule was never mentioned in ground truth for 2019 agreement\n   - LLM introduces '$30 billion ceiling' for 2023-2024, which matches ground truth but context is muddled\n\n2. FACTUAL INACCURACIES:\n   - The LLM fabricates specific constraints (50B minimum, 80% fixed-rate) that don't appear in the ground truth\n   - Ground truth clearly states in 2022 the option was 'up to $10 billion annually' with 'capital sufficiency and other limitations' - NOT the specific constraints LLM lists\n   - LLM's claim about 'floating-rate balances only' is not mentioned in ground truth\n   - LLM's statement about 'customer-initiated amounts' limiting withdrawals in 2023 is not in ground truth\n\n3. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the evolution across years\n   - Ground truth shows clear progression: 2022 (annual $10B option) → 2023 (new agreement with minimum/maximum thresholds) → 2024 (same constraints as 2023)\n   - LLM conflates details and introduces unsupported specifics\n\n4. WHAT WAS CORRECT:\n   - Correctly identifies 2019 and 2023 IDA agreements\n   - Correctly states no migrations in 2023 and 2024\n   - Correctly identifies $30 billion maximum threshold\n   - Correctly notes capital contingency\n   - Correctly identifies the tightening of constraints over time\n\n5. CRITICAL ISSUE:\n   - The LLM appears to have hallucinated specific constraint details (50B minimum, 80% fixed-rate rule) that are not in the ground truth, which is a serious factual error in a financial context where precision is essential",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 564,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments listed Melaka, Malaysia as an analog‑manufacturing site in its 2022, 2023 and 2024 10‑K filings (TXN_10k_2022.pdf pp. 16‑18; TXN_10k_2023.pdf pp. 14‑18; TXN_10k_2024.pdf pp. 14‑18). The site remained solely an analog facility, with no embedded‑processing designation, across all three years. This persistent, multi‑year presence signals a deliberate, long‑term commitment to analog production at Melaka, underscoring its strategic value as a stable, cost‑effective manufacturing hub in Southeast Asia.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Melaka, Malaysia was listed as an analog manufacturing site across all three years (2022, 2023, 2024) in Texas Instruments' 10-K filings. The core factual claim about consistent presence is accurate. The page references provided (pp. 16-18 for 2022, pp. 14-18 for 2023 and 2024) are plausible and specific. The conclusion about strategic importance and long-term commitment is reasonable. WEAKNESSES: (1) The LLM answer omits the specific marking symbols mentioned in the ground truth († in 2022, * in 2023, ** in 2024), which are factually important details that indicate potential escalation in operational emphasis. (2) The ground truth explicitly notes 'potentially signaling continued operational emphasis' based on the progression of symbols, but the LLM answer does not capture this nuance about the evolution of the markings. (3) The LLM adds interpretive language ('solely an analog facility, with no embedded-processing designation') that goes beyond what the ground truth states—while this may be accurate, it represents additional claims not verified against the source material. (4) The LLM's characterization of Melaka as 'cost-effective manufacturing hub' is an inference not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the pattern of consistent presence. However, it misses the specific evolution indicated by the changing symbols, which is a key part of the 'multi-year consistency' analysis requested. The reasoning about strategic importance is sound but incomplete relative to the ground truth's more detailed observation about potential escalation. FACTUAL ACCURACY: The core facts are correct (location, years, product type), but the omission of the symbol progression represents incomplete capture of the factual record.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 509,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Circle Card penetration – which includes the Target Debit Card – fell from **20.5 % in 2022** to **19.8 % in 2023** and **18.6 % in 2024** (2024 Form 10‑K, p. 27‑31; 2023 Form 10‑K, p. 25‑29; 2022 Form 10‑K, p. 44‑48). This downward trend suggests the card’s ability to generate incremental sales is weakening, as fewer guests are using it for purchases, thereby reducing its incremental‑sales contribution over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the 2024 penetration rate as 18.6%, but the ground truth shows it as 17.8%. This is a factual error of 0.8 percentage points, which is material for a metric tracking card penetration trends. CORRECT FIGURES: 2022 (20.5%) and 2023 (19.8%) are accurate. REASONING QUALITY: The LLM correctly identifies the downward trend and appropriately interprets it as suggesting weakening incremental sales contribution. The synthesis of information across multiple years is sound, and the conclusion about reduced effectiveness is logically consistent with the declining penetration rates. COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates AND what the trend suggests about the card's role. ENTITY ACCURACY: Correctly identifies Target Circle Card (which includes Target Debit Card) and properly references the 10-K filings. SEMANTIC EQUIVALENCE: The interpretation that declining penetration suggests 'weakening ability to generate incremental sales' and 'reduced effectiveness' aligns well with the ground truth's assessment of 'diminishing role' and 'reduced effectiveness.' The mention of the 5% discount incentive in the ground truth is not included in the LLM answer, but this is a minor omission. The core issue is the quantitative error in the 2024 figure, which undermines the accuracy of the trend analysis despite the sound reasoning about what the trend means.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 402,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "Texas Instruments’ 2003 Director Compensation Plan has been largely exhausted over the past three years – the plan’s shares are no longer separately disclosed in the 2024 equity‑compensation table (the total shares available for future issuance under all plans fell from 69.8 million in 2022 to 58.5 million in 2023 and rose to 65.5 million in 2024). This trend indicates the company is depleting the older plan’s balance and replenishing director equity incentives through newer plans (e.g., the 2024 LTIP) rather than restocking the 2003 plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors and fails to address the specific question asked. Critical issues: (1) WRONG NUMBERS: The LLM provides completely different share counts (69.8M, 58.5M, 65.5M) that do not match the ground truth figures (35.4M in 2022, 25.3M in 2023, 24.5M in 2024). These appear to be aggregate figures across all equity plans, not the 2003 Director Compensation Plan specifically. (2) MISIDENTIFICATION OF PLAN: The question explicitly asks about the 2003 Director Compensation Plan, but the LLM conflates this with total shares available under all plans combined. The ground truth clearly tracks the specific 2003 plan's evolution. (3) INCORRECT INTERPRETATION: The LLM claims the 2003 plan 'is no longer separately disclosed in the 2024 equity-compensation table,' but the ground truth shows it was tracked through 2024 with 24,503,062 shares available. (4) WRONG TREND ANALYSIS: The LLM describes a rise from 2023 to 2024 (58.5M to 65.5M), which contradicts the ground truth showing a continued decline (25.3M to 24.5M). (5) UNSUPPORTED CONCLUSION: The LLM's inference about 'newer plans (e.g., the 2024 LTIP)' replenishing director equity is not supported by the ground truth, which shows consistent depletion without replenishment. The LLM appears to have confused aggregate plan data with plan-specific data and provided numbers from a different context entirely. The answer fails to directly answer the specific question about the 2003 Director Compensation Plan's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 418,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In 2022 Visa Direct added push‑to‑wallet capabilities that let financial institutions send funds to nearly 7 billion cards, accounts and wallets worldwide, expanding its card‑based, ACH and RTP reach. By 2023 the platform had broadened its cross‑border reach—supporting P2P, A2A and government payouts in 195 + countries—yet still relied on traditional account identifiers. In 2024 Visa integrated its digitally native Currencycloud platform into Visa Direct, adding virtual accounts, real‑time FX rates and enhanced liquidity/settlement, thereby expanding cross‑border use cases and enabling new digital flows.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM states 7 billion endpoints in 2022, but ground truth indicates 11 billion endpoints were mentioned in 2024\n   - LLM mentions 195+ countries in 2023, but ground truth does not provide this specific metric\n   - Ground truth emphasizes $20 trillion in B2B cross-border opportunities in 2024, which LLM completely omits\n   - The endpoint numbers appear to be conflated or misplaced chronologically\n\n2. ENTITY AND TIMELINE ACCURACY ISSUES:\n   - LLM incorrectly sequences the Currencycloud integration: states it occurred in 2024, but ground truth indicates Currencycloud was introduced in 2022 as part of Visa Treasury as a Service\n   - LLM describes 2022 as when Visa Direct added push-to-wallet capabilities, but ground truth focuses on virtual accounts introduction in 2022\n   - The chronological progression is reversed/misaligned\n\n3. COMPLETENESS ISSUES:\n   - LLM mentions push-to-wallet and traditional account identifiers, which are not emphasized in ground truth\n   - LLM omits the specific mention of Visa Treasury as a Service context from 2022\n   - LLM omits the $20 trillion B2B opportunity figure entirely\n   - LLM does not adequately capture the 'deepening integration' narrative that is central to ground truth\n\n4. MULTI-HOP REASONING:\n   - The LLM fails to correctly synthesize the three-year progression\n   - It reverses the timeline of Currencycloud integration (placing it in 2024 when it was introduced in 2022)\n   - The connection between virtual accounts and the broader digital capabilities network is not clearly established\n\n5. SEMANTIC ISSUES:\n   - While the LLM correctly identifies virtual accounts, Visa Direct, and cross-border capabilities as key elements, it misorders their evolution\n   - The narrative of 'deepening integration' from ground truth is not captured\n   - The strategic context around B2B opportunities is missing\n\nThe answer demonstrates partial understanding of the topic but contains fundamental chronological errors and omits critical quantitative and strategic information from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 594,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s revenue slipped 1 % in 2023, prompting Pfizer to ramp up lifecycle‑management efforts.  This focus helped secure the EU indication approval in April 2024 (PFE_10k_2024, pp. 44‑48).  The asset’s value within Pfizer’s intangible portfolio was recorded at $19.6 billion in 2022, reflecting the developed‑technology‑rights carrying amount that includes Xtandi (PFE_10k_2022, pp. 90‑94).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key facts: (1) Xtandi's 1% revenue decline in 2023 is accurate; (2) the 2024 EU indication approval in April is correctly cited; (3) the $19.6 billion valuation for developed technology rights in 2022 is accurate. However, there are notable gaps and minor issues: (1) The LLM mentions only the EU indication approval but does not specify the indication itself (nmCSPC with biochemical recurrence at high risk for metastasis), which is a material detail in the ground truth; (2) The LLM does not fully articulate the strategic connection between revenue pressures and lifecycle management investment—it states the relationship but doesn't explain the causal logic as thoroughly as the ground truth; (3) The LLM correctly identifies the $19.6 billion figure but doesn't contextualize it as clearly as the ground truth regarding Xtandi's significance within Pfizer's oncology portfolio; (4) The multi-hop synthesis is present but incomplete—the answer connects 2023 pressures to 2024 actions and 2022 valuation, but the narrative could be stronger in explaining how the 2022 valuation informed strategic decisions. The quantitative data is accurate (1% decline, $19.6B, April 2024), and the document citations appear appropriate. The answer is factually sound but lacks the depth of contextual explanation present in the ground truth regarding the strategic importance of lifecycle management in offsetting market challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 403,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (total RedCard penetration for the same periods). This downward trend signals a gradual shift in consumer preference away from the card and a weakening of engagement with Target’s loyalty program, suggesting the need for refreshed incentives to retain card usage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All three penetration rate figures are correct (20.5% in 2022, 19.8% in 2023, 18.6% in 2024). The numerical data matches the ground truth exactly with no calculation errors. ENTITY ACCURACY: The answer correctly identifies the Target MasterCard Credit Card and appropriately notes the rebranding context (RedCard to Target Circle Cards), showing understanding of the product evolution. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend data and correctly interprets the downward trajectory as indicating a shift in consumer preferences and weakening loyalty engagement. SEMANTIC EQUIVALENCE: The LLM's interpretation that the trend 'signals a gradual shift in consumer preference away from the card and a weakening of engagement with Target's loyalty program' is semantically equivalent to the ground truth's statement about 'a shift in consumer payment preferences or a weakening in loyalty program engagement.' MINOR OBSERVATION: The LLM adds an interpretive element ('suggesting the need for refreshed incentives to retain card usage') that goes slightly beyond the ground truth's more neutral observation of what the trend 'indicates.' This is a reasonable inference but represents a minor addition beyond the factual analysis. The parenthetical note about 'total RedCard penetration' is slightly ambiguous in phrasing but contextually appropriate. Overall, the answer is factually accurate, complete, and demonstrates sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 438,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa’s Currencycloud platform began offering virtual accounts in FY 2022 as a way to give clients a “digital‑only” bank‑account that could receive, hold, and send funds across Visa’s network. By FY 2023 the platform had expanded to support real‑time foreign‑exchange rates and liquidity management, allowing cross‑border payments to be settled in multiple currencies and routed through Visa’s growing multilateral B2B network. In FY 2024 the service was further scaled to cover more than 11 billion cards, bank accounts and digital wallets, extending virtual‑account coverage to over 195 countries and enabling instant, real‑time cross‑border transfers with enhanced settlement and liquidity controls. Thus, over three years the virtual‑account offering evolved from a basic digital‑account tool to a fully integrated, multi‑currency, real‑time cross‑border payment engine that reaches Visa’s entire global network.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a major factual error regarding network reach. The ground truth states the network reached 'over 11 billion endpoints' by 2023, but the LLM incorrectly attributes this to 2024 and then adds an unsupported claim of 'over 195 countries' coverage. The ground truth specifies 'more than 100 countries' via Visa B2B Connect in 2024, not 195. This is a significant numerical discrepancy. (2) TIMELINE MISALIGNMENT - The LLM conflates the 11 billion endpoint metric with 2024, when the ground truth clearly places this milestone in 2023. The progression of capabilities is therefore misrepresented chronologically. (3) MISSING KEY DETAILS - The ground truth emphasizes 'real-time foreign exchange rates and enhanced liquidity and settlement capabilities' as introduced in 2022, but the LLM attributes these to 2023. The ground truth also specifically mentions 'Visa Direct Platform' integration in 2023 and 'Visa B2B Connect' in 2024, which the LLM mentions generically without proper temporal attribution. (4) UNSUPPORTED CLAIMS - The '195 countries' figure appears nowhere in the ground truth and represents a factual error. The ground truth's 'over 100 countries' through B2B Connect is the correct metric for 2024. (5) PARTIAL CREDIT - The LLM correctly identifies the basic evolution of virtual accounts from a digital-only account tool to a multi-currency cross-border payment solution, and correctly names the Currencycloud platform. The overall narrative structure is sound, but the specific quantitative details and temporal attribution are significantly flawed. The answer demonstrates understanding of the general concept but fails on precise factual accuracy required for financial/technical documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 486,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑Ks all list “difficulties in protecting our intellectual property” as a key risk tied to its worldwide operations and reliance on third‑party wafer foundries and manufacturing facilities in China, Malaysia and Taiwan.  While the core exposure has remained unchanged, the 2023 and 2024 filings add context of heightened geopolitical tensions and U.S. sanctions (e.g., against Russia, Belarus and the DNR/LNR regions) and export‑control revisions that amplify the IP‑risk for those overseas partners, underscoring an increasingly volatile environment for AMD’s international supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across AMD's 2022, 2023, and 2024 10-K filings. STRENGTHS: (1) Correctly identifies the consistent mention of 'difficulties in protecting our intellectual property' across all three years; (2) Accurately names the specific manufacturing locations (China, Malaysia, Taiwan); (3) Properly identifies the evolution of geopolitical concerns, including references to Russia, Belarus, DNR/LNR sanctions, and export controls; (4) Correctly characterizes the progression from baseline IP risk to increasingly complex geopolitical and regulatory pressures; (5) Accurately synthesizes the connection between third-party manufacturing dependencies and IP protection challenges. MINOR GAPS: (1) The ground truth specifically mentions the China-Taiwan geopolitical instability as a distinct concern in 2023, which the LLM answer does not explicitly call out (though it references geopolitical tensions generally); (2) The ground truth mentions the Israel-Hamas conflict as an additional regulatory pressure in 2024, which the LLM answer omits; (3) The LLM answer could have been more explicit about the 2024 addition of 'evolving export control regulations and sanctions' as a new dimension. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023, 2024) are correct; geographic references are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing documents, correctly identifying the evolution pattern and connecting IP protection challenges to both manufacturing dependencies and geopolitical factors. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—AMD's IP protection concerns have remained consistent while becoming increasingly complex due to geopolitical and regulatory factors. The LLM's characterization of an 'increasingly volatile environment' effectively captures the ground truth's notion of 'deepening concern over time.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 558,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "UNP’s pension plan shifted its corporate‑stock holdings from largely Level 2/3 in 2022 (1,104 million at Level 2 and 7 million at Level 3【UNP_10k_2022.pdf: pages 70‑74】) to predominantly Level 1 in 2023 (176 million at Level 1 and 5 million at Level 2【UNP_10k_2023.pdf: pages 56‑60】) and maintained a Level 1‑heavy composition in 2024 (220 million at Level 1 and 6 million at Level 2【UNP_10k_2024.pdf: pages 54‑58】). The dollar amount of corporate stock fell from 1,111 million (≈37 % of fair‑value assets) in 2022 to 181 million (≈5 %) in 2023, then rose modestly to 226 million (≈7 %) in 2024 but remained well below 2022 levels【UNP_10k_2022.pdf: pages 70‑74】【UNP_10k_2023.pdf: pages 56‑60】【UNP_10k_2024.pdf: pages 54‑58】. This evolution reflects a de‑risking pension strategy that reduces direct corporate‑equity exposure while increasing liquidity and aligning the plan’s market exposure with its target equity allocation of 20‑30 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years:\n\n2022 VALUATION ERROR: LLM claims 1,104 million at Level 2 and 7 million at Level 3, totaling ~1,111 million. Ground truth shows 1,980 million at Level 1 and 10 million at Level 2, totaling 1,990 million. This is a massive discrepancy - the LLM has the wrong classification structure entirely (claims Level 2/3 dominance when ground truth shows Level 1 dominance) and wrong dollar amounts ($1,111M vs $1,990M).\n\n2023 VALUATION: LLM correctly states 176 million at Level 1 and 5 million at Level 2 (total 181 million), matching ground truth. This is the only correct data point.\n\n2024 VALUATION ERROR: LLM claims 220 million at Level 1 and 6 million at Level 2 (total 226 million). Ground truth explicitly states 'no updated dollar figures were provided in the disclosure' for 2024, so the LLM fabricated specific numbers that cannot be verified.\n\nPERCENTAGE CALCULATIONS: LLM's percentages (37% in 2022, 5% in 2023, 7% in 2024) cannot be verified against ground truth since the 2022 base number is wrong and 2024 figures are fabricated.\n\nCLASSIFICATION STRUCTURE ERROR: The LLM fundamentally mischaracterizes the 2022 classification, claiming Level 2/3 dominance when ground truth clearly shows Level 1 dominance ($1,980M Level 1 vs $10M Level 2).\n\nMULTI-HOP REASONING: While the LLM's interpretation of the strategic shift (de-risking, reducing equity exposure, increasing liquidity) is reasonable and aligns with the ground truth narrative, this reasoning is built on incorrect foundational numbers, making the overall analysis unreliable.\n\nCONCLUSION: The answer fails on quantitative accuracy due to systematic number errors in 2022 and fabricated 2024 figures. Only 1 of 3 years has correct data. This is a critical failure for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 523,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott’s 2022 10‑K disclosed the 4.75 % Senior Notes due 2043 as part of its debt schedule and referenced the original indenture (Exhibit 4.17)【source】. In the 2023 10‑K the company added a supplemental indenture (Exhibit 4.18) that clarified covenants and terms, and the 2024 10‑K continued to reference this supplemental indenture while updating covenant details【source】. This progressive deepening of disclosure signals Abbott’s commitment to proactive long‑term debt management and transparent communication with investors.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. Specific issues: (1) EXHIBIT NUMBERS INCORRECT: The LLM claims Exhibit 4.17 in 2022 and Exhibit 4.18 in 2023, but the ground truth specifies Exhibit 4.6 to Form 8-K dated March 22, 2017. The LLM provides no exhibit numbers matching the ground truth. (2) DOCUMENT TYPE CONFUSION: The ground truth clearly identifies the Form of 4.75% Notes due 2043 as Exhibit 4.6 to a Current Report on Form 8-K (dated March 22, 2017), not a supplemental indenture. The LLM incorrectly references a 'supplemental indenture (Exhibit 4.18)' in 2023, which is not mentioned in the ground truth. (3) MISSING KEY CONTEXT: The ground truth specifically mentions St. Jude Medical's Fourth Supplemental Indenture from April 2, 2013 in 2022, which the LLM completely omits. This is a critical detail showing legacy integration. (4) INACCURATE EVOLUTION NARRATIVE: The ground truth describes a shift from 'legacy-based referencing' (2022) to 'standardized, transparent disclosure' (2023-2024), with specific reference to the Form 8-K dated March 22, 2017. The LLM's narrative about 'supplemental indentures' and 'covenant clarifications' does not align with the ground truth's actual progression. (5) UNSUPPORTED CLAIMS: The LLM states the 2024 10-K 'continued to reference this supplemental indenture while updating covenant details,' but the ground truth indicates 2024 maintained 'structured disclosure' and 'consistency in long-term debt communication' without mentioning covenant updates. (6) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the multi-year progression across 2022-2024 as documented in the ground truth. The answer demonstrates fundamental misunderstanding of the actual disclosure strategy evolution. The only correct element is the identification of the 4.75% Senior Notes due 2043 and the general theme of debt management, but the specific documentation details, exhibit numbers, and evolution narrative are substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 556,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "Target’s credit‑card penetration fell from **20.5 % in 2022** to **19.8 % in 2023** and to **18.6 % in 2024**【TGT_10k_2023.pdf pages 27‑29】【TGT_10k_2024.pdf pages 27‑31】. This gradual decline signals a slowing adoption of the branded card, suggesting that the incremental sales lift that the card previously drove is likely to diminish as fewer purchases are made with the card.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match ground truth exactly. (2) The trend identification is accurate - the LLM correctly identifies a gradual decline across the three-year period. (3) The reasoning about declining adoption and reduced incremental sales lift is sound and logically follows from the data. (4) Proper citation of source documents provided. WEAKNESSES: (1) The LLM answer is somewhat incomplete compared to ground truth - it omits important context that the card remained 'a key part of Target's loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.' This contextual information is relevant to understanding the full impact despite the decline. (2) The answer focuses primarily on the negative implications (diminishing sales lift) without acknowledging that the company continued to view this as strategically important despite the declining penetration. (3) The question asks about 'impact on incremental sales' but the LLM only speculates that the lift 'is likely to diminish' rather than providing concrete data on actual sales impact if available. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years (2022-2024) and correctly connects the penetration rate trend to its business implications. The logic is sound: declining penetration → fewer card purchases → reduced incremental sales lift. OVERALL ASSESSMENT: The answer is factually accurate on all quantitative measures and demonstrates correct multi-hop reasoning across the three-year period. However, it lacks some of the strategic context provided in the ground truth regarding the card's continued importance to Target's business model despite the declining trend. This represents a minor but meaningful omission in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 508,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (average age 22.5 years) in 2022 to 6,893 units (average age 25.2 years) in 2024—a decline of 349 locomotives and a 2.7‑year rise in age (UNP 10‑K 2022, pp. 22‑26; UNP 10‑K 2024, pp. 17‑21). This trend reflects a deliberate asset‑management strategy that gradually retires older units while maintaining a leaner, more modern fleet to optimize capital spend and operational efficiency.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUE - CONTRADICTORY INTERPRETATION: The LLM answer contains a fundamental logical contradiction that directly contradicts the ground truth. While the quantitative data is entirely correct (7,242 to 6,893 units, 22.5 to 25.2 years average age, 349-unit decline, 2.7-year age increase), the LLM's interpretation of what this means is factually wrong. The LLM states the trend 'gradually retires older units while maintaining a leaner, more modern fleet,' but this is contradicted by the data itself: the average age INCREASED from 22.5 to 25.2 years, meaning the fleet became OLDER, not more modern. The ground truth correctly identifies this as 'a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy.' The LLM's claim about 'maintaining a leaner, more modern fleet' is semantically and factually incorrect—the fleet is leaner (fewer units) but demonstrably LESS modern (older average age). This represents a failure in multi-hop reasoning: while the LLM correctly extracted and calculated the numbers, it failed to properly synthesize what those numbers mean for asset management strategy. The LLM appears to have assumed that fleet reduction equals modernization, when the data clearly shows the opposite. All numeric values are accurate (9/10 quantitative), but the interpretation is fundamentally flawed (2/10 qualitative), making the overall answer misleading despite correct numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 398,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds (within its private‑fund portfolio) fell from **$569 million in 2022 to $555 million in 2023 and to $540 million in 2024**—a modest decline of roughly 5 % per year. This steady, slightly reduced exposure indicates that Abbott is maintaining a long‑term alternative‑asset strategy that balances the pursuit of higher returns with liquidity and risk‑management considerations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY NUMBERS: The LLM provides incorrect 2022 figure ($569 million vs. ground truth $585 million), representing a $16 million discrepancy. This is a material error for a financial metric. The 2023 ($555M) and 2024 ($540M) figures are correct. CALCULATION ERROR: The LLM states 'roughly 5% per year' decline, but the actual decline is $45M over 3 years ($585M to $540M), or approximately 7.7% total (2.5% annualized), not 5% per year. The year-over-year declines are $30M (2022-2023, 5.1%) and $15M (2023-2024, 2.7%), averaging 3.9% annually—not 5%. MISSING DETAIL: The ground truth specifies the decline pattern as '$15 million over the three-year period' with consistent $15M annual reductions (2022-2023: $30M, 2023-2024: $15M), which the LLM fails to capture accurately. QUALITATIVE ASSESSMENT: The LLM's interpretation of the trend (measured approach, long-term participation, balance of returns with liquidity) is reasonable and aligns with ground truth reasoning, though it doesn't explicitly mention 'gradual reduction' or 'continued long-term participation through fund distributions.' The semantic understanding of the strategic implications is sound. ENTITY ACCURACY: Abbott Laboratories correctly identified; private real estate funds correctly identified; years 2022-2024 correct. The answer addresses the question's two parts (evolution and strategic implications) but with significant quantitative errors that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 405,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "At year‑end 2022, NVIDIA carried $1,637 million of its 3.50% Notes Due 2050 (NVDA_10k_2022.pdf: pages [78‑82]); the balance was unchanged at $1,637 million at year‑end 2023 (NVDA_10k_2023.pdf: pages [65‑69]) and fell to $1,604 million at year‑end 2024 (NVDA_10k_2024.pdf: pages [70‑74]), a $33 million decline. This modest reduction reflects slight debt amortization or repayments, indicating that NVIDIA is maintaining a stable long‑term debt profile while gradually trimming its long‑term liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports FY2022 carrying value as $1,637 million, but ground truth shows $2,147 million - a $510 million discrepancy (24% error). The LLM reports FY2023 as $1,637 million (unchanged), but ground truth shows $1,604 million - a $33 million error. The LLM reports FY2024 as $1,604 million, which matches ground truth. The LLM calculates a $33 million decline from 2023-2024, but this ignores the massive $543 million decline from 2022-2023 ($2,147M to $1,604M). (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to capture the critical pattern in the data - a significant drop in 2023 followed by a rebound in 2024 to $2,000 million. This is a key insight about revaluation and strategic positioning that the ground truth emphasizes. The LLM's narrative of 'stable long-term debt profile with gradual trimming' is contradicted by the actual volatility: $2,147M → $1,604M → $2,000M. (3) REASONING QUALITY: The LLM's interpretation of 'modest reduction' and 'slight debt amortization' is inconsistent with the actual data pattern showing significant fluctuations and a rebound, suggesting the LLM did not properly synthesize the multi-year progression. (4) MISSING CONTEXT: The LLM completely missed the ground truth's key insight about revaluation, refinancing implications, and strategic debt management positioning indicated by the 2024 rebound. The answer fundamentally misrepresents NVIDIA's long-term debt trajectory and positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 439,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 2022 10‑K (pp. 35‑39) listed the risk of losing tax and tariff exemptions as part of a broad set of political, legal and economic risks. The 2023 filing (pp. 39‑43) reiterated that risk but added more detail on trade‑protection measures, import/export licensing and sanctions. By 2024 (pp. 38‑42) the description expanded further to explicitly reference sanctions, export‑control revisions and geopolitical tensions, underscoring a growing complexity and uncertainty in AMD’s global regulatory environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the general progression of AMD's risk disclosures regarding tax and tariff exemptions from 2022-2024 and appropriately cites page ranges from the respective 10-K filings. However, there are significant gaps in completeness and specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024); (2) Accurately notes the increasing detail and complexity in disclosures; (3) Properly references geopolitical tensions and regulatory complexity; (4) Page citations appear reasonable for 10-K risk factor sections. WEAKNESSES: (1) MAJOR OMISSION - The LLM answer fails to mention specific geopolitical events that are central to the ground truth narrative: U.S. sanctions against Russia and Belarus (2023), Ukraine-Russia conflict (2023), Israel-Hamas conflict (2023), and China-Taiwan tensions (2024). These specific examples are critical to demonstrating the 'evolution' requested in the question; (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes how AMD's exposure evolved in response to specific geopolitical crises, but the LLM answer only provides generic references to 'geopolitical tensions' without the concrete examples that illustrate the trend; (3) MISSING CONTEXT - The ground truth notes AMD's expansion of global operations and third-party manufacturing partnerships (particularly relevant to China-Taiwan risk), which the LLM answer does not address; (4) VAGUE CHARACTERIZATION - The LLM answer mentions 'trade-protection measures, import/export licensing and sanctions' but doesn't connect these to specific regional conflicts or their impact on AMD's supply chain. The answer demonstrates understanding of the general trend but lacks the detailed multi-hop synthesis across specific geopolitical events and their regulatory implications that the question requires. The answer is partially correct but substantially incomplete in addressing the 'how' and 'what does this suggest' components of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 543,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 10‑Ks all contain the same risk‑factor statement that its ability to return capital—through dividends or share repurchases—is limited by U.S. banking laws, capital‑planning rules, Delaware law and the requirement to pay full and timely preferred‑stock dividends.  In other words, the company’s exposure to regulatory constraints on capital return flexibility has not materially changed over that period; the risk factor remains unchanged, underscoring that dividend payments and share repurchases continue to be subject to the same legal and regulatory limits.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct in its core assertion that BNY Mellon's regulatory constraints on capital returns remained unchanged across 2022-2024. The answer accurately identifies the key regulatory limitations (U.S. banking laws, capital-planning rules, Delaware law, preferred stock dividend obligations) and correctly characterizes the exposure as stable/unchanged over the period. The LLM's statement that 'the risk factor remains unchanged' aligns with the ground truth's conclusion about 'consistent emphasis across all three years shows a stable regulatory environment.' However, there are some notable differences in completeness: (1) The ground truth provides more granular detail about 2023-specific concerns (credit rating reductions, Title I and II resolution strategies, liquidity impacts) and 2024 context (liquidity management, strategic initiatives), whereas the LLM answer treats all three years as essentially identical without acknowledging these nuanced developments. (2) The LLM's phrasing 'the risk factor remains unchanged' is slightly more absolute than the ground truth's more nuanced description of 'reiterated constraints with emphasis on' different aspects each year. (3) The LLM correctly synthesizes the multi-hop requirement (comparing 2022, 2023, 2024) and reaches the correct conclusion about stability. No quantitative errors are present. The answer is semantically equivalent to the ground truth on the main point (constraints remained consistent) but misses some of the contextual evolution in how those constraints were framed and emphasized across the three-year period. This represents a minor omission of contextual detail rather than factual incorrectness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 466,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott Laboratories has continued to disclose the 2.950% Note due 2025 as Exhibit 4.1 in each 10‑K from 2022 through 2024, referencing the original Form 8‑K filed in March 2015.  The note’s terms, maturity date and associated documentation have remained unchanged, and no new amendments or supplemental exhibits were added in 2023 or 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER ERROR: The LLM states the note was disclosed as 'Exhibit 4.1' in 10-K filings, but the ground truth clearly indicates it was 'Exhibit 99.6' in an 8-K filing. This is a critical factual error - the exhibit numbers and filing types are fundamentally different. (2) FILING TYPE ERROR: The ground truth specifies the note was referenced in an '8-K filing dated March 5, 2015,' not in 10-K filings as the LLM claims. This is a major distinction in SEC filing types and documentation structure. (3) PARTIAL CORRECTNESS: The LLM correctly identifies the note as 2.950% due 2025, correctly notes the March 2015 reference date, and correctly states that terms remained unchanged with no amendments. (4) MISSING DETAIL: The LLM fails to mention the specific exhibit designation (99.6) that was consistently used across all three years, which is a key part of how the disclosure 'evolved' (or rather, remained static). (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across 2022-2024, it does so with incorrect foundational facts about the exhibit structure. The core claim about consistency is correct, but the supporting details are wrong. The answer demonstrates partial understanding of the disclosure pattern but fundamentally misidentifies the exhibit classification and filing type, which are essential to answering how the disclosure was structured in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 414,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 carried **$1,089 million** at the end of FY 2022, **$1,099 million** at the end of FY 2023, and **$1,115 million** at the end of FY 2024. The modest, steady increase in carrying value reflects an incremental borrowing strategy that supports growth while keeping long‑term debt levels relatively stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - All three carrying values are factually incorrect: (1) FY 2022: LLM states $1,089M but ground truth is $1,200M (error of $111M or 9.3% understatement); (2) FY 2023: LLM states $1,099M which matches ground truth - this is the only correct number; (3) FY 2024: LLM states $1,115M but ground truth is $1,250M (error of $135M or 10.8% understatement). The LLM's characterization of the trend is also fundamentally wrong - it describes a 'modest, steady increase' when the actual progression shows: $1,200M → $1,099M (decrease of $101M) → $1,250M (increase of $151M). This is not a steady increase but rather a dip followed by a recovery. The ground truth indicates strategic management with fluctuation, while the LLM incorrectly portrays consistent incremental growth. The reasoning about 'incremental borrowing strategy' and 'relatively stable' debt levels contradicts the actual data pattern. Only 1 of 3 key numbers is correct, the trend analysis is inverted, and the strategic interpretation is misleading. This represents a fundamental failure in multi-hop financial data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 314,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "AMD’s 10‑K filings show a steady, but increasingly formalized, approach to working with add‑in‑board (AIB) partners. In 2022 the company noted that its agreements “protect AIB inventory against price reductions” and that AIBs use discrete graphics to differentiate their products. By 2023 the language was expanded to emphasize that the protection covers “inventory of our products against price reductions” and that AIBs and system integrators “often use discrete graphics solutions as a means to differentiate their products and add value to their customers.” In 2024 the policy is reiterated with the same inventory‑protection language, but the filing adds that AIBs are “typically built and sold by system integrators, retail buyers and sub‑distributors” and that the discrete‑graphics strategy remains a key differentiator for SIs, underscoring a continued focus on discrete GPU solutions as a market‑differentiating tool while maintaining consistent inventory‑protection guarantees across all years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AMD's AIB strategy evolution but contains significant issues in accuracy and completeness. STRENGTHS: (1) Correctly identifies the core inventory protection policy across all three years (2022-2024); (2) Accurately notes the emphasis on discrete graphics solutions as a differentiation tool; (3) Properly cites the 12-month return window for products removed from price book (implied in 2022 reference); (4) Correctly identifies the progression of language emphasis from 2022 to 2024. CRITICAL ERRORS: (1) The LLM introduces information about AIBs being \"typically built and sold by system integrators, retail buyers and sub-distributors\" in 2024 that appears to conflate or misrepresent the actual filing language - this statement is awkwardly phrased and potentially inaccurate regarding what the 2024 filing actually states; (2) The answer lacks the explicit mention of the 12-month return policy for products removed from the price book, which was a specific detail in the ground truth for 2022; (3) The characterization of 2023 language as \"expanded\" is somewhat misleading - the ground truth indicates the 2023 emphasis was on \"timely product introductions and market competitiveness\" rather than simply expanding the protection language itself. MULTI-HOP REASONING: The answer does attempt to synthesize information across three years and show evolution, but the synthesis is incomplete and contains some inaccuracies in how the evolution is characterized. The connection between inventory protection and discrete graphics differentiation is made, but the nuance about how AMD adapted messaging to market pressures is not fully captured. QUANTITATIVE ACCURACY: No specific numbers or calculations are present, so this scores well by default, though the absence of the 12-month detail is a minor omission. OVERALL: The answer demonstrates understanding of the general trajectory but contains factual inaccuracies and omissions that prevent it from fully matching the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 548,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD’s 2022 10‑K (pp. 35‑39) warned of “difficulties in protecting our intellectual property” in foreign jurisdictions, noting its use of third‑party wafer foundries in the U.S., Europe and Asia and that most assembly and testing occurs in China, Malaysia and Taiwan. The 2023 10‑K (pp. 39‑43) repeated this risk but added no new geopolitical detail, while the 2024 10‑K (pp. 38‑42) broadened the disclosure to include sanctions and export‑control changes against Russia, Belarus and Ukraine and explicitly warned that geopolitical tensions between China and Taiwan could disrupt its Taiwan‑based third‑party manufacturing, reflecting the company’s continued expansion of international sales (66 % of revenue in 2024) and growing reliance on politically sensitive facilities. Thus, AMD’s exposure to IP‑protection difficulties evolved from a general foreign‑jurisdiction risk in 2022 to a more detailed, geopolitically‑charged risk in 2024 that underscores the heightened impact of its expanding global operations and dependence on third‑party manufacturing in sensitive regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor qualifications. STRENGTHS: (1) All quantitative data is correct - the 66% international sales figure for 2024 matches ground truth, and the comparison showing growth from 65% in 2023 is accurate. (2) The multi-hop synthesis is sound, correctly tracing the evolution of AMD's IP protection risk disclosure across three fiscal years (2022-2024). (3) Entity identification is accurate - correctly identifies AMD, the specific years, and geopolitically sensitive regions (China, Taiwan, Russia, Belarus, Ukraine). (4) The narrative arc is well-constructed, showing progression from general foreign jurisdiction risks to specific geopolitical concerns. (5) Specific manufacturing locations are correctly identified (China, Malaysia, Taiwan for assembly/testing; Taiwan for foundries). MINOR WEAKNESSES: (1) The statement that 2023 'added no new geopolitical detail' is slightly imprecise - the ground truth indicates 2023 did expand risk disclosure to emphasize geopolitical tensions (Ukraine conflict, China-Taiwan tensions), though the LLM's characterization that 2024 'broadened' the disclosure more substantially is reasonable. (2) The LLM could have been more explicit about the 'unspecified but lower' 2022 international sales percentage mentioned in ground truth, though this omission is minor since exact 2022 figures weren't available. (3) The answer could have slightly more explicitly stated the 'transforming trend' toward regional concentration of IP risks, though this is implied. CALCULATION VERIFICATION: No calculations required; all percentages and comparisons are accurate. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution from 'general foreign-jurisdiction risk' to 'geopolitically-charged risk' effectively captures the ground truth's concept of transformation and increasing complexity. The answer appropriately emphasizes the connection between expanding international operations and heightened IP protection concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 543,
        "total_tokens": 2180
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "From 2022 to 2024 BNY Mellon kept using its 2019 Long‑Term Incentive Plan to award equity, issuing a 2022 Performance Share Unit Agreement and a 2022 Restricted Stock Unit Agreement (pages 18‑22 of the 2022 10‑K), a 2023 Performance Share Unit Agreement and a 2023 Restricted Stock Unit Agreement (pages 16‑20 of the 2023 10‑K), and a 2024 Performance Share Unit Agreement and a 2024 Restricted Stock Unit Agreement (pages 16‑20 of the 2024 10‑K). This steady use of the same plan for successive award cycles signals a deliberate strategy of maintaining a stable, long‑term equity‑based incentive framework that aligns executive rewards with the company’s long‑term performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) ENTITY MISMATCH: The LLM identifies the company as 'BNY Mellon' when the question asks about 'BK' (Bank of New York Mellon's ticker). While BNY Mellon is the correct full name, the question specifically uses 'BK' as the identifier. (2) FACTUAL INACCURACY - FORMS REFERENCED: The ground truth states that in 2022 BK referenced the 2021 Form of PSU Agreement, in 2023 the 2020 Form of PSU Agreement, and in 2024 the 2022 Form of PSU Agreement. The LLM incorrectly states that 2022 introduced a '2022 Performance Share Unit Agreement' - this is chronologically inconsistent with the ground truth which indicates the 2021 form was used in 2022. The LLM also introduces Restricted Stock Unit (RSU) Agreements which are not mentioned in the ground truth answer, suggesting either fabrication or confusion about what specific instruments were actually introduced. (3) MULTI-HOP SYNTHESIS FAILURE: The ground truth carefully tracks the evolution of WHICH FORM YEAR was introduced in each calendar year (2021 form in 2022, 2020 form in 2023, 2022 form in 2024), showing a pattern of updating forms. The LLM misses this nuance entirely by stating forms matching the calendar year (2022 form in 2022, 2023 form in 2023, 2024 form in 2024), which contradicts the ground truth's documented progression. (4) REASONING QUALITY: While the LLM's conclusion about 'stable, long-term equity-based incentive framework' is semantically similar to the ground truth's 'adaptive executive compensation strategy,' the underlying factual basis is incorrect. The LLM's reasoning is sound in structure but built on incorrect premises. (5) PAGE REFERENCES: The LLM provides specific page numbers (18-22, 16-20, etc.) which cannot be verified against the ground truth and may be fabricated or incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 487,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s diagnostics‑instrument leasing portfolio grew from roughly **$3.5 billion of original cost and $1.6 billion of net book value at year‑end 2022** to **$3.9 billion of original cost and $1.8 billion of net book value at year‑end 2024** (≈ 12 % increase in the asset base). This upward trend shows the company is actively investing in diagnostics equipment to expand its leasing model and generate recurring revenue, underscoring a capital‑deployment strategy focused on long‑term growth in the diagnostics business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are central to answering this question. Specifically: (1) 2022 Original Cost: LLM states '$3.5 billion' but ground truth is '$3.3 billion' (error of $200M or 6% overstatement). (2) 2022 Net Book Value: LLM states '$1.6 billion' but ground truth is '$1.4 billion' (error of $200M or 14% overstatement). (3) 2024 Net Book Value: LLM states '$1.8 billion' but ground truth is '$1.6 billion' (error of $200M or 12.5% overstatement). (4) The LLM correctly identifies 2024 original cost at $3.9 billion and correctly notes the 2023 intermediate year, but the starting point errors compound the analysis. (5) The percentage increase calculation (≈12%) is based on incorrect starting numbers and therefore misleading. MULTI-HOP REASONING: The LLM correctly synthesizes the concept that the trend indicates a strategic capital deployment focused on leasing to drive recurring revenue and downstream consumables sales, which aligns with the ground truth interpretation. However, this qualitative reasoning cannot compensate for the quantitative inaccuracies in the foundational data. COMPLETENESS: The answer addresses the evolution question and capital deployment strategy question, but the incorrect numbers undermine the credibility of the trend analysis. The ground truth shows a more modest growth pattern (2022-2023: $1.4B to $1.6B, then flat 2023-2024 at $1.6B) versus the LLM's implied continuous growth trajectory. This is a material difference in characterizing the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 435,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across all three filings, Lumentum Holdings is consistently listed as a competitor in NVIDIA’s “networking products” category—switches, network adapters (including DPUs), and optical cable solutions.  While NVIDIA’s 2023 and 2024 10‑Ks emphasize a growing focus on AI‑driven networking and interconnect technologies, the competitor list itself has not changed, indicating that Lumentum remains a relevant rival in that space but has not been singled out or removed as NVIDIA’s AI‑centric strategy has expanded.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to capture the key evolution described in the ground truth. Specific issues: (1) FACTUAL ERRORS: The LLM claims 'the competitor list itself has not changed' across all three years, directly contradicting the ground truth which explicitly documents a clear evolution—FY2022 showed Lumentum grouped with Juniper Networks and Applied Optoelectronics in a general interconnect category; FY2023 showed repositioning to a specialized high-performance interconnect segment focused on InfiniBand/Ethernet/proprietary tech; FY2024 showed more specific corporate identity designation. This is a fundamental misreading of the source material. (2) MISSING KEY DETAILS: The LLM completely omits the important contextual shifts: the FY2023 repositioning to align with NVIDIA's AI/accelerated computing emphasis, and the FY2024 sharpened recognition of Lumentum's corporate identity and strategic relevance. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that Lumentum appears in networking products across all three years, it fails to synthesize the qualitative evolution in how Lumentum was categorized and positioned relative to NVIDIA's strategic pivot toward AI infrastructure. (4) REASONING FLAW: The conclusion that 'the competitor list itself has not changed' demonstrates a failure to recognize the nuanced repositioning and re-categorization that occurred. The ground truth shows clear evolution in competitive positioning, not stasis. (5) QUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this dimension is neutral, though the LLM's claim about consistency across years is factually wrong. The answer reads as a surface-level observation that misses the substantive competitive positioning evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 502,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "Emerson moved pipe‑cutters out of its 2022 “Safety & Productivity” segment and into a newly created “Tools & Home Products” segment in 2024 (EMR_10k_2024.pdf, pages 71‑75).  The 2024 filing lists pipe‑cutters under Tools & Home Products, whereas the 2022 filing had no such segment and the cutters were only described within Safety & Productivity (EMR_10k_2022.pdf, pages 7‑11).  This shift signals Emerson’s intent to consolidate its professional‑tool portfolio under a dedicated segment, underscoring a focused strategy to serve professional and homeowner markets more effectively.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) DIRECTIONAL ERROR: The LLM claims pipe cutters moved FROM Safety & Productivity TO Tools & Home Products in 2024, when the ground truth states the opposite - they moved FROM Tools & Home Products (2022) TO Safety & Productivity (2023-2024). This is a complete reversal of the actual repositioning. (2) SEGMENT EXISTENCE ERROR: The LLM claims 'Tools & Home Products' was a 'newly created' segment in 2024, but the ground truth indicates Tools & Home Products existed in 2022 and was subsequently divested/de-emphasized. The Safety & Productivity segment is the one that received pipe cutters in the later period. (3) STRATEGIC INTERPRETATION ERROR: The LLM suggests consolidation under a 'dedicated segment' for professional tools, but the ground truth reveals the opposite strategy - a deliberate shift AWAY from consumer-focused home products (evidenced by InSinkErator divestiture in late 2022) and TOWARD professional/industrial applications within Safety & Productivity. (4) MISSING CONTEXT: The LLM completely omits the critical InSinkErator divestiture in late 2022, which is central to understanding the strategic shift. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the broader portfolio realignment toward infrastructure and industrial-grade tools, instead suggesting a consumer-inclusive strategy. The answer demonstrates fundamental misunderstanding of the multi-hop question requiring synthesis across 2022-2024 filings and strategic business decisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 435,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 to 2024 Schwab’s RIA‑focused interactive tools stayed centered on the Advisor Services website and the free Schwab Advisor Portfolio Connect, which offered core account‑management, trade, and reporting functions (SCHW_10k_2022.pdf: 7‑9).  In 2023 the platform added new integration capabilities—most notably the thinkpipes real‑time trading platform and the iRebal portfolio‑rebalancing solution—expanding the toolset for RIAs (SCHW_10k_2023.pdf: 5‑9).  By 2024 the core features remained, but Schwab further broadened advisor support with enhanced consulting, technology engineering, and dedicated service teams while continuing to provide interactive educational content and third‑party integrations (SCHW_10k_2024.pdf: 5‑9).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. MAJOR ISSUES: (1) The LLM introduces 'thinkpipes real-time trading platform' and 'iRebal portfolio-rebalancing solution' as 2023 additions with specific citations (SCHW_10k_2023.pdf: 5-9), but these products are NOT mentioned in the ground truth and appear to be fabricated or misattributed. This is a critical hallucination that damages the answer's reliability. (2) The LLM cites specific page ranges (7-9, 5-9) which cannot be verified and may be invented citations. (3) The ground truth emphasizes key 2024 developments like 'multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer' - these specific compliance and operational enhancements are completely absent from the LLM answer, representing a significant omission of material information. (4) The ground truth describes a 'strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly' - the LLM answer fails to capture this important strategic evolution, particularly the compliance workflow dimension. WHAT WAS CORRECT: The LLM correctly identifies the core platforms (Advisor Services website, Schwab Advisor Portfolio Connect), correctly notes these are free tools, and correctly identifies the general trend of expanding advisor support and integrations. The 2022-2024 timeframe is accurate. However, the introduction of unverified product names and the omission of critical compliance-related enhancements represent material errors in a multi-hop synthesis question. The answer reads plausibly but contains fabricated details that would mislead someone relying on this information for understanding Schwab's actual product evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 484,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650 % Notes due 2026 in its 2022 10‑K as a long‑term debt instrument with a 1.650 % coupon and a principal of $2.5 billion (2022 10‑K, pp. 112‑116).  In the 2023 10‑K (pp. 108‑112) and 2024 10‑K (pp. 109‑113) the notes were reported unchanged—still classified as long‑term debt with no current‑portion adjustments and no changes to the coupon or maturity.  This consistency demonstrates Oracle’s preference for a stable, low‑cost long‑term debt base and a conservative short‑to‑intermediate‑term financing strategy that relies on refinancing rather than frequent issuance or repurchase.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the question's intent and provides reasonable analysis of Oracle's debt strategy consistency. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the 1.650% Notes due 2026 across all three years (2022, 2023, 2024)\n2. Accurately notes the consistent treatment and lack of modifications\n3. Provides sound qualitative reasoning about Oracle's stable financing strategy\n4. Correctly characterizes the notes as long-term debt with no current-portion adjustments\n5. Appropriately synthesizes the multi-hop information across three filing years\n6. The strategic interpretation (preference for stable, low-cost debt; conservative financing) is reasonable\n\nWEAKNESSES:\n1. CRITICAL: The LLM introduces a specific principal amount of $2.5 billion that is NOT mentioned in the ground truth answer. This is a factual claim that cannot be verified against the provided ground truth and represents an unsupported quantitative assertion.\n2. The LLM provides specific page numbers (pp. 112-116 for 2022, pp. 108-112 for 2023, pp. 109-113 for 2024) that are not mentioned in the ground truth. While these may be accurate, they are not verifiable from the provided context.\n3. The ground truth specifically references Exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024), but the LLM answer does not mention these exhibit references, which were explicitly noted in the original answer.\n4. The LLM adds interpretive language about \"refinancing rather than frequent issuance or repurchase\" that goes beyond what the ground truth supports.\n\nMULTI-HOP REASONING:\nThe multi-hop synthesis is sound—the LLM correctly traces the note through three years and identifies the consistency pattern. However, the introduction of unverified quantitative details (the $2.5 billion principal) undermines confidence in the factual accuracy.\n\nQUANTITATIVE ACCURACY PENALTY:\nThe $2.5 billion principal amount claim is a significant quantitative assertion without ground truth support. This is treated as a factual error in the quantitative accuracy score, even though the core percentage (1.650%) and year (2026) are correct.\n\nOVERALL ASSESSMENT:\nThe answer captures the essence of Oracle's consistent debt treatment and provides reasonable strategic interpretation, but the introduction of unverified financial figures and missing exhibit references reduces confidence in the response's factual grounding. The answer would be stronger if it stuck to verifiable facts from the filings without adding specific dollar amounts not mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 706,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson has kept electrical distribution equipment firmly within its Discrete Automation segment, with the segment description unchanged in the 2022 10‑K (pages 74‑78) and the 2023/2024 10‑Ks (pages 71‑75). This continuity shows that Emerson still views electrical distribution equipment as a core part of its discrete‑automation portfolio, underscoring a sustained strategic emphasis on industrial electrification solutions across discrete industries.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) MAJOR FACTUAL ERROR - POSITIONING EVOLUTION: The ground truth clearly states that Electrical Distribution Equipment evolved from being grouped under 'Industrial Solutions' in 2022 to being explicitly included within the Discrete Automation segment in 2023, representing a strategic shift. The LLM incorrectly claims the segment description was 'unchanged in the 2022 10-K' and remained the same through 2023/2024. This is the opposite of what actually occurred - there WAS a significant change from 2022 to 2023. (2) MISSING KEY EVOLUTION: The ground truth emphasizes the evolution across three years (2022→2023→2024), with 2023 marking a pivotal shift to explicit inclusion in Discrete Automation. The LLM completely misses this temporal evolution and incorrectly characterizes the positioning as continuous/unchanged. (3) INCOMPLETE CONTEXT: The ground truth notes that in 2023, Electrical Distribution Equipment was positioned 'alongside solenoid valves and programmable control systems,' signaling an integrated approach to automation. The LLM provides no such contextual detail about what changed or why. (4) MISCHARACTERIZATION OF STRATEGIC EMPHASIS: While the LLM correctly identifies industrial electrification as a strategic focus, it frames this as 'continuity' when the ground truth reveals it as an evolution - a deliberate repositioning to emphasize automation infrastructure rather than general-purpose offerings. (5) PAGE REFERENCES: The LLM cites specific page numbers (74-78 for 2022, 71-75 for 2023/2024) but these cannot be verified and appear to be fabricated details that don't align with the actual evolution described in the ground truth. The core answer fundamentally misrepresents the nature of Emerson's strategic positioning changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 503,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million at year‑end 2022** to **$555 million in 2023** and further to **$540 million in 2024** (see Note 14, pages 68‑72 of the 2024 filing, and the analogous tables in the 2023 and 2022 filings). The modest, steady decline indicates the pension plan is trimming or holding steady its exposure to illiquid alternative assets, reflecting a cautious, liquidity‑aware strategy in managing its defined‑benefit obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2022 FIGURE: The LLM states $569 million for 2022, while the ground truth specifies $585 million. This is a $16 million error (2.7% variance) on a key data point. The 2023 ($555M) and 2024 ($540M) figures are correct. QUANTITATIVE ACCURACY ASSESSMENT: The LLM's 2022 number is factually incorrect, which is a significant error for a multi-year trend analysis. The year-over-year changes reported by the LLM ($569M→$555M = $14M decline; $555M→$540M = $15M decline) differ from the ground truth ($585M→$555M = $30M decline; $555M→$540M = $15M decline). This affects the characterization of the trend magnitude. QUALITATIVE ACCURACY: The LLM correctly identifies the overall trend direction (declining commitments), appropriately characterizes it as 'modest, steady decline,' and correctly interprets this as reflecting a 'cautious, liquidity-aware strategy.' The reasoning about de-risking and pension fund management is sound and semantically equivalent to the ground truth. COMPLETENESS: The LLM partially addresses the question but omits important context from the ground truth: (1) the long time horizon for fund liquidation (through 2034), (2) the indication of continued belief in long-term value despite reduced exposure, and (3) the characterization as 'measured de-risking or rebalancing.' These omissions represent incomplete synthesis of the multi-hop question about strategy implications. CONTEXTUAL RELEVANCE: The answer appropriately cites source documents (Note 14, pages 68-72) and maintains focus on pension fund strategy in alternative assets. The interpretation of the trend is contextually appropriate. OVERALL ASSESSMENT: The answer demonstrates good qualitative reasoning and appropriate interpretation of the trend, but contains a material quantitative error in the 2022 baseline figure that undermines the accuracy of the multi-year trend analysis. The omission of the long-term liquidation horizon and continued strategic belief in these assets represents incomplete answer to the full question about strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 556,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle consistently reports the 1.650% Notes due 2026 as long‑term debt in each filing – the 2022 10‑K (p. 112‑116), the 2023 10‑K (p. 108‑112) and the 2024 10‑K (p. 109‑113) all list the notes with the same 1.650% coupon and 2026 maturity and no reclassification to short‑term debt. This unchanged treatment shows that Oracle treats the notes as a stable long‑term financing source, using them to back its short‑term liquidity (e.g., through its revolving credit facility) rather than issuing new short‑term debt, underscoring a conservative, steady short‑term debt strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant conceptual and factual errors that undermine its credibility:\n\n1. CRITICAL CONCEPTUAL ERROR: The LLM classifies the 1.650% Notes due 2026 as \"long-term debt\" and argues Oracle uses them to \"back its short-term liquidity.\" However, the ground truth explicitly states these are short-term debt obligations (due 2026, which would be within 1-2 years from 2024-2025 filings). The LLM fundamentally misunderstands the debt classification and strategy.\n\n2. PAGE REFERENCE ISSUES: The LLM provides specific page numbers (p. 112-116 for 2022, p. 108-112 for 2023, p. 109-113 for 2024) without verification. These cannot be confirmed against the ground truth and appear to be hallucinated specificity.\n\n3. MISSING KEY INFORMATION: The ground truth emphasizes the consistent referencing of the original March 24, 2021 8-K filing across all three years (2022, 2023, 2024), which is a crucial detail about how Oracle documents and maintains continuity of these obligations. The LLM completely omits this important aspect of the answer.\n\n4. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about \"evolution\" and \"continuity\" across three filings. The ground truth shows that Oracle maintained unchanged structure and terms by consistently referencing the same 8-K. The LLM merely states the notes appear unchanged but doesn't explain the mechanism (consistent 8-K referencing) or provide the temporal evolution narrative.\n\n5. STRATEGIC INTERPRETATION MISMATCH: The ground truth describes a \"deliberate strategy of maintaining stable short-term debt obligations without modification.\" The LLM's interpretation about using long-term debt to back short-term liquidity is conceptually different and appears incorrect.\n\n6. QUANTITATIVE ACCURACY: The 1.650% coupon rate is correct, and the 2026 maturity date is correct. However, the classification as \"long-term\" vs. the ground truth's implicit treatment as short-term is a fundamental error.\n\nThe answer demonstrates partial understanding of the basic facts (coupon rate, maturity date, consistency across years) but fails on the core conceptual understanding of debt classification and the specific mechanism of continuity (8-K referencing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 598,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014 as part of a set of long‑term notes.  In its 2022 10‑K (pages 111‑112) the note is listed as outstanding with a 4.30% coupon and 2034 maturity, and the same disclosure appears unchanged in the 2023 10‑K (pages 108‑109) and the 2024 10‑K (pages 108‑109).  This steady, multi‑year reporting shows Oracle’s long‑term debt strategy is to keep a stable, fixed‑rate portfolio with long maturities that align with its cash‑flow profile and provide predictable interest costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Oracle's 4.30% Note due 2034 and its consistent presence across 2022-2024 filings, which aligns with the ground truth's core finding. However, there are significant issues: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM introduces an unsupported claim that the note was 'first issued in 2014' - this date does not appear in the ground truth and cannot be verified from the provided context. This is a factual error that reduces confidence in the answer. (2) PAGE NUMBER DISCREPANCIES: The LLM cites specific page numbers (111-112 for 2022, 108-109 for 2023 and 2024) that are not mentioned in the ground truth, which references only exhibit numbers (4.11 for 2022, 4.09 for 2023-2024). These page citations may be accurate but cannot be verified against the ground truth. (3) EXHIBIT NUMBER INCONSISTENCY: The ground truth specifies Exhibit 4.11 for 2022 and Exhibit 4.09 for 2023-2024, but the LLM does not mention these exhibit numbers at all, missing a key detail from the original answer. (4) REASONING QUALITY: The LLM's interpretation of the multi-year pattern (stable, fixed-rate portfolio with predictable costs) is reasonable and semantically similar to the ground truth's conclusion about 'stable component of long-term financing strategy,' showing sound qualitative reasoning. (5) COMPLETENESS: Both answers address the evolution across the three years and draw conclusions about long-term debt strategy, but the LLM adds unsourced information (2014 issuance date) rather than sticking to verifiable filing data. The core finding that the note remained consistently documented is correct, but the execution contains unverified details that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 469,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab exercised the 2019 IDA agreement’s option to move up to $10 billion of IDA balances to its balance sheet (about $10 billion was migrated that year), a provision that required the balances to be floating‑rate obligations, a minimum $50 billion IDA balance through June 2031, and that at least 80 % of the balances be fixed‑rate through June 2026. The 2023 IDA agreement, which replaced the 2019 terms on May 4 2023, removed the 80 % fixed‑rate requirement, allowed Schwab to buy down up to $5 billion of fixed‑rate balances, and imposed stricter withdrawal limits (customer‑initiated withdrawals only until September 10 2025) while setting new minimum and maximum balance thresholds ($30 billion above the fixed‑rate total through 2025, then $60 billion minimum and $90 billion maximum thereafter); Schwab chose not to migrate any balances in 2023. In 2024, under the same 2023 agreement Schwab again did not move IDA balances to its balance sheet, and the contract continued to require maintaining a minimum of $60 billion (post‑Sept 2025) with a $90 billion cap, reflecting a shift toward tighter control over balance composition but reduced flexibility to shift balances to the balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - 2022 Migration Amount: LLM states \"about $10 billion was migrated that year\" but ground truth indicates $10.1 billion had been moved by Dec 31, 2021, with $10 billion moved subsequent to that date. The LLM conflates timing and amounts.\n   - Fixed-Rate Requirement: LLM incorrectly states the 2019 agreement \"required the balances to be floating-rate obligations\" - this is contradictory and unclear. Ground truth specifies the requirement was that \"at least 80% of IDA balances be fixed-rate obligations.\"\n   - 2023 Agreement Details: LLM introduces specific thresholds ($30 billion, $60 billion minimum, $90 billion maximum) and dates (September 10, 2025) that are not mentioned in the ground truth. These appear to be fabricated details.\n   - Buy-down provision: LLM mentions \"allowed Schwab to buy down up to $5 billion of fixed-rate balances\" - this detail is not in the ground truth.\n\n2. COMPLETENESS ISSUES:\n   - The LLM adds extensive contractual details (customer-initiated withdrawal restrictions, specific balance thresholds with dates) that go beyond what the ground truth provides.\n   - While the LLM addresses the 2022-2024 evolution, it introduces information not supported by the ground truth source.\n\n3. ENTITY AND REASONING ACCURACY:\n   - The core narrative structure is correct (2022 active migration → 2023 agreement change → 2023-2024 no migration).\n   - However, the specific contractual terms are either misrepresented or fabricated.\n   - The characterization of the shift from \"active migration to constrained approach\" is correct in spirit but the supporting details are inaccurate.\n\n4. KEY DISCREPANCIES:\n   - Ground truth: 2019 agreement required \"at least 80% fixed-rate\" - LLM reverses this to \"floating-rate obligations\"\n   - Ground truth: 2023 agreement \"eliminated the requirement that at least 80% of IDA balances be fixed-rate\" - LLM correctly states this was removed\n   - Ground truth: No migration in 2023 and 2024 - LLM correctly states this\n   - Ground truth: Maintains restrictions based on \"capital sufficiency and balance thresholds\" - LLM provides specific numbers not in ground truth\n\n5. SEMANTIC EQUIVALENCE:\n   - The overall conclusion about the shift from active to passive approach is semantically aligned with ground truth.\n   - However, the specific contractual mechanics are substantially different, making this a partially correct but significantly flawed answer.\n\nThe LLM appears to have either hallucinated specific contractual details or conflated information from multiple sources. While the high-level narrative is directionally correct, the quantitative and contractual specifics contain material errors that would mislead a reader about the actual terms of the agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 773,
        "total_tokens": 2309
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Abbott’s 2.000 % Senior Notes due 2018 had already matured and been repaid by the time of the 2022 filing, and the 2022 10‑K (pp. 85‑89) lists no outstanding balance or new indenture for those notes.  The 2023 10‑K (pp. 84‑88) likewise reports no remaining 2.000 % Senior Notes due 2018 and no supplemental indenture or refinancing activity.  The 2024 10‑K (pp. 84‑88) continues to show no outstanding 2.000 % Senior Notes due 2018 and no further documentation updates or refinancing of that debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth. The ground truth explicitly states that the 2.000% Senior Notes due 2018 were STILL INCLUDED in Abbott's 10-K filings across 2022, 2023, and 2024, referenced in Exhibit 4.21 and the Fifth Supplemental Indenture dated September 23, 2015. The LLM claims these notes 'had already matured and been repaid by the time of the 2022 filing' and shows 'no outstanding balance' across all three years. This is a critical factual error. The ground truth indicates the notes were 'gradually maturing' and 'nearing maturity' but were still being documented and disclosed in the exhibits through 2024, not already repaid. The LLM's assertion that there was 'no new issuance or amendments' aligns with ground truth, but the core claim about maturity/repayment status is incorrect. The LLM also cites specific page numbers (pp. 85-89 for 2022, pp. 84-88 for 2023 and 2024) which cannot be verified against the ground truth but appear to be fabricated details. The answer fails to capture the key insight from the ground truth: that Abbott continued to reference and document these legacy St. Jude Medical debt instruments across all three years, showing 'continuity in disclosure practices' rather than complete repayment. This represents a major factual error on the primary question of how the engagement 'evolved' - the LLM describes a different scenario entirely (repayment vs. continued documentation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 403,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% Notes due 2041 in 2021 as part of a $3.5 billion long‑term debt program.  In the 2022 10‑K (p. 112) the notes appear as outstanding with a principal of $3.5 billion; the 2023 10‑K (p. 108) and 2024 10‑K (p. 109) report the same principal and coupon, with no repayment or additional issuance.  This steady presence over three years indicates Oracle’s strategy of maintaining a stable, long‑term debt profile that balances moderate interest costs with liquidity and capital‑structure flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM states the 3.650% Notes due 2041 were 'first issued in 2021,' but the ground truth explicitly states Oracle 'first introduced' these notes 'in 2022.' This is a fundamental factual error regarding the introduction date. QUANTITATIVE ISSUES: The LLM provides a specific principal amount of $3.5 billion, which is not mentioned in the ground truth. While this detail may be accurate from the 10-K filings, it represents information beyond what the ground truth confirms, and the specificity could be misleading if incorrect. PARTIAL CORRECTNESS: The LLM correctly identifies that the notes appear in 2022, 2023, and 2024 10-Ks with consistent principal and coupon amounts, and correctly notes no repayment or additional issuance occurred. The page references (p. 112, p. 108, p. 109) are specific but cannot be verified against the ground truth. REASONING QUALITY: The LLM's conclusion about Oracle's 'stable, long-term debt profile' and 'balanced moderate interest costs with liquidity and capital-structure flexibility' is reasonable and aligns with the ground truth's characterization of a 'stable long-term financing approach.' However, the reasoning is built on a factually incorrect foundation (2021 vs. 2022 introduction date). MULTI-HOP SYNTHESIS: The LLM appropriately synthesizes information across three years of filings, but the foundational error undermines the entire analysis. The ground truth emphasizes the 2022 introduction as the starting point for the three-year pattern analysis. SEMANTIC EQUIVALENCE: While the LLM's interpretation of Oracle's strategy is semantically similar to the ground truth, the factual error regarding the introduction year is not a wording difference—it is a material factual mistake that affects the accuracy of the multi-year pattern analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 494,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle issued its 2.300% Notes due 2028 on March 24 2021 as part of a senior‑secured, fixed‑rate debt issuance (Exhibit 4.14).  The notes remained unchanged in coupon, maturity and principal through fiscal 2022, 2023 and 2024, as reflected in each 10‑K’s debt schedule (pages 112‑116 of the 2022 10‑K, pages 108‑112 of the 2023 10‑K, and pages 109‑113 of the 2024 10‑K).  This consistent, long‑term debt profile indicates Oracle’s preference for stable, fixed‑rate financing to manage interest‑rate risk and preserve liquidity while supporting its growth initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) EXHIBIT REFERENCE MISMATCH: LLM cites Exhibit 4.14 while ground truth specifies Exhibit 4.16 - this is a factual error in document reference. (2) ISSUANCE DATE DISCREPANCY: LLM states the notes were issued March 24, 2021, but ground truth indicates the Officers' Certificate was issued March 24, 2021 (the certificate date, not necessarily the issuance date). The ground truth states the notes were 'first introduced' in 2022, suggesting the actual issuance occurred in 2022, not 2021. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution across three years and what the pattern indicates. Ground truth shows: (a) 2022: introduction of 2.300% Notes, (b) 2023: expansion with additional 4.500% Notes (diversification), (c) 2024: maintained same structure. LLM fails to mention the 2023 expansion with 4.500% Notes, which is a key part of the multi-year pattern showing diversification strategy. (4) STRUCTURAL CHARACTERIZATION ERROR: LLM describes notes as 'senior-secured' but ground truth does not use this characterization - this may be incorrect. (5) REASONING QUALITY: While LLM correctly identifies the notes remained unchanged in coupon/maturity/principal across the three years, it misses the critical 2023 diversification event that the ground truth emphasizes as showing 'diversification of interest rate profiles.' The LLM's conclusion about 'stable, fixed-rate financing' is partially correct but incomplete - it should also address the diversification strategy evident in 2023. CORRECT ELEMENTS: The coupon rate (2.300%), maturity year (2028), and the fact that the notes remained consistent across fiscal years 2022-2024 are accurate. The page references provided appear reasonable but cannot be verified against ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 483,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022, Visa’s Treasury‑as‑a‑Service launch highlighted the Currencycloud platform’s virtual‑account feature as a new tool for cross‑border treasury, but those accounts were still separate from the Visa Direct network. By 2023, Visa formally integrated Currencycloud’s virtual‑account capability into the Visa Direct Platform, enabling real‑time FX, virtual accounts and liquidity for instant domestic and cross‑border transfers. In 2024 the platform expanded further, adding Visa Cross‑Border Solutions and enhanced settlement liquidity so that virtual accounts could power a broader range of real‑time, cross‑border payments across the network.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) MAJOR ERROR - The LLM states virtual accounts were 'still separate from the Visa Direct network' in 2022, but the ground truth indicates they were introduced 'as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform' - no separation is mentioned. (2) TIMELINE CONTRADICTION - The LLM claims integration happened in 2023 as a 'formal integration,' but the ground truth states they were 'fully integrated into the Visa Direct Platform' by 2023, suggesting the integration process may have begun earlier. (3) MISSING KEY DETAIL - The ground truth mentions the 11 billion endpoints figure for 2024, which the LLM completely omits. (4) INACCURATE CHARACTERIZATION - The LLM describes 2024 expansion as adding 'Visa Cross-Border Solutions' as a new feature, but the ground truth indicates virtual accounts 'continued to be a core component' suggesting continuity rather than new additions. (5) INCOMPLETE SYNTHESIS - The LLM fails to properly synthesize the evolution narrative; it creates a false narrative of separation in 2022 that contradicts the ground truth. The answer does correctly identify the three-year timeframe and mentions real-time FX and cross-border capabilities, but the fundamental mischaracterization of the 2022 status and missing quantitative details (11 billion endpoints) significantly undermine accuracy. The multi-hop reasoning is flawed because it misinterprets the relationship between Currencycloud and Visa Direct in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 452,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "Caterpillar’s ME&T dealer network for EMD‑branded products expanded from 156 dealers (43 U.S., 113 abroad) serving 191 countries in 2022 to 160 dealers (44 U.S., 116 abroad) serving 193 countries in 2024, after a brief contraction in 2023 (41 U.S., 111 abroad, 187 countries). This growth signals Caterpillar’s intent to broaden its global dealer footprint and deepen market penetration for EMD, underscoring a strategy to enhance accessibility and presence in key regions (2022 pages 74‑78; 2023 pages 63‑67; 2024 pages 64‑68).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference completely different data than the ground truth. Critical discrepancies: (1) QUANTITATIVE ERRORS - The LLM reports 156-160 dealers with 191-193 countries, while ground truth shows 108-110 distributors with 109-158 countries. These are entirely different numbers with no overlap. The LLM's figures are roughly 50% higher for dealer count and dramatically higher for country count. (2) ENTITY CONFUSION - The LLM discusses 'ME&T dealer network' with U.S./abroad breakdowns (43-44 U.S., 113-116 abroad), while ground truth specifically references 'FG Wilson branded electric power generation systems' sold through 'distributors' (not dealers) with no geographic breakdown by U.S./abroad. (3) MULTI-HOP SYNTHESIS FAILURE - The question asks about EMD-branded products' geographic distribution evolution. Ground truth correctly identifies this as FG Wilson branded systems (which are EMD-related) with consistent distributor counts (108-110) but expanding country coverage (109→158). The LLM appears to have pulled data from an entirely different product line or segment. (4) YEAR-BY-YEAR PROGRESSION - Ground truth shows: 2022 (110 distributors, 109 countries) → 2023 (110 distributors, 109 countries) → 2024 (108 distributors, 158 countries). LLM shows: 2022 (156 dealers, 191 countries) → 2023 (contraction) → 2024 (160 dealers, 193 countries). These are incompatible datasets. (5) STRATEGIC INTERPRETATION - While both answers attempt to interpret strategy, the LLM's interpretation is based on entirely incorrect numbers. The ground truth's insight about 'optimizing distribution efficiency while increasing international market access' is sound given the actual data (fewer distributors, more countries). The LLM's interpretation of 'broadening dealer footprint and deepening market penetration' contradicts its own data showing slight growth. The answer demonstrates a fundamental failure to locate or synthesize the correct information from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 544,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s diagnostics‑instrument lease portfolio grew modestly from 2022 to 2023, with the original cost rising from **$3.6 billion to $3.9 billion** (a $300 million increase) and the net book value climbing from **$1.6 billion to $1.8 billion** (a $200 million gain).  By 2024 the balance‑sheet figures remained flat at **$3.9 billion and $1.8 billion**, indicating that the investment plateaued after the 2023 uptick.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally misrepresent Abbott's diagnostics instrument investment evolution. (1) QUANTITATIVE ERRORS - The LLM shifted all numbers by one year: it reports 2022-2023 figures as $3.6B→$3.9B and $1.6B→$1.8B, when the ground truth shows 2022 started at $3.3B (original cost) and $1.4B (net book value). The LLM completely omits the 2022 baseline figures and incorrectly presents 2023-2024 data as if it were 2022-2023. The claim that 2024 figures 'remained flat' at $3.9B and $1.8B is correct for 2024, but this contradicts the ground truth which shows growth through 2024. (2) MULTI-HOP SYNTHESIS FAILURE - The answer fails to properly synthesize the three-year evolution (2022→2023→2024). It only addresses two years of comparison and misaligns them temporally. The ground truth clearly shows consistent growth across all three years: original cost $3.3B→$3.6B→$3.9B and net book value $1.4B→$1.6B→$1.8B. The LLM's narrative of 'plateau after 2023 uptick' contradicts the actual data showing continued growth into 2024. (3) MISSING CONTEXT - The answer fails to capture the consistent upward trend across the full three-year period, instead suggesting stagnation in 2024. (4) CALCULATION VERIFICATION - While the $300M and $200M increments are mathematically correct for the years the LLM references, they are applied to the wrong year-pairs, making the calculations contextually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 400,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "PepsiCo’s repeated listing of the 3.450% Senior Note due 2046 in the 2022, 2023, and 2024 10‑K filings shows that the note remains a core, long‑term debt instrument in its capital‑structure mix. The consistent disclosure indicates that PepsiCo continues to rely on this moderate‑coupon, long‑maturity note as part of a diversified debt strategy designed to support growth, acquisitions and shareholder returns while keeping the cost of capital stable.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 3.450% Senior Note due 2046 and accurately conveys that it appears consistently across the 2022, 2023, and 2024 10-K filings. The numeric values (3.450%, 2046 maturity date) are correct. The answer appropriately interprets the consistent disclosure as indicating the note's strategic importance to PepsiCo's long-term capital structure. However, there are notable differences from the ground truth: (1) The LLM answer does not mention the specific exhibit numbers (4.17, 4.16, 4.15) where the note appears in each year's filing, which the ground truth explicitly references as evidence of consistent disclosure. (2) The LLM answer adds interpretive language about 'growth, acquisitions and shareholder returns' that goes beyond what the ground truth states—the ground truth focuses on the note providing 'long-dated, fixed-rate funding' and being 'strategically maintained.' (3) The ground truth emphasizes the note was disclosed 'without any indication of modification or removal,' which the LLM answer does not explicitly state. The LLM's characterization of the note as 'moderate-coupon' is reasonable given the 3.450% rate, though this specific descriptor doesn't appear in the ground truth. Overall, the core insight about the note's stable role in capital structure is present and correct, but the answer lacks the specific documentary evidence (exhibit numbers) and is slightly more speculative in its interpretation of the company's strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 413,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in March 2021 as part of a $2.5 billion debt package and were still outstanding in the 2022 10‑K (p. 112‑116) and the 2023 10‑K (p. 108‑112), with no principal repayment or rate change reported. In 2023 Oracle added a new 4.500% Notes due 2028 (Feb 2023) and the 2024 10‑K (p. 109‑113) reiterated the 2.300% Notes as still outstanding while highlighting the 4.500% Notes as part of a broader debt mix. This multi‑year pattern indicates Oracle’s strategy of maintaining a stable base of lower‑rate debt while layering new maturities and coupons to manage its capital structure and capitalize on favorable market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The core narrative about Oracle maintaining the 2.300% Notes due 2028 across multiple years is accurate; (2) The identification of the 4.500% Notes due 2028 being added in 2023 aligns with the ground truth; (3) The strategic interpretation about layering new issuances with higher yields to reflect market conditions matches the ground truth's conclusion; (4) The general characterization of Oracle's debt strategy is sound. PROBLEMATIC ASPECTS: (1) The LLM specifies the 2.300% Notes were issued in March 2021 as part of a $2.5 billion debt package - this specific date and amount are NOT mentioned in the ground truth, which only states they were 'first introduced in 2022' in the context of Exhibit 4.16. This represents a factual discrepancy about the issuance date; (2) The LLM cites specific page numbers (p. 112-116 for 2022 10-K, p. 108-112 for 2023 10-K, p. 109-113 for 2024 10-K) which cannot be verified against the ground truth and may be inaccurate; (3) The ground truth emphasizes that the notes were 'referenced' in exhibits across years (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023 and 2024), suggesting these are disclosure exhibits rather than new issuances, but the LLM's framing of 'outstanding' notes could be interpreted similarly; (4) The LLM states 'no principal repayment or rate change reported' which is a reasonable inference but adds detail not explicitly in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the pattern of maintaining older debt while adding new instruments. However, the introduction of the March 2021 issuance date creates a temporal inconsistency with the ground truth's 2022 introduction point. The strategic conclusion about managing capital structure is sound and well-reasoned. QUANTITATIVE ACCURACY: The specific date (March 2021) and dollar amount ($2.5 billion) are not verified in the ground truth and appear to be either hallucinated or from external knowledge not matching the filing exhibits referenced. This is a significant concern for quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 586,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has kept the Series B Convertible Participating Preferred Stock in the same form across its 2022‑, 2023‑, and 2024‑10 K filings, with Exhibit 4.4 (Certificate of Designations of Series B Convertible Participating Preferred Stock) appearing unchanged in each report (2022 p. 112; 2023 p. 108; 2024 p. 108).  None of the filings disclose any issuance or conversion of that series, indicating the instrument has remained a dormant, designated option.  This consistency signals Visa’s long‑term capital‑structure priority of maintaining a flexible, convertible‑preferred tool while primarily relying on debt and common equity for actual financing needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies the core fact that Series B Convertible Participating Preferred Stock remained unchanged across 2022-2024 filings; (2) Accurately cites Exhibit 4.4 and page numbers (112 for 2022, 108 for 2023 and 2024), demonstrating specific document verification; (3) Correctly notes the Certificate of Designations date (June 21, 2016, implied through consistency across filings); (4) Accurately states no issuance or conversion occurred; (5) Provides sound multi-hop reasoning connecting the unchanged instrument to capital structure priorities. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer characterizes the instrument as 'dormant, designated option' which is a reasonable inference but adds interpretive language not explicitly in the ground truth; (2) The LLM answer emphasizes 'primarily relying on debt and common equity for actual financing needs' which is a logical inference about capital structure priorities but goes slightly beyond what the ground truth explicitly states about 'preserving existing shareholder rights and financing flexibility'; (3) The ground truth mentions the unchanged Bylaws (2022) and 2024 Certificate of Incorporation updates as supporting evidence of broader stability, which the LLM answer does not reference. QUANTITATIVE VERIFICATION: All dates and page numbers cited are consistent with typical 10-K filing structures and the stated facts. The three-year period (2022-2024) is correctly identified. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly connects the unchanged preferred stock designation across multiple years to conclusions about capital structure strategy. The logic that lack of issuance/conversion indicates a 'flexible tool' is reasonable. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth: Visa maintained stability in this preferred equity instrument, suggesting deliberate capital structure continuity. The LLM's framing is slightly more analytical/interpretive but not contradictory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 558,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "Caterpillar’s 2022 10‑K (pp. 20‑24) noted that it uses currency‑hedging instruments to offset foreign‑currency costs but did not discuss the LIBOR‑to‑SOFR transition. In the 2023 filing (pp. 17‑21) the company added a specific risk paragraph explaining that some of its variable‑rate loans and derivatives are LIBOR‑based, that the forthcoming transition to SOFR could alter the valuation and effectiveness of those hedges, and that a cross‑functional team is monitoring the impact. By the 2024 filing (pp. 17‑21) Caterpillar updated the disclosure to state that it has begun replacing LIBOR‑linked derivatives with SOFR‑based instruments, has adjusted its hedging strategy accordingly, and continues to evaluate the transition’s effect on hedging effectiveness and overall currency‑risk exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides a chronological narrative of Caterpillar's LIBOR-to-SOFR transition disclosures across 2022-2024, which partially aligns with the ground truth. However, there are significant issues with accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the three-year progression (2022-2023-2024)\n2. Accurately notes that 2022 filing did not discuss LIBOR-to-SOFR transition\n3. Correctly identifies that 2023 added specific risk disclosure about LIBOR-based instruments and SOFR transition\n4. Appropriately mentions the cross-functional team monitoring impact\n5. Correctly states 2024 involved replacement of LIBOR-linked derivatives with SOFR-based instruments\n6. Page references appear reasonable (though not verifiable against ground truth)\n\nWEAKNESSES:\n1. CRITICAL: The LLM answer contradicts the ground truth on a key point. Ground truth states that in 2022, Cat Financial \"had formed a cross-functional team to evaluate risks,\" but the LLM claims the 2022 filing \"did not discuss the LIBOR-to-SOFR transition.\" The ground truth explicitly indicates LIBOR transition assessment was happening in 2022, not absent.\n2. The LLM answer presents the evolution as more linear/progressive than the ground truth suggests. Ground truth emphasizes \"consistent reliance on currency hedging instruments\" across all three years, while LLM focuses heavily on the LIBOR-SOFR transition narrative.\n3. Missing emphasis on the consistent use of hedging instruments as a strategic constant across all three years - the LLM focuses too narrowly on LIBOR-SOFR transition rather than the broader currency hedging evolution.\n4. The LLM answer doesn't adequately capture that currency hedging was the primary focus throughout, with LIBOR-SOFR being a secondary but important adaptation.\n5. Ground truth mentions \"match funding, selective derivatives, and diversified funding\" in 2023 - the LLM doesn't capture this level of detail about the hedging strategy components.\n6. Ground truth notes \"no significant changes in approach\" in 2024 but \"ongoing acknowledgment of risks\" - the LLM's framing of \"begun replacing\" and \"adjusted its hedging strategy accordingly\" may overstate the magnitude of change.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the LIBOR-SOFR transition as a connecting thread. However, it fails to properly synthesize the relationship between currency hedging (the primary topic) and LIBOR-SOFR transition (a secondary adaptation). The ground truth presents these as interconnected but distinct elements; the LLM conflates them.\n\nFACTUAL ACCURACY:\nThe core factual claims about what was disclosed in each year appear directionally correct, but the characterization of 2022 as having \"no discussion\" of LIBOR-SOFR contradicts the ground truth's explicit statement that assessment was underway in 2022. This is a material factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 777,
        "total_tokens": 2286
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "From 2022 to 2024, Johnson & Johnson shifted from a single $2 billion trust funded to satisfy amounts owed to LTL Management LLC after its 2021 bankruptcy filing to a broader, multi‑year resolution strategy. By 2023 the reserve had expanded to roughly $9 billion (present‑value $12 billion) as part of the LTL 2 bankruptcy and a proposed pre‑packaged plan, and in 2024 the company further increased the reserve to a present‑value of $11.6 billion while pursuing a $6.475 billion, 25‑year payment plan that would resolve 99.75 % of remaining talc claims, all while continuing to file new bankruptcy petitions to isolate and settle claims.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a $9 billion reserve (present-value $12 billion) for 2023 and $11.6 billion present-value for 2024, but the ground truth makes no mention of these figures. The ground truth only confirms a $2 billion trust established in 2022. The LLM's claim about a '$6.475 billion, 25-year payment plan' and '99.75% of remaining talc claims' are not mentioned in the ground truth and appear to be fabricated or confused with other cases. (2) TIMELINE ISSUES: The LLM incorrectly references a '2021 bankruptcy filing' for LTL Management LLC, while the ground truth indicates LTL's Chapter 11 filing occurred before 2022 (timing unclear but referenced as already established). The LLM conflates LTL and LTL 2 filings without clearly explaining the sequence. (3) MISSING KEY FACTS: The LLM fails to mention the Third Circuit's reversal of the bankruptcy court's decision in 2023, which was a critical turning point in the strategy. It also omits the lifting of the stay and the dismissal of the initial LTL bankruptcy. (4) REASONING QUALITY: While the LLM attempts to show evolution of strategy, it does so by introducing unsupported numbers rather than synthesizing the actual documented facts. The ground truth emphasizes legal maneuvering and appellate efforts, while the LLM focuses on reserve increases without proper documentation. (5) SEMANTIC ISSUES: The LLM's characterization of the strategy as 'broader, multi-year resolution strategy' is vague and doesn't capture the complex legal battles and reversals documented in the ground truth. The answer reads as if it's describing a straightforward settlement progression rather than the contested, multi-filing approach actually documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 499,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "In 2022, Adobe positioned its Photography Plan as a limited cloud‑based subscription within Creative Cloud that bundled Photoshop, Lightroom and Lightroom Classic for photographers and photo enthusiasts (2022 10‑K, pp. 5‑9). By 2023, the plan was deepened into the broader Creative Cloud ecosystem—Adobe added generative‑AI (Firefly) and AI‑powered tools across its apps, expanded cloud storage, collaboration, and Adobe Stock access to broaden appeal (2023 10‑K, pp. 3‑7). In 2024 the plan was further refined as a standalone, cost‑effective offering that still includes Photoshop, Lightroom, Lightroom Classic, new AI features such as Generative Fill/Expand and generative credits, and tighter integration with Creative Cloud Libraries and cloud services, positioning it as a focused, cloud‑centric solution for photographers while remaining part of the larger Creative Cloud ecosystem (2024 10‑K, pp. 8‑12).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 evolution of Adobe's Photography Plan. STRENGTHS: (1) Correctly identifies the core product bundle (Photoshop, Lightroom, Lightroom Classic) across all three years; (2) Accurately captures the strategic shift toward AI integration, specifically mentioning Firefly, Generative Fill/Expand, and generative credits; (3) Properly synthesizes the multi-hop information showing progression from 2022 positioning through 2023 expansion to 2024 refinement; (4) Correctly identifies the Photography Plan's role as a streamlined alternative within the broader Creative Cloud ecosystem; (5) Appropriately cites 10-K filings as sources with page ranges. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer adds some details not explicitly in the ground truth (e.g., 'cloud-centric solution,' 'Creative Cloud Libraries integration,' 'expanded cloud storage, collaboration, and Adobe Stock access') - while these are reasonable inferences about product evolution, they go slightly beyond what the ground truth explicitly states; (2) The ground truth mentions 'Lens Blur' and 'People Masking' as specific 2024 enhancements, which the LLM answer does not include, though it does mention 'Generative Fill/Expand'; (3) The characterization of 2022 as 'limited cloud-based subscription' is slightly different from ground truth's simpler 'targeted package' framing. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly traces the evolution of the product positioning and feature set. The logical flow from targeted package → broader integration with AI → refined AI-powered offering is sound and matches the ground truth narrative. SEMANTIC EQUIVALENCE: The core message is equivalent - the Photography Plan evolved from a basic bundle to an AI-enhanced, integrated offering within Creative Cloud. The LLM's additional contextual details about cloud services and collaboration, while not explicitly in the ground truth, do not contradict it and represent reasonable elaboration on the strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 619,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has continued to reference the same exhibit for its class C common stock certificate in each 10‑K – exhibit 4.2, a form 8‑A filed on 1/28/2009 – in the 2022, 2023 and 2024 filings, with no changes to the form or filing date. This unaltered documentation signals a deliberate commitment to stable, predictable governance practices, giving investors and regulators a clear, consistent reference point even as broader regulatory and market conditions evolve.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key factual elements: (1) Exhibit 4.2 is the correct exhibit number, (2) Form 8-A filing date of January 28, 2009 is accurate, (3) The consistency across 2022, 2023, and 2024 filings is correctly stated, (4) File number 000-53572 is implicitly correct though not mentioned. All quantitative data (dates, exhibit numbers) are accurate with no calculation errors. The core multi-hop synthesis is sound - the model correctly identified that the same documentation persists across three years and drew appropriate conclusions about governance stability.\n\nWEAKNESSES: (1) The LLM answer omits the File Number (000-53572) that was included in the ground truth, which is a minor but relevant detail for complete documentation reference. (2) The answer lacks the important contextual contrast mentioned in the ground truth - that other governance documents like the Certificate of Incorporation were revised in 2024, which strengthens the argument about selective stability in governance practices. This omission weakens the analytical depth. (3) The phrase 'giving investors and regulators a clear, consistent reference point' is somewhat interpretive and less grounded in the specific governance implications than the ground truth's discussion of 'confidence in the adequacy of its existing governance framework.' (4) The answer doesn't explicitly address the 'contrast with updates seen in other governance documents' which is a key insight about Visa's selective approach to governance updates.\n\nMULTI-HOP REASONING: The model successfully synthesized information across three years of filings and correctly identified the pattern of consistency. However, it missed the opportunity to synthesize the contrast with other governance document changes, which would have provided more complete multi-hop analysis.\n\nSEMANTIC EQUIVALENCE: The core message about stability and deliberate governance approach is conveyed, though with less nuance than the ground truth regarding the selective nature of this stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 554,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s carrying amount of liabilities for performance and operating‑cost guarantees declined from $1,109 million at year‑end 2022 to $1,091 million in 2023 and to $993 million in 2024 (see the “Balance as of December 31” rows in Note 16). The drop reflects fewer new guarantees issued (264 m in 2022 to 216 m in 2024) and larger settlements (–284 m to –247 m), indicating that the company is actively trimming its contingent exposure and improving risk management in its commercial aerospace contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different metric than the ground truth. Critical issues: (1) WRONG NUMBERS: The LLM cites $1,109M (2022), $1,091M (2023), and $993M (2024) for 'carrying amount of liabilities for performance and operating-cost guarantees,' while the ground truth specifies $140M (2022), $135M (2023), and $131M (2024) for 'collaboration partners' share of financing guarantees.' These are different metrics entirely - the LLM appears to be referencing total guarantee liabilities rather than the specific partnership-shared portion. (2) MAGNITUDE ERROR: The LLM's numbers are roughly 8x larger than the ground truth figures, indicating the wrong line item was selected from the financial statements. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the declining trend (which matches the ground truth's direction), it misidentifies the specific liability category and provides incorrect absolute values. (4) MISSING CONTEXT: The ground truth emphasizes the 'collaboration partners' share' specifically, which is a key distinction the LLM missed. The LLM's discussion of 'new guarantees issued' and 'settlements' may be relevant context, but cannot compensate for citing entirely wrong numbers. (5) MULTI-HOP FAILURE: The question asks about RTX's liabilities evolution - the LLM failed to correctly identify which specific liability line item to track across the three years. The answer demonstrates a fundamental misreading of the source data rather than a minor calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 425,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco has applied the same lease‑accounting policy for free‑rent periods in FY 2022, FY 2023 and FY 2024.  In each 10‑K the company notes that “some leases include free‑rent periods and step‑rent provisions, which are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise from the date the Company has control of the property” (Leases, pages 43‑47).  The lease‑term definition has also remained unchanged: “the lease term is defined as the non‑cancelable period of the lease plus any options to extend when it is reasonably certain that the Company will exercise the option” (Leases, pages 43‑47).  Because free‑rent periods reduce the lease payments, they lower the initial right‑of‑use (ROU) asset valuation, and no material changes to this treatment or disclosure were reported between FY 2022 and FY 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Costco applied consistent straight-line accounting for free-rent periods and step-rent provisions across FY 2022-2024, which matches the ground truth. The quote about lease-term definition and the mechanism by which free-rent periods reduce ROU asset valuations are accurate. The core accounting policy stability is correctly stated. CRITICAL WEAKNESSES: (1) The LLM answer significantly OMITS key evolution details that the ground truth explicitly highlights. The ground truth describes important disclosure expansions: in 2023, clarification about variable lease payments tied to price indices/sales volume; by 2024, heightened emphasis on impairment evaluation of long-lived assets in context of facility relocations/closures. The LLM states 'no material changes to this treatment or disclosure were reported' which contradicts the ground truth's description of evolving context and emphasis. (2) The LLM fails to address the 2022-specific detail about incremental borrowing rate calculations derived from quoted interest rates. (3) The LLM misses the nuanced point that while core policy remained stable, the CONTEXT and EMPHASIS evolved - the ground truth explicitly states 'the context in which it was presented evolved to reflect growing operational complexity in lease management.' The LLM's conclusion that there were 'no material changes' is too absolute and misses the evolution in disclosure emphasis and operational context. MULTI-HOP REASONING: The question asks about evolution FROM 2022 THROUGH 2024, requiring synthesis of changes across three years. The LLM identifies consistency but fails to capture the progressive evolution in disclosure focus and operational context that the ground truth documents. This is a significant gap in addressing the 'evolution' aspect of the multi-part question. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is less critical, but the LLM's statement about 'no material changes' is factually incomplete relative to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 556,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "Adobe’s 2022 10‑K (pp. 7‑8) framed Acrobat as the core PDF tool of its Document Cloud, noting that Adobe Sensei AI was already adding intelligent actions and that R&D was focused on expanding those AI‑driven features.  By the 2023 10‑K (pp. 4‑5) the company had broadened Acrobat’s AI role to include generative‑AI (Firefly) workflows and announced a higher R&D spend on AI and machine‑learning to support these capabilities.  In the 2024 10‑K (pp. 94‑98) Acrobat is positioned as the flagship of the unified “Adobe Document Cloud,” with AI‑powered features highlighted, R&D investment further ramped up, and formal product branding shifted to present Acrobat as the central AI‑enabled PDF platform within the Document Cloud suite.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Adobe's AI strategy evolution across 2022-2024 and correctly identifies the key trajectory from foundational document tools to AI-enhanced productivity. The answer appropriately synthesizes multi-hop information across three fiscal years and correctly identifies the three main dimensions requested: Acrobat's role, R&D investments, and product branding.\n\nSTRENGTHS:\n1. Correctly identifies the 2022 baseline with Acrobat as core PDF tool and Adobe Sensei AI integration\n2. Accurately captures the 2023 shift to generative AI (Firefly) and increased R&D spending\n3. Properly recognizes the 2024 formalization with 'Adobe Document Cloud' branding and AI-powered positioning\n4. Demonstrates sound multi-hop reasoning by synthesizing information across three years\n5. Correctly identifies 'Acrobat AI Assistant' as formal product branding (aligns with ground truth)\n6. Appropriately contextualizes the evolution as strategic and multi-year\n\nWEAKNESSES:\n1. QUANTITATIVE ISSUE: The answer references specific page numbers (pp. 7-8, pp. 4-5, pp. 94-98) that cannot be verified against the ground truth. While these may be accurate, they represent unverified quantitative claims that could be incorrect.\n2. MISSING CONTEXT: The ground truth mentions 'trillions of PDFs created annually' as a key 2022 metric, which the LLM answer does not include. This is a specific quantitative detail that should have been incorporated.\n3. VAGUE R&D CLAIMS: The answer states 'higher R&D spend' and 'further ramped up' without providing specific dollar amounts or percentages. The ground truth doesn't provide these either, but the vagueness reduces precision.\n4. MINOR SEMANTIC DIFFERENCE: The ground truth emphasizes 'document intelligence' as the market opportunity, while the LLM answer focuses more on 'AI-enabled PDF platform' - slightly different framing though semantically related.\n\nMULTI-HOP REASONING ASSESSMENT:\nThe answer successfully synthesizes information across three fiscal years and correctly identifies the progression: foundational role → generative AI integration → formal AI branding. The logic is sound and the connections between years are clear.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (7/10): Core narrative is correct and well-structured, but unverified page citations and missing 'trillions of PDFs' metric prevent higher score\n- Quantitative Accuracy (6/10): No specific dollar amounts provided for R&D; page numbers unverified; missing the 'trillions of PDFs' quantitative detail\n- Qualitative Accuracy (8/10): Strong synthesis and reasoning; correctly identifies all three dimensions; minor semantic variations from ground truth\n- Contextual Relevance (8/10): Highly relevant to question; addresses all sub-components; appropriate level of detail",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 747,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "Costco continued to classify the 1.375 % Senior Notes due June 2027 as long‑term debt at a carrying amount of $1.25 bn in each filing (2022, 2023 and 2024).  The total long‑term debt fell from $6.59 bn in 2022 to $5.92 bn in 2024 as the 2.75 % Senior Notes due May 2024 were repaid, while other long‑term debt rose from $590 m to $919 m, and the current portion of long‑term debt dropped from $73 m in 2022 to $103 m in 2024 (peaking at $1.08 bn in 2023 when the 2.75 % notes were still outstanding).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CORRECT ELEMENTS: (1) The 1.375% Senior Notes were consistently valued at $1.25 billion across 2022-2024 - this matches ground truth. (2) The general narrative about reclassification of 2.750% Senior Notes due May 2024 is correct. (3) The identification of the key drivers of change is sound. CRITICAL ERRORS: (1) Long-term debt figures are incorrect: LLM states $6.59 billion in 2022, but ground truth shows $6.484 million (or $6,484 million). The LLM's $6.59 billion appears to be a calculation error or misreading. (2) LLM states long-term debt fell to $5.92 billion in 2024, but ground truth shows $5.794 billion - a discrepancy of $126 million. (3) The LLM introduces 'other long-term debt' figures ($590M to $919M) that are not mentioned in the ground truth answer and appear to be unsupported or incorrectly derived. (4) Current portion figures are problematic: LLM states it 'dropped from $73M in 2022 to $103M in 2024' which contradicts the narrative that current portion should have increased as notes approached maturity. The ground truth doesn't provide these specific current portion figures, suggesting the LLM may be confabulating. (5) The $1.08 billion figure for 2023 current portion is not verified in ground truth. MULTI-HOP REASONING: The LLM correctly identifies the multi-year evolution and the relationship between reclassification and total debt changes, but the numerical foundation is flawed. The answer demonstrates understanding of the conceptual framework but fails on execution with multiple quantitative errors that compound to create an unreliable response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 458,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe has consistently positioned its free online self‑service learning as a core element of its Digital Learning Services portfolio, but the emphasis has shifted from a general training resource in 2022 to a strategic pillar integrated with enterprise customer‑success initiatives by 2024. While 2022 and 2023 highlighted the platform as a complement to fee‑based programs and custom services for enterprise customers, the 2024 filing explicitly ties the free learning hub to Customer Success Managers, using skills assessments and tailored training to accelerate adoption and maximize ROI for large enterprises.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core factual elements but with some notable differences in framing and emphasis. STRENGTHS: (1) Correctly identifies the three-year timeframe (2022-2024) and Adobe's consistent positioning of free online self-service learning as a core component. (2) Accurately captures the evolution from general training resource to enterprise-integrated strategy. (3) Correctly references the integration with Customer Success Managers, skills assessments, and enterprise ROI focus in 2024. (4) No quantitative errors or incorrect dates/entities. (5) Properly synthesizes multi-hop information across the three-year period. WEAKNESSES: (1) The LLM answer uses slightly different terminology ('Digital Learning Services portfolio' vs. the ground truth's 'learning and enablement services') - while semantically similar, this represents a minor deviation. (2) The LLM answer emphasizes 'Customer Success Managers' explicitly in 2024, which is a specific detail not explicitly mentioned in the ground truth's description of 2024 positioning, though it aligns with the broader enterprise integration theme. (3) The ground truth emphasizes 'learning.adobe.com' as a specific platform mentioned in 2023, which the LLM answer does not reference. (4) The LLM answer's characterization of the shift as 'from general training resource' in 2022 is slightly more definitive than the ground truth, which describes 2022 as introducing the service 'as part of a broader strategy.' The LLM answer captures the essential evolution and maintains factual accuracy on the key points about enterprise integration, skills assessments, and the consistent presence of free learning options. The reasoning is sound and the multi-hop synthesis across years is appropriate, though the framing differs slightly from the ground truth's more measured description of 'maturation' versus the LLM's more pronounced 'shift.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 525,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 has been essentially flat – $1,250 million in 2024 (the 2024 10‑K table shows $1,250 million for the note, unchanged from the prior year) and the same figure appears in the 2023 and 2022 10‑Ks, indicating a deliberate, low‑interest, long‑maturity debt profile. This stability shows the company is deliberately keeping its long‑term debt structure steady while using the low‑cost, long‑term capital to fund its rapid AI‑driven revenue expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the 2.00% Notes Due 2031 were $1,250 million in 2024, 2023, and 2022 - stating they were 'essentially flat' and 'unchanged from the prior year.' This is factually wrong. Ground truth shows: 2022: $1.20 billion ($1,200M), 2023: $1.057 billion ($1,057M), 2024: $1.25 billion ($1,250M). The LLM missed the significant 2022-2023 decrease of $143M (11.9% reduction) and the 2023-2024 increase of $193M (18.3% increase). (2) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the three-year trend correctly. It incorrectly characterized the data as 'flat' when there was clear volatility - a decrease followed by an increase. This is a fundamental analytical error that undermines the entire response. (3) STRATEGIC INTERPRETATION ERROR: Because the LLM misidentified the pattern as 'stable,' its interpretation of NVIDIA's debt management strategy is incorrect. The ground truth correctly identifies this as a 'dynamic debt management strategy' with deliberate fluctuations, while the LLM incorrectly suggests intentional stability. (4) MISSING KEY INSIGHT: The ground truth provides important context about the 2023 reduction potentially being for 'refinancing opportunities' and the 2024 increase for 'strategic investments in AI infrastructure and R&D.' The LLM completely misses this nuanced analysis. The LLM's claim that figures are 'unchanged from the prior year' is demonstrably false and represents a critical failure in data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 444,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson launched a multi‑year, enterprise‑wide initiative in 2022 to “integrate, simplify and standardize processes and systems for the human resources, information technology, procurement, supply chain and finance functions” to grow its financial shared‑service capabilities (2022, pp. 115‑118).  The same language appears unchanged in the 2023 and 2024 10‑Ks (2023, pp. 116‑120; 2024, pp. 117‑121), showing the program has continued and deepened with an ongoing emphasis on aligning and streamlining the design and operation of its financial control environment.  This steady evolution signals a strategic priority on standardizing financial processes and reinforcing the control environment to support a scalable shared‑services model.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year enterprise-wide initiative spanning 2022-2024 with accurate characterization of its scope (integrating, simplifying, standardizing processes across HR, IT, procurement, supply chain, and finance). (2) Accurately notes the consistent language appearing unchanged across all three years (2022, 2023, 2024 10-Ks), which directly supports the ground truth's assertion of 'consistent messaging.' (3) Properly synthesizes the multi-hop information showing evolution from 2022 launch through 2024 continuation, with correct identification of the strategic focus on financial process standardization and control environment alignment. (4) Includes specific page references (2022 pp. 115-118; 2023 pp. 116-120; 2024 pp. 117-121) that add credibility and demonstrate source verification. (5) Correctly interprets the proactive nature of the initiative (not reactive to deficiencies) and its long-term strategic positioning. (6) Uses semantically equivalent language to convey the same concepts as ground truth (e.g., 'steady evolution signals a strategic priority' matches 'sustained strategic focus'). MINOR CONSIDERATIONS: The LLM answer is slightly more specific in naming the functions included (explicitly listing HR, IT, procurement, supply chain) compared to the ground truth's more general reference to 'key functions,' but this represents added precision rather than error. The answer also emphasizes the 'scalable shared-services model' which aligns with the ground truth's focus on 'enhancing financial shared service capabilities.' No quantitative errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across three fiscal years to demonstrate continuity and strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 511,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 10‑K filings from 2022 through 2024 all describe competition with BJ’s Wholesale Club in a generic, unchanged way—simply noting it as one of the other warehouse clubs in the U.S. The company consistently highlights its private‑label brand, Kirkland Signature, as a differentiator—emphasizing its lower prices, high quality, and higher margins—to set Costco apart from competitors like BJ’s, a focus that remains unchanged through the 2024 filing. No major shift in competitive‑positioning language is evident, but the 2024 filing reiterates the strategic importance of Kirkland Signature in differentiating Costco’s merchandise offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant qualitative inaccuracies that undermine its overall correctness despite getting some facts right. CORRECT ELEMENTS: (1) The LLM correctly identifies that Kirkland Signature is positioned as a differentiator across all three years (2022-2024); (2) Correctly notes the emphasis on lower prices, high quality, and higher margins; (3) Correctly identifies BJ's Wholesale Club as a competitor; (4) Correctly notes that Kirkland Signature remains core to competitive strategy through 2024. CRITICAL ERRORS: (1) The LLM states 'No major shift in competitive-positioning language is evident' and describes the competition language as 'generic, unchanged'—this directly contradicts the ground truth which explicitly documents an EVOLUTION in tone from 2022 to 2024, including: added emphasis on sustainability initiatives in 2023, and a 'stronger tone around differentiating our merchandise offerings' in 2024 in response to competitive pressures; (2) The LLM fails to capture the 2023 evolution regarding sustainability initiatives tied to brand loyalty; (3) The LLM misses the key finding that the 2024 language introduced 'stronger tone' and 'growing emphasis on differentiation' in response to 'increasingly competitive metropolitan markets'—this is a material evolution that the LLM explicitly denies occurred. MULTI-HOP REASONING FAILURE: The question asks specifically about how the language 'evolved' from 2022 to 2024. The ground truth identifies three distinct periods with different emphases (2022 baseline, 2023 sustainability addition, 2024 stronger differentiation tone). The LLM collapses these into 'unchanged' language, fundamentally failing the multi-hop synthesis task of tracking evolution across three years. The LLM's conclusion that 'no major shift' occurred is factually incorrect according to the ground truth. While the LLM correctly identifies some core facts about Kirkland Signature's role, it completely misses the primary analytical finding of the question—the evolution and changing emphasis over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 554,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Schwab’s U.S. state‑and‑municipal holdings were $638 million in both 2022 (page 54) and 2023 (page 114), then fell to $579 million by year‑end 2024 (page 48).  In each MD&A Schwab stresses that “substantially all securities in the investment portfolios were rated investment‑grade” (2022, page 54; 2023, page 114; 2024, page 50), underscoring a conservative fixed‑income strategy that prioritizes credit quality and capital preservation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding 2022 holdings. The ground truth states that in 2022, Schwab's investment portfolio included U.S. State and Municipal Securities but does NOT provide a specific dollar amount for 2022. The LLM incorrectly claims holdings were $638 million in 2022, when the ground truth explicitly states this $638 million figure was disclosed in 2023. This is a fundamental misreading of the temporal sequence. The LLM correctly identifies the 2023 figure ($638 million) and 2024 figure ($579 million), but the attribution of $638 million to 2022 is factually wrong. MULTI-HOP REASONING ISSUE: The question asks about evolution from 2022 to 2024. The ground truth indicates: 2022 (qualitative disclosure only - investment grade emphasis), 2023 ($638 million specific), 2024 (reaffirmed investment-grade focus). The LLM's claim of $638 million in both 2022 and 2023 misrepresents the evolution and suggests no change between those years, when the ground truth indicates 2023 was the first year a specific quantifiable amount was disclosed. CORRECT ELEMENTS: The LLM correctly identifies the 2024 figure of $579 million and accurately captures the consistent emphasis on investment-grade quality across all three years. The qualitative assessment about conservative fixed-income strategy and credit quality focus is appropriate and well-supported. COMPLETENESS: The answer addresses the evolution question and the strategic emphasis question, but the temporal accuracy is compromised by the 2022 data error. The page citations appear plausible but cannot be verified against the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 458,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer‑financing guarantees has trended downward: the collaboration‑partner share of guarantees fell from $140 million at year‑end 2022 to $135 million in 2023 and $131 million in 2024 (Note 16, Guaranties). This gradual decline indicates that RTX is actively shifting risk to its partners—reducing its own liability while maintaining residual‑value guarantees—reflecting a deliberate risk‑transfer strategy in this area.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $140M (2022), $135M (2023), $131M (2024) match ground truth exactly. (2) Dates and time periods are accurate. (3) Company identification (RTX) and metric (collaboration partners' share of guarantees) are correct. (4) Number formatting is acceptable. WEAKNESSES: (1) CRITICAL INTERPRETATION ERROR: The LLM states RTX is 'actively shifting risk to its partners—reducing its own liability,' which is the OPPOSITE of what the ground truth indicates. The ground truth explicitly states the decline 'suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing' and 'increased internal risk retention.' A declining collaboration partner share means LESS risk transfer to partners, not more. (2) The LLM answer misinterprets the trend direction of the risk transfer strategy. (3) Missing important context from ground truth: the statement that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.' This is a significant omission that provides important context about RTX's overall risk management posture. (4) The reasoning about what the declining numbers mean is fundamentally flawed—the LLM has inverted the strategic implication. MULTI-HOP SYNTHESIS: The answer does synthesize the three-year trend correctly in terms of numbers, but fails in the interpretation of what that trend means for RTX's strategy. The question asks what the trend 'indicates about the company's risk transfer strategy,' and the LLM provides an incorrect interpretation that contradicts the ground truth analysis. This is a significant error that undermines the core analytical value of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 487,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 to 2024, Adobe’s Frame.io evolved from a post‑production collaboration tool to a core hub for end‑to‑end content production. In 2022, Frame.io supported video, still images, design files and PDFs and was primarily integrated with Premiere Pro and After Effects for review and comment workflows [2022, 95‑99]. By 2023, Adobe added integration with Photoshop, Lightroom, camera‑to‑cloud uploads, and broadened file‑type support, embedding Frame.io more deeply into creative workflows [2023, 10‑14]. In 2024, Frame.io further integrated with Adobe Express, Firefly Services, and Workfront, added native still‑image camera support, and was positioned as part of Adobe G enStudio to enable scalable, cloud‑native production across all Adobe creative applications [2024, 10‑14].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) TIMELINE ERRORS: The LLM claims Photoshop and Lightroom integration occurred in 2023, but ground truth states this happened in 2024. The LLM also claims Camera-to-Cloud was added in 2023, but ground truth indicates it was already present in 2023 as an existing feature. (2) INTEGRATION SEQUENCE ERRORS: The LLM incorrectly attributes Adobe Express, Firefly Services, and GenStudio integration to 2024, which are not mentioned in the ground truth answer at all. These appear to be hallucinated details. (3) MISSING KEY INFORMATION: The LLM fails to mention that Frame.io was listed as a registered trademark in 2022, which was the ground truth's opening point about initial acquisition and branding alignment. (4) WORKFLOW EXPANSION ERRORS: The ground truth explicitly states that by 2024, Frame.io expanded beyond post-production into 'casting, location scouting, and marketing campaign management.' The LLM answer does not mention these specific workflow expansions, instead focusing on technical integrations that aren't verified in the ground truth. (5) CITATION ISSUES: The LLM provides specific citation references [2022, 95-99], [2023, 10-14], [2024, 10-14] that cannot be verified against the ground truth and may indicate fabricated sourcing. The core narrative structure is reasonable (evolution from post-production to end-to-end), but the specific factual claims about WHEN integrations occurred and WHAT integrations were added are materially incorrect. The answer demonstrates partial understanding of the general trajectory but fails on precise chronological accuracy and specific feature attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 473,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s Rotary and Mission Systems segment consistently reported lower production volume for the VH‑92A helicopter each year from 2022 through 2024, as noted in the segment’s net‑sales commentary for those years (LMT_10k_2024, pp. 38‑42; LMT_10k_2023, pp. 2‑6; LMT_10k_2022, pp. 48‑52). This steady decline indicates that while the VH‑92A remains a key Marine Corps platform, it is not a primary growth driver for the segment, which is instead concentrating on other helicopter and ISR programs such as the CH‑53K, IWSS, and C6ISR.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - Production Volume Claim: The LLM asserts that VH-92A production volume 'consistently reported lower production volume...each year from 2022 through 2024' with a 'steady decline.' The ground truth makes no mention of declining production volumes and instead emphasizes consistent, stable presence of the program across all three years. The LLM provides no actual production numbers to support this claim, making it an unsupported assertion. (2) CONTRADICTORY CHARACTERIZATION: The LLM states the VH-92A 'is not a primary growth driver for the segment,' which contradicts the ground truth's emphasis on 'sustained strategic importance' and 'stable, long-term commitment.' The ground truth indicates consistent strategic importance, not diminished importance. (3) MISSING CORE INFORMATION: The LLM fails to address the key finding from the ground truth - that the VH-92A was explicitly listed as a major program in 2022, 2023, and 2024, demonstrating sustained portfolio presence. Instead, the LLM focuses on an unsupported narrative about declining production. (4) CITATION ISSUES: While the LLM cites specific page numbers from 10-K filings, the actual content cited does not support the claims made about declining production volumes. The ground truth indicates the program remained consistently named and highlighted, not declining. (5) MULTI-HOP REASONING FAILURE: The question asks about evolution and strategic importance. The ground truth correctly synthesizes that consistent mention across years indicates stable commitment. The LLM incorrectly synthesizes this as declining importance without evidence. (6) SEMANTIC MISMATCH: The ground truth's message is 'stable and strategically important despite other priorities.' The LLM's message is 'declining and not a growth driver.' These are fundamentally different conclusions about the same program.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 529,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "In the 2022 10‑K (pp. 13‑17), MDLZ noted that sales‑and‑media marketing restrictions limit promotions or advertising of products with specified nutrient profiles on certain channels or platforms or during certain hours, and that over 25 EU countries had adopted extended‑producer‑responsibility (EPR) policies. The 2023 10‑K (pp. 9‑13) repeated that language with no change in geographic scope, while the 2024 10‑K (pp. 9‑13) added that the EU has adopted its Packaging and Packaging Waste Directive and that emerging markets such as India, Vietnam, Indonesia, and the Philippines are also considering single‑use plastic bans and other plastic taxes—signaling a tightening of regulatory stringency across both the EU and key emerging markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the key evolution of MDLZ's regulatory environment from 2022-2024. STRENGTHS: (1) Correctly identifies the 25+ EU countries with EPR policies in 2022; (2) Accurately notes the 2023 reiteration with data privacy addition; (3) Correctly identifies the 2024 EU Packaging and Packaging Waste Directive adoption; (4) Properly identifies emerging markets (India, Vietnam, Indonesia, Philippines) considering plastic restrictions; (5) Appropriately synthesizes the trajectory showing geographic expansion and regulatory intensification; (6) Correctly cites page ranges from 10-K filings. MINOR WEAKNESSES: (1) The LLM states the 2023 10-K had 'no change in geographic scope' when the ground truth indicates data privacy was added as a regulatory area affecting marketing—this is a slight understatement of the 2023 evolution; (2) The LLM mentions Indonesia and Philippines as emerging markets considering restrictions, but the ground truth specifically mentions India and Vietnam with EPR policies being 'implemented or contemplated'—the LLM's broader list is not incorrect but adds countries not explicitly mentioned in ground truth; (3) The answer could have been more explicit about the 'stringency' aspect by noting the progression from consideration/contemplation to formal adoption (2024 Directive). QUANTITATIVE ACCURACY: All numeric references (25+ EU countries, years 2022-2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple geographic regions, correctly identifying the pattern of expansion. The logic connecting geographic scope expansion with regulatory stringency is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential information from the ground truth with appropriate emphasis on both geographic and regulatory dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 517,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft continues to report its 3.700% Notes due 2046 under the 11th Supplemental Indenture (Exhibit 4.14) as long‑term debt in each 10‑K (2022, 2023, and 2024) with the same coupon, maturity, and indenture terms (see MSFT_10k_2022 p. 103‑107, MSFT_10k_2023 p. 103‑107, MSFT_10k_2024 p. 103‑107).  The notes are consistently disclosed in the debt schedule without any changes to their structure or repayment plan, indicating that Microsoft maintains a stable, long‑term debt profile and relies on moderate‑rate, long‑maturity notes as a core component of its financing strategy while preserving flexibility to refinance or repay as market conditions allow.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Microsoft's 3.700% Notes due 2046 across three fiscal years. STRENGTHS: (1) All key numeric values are correct - the coupon rate (3.700%), maturity year (2046), and indenture reference (11th Supplemental Indenture dated August 8, 2016) match the ground truth. (2) The answer correctly identifies that the notes appear consistently across all three years (2022, 2023, 2024) without modifications. (3) Multi-hop synthesis is sound - the LLM successfully synthesized information across three separate 10-K filings and drew appropriate conclusions about Microsoft's debt strategy. (4) The reasoning about stable, long-dated liabilities and fixed interest obligations aligns with the ground truth interpretation. (5) Page references (p. 103-107) are provided and appear reasonable for debt disclosures in 10-K filings. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language about 'moderate-rate' and 'preserving flexibility to refinance or repay as market conditions allow' which goes slightly beyond the ground truth's focus on 'maintaining stable, long-dated liabilities' and 'confidence in long-term cash flow projections.' However, this additional interpretation is reasonable and not contradictory. (2) The ground truth explicitly mentions the 'Eleventh Supplemental Indenture dated August 8, 2016' while the LLM references '11th Supplemental Indenture (Exhibit 4.14)' - both are correct and semantically equivalent. (3) The LLM's characterization of the strategy as reflecting 'moderate-rate' debt is a reasonable inference, though the ground truth emphasizes 'fixed interest obligations' more directly. Overall, the answer correctly addresses all components of the multi-part question: the evolution (consistency across years), the specific debt instrument details, and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 518,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "In the 2022 10‑K, Microsoft’s 2.000 % Notes due 2023 were issued under the Eleventh Supplemental Indenture (dated Aug. 8 2016) and remained outstanding through the 2023 filing, which still referenced the same indenture.  By the 2024 10‑K the 2.000 % Notes had matured or been repaid, and the debt‑maturity profile had shifted to later maturities, as shown by the new Fifteenth Supplemental Indenture (dated Nov. 6 2023) that introduces notes with maturities beyond 2023.  This progression illustrates a move from a 2023‑maturity note to a more extended debt horizon in Microsoft’s capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims the 2.000% Notes 'had matured or been repaid' by 2024, but the ground truth explicitly states they 'remained listed in Exhibit 4.14' in the 2024 filing, indicating continued disclosure. This is a fundamental mischaracterization of the debt's status. (2) INCORRECT INDENTURE REFERENCE - The LLM introduces a 'Fifteenth Supplemental Indenture (dated Nov. 6 2023)' which is not mentioned in the ground truth. The ground truth consistently references the Eleventh Supplemental Indenture (Aug. 8, 2016) across all three years. This appears to be fabricated information. (3) INCOMPLETE ANALYSIS - The LLM fails to address the key insight from the ground truth: that the 2.000% Notes due 2023 remained listed in 2024 'even as the actual maturity year had passed,' suggesting either a rollover, delayed maturity, or continued disclosure requirement. Instead, the LLM makes an unsupported assumption that they were repaid. (4) MISSING CONTEXT - The LLM does not adequately explain the consistent presence of these notes across all three years or the structured approach to debt management mentioned in the ground truth. (5) QUANTITATIVE ACCURACY - The dates provided (Aug. 8, 2016 for Eleventh Supplemental Indenture) are correct, but the introduction of Nov. 6, 2023 date for a Fifteenth Supplemental Indenture is unverified and contradicts the ground truth's focus on the Eleventh Indenture. The core narrative of the LLM answer diverges significantly from the ground truth's emphasis on consistent presence and ongoing disclosure requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 461,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "In the 2022 10‑K (pp. 113‑117), Medtronic’s Non‑Employee Restricted Stock Unit Award Agreements were issued under the **Amended and Restated 2013 Stock Award and Incentive Plan**.  By the 2023 filing (pp. 111‑115), the agreements had shifted to the **2021 Long‑Term Incentive Plan**, reflecting a new incentive framework for non‑employee directors.  The 2024 filing (pp. 111‑115) continued to reference the 2021 Long‑Term Incentive Plan, indicating no further plan change but maintaining the same underlying incentive structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that across all three years (2022, 2023, and 2024), Medtronic's Non-Employee Restricted Stock Unit Award Agreements referenced the SAME underlying plan: the 'Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017).' The LLM answer incorrectly claims that by 2023, the agreements 'shifted to the 2021 Long-Term Incentive Plan' and that 2024 'continued to reference the 2021 Long-Term Incentive Plan.' This is a direct contradiction of the ground truth, which emphasizes 'continuity in form and structure across the three years' with consistent reference to the 2013 plan. The LLM has fabricated a plan transition (from 2013 to 2021 plan) that did not occur according to the actual filings. The page number citations (pp. 113-117 for 2022, pp. 111-115 for 2023 and 2024) cannot be verified but appear plausible in format. However, the core factual claim about which plan was referenced is demonstrably incorrect. The question asks about evolution across the three years, and while the LLM correctly identifies this as a multi-hop synthesis task and addresses all three years, the synthesis itself is factually wrong. The ground truth emphasizes 'long-term stability in the structure' and 'standardized compensation instruments,' whereas the LLM incorrectly portrays a significant plan change. This is a severe accuracy failure on the primary factual content of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 428,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated **17 % of assets to buy‑in annuity policies in 2022** (MDLZ_10k_2022, p. 118‑122), **slightly reduced to 16 % in 2023** (MDLZ_10k_2023, p. 103‑107), and **returned to 17 % in 2024** (MDLZ_10k_2024, p. 101‑105). The near‑constant target mix, with only a one‑percentage‑point dip in 2023, indicates that MDLZ maintains a deliberate, risk‑managed liability‑coverage strategy for its international pension obligations, adjusting the allocation only when plan asset or liability profiles warrant a temporary shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. According to the original answer, MDLZ's allocation to buy-in annuity policies decreased from 17% (2022) to 16% (2023) and was 'effectively discontinued by 2024.' However, the LLM claims the allocation 'returned to 17% in 2024,' which is factually incorrect. The ground truth explicitly states the allocation was discontinued in 2024, not maintained at 17%. This is a fundamental quantitative error on a key metric. Additionally, the LLM's interpretation of the trend is completely opposite to the ground truth: the LLM characterizes this as a 'deliberate, risk-managed liability-coverage strategy' with 'near-constant target mix,' while the ground truth indicates a 'strategic move away from insurer-backed annuities toward more direct liability management.' The LLM misses the critical insight that the company shifted to 'fair value estimation methods' in 2024, representing a strategic pivot away from buy-in annuities. The LLM also provides specific page citations (p. 118-122, p. 103-107, p. 101-105) that cannot be verified against the ground truth and may be fabricated. The reasoning about 'temporary shift' based on 'plan asset or liability profiles' contradicts the ground truth's explanation of a deliberate strategic shift away from insurer-backed instruments. This is a multi-hop question requiring synthesis of pension allocation data across three years, and the LLM failed to correctly synthesize the 2024 data and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 426,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft issued $2.5 billion of 2.000 % Notes due 2023 in FY 2022, cut the issuance to $1.5 billion in FY 2023, and further trimmed it to $1.0 billion in FY 2024. This gradual decline shows the company’s intent to keep a low‑coupon, diversified debt mix while using long‑term debt to fund capital allocation, share repurchases, and acquisitions, thereby preserving liquidity and supporting a strong balance sheet.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM fabricates specific dollar amounts ($2.5B, $1.5B, $1.0B) that do not appear in the ground truth and are not supported by the SEC filings. The ground truth makes no mention of these issuance amounts or any changes in issuance volumes across the three years. (2) FACTUAL INACCURACY: The ground truth explicitly states the notes were 'consistently referenced' with 'no change in the structure or maturity' and that Microsoft 'did not retire or refinance the 2.000% Notes ahead of schedule.' The LLM claims a 'gradual decline' in issuance amounts, which directly contradicts the consistency documented in the ground truth. (3) MULTI-HOP REASONING FAILURE: The LLM fails to synthesize the actual information from the filings. The ground truth shows the notes appeared in Exhibit 4.14 across all three years with identical details, indicating stability. The LLM instead invents a narrative of declining issuances with no evidentiary basis. (4) MISINTERPRETATION OF DEBT STRATEGY: The ground truth reveals Microsoft's strategy was to maintain this liability through the maturity date without early retirement or refinancing. The LLM mischaracterizes this as a 'gradual decline' strategy, which is factually wrong. (5) UNSUPPORTED CLAIMS: The LLM's statements about 'capital allocation, share repurchases, and acquisitions' are not connected to the specific 2.000% Notes and appear to be generic debt strategy language rather than analysis of the actual filing data. The answer demonstrates hallucination of specific financial figures and fundamental misunderstanding of what the ground truth documents reveal about Microsoft's approach to these particular notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 488,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "In the 2022 10‑K, Microsoft disclosed the 4.000% Notes due 2021 as part of the third supplemental indenture (Exhibit 4.6) under the base indenture, describing them as a long‑term debt instrument with a 4 % coupon and a 2021 maturity. The 2023 filing kept the same notes under that same indenture but added a new supplemental indenture (Exhibit 4.18) that re‑issued or consolidated the 4.000% Notes into a larger debt package. By the 2024 filing the 4.000% Notes remained in the third supplemental indenture, yet the new supplemental indenture (Exhibit 4.18) further integrated them into a broader, more diversified debt‑instrument structure while preserving the same coupon and maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) EXHIBIT NUMBERS: The LLM claims the 4.000% Notes due 2021 appeared in Exhibit 4.18 in 2023 and 2024 filings, but the ground truth explicitly states they were consistently listed in Exhibit 4.6 across all three years. This is a critical factual error. (2) SUPPLEMENTAL INDENTURE CLAIMS: The LLM incorrectly suggests that a 'new supplemental indenture (Exhibit 4.18)' re-issued or consolidated the 4.000% Notes in 2023 and further integrated them in 2024. The ground truth indicates the notes remained under the Third Supplemental Indenture (dated February 8, 2011) consistently across all years, with no re-issuance or consolidation of these specific notes. (3) STRUCTURAL CHANGES: The LLM implies significant structural evolution and integration of the 4.000% Notes into broader debt packages, but the ground truth states the treatment 'remained consistent' and was 'unchanged' across the three years. (4) MISSING CONTEXT: The LLM fails to mention that while the 4.000% Notes remained unchanged, Microsoft introduced OTHER new debt instruments under subsequent supplemental indentures (like 2.375% Notes due 2023 and 2.125% Notes due 2022), which is a key distinction the ground truth makes. (5) SEMANTIC ACCURACY: The LLM's narrative of evolution and integration contradicts the ground truth's emphasis on consistency and lack of change. The answer fundamentally mischaracterizes the treatment of these notes across the filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 425,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K filings for FY 2022, 2023 and 2024 all state that the company had **no Euro Deferred Shares issued or outstanding** (authorized at 40 000 shares) as of the reporting dates—April 29 2022 [79], April 28 2023 [79] and April 26 2024 [79].  The unchanged, zero‑balance disclosure shows that Medtronic does not employ Euro Deferred Shares as part of its capital structure, instead relying on ordinary shares and share‑repurchase programs, reflecting a conservative, straightforward equity‑capital strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) All numeric values are correct - 40,000 authorized shares, €1.00 par value, zero issued/outstanding across all three fiscal years; (2) Dates are accurate - April 29, 2022; April 28, 2023; April 26, 2024; (3) The multi-hop synthesis correctly identifies the consistent pattern across three fiscal years and draws appropriate conclusions about capital structure strategy; (4) The answer properly addresses both parts of the question: evolution of disclosures (showing consistency/no change) and what this reveals about strategy; (5) The reasoning is sound - the absence of issuance across multiple years logically suggests strategic non-utilization. MINOR CONSIDERATIONS: (1) The LLM adds interpretive detail about 'ordinary shares and share-repurchase programs' and 'conservative, straightforward equity-capital strategy' which goes slightly beyond the ground truth's more cautious language ('potentially signaling' and 'lack of demand'). However, this represents reasonable inference rather than factual error; (2) The ground truth uses more hedging language ('potentially signaling'), while the LLM is more definitive ('does not employ'). This is a stylistic difference rather than a factual error, as the data does support the LLM's stronger conclusion. QUANTITATIVE VERIFICATION: All numbers match exactly - 40,000 shares, €1.00 par value, zero balances across all three years. No calculation errors present. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years and correctly identifies the pattern and its implications for capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 465,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023, and 2024 all list the 4.000% Notes due 2021 as part of the third supplemental indenture (Exhibit 4.6) with the same coupon rate, maturity date, and principal amount [MSFT_10k_2022, pages 102‑106; MSFT_10k_2023, pages 102‑106; MSFT_10k_2024, pages 102‑106]. The unchanged disclosure across the three years indicates that Microsoft continued to carry the notes as a long‑term liability (or had not yet fully retired them) and maintained a stable reporting of the debt instrument over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Microsoft's 4.000% Notes due 2021 were consistently referenced across 2022, 2023, and 2024 10-K filings with the same exhibit (Exhibit 4.6) and indenture date (February 8, 2011). The numeric values (4.000% coupon rate, 2021 maturity date) are accurate. However, there are significant issues with the answer's reasoning and completeness: (1) The LLM states the notes were 'carried as a long-term liability (or had not yet fully retired them)' which is problematic - notes due in 2021 would have matured by 2022, so they should not appear as long-term liabilities in 2022-2024 filings unless they were refinanced or rolled over. The ground truth indicates the notes 'were matured or fully accounted for,' suggesting they were no longer active obligations. (2) The LLM's interpretation that unchanged disclosure indicates the notes 'continued to carry' as liabilities contradicts the ground truth's interpretation that consistency indicates the notes were 'matured or fully accounted for, with no further amendments or actions required.' (3) The LLM provides page references (pages 102-106) without verification that these are accurate locations in the actual filings. (4) The answer lacks discussion of why a 2021-maturity note would still appear in 2022-2024 filings if not refinanced or retired. The core factual elements about consistent disclosure are correct, but the interpretation of what that consistency means is flawed, suggesting incomplete understanding of debt lifecycle and maturity implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 426,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "In each of the three most recent 10‑Ks, Coca‑Cola reports the 0.125% Notes due 2029 as a single, long‑term debt instrument with a fixed 0.125% coupon and a maturity of 2029. The 2022 filing lists the note as part of the company’s debt program (Exhibit 4.23, issued September 18 2020), the 2023 filing repeats the same terms and notes the same issuance date (Exhibit 4.31, March 9 2021), and the 2024 filing again presents the note unchanged as senior unsecured debt with the same coupon and maturity. The unchanged disclosure and classification across all three filings demonstrate that Coca‑Cola’s debt‑instrument structuring has remained stable and consistent over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM incorrectly attributes the issuance date of September 18, 2020 to Exhibit 4.23 in the 2022 filing, when the ground truth indicates Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021 are the source documents. (2) The LLM confuses the exhibit numbers and dates by stating '(Exhibit 4.31, March 9 2021)' which mixes exhibit numbers with dates in a contradictory way - the ground truth shows both 4.23 and 4.31 appear in each year, not that they correspond to different dates. (3) The LLM fails to accurately capture the multi-hop structure: the ground truth explicitly states the note appears in BOTH Exhibit 4.23 AND 4.31 in each year (2022, 2023, 2024), with consistent references to the same underlying Form 8-K filings. The LLM presents this as if different exhibits correspond to different years/dates. (4) The LLM's statement about 'issued September 18 2020' and 'March 9 2021' appears to conflate the Form 8-K filing dates with exhibit numbers in a confusing manner. WHAT WAS CORRECT: The LLM correctly identifies that the note is 0.125% coupon, due 2029, and that disclosure remained consistent across all three years. The conclusion about stable debt structuring is semantically aligned with the ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the exhibit structure across the three years - it should have clearly stated that in EACH year (2022, 2023, 2024), the note appeared in BOTH 4.23 and 4.31, all referencing the same underlying documentation. Instead, the answer creates confusion about which exhibits correspond to which years. The answer demonstrates partial understanding of consistency but fails on the specific structural details that are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 497,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liabilities for performance and operating‑cost guarantees declined from **$1,109 million** at year‑end 2022 to **$1,091 million** in 2023 and further to **$993 million** in 2024 (a $18 million drop in 2023 and a $98 million drop in 2024). This downward trend indicates that the company’s estimated future costs for warranty and performance guarantees are shrinking, suggesting a lower exposure to long‑term product‑performance risks in its commercial aerospace business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that do not match the ground truth data. Specific issues: (1) QUANTITATIVE ERRORS - The LLM cites total liabilities of $1,109M (2022), $1,091M (2023), and $993M (2024), but the ground truth specifies only the collaboration partners' share: $141M (2022), $135M (2023), and $131M (2024). The LLM appears to have cited different or incorrect line items entirely, representing a massive discrepancy (nearly 8x larger figures). The calculations shown ($18M and $98M declines) are mathematically correct for the numbers provided, but those numbers themselves are wrong. (2) INCOMPLETE SYNTHESIS - The ground truth explicitly notes that 'the company's own liabilities related to these guarantees were not explicitly stated,' indicating the answer should acknowledge this limitation. The LLM provides a single consolidated figure without distinguishing between RTX's own liabilities and the collaboration partners' share, failing to properly synthesize the available information. (3) REASONING FLAW - While the LLM's logic about declining liabilities indicating lower exposure is sound in principle, it is built on incorrect data. The ground truth shows a much smaller decline ($141M to $131M, or 7.1% decrease), which still supports a 'stable' characterization rather than a significant downward trend. (4) ENTITY/METRIC CONFUSION - The LLM appears to have pulled figures from a different section of RTX's financials or confused this metric with another liability category. The magnitude of error suggests a fundamental data retrieval or matching problem rather than a minor transcription error. The answer fails on the primary criterion of factual accuracy for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 473,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes assumptions for non‑qualified options have become more conservative: the volatility input rose from 23.0 % in 2022 to 24.3 % in 2024, the risk‑free rate jumped from 0.9 % to 4.2 %, and the dividend yield increased to 3.2 % while the expected life lengthened to 6.1 years. These higher volatility and risk‑free rate inputs, coupled with a modest rise in dividend yield, lowered the weighted‑average fair value of options from $22.83 to $18.49 per share, indicating Medtronic’s shift toward a more market‑based, risk‑averse equity‑compensation model that reflects heightened stock‑price volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misaligns with the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The LLM provides specific numerical values (volatility 23.0% to 24.3%, risk-free rate 0.9% to 4.2%, dividend yield 3.2%, expected life 6.1 years, fair values $22.83 to $18.49) that cannot be verified against the ground truth and appear to be fabricated or hallucinated. The ground truth makes no mention of these specific percentages or dollar amounts. (2) METHODOLOGICAL MISALIGNMENT: The ground truth focuses on the DISCLOSURE EVOLUTION and TRANSPARENCY improvements regarding how volatility assumptions are derived (historical vs. implied, market-traded options), not on the actual numerical changes in volatility inputs themselves. The LLM completely misses this key insight about the company's shift toward more explicit disclosure of methodology. (3) REASONING FAILURE: The LLM interprets the question as asking about numerical parameter changes and their impact on option valuations, when the ground truth indicates the question is really about how the company's APPROACH to valuing options evolved in terms of transparency and methodology. The LLM's conclusion about 'more market-based, risk-averse' modeling is speculative and not supported by the ground truth. (4) MISSING CORE INSIGHT: The ground truth emphasizes that Medtronic added explicit disclosure that implied volatility comes from 'market-traded options' in 2023-2024, suggesting improved risk modeling alignment with market behavior. The LLM completely omits this critical evolution in disclosure practices. (5) SEMANTIC DISCONNECT: While the LLM uses appropriate financial terminology, it answers a different question than what was asked—it provides a quantitative analysis of parameter changes rather than addressing the evolution of the company's valuation approach and disclosure methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 509,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "In 2022 Coca‑Cola issued a $1.0 billion 1.000% note due 2028; it followed that with an additional $500 million of the same instrument in 2023 and a further $300 million in 2024. The steady, incremental issuance of this low‑interest, long‑term debt shows the company’s intent to lock in favorable rates and keep a stable, long‑term debt profile to finance its capital needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims specific issuance amounts ($1.0B in 2022, $500M in 2023, $300M in 2024) with no supporting evidence in the ground truth. The ground truth explicitly states the company 'consistently referenced' the 1.000% Notes due 2028 across all three years but does NOT provide specific issuance amounts or incremental increases. The LLM fabricated precise dollar figures that cannot be verified. (2) REASONING ERROR: The LLM's core interpretation is backwards. The ground truth indicates the 1.000% Notes were 'consistently referenced' (suggesting they were already issued and maintained), not that new incremental issuances occurred in 2022, 2023, and 2024. The ground truth emphasizes that in 2024, the company shifted strategy toward HIGHER-yielding instruments (5.000% and 5.300% notes), not continued issuance of the low-rate 1.000% notes. (3) MISSING KEY INSIGHT: The LLM completely missed the strategic shift highlighted in the ground truth—that 2024 marked a departure toward more aggressive borrowing terms with significantly higher interest rates. The ground truth's main point is about the CONTRAST between maintaining the old 1.000% instrument while introducing much higher-yielding debt in 2024. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to synthesize the comparative analysis across years. It presented a simplistic narrative of 'steady incremental issuance' rather than capturing the strategic evolution and shift in 2024. The answer reads as plausible but is factually unsupported by the ground truth and misses the essential strategic insight about the company's debt strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 474,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "In the 2022 10‑K (pages 102‑106) Microsoft disclosed its 2.125 % Notes due 2022 under the Fourth Supplemental Indenture (Exhibit 4.7) with The Bank of New York Mellon Trust Company, N.A. as trustee. The 2023 filing (pages 102‑106) shifted the 2.125 % Notes to the Seventh Supplemental Indenture (Exhibit 4.10) for the 2021 notes, again with the same trustee. The 2024 filing (pages 102‑106) continued to reference the 2.125 % Notes due 2022 under Exhibit 4.7 while adding a new Fifteenth Supplemental Indenture (Exhibit 4.18) with The Bank of New York Mellon Trust Company, N.A., indicating a consistent trustee arrangement but an expanding portfolio of related debt instruments such as the 3.500 % Notes due 2042 and 3.125 % Notes due 2028.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MATURITY DATE CONFUSION: The LLM states '2.125% Notes due 2022' in 2022 and 2024 filings, but the ground truth clearly indicates these are '2.125% Notes due 2021' - this is a critical error in identifying the correct debt instrument. (2) SUPPLEMENTAL INDENTURE MISMATCH: The LLM claims 2022 used 'Fourth Supplemental Indenture (Exhibit 4.7)' but ground truth states 'Seventh Supplemental Indenture' was disclosed in 2022. The LLM then claims 2023 shifted to Seventh Supplemental Indenture, which contradicts the ground truth showing consistency across years. (3) STRUCTURAL INCONSISTENCY CLAIM: The LLM suggests the structure 'shifted' between 2022 and 2023, but ground truth explicitly states the structure 'remained consistent' with 'no changes in the structure or administration' over the three-year period. (4) EXHIBIT NUMBER ERRORS: The LLM references different exhibit numbers (4.7, 4.10, 4.18) without clear justification, and the ground truth does not specify these particular exhibit numbers. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the evolution across the three years - it incorrectly portrayed changes where ground truth shows stability. The only correct element is identifying The Bank of New York Mellon Trust Company, N.A. as the consistent trustee. The answer fundamentally misrepresents the stability and consistency of Microsoft's approach to these debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 418,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in IAE stayed at 57 % and in IAE LLC at 51 % from 2022 through 2024, as disclosed in the variable‑interest‑entity notes of the 2022, 2023 and 2024 10‑K filings [108‑112, 97‑101, 99‑103]. This unchanged majority stake in IAE and controlling interest in IAE LLC underscores RTX’s sustained strategic focus and influence over the V2500 and PW1100G‑JM engine programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer fundamentally misrepresents the evolution of Pratt & Whitney's net program share interest from 2022 to 2024. QUANTITATIVE ACCURACY ISSUES: (1) The LLM claims the percentages 'stayed at 57% and...51%...from 2022 through 2024,' which directly contradicts the ground truth. According to the original answer, 2022 had different values (61% for IAE and 59% for IAE LLC as program share interest), which then decreased to 57% and 51% respectively by 2023. (2) The LLM fails to distinguish between the 2022 baseline (61%/59%) and the 2023-2024 stabilized levels (57%/51%), missing the critical 'evolution' that the question specifically asks about. (3) The LLM incorrectly characterizes the 2023 change as non-existent, when the ground truth explicitly states 'the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares.' MULTI-HOP REASONING FAILURE: The question asks 'how did...evolve from 2022 to 2024,' requiring synthesis of three distinct time periods. The LLM collapses all three years into a single static statement, failing to capture the temporal progression and the strategic recalibration that occurred in 2023. COMPLETENESS ISSUES: The LLM misses the key insight from the ground truth—that there was a strategic adjustment in 2023 followed by stabilization in 2024. This progression is central to understanding RTX's strategic positioning. The LLM's statement that percentages 'stayed...from 2022 through 2024' is factually incorrect and represents a fundamental misunderstanding of the data. While the LLM correctly identifies the 2023-2024 values (57% and 51%), it incorrectly extends these backward to 2022, creating a false narrative of consistency rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 485,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** (2022 filing, Note 7, p. 76‑80) to **$468 million in 2023** (2023 filing, Note 7, p. 51‑55), then fell to **$443 million in 2024** (2024 filing, Note 7, p. 65‑69). This pattern shows a peak in 2023 followed by a modest decline, suggesting the company remains heavily invested in employee benefits but is slightly scaling back or adjusting its cost structure in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM provided incorrect 2022 figure. Ground truth states $299 million for 2022, but LLM claims $402 million - a $103 million discrepancy (34% error). The 2023 ($468 million) and 2024 ($443 million) figures are correct. The LLM's reasoning about the trajectory (peak in 2023, modest decline in 2024) is logically sound and matches the ground truth narrative. However, the fundamental quantitative error in the 2022 baseline figure undermines the entire analysis. The LLM correctly identified the metric (defined contribution plans/401(k)), the company (TMO), and the time period (2022-2024), and provided appropriate contextual interpretation about workforce investment strategy. The citation format and page references appear plausible but cannot be verified. The semantic interpretation of the trend is reasonable, but it's based on an incorrect starting point. This is a significant factual error that would mislead anyone relying on the 2022 comparison or year-over-year growth calculations. The error appears to stem from potential confusion with a different metric or filing section.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 315,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "In each of the three reporting years the 3.000 % Notes due 2051 remained a core part of Coca‑Cola’s long‑term debt ladder.  The 2022 10‑K (pp. 134‑138) shows the company had issued $2.0 billion of those notes, a figure that is unchanged in the 2023 10‑K (pp. 132‑136) and the 2024 10‑K (pp. 128‑132).  This steady issuance of low‑rate, long‑term debt demonstrates a deliberate capital‑structure strategy of maintaining a diversified maturity profile while locking in attractive borrowing costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIABLE CLAIMS: The LLM answer provides specific dollar amounts ($2.0 billion) and page numbers (pp. 134-138 for 2022, pp. 132-136 for 2023, pp. 128-132 for 2024) that cannot be verified against the ground truth. The ground truth makes no mention of these specific dollar amounts or page references. This is a major red flag for fabrication. (2) FACTUAL DIVERGENCE: The ground truth explicitly states that the 3.000% Notes due 2051 were 'referenced' in filings via exhibit references (Exhibit 4.6 to May 5, 2021 Form 8-K), indicating these were historical instruments. The ground truth also emphasizes that by 2024, Coca-Cola 'introduced new instruments with higher coupon rates' (5.000% Notes due 2034, 5.300% Notes due 2054), suggesting a shift in strategy. The LLM answer claims the notes remained 'unchanged' across all three years, which contradicts the ground truth's narrative of portfolio diversification with new higher-yielding instruments. (3) MISSING KEY INFORMATION: The LLM answer fails to mention the introduction of new debt instruments in 2024 (5.000% Notes due 2034 and 5.300% Notes due 2054), which is a critical part of the ground truth's explanation of capital structure evolution. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize across three years, it misses the key insight that the strategy evolved from maintaining the 3.000% Notes to diversifying with higher-coupon instruments, reflecting changing market conditions. (5) SEMANTIC ISSUES: The phrase 'steady issuance' is misleading if the amounts remained unchanged—this suggests ongoing new issuance rather than retention of existing instruments. The ground truth's emphasis on 'continuity' combined with 'diversification' is more nuanced than the LLM's simpler narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 489,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first issued the 2.875% Notes due 2031 in a 2021 offering, as disclosed in the 2022 10‑K (p. 112).  The 2023 10‑K (p. 108) confirms the notes remain outstanding as part of its long‑term debt portfolio, and the 2024 10‑K (p. 109) again reports the same notes, noting no refinancing has been undertaken.  This steady reporting shows Oracle’s long‑term debt strategy of issuing long‑dated, moderate‑coupon notes to manage interest costs while preserving flexibility for future refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 2.875% Notes due 2031 are correctly identified; (2) The notes are accurately reported as appearing in 2022, 2023, and 2024 10-K filings; (3) The page references (112, 108, 109) appear plausible for debt disclosures; (4) The characterization of the notes as 'long-dated, moderate-coupon' is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM claims the notes were 'first issued in a 2021 offering,' which goes beyond the ground truth scope (which only addresses 2022-2024 progression). While this may be factually correct, it shifts focus away from the requested 2022-2024 evolution; (2) The LLM fails to address the key strategic insight from the ground truth: the introduction of NEWER, HIGHER-YIELDING notes (4.500% due 2028, 4.900% due 2033) alongside the 2.875% notes in 2024, which indicates portfolio diversification and changing market conditions; (3) The LLM's conclusion about 'preserving flexibility for future refinancing' is generic and misses the more specific strategic shift toward higher-yielding instruments documented in the ground truth; (4) The statement 'no refinancing has been undertaken' is incomplete—the ground truth indicates Oracle added NEW debt instruments rather than refinancing existing ones, a crucial distinction. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings but fails to capture the comparative analysis that reveals strategic evolution. The ground truth emphasizes the LAYERING of newer, costlier debt as a strategic shift, while the LLM presents a static view of debt management. COMPLETENESS: The answer addresses the 2022-2024 progression but misses the critical element of how Oracle's strategy EVOLVED—specifically the shift toward higher-yielding instruments. The question asks 'what does this progression indicate,' and the LLM's answer is too general and doesn't capture the specific strategic implications evident in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 542,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s debt schedule lists the same 2.000% Notes due 2023 in each 10‑K (see MSFT_10k_2022.pdf p.104, MSFT_10k_2023.pdf p.104, MSFT_10k_2024.pdf p.104). This consistent reporting shows that the company maintains a stable, long‑term debt structure and deliberately provides investors with clear, comparable information over time, underscoring disciplined debt management and a strong transparency strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Microsoft's consistent disclosure of the 2.000% Notes due 2023 across three consecutive 10-K filings (2022, 2023, 2024) demonstrates stable debt management and transparency. The answer accurately conveys the main thesis and provides appropriate page references (p.104 for each filing). However, there are notable omissions compared to the ground truth: (1) The LLM does not mention the specific originating document (Eleventh Supplemental Indenture dated August 8, 2016), which provides important historical context; (2) The LLM does not explicitly note that the notes were 'unchanged' or 'unaltered' across the three years, which is a key detail supporting the stability argument; (3) The LLM does not mention specific filing details like trustee information or the explicit connection to investor confidence and credit ratings. The reasoning is sound and the semantic meaning aligns well with the ground truth - both conclude that consistent disclosure indicates disciplined debt management and transparency. The quantitative elements (dates, percentages, page numbers) are accurate. The answer is somewhat more concise than the ground truth but captures the essential analytical points. The omission of historical context and specific details prevents this from being a 9-10 score, though the core message and reasoning are fundamentally correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 390,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent flight‑hour obligation to Rolls‑Royce – the payment for each hour flown by V2500‑powered aircraft through June 2027 – is reflected in the “Other commercial aerospace commitments” line.  The amounts increased from $735 million in 2022 to $1,053 million in 2023 and then fell to $765 million in 2024 (NOTE 19, p. 110‑114; 71‑75; 101‑105).  This pattern shows that the obligation remains sizable but is gradually being satisfied as flight hours accrue, underscoring a long‑term exposure that will continue until the 2027 cut‑off under the 2012 IAE acquisition agreement.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key elements: (1) RTX's contingent flight-hour payments to Rolls-Royce under the 2012 IAE acquisition agreement, (2) the V2500-powered aircraft connection, (3) the June 2027 cutoff date, (4) the 'Other commercial aerospace commitments' categorization, and (5) the general interpretation that obligations are being satisfied as flight hours accrue. The reasoning about long-term exposure is sound and relevant.\n\nCRITICAL ISSUES - QUANTITATIVE ACCURACY: The LLM provides specific dollar amounts ($735M in 2022, $1,053M in 2023, $765M in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific numerical values - it only describes the accounting treatment and categorization. The LLM cites 'NOTE 19, p. 110-114; 71-75; 101-105' but these numbers are not confirmed in the ground truth data. This is a significant problem because the question explicitly asks about how obligations 'evolved' - implying quantitative progression - and the LLM provides unverified figures.\n\nMISSING ELEMENTS: The ground truth emphasizes important accounting nuances that the LLM omits or underemphasizes: (1) the shift in 2023 where RTX clarified that payments were being 'capitalized and amortized to cost of sales as they were made' - this is a key accounting treatment detail, (2) the characterization as 'collaboration intangible assets' in 2022, (3) the explicit statement that the pattern remained 'consistent' through 2024. The LLM's answer is more focused on the dollar amounts and less on the accounting methodology evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across years and connects the payment structure to the underlying acquisition agreement. However, it prioritizes quantitative data (the dollar amounts) over the qualitative accounting treatment evolution that the ground truth emphasizes as the key indicator of 'stable long-term financial exposure.'\n\nSEMANTIC ISSUES: The LLM's interpretation that 'the obligation remains sizable but is gradually being satisfied' is reasonable but not explicitly supported by the ground truth, which focuses on recognition and amortization patterns rather than satisfaction of obligations.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the question's structure and provides relevant context, but the unverified specific dollar amounts and the de-emphasis of accounting treatment details represent material gaps. The quantitative accuracy score is low due to inability to verify the cited figures against ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 691,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "TMO’s domestic pension plan assets in U.S. equity funds grew from **$89 million (≈9.5 % of $937 million)** in 2022 to **$91 million (≈10.2 % of $895 million)** in 2024, a $2 million increase and about a 0.7‑percentage‑point rise in relative allocation【TMO_10k_2022.pdf】【TMO_10k_2024.pdf】.  This modest, steady uptick aligns with the company’s stated target of roughly 10 % in U.S. equities, indicating a deliberate, incremental tilt toward domestic equity exposure over the three‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports 2022 allocation as $89 million, but ground truth shows $125 million in 2022. This is a $36 million discrepancy (29% error). The LLM reports 2024 as $91 million, but ground truth shows $93 million (2% error). The LLM completely omits the 2023 data point ($89 million), which is essential for understanding the 3-year trajectory. (2) DIRECTIONAL MISINTERPRETATION - Ground truth shows a DECREASE from $125M (2022) to $89M (2023), representing a significant reduction in U.S. equity exposure. The LLM incorrectly characterizes this as a 'modest, steady uptick' and claims a $2 million increase from 2022 to 2024, when the actual net change is a $32 million decrease ($125M to $93M). (3) STRATEGIC NARRATIVE REVERSAL - Ground truth indicates 'cautious reduction in exposure to U.S. equities' with a 'modest rebound in 2024.' The LLM inverts this to suggest 'deliberate, incremental tilt toward domestic equity exposure,' which contradicts the actual data showing net divestiture. (4) INCOMPLETE ANALYSIS - The LLM fails to address the significant 2023 decline, which is the most important inflection point in the 3-year trajectory. The ground truth explicitly notes this pattern indicates 'strategic rebalancing rather than complete divestiture,' but the LLM misses this nuance entirely. (5) CALCULATION ISSUES - While the percentage calculations shown ($89M/937M ≈ 9.5%) are mathematically plausible, they are based on incorrect base numbers for 2022. The LLM appears to have confused or transposed the 2022 and 2023 figures. This is a critical failure on a multi-hop question requiring synthesis of three years of pension plan data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 475,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s long‑term debt mix in 2022 was largely anchored by the 1.000% Notes due 2041, a low‑coupon, long‑dated instrument that provided stable financing (KO_10k_2022.pdf, pp. 134‑138). By 2024 the company broadened its debt profile, issuing a series of higher‑yielding notes—5.000% Notes due 2034, 5.300% Notes due 2054, 5.400% Notes due 2064, and other 4–5% notes—reflecting a shift toward a more diversified maturity structure and a willingness to accept higher yields to fund growth and refinance (KO_10k_2024.pdf, pp. 128‑132). The 2023 filing confirms the continued presence of the 1.000% Notes due 2041 while also showing the early stages of the new higher‑yielding debt mix (KO_10k_2023.pdf, pp. 132‑136).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of Coca-Cola filings. STRENGTHS: (1) All key financial instruments are correctly identified with accurate coupon rates and maturity dates: 1.000% Notes due 2041, 5.000% Notes due 2034, 5.300% Notes due 2054, 5.400% Notes due 2064. (2) The temporal evolution is correctly captured: low-yield instruments in 2022-2023 (1.000%, 0.400%, 0.950%) transitioning to higher-yield instruments in 2024 (5.000%-5.400%). (3) The strategic narrative is sound—the answer correctly identifies this as a shift in financing strategy responding to market conditions. (4) Multi-hop synthesis is effective, connecting information across three separate 10-K filings to show the progression. (5) Page references are provided and appear reasonable for debt instrument disclosures. MINOR WEAKNESSES: (1) The original answer explicitly mentions that the 1.000% Notes due 2041 appeared in Exhibit 4.33 across all three years, which the LLM answer does not specifically reference. (2) The LLM answer mentions 'other 4–5% notes' without specifying which ones, whereas the original answer lists specific instruments (0.400% Notes due 2030 in 2022, 0.950% Notes due 2036 in 2023). This is a minor omission of detail rather than an error. (3) The LLM answer characterizes 2023 as showing 'early stages' of the new debt mix, while the original answer presents 2023 as still featuring lower-yielding instruments, suggesting the transition may have been more abrupt in 2024. QUANTITATIVE VERIFICATION: All coupon rates and maturity years are accurate. The characterization of yields as 'low' (0.4%-1.0%) versus 'high' (5.0%-5.4%) is mathematically sound. REASONING QUALITY: The multi-hop reasoning correctly synthesizes information across three years and identifies the strategic shift. The logic connecting market conditions to debt issuance strategy is appropriate and well-supported by the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 537,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle kept the 1.650% Notes due 2026 on its debt schedule in each of the three fiscal‑year reports (FY 2022 p. 112‑116; FY 2023 p. 108‑112; FY 2024 p. 109‑113), showing a continued reliance on a low‑cost, long‑term debt core.  In the same periods the company also issued newer notes with higher coupons—such as 2.300% 2028, 2.875% 2031, 3.650% 2041, and 5.800% 2025—to diversify maturities and capture favorable market conditions, reflecting a strategy that balances a stable low‑interest base with higher‑yield instruments for liquidity and flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM introduces notes that are NOT mentioned in the ground truth answer. The ground truth specifically identifies only the 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024) as examples of newly introduced higher-rate notes. The LLM lists 2.300% 2028, 2.875% 2031, 3.650% 2041, and 5.800% 2025, which represents a significant factual discrepancy. While 5.800% 2025 matches, the others (2.300%, 2.875%, 3.650%) are either incorrect or unsupported by the ground truth. The 4.500% Notes due 2028 mentioned in ground truth is notably absent from LLM answer. (2) PAGE REFERENCES - The LLM provides specific page numbers (FY 2022 p. 112-116; FY 2023 p. 108-112; FY 2024 p. 109-113) which cannot be verified against the ground truth, which cites Exhibit references instead. This is a methodological difference that raises verification concerns. (3) EXHIBIT REFERENCES - Ground truth cites specific Exhibits (4.16 for 2022, 4.14 for 2023 and 2024) as evidence; LLM omits these entirely, weakening the sourcing. (4) MULTI-HOP REASONING - Both answers correctly synthesize the core concept: Oracle maintained low-cost debt (1.650% Notes due 2026) while issuing higher-rate instruments. The reasoning about dual strategy is sound in both. (5) SEMANTIC ALIGNMENT - The LLM's characterization of the strategy (balancing stable low-interest base with higher-yield instruments) aligns with ground truth's interpretation, but the factual foundation is compromised by the incorrect note listings. The core insight about maintaining access to lower-cost debt while raising capital at varying rates is present in both, but the LLM's specific examples are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 465,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the 4.000 % Notes due 2021 in Exhibit 4.6 – the Third Supplemental Indenture that also covers 2.500 % Notes due 2016 and 5.300 % Notes due 2041.  The unchanged inclusion shows that Microsoft is keeping the same debt instrument in its long‑term portfolio and has not pursued refinancing or restructuring of that tranche.  It also signals that the company is updating its exhibits to keep the indenture current, but the underlying debt remains unchanged until its 2021 maturity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 4.000% Notes due 2021 appear consistently in Exhibit 4.6 across 2022, 2023, and 2024; (2) they are part of the Third Supplemental Indenture alongside 2.500% Notes due 2016 and 5.300% Notes due 2041; (3) no refinancing or restructuring occurred. All numeric values (percentages, years) are accurate. However, there are significant omissions and a critical logical error: (1) The LLM states 'the underlying debt remains unchanged until its 2021 maturity' - this is problematic because the notes were due in 2021, yet they appear in 2022, 2023, and 2024 filings. The ground truth explicitly addresses this anomaly, noting the notes 'continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021.' The LLM fails to acknowledge or explain this temporal inconsistency. (2) The ground truth mentions a specific administrative update in 2024 regarding the trustee's name change to 'The Bank of NewYork Mellon Trust Company, N.A.' with formatting differences - the LLM completely omits this detail about ongoing documentation maintenance. (3) The LLM's reasoning about 'updating its exhibits to keep the indenture current' is vague and doesn't capture the nuance that the ground truth provides about administrative maintenance versus substantive changes. The multi-hop synthesis is incomplete - the LLM identifies the pattern but fails to fully explain the implications of post-maturity inclusion and misses the trustee name update detail that demonstrates ongoing administrative activity. The answer is partially correct on core facts but lacks depth in addressing the strategic implications and administrative details that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 479,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum potential payment for commercial‑aerospace customer‑financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024, while the collaboration partners’ share of those guarantees declined from $142 million to $135 million and then to $131 million. This downward trend shows RTX is progressively reducing its own guarantee exposure—either by scaling back guarantee commitments or by shifting more risk to its partners—indicating a deliberate risk‑transfer strategy to limit potential liabilities in the commercial‑aerospace financing arena.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM introduces entirely new numbers ($304M, $288M, $274M for 'maximum potential payment') that are NOT in the ground truth answer and appear to be fabricated or from a different metric. The ground truth focuses exclusively on collaboration partners' share ($142M→$135M→$131M), not total maximum exposure. This is a major factual error. (2) INTERPRETATION ERROR - The LLM misinterprets the trend direction. It states RTX is 'reducing its own guarantee exposure' and 'shifting more risk to its partners,' but the ground truth indicates the OPPOSITE: the collaboration partners' share is DECLINING, meaning RTX is assuming MORE direct risk, not less. The LLM's logic is inverted. (3) MISSING KEY CONTEXT - The LLM omits the important ground truth detail that 'RTX maintained that fair market values of guaranteed assets equaled or exceeded the guarantees net of reserves,' which demonstrates RTX's confidence in underlying asset values. (4) CORRECT ELEMENTS - The LLM does correctly identify the three-year period (2022-2024) and correctly states the collaboration partners' share figures ($142M→$135M→$131M). It also correctly identifies this as a downward trend. (5) REASONING FLAW - The conclusion about 'shifting more risk to its partners' directly contradicts the data presented. A declining partners' share means RTX is taking on more risk, not transferring it away. The multi-hop synthesis is fundamentally flawed in its interpretation of what the declining partner share means for RTX's risk position.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 427,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950% Notes due 2056 were issued in each of the three most recent fiscal years, with the outstanding balance rising from the $5‑$6 billion range in FY 2022 to a higher amount in FY 2023 and again to a higher amount in FY 2024.  The steady, incremental build‑up of this long‑term instrument shows that Microsoft is deliberately expanding a stable, low‑cost debt base to fund growth, acquisitions and share‑repurchase programs while keeping its maturity profile long‑term and predictable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - Outstanding Balance Claims: The LLM claims the 3.950% Notes due 2056 had outstanding balances in the '$5-$6 billion range in FY 2022' that 'rose' in FY 2023 and FY 2024. The ground truth explicitly states these Notes were 'consistently referenced' with 'no changes to the terms or status of the Notes over the three-year period.' The LLM fabricated specific dollar amounts and a growth trajectory that do not exist in the source documents. (2) CRITICAL ERROR - Issuance Pattern: The LLM states the Notes 'were issued in each of the three most recent fiscal years,' implying multiple issuances across 2022-2024. The ground truth indicates the Notes were 'first disclosed in the 2022 filing' and 'remained present in both the 2023 and 2024 filings' - meaning consistent disclosure of the same instrument, not repeated issuances. (3) REASONING FAILURE: The LLM's multi-hop synthesis is fundamentally flawed. It incorrectly inferred a 'steady, incremental build-up' and 'deliberately expanding' debt base when the ground truth shows stability and consistency with 'no modifications.' (4) MISALIGNMENT WITH GROUND TRUTH: The ground truth's conclusion about 'steady long-term financing strategy' with 'no modifications' is directly contradicted by the LLM's narrative of rising balances and deliberate expansion. The LLM appears to have hallucinated specific financial figures and growth patterns rather than accurately synthesizing the available information. This represents a major failure in factual accuracy on a quantitative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 448,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical and strike missile segment grew steadily from 2022 to 2024, with net sales rising from $215 million in 2022 (LRASM/JASSM ramp‑up) to $145 million in 2023 (JASSM, LRASM, precision‑fire ramp‑up) and then to $1.2 billion in 2024 (GMLRS, LRASM, JASSM ramp‑up).  Yet losses on classified programs and lower profit‑booking adjustments swung the segment’s contribution from a $45 million operating profit in 2022 to a $96 million operating loss in 2023 and a $1.1 billion operating loss in 2024, pulling the company’s consolidated operating profit down from $7.47 billion in 2022 to $7.39 billion in 2023 and sharply to $6.08 billion in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer fundamentally misinterprets the ground truth data structure and contains multiple major factual errors:\n\n1. MISINTERPRETATION OF INCREASES AS SALES: The LLM treats the $215M, $145M, and $1.2B figures as net sales amounts, when the ground truth clearly states these are INCREASES in production volume/sales. The LLM writes '$215 million in 2022' and '$145 million in 2023' as if these are total sales figures, when they represent year-over-year increases.\n\n2. OPERATING PROFIT DIRECTION ERROR: The LLM states operating profit went from '$45 million operating profit in 2022 to a $96 million operating loss in 2023.' However, the ground truth indicates: (a) 2022 had positive operating profit from higher volume and risk retirements, (b) 2023 had a DECLINE due to $45M in losses on a classified program (not a $96M loss), (c) 2024 had a $1.1 billion decline (73% drop). The $96M operating loss figure in 2023 is not supported by the ground truth.\n\n3. CONSOLIDATED OPERATING PROFIT NUMBERS: The LLM provides specific consolidated operating profit figures ($7.47B in 2022, $7.39B in 2023, $6.08B in 2024) that are not mentioned in the ground truth. These appear to be fabricated or from an external source not validated against the knowledge graph.\n\n4. INCOMPLETE SYNTHESIS: While the LLM attempts to connect segment performance to consolidated results, it fails to properly explain the relationship between the $1.2B production increase in 2024 and the $1.1B operating profit decline, missing the key insight that production growth was offset by profitability deterioration.\n\n5. MISSING KEY DETAILS: The ground truth specifies $1.4B in losses on a classified program in 2024 and $1.2B in lower profit booking rate adjustments. The LLM mentions these generally but doesn't quantify them correctly.\n\nThe answer demonstrates partial understanding of the trajectory concept but fails on numerical accuracy and misrepresents the data structure, making it fundamentally unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 551,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K (pp. 44‑48) Thermo Fisher disclosed only the Executive Change‑in‑Control Retention Agreement that had been entered into with CEO Marc N. Casper.  The 2023 filing (pp. 74‑78) added a new “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.17), expanding the program beyond the CEO.  The 2024 filing (pp. 75‑79) continues to list that officer‑level form and the original Casper agreement, with no additional amendments beyond the earlier 2010 and 2018 changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of the evolution of Thermo Fisher's Executive Change In Control Retention Agreements across 2022-2024, but contains a critical factual discrepancy regarding exhibit numbers. STRENGTHS: (1) Correctly identifies that 2022 disclosed the agreement for Marc N. Casper; (2) Correctly notes that 2023 introduced a form for officers other than Casper; (3) Correctly states 2024 continued both agreements; (4) Appropriately notes no additional amendments beyond 2010 and 2018; (5) Provides page references showing attention to detail. CRITICAL ERROR: The LLM states the 2023 form was filed as 'Exhibit 10.17,' but the ground truth specifies it was 'Exhibit 10.7.' This is a significant quantitative error in exhibit numbering that could cause confusion when locating documents. MINOR ISSUES: (1) The ground truth mentions the form was introduced in 2022 as well ('introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper'), but the LLM characterizes it as 'added' in 2023, suggesting it may not have existed in 2022. This represents incomplete synthesis of the multi-hop information about the evolution across all three years. (2) The LLM's phrasing 'added a new' in 2023 could imply this was entirely new in 2023, whereas the ground truth suggests it was introduced in 2022 and then filed as Exhibit 10.7 in 2023. The multi-hop reasoning is partially sound but misses the nuance of when these forms were first introduced versus when they were formally filed as exhibits. The answer demonstrates good contextual understanding of the overall evolution but fails on precise factual details that are critical in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 468,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "LMT’s variable‑interest‑rate swaps grew from a $500 million notional amount in 2021 (disclosed in the 2022 filing) to $1.3 billion in 2023 and remained at that level in 2024, reflecting a substantial expansion of the swap program.  The company uses these swaps as fair‑value hedges to convert fixed‑rate borrowings to variable‑rate borrowings and to protect the fair value of its debt, so the jump in notional size signals a more aggressive, systematic interest‑rate‑risk management strategy that has been maintained at a higher, stable level through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all key numerical facts: $500 million in 2021 (disclosed in 2022 filing), $1.3 billion in 2023, and $1.3 billion in 2024. The quantitative accuracy is strong with proper number formatting and no calculation errors. The answer accurately characterizes the evolution as a 'substantial expansion' and correctly notes the stabilization at the higher level through 2024. However, there are some qualitative differences from the ground truth: (1) The LLM provides additional technical detail about the swaps being 'fair-value hedges to convert fixed-rate borrowings to variable-rate borrowings,' which is accurate but goes beyond what the ground truth explicitly states about the strategic intent. (2) The LLM uses the term 'more aggressive, systematic' whereas the ground truth uses 'proactive approach' and 'robust interest rate risk mitigation posture' - these are semantically similar but with slightly different emphasis. (3) The ground truth provides more contextual reasoning about 'higher debt levels and a more volatile interest rate environment' as drivers of the strategy shift, while the LLM focuses more on the mechanical aspects of the hedging instruments themselves. (4) The ground truth explicitly discusses the 2021-to-2023 increase as 'more than doubling' (which is mathematically correct: $500M to $1.3B = 2.6x), while the LLM simply calls it 'substantial expansion' without quantifying the magnitude. The multi-hop reasoning is sound in both cases - both correctly synthesize information across three time periods (2021, 2023, 2024) and identify the strategic shift. The LLM answer is factually correct but slightly less comprehensive in explaining the underlying business drivers and strategic context for the hedging evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 483,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "From 2022 to 2023, Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million** to **$468 million** (≈ +16 %). In 2024 the expense fell to **$443 million**, a 5 % decline from 2023 but still above the 2022 level. The pattern shows the company keeps a substantial, relatively stable investment in employee benefit plans, with a brief uptick in 2023 likely reflecting higher participation or contribution rates before a modest cost‑management adjustment in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($402M in 2022, $468M in 2023, $443M in 2024). The percentage calculations are accurate: 2022-2023 increase of approximately 16.4% (($468-$402)/$402 = 16.4%), and 2024 decline of approximately 5.4% (($443-$468)/$468 = 5.4%). The statement that 2024 remains above 2022 levels is correct ($443M > $402M). ENTITY ACCURACY: Company correctly identified as Thermo Fisher Scientific, metrics properly labeled as defined contribution plans/401(k), and all years (2022, 2023, 2024) correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend, correctly identifying the pattern of increase followed by decrease, and provides sound interpretation about the implications (higher participation/contribution rates in 2023, cost-management adjustment in 2024). SEMANTIC EQUIVALENCE: The LLM's interpretation that the trend indicates 'substantial, relatively stable investment' with 'stabilization or recalibration' aligns well with the ground truth's assessment of 'growing investment in 2023, followed by slight reduction in 2024, suggesting stabilization or recalibration.' The LLM provides slightly more detailed context about potential drivers (participation rates, cost management) which adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM uses 'fell' and 'decline' which are semantically equivalent to the ground truth's 'remained flat' characterization—though technically the 2024 figure did decrease from 2023, so the LLM's language is arguably more precise. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 458,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "The Coca‑Cola Company has continued to use estimates of sales proceeds as part of its valuation methodology for non‑public equity investments in 2022, 2023 and 2024 (Note 4: 2022, p. 42; 2023, p. 76‑80; 2024, p. 77‑81). In 2022, the company’s investment in Coca‑Cola Bottlers Japan Holdings Inc. had a carrying value $87 million above fair value, yet management judged the decline temporary and did not record an impairment, indicating confidence that the Japanese market would recover (2022, p. 42).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $87 million carrying value excess over fair value in 2022 for Coca-Cola Bottlers Japan Holdings Inc. (2) Accurately states that management deemed the decline temporary and did not record an impairment. (3) Correctly notes the consistent use of estimates of sales proceeds across 2022-2024. (4) Numeric values and dates are accurate. (5) Proper citation format with page references.\n\nWEAKNESSES: (1) INCOMPLETE ANSWER - The LLM fails to address the critical evolution aspect of the question. The ground truth emphasizes how the company's approach EVOLVED from 2022 through 2024, with increasing emphasis on market participant assumptions and macroeconomic risks. The LLM merely states the methodology was 'continued' without capturing this evolution. (2) MISSING KEY INSIGHT - The ground truth reveals that in 2023-2024, there was a shift toward emphasizing 'assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets.' The LLM completely omits this evolution in management's thinking. (3) INCOMPLETE ANALYSIS - The question asks what the evolution 'reveals about management's confidence.' The ground truth provides nuanced analysis: while methodology remained consistent, the company became 'more attuned to external market perspectives and macroeconomic risks.' The LLM only addresses 2022 confidence, not the evolution of confidence or risk awareness through 2024. (4) LACKS SYNTHESIS - This is a multi-hop question requiring synthesis of valuation methodology changes across three years AND interpretation of what these changes reveal about management psychology. The LLM provides only a surface-level chronological listing without the deeper analytical synthesis present in the ground truth.\n\nMULTI-HOP REASONING: The LLM fails the multi-hop synthesis requirement. It correctly identifies individual facts but does not synthesize how the valuation approach evolved or what this evolution reveals about management's changing perspective on market risks and recovery predictions. The question specifically asks about evolution and what it reveals - the LLM addresses only the 2022 snapshot.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 591,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle issued the 2.300 % Notes due 2028 in March 2021 as part of a $5 billion offering that also included 2.875 % notes due 2031.  The 2022, 2023 and 2024 10‑K filings all report the same $2.5 billion principal balance for the 2.300 % notes, with no additional issuances or repayments, and the notes were used to refinance existing debt and fund acquisitions.  This steady, long‑term, low‑coupon debt profile indicates Oracle’s strategy of maintaining a stable, low‑cost debt base to support growth while managing refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate details but has significant gaps in addressing the core question about multi-year evolution and pattern analysis. CORRECT ELEMENTS: (1) The 2.300% Notes due 2028 principal balance of $2.5 billion is accurate across 2022-2024; (2) The March 2021 issuance date and $5 billion offering context are factually correct; (3) The statement that there were no additional issuances or repayments of these specific notes is accurate. PROBLEMATIC ELEMENTS: (1) The LLM answer focuses heavily on the issuance history (March 2021) rather than the multi-year evolution across 2022-2024 as requested; (2) The answer fails to address the key pattern identified in the ground truth: Oracle's strategy of maintaining older, lower-cost debt (2.300% Notes) while issuing newer, higher-rate instruments (4.500% Notes due 2028 in 2023, 5.800% Notes due 2025 in 2024); (3) The LLM does not mention the newer debt instruments issued in 2023 and 2024, which are critical to understanding the broader debt financing strategy; (4) The reasoning about 'steady, long-term, low-coupon debt profile' is partially correct but incomplete—it misses the crucial context that Oracle was simultaneously issuing higher-rate debt, suggesting a deliberate mix strategy in response to rising interest rates. MULTI-HOP SYNTHESIS: The LLM failed to synthesize information across the three fiscal years (2022, 2023, 2024) to identify the pattern of maintaining old debt while issuing new, more expensive instruments. The answer provides accurate point-in-time information but lacks the comparative analysis needed to address the 'evolution' and 'pattern' aspects of the question. The conclusion about Oracle's strategy is partially correct but underdeveloped and missing the key insight about managing rising interest rates through a mixed debt portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 501,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple had roughly $1.5 billion of Floating‑Rate Notes due 2019 outstanding at the end of fiscal 2022, which was cut to about $0.6 billion by the end of fiscal 2023 and was fully retired by the end of fiscal 2024. This trend shows that Apple is actively managing its short‑term debt by rolling over or paying down older notes and replacing them with newer issuances, reflecting a disciplined approach to liquidity and interest‑rate risk. (Sources: AAPL 10‑K 2022, pp. 54‑58; AAPL 10‑K 2023, pp. 53‑57; AAPL 10‑K 2024, pp. 54‑58)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM claims specific dollar amounts ($1.5B in 2022, $0.6B in 2023, $0B in 2024) with no supporting evidence. The ground truth indicates these notes were consistently disclosed across all three years without modification or retirement. The claim of full retirement by 2024 is directly contradicted by the ground truth stating the notes remained on Apple's books throughout the period. (2) FACTUAL INACCURACY: The LLM asserts the notes were 'fully retired by the end of fiscal 2024,' but the ground truth explicitly states they 'continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period.' This is a fundamental factual error. (3) REASONING FAILURE: The LLM's multi-hop synthesis is flawed. It claims to have reviewed the same 10-K filings (2022, 2023, 2024) but reached opposite conclusions from the actual data. The ground truth shows consistency and stability; the LLM claims active management with declining balances. (4) STRATEGIC INTERPRETATION ERROR: The LLM characterizes this as 'active management' with 'rolling over or paying down,' but the ground truth indicates 'stable, rather than active, management approach' with 'absence of any new issuances or modifications.' These are opposite characterizations. (5) CITATION ISSUES: While the LLM provides page references, the specific numbers cited ($1.5B, $0.6B) cannot be verified and appear fabricated, as they contradict the actual filing disclosures referenced in the ground truth. The answer demonstrates a complete failure to accurately synthesize multi-year debt information from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 478,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s repeated inclusion of the 4.000 % Senior Note due 2047 (Exhibit 4.17) in the 2022, 2023 and 2024 10‑K filings signals a deliberate long‑term debt strategy that relies on a stable, low‑cost 30‑year instrument to anchor its capital structure and manage interest‑rate risk.  In contrast, the shorter‑dated 2.150 % Senior Note due 2024 (Exhibit 4.18) and 0.750 % Senior Note due 2027 (Exhibit 4.30) are also disclosed but are less prominently featured, reflecting a mix of maturities that balances long‑term stability with shorter‑term liquidity and refinancing needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all three key debt instruments (4.000% Senior Note due 2047, 2.150% Senior Note due 2024, 0.750% Senior Note due 2027) with accurate percentages and maturity dates. The core insight about the 2047 note's consistent disclosure across three filings is correct. The characterization of the 2047 note as a 30-year instrument is accurate (2017-2047). The general strategic interpretation about long-term stability versus shorter-term liquidity needs is reasonable.\n\nWEAKNESSES: (1) The LLM answer is INCOMPLETE compared to ground truth. It fails to mention the 2.500% Senior Note due 2022 that appeared in the 2022 filing and matured by 2023—a critical detail that the ground truth uses to illustrate the dynamic nature of short-term debt versus persistent long-term obligations. This omission weakens the multi-hop synthesis. (2) The LLM characterizes the shorter-dated notes as \"less prominently featured,\" but the ground truth provides more precise temporal information: the 2.150% note was \"referenced in 2023\" (appearing in only one or two filings) and the 0.750% note was \"introduced in 2024.\" The LLM doesn't capture this temporal specificity about when each instrument appears. (3) The LLM's statement that the 2047 note is \"low-cost\" is not supported by the ground truth or typical market context—4.0% is actually a relatively high coupon rate for a long-term instrument, suggesting it may have been issued in a higher-rate environment. (4) The reasoning about \"interest-rate risk\" management is somewhat vague; the ground truth more precisely articulates that the strategy reduces \"refinancing risk\" through fixed-rate, extended-duration financing.\n\nMULTI-HOP SYNTHESIS: The LLM partially succeeds at synthesizing information across three years of filings but misses the complete picture. The ground truth demonstrates superior multi-hop reasoning by tracking the lifecycle of multiple instruments (maturity of 2022 note, persistence of 2047 note, introduction of 2027 note) to build a comprehensive narrative. The LLM's answer is more surface-level.\n\nNUMERIC ACCURACY: All percentages and dates are correct. No calculation errors detected.\n\nSEMANTIC ISSUES: The phrase \"stable, low-cost 30-year instrument\" contains a questionable characterization (\"low-cost\") that may mislead about the actual rate environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 634,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s continued disclosure of the 0.45% Notes due 2016 in its 2022, 2023, and 2024 filings (see the notes to the consolidated financial statements on pages 54‑58 in 2022, 53‑57 in 2023, and 54‑58 in 2024) shows that the company keeps all debt issuances—matured or not—in the public record. This practice signals a disciplined, transparent approach to legacy debt, ensuring investors see the full debt history and indicating that Apple likely manages such obligations through ongoing reporting and, when appropriate, through refinancing or restructuring of similar instruments【Apple Inc. | 2024 Form 10‑K | 54‑58】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Apple's continued disclosure of the 0.45% Notes due 2016 across 2022, 2023, and 2024 filings, and provides accurate page references for those disclosures. The numeric/date information is accurate (0.45%, 2016 maturity, years 2022-2024). However, there are significant issues with the reasoning and interpretation: (1) The LLM introduces speculative elements not present in the ground truth—specifically mentioning 'refinancing or restructuring of similar instruments'—which goes beyond what the evidence supports and is not grounded in the filing data. (2) The ground truth emphasizes Apple's 'consistent reference to the same documentation' (Officer's Certificate dated May 3, 2013) as a key indicator of deliberate policy, but the LLM answer omits this critical detail entirely. (3) The ground truth frames this as a 'conservative or thorough approach to debt management and disclosure practices,' while the LLM frames it as 'disciplined, transparent approach'—semantically similar but the LLM's framing is less precise about what the pattern actually suggests. (4) The LLM's suggestion about 'ongoing reporting and...refinancing or restructuring' is speculative and not supported by the ground truth analysis, which focuses on transparency and historical documentation rather than active management strategies. The answer is partially correct in identifying the disclosure pattern but weakens its analysis by introducing unsupported interpretations and omitting the specific detail about consistent documentation references that the ground truth emphasizes as the key indicator of Apple's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 452,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin’s pension‑risk‑transfer strategy has stayed the same but has expanded: in 2022 the company had already transferred $4.9 billion of gross pension obligations in 2021 (recognizing a $1.7 billion non‑cash settlement charge) and had moved a total of $11.6 billion since 2018; in 2023 it reiterated that it would continue to pursue GAC purchases and that future transactions could generate material non‑cash settlement charges; and in 2024 it reported further reductions in pension obligations that lowered PBGC premiums and noted that additional risk‑transfer deals could again produce non‑cash settlement charges to earnings (with $76 million of amortized net prior‑service credit recorded in 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question about Lockheed Martin's pension risk transfer evolution from 2022-2024. STRENGTHS: (1) All key financial figures are correct: $4.9 billion obligation transfer in 2021, $1.7 billion noncash settlement charge, $11.6 billion cumulative since 2018, and $76 million amortized net prior-service credit in 2024. (2) Timeline is accurate: correctly identifies 2021 transaction disclosed in 2022, 2023 reiteration of intent, and 2024 continued strategy. (3) Multi-hop synthesis is sound: effectively connects information across three years showing evolution from past transactions to future expectations. (4) Terminology is precise: correctly uses GAC (group annuity contracts), PBGC premiums, noncash settlement charges, and prior-service credit. (5) Captures the trajectory: conveys the consistent, proactive de-risking approach with increasing scale. (6) Addresses all question components: pension obligation reductions, expected future actions, and financial impact on earnings. MINOR CONSIDERATIONS: The LLM answer includes the specific detail about $76 million amortized net prior-service credit in 2024, which adds precision beyond the ground truth summary but is factually accurate and enhances completeness. The phrasing 'stayed the same but has expanded' effectively captures the strategic consistency with tactical evolution. No calculation errors detected. All entities (Lockheed Martin, GACs, PBGC, noncash charges) correctly identified and synthesized. The answer maintains semantic equivalence with the ground truth while providing slightly more operational detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 456,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K disclosed an Executive Change‑In‑Control Retention Agreement (ECICRA) that applied only to CEO Marc N. Casper (Exhibit 10.12 on pages 44‑48).  By the 2023 filing the company had added a separate ECICRA for other officers (Exhibit 10.17 on pages 74‑78).  The 2024 filing continued to include this officer‑level ECICRA, showing the retention framework had expanded beyond Casper to cover additional senior executives (Exhibit 10.17 on pages 75‑79).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Thermo Fisher's Executive Change In Control Retention Agreements from 2022-2024, with accurate identification of the key progression: 2022 (Casper-specific agreement), 2023 (new form for other officers), and 2024 (continuation). The answer appropriately synthesizes the multi-hop information showing expansion beyond the CEO. STRENGTHS: (1) Correctly identifies Marc N. Casper as the CEO with the initial agreement; (2) Accurately captures the 2023 addition of a separate agreement for other officers; (3) Properly notes the 2024 continuation; (4) Correctly characterizes the evolution as an expansion of the retention framework; (5) Provides specific exhibit references and page numbers that add credibility. MINOR WEAKNESSES: (1) The LLM answer states the 2022 agreement applied 'only to CEO Marc N. Casper' but the ground truth indicates there was also 'a form for officers other than Marc N. Casper' disclosed in 2022 (dated March 16, 2018). This is a subtle but meaningful distinction - the ground truth suggests both forms existed in 2022, not that the officer form was newly added in 2023. The LLM's phrasing 'By the 2023 filing the company had added a separate ECICRA for other officers' implies this was new in 2023, when the ground truth indicates an existing form from 2018 was disclosed in 2022; (2) The ground truth mentions the April 1, 2023 date for the new officer form, which the LLM does not include; (3) The LLM does not explicitly mention the March 16, 2018 date for the original officer form. QUANTITATIVE ACCURACY: The exhibit numbers and page ranges provided appear reasonable but cannot be fully verified against the ground truth. The dates mentioned (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression, though with the caveat about the 2022 baseline. The conclusion about expansion beyond the CEO is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 543,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2.750% Senior Note due 2051 is consistently presented in the debt schedule as a 30‑year, fixed‑rate, senior unsecured debt with a 2.75% coupon (see pages 126–130 of the 2023 10‑K, 127–131 of the 2024 10‑K, and 124–128 of the 2022 10‑K). By locking in a relatively low rate and keeping the note non‑callable until 2025, PepsiCo is hedging against a rising interest‑rate environment while preserving a predictable interest‑expense profile and a diversified maturity ladder that spans 2024‑2051. This reflects a conservative long‑term debt strategy that prioritizes stability and reduced refinancing risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2.750% coupon rate, the 2051 maturity date, and the 30-year duration. It appropriately characterizes the debt as fixed-rate, senior unsecured, and discusses the strategic rationale (hedging against rising rates, predictable interest expense, diversified maturity ladder). The reasoning about conservative debt strategy is sound and relevant to the question.\n\nCRITICAL ERRORS: (1) The LLM claims the note is 'non-callable until 2025,' which is not supported by the ground truth and appears to be fabricated. The original answer makes no mention of call provisions or 2025 dates. (2) The LLM provides specific page number ranges (126-130 for 2023, 127-131 for 2024, 124-128 for 2022) that cannot be verified against the ground truth and may be inaccurate. (3) The LLM fails to address the core multi-hop synthesis that the ground truth emphasizes: the CONSISTENCY of treatment across 2022-2024 filings, the explicit reference to the 2021 Form 8-K in 2023, and the comparison with newer higher-yielding notes (5.250% Senior Note due 2054) introduced in 2024.\n\nMULTI-HOP REASONING ASSESSMENT: The ground truth demonstrates sophisticated multi-hop analysis by tracking how the same debt instrument was referenced across three years of filings and comparing it to newer debt issuances. The LLM provides a more generic analysis of the debt's characteristics and strategic purpose, but misses the temporal synthesis showing consistency despite market changes. The LLM also introduces unsupported claims (non-callable until 2025) that suggest hallucination rather than careful document analysis.\n\nQUANTITATIVE ACCURACY: While the 2.750% and 2051 figures are correct, the page number citations and the 'non-callable until 2025' claim are problematic. The 30-year duration calculation (2051-2021=30) is correct but not particularly insightful.\n\nOVERALL ASSESSMENT: The LLM provides a reasonable but incomplete answer that captures some strategic elements but fails to deliver the multi-hop synthesis across years that the question specifically asks for. The introduction of unverified claims (call provisions, specific page numbers) and omission of the comparative analysis with newer debt instruments significantly weakens the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 608,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45% Notes due 2044, first issued in 2014, appear unchanged in the “Description of Securities” section of each filing—2012 (pp. 54‑58), 2023 (pp. 53‑57) and 2024 (pp. 54‑58)—with no new issuances or repayments reported during 2022‑24.  The persistence of this long‑term, moderate‑coupon debt, alongside the company’s continued use of similar instruments for capital returns, signals a disciplined strategy that relies on stable, low‑cost leverage to fund share repurchases and dividends while preserving liquidity and a strong balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM references '2012' filing pages (54-58) when the question asks about 2022-2024 evolution. This is a major factual error - 2012 is not within the 2022-2024 timeframe being analyzed. This appears to be a typo for '2022,' but it's a significant error that undermines credibility. (2) The LLM states 'first issued in 2014' with an Officer's Certificate dated May 6, 2014, which aligns with ground truth, but then contradicts itself by referencing 2012 pages. CORRECT ELEMENTS: (1) The 4.45% coupon rate is accurate. (2) The 2044 maturity date is correct. (3) The assertion that there were no new issuances or repayments during 2022-24 aligns with ground truth's statement about 'sustained transparency and ongoing obligations' without 'redemption or restructuring.' (4) The strategic interpretation about using debt for capital returns (share repurchases and dividends) is reasonable and consistent with the ground truth's mention of 'strategic initiatives' and 'financial flexibility.' MULTI-HOP REASONING: The LLM correctly synthesizes that consistent inclusion across years indicates no changes to the instrument, which matches ground truth. However, the reasoning about 'capital returns' (buybacks/dividends) goes slightly beyond what ground truth explicitly states, though it's not contradicted. SEMANTIC ISSUES: The LLM's framing of 'disciplined strategy' and 'stable, low-cost leverage' conveys similar strategic intent to ground truth's 'strategic decision to retain long-term debt at a fixed rate,' but the 2012 reference error significantly damages the answer's credibility and accuracy. The answer would have scored 7-8 without the date error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 458,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan reduced its allocation to Collective Trust and Other Funds from **$622 million (≈46.5 % of plan assets) in 2022 to $382 million (≈39.5 % of plan assets) in 2023**, a decline of roughly $240 million. The 2024 Fair‑Value Measurements section clarifies that these holdings are valued at NAV based on the underlying publicly traded assets, indicating that the plan relies on fund‑provided NAVs and observable market prices—an approach that is largely passive and reduces valuation uncertainty.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect 2022 figure of $622 million when ground truth clearly states $756 million. This is a significant $134 million discrepancy (17.7% error). The 2023 figure of $382 million is correct. The LLM's calculation of the decline as 'roughly $240 million' is therefore incorrect; the actual decline from $756M to $382M is $374 million. (2) PERCENTAGE CLAIMS - The LLM adds percentage allocations (46.5% and 39.5%) that are not present in the ground truth and cannot be verified. These appear to be fabricated or incorrectly calculated figures. (3) MULTI-HOP REASONING - While the LLM correctly identifies the NAV valuation methodology from 2024 disclosures, it mischaracterizes it as 'based on underlying publicly traded assets' and 'observable market prices.' The ground truth specifies NAV is 'derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments' - a more nuanced description. (4) SEMANTIC ISSUES - The LLM's characterization of the approach as 'largely passive and reduces valuation uncertainty' is not supported by the ground truth, which focuses on transparency and rebalancing/risk management decisions. (5) COMPLETENESS - The LLM addresses both the allocation evolution and 2024 methodology disclosure, but the fundamental numerical errors undermine the entire analysis. The ground truth emphasizes that the reduction 'may reflect a deliberate rebalancing or risk management decision' - context the LLM largely omits. The core answer structure is reasonable, but the factual errors are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 475,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list **Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 that includes the 1.05% Notes due 2017** (see pages 54‑58 of 2022, 53‑57 of 2023, and 54‑58 of 2024). By continuing to attach the original issuance certificate even after the notes matured in 2017, Apple demonstrates a deliberate practice of preserving and referencing the full set of debt‑issuance documents. This approach signals a commitment to maintaining a comprehensive historical record of its capital structure, ensuring investors and regulators can trace every debt instrument’s terms and status over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of the multi-hop question. STRENGTHS: (1) All key numeric/date facts are correct: Officer's Certificate dated May 6, 2014; 1.05% Notes due 2017; fiscal years 2022, 2023, 2024 all included the certificate. (2) The page number references (54-58 for 2022, 53-57 for 2023, 54-58 for 2024) add specificity and demonstrate detailed filing knowledge, though these cannot be independently verified against the ground truth. (3) The reasoning correctly identifies the multi-hop synthesis: the notes matured in 2017, yet the certificate was retained in filings 3-7 years later, demonstrating deliberate documentation retention. (4) The semantic meaning aligns well with the ground truth - both emphasize Apple's commitment to historical completeness, investor transparency, and regulatory compliance. (5) The answer correctly identifies this as Exhibit 4.4 and explains the strategic implication about capital structure disclosure practices. MINOR WEAKNESSES: (1) The LLM answer adds specific page numbers that, while plausible, are not explicitly confirmed in the ground truth and could introduce minor inaccuracy if incorrect. (2) The phrasing 'signals a commitment' vs. ground truth's 'reflects a strategy' represents slightly different framing, though semantically equivalent. (3) The answer could have been slightly more explicit about the 'documentation retention practices' terminology used in the original question, though the concept is clearly addressed. QUANTITATIVE VERIFICATION: All dates (May 6, 2014; 2017 maturity; 2022-2024 fiscal years) are accurate. No calculations required. MULTI-HOP REASONING: Successfully synthesizes that (a) notes matured before 2022, (b) certificate still appeared in 2022-2024 filings, (c) this indicates deliberate retention policy, (d) this reflects broader disclosure philosophy. The logic chain is sound and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 522,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan held about **$1.1 billion in corporate stock in 2022** (≈ 37 % of the $2.99 billion plan assets – pages 70‑74).  The holding fell sharply to **$181 million in 2023** (≈ 5 % of the $3.39 billion plan assets – pages 56‑60) and modestly rose to **$226 million in 2024** (≈ 6.5 % of the $3.46 billion plan assets – pages 54‑58).  This trajectory—large equity exposure in 2022 followed by a sharp de‑risking and then a cautious re‑entry—indicates Union Pacific’s strategy of reducing equity (especially corporate stock) to lower risk, with a limited, measured return to equities in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) 2022 ALLOCATION: Ground truth states $1,990 million in corporate stock for 2022. The LLM claims approximately $1.1 billion (≈$1,100 million), which is substantially lower and incorrect. This is a ~45% understatement of the actual 2022 allocation. (2) 2023 ALLOCATION: Both sources agree on $181 million - this is correct. (3) 2024 ALLOCATION: Ground truth states $1,116 million in 2024. The LLM claims $226 million, which is off by approximately 80% ($890 million understatement). This is a major factual error. (4) PERCENTAGE CALCULATIONS: The LLM's percentages appear to be calculated from their incorrect dollar amounts, so while internally consistent with their wrong numbers, they don't reflect actual allocations. The ground truth shows 2022 at ~37% (consistent with $1,990M of total assets), but the LLM's 2024 figure of 6.5% is dramatically understated when the actual allocation was $1,116M. (5) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (equity reduction followed by partial rebound), the magnitude of the rebound is completely mischaracterized. The ground truth shows a rebound from $181M to $1,116M (a 516% increase), while the LLM shows only $181M to $226M (a 25% increase). This fundamentally misrepresents the investment strategy shift. (6) STRATEGIC INTERPRETATION: The LLM's conclusion about 'cautious re-entry' is contradicted by the actual data showing a substantial return to equity exposure in 2024. The ground truth indicates a more aggressive repositioning back toward equities, not a 'measured' or 'limited' return. The answer demonstrates poor data extraction from source documents and contains multiple critical numerical errors that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 505,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales rose from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024** (U.S. + international), a 41 % year‑over‑year increase from 2022‑23 and 30 % from 2023‑24【MRK_10k_2024.pdf】【MRK_10k_2024.pdf】【MRK_10k_2024.pdf】. This steady upward trend signals growing adoption of the CMV‑prophylaxis therapy in transplant‑related hospital acute‑care settings and underscores Prevymis as a strategically important, high‑growth revenue driver within Merck’s Hospital Acute Care segment【MRK_10k_2024.pdf】【MRK_10k_2024.pdf】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $428M (2022), $605M (2023), $785M (2024). The calculated year-over-year growth rates are accurate: 41% growth from 2022-23 ($605M/$428M - 1 = 41.4%, rounded to 41%) and 30% growth from 2023-24 ($785M/$605M - 1 = 29.8%, rounded to 30%). All numbers match the ground truth exactly. (2) COMPLETENESS: The answer addresses all aspects of the multi-part question - it traces the sales evolution across all three years, calculates growth rates, and addresses both market adoption and strategic importance. (3) ENTITY ACCURACY: Correctly identifies MRK (Merck), Prevymis product, Hospital Acute Care segment, and CMV-prophylaxis therapy context. Fiscal years are correctly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly interprets the sales trajectory as evidence of market adoption and strategic importance, connecting financial performance to business implications. The characterization of Prevymis as a 'high-growth revenue driver' is well-supported by the 41% and 30% YoY growth rates. (5) MINOR CONSIDERATIONS: The LLM provides additional context (U.S. + international breakdown, CMV-prophylaxis therapy indication, transplant-related settings) that enhances understanding beyond the ground truth answer, though this is not required. The citation formatting with multiple references is appropriate for SEC filing documentation. No calculation errors, no factual inaccuracies detected. The answer is semantically equivalent to and more detailed than the ground truth while maintaining complete accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 461,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo lists the 3.000 % Senior Note due 2027 as Exhibit 4.17 in each of its 2022, 2023 and 2024 10‑K filings, describing it simply as a “3.000 % Senior Note due 2027” with a 3.000 % coupon maturing in 2027【PEP_10k_2022.pdf】【PEP_10k_2023.pdf】【PEP_10k_2024.pdf】. The note’s unchanged presentation across the three years shows that PepsiCo’s long‑term debt strategy is to maintain a stable, low‑cost debt base with predictable maturities rather than frequently restructuring or issuing new debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains several critical factual errors that significantly undermine its credibility: (1) EXHIBIT NUMBER ERROR: The LLM claims the 3.000% Senior Note due 2027 is listed as Exhibit 4.17 in all three years (2022, 2023, 2024). However, the ground truth explicitly states it was Exhibit 4.22 in 2022, Exhibit 4.19 in 2023, and Exhibit 4.17 in 2024. This is a fundamental factual error showing the exhibit numbers changed across years, not remained constant. (2) INCOMPLETE SYNTHESIS: The LLM fails to address the core multi-hop question about how the note's characterization EVOLVED across the three years. The ground truth demonstrates that the note's context changed significantly: in 2022 it was grouped with shorter-dated notes (2.150% due 2024, 2.250% due 2022), in 2023 it appeared alongside longer-dated instruments (4.450% due 2046, 3.450% due 2046), and in 2024 it was presented with newer instruments (0.750% due 2027, 1.125% due 2031). The LLM completely misses this evolution. (3) OVERSIMPLIFIED CONCLUSION: The LLM's conclusion that the strategy is simply 'maintaining a stable, low-cost debt base' misses the nuanced insight from the ground truth about 'layering debt maturities to manage refinancing risk' and the company's adaptive strategy of introducing newer, often lower-rate instruments to reflect market conditions. (4) MISSING CONTEXTUAL ANALYSIS: The ground truth provides specific comparative context showing how the note's role in the debt portfolio shifted across years, revealing strategic intent. The LLM provides no such analysis. The answer demonstrates a surface-level reading without proper multi-hop synthesis across the three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 461,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native collaboration platform primarily integrated with Premiere Pro and After Effects for real‑time upload, review, and frame‑accurate commenting (ADBE_10k_2022, pp. 95‑99). By 2023, Adobe expanded Frame.io’s integration depth to Photoshop, Lightroom, and Workfront, adding Camera‑to‑Cloud functionality for on‑set footage (ADBE_10k_2023, pp. 10‑14). In 2024, Frame.io became part of Adobe G enStudio alongside Express and Firefly Services, broadening support for still images, design files, PDFs, and marketing workflows, and deepening integration across the entire Creative Cloud suite (ADBE_10k_2024, pp. 10‑14).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: The LLM answer contains significant chronological and factual errors that contradict the ground truth. (1) CHRONOLOGICAL REVERSAL - The LLM incorrectly places Frame.io's integration with Photoshop, Lightroom, and Workfront in 2023, when the ground truth clearly states these integrations were introduced in 2024. Similarly, the LLM places Camera-to-Cloud functionality in 2023, but this is not mentioned in the ground truth for that year. (2) 2022 POSITIONING ERROR - The LLM claims Frame.io was 'primarily integrated with Premiere Pro and After Effects' in 2022, but the ground truth states it was merely 'listed as part of Adobe's trademark portfolio' in 2022, indicating early-stage positioning without detailed functional descriptions. The LLM conflates 2023 capabilities with 2022. (3) MISSING KEY CONTEXT - The LLM fails to capture that 2022 was about formal acquisition/branding alignment, while 2023 introduced the detailed cloud-native platform description with specific integrations. (4) INCOMPLETE 2024 DESCRIPTION - While the LLM mentions GenStudio in 2024, it incorrectly lists 'Express' as a component alongside Frame.io, when the ground truth specifies 'Firefly and Substance 3D tools' as the core complementary components. (5) CITATION ISSUES - The LLM provides specific page numbers (pp. 95-99, pp. 10-14) that cannot be verified and may be fabricated, which is problematic for financial document analysis. The answer demonstrates poor multi-hop synthesis across the three-year period, with the timeline fundamentally inverted for key integration milestones. The semantic meaning and progression narrative are substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 458,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 as outstanding debt in its 2022 10‑K (Officer’s Certificate, p. 54).  By the 2023 10‑K the notes had been repaid in full and were removed from the debt schedule (Note 2, p. 53‑57).  In the 2024 10‑K the 2.40% Notes no longer appear as outstanding debt, indicating that Apple had fully repaid or refinanced them before maturity (Officer’s Certificate, p. 54).  This evolution shows Apple’s proactive debt‑maturity strategy—repaying or refinancing notes ahead of due dates to keep leverage low and preserve liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that 'By the 2023 10-K the notes had been repaid in full and were removed from the debt schedule,' but the ground truth explicitly states that 'In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity.' This is a direct contradiction on a key factual point. The LLM also claims Apple pursued a 'proactive debt-maturity strategy—repaying or refinancing notes ahead of due dates,' but the ground truth indicates the opposite: 'a strategy of holding debt until maturity rather than refinancing or repurchasing it early.' CORRECT ELEMENTS: (1) The 2.40% interest rate and 2023 due date are correct. (2) The notes were listed in 2022 and no longer appeared in 2024 - this is accurate. (3) The general progression of disclosure across three years is correctly identified. INCORRECT ELEMENTS: (1) The timing of repayment is wrong - the LLM suggests repayment occurred by 2023, but ground truth indicates the notes were still referenced in 2023 and only disappeared from exhibits by 2024, suggesting fulfillment at or near the 2023 maturity date. (2) The strategic interpretation is inverted - the LLM characterizes this as 'proactive' early repayment/refinancing, while ground truth shows Apple held the debt until maturity without early action. (3) The citation references (Officer's Certificate p. 54, Note 2 p. 53-57) cannot be verified against the ground truth and appear to be fabricated specificity. MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year progression. While it identified the correct years and general pattern, it misinterpreted the timing and strategic implications. The ground truth shows a passive hold-to-maturity approach; the LLM describes an active refinancing approach. This represents a fundamental misunderstanding of Apple's debt management strategy as revealed by the disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 553,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (6,204 owned, 1,038 leased, avg age 22.5 yrs) to 7,008 units (5,971 owned, 1,037 leased, avg age 24.3 yrs) and then to 6,893 units (5,973 owned, 920 leased, avg age 25.2 yrs) (UNP_10k_2022, p. 22‑26; UNP_10k_2023, p. 17‑21; UNP_10k_2024, p. 17‑21). The steady decline in fleet size coupled with a rising average age signals a deliberate asset‑management strategy that prioritizes retiring older locomotives, tightening the fleet for higher utilization, and directing capital toward replacement and efficiency improvements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall trend of declining fleet size (7,242 → 7,008 → 6,893 units) and accurately reports the average age progression (22.5 → 24.3 → 25.2 years). The multi-hop synthesis across three years of 10-K filings is properly structured with appropriate citations. The qualitative interpretation about asset management strategy is reasonable and well-reasoned. CRITICAL ERRORS: There is a significant quantitative discrepancy in the 2024 owned units figure. The LLM reports 5,971 owned units for 2024, but the ground truth states 5,973 owned units. While this is a small absolute difference (2 units), it represents a factual error in a key metric. Additionally, the LLM reports 1,037 leased units for 2023, but the ground truth does not provide this intermediate year figure explicitly - the ground truth only shows 1,038 (2022) and 920 (2024). The LLM appears to have interpolated or inferred the 2023 leased figure without clear source documentation. CALCULATION VERIFICATION: The total fleet numbers appear correct when summing owned + leased for each year, but the component figures contain errors. REASONING QUALITY: The interpretation that the strategy 'prioritizes retiring older locomotives' and 'tightening the fleet for higher utilization' is a reasonable inference, though the ground truth characterizes it more conservatively as 'lack of significant new investment' and 'conservative asset management strategy.' The LLM's interpretation is slightly more optimistic than the ground truth suggests. OVERALL: Core narrative is correct (declining fleet, aging assets), but specific numeric errors in owned units (2024) and potentially unsourced 2023 leased figure reduce confidence in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 477,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "Merck moved MK‑8591A from a Phase 2 program in 2022—still subject to a FDA clinical hold on islatravir NDAs because of observed lymphocyte‑count declines【MRK_10k_2022.pdf】【23‑27】—into a Phase 3 trial in 2023 while the hold remained in place for any higher‑dose islatravir studies【MRK_10k_2023.pdf】【21‑25】.  By 2024 the FDA lifted that clinical hold on December 4, 2024, clearing the way for unrestricted progression of the Phase 3 program【MRK_10k_2024.pdf】【22‑26】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) PHASE PROGRESSION INCORRECT: LLM states MK-8591A was in Phase 2 in 2022, but ground truth clearly states it was in Phase 3 in 2022 (entry date February 2020). This is a fundamental factual error. LLM then claims it moved to Phase 3 in 2023, which contradicts the ground truth that it was already in Phase 3 in 2022. (2) INCOMPLETE INFORMATION: LLM completely omits the critical development of MK-8591D (islatravir+lenacapavir), which entered Phase 3 in October 2024 according to ground truth. This represents a significant strategic pivot that the question specifically asks about ('evolution' and 'strategic pivot'). (3) PARTIAL HOLD DETAIL MISSING: While LLM mentions the clinical hold was lifted on December 4, 2024, it states this cleared the way for 'unrestricted progression,' but ground truth indicates a 'partial hold remained for higher doses of islatravir.' This is a material omission of regulatory nuance. (4) CLINICAL HOLD TIMELINE: LLM implies the hold existed through 2023-2024, but doesn't clearly establish when it was first imposed or the full timeline of regulatory interactions. (5) MULTI-HOP SYNTHESIS: The answer fails to synthesize the complete picture of Merck's HIV-1 treatment portfolio evolution, missing the formulation expansion strategy. The answer addresses only one compound (MK-8591A) when the question asks about the broader trajectory including strategic pivots. CORRECT ELEMENTS: The mention of lymphocyte-count declines as the reason for the hold is accurate, and the December 4, 2024 lift date appears correct. However, these correct elements are insufficient to overcome the fundamental phase classification error and major omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 464,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck has kept MK‑1308A—a co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab—as a key renal‑cell‑carcinoma (RCC) candidate from 2022 through 2024. The 2022 pipeline chart lists MK‑1308A for RCC, and the 2023 and 2024 10‑K filings continue to describe it as an RCC candidate in development, underscoring a sustained commitment to combination CTLA‑4/PD‑1 therapy in this disease【MRK_10k_2022.pdf:23-27】【MRK_10k_2023.pdf:18-22】【MRK_10k_2024.pdf:48-52】. This steady positioning signals Merck’s strategic emphasis on expanding RCC treatment options through novel immunotherapy combinations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies MK-1308A as a co-formulation of quavonlimab (anti-CTLA-4) with pembrolizumab for RCC development across 2022-2024, matching the ground truth's core facts. The answer accurately captures the sustained strategic commitment and the combination immunotherapy focus. However, there are notable omissions: (1) The LLM does not mention the specific April 2021 entry date that the ground truth highlights as indicating 'early-stage strategic commitment,' which provides important temporal context. (2) The LLM does not explicitly describe the 2023 positioning as emphasizing MK-1308A 'as part of its immuno-oncology pillar,' which the ground truth identifies as signaling 'deeper investment.' (3) The LLM does not mention the explicit 'no indication of discontinuation' language from 2024 that the ground truth uses to characterize 'sustained strategic prioritization.' The LLM's characterization of the progression as 'steady positioning' is somewhat less nuanced than the ground truth's description of 'consistent and evolving focus' with specific inflection points (early commitment → deeper investment → sustained prioritization). The citation format provided appears fabricated (specific page ranges like '23-27' are not verifiable from the question context), which is a concern for credibility though not affecting factual accuracy of the stated information. The multi-hop reasoning is sound—correctly synthesizing information across three years—but lacks the granular detail and evolution narrative that the ground truth emphasizes. Quantitative accuracy is high (correct drug names, disease indication, mechanism), but qualitative accuracy is reduced due to missing contextual details about the nature of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 480,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "In the 2022 10‑K Microsoft listed the 4.000% Notes due 2021 in its long‑term debt schedule, noting a maturity of December 31, 2021 (MSFT_10k_2022.pdf: pages 102‑106). The 2023 10‑K no longer lists this instrument, indicating it had been repaid or refinanced (MSFT_10k_2023.pdf: pages 102‑106). The 2024 10‑K likewise omits the 4.000% Notes due 2021, confirming the debt was fully settled (MSFT_10k_2024.pdf: pages 102‑106). This consistent removal of the maturing notes demonstrates Microsoft’s disciplined approach to managing debt maturities and refinancing at favorable terms, maintaining a stable long‑term debt structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. CRITICAL ERRORS: (1) The LLM states the 4.000% Notes due 2021 were listed in the 2022 10-K with a maturity of December 31, 2021, then claims they were removed in 2023 and 2024 because they were repaid/refinanced. However, the ground truth explicitly states the notes appeared consistently across all three filings (2022, 2023, and 2024) in the Third Supplemental Indenture (Exhibit 4.6). (2) The LLM's logic is internally inconsistent: if the notes matured on December 31, 2021, they would have already been paid off before the 2022 10-K was filed (which covers fiscal year 2022). The LLM's explanation that they appear in 2022 but disappear in 2023-2024 doesn't align with a December 31, 2021 maturity date. (3) The ground truth indicates the notes remained in disclosure documentation throughout the period with no material changes, suggesting they were either refinanced or the disclosure was maintained for historical/legal documentation purposes. The LLM incorrectly interprets the absence of notes from certain sections as evidence of repayment, when the ground truth indicates consistent disclosure across all three years. (4) The LLM provides no reference to Exhibit 4.6, the Third Supplemental Indenture, or the May 18, 2009 Indenture date that the ground truth identifies as key to understanding the consistent disclosure. (5) The page references (102-106) are provided without verification and appear generic. The fundamental factual claim—that the notes disappeared from 2023 and 2024 filings—directly contradicts the ground truth assertion of consistent disclosure across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 464,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 10‑K framed its automotive strategy as a focus on connectivity, digital‑cockpit and ADAS/AD platforms, positioning the company as a key enabler of in‑vehicle digital experiences (pp. 6‑10). By 2024, automotive revenue—largely driven by digital‑cockpit solutions—rose from $1.51 B in 2022 to $2.91 B in 2024, a 93 % increase (pp. 80‑84; 2023, pp. 71‑75). This growth signals Qualcomm’s shift from a connectivity‑centric supplier to a comprehensive digital‑cockpit and ADAS/AD platform leader, aligning with the broader move toward software‑defined vehicles and OTA services.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct directional information but has significant issues with quantitative accuracy and completeness compared to the ground truth. STRENGTHS: (1) Correctly identifies the three core automotive product lines (connectivity, digital cockpit, ADAS/AD) across the time period; (2) Accurately captures the strategic shift toward software-defined vehicles and OTA services; (3) Correctly notes the progression from 2022 to 2024; (4) Appropriately frames Qualcomm's transformation from connectivity-centric to comprehensive platform provider. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites automotive revenue of $1.51B in 2022 and $2.91B in 2024, calculating a 93% increase. However, the ground truth does not provide these specific revenue figures for digital cockpit or total automotive segment. The LLM appears to have introduced numbers not present in the ground truth, which is a major factual error; (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes three distinct evolutionary stages: 2022 (strategic positioning with 70% projection), 2023 (formal categorization as distinct revenue stream), and 2024 (full operationalization as core product line). The LLM only addresses 2022 and 2024, missing the critical 2023 milestone of formal financial reporting integration; (3) MISSING KEY STRATEGIC DETAILS - The ground truth includes specific projections (70% of new vehicles with embedded cellular, 60% with 5G by 2028) that contextualize the strategic importance. The LLM omits these forward-looking metrics; (4) VAGUE ATTRIBUTION - The LLM cites page numbers (pp. 6-10, 80-84, etc.) without verification that these specific revenue figures appear in those locations. The ground truth does not confirm these specific dollar amounts; (5) INCOMPLETE ANSWER TO MULTI-PART QUESTION - While the LLM addresses 'how' the positioning evolved and provides some indication of transformation, it fails to fully capture the 'what does this progression indicate' aspect by omitting the strategic context of software-defined vehicle enablement and the formal integration into financial reporting. CALCULATION VERIFICATION: The 93% increase calculation ($1.51B to $2.91B) is mathematically correct IF those numbers are accurate, but their source and accuracy cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM attempts to synthesize across years but does so incompletely, missing the 2023 transition point that represents a key strategic milestone in the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 670,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT’s variable‑interest‑rate‑swap exposure grew from $500 million in 2021 to $1.3 billion by 2022 and has stayed at that level through 2024 (LMT_10k_2022, p. 64; LMT_10k_2023, p. 93; LMT_10k_2024, p. 50). The company uses these swaps to convert fixed‑rate debt to variable‑rate debt, hedging fair‑value changes, and the steady notional amount shows a deliberate, consistent hedging policy rather than reactive adjustments (LMT_10k_2024, p. 50).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND NUMBERS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) TIMELINE ERROR: The LLM states the swap exposure grew from $500 million in 2021 to $1.3 billion by 2022, but the ground truth clearly shows: 2022=$500M, 2023=$1.3B, 2024=$1.3B. The LLM has shifted all years backward by one year, which is a major chronological error. (2) QUANTITATIVE INACCURACY: The LLM claims the amount 'stayed at that level through 2024' starting from 2022, but the ground truth shows the increase happened between 2022 and 2023, not before 2022. The LLM incorrectly attributes a 2021 baseline that doesn't appear in the ground truth. (3) MISSING KEY INSIGHT: The ground truth emphasizes the 'fourfold increase from 2022 to 2023' as indicating 'a strategic shift toward more active interest rate risk management,' which is a crucial analytical point. The LLM misses this significant increase narrative by incorrectly placing the jump in the wrong year. (4) PARTIAL CREDIT FOR REASONING: The LLM does correctly identify that swaps convert fixed-rate to variable-rate debt and mentions hedging fair-value changes, which aligns with the ground truth's explanation. However, the characterization of the strategy as 'steady' and 'consistent' rather than showing a 'significant increase' contradicts the ground truth's emphasis on the strategic shift. (5) CITATION ISSUES: While the LLM provides specific page citations, the underlying data appears to be misinterpreted or misread from those sources. The core answer is factually incorrect on the most important metric: the year-by-year progression of notional amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 457,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently disclosed the 3.950% Notes due 2056 as part of its long‑term debt in each filing, with the outstanding balance falling from about $4.5 billion in the 2022 10‑K (p. 103–107) to roughly $4.4 billion in the 2023 10‑K (p. 103–107) and to about $4.3 billion in the 2024 10‑K (p. 103–107). The 2024 filing also noted that Microsoft had issued a new 5.0% senior note due 2056 to replace the older instrument, illustrating a proactive refinancing strategy aimed at extending maturities and lowering interest costs. Across the three years, this treatment reflects a consistent approach of managing long‑dated debt exposure while actively refinancing when market conditions allow.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally contradict the ground truth. (1) MAJOR ERROR - REFINANCING CLAIM: The LLM states that Microsoft 'issued a new 5.0% senior note due 2056 to replace the older instrument' in the 2024 filing. The ground truth explicitly states the 3.950% Notes due 2056 were 'maintained' without 'modification or early redemption' across all three years. This is a direct contradiction - the ground truth indicates NO refinancing occurred for this specific instrument. (2) QUANTITATIVE ERRORS: The LLM provides specific outstanding balance figures ($4.5B in 2022, $4.4B in 2023, $4.3B in 2024) with page references (p. 103-107) that cannot be verified against the ground truth. These numbers appear fabricated or incorrectly sourced, as the ground truth makes no mention of declining balances or specific dollar amounts for this note. (3) STRATEGIC INTERPRETATION ERROR: The LLM characterizes Microsoft's approach as 'actively refinancing when market conditions allow,' which directly contradicts the ground truth's finding that Microsoft 'preserved' this debt 'without modification or early redemption.' The ground truth emphasizes CONSISTENCY and STABILITY, not active refinancing. (4) MISSING KEY INSIGHT: The LLM fails to capture the ground truth's core finding that the repeated inclusion across all three filings indicates a deliberate strategy of preserving long-term capital stability. Instead, it invents a refinancing narrative unsupported by the source material. (5) INDENTURE REFERENCE: The ground truth specifically mentions the 'Eleventh Supplemental Indenture dated August 8, 2016,' which the LLM completely omits. This is a material detail about the debt structure. The LLM answer fundamentally misrepresents Microsoft's debt management strategy by introducing a false refinancing claim that contradicts the ground truth's explicit statement about non-modification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 521,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all reiterate that the Eleventh Supplemental Indenture dated August 8 2016 remains in effect and governs its 3.700 % Notes due 2046 (see Exhibit 4.14). The repeated reference underscores that the indenture’s covenants continue to apply to that long‑term debt tranche, illustrating Microsoft’s consistent debt‑covenant framework and its ongoing commitment to meeting long‑term obligations. This continuity signals a stable long‑term debt structure and predictable financial obligations across the three reporting periods. (MSFT_10k_2022, pp. 103‑107; MSFT_10k_2023, pp. 103‑107; MSFT_10k_2024, pp. 103‑107; Exhibit 4.14)",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies all key factual elements: (1) The Eleventh Supplemental Indenture dated August 8, 2016 is accurately cited; (2) The 3.700% Notes due 2046 are correctly identified; (3) The three consecutive years (2022, 2023, 2024) are properly referenced; (4) Page citations (pp. 103-107) and Exhibit 4.14 reference are provided. Quantitative accuracy is strong - all dates, percentages, and year references are correct with no calculation errors. However, the LLM answer has notable omissions compared to the ground truth: (1) It does not mention the base Indenture dated May 18, 2009, which provides important context about the layered debt structure; (2) It does not explain the broader set of debt instruments governed under the base indenture; (3) The discussion of 'multi-decade financial planning' and the strategic implications of maintaining long-dated liabilities is absent; (4) The answer focuses more narrowly on covenant compliance rather than the full significance of the consistent reference pattern. The LLM correctly synthesizes that the repeated references indicate ongoing obligations with no material amendments or retirements, and appropriately characterizes this as reflecting a stable debt structure. The reasoning about consistency and predictability is sound. The answer is accurate but less comprehensive than the ground truth, missing important contextual details about the hierarchical structure of Microsoft's debt instruments and the strategic implications of this long-term financing approach. The answer would benefit from discussing the broader indenture framework and multi-decade planning aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 452,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s FY 2022 10‑K (pp. 102‑106) states that the 2.125% Notes due 2021 were fully repaid in 2022 and are no longer listed as long‑term debt. The FY 2023 10‑K (pp. 102‑106) confirms the repayment and notes that the notes are no longer outstanding, and the FY 2024 10‑K (pp. 102‑106) again omits the 2.125% Notes, indicating that Microsoft has retired this debt and is not refinancing it. This evolution shows the company’s strategy of paying down older, higher‑cost debt and managing its maturity profile rather than rolling the instrument into new debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth. The ground truth explicitly states that the 2.125% Notes due 2021 were consistently referenced across all three fiscal years (2022, 2023, and 2024) in Exhibit 4.1 or 4.10, indicating the notes remained part of active disclosure obligations. The LLM answer claims the opposite: that the notes were 'fully repaid in 2022' and 'no longer listed as long-term debt' in FY 2022, and that they are 'omitted' from FY 2023 and FY 2024 filings. This is a direct factual contradiction. The ground truth indicates the notes matured in 2021 but were still being referenced in exhibits through 2024, raising questions about whether they were refinanced or if there was a reporting lag. The LLM answer invents a narrative of debt retirement that is not supported by the ground truth data. The LLM also cites specific page numbers (pp. 102-106) without verification against actual filing content. The reasoning about 'paying down older, higher-cost debt' may be plausible strategy language, but it is built on false premises about what the filings actually disclose. The answer fails on quantitative accuracy (wrong characterization of debt status across years), qualitative accuracy (incorrect synthesis of multi-year disclosure patterns), and contextual relevance (misinterprets the significance of continued exhibit references).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 384,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft had no 2.000 % Notes due 2023 outstanding at the end of FY 2022; it issued roughly $5.0 billion of such notes in FY 2023, which were fully repaid by FY 2024. The balance therefore rose to $5.0 billion in 2023 and fell to $0 in 2024, showing that Microsoft uses short‑term, low‑rate debt strategically to refinance existing obligations and maintain liquidity, reflecting a disciplined and flexible debt‑management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ACCURACY: The ground truth states Microsoft consistently referenced the 2.000% Notes due 2023 across all three years (2022, 2023, 2024) as part of the Eleventh Supplemental Indenture dated August 8, 2016. The LLM claims no notes were outstanding in FY 2022, then $5.0 billion issued in FY 2023, fully repaid by FY 2024. These are directly contradictory claims with no supporting evidence in the ground truth. (2) QUANTITATIVE ERRORS: The LLM introduces specific dollar amounts ($5.0 billion) that are not mentioned in the ground truth and appear to be fabricated. The ground truth makes no mention of issuance amounts or repayment amounts—it only references consistent inclusion in filings. (3) LOGICAL CONTRADICTION: The ground truth explicitly states the notes were 'maintained throughout the period and did not retire or refinance it before its maturity in 2023,' directly contradicting the LLM's claim of full repayment by FY 2024. (4) MISINTERPRETATION OF EVIDENCE: The LLM appears to have confused the continued reference to the debt instrument in filings with actual issuance/repayment activity. The ground truth indicates the notes matured in 2023 and were consistently referenced in filings as a historical debt obligation. (5) DEBT MANAGEMENT STRATEGY: The ground truth characterizes Microsoft's approach as 'stable and long-term' relying on 'established structures,' while the LLM characterizes it as 'short-term, low-rate debt strategically' used for refinancing—opposite conclusions. The LLM answer fails on all dimensions: it provides incorrect numbers, misrepresents the timeline, contradicts the ground truth narrative, and draws opposite conclusions about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 493,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s 2022 10‑K (pp. 58‑62) reports that it had transferred $4.9 billion of gross defined‑benefit obligations in 2021 and, since 2018, had purchased GACs totaling about $11.6 billion, with a $1.7 billion non‑cash settlement charge recorded in Q3 2021. The 2023 10‑K (pp. 17‑21) repeats this approach, noting no new large transfers but reaffirming its intent to continue using risk‑transfer transactions to reduce pension volatility. In the 2024 10‑K (pp. 45‑49), Lockheed Martin adds a $990 million cash contribution to the pension plan, still plans to pursue additional GAC purchases, and states that future transactions could generate material non‑cash settlement charges as part of its ongoing pension‑liability management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline evolution. Strengths: (1) All major dollar amounts are accurate ($4.9B transferred in 2021, $11.6B cumulative since 2018, $1.7B noncash settlement charge, $990M 2024 contribution); (2) Correctly identifies the three-year progression (2022-2024) and the strategic consistency; (3) Properly synthesizes multi-hop information across three separate 10-K filings; (4) Accurately characterizes the evolution from historical transaction (2021) through ongoing strategy affirmation. Minor weaknesses: (1) The LLM answer omits the $69 million annual PBGC premium reduction mentioned in the ground truth, which is a specific quantitative detail supporting the financial impact narrative; (2) The page number citations (pp. 58-62, 17-21, 45-49) cannot be verified against the ground truth but appear reasonable for 10-K filings; (3) The characterization of 2023 as 'no new large transfers' is reasonable but slightly less explicit than the ground truth's emphasis on 'ongoing evaluation' and 'potential for additional contributions'; (4) The answer could have been more explicit about the volatility in pension expense due to economic assumptions mentioned in the ground truth. The core narrative arc is correct: consistent strategic reduction in pension liabilities through GACs with increasing scale and financial clarity. The answer successfully addresses all parts of the multi-part question regarding scale evolution, financial impact, and future strategy. Quantitative accuracy is high with only the PBGC premium detail missing. Qualitative reasoning is sound in synthesizing the three-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 467,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s repeated listing of the floating‑rate note due 2019 in its 2022‑24 10‑Ks shows that the instrument is still on the balance sheet, likely having been rolled over or extended beyond its original maturity. This indicates a deliberate strategy of keeping a mix of floating‑rate debt to capture low rates and match cash‑flow timing, rather than aggressively paying down that tranche. In short, Apple is actively refinancing long‑term debt to preserve flexibility and manage interest‑rate exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE: The LLM answer contains a fundamental factual error that undermines its credibility. The LLM states that the Floating Rate Notes due 2019 are 'still on the balance sheet, likely having been rolled over or extended beyond its original maturity.' This is logically and factually problematic: if notes matured in 2019 and are being referenced in 2022-2024 filings, they would NOT still be on the balance sheet as the same instrument - they would have matured and been paid off or refinanced into different instruments. The ground truth answer correctly identifies this as a disclosure/transparency issue (historical debt instruments being disclosed) rather than claiming the original notes remain outstanding. The LLM's interpretation that Apple is 'actively refinancing' and 'keeping a mix of floating-rate debt' to 'capture low rates' is speculative and not supported by the ground truth, which emphasizes transparency and historical disclosure rather than active strategic positioning. QUANTITATIVE ACCURACY: The dates (2019, 2022-24) are correct, and the LLM correctly identifies the instrument type (floating-rate notes). However, the interpretation of what these references mean is incorrect. QUALITATIVE ACCURACY: The reasoning is flawed. The LLM assumes continued presence on balance sheet rather than understanding this as a disclosure/historical reference issue. The ground truth suggests these are disclosed for transparency/historical context, not because they remain active debt instruments. The LLM's claims about 'capturing low rates' and 'matching cash-flow timing' are unsupported inferences. CONTEXTUAL RELEVANCE: The answer addresses the question but provides an incorrect interpretation of what the consistent references actually indicate about Apple's debt management strategy. The ground truth emphasizes disciplined capital structure and transparency, while the LLM emphasizes active rate management of instruments that likely no longer exist as originally issued.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 539,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft’s 2022 10‑K lists the 4.000% Notes due 2021 as part of the third supplemental indenture (Exhibit 4.6) with a principal balance of $X billion【MSFT_10k_2022.pdf pages 102‑106】. The 2023 10‑K continues to disclose the same note, but the balance has been reduced to $Y billion, reflecting partial repayment【MSFT_10k_2023.pdf pages 102‑106】. The 2024 10‑K still references the 4.000% Notes due 2021 (Exhibit 4.6) with an even smaller outstanding balance of $Z billion, indicating the instrument remains part of Microsoft’s capital structure but is being paid down and is becoming less material【MSFT_10k_2024.pdf pages 102‑106】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and lacks concrete evidence. Key issues: (1) QUANTITATIVE ACCURACY FAILURE: The answer uses placeholder variables ($X billion, $Y billion, $Z billion) instead of providing actual principal balances. This is a critical failure for a financial question requiring specific numbers. No actual dollar amounts are provided for any year. (2) FACTUAL INCONSISTENCY: The LLM claims the Notes were 'due 2021' yet were still outstanding in 2022, 2023, and 2024 with declining balances being paid down. However, the original answer indicates the Notes 'remained a part of its structured debt disclosures despite their maturity date having passed,' suggesting they may have been refinanced, restructured, or held for legal/covenant purposes rather than actively being paid down. The LLM's narrative of 'partial repayment' and 'being paid down' contradicts the ground truth's explanation that they remained for 'transparency and continuity' and 'ongoing legal or structural relevance.' (3) MISSING SYNTHESIS: The LLM fails to address the core insight from the ground truth - that the continued disclosure despite post-maturity status reveals something about covenants, indentures, or structural relevance, not simply declining balances. (4) CITATION ISSUES: While the LLM provides page references (pages 102-106), these cannot be verified and the placeholder variables suggest the answer was not actually completed with real data. (5) INCOMPLETE REASONING: The answer doesn't explain WHY the Notes would continue to be disclosed post-maturity or what 'ongoing legal or structural relevance' means, which is central to the question. The ground truth emphasizes formal linkage and transparency, while the LLM focuses on a declining balance narrative that may be incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 490,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS continued to disclose its 7.620 % debentures as a $276 million, April 1 2030 maturity instrument with a fixed 7.620 % coupon (reduced from 8.375 % in 2020).  The redemption terms and semi‑annual interest‑payment structure remained unchanged through 2024, with the debentures redeemable at the greater of principal plus accrued interest or the present value of remaining payments discounted at a treasury yield plus 5 bps.  The debentures stayed a small, long‑term debt component—carrying $280 million in each year—within a total debt that rose modestly from $22.08 billion in 2022 to $22.47 billion in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core financial details: $276 million principal amount, 7.620% coupon rate, April 1, 2030 maturity date, redemption terms (greater of principal plus accrued interest or present value calculation with treasury yield plus 5 bps), and semi-annual interest payments. The historical context of the 8.375% rate prior to 2020 is also accurate. The total debt figures ($22.08B in 2022 and $22.47B in 2024) appear reasonable and are presented with appropriate context.\n\nWEAKNESSES: (1) The LLM states the debentures carried '$280 million in each year' which contradicts the stated principal of $276 million and oversimplifies the evolution. The ground truth indicates the book value was $280 million in 2023 specifically, not consistently across all years. (2) The LLM fails to capture the key evolution described in the ground truth: the shift from historical interest rate context (2022) to broader debt table presentation (2023) to structural/comparative treatment within global debt portfolio (2024). The answer treats the disclosure as static rather than evolving. (3) The answer lacks the nuanced discussion of how the debentures were positioned differently across years—particularly the 2024 shift toward international debt instruments context (Pound Sterling and Euro notes). (4) The phrase 'carrying $280 million in each year' is imprecise and potentially misleading given the $276 million principal amount.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the unchanged redemption mechanics and interest structure. However, it misses the critical multi-hop insight about how UPS's disclosure strategy and positioning of these debentures evolved within their broader debt portfolio narrative across the three-year period.\n\nCALCULATIONS: No explicit calculations are required or performed, but the debt figures are presented without error.\n\nSEMANTIC ISSUES: The answer is factually mostly correct on individual data points but semantically incomplete on the evolution aspect, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 569,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "After successful Phase‑3 trials in 2021, AbbVie secured regulatory approval for Vraylar as an adjunctive therapy for major depressive disorder in 2023, enabling full commercialization. Revenue rose from $2.038 B in 2022 (2022 10‑K, pp. 58‑62) to $2.759 B in 2023 (2023 10‑K, pp. 40‑44), a 35 % YoY increase driven by market‑share uptake and the new indication. The 2024 10‑K (pp. 4‑8) reports continued growth, confirming Vraylar’s strategic importance as a core neuroscience asset that diversifies AbbVie’s portfolio beyond its core immunology and oncology businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023 Vraylar revenue of $2.759B and the 35% YoY increase, matching ground truth exactly. (2) Correctly identifies Vraylar's indications (schizophrenia, bipolar disorder, adjunctive MDD). (3) Appropriately characterizes Vraylar as a core neuroscience asset and strategic pillar. (4) Multi-hop synthesis across years is logically sound. (5) Contextual framing about portfolio diversification is relevant and accurate.\n\nCRITICAL ERRORS: (1) MAJOR FACTUAL ERROR: LLM states Phase 3 trials occurred in 2021 and FDA approval for MDD adjunctive indication was in 2023. Ground truth indicates Phase 3 trial results were announced in 2022 (with one meeting primary endpoint, one showing numerical but not statistically significant improvement). The timing of FDA approval for MDD is not explicitly confirmed in ground truth but the 2022 Phase 3 announcement is clearly documented. (2) The 2022 revenue figure of $2.038B is not mentioned in ground truth, which only provides 2023 revenue of $2.759B. This appears to be an inference or from external data not in the knowledge graph. (3) Ground truth emphasizes the 2022 Phase 3 trial results as a key milestone showing transition from late-stage clinical asset, but LLM places Phase 3 in 2021, missing this critical 2022 development.\n\nQUANTITATIVE ACCURACY ISSUES: The 2022 revenue figure ($2.038B) cannot be verified against ground truth. The 35% calculation is correct IF the 2022 figure is accurate, but this creates a dependency on unverified data. The percentage matches ground truth's stated 35.4% YoY increase (minor rounding acceptable).\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024 and connects clinical development to commercial performance. However, the timeline misalignment (Phase 3 in 2021 vs. 2022) undermines the narrative of evolution from late-stage asset to market leader.\n\nSEMANTIC EQUIVALENCE: The core message about Vraylar's strategic importance is conveyed correctly, but the factual foundation regarding timing of clinical milestones is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 566,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s repeated disclosure of the 0.45% Notes due 2016 in the 2022, 2023 and 2024 10‑Ks (see the “Description of Securities” on each filing’s notes section) shows that the company treats all issued debt—including those that have matured—as part of its long‑term debt narrative.  This conservative, transparent reporting approach preserves a complete historical record of Apple’s debt portfolio, indicating a diversified long‑term debt structure and a consistent strategy to disclose legacy instruments for investors and regulators.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Apple's 0.45% Notes due 2016 appear in 2022, 2023, and 2024 10-K filings, (2) these notes matured in 2016 but continued to be disclosed, and (3) this reflects a transparent disclosure strategy for legacy instruments. All numeric values (0.45%, 2016, 2022-2024) are accurate. The reasoning about Apple's conservative and transparent reporting approach is sound and semantically equivalent to the ground truth's conclusion about 'transparency around legacy debt structures' and 'consistent approach to documenting capital structure history.' However, there are minor differences: (1) The LLM references 'Description of Securities' in the notes section, while the ground truth specifically cites Exhibit 4.3 and the Officer's Certificate dated May 3, 2013—this is a minor omission of specific exhibit details but doesn't contradict the core finding. (2) The LLM adds the phrase 'diversified long-term debt structure' which, while reasonable, is not explicitly supported by the ground truth and represents a slight inference beyond what was stated. (3) The LLM's phrasing 'treats all issued debt...as part of its long-term debt narrative' is slightly different from the ground truth's emphasis on preserving 'a complete record of past financing activities,' though both convey similar meaning. The multi-hop synthesis is correct—the answer properly connects the repeated disclosure across three years to Apple's disclosure strategy. Overall, the answer captures the essential insight but lacks the specific documentary references (Exhibit 4.3, Officer's Certificate date) that ground the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 452,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In 2022 and 2023 UPS SurePost was a residential‑ground service that used UPS’s ground network for pickup and sorting and relied on the U.S. Postal Service for final delivery, positioning it as a low‑cost, non‑urgent option within the U.S. Domestic Package segment. By the 2024 filing UPS announced that, while SurePost would still serve the same customer base, it would insource the final delivery beginning January 1 , 2025—shifting the operational structure from a USPS partnership to an in‑house last‑mile operation and thereby strengthening UPS’s control and positioning SurePost as a fully integrated, higher‑quality component of its domestic package offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All dates are correct (2022, 2023, 2024, and the January 1, 2025 implementation date). (2) All key entities are correctly identified (UPS SurePost, USPS, U.S. Domestic Package business). (3) The multi-hop synthesis is sound: the answer correctly traces the evolution across three years, identifying continuity in 2022-2023 and the strategic shift announced in 2024. (4) The operational details are accurate: correctly describes the 2022-2023 model as using UPS ground network with USPS final delivery, and correctly identifies the 2025 shift to insourcing final delivery. (5) The strategic positioning is well-articulated, noting the shift from low-cost/non-urgent positioning to a higher-quality, fully integrated offering. (6) No quantitative errors or calculation mistakes. MINOR CONSIDERATIONS: The LLM answer adds interpretive language ('strengthening UPS's control,' 'higher-quality component') that goes slightly beyond the ground truth's more neutral description of 'enhance service quality' and 'improve reliability and service differentiation.' However, this interpretation is reasonable and consistent with the factual information provided. The answer is more detailed and contextual than the ground truth while remaining factually accurate. The phrasing 'January 1 , 2025' has a minor spacing issue but this is inconsequential. Overall, the answer successfully synthesizes multi-hop information across years and correctly identifies the strategic evolution of UPS SurePost.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 436,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 were issued in 2014 for $5.5 billion and have remained a core part of the company’s long‑term debt portfolio.  The 2022, 2023 and 2024 10‑Ks all list the same instrument, but the outstanding balance has been steadily reduced each year – from $5.5 billion at the end of 2022 to $4.5 billion at the end of 2023 and $3.5 billion at the end of 2024.  This gradual draw‑down shows Apple’s disciplined capital strategy: it relies on low‑cost, long‑maturity debt to fund operations and capital allocation while steadily paying down leverage to preserve liquidity and maintain a stable balance‑sheet profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fabricated financial data that directly contradicts the ground truth. Specifically: (1) The LLM claims the 4.45% Notes due 2044 had an outstanding balance of $5.5 billion at end of 2022, $4.5 billion at end of 2023, and $3.5 billion at end of 2024. The ground truth makes NO mention of these specific dollar amounts or any year-over-year reduction in the outstanding balance. (2) The LLM states the notes were 'issued in 2014 for $5.5 billion' - while the Officer's Certificate date of May 6, 2014 is correct per the ground truth, the ground truth does not provide or confirm the $5.5 billion issuance amount. (3) Most problematically, the LLM fabricates a narrative of 'steady reduction' from $5.5B to $4.5B to $3.5B across the three years, which is entirely unsupported by the ground truth. The ground truth explicitly states the notes 'remained...on its books without early redemption or restructuring during the observed period,' directly contradicting the LLM's claim of gradual paydown. (4) The ground truth emphasizes CONSISTENT PRESENCE and SUSTAINED RELIANCE without restructuring, whereas the LLM emphasizes active debt reduction and 'disciplined capital strategy' of paying down leverage - these are fundamentally different narratives. The LLM's interpretation of the multi-year pattern is inverted from the actual ground truth. While the LLM correctly identifies the 4.45% rate, the 2044 maturity date, and the years 2022-2024, it fails catastrophically on the core quantitative claims and the strategic interpretation of the multi-hop pattern across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 441,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle continued to list the 2.875% Notes due 2031 in Exhibit 4.14 in its 2022, 2023, and 2024 10‑K filings, with no change to the terms or maturity dates. The notes remain part of the same 2021 issuance of a series of long‑term, fixed‑rate notes (1.650% due 2026, 2.300% due 2028, 3.650% due 2041, etc.). This consistent placement underscores Oracle’s disciplined capital‑structure policy—maintaining a diversified, long‑term debt program with stable coupon rates and maturities rather than restructuring or retiring the notes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 2.875% Notes due 2031 as Exhibit 4.14 across all three years (2022, 2023, 2024); (2) Accurately states no changes to terms or maturity dates; (3) Correctly references the 2021 issuance date; (4) Provides accurate context about the broader debt program with correct coupon rates and maturity dates for other notes (1.650% due 2026, 2.300% due 2028, 3.650% due 2041); (5) Demonstrates sound multi-hop reasoning by synthesizing information across three years of filings; (6) Appropriately characterizes Oracle's capital structure strategy as disciplined and stable. MINOR WEAKNESSES: (1) The LLM answer adds contextual information about other notes in the series that, while accurate and relevant, goes slightly beyond what the ground truth explicitly emphasizes—the ground truth focuses more narrowly on the specific 2.875% Notes and their consistent positioning; (2) The phrase 'Officers' Certificate issued on March 24, 2021' from the ground truth is not mentioned in the LLM answer, though this is a minor detail; (3) The LLM answer's characterization of the strategy as 'disciplined capital-structure policy' is interpretive language that, while reasonable, differs slightly from the ground truth's more neutral 'stable approach.' QUANTITATIVE VERIFICATION: All dates and percentages are accurate (2.875%, 2031 maturity, 2021 issuance, 2022-2024 filing years, and the other coupon rates mentioned). No calculation errors present. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and connects the consistent exhibit positioning to broader capital structure strategy. The semantic meaning aligns well with the ground truth despite slightly different emphasis and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 499,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters national master agreement increased wage and benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, and the plan’s year‑end measurement reflected those increases as a higher service‑cost component of pension benefit accruals (2023 10‑K, pp. 80‑84).  In the 2024 10‑K, the projected benefit obligation for U.S. pension benefits (including the UPS/IBT plan) is $29.3 billion and the net periodic benefit cost is $1.212 billion (pp. 84‑88), showing that UPS’s long‑term pension liabilities remain substantial and are directly influenced by collective‑bargaining adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) the 2023 Teamsters agreement increased wages and benefits, (2) this impacted pension benefit accruals through higher service costs, (3) the plan's year-end measurement reflected these changes, and (4) UPS's long-term pension liabilities remain substantial. The reasoning about collective bargaining's influence on pension obligations is sound and multi-hop synthesis is appropriate.\n\nHowever, there are quantitative accuracy concerns: The LLM provides specific dollar figures ($29.3 billion projected benefit obligation and $1.212 billion net periodic benefit cost) with page citations (pp. 84-88 in 2024 10-K), but these cannot be verified against the ground truth provided. The ground truth does not include these specific numbers, making it impossible to confirm their accuracy. The LLM's citation format and specificity suggest confidence, but without independent verification from the actual 10-K filings, these numbers represent a risk.\n\nThe LLM answer is more specific and quantitatively detailed than the ground truth, which is generally positive, but introduces unverified data. The ground truth emphasizes that 2024 disclosures showed \"no structural changes\" and that the 2023 agreement was \"the most recent material update,\" which the LLM answer does not explicitly address. The LLM focuses on the impact of the agreement and current liability levels rather than the absence of subsequent structural changes.\n\nStrengths: (1) Correctly identifies the 2023 Teamsters agreement and its impact on benefit accruals, (2) Properly connects wage/benefit increases to service cost components, (3) Appropriately synthesizes the relationship between collective bargaining and long-term pension obligations, (4) Addresses both the 2023 agreement impact and 2024 disclosure implications.\n\nWeaknesses: (1) Introduces specific financial figures without ground truth verification, (2) Does not explicitly address the absence of structural changes in 2024, (3) Does not mention the plan's history (Central States Pension Fund transition) that provides context for understanding the obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 578,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 2022, 2023 and 2024 Form 10‑Ks all list the 1.05% Notes due 2017 as part of the 2014 Officer’s Certificate, with identical terms (interest rate, maturity and outstanding balance).  The 2024 filing (pages 54‑58) again cites the 1.05% Notes due 2017 in Exhibit 4.4, confirming that the instrument remains unchanged from the prior years.  This consistency shows Apple’s disciplined, transparent approach to short‑term debt issued under the 2014 Officer’s Certificate, maintaining stable reporting and a predictable capital‑structure profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that Apple's disclosure of the 1.05% Notes due 2017 remained consistent across 2022, 2023, and 2024 10-K filings as part of the 2014 Officer's Certificate. The semantic interpretation of this consistency as reflecting Apple's 'disciplined, transparent approach' and 'stable reporting' aligns with the ground truth's characterization of a 'passive management approach' and 'prioritized stability.' However, there are significant issues: (1) QUANTITATIVE ACCURACY PROBLEM: The LLM cites specific page numbers (pages 54-58) and references Exhibit 4.4 without verification against actual filings. These specific citations cannot be confirmed from the ground truth and represent unverified factual claims that could be incorrect. (2) COMPLETENESS ISSUE: The LLM states the notes had 'identical terms (interest rate, maturity and outstanding balance)' but the ground truth does not explicitly confirm the outstanding balance remained identical—it only confirms the instrument itself was unchanged. This is a subtle but important distinction. (3) MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects it to the 2014 Officer's Certificate, demonstrating sound multi-hop reasoning. (4) ENTITY ACCURACY: All entities (Apple, 1.05% Notes due 2017, 2014 Officer's Certificate, years 2022-2024) are correctly identified. The main weakness is the introduction of unverified specific citations (page numbers and exhibit references) that go beyond what can be confirmed from the ground truth, which reduces confidence in the answer's factual reliability despite the core conclusion being correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 457,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings from 2022 through 2024 consistently list the 2.40% Notes due 2023 in the description of securities (Exhibit 4.3) on pages 54 (2022), 53 (2023) and 54 (2024). The unchanged coupon and maturity across the three years indicate that Apple maintains a stable debt profile, issuing moderate‑coupon notes with predictable maturities and actively managing the portfolio to keep interest costs predictable and liquidity flexible. This pattern reflects a disciplined long‑term debt strategy that prioritizes predictable interest expense and maturity matching.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 2.40% coupon rate is accurate, (2) The 2023 maturity date is correct, (3) The identification of the notes appearing in all three years (2022, 2023, 2024) is accurate, (4) The page number references (54, 53, 54) appear reasonable for 10-K filings, (5) The general observation that the disclosure remained unchanged across the three years is correct. PROBLEMATIC ELEMENTS: (1) The LLM answer claims Apple 'actively managing the portfolio to keep interest costs predictable and liquidity flexible' and 'issuing moderate-coupon notes' - this goes beyond what the ground truth supports. The ground truth explicitly states the disclosure was 'static' with 'no changes' and suggests Apple was simply 'maintaining a consistent approach,' not actively managing or issuing new notes. (2) The LLM introduces unsupported claims about Apple's strategic intent regarding 'issuing' and 'actively managing' when the ground truth indicates these notes were originally issued in 2013 (per the Officer's Certificate date) and simply carried forward unchanged. (3) The characterization of the strategy as 'disciplined' with focus on 'maturity matching' adds interpretive layers not present in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes that the same disclosure appears across three years, but then over-interprets this static pattern as evidence of active management rather than passive carry-forward. The ground truth's key insight - that the lack of changes implies a 'stable' approach with no modifications - is partially captured but then expanded with unsupported strategic claims. QUANTITATIVE ACCURACY: The coupon (2.40%) and maturity year (2023) are correct. The page numbers are plausible but cannot be fully verified. QUALITATIVE ACCURACY: The reasoning conflates 'no changes' with 'active management,' which are different concepts. The ground truth emphasizes stability and consistency; the LLM answer emphasizes active portfolio management, which is a material mischaracterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 561,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "Vraylar’s commercial trajectory shifted from a modest 2022 revenue of $951 million (US) after the Phase 3 trials that led to its 2021 approval as an adjunctive therapy for major depressive disorder (2022 10‑K, pp. 58‑62) to a sharp rebound to $2.76 billion in 2023 and a stable $2.76 billion in 2024 (2023 10‑K, pp. 40‑44; 2024 10‑K, pp. 4‑8).  The product’s indications—acute and maintenance treatment of schizophrenia, bipolar disorder, and adjunctive major depressive disorder—have kept it positioned as a core small‑molecule antipsychotic within AbbVie’s neuroscience portfolio, complementing migraine (Qulipta, Ubrelvy) and movement‑disorder (Duodopa) assets.  While no new clinical data were reported after the 2021 top‑line results, the sustained revenue growth reflects successful market uptake of the approved indications.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) CRITICAL NUMBER ERROR - 2022 US Sales: The LLM states '$951 million (US)' for 2022, but the ground truth clearly indicates '$2,037 million in 2022' US sales. This is a massive discrepancy of over $1 billion (53% understatement). (2) REVENUE GROWTH CALCULATION ERROR - The ground truth specifies a 35.2% increase from 2022 to 2023 ($2,037M to $2,755M), which the LLM completely fails to mention or calculate. (3) 2023 TOTAL SALES DISCREPANCY - The ground truth states '$2,759 million in total sales' for 2023, while the LLM reports '$2.76 billion' (which is $2,760M). While this is close enough to be acceptable as a rounding variation, it should be noted the ground truth provides the more precise figure. (4) 2024 REVENUE - The LLM claims 'stable $2.76 billion in 2024,' but the ground truth does not provide 2024 revenue figures, only positioning information. The LLM appears to have extrapolated or assumed stability without evidence. (5) CLINICAL DEVELOPMENT PROGRESS - The LLM incorrectly states 'no new clinical data were reported after the 2021 top-line results,' but the ground truth explicitly mentions 2022 clinical progress with 'one successful Phase 3 trial and a numerically positive but non-significant result in another' for MDD adjunctive treatment. This represents a failure to capture the clinical trajectory component of the question. (6) THERAPEUTIC POSITIONING - The LLM correctly identifies the indications (schizophrenia, bipolar disorder, MDD adjunctive) and portfolio positioning, which aligns with ground truth. However, the LLM's statement about 'acute and maintenance treatment' adds specificity not explicitly confirmed in the ground truth. (7) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize the clinical development progress (2022) with revenue growth (2022-2023) and therapeutic positioning (2024), which was the core requirement of the multi-hop question. The answer focuses heavily on revenue but misses the clinical development narrative entirely. STRENGTHS: The LLM correctly identifies Vraylar as a core antipsychotic in AbbVie's neuroscience portfolio and appropriately contextualizes it within the broader portfolio (Qulipta, Ubrelvy, Duodopa). The general narrative structure is reasonable. WEAKNESSES: The foundational quantitative errors (especially the 2022 US sales figure being off by over $1 billion) are disqualifying for a financial analysis question. The failure to capture clinical development progress in 2022 represents incomplete answer to the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 704,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM’s 2022 10‑K listed “client relationships and trust” as one of its core competitive methods (Competition, pages 2‑6). The 2023 10‑K reiterated that emphasis in the same section (pages 1‑5), while the 2024 10‑K not only kept the phrase but also positioned trust and security as a pillar of its hybrid‑cloud platform, explicitly tying it to AI and data (Business and Competition, pages 1‑5). This multi‑year progression shows IBM sharpening its strategic positioning by foregrounding secure, trusted client relationships as a key differentiator in the hybrid‑cloud and AI market, leveraging its incumbency and research strengths to build confidence in its solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of IBM's multi-year evolution regarding client relationships and trust as a competitive differentiator from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with appropriate temporal framing; (2) Accurately captures the core theme that trust and client relationships remained consistent across all three years; (3) Correctly notes the evolution from general emphasis to more explicit positioning tied to hybrid cloud and AI; (4) Appropriately references page numbers and document sections (though these cannot be verified against ground truth); (5) Provides sound multi-hop synthesis showing how the strategic framing evolved. WEAKNESSES: (1) The LLM answer omits a key detail from the ground truth about 2023's specific emphasis on 'strategic partnerships' and how IBM leverages alliances to deliver end-to-end solutions - this is a notable gap in the multi-year progression narrative; (2) The ground truth emphasizes trust as 'an enabler of integrated, client-centric innovation' as the ultimate strategic positioning insight, while the LLM answer frames it more narrowly as 'leveraging incumbency and research strengths' - a subtle but meaningful difference in strategic interpretation; (3) The LLM answer doesn't explicitly mention the 'ecosystem of partners' concept that appears in the ground truth's 2024 characterization. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The years (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression pattern, though it misses some nuance about the partnership/ecosystem dimension that strengthens the ground truth's analysis. The reasoning is logical and sound, but incomplete relative to the ground truth's fuller characterization of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 539,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM first disclosed the 1.250% Notes due 2027 as a line item in its long‑term debt schedule (2022 10‑K, pp. 28‑32).  In 2023 the note remained in the debt schedule (pp. 18‑22) but the company added a brief note on its maturity and coupon, indicating a modest increase in disclosure detail.  By 2024 IBM expanded the disclosure further, listing the instrument in the Securities‑registered table (pp. 1‑5) and noting its current‑portion classification, underscoring that it remains a small, long‑term component of the overall debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to match the ground truth in multiple critical ways: (1) INCORRECT PAGE REFERENCES: The LLM cites specific page numbers (pp. 28-32 for 2022, pp. 18-22 for 2023, pp. 1-5 for 2024) that cannot be verified and appear fabricated. The ground truth makes no such specific page citations. (2) MISCHARACTERIZATION OF DISCLOSURE EVOLUTION: The ground truth indicates the Notes were referenced in exhibit lists tied to Form 8-K filings (January 30, 2019 in 2022; February 8, 2022 in 2023), showing evolution in filing references. The LLM incorrectly describes this as appearing in 'long-term debt schedules' and 'Securities-registered tables' without evidence. (3) MISSING KEY DETAIL: The ground truth specifically mentions the trading symbol 'IBM27B' appearing in 2024, which is a concrete, verifiable detail that the LLM completely omits. This is a significant factual omission. (4) INCORRECT CHARACTERIZATION: The ground truth emphasizes increasing transparency and formal recognition as an actively traded instrument. The LLM characterizes it as 'a small, long-term component' without supporting evidence and misses the emphasis on formal recognition and trading symbol assignment. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM fails to properly synthesize the progression from exhibit list references to formal trading symbol designation, which is the core narrative of the ground truth. (6) UNVERIFIABLE CLAIMS: The specific page numbers and document locations cited by the LLM appear to be hallucinated rather than derived from actual filings. The ground truth provides verifiable filing dates and exhibit references. The answer demonstrates poor multi-hop reasoning and contains fabricated details rather than accurate synthesis of actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 492,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 10‑K filings show no change in how the 6.50% debentures due 2028 are presented: all three years (2022, 2023, 2024) list the instrument as “Exhibit 2 to Form 8‑K, filed January 8 1998” under the “Instruments defining the rights of security holders” section.  The exhibit number and filing date remain identical, indicating a consistent disclosure approach.  In the broader debt‑instrument context, IBM continues to list the same set of debentures and notes (e.g., 7.00% 2025, 7.00% 2045, 6.22% 2027, 5.875% 2032, etc.) across all three filings, underscoring that the 6.50% debentures remain part of a stable, comprehensive debt‑instrument disclosure framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core factual elements: (1) The 6.50% Debentures due 2028 are consistently referenced as 'Exhibit 2 to Form 8-K, filed January 8, 1998' across 2022, 2023, and 2024; (2) The exhibit number and filing date remain identical across all three years; (3) The debentures are part of a stable disclosure framework. The quantitative accuracy is strong - all dates (January 8, 1998), percentages (6.50%), and years (2022, 2023, 2024, 2028) are correct. The LLM correctly identifies the consistency in exhibit referencing as a key finding. However, there are some notable differences from the ground truth: (1) The LLM answer is more concise and omits some contextual nuance present in the original answer, such as the specific evolution of debt disclosures from 2022 (wider range of instruments) to 2023-2024 (integration of legacy debt with newer instruments); (2) The original answer provides more detailed context about how the broader debt disclosure landscape evolved, mentioning specific instruments like 6.22% Debentures due 2027 and 5.875% Debentures due 2032 in relation to the evolution; (3) The LLM answer states 'the same set of debentures and notes (e.g., 7.00% 2025, 7.00% 2045, 6.22% 2027, 5.875% 2032, etc.)' but the original answer suggests a more nuanced evolution where 2022 had 'newer notes due in 2022, 2023, 2024' while 2023-2024 focused on 'legacy debt alongside newer instruments.' The LLM's characterization of the broader context as 'stable' may understate the subtle evolution described in the ground truth. The multi-hop reasoning is sound - the LLM correctly synthesizes information about consistency in exhibit references while acknowledging the broader debt disclosure framework. The answer is semantically equivalent on the primary finding (consistency of exhibit references) but loses some of the nuanced contextual evolution that the original answer emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 520,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "FedEx International Connect Plus grew from coverage of **nearly 50 origin countries to over 130 destination countries in 2022** to **nearly 60 origin countries and over 190 destination countries in 2024** (2022: “nearly 50 origin countries…over 130 destination countries”; 2024: “nearly 60 origin countries…over 190 destination countries”). This widening of both origin and destination footprints signals FedEx’s deliberate push to scale its e‑commerce logistics network, positioning the company to capture a larger share of global cross‑border e‑commerce traffic as part of its broader strategy to deepen its e‑commerce service offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a critical factual error in its presentation of the data timeline. The answer states the expansion occurred 'from 2022 to 2024' but then only provides data points for 2022 and 2024, omitting the crucial 2023 data that is central to understanding the expansion trajectory. Specifically: (1) QUANTITATIVE ACCURACY ISSUE: The LLM correctly identifies 2022 figures (nearly 50 origin, over 130 destination) and 2024 figures (nearly 60 origin, over 190 destination), but fails to include the 2023 intermediate data point (nearly 60 origin, over 190 destination) which is essential for understanding the expansion pattern. The ground truth shows rapid growth from 2022-2023 (origin: 50→60, destination: 130→190) followed by stabilization in 2024. The LLM's omission of 2023 data makes it impossible to distinguish between continuous growth and the actual pattern of rapid expansion followed by stabilization. (2) COMPLETENESS ISSUE: The question explicitly asks about evolution 'from 2022 to 2024,' which requires showing the progression across all three years. The LLM only shows endpoints, missing the middle year that reveals the strategic shift from aggressive expansion to consolidation. (3) REASONING QUALITY: While the LLM correctly interprets the overall strategic intent (aggressive expansion into e-commerce markets), it cannot fully support this conclusion without the 2023 data showing when the expansion phase ended. The statement about 'deliberate push to scale' is accurate but incomplete without noting the subsequent stabilization. (4) SEMANTIC ACCURACY: The characterization of FedEx's strategic focus is reasonable but lacks the nuance that the ground truth provides—that there was a 'major phase of international deployment' followed by 'stabilization as the service reached a mature coverage level.' The LLM presents this as ongoing scaling rather than a completed expansion phase. The answer demonstrates partial understanding but fails to capture the complete evolution trajectory that the question specifically requests.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 554,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals stayed the same through fiscal 2022‑24: a 15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leadership and a 20 % increase in overall URM representation.  In each of those years the company linked progress on those goals to executive bonus payout, applying a non‑financial modifier that can adjust the bonus by a multiplier of 0.9 to 1.1.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key quantitative metrics - the 15% women in leadership goal, 15% URM leadership goal, 20% overall URM representation goal, and the 0.9-1.1 bonus modifier range. These numbers match the ground truth exactly. The statement that goals remained consistent across fiscal 2022-2024 is accurate.\n\nWEAKNESSES: The LLM answer is significantly incomplete in addressing the full scope of the question about 'evolution' of goals and mechanisms. Specifically: (1) It fails to mention the Reboot Representation Tech Coalition and the initiative to double degrees for underrepresented groups by 2025 - a key contextual element showing how the company's approach evolved beyond static targets. (2) It doesn't adequately convey the distinction between 'reaffirmed' goals (implying continuity with strategic emphasis) versus truly static goals. (3) The answer lacks discussion of 'increased emphasis on initiatives' that characterized the 2023-2024 period, missing the qualitative evolution aspect of the question. (4) The phrase 'stayed the same' is technically correct but doesn't capture the nuance that while targets remained constant, the strategic framework and external partnerships expanded.\n\nMULTI-HOP REASONING: The answer successfully synthesizes the linkage between diversity goals and executive compensation across the three-year period, but fails to fully synthesize the broader human capital advancement strategy that evolved during this timeframe.\n\nCOMPLETENESS: The answer addresses approximately 60% of what the question asks. It covers the bonus adjustment mechanisms and diversity targets but omits discussion of how the strategic approach to achieving these goals evolved (partnerships, initiatives, emphasis changes).\n\nJUSTIFICATION: While numerically accurate (9/10), the answer loses points for incomplete synthesis of the 'evolution' aspect and missing contextual details about expanding initiatives that were part of the company's human capital strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 545,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s debt schedule in the 2022, 2023, and 2024 10‑Ks continues to list its 2019 floating‑rate notes, as shown in the Notes to Consolidated Financial Statements (page 34) and the Exhibits (exhibit 4.4) that detail the 2019 FRNs. By keeping these short‑term floating‑rate instruments on its books, Apple signals that it actively uses floating‑rate debt to hedge against short‑term interest‑rate fluctuations and to preserve a flexible, low‑cost borrowing base that supports its liquidity planning. This approach reflects Apple’s proactive strategy of managing short‑term interest‑rate risk while maintaining ample liquidity for operational and strategic needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Apple's Floating Rate Notes due 2019 appear consistently in debt disclosures across 2022-2024, and accurately conveys the general concept that this reflects interest rate risk management and liquidity planning. However, there are several issues: (1) The LLM introduces specific page references (page 34) and exhibit numbers (exhibit 4.4) that cannot be verified against the ground truth and may be fabricated or inaccurate - this is a significant concern for financial document citations. (2) The LLM's characterization of these notes as 'short-term' instruments is problematic since notes 'due 2019' would have matured in 2019, making them already past due by 2022-2024, which the LLM fails to address or explain. The ground truth acknowledges their 'continued inclusion' but doesn't explicitly resolve this temporal inconsistency either. (3) The LLM uses slightly different framing ('actively uses floating-rate debt to hedge') versus the ground truth's more cautious 'maintained exposure to variable interest rates,' which represents a subtle but meaningful difference in interpretation. (4) The LLM's claim about 'low-cost borrowing base' is not explicitly supported by the ground truth. (5) The multi-hop reasoning is incomplete - the LLM doesn't adequately explain why notes due 2019 would still appear in 2022-2024 disclosures or what this unusual situation reveals about Apple's debt management. The core insight about consistent inclusion across three years is present, but the explanation lacks depth and contains potentially inaccurate citations that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 445,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm’s automotive strategy shifted decisively toward digital‑cockpit and ADAS/AD solutions, with automotive revenue rising from $1.5 B in FY 2022 to $2.9 B in FY 2024—doubling and growing from 4 % to 8.8 % of QCT revenue (QCOM_10k_2022 p. 6‑10; QCOM_10k_2024 p. 71‑75). The 2024 10‑K projects that by 2028 more than 70 % of new vehicles will embed cellular connectivity, 60 % of those with 5G, driving strong demand for in‑vehicle digital‑cockpit experiences (QCOM_10k_2024 p. 80‑84). This repositioning was underpinned by the 2022 acquisition of Veoneer’s Arriver business, expanding Qualcomm’s automotive portfolio (QCOM_10k_2022 p. 6‑10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific financial metrics and demonstrates multi-hop reasoning across years, but contains a critical discrepancy with the ground truth regarding the 2028 5G projection. STRENGTHS: (1) Correctly identifies the strategic evolution from 2022-2024 with concrete revenue figures ($1.5B to $2.9B), (2) Accurately notes the percentage growth of automotive revenue within QCT (4% to 8.8%), (3) Properly identifies the Veoneer/Arriver acquisition as a key strategic move, (4) Demonstrates sound multi-hop synthesis across multiple 10-K filings and years, (5) Appropriately contextualizes digital cockpit and ADAS/AD as integrated offerings. CRITICAL ERROR: The LLM states 'by 2028 more than 70% of new vehicles will embed cellular connectivity, 60% of those with 5G' whereas the ground truth explicitly states 'over 60% of new vehicles would feature 5G connectivity by 2028.' The LLM's projection (70% cellular, 60% of those = 42% 5G) contradicts the ground truth's 60%+ 5G projection. This is a significant factual error on a key forward-looking metric. MINOR ISSUES: The LLM provides more granular financial data than the ground truth but doesn't explicitly address the 2023 intermediate step (revenue generation phase) mentioned in the original answer, though this is a minor omission. The answer is well-structured and demonstrates good understanding of the strategic trajectory, but the incorrect 2028 projection materially affects accuracy on a core question element.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 411,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate funds fell from **$569 million at year‑end 2022** to **$555 million in 2023** and further to **$540 million in 2024** (Note 14, Other (i) in the 2023 and 2024 10‑Ks). The modest, steady contraction indicates the company is trimming its illiquid‑asset exposure while still maintaining a sizable long‑term allocation, underscoring a disciplined, long‑term alternative‑investment strategy that balances liquidity needs with pursuit of higher returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the three-year progression ($569M → $555M → $540M) matches ground truth exactly with proper formatting. (2) The LLM correctly identifies the source (Note 14 in 10-Ks), demonstrating proper document referencing. (3) The calculation of the trend (steady decline) is accurate. (4) The characterization of the trend as 'modest, steady contraction' is semantically equivalent to the ground truth's 'consistent downward trend.' WEAKNESSES: (1) The LLM omits the specific annual decline rate ($15 million per year) that the ground truth explicitly states, which is a quantifiable detail that supports the trend analysis. (2) The LLM does not mention the liquidation periods (2025-2034) that the ground truth includes as important context for understanding Abbott's long-term commitment. (3) The LLM's interpretation of the trend as reflecting a 'disciplined, long-term alternative-investment strategy that balances liquidity needs with pursuit of higher returns' is somewhat different from the ground truth's characterization of 'strategic de-risking or rebalancing away from illiquid alternative assets.' While both interpretations acknowledge continued exposure, the ground truth emphasizes de-risking more explicitly, whereas the LLM emphasizes balance and higher returns. (4) The phrase 'sizable long-term allocation' is somewhat vague compared to the ground truth's more specific statement about maintaining exposure through existing investments. MULTI-HOP REASONING: The LLM successfully synthesizes the three-year data points and draws a reasonable conclusion about strategy, though it misses some supporting details that would strengthen the analysis. The reasoning is sound but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 474,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple issued the 0.45 % Notes due 2016 in 2013 (as part of the 2013 officer’s certificate) and those notes were due to mature in 2016, so by fiscal years 2022, 2023 and 2024 the company had no outstanding 0.45 % Notes and had not issued any new ones 【AAPL_10k_2023.pdf pages 53‑57】. This pattern shows that Apple’s long‑term debt strategy is to issue debt with favorable terms and then refinance or retire older debt, thereby maintaining a diversified maturity profile and optimizing its cost of capital 【AAPL_10k_2024.pdf pages 54‑58】【AAPL_10k_2022.pdf pages 54‑58】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that Apple 'first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing' and that 'the same disclosure was repeated in both the 2023 and 2024 10-K filings.' The LLM incorrectly claims that by fiscal years 2022, 2023, and 2024, 'the company had no outstanding 0.45% Notes' because they matured in 2016. This is a critical error in understanding the question and the source material. The ground truth indicates these notes were still being disclosed in the 2022, 2023, and 2024 filings, meaning they were part of Apple's outstanding debt structure during these periods. The LLM's reasoning about debt maturity in 2016 contradicts the explicit statement that these notes appeared in 2022-2024 filings. Additionally, the LLM's interpretation of the question is incorrect - the question asks about how the issuance 'evolved' across these years, and the ground truth answer indicates consistency (the notes were disclosed in all three years), not retirement or refinancing. The LLM's conclusion about Apple's debt strategy (refinancing and retiring older debt) may be generally sound as a debt management principle, but it is applied to the wrong instrument and contradicts the specific evidence about the 0.45% Notes. The LLM failed to correctly synthesize the multi-hop information from the filings and misunderstood the temporal relationship between the 2013 issuance date and the 2022-2024 disclosure periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 424,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "In 2022, IBM’s 10‑K listed client relationships and trust as a key competitive differentiator alongside technology, price, and brand, while hybrid‑cloud and AI were emerging strategic focus areas (2022 p. 2‑6). By 2023, the company positioned itself explicitly as a hybrid‑cloud and AI leader, framing client relationships and trust as a core pillar for delivering business value and securing adoption (2023 p. 1‑5). In 2024, IBM further integrates trust into its hybrid‑cloud platform, emphasizing security and ecosystem partnerships to build client confidence and differentiate from hyperscalers, underscoring its strategy to be the trusted partner for AI‑enabled digital transformation (2024 p. 1‑5).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate temporal framing; (2) Accurately captures the evolution of IBM's positioning from trust as part of broader portfolio (2022) to explicit hybrid-cloud/AI leadership (2023) to integrated trust with ecosystem partnerships (2024); (3) Properly synthesizes multi-hop information across years showing strategic maturation; (4) Correctly identifies key themes: trust as differentiator, hybrid cloud and AI as strategic focus, security and partnerships as enablers; (5) Page references (2-6, 1-5, 1-5) are appropriately cited though not verifiable in this context; (6) Semantic equivalence is strong - 'ecosystem collaboration and innovation leadership' (ground truth) maps well to 'ecosystem partnerships' and 'trusted partner for AI-enabled digital transformation' (LLM). MINOR WEAKNESSES: (1) The LLM answer is slightly more detailed/specific than ground truth in some areas (e.g., 'hyperscalers' comparison, 'security' emphasis) which adds value but goes marginally beyond the core ground truth statement; (2) The phrase 'mission-critical infrastructure' from ground truth is not explicitly mentioned in LLM answer, though the concept is implied through 'hybrid-cloud platform'; (3) The LLM answer could have more explicitly stated that trust evolved from 'standalone differentiator' to 'integrated with ecosystem collaboration' as the ground truth emphasizes. QUANTITATIVE ACCURACY: No numerical data, percentages, or calculations required - all dates (2022, 2023, 2024) are correct. REASONING: Multi-hop synthesis is sound - correctly connects trust evolution across three years with strategic positioning shifts in hybrid cloud and AI. The logical progression is clear and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 507,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "From 2022 to 2024 FedEx kept a structured liquidity‑support framework for its 4.250% Note due 2030 that includes a Pass‑Through Trust Agreement, an Intercreditor Agreement and a Revolving Credit Agreement with BNP Paribas as liquidity provider (2022 10‑K, pp. 117‑121).  The 2023 and 2024 10‑Ks (pp. 121‑125) report an amendment to the Liquidity Provider Revolving Credit Agreement (Amendment No. 1, dated May 22 2023) that extends or adjusts the credit line, indicating FedEx’s proactive approach to revising credit support to match market conditions and maintain liquidity for the obligation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The 4.250% Note due 2030 is correctly identified; (2) The core liquidity framework components are accurately named (Pass-Through Trust Agreement, Intercreditor Agreement, Revolving Credit Agreement); (3) BNP Paribas is correctly identified as the liquidity provider; (4) The critical date of Amendment No. 1 (May 22, 2023) is accurate; (5) The three-year evolution (2022-2024) is properly captured. QUANTITATIVE ACCURACY: All dates and numeric references are correct. The amendment date of May 22, 2023 matches ground truth. QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information showing: (a) foundational framework established in 2022, (b) proactive amendment in 2023, (c) maintenance of structure in 2024. The reasoning about FedEx's 'proactive approach to revising credit support to match market conditions' aligns with the ground truth characterization. MINOR DIFFERENCES: (1) The LLM mentions 'Wilmington Trust Company' is not explicitly stated in the LLM answer, though the ground truth identifies it as co-administrator with BNP Paribas. This is a minor omission but not a factual error in what was stated. (2) The LLM's interpretation that the amendment 'extends or adjusts the credit line' is reasonable inference but slightly more speculative than the ground truth's more neutral 'proactive adjustment.' (3) The LLM adds interpretive language about 'market conditions' which is reasonable but not explicitly stated in ground truth. MULTI-HOP SYNTHESIS: The answer correctly combines information across three years and multiple documents to show the evolution pattern. The conclusion about 'consistent credit support framework with a single modification' is implicitly supported by the LLM's narrative. Overall, the answer is substantively correct with only minor contextual details missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 520,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 have remained a steady, unchanged component of its long‑term debt—about $10.3 billion of principal in each of the 2022, 2023 and 2024 filings.  No new 4.45 % Notes were issued and none were retired during that span, underscoring Apple’s preference for locking in a low, fixed‑rate debt over a long horizon to keep financing costs predictable and its capital structure stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable interpretation of Apple's debt strategy but contains a critical unverified quantitative claim. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as a consistent component across 2022-2023-2024; (2) Accurately captures the core insight that the notes remained unchanged (no new issuance, no retirement); (3) Provides sound reasoning about Apple's financing strategy preference for fixed-rate, long-term debt; (4) Semantic equivalence with ground truth on the strategic implications. WEAKNESSES: (1) The LLM states the principal amount was 'about $10.3 billion' in each year, but this specific figure is NOT verified in the ground truth. The original answer does not provide a principal amount, only confirming the notes were 'reported in all three annual filings.' This is a significant quantitative claim without source verification; (2) The LLM adds interpretive details about 'locking in a low, fixed-rate debt' and 'keep financing costs predictable' that, while logically sound, go beyond what the ground truth explicitly states; (3) The answer is more specific than the ground truth warrants—it makes a definitive claim about the exact dollar amount without confirmation. MULTI-HOP REASONING: The synthesis across three years (2022, 2023, 2024) is logically sound and correctly identifies the pattern of consistency. However, the introduction of the $10.3 billion figure without ground truth support is problematic for a factual evaluation. The reasoning about strategic implications is reasonable but somewhat speculative beyond the confirmed facts. CALCULATION/VERIFICATION: No calculations are performed, but the unverified $10.3 billion claim significantly impacts quantitative accuracy scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 476,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "FedEx International Connect Plus grew from roughly **50 origin countries and 130 destination countries in 2022** to about **60 origin countries and 190 destination countries by 2024** (2022: “nearly 50…over 130”; 2024: “nearly 60…over 190”). This widening footprint shows FedEx is deliberately expanding its global e‑commerce logistics network, aiming to capture more cross‑border e‑commerce volume and reinforce its competitive position in the worldwide logistics market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - INCOMPLETE TEMPORAL COVERAGE: The LLM answer conflates 2023 and 2024 data. The ground truth clearly states: 2022 (50 origin, 130 destination) → 2023 (60 origin, 190 destination) → 2024 (remained consistent at 60 origin, 190 destination). The LLM presents the 2023 expansion figures as if they represent the full 2022-2024 trajectory, stating 'by 2024' the service reached 60 origin and 190 destination countries. This is technically accurate for 2024 but OMITS the critical 2023 milestone and misses the key insight from the ground truth: that expansion occurred in 2022-2023, followed by stabilization in 2024. QUANTITATIVE ACCURACY: The numbers cited (50→60 origin, 130→190 destination) are correct, but the temporal attribution is imprecise. The LLM should have explicitly mentioned the 2023 expansion and 2024 stabilization to fully capture the 'evolution trajectory.' QUALITATIVE ACCURACY: The reasoning about FedEx's strategic focus on e-commerce logistics is sound and aligns with the ground truth's interpretation. However, the LLM misses the important strategic implication of the stabilization phase - the ground truth notes 'consolidation and optimization' after the expansion push, which suggests a shift from growth to efficiency. The LLM only emphasizes the expansion narrative without acknowledging the plateau. COMPLETENESS: The answer addresses the 'how' of geographic reach evolution but incompletely addresses the 'what this suggests' about strategic focus by missing the consolidation phase insight. The multi-hop synthesis is partially successful but incomplete due to the temporal conflation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 446,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 matured in 2017 and were fully repaid by the end of 2022, so the notes were not outstanding in the 2022, 2023, or 2024 10‑K filings.  The notes are still listed in the debt schedule and referenced in the Notes to Consolidated Financial Statements for each year, illustrating Apple’s practice of keeping a complete historical record of all debt issuances—even those that have matured—to provide transparency and to manage its debt‑maturity profile proactively.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT: The notes did mature in 2017 and were fully repaid, so they were not outstanding in 2022-2024. The LLM correctly identifies that the notes are still referenced in disclosures despite maturity. INCORRECT/PROBLEMATIC: (1) The LLM states the notes were 'fully repaid by the end of 2022' - this is imprecise since they matured in 2017, not 2022. The repayment would have occurred in 2017, not 2022. (2) The LLM claims the notes appear in 'the debt schedule and referenced in the Notes to Consolidated Financial Statements' but the ground truth specifically states they appear in 'Exhibit 4.4' as part of an Officer's Certificate. This is a material difference in disclosure location. (3) The ground truth indicates the references were in Exhibit 4.4 consistently across all three years with 'identical language,' suggesting standardized historical documentation. The LLM's explanation about 'keeping a complete historical record' is reasonable but differs from the ground truth's more cautious assessment that Apple 'may have retained historical references...possibly to maintain continuity.' The LLM is more definitive than the ground truth warrants. MULTI-HOP REASONING: The LLM attempts to synthesize the status across three years but conflates the maturity date (2017) with a repayment date (end of 2022), which is a logical error. The answer addresses the core question about why the notes continue to be referenced, but the explanation differs from and is less precise than the ground truth. The answer is partially correct on the main facts but contains a significant dating error and misidentifies the disclosure location.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 463,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "Qualcomm kept 5G at the heart of its 2022‑2024 strategy, with licensing revenue remaining a large share of total income but increasingly concentrated in per‑unit royalties; the 2024 MD&A notes a $560 M loss of Huawei revenue after a U.S. revocation, illustrating the shift (QCOM_10k_2024, pp. 11‑15).  The company ramped up R&D and strategic investments in automotive, IoT, XR and other new applications (see 2022 pages 6‑10 and 2023 pages 18‑22), while its exposure to geopolitical risk intensified—particularly U.S./China trade and national‑security tensions that threaten licensing and supply‑chain stability (see 2024 pages 11‑15 and 2023 pages 18‑22).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the multi-part question effectively. STRENGTHS: (1) Correctly identifies the $560M Huawei revenue loss in fiscal 2024 as a key geopolitical impact, matching the ground truth exactly. (2) Accurately captures the evolution of Qualcomm's 5G strategy across 2022-2024, including the shift toward per-unit royalties and licensing revenue concentration. (3) Properly synthesizes multi-hop information about R&D investments, new applications (automotive, IoT, XR), and geopolitical risks across multiple fiscal years. (4) Correctly identifies the U.S./China trade tensions and national security concerns as drivers of geopolitical exposure. (5) Appropriately references specific document sections and page numbers, demonstrating source awareness. MINOR WEAKNESSES: (1) Does not explicitly mention the 'over 27 billion IoT devices by 2026' projection from fiscal 2022, which was included in the ground truth as evidence of strategic focus. (2) Does not explicitly reference Qualcomm Ventures as a vehicle for strategic investments, though it does mention the investment areas (automotive, IoT, XR). (3) The phrase 'increasingly concentrated in per-unit royalties' is somewhat vague compared to the ground truth's emphasis on 'OFDMA-based (including 5G) devices' as the majority source of QTL revenues. (4) Does not explicitly state that 5G was positioned as a 'foundational enabler of immersive mobile experiences' in fiscal 2022. QUANTITATIVE VERIFICATION: The $560M figure is correct and properly contextualized. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and connects strategic focus, financial commitment, licensing revenue, new applications, and geopolitical risks as required. The logical flow from strategic emphasis to R&D investment to geopolitical challenges is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative of deepening commitment to 5G despite rising external risks, matching the ground truth's core message.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 565,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From the 2022 10‑K, domestic pension plan assets were 89 m in U.S. equity funds (≈9.5 %), 91 m in international equity funds (≈9.7 %) and 739 m in fixed‑income funds (≈78.9 % of the 937 m total). In 2024 those figures were 91 m (≈10.2 %), 89 m (≈9.9 %) and 692 m (≈77.4 % of the 895 m total), respectively. The allocation therefore stayed near the company’s target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed income, but with a modest shift toward slightly higher equity exposure and a small reduction in fixed‑income holdings, indicating a continued liability‑hedged framework that is gradually tilting toward higher return‑seeking equity assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that make it largely incorrect:\n\n1. YEAR MISMATCH: The LLM conflates 2022 and 2024 data. It states '2022 10-K' figures but then provides numbers that match 2023 data from the ground truth (89M U.S. equity, 91M international, 739M fixed income). This is a major error in entity identification.\n\n2. QUANTITATIVE ERRORS:\n   - Ground Truth 2022: $125M U.S. equity, $126M international, $1,001M fixed income\n   - LLM claims 2022: $89M U.S. equity, $91M international, $739M fixed income (these are actually 2023 figures)\n   - Ground Truth 2024: $93M U.S. equity, $93M international, $739M fixed income\n   - LLM claims 2024: $91M U.S. equity, $89M international, $692M fixed income (INCORRECT - fixed income should be $739M, not $692M)\n   - Total assets: LLM states $895M for 2024, but ground truth shows $947M\n\n3. MISSING 2023 DATA: The question asks about change from 2022 to 2024, which requires understanding the 2023 transition year. The LLM completely omits 2023 data, failing to capture the significant 2022-2023 decline ($1,267M to $937M) that is central to understanding the strategy evolution.\n\n4. INCORRECT NARRATIVE: The LLM's interpretation of 'shift toward higher equity exposure' contradicts the ground truth, which shows a strategic shift toward REDUCED equity exposure and MORE stability, particularly evident in the 2022-2023 transition.\n\n5. CALCULATION ERRORS: The percentages provided don't align with the stated dollar amounts. For example, LLM states 692M is 77.4% of 895M total, but 692/895 = 77.3%, which is close but the underlying numbers are wrong.\n\n6. INCOMPLETE MULTI-HOP SYNTHESIS: The answer fails to synthesize the three-year trend properly. It should show: 2022 (high equity exposure) → 2023 (significant reduction, liability-hedged shift) → 2024 (stabilization). Instead, it presents only two years with incorrect data.\n\nThe LLM answer demonstrates poor data retrieval, year confusion, and misinterpretation of the strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 551,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 10‑K positioned edge‑networking as a core part of its IoT portfolio, with $7.353 B in IoT revenue that included mobile‑broadband and Wi‑Fi 6/6E access‑point products (QCOM_10k_2022, pages 6‑10). By 2024, the company continued to push Wi‑Fi 6E and 5G NR‑U access‑point technology, but IoT revenue fell to $5.423 B, indicating a relative decline in edge‑networking contribution as the firm shifted focus toward automotive and handset segments (QCOM_10k_2024, pages 71‑75).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM cites specific IoT revenue figures ($7.353B in 2022 and $5.423B in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific numbers, and the LLM appears to have fabricated or misattributed these figures. This is a major red flag for hallucination. (2) INCOMPLETE SYNTHESIS - While the LLM attempts to address the 2022-2024 evolution, it only explicitly covers 2022 and 2024, missing the critical 2023 data point that the ground truth identifies as important (2023 being when edge networking was 'explicitly listed as a key revenue contributor'). (3) CONTRADICTORY NARRATIVE - The LLM's conclusion that edge networking showed 'relative decline' based on falling IoT revenue contradicts the ground truth's assertion of 'consistent and maturing strategic focus.' The ground truth emphasizes continued emphasis and consistency, while the LLM emphasizes decline and shifting focus away from edge networking. (4) REASONING FLAW - The LLM's logic that declining IoT revenue indicates declining edge networking focus is questionable and not supported by the ground truth, which focuses on strategic positioning and product development rather than revenue trends. (5) MISSING CONTEXT - The LLM fails to mention the specific market drivers identified in the ground truth (hybrid work environments, 5G adoption) and doesn't adequately capture the product development narrative (mobile broadband and wireless access points as consistent offerings). The answer does correctly identify Qualcomm, the correct time period (2022-2024), and the general topic area, but the specific financial claims and the overall narrative direction are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 492,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K filings consistently list the 0.45% Notes due 2016 in the “Description of Securities” section (2022, 2023, 2024 10‑K pages 54–58, 53–57, 54–58). By continuing to disclose this low‑coupon, fixed‑rate debt that matured in 2016, Apple signals a disciplined maturity‑management strategy that keeps a predictable debt profile and avoids volatility from refinancing or new debt issuance, thereby supporting capital‑structure stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental factual error that undermines the entire response. The ground truth explicitly states that the 0.45% Notes due 2016 'are no longer outstanding' - meaning they matured in 2016 and are no longer active debt. However, the LLM answer claims Apple is 'continuing to disclose this low-coupon, fixed-rate debt that matured in 2016' and frames this as part of a 'disciplined maturity-management strategy' for current debt management. This is logically inconsistent and factually misleading. The notes matured in 2016, so they cannot be part of current capital structure management or debt profile strategy. The LLM misinterprets the reason for continued disclosure - it's for historical tracking and comprehensive debt disclosure, not for active debt management. Additionally, the LLM provides specific page numbers (54-58, 53-57, 54-58) that cannot be verified against the ground truth and appear to be fabricated details. The LLM's reasoning that continued disclosure 'signals a disciplined maturity-management strategy' and 'supports capital-structure stability' is incorrect because these notes are historical, not active. The ground truth correctly identifies this as 'comprehensive debt disclosure and historical tracking,' not active management. The LLM fundamentally misunderstands the nature of the disclosure - it's backward-looking documentation, not forward-looking debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 403,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑brand distribution network reached **193 countries in 2022** and **191 countries in 2024**, a decline of **two countries** in its geographic reach【CAT_10k_2022.pdf: 74‑78】【CAT_10k_2024.pdf: 64‑68】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative metrics. Ground truth states: 2022 = 130 countries, 2024 = 109 countries (decline of 21 countries, ~16%). LLM claims: 2022 = 193 countries, 2024 = 191 countries (decline of 2 countries). All numeric values are wrong - the LLM reports numbers that are 48% higher than actual (193 vs 130 in 2022) and 75% higher than actual (191 vs 109 in 2024). The calculation of the decline is also incorrect (2 vs 21 countries). While the LLM correctly identified the question's focus (geographic reach change of EMD brand distribution network from 2022-2024) and provided a structured answer addressing the time period and direction of change, the complete failure on quantitative accuracy is disqualifying. The contextual relevance is high because the answer format and structure appropriately address the question, but the factual content is entirely wrong. This represents a critical failure in multi-hop synthesis - the model either hallucinated the numbers or retrieved incorrect data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 305,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "At year‑end 2022 the 1.75% 7‑Year Senior Notes (euro‑denominated, due 4/15/2027) had an outstanding principal of **$642 million**; this rose to **$662 million** at year‑end 2023 and fell to **$621 million** at year‑end 2024 (see Note 10 tables in the 2023 10‑K for 2022/2023 values [TMO_10k_2023, pp. 60‑64] and in the 2024 10‑K for the 2024 value [TMO_10k_2024, pp. 45‑49]). The modest increase in 2023 followed by a reduction in 2024 indicates that Thermo Fisher is keeping its medium‑term debt level relatively stable, using the notes to fund operations or acquisitions while gradually refinancing or repaying to maintain a balanced debt profile in the healthcare sector.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG INSTRUMENT: The ground truth identifies the '1.750% 7-Year Senior Notes due October 15, 2028' (USD-denominated), but the LLM references '1.75% 7-Year Senior Notes (euro-denominated, due 4/15/2027)' - these are different debt instruments with different maturity dates and currencies. (2) WRONG NUMBERS: Ground truth shows $700M outstanding for all three years (2022-2024), but LLM reports $642M (2022), $662M (2023), and $621M (2024) - all three values are incorrect. (3) WRONG TREND ANALYSIS: Ground truth indicates stable, unchanged $700M across all years, suggesting a steady debt strategy. LLM incorrectly describes a rise then fall pattern ($642M→$662M→$621M), leading to a fundamentally different interpretation of TMO's debt strategy. (4) CITATION ISSUES: While the LLM provides specific page references, these appear to reference the wrong debt instrument entirely. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and track the specific debt instrument across the three-year period, which is the core requirement of this multi-hop question. The answer demonstrates a complete failure to match the ground truth on the primary factual elements (instrument identification, outstanding values, and trend analysis), making it unsuitable as an answer to the question posed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 384,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "From 2022 through 2024 Caterpillar shifted its interest‑rate hedging exposure from LIBOR‑based derivatives to SOFR‑based instruments, creating a cross‑functional team in 2023 to assess floating‑rate risk and updating its hedging documentation to reflect the new benchmark.  While it continued to use currency‑hedging instruments to mitigate FX risk, the company noted that such hedges could forego gains from favorable currency movements.  These changes show Caterpillar’s proactive adaptation to global benchmark reforms—aligning its risk‑management framework with regulatory shifts while maintaining robust currency‑risk mitigation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Caterpillar's transition from LIBOR to SOFR-based instruments from 2022-2024, which aligns with the ground truth. Key strengths: (1) Correctly identifies the shift from LIBOR to SOFR as the central evolution; (2) Accurately notes the formation of a cross-functional team (though the LLM states 2023 while ground truth indicates 2022 formation with expansion in 2023—minor temporal imprecision); (3) Properly emphasizes currency hedging instruments and their dual nature (risk mitigation vs. foregone gains); (4) Correctly identifies the strategic adaptation to regulatory changes. Weaknesses: (1) The LLM omits specific regulatory dates mentioned in ground truth (FCA announcement, IBA's June 30, 2023 USD LIBOR phase-out deadline), which were important context for understanding the timeline; (2) The statement about the cross-functional team being formed in 2023 is slightly inaccurate—ground truth indicates it was formed in 2022 and expanded in 2023; (3) The LLM doesn't explicitly mention that by 2024 Caterpillar had completely eliminated LIBOR references, focusing entirely on SOFR (though this is implied); (4) Missing the detail about Cat Financial's specific role in managing LIBOR exposure. Quantitative accuracy is strong (no numerical errors), but the temporal sequencing of team formation is slightly off. The multi-hop reasoning is sound—the LLM successfully synthesizes information about interest rate benchmarks, currency hedging, and regulatory adaptation. The answer is semantically equivalent to the ground truth in its main conclusions about strategic adaptation, though it lacks some of the granular historical detail and specific regulatory context that would make it fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 478,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "In the 2022 Form 10‑K (pages 44‑48), Thermo Fisher’s only Executive Change in Control Retention Agreement was a CEO‑specific contract (Exhibit 10.11). By the 2023 filing (pages 74‑78), the company had adopted a standardized form for all officers other than the CEO (Exhibit 10.17). The 2024 10‑K (pages 75‑79) continues to use that same standardized officer agreement, indicating a shift toward uniform retention agreements for all non‑CEO officers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) Exhibit number discrepancy - Ground truth identifies the CEO agreement as Exhibit 10.12 with amendments in Exhibit 10.17, but LLM states it was Exhibit 10.11. This is a factual error in document identification. (2) The LLM incorrectly characterizes the evolution - it claims the 2023 form was 'adopted' for 'all officers other than the CEO,' but the ground truth specifically states it was a 'standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper,' which is a more precise distinction. (3) The LLM references specific page numbers (44-48, 74-78, 75-79) that cannot be verified against the ground truth and may be inaccurate. PARTIAL CREDIT: The LLM does correctly identify the overall evolution pattern - from CEO-specific to standardized officer agreements across 2022-2024. The semantic understanding of the progression is sound. However, the specific exhibit numbers are wrong, and the characterization of scope ('all officers' vs. the more precise 'officers other than the CEO') differs from ground truth. The multi-hop reasoning about the three-year evolution is present but marred by factual inaccuracies in supporting details. The answer demonstrates understanding of the general trend but fails on precise factual accuracy regarding exhibit numbers and specific agreement scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 400,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "In 2022 Intel introduced PowerVia as a breakthrough backside‑power delivery technology for its planned Intel 20A node, positioning it as a key differentiator in the advanced process roadmap (2022 10‑K, pp. 5‑9). The 2023 filing continued to highlight PowerVia as part of the 20A strategy, but the company began shifting focus toward the 18A node. By 2024 Intel announced the cancellation of the 20A node and the prioritization of Intel 18A, which still incorporates PowerVia (2024 10‑K, pp. 8‑12), underscoring that PowerVia remains a core technology for improving performance‑per‑watt and signal integrity in Intel’s next‑generation process nodes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop evolution of PowerVia technology across 2022-2024. STRENGTHS: (1) Correctly identifies PowerVia as a backside-power delivery technology introduced in 2022 for Intel 20A; (2) Accurately captures the strategic shift from 20A to 18A between 2023-2024; (3) Properly notes that PowerVia was retained in Intel 18A despite the node cancellation; (4) Correctly emphasizes PowerVia's continued centrality to Intel's advanced process strategy; (5) Appropriately cites 10-K filings as sources with page references. MINOR GAPS: (1) The LLM answer mentions PowerVia's role in 'performance-per-watt and signal integrity' but the ground truth specifically emphasizes 'eliminating front-side power routing' and 'optimizing signal transmission' - while semantically related, the ground truth provides more specific technical detail about the mechanism; (2) The ground truth explicitly mentions RibbonFET as a companion breakthrough innovation for 20A, which the LLM answer omits; (3) The ground truth specifies 'high-volume manufacturing starting in 2025' as the timeline for 18A, while the LLM answer is less specific about manufacturing timelines. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and node designations (20A, 18A) are correct. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two different nodes, correctly showing the progression and strategic continuity. The logic that PowerVia's retention in 18A despite 20A's cancellation indicates its strategic importance is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth - PowerVia evolved from a 20A innovation to a retained core component of 18A, demonstrating its importance to Intel's roadmap. The answer is well-structured and directly addresses the question's three components (evolution, progression, and role indication).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 528,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all contain a separate note on the 1.05% Notes due 2017 in the “Notes to Consolidated Financial Statements” section (pages 54‑58 in 2022, 53‑57 in 2023, and 54‑58 in 2024).  The wording, principal amount, 1.05 % coupon, maturity date and covenants are identical across the three filings, with no change in figures or terms.  The unchanged, repeated disclosure indicates that Apple continues to hold or refinance this long‑term debt instrument and that it follows a disciplined, transparent debt‑management policy for it.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about Apple's disclosure of the 1.05% Notes due 2017 across multiple years and attempts to characterize the debt management implications. However, there are significant issues with accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies that the instrument appears in 2022, 2023, and 2024 10-K filings\n2. Correctly notes the 1.05% coupon rate\n3. Correctly identifies the maturity date as 2017\n4. Appropriately concludes that repeated disclosure suggests deliberate reporting practice\n5. Contextually relevant interpretation of debt management implications\n\nCRITICAL ISSUES:\n1. QUANTITATIVE ACCURACY PROBLEM: The LLM provides specific page numbers (pages 54-58 in 2022, 53-57 in 2023, and 54-58 in 2024) that cannot be verified against the ground truth. The ground truth specifically references the Officer's Certificate dated May 6, 2014 filed as Exhibit 4.4, but the LLM claims the disclosure is in the \"Notes to Consolidated Financial Statements\" section. This is a material discrepancy in locating the source document.\n\n2. MISSING KEY DETAIL: The ground truth specifically identifies the source as \"Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4)\" - this is a critical detail about HOW and WHERE the disclosure appears. The LLM's claim that it appears in the notes section contradicts this.\n\n3. INCOMPLETE SYNTHESIS: The ground truth suggests the post-maturity inclusion (2017 maturity but disclosed in 2022, 2023, 2024) is noteworthy and implies either rollover or continuation. The LLM mentions \"continues to hold or refinance\" but doesn't adequately address the temporal anomaly of disclosing a debt that matured in 2017 in filings from 2022-2024.\n\n4. VAGUE LANGUAGE: The LLM states \"wording, principal amount...are identical\" but provides no actual figures or amounts, making it impossible to verify the claim.\n\n5. REASONING GAP: While both answers suggest deliberate reporting, the ground truth more explicitly highlights the unusual nature of post-maturity disclosure, which is a key insight about Apple's debt management practices.\n\nThe answer is partially correct in identifying the instrument's repeated appearance but appears to misidentify the location/format of disclosure and lacks the specificity needed for a high-confidence evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 625,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "From 2022 to 2024, Intel continued to use the 2006 Equity Incentive Plan mainly to grant restricted‑stock units (RSUs) to executives and non‑employee directors. The plan’s award types remained consistent—time‑based RSUs with or without retirement vesting, and performance‑based RSUs for both grandfathered and non‑grandfathered executives—while the addition of RSUs for non‑employee directors in 2022 marked the only expansion. Vesting conditions stayed largely unchanged: retirement‑vesting RSUs vest upon retirement, time‑based RSUs vest over a set schedule, and performance‑based RSUs vest when specified performance metrics are met (INTC_10k_2024, pp.104‑108; INTC_10k_2023, pp.99‑103; INTC_10k_2022, pp.112‑116).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. STRENGTHS: (1) Correctly identifies the 2006 Equity Incentive Plan as the primary vehicle; (2) Accurately describes the types of awards (time-based RSUs, performance-based RSUs, retirement vesting variants); (3) Correctly identifies recipients (executives and non-employee directors); (4) Provides appropriate page citations; (5) Correctly describes vesting mechanics. CRITICAL WEAKNESSES: (1) The LLM claims 'award types remained consistent' and that there was 'only expansion' with non-employee directors in 2022, which contradicts the ground truth's key finding that the plan was 'amended and restated' effective May 11, 2023, introducing a 'broader range of RSU agreements'; (2) Fails to capture the significant structural evolution described in the ground truth—specifically the 2023 amendment/restatement as a pivotal change; (3) Misses the ground truth's emphasis on 'consolidation in documentation structure' and 'streamlined format' in 2024; (4) Does not adequately convey the shift toward 'more nuanced performance alignment' that the ground truth highlights; (5) The characterization of the evolution as merely 'addition of RSUs for non-employee directors' significantly understates the documented changes. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the three years. The ground truth clearly indicates a 2023 amendment/restatement as a turning point, followed by consolidation in 2024. The LLM presents the period as relatively static with minimal change. This represents a fundamental misunderstanding of the multi-hop synthesis required. QUANTITATIVE ELEMENTS: The page citations appear reasonable but cannot be verified without access to actual filings. The dates mentioned (2022-2024) are correct, but the critical 2023 amendment date (May 11, 2023) is not mentioned by the LLM, which is a significant omission given its importance in the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 533,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across FY 2022, 2023 and 2024 Medtronic’s 10‑K notes consistently report that 40,000 Euro‑Deferred Shares are authorized but “no Euro Deferred Shares were issued or outstanding” (April 29 2022, April 28 2023, April 26 2024). The unchanged authorization and zero issuance indicate the company has not used this instrument for capital raising, instead relying on other equity or debt mechanisms while keeping the Euro‑Deferred Shares available for future strategic flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Medtronic's Euro Deferred Shares capital structure evolution. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 40,000 (or 40 thousand) Euro Deferred Shares authorized, €1.00 par value, zero issuance across all three fiscal years (2022, 2023, 2024). The fiscal year end dates provided (April 29 2022, April 28 2023, April 26 2024) are accurate. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) how disclosures evolved (consistent pattern across three years), (2) the specific authorization amount and par value, (3) the zero issuance pattern, and (4) what this suggests about financing strategy. ENTITY ACCURACY (9/10): Correctly identifies Medtronic, the specific security type (Euro Deferred Shares), and the relevant fiscal years. The 10-K filing references are appropriately cited. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three fiscal years to identify the consistent pattern, then draws a logical inference about financing strategy preferences. The conclusion that the company prefers other capital structure tools (equity repurchases, dividends, debt mechanisms) is well-supported by the evidence of non-utilization. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while using slightly different phrasing. Both identify the consistent absence of issuance, the maintained authorization, and the strategic implications. The LLM adds the phrase 'keeping the Euro-Deferred Shares available for future strategic flexibility' which is a reasonable inference not contradicted by the ground truth. MINOR OBSERVATIONS: The ground truth specifically mentions 'ordinary share repurchases and dividend policies' while the LLM uses the broader term 'other equity or debt mechanisms' - this is a slight generalization but not inaccurate. The LLM's phrasing is slightly more concise while maintaining all essential information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 554,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s focus on advanced packaging shifted from a modest niche in 2022 to a core pillar of its IDM 2.0 strategy by 2024.  In 2023 the company began securing Intel 18A design wins, especially for AI‑related systems, and in 2024 it adopted a disaggregated‑design approach that increased manufacturing complexity and cost.  R&D spend remained high—$17.5 B in 2022, $16.0 B in 2023 and $16.5 B in 2024—while the financial impact grew from a $482 M operating loss in 2023 (due to strategic growth spend) to $3.1 B in impairment charges, $922 M in Gaudi AI inventory write‑downs and $755 M in construction penalty charges in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative arc of Intel's advanced packaging strategy evolution from 2022-2024, but contains several significant issues:\n\nSTRENGTHS:\n1. Correctly identifies IDM 2.0 strategy as the overarching framework\n2. Accurately cites the $3.1B impairment charges in 2024 (matches ground truth)\n3. Correctly mentions manufacturing complexity and disaggregated design approach\n4. Appropriately references AI-driven systems as a key focus area\n5. Provides R&D spending figures ($17.5B 2022, $16.0B 2023, $16.5B 2024) that appear reasonable\n6. Mentions specific 2024 financial impacts (Gaudi inventory write-downs, construction penalties)\n\nWEAKNESSES:\n1. FACTUAL ERROR: Claims Intel \"began securing Intel 18A design wins\" in 2023 - the ground truth mentions Intel 4 delays in 2022 and UCIe demonstration in 2023, not Intel 18A wins\n2. INCOMPLETE SYNTHESIS: Fails to mention the Universal Chiplet Interconnect Express (UCIe) standard demonstration in silicon, which was a key technical milestone in 2023\n3. MISSING CONTEXT: Does not adequately address Intel 4 and 10nm process delays mentioned in 2022 as foundational execution risks\n4. VAGUE ATTRIBUTION: The $482M operating loss in 2023 is mentioned but not clearly tied to strategic growth spend context from ground truth\n5. INCOMPLETE FINANCIAL PICTURE: While mentioning 2024 impairments, the answer doesn't clearly convey the escalation from modest strategic positioning to severe financial strain\n6. MISSING NUANCE: Doesn't capture the progression from \"initial strategic bet → technical progress → financial/operational setbacks\" narrative arc as clearly as ground truth\n\nQUANTITATIVE VERIFICATION:\n- R&D figures appear plausible but cannot be independently verified from provided ground truth\n- $3.1B impairment: CORRECT (matches ground truth)\n- $482M operating loss 2023: Mentioned in LLM but not explicitly confirmed in ground truth\n- $922M Gaudi write-downs and $755M construction penalties: Mentioned in LLM but not in ground truth excerpt\n\nMULTI-HOP REASONING:\nThe answer attempts to synthesize across years and connect R&D investment to financial outcomes, but the reasoning is somewhat linear rather than deeply integrated. The connection between manufacturing complexity and financial impact could be stronger.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates understanding of the general trajectory but contains factual errors (Intel 18A timing), omits key technical achievements (UCIe), and doesn't fully capture the escalating severity of execution risks. The financial data provided goes beyond the ground truth but cannot be verified as incorrect. The core narrative is directionally correct but lacks precision in key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 725,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In the 2022 10‑K (pp. 5‑9), Intel positioned PowerVia as a new backside‑power‑delivery technology for the upcoming 20A node, noting it would eliminate front‑side power routing and serve as a future packaging innovation. By the 2023 10‑K (pp. 12‑16), the roadmap update framed PowerVia as a breakthrough technology expected to deliver up to a 15 % performance‑per‑watt improvement over Intel 3. In the 2024 10‑K (pp. 8‑12), Intel disclosed that PowerVia is now part of the Intel 18A node—a first high‑volume commercial implementation offered to external foundry customers—indicating the technology is ready for high‑volume manufacturing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes information across three years of Intel filings. STRENGTHS: (1) All key numeric values are correct - the 15% performance-per-watt improvement is accurately cited; (2) Timeline progression is accurate: 2022 introduction, 2023 roadmap solidification, 2024 manufacturing readiness disclosure; (3) Process node progression is correct: PowerVia initially positioned for 20A, then disclosed as part of Intel 18A in 2024; (4) Core technical positioning is accurate - backside power delivery, elimination of front-side power routing, and integration with advanced nodes; (5) Multi-hop synthesis is sound, connecting strategic positioning across three fiscal years. MINOR WEAKNESSES: (1) The LLM answer adds contextual detail about 'first high-volume commercial implementation offered to external foundry customers' which, while potentially accurate, is not explicitly confirmed in the ground truth statement and represents slight elaboration beyond the core facts; (2) The ground truth emphasizes the shift from 'conceptual introduction to mature, production-ready innovation' as a key evolution theme, while the LLM answer focuses more on technical specifications and node assignments rather than explicitly highlighting this strategic maturation narrative; (3) The ground truth notes Intel 18A is 'the successor to Intel 20A,' which the LLM answer implies but doesn't explicitly state. CALCULATION/DATE VERIFICATION: All dates (2022, 2023, 2024, 2025) are correct; the 15% performance-per-watt figure is accurate; process node references (20A, 18A, Intel 3) are all correct. The answer successfully demonstrates multi-hop reasoning by connecting information across three separate 10-K filings and showing the evolution of PowerVia's positioning. The semantic meaning aligns well with the ground truth despite slightly different emphasis and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 519,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "No – Medtronic’s U.S. employee Restricted Stock Unit (RSU) agreement has remained the same between FY 2022 and FY 2024.  Both the 2022 10‑K (page 113) and the 2024 10‑K (page 112) refer to the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (exhibit 10.54).  The unchanged wording and continued use of the 2013 plan suggest a deliberate emphasis on stability and continuity in its equity‑compensation approach for U.S. employees.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Medtronic has not updated its U.S. employee RSU agreements between FY2022 and FY2024, and accurately references the same Form of Restricted Stock Unit Award Agreement under the 2013 Stock Award and Incentive Plan. The answer appropriately cites specific page numbers (page 113 for 2022 10-K and page 112 for 2024 10-K) and exhibit reference (10.54), demonstrating document-specific accuracy. The interpretation that this consistency suggests a 'deliberate emphasis on stability and continuity' aligns well with the ground truth's characterization of a 'stable and consistent equity compensation strategy.' However, there are minor gaps: (1) The LLM answer does not mention the original filing date of August 27, 2013 (File No. 001-07707), which the ground truth specifically includes as supporting evidence of the agreement's longevity; (2) The LLM answer does not explicitly state that the agreement was 'first filed' on that date, which provides important context about the three-year span of consistency; (3) The phrase 'without introducing structural changes to this particular award vehicle' from the ground truth is not captured, though the LLM's 'unchanged wording' conveys similar meaning. The multi-hop reasoning is sound—the answer correctly synthesizes information across two fiscal years (FY2022 and FY2024) to reach a conclusion about consistency. The quantitative accuracy is strong with correct page numbers and exhibit references. The qualitative reasoning about what this consistency suggests is appropriate and well-reasoned, though slightly less comprehensive than the ground truth's framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 452,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan has been progressively broadened to include performance‑based RSU grants. In 2022 the plan was amended to allow performance‑based RSUs for non‑employee directors, while in 2023 it was further expanded to grant performance‑based RSUs with retirement‑vesting terms to executives. By 2024 the plan had been refined to align performance metrics and vesting schedules more closely with the company’s long‑term strategic objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Specific issues: (1) INCORRECT CLAIMS: The LLM states the plan was 'amended to allow performance-based RSUs for non-employee directors' in 2022 - the ground truth makes no mention of non-employee directors and instead references executives granted RSUs on or after February 1, 2019. (2) INCORRECT CLAIMS: The LLM claims the 2023 expansion included 'retirement-vesting terms' - the ground truth mentions 'separate agreements for grandfathered and non-grandfathered executives' with no reference to retirement-vesting terms. (3) VAGUE/UNSUPPORTED: The LLM's 2024 description about 'refined to align performance metrics and vesting schedules' is generic and lacks the specific factual grounding provided in the ground truth (amendment effective May 11, 2023, S-8 registration on September 26, 2023). (4) MISSING KEY DETAILS: The LLM fails to mention the specific dates (February 1, 2019 eligibility threshold, May 11, 2023 amendment date, September 26, 2023 S-8 filing) that are central to understanding the evolution. (5) MULTI-HOP REASONING: The LLM does not properly synthesize the consistent strategic focus across the three years - instead it presents speculative 'progressive broadening' that contradicts the ground truth's emphasis on consistency. The answer appears to fabricate details about non-employee directors and retirement-vesting rather than accurately reflecting the documented executive compensation structure. The ground truth emphasizes continuity and consistency, while the LLM incorrectly portrays progressive expansion with unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 456,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s focus on advanced packaging grew steadily from 2022‑24: in 2022 the company framed packaging as a high‑risk, early‑stage element of its disaggregated‑design strategy (pages 52‑56), then in 2023 it reported accelerated interest and five new design wins for AI‑related packaging (pages 35‑39), and by 2024 it positioned advanced packaging as a key differentiator for AI workloads under its IDM 2.0 strategy (pages 32‑36). This trajectory—coupled with a sustained R&D spend of $17.5 B (2022), $16.0 B (2023), and $16.5 B (2024)—shows Intel is allocating more resources to chip‑let packaging to support its disaggregated architecture, thereby strengthening its competitive stance in the AI‑driven market, though execution remains complex and subject to delays.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year progression (2022-2024) and captures the key narrative arc: early-stage challenges → accelerated progress with design wins → positioning as AI differentiator. The qualitative assessment of Intel's strategic positioning is sound. The answer appropriately addresses the multi-hop synthesis across years and connects packaging investments to AI market competition.\n\nCRITICAL ERRORS - QUANTITATIVE: (1) R&D spending figures are INCORRECT. LLM states $17.5B (2022), $16.0B (2023), $16.5B (2024). Ground truth confirms $16.5B for 2024 but does not validate the 2022 and 2023 figures provided. More importantly, the LLM omits the crucial $3.1 billion in charges (non-cash impairments and accelerated depreciation) recorded in 2024, which is a material fact revealing execution risks. (2) The LLM mentions \"five new design wins for AI-related packaging\" in 2023 without ground truth validation of this specific number.\n\nSIGNIFICANT OMISSIONS: The ground truth emphasizes that 2024 saw $3.1 billion in charges related to manufacturing assets and Intel 7 process node, indicating \"ongoing execution risks and financial pressures.\" This is a critical data point showing the financial strain of scaling advanced packaging—the LLM's statement that \"execution remains complex and subject to delays\" is vague and misses the concrete evidence of financial distress. The ground truth also specifically mentions the UCIe standard demonstration in silicon (2023), which the LLM does not reference.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects R&D spending to strategic positioning. However, it fails to complete the full narrative arc by omitting the 2024 financial charges, which fundamentally alter the conclusion about Intel's execution capability. The ground truth reveals a more nuanced story: despite sustained R&D investment, Intel faced significant financial headwinds in 2024, suggesting execution challenges are more severe than the LLM conveys.\n\nSEMANTIC ISSUES: The LLM's framing of \"strengthening its competitive stance\" is somewhat optimistic given the ground truth's emphasis on \"persistent execution challenges and high financial stakes.\" The omission of the $3.1B charge represents a material gap in conveying the true competitive and financial picture.\n\nVERIFICATION: Ground truth R&D 2024 = $16.5B ✓ (LLM correct). Ground truth 2024 charges = $3.1B ✗ (LLM omitted entirely). Ground truth mentions UCIe in 2023 ✗ (LLM did not reference). LLM R&D 2022-2023 figures unvalidated against ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 696,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Across 2022‑2024 Intel continued to use the 2006 Equity Incentive Plan to award RSUs to executives, non‑employee directors and performance‑based RSUs—granting RSUs with retirement vesting terms, without retirement vesting terms, and performance‑based RSUs for both grandfathered and non‑grandfathered executives (see pages 112‑116, 99‑103, 104‑108). No amendments to the plan itself were disclosed in those filings, indicating the plan’s structure remained unchanged while the scope of grant agreements broadened.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION ON AMENDMENTS: The LLM answer explicitly states 'No amendments to the plan itself were disclosed in those filings, indicating the plan's structure remained unchanged,' which directly contradicts the ground truth that states 'In 2023, the company filed an amended and restated version of the plan effective May 11, 2023.' This is a fundamental factual error on a core aspect of the question. (2) INCOMPLETE SYNTHESIS: The LLM answer fails to capture the key evolution described in the ground truth—specifically the 2023 amended and restated version of the plan effective May 11, 2023, which represents a significant structural update. This is a major omission for a question specifically asking about 'plan amendments.' (3) PAGE REFERENCES: The LLM provides specific page references (112-116, 99-103, 104-108) that cannot be verified against the ground truth and appear to be fabricated details, which is problematic. (4) PARTIAL CORRECTNESS: The LLM correctly identifies that Intel continued using the 2006 Equity Incentive Plan across 2022-2024 and correctly notes the types of awards (RSUs, performance-based RSUs, retirement vesting terms), which aligns with the ground truth. (5) MISSING CONTEXT: The answer fails to convey the 'increasingly mature application of the plan' and the significance of the 2023 formal amendments as described in the ground truth. The core claim about 'no amendments' being disclosed is factually incorrect and represents a failure in multi-hop reasoning across the three-year period. This is a critical error that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 450,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm continued to classify revenue from wireless access points under its IoT segment’s edge‑networking sub‑category in both 2022 and 2024 (see the QCT revenue‑streams table – 2024, pp. 71‑75). In 2022 the company framed wireless access points as part of a broader edge‑networking growth narrative driven by Wi‑Fi 6/6E and 5G NR‑U (2022, pp. 6‑10), whereas by 2024 it positioned them as a core driver of its edge‑computing strategy, emphasizing leadership in Wi‑Fi 6E/7 and 5G NR‑U and the expansion of its portfolio to deliver high‑speed, low‑latency connectivity for both mobile and fixed wireless users (2024, pp. 71‑75).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies wireless access points as part of edge networking segment in both 2022 and 2024; (2) Accurately captures the evolution of strategic positioning from Wi-Fi 6/6E focus in 2022 to Wi-Fi 6E/7 emphasis in 2024; (3) Properly identifies the multi-hop synthesis across years showing consistent categorization; (4) Correctly notes the strategic emphasis on edge-computing and connectivity solutions. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth explicitly mentions the 2023 formal financial classification of wireless access points under edge networking revenue segment - the LLM answer completely skips 2023, only addressing 2022 and 2024, thus failing to capture the full three-year evolution requested; (2) The ground truth mentions the specific IoT projection (doubling of IoT devices between 2022-2026 to over 27 billion) which provides important quantitative context for understanding strategic emphasis - the LLM answer omits this entirely; (3) The LLM answer claims 'IoT segment's edge-networking sub-category' but the ground truth indicates edge networking is the segment itself (not a sub-category of IoT), suggesting potential structural misunderstanding; (4) The LLM answer provides page references (pp. 71-75, pp. 6-10) that cannot be verified against the ground truth, raising questions about citation accuracy. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2024 but fails the three-year synthesis by omitting 2023 entirely. The reasoning about strategic evolution (Wi-Fi technology progression, positioning shift) is sound but incomplete. QUANTITATIVE ACCURACY: While no specific revenue figures are disclosed (correctly noted in both answers), the LLM omits the concrete IoT projection numbers from the ground truth (27 billion devices, doubling 2022-2026), which are factual data points relevant to understanding strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 542,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose from **$428 million in 2022** (MRK_10k_2022 p. 139‑143) to **$605 million in 2023** (MRK_10k_2023 p. 2‑6) and to **$785 million in 2024** (MRK_10k_2024 p. 128‑132). This steady growth—over 40 % in two years—indicates that Prevymis is gaining traction and solidifying its position as a key CMV‑prophylaxis therapy within the Hospital Acute Care segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core financial numbers that are the primary focus of the question. Specifically: (1) 2022 sales are stated as $428 million in the LLM answer, but the ground truth shows $370 million - this is a $58 million error (15.7% overstatement). (2) 2023 sales are stated as $605 million in the LLM answer, but the ground truth shows $428 million - this is a $177 million error (41.4% overstatement). (3) 2024 sales of $785 million are correct. The LLM appears to have shifted the data points by one year, presenting 2023 data as 2022, and 2024 data as 2023. This fundamental misalignment of years to values is a critical multi-hop synthesis failure. CALCULATION ERRORS: The LLM states 'over 40% in two years' growth, but with the correct numbers ($370M to $785M), the actual growth is approximately 112% over two years, or a CAGR of ~46% - which the ground truth correctly identifies. The LLM's percentage is significantly understated due to the incorrect base numbers. POSITIVE ASPECTS: The LLM correctly identifies Prevymis as a CMV-prophylaxis therapy in the Hospital Acute Care segment and appropriately discusses market positioning and adoption trends. The qualitative reasoning about market positioning is sound. However, these qualitative strengths cannot compensate for the fundamental quantitative errors in the core financial data that the question specifically asks about. The answer fails the primary requirement of accuracy on multi-hop financial synthesis from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 432,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022 to 2024 Intel shifted its advanced‑packaging focus from a nascent, disaggregated‑design approach (2022 MD&A, pp. 52‑56) that was hampered by 10 nm and 7 nm delays, to a more mature positioning—2023 MD&A (pp. 35‑39) reports accelerated AI‑related interest, five new design wins and a growing IFS accelerator ecosystem, and 2024 MD&A (pp. 32‑36) notes further expansion of packaging capabilities, new ARM and Synopsys agreements, and additional design wins under the Smart Capital joint‑investment model. This multi‑year trajectory shows Intel has steadily increased investment and strategic emphasis on advanced packaging as a key IDM 2.0 differentiator, yet the persistent manufacturing delays and high capital requirements (e.g., joint investments, EUV tool costs, and government‑grant contingencies) continue to constrain full execution of the IDM 2.0 strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the multi-year evolution of Intel's advanced packaging strategy from 2022-2024, appropriately references the IDM 2.0 framework, and accurately notes the shift from nascent disaggregated design to more mature positioning. The answer correctly identifies key strategic elements (UCIe standard, design wins, partnerships with ARM and Synopsys, joint-investment models) and acknowledges persistent manufacturing delays and capital constraints. The reasoning about the tension between strategic progress and execution challenges is sound.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to cite the specific R&D investment figure ($16.5 billion in 2024) mentioned in the ground truth, which is a concrete, verifiable metric that directly supports the capital constraints argument. More critically, the LLM completely omits the $3.1 billion non-cash impairment in Q3 2024 affecting Intel 7, which is a major factual point demonstrating execution challenges and financial impact. These omissions weaken the quantitative support for the conclusion about execution challenges.\n\nWEAKNESSES - ENTITY/DETAIL ACCURACY: The LLM references \"10 nm and 7 nm delays\" in 2022, but the ground truth specifically mentions \"Intel 4 (formerly 7nm)\" and \"Intel 7 process node,\" showing some imprecision in process node nomenclature. The LLM mentions \"five new design wins\" but provides no year context or verification against ground truth. The reference to \"EUV tool costs\" and \"government-grant contingencies\" appears to be inference rather than direct citation from the filings.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects strategic positioning to execution constraints. However, the synthesis is incomplete because it doesn't fully integrate the quantitative evidence (R&D spending, impairments) that would strengthen the causal argument about capital constraints undermining execution.\n\nSEMANTIC EQUIVALENCE: The core narrative matches the ground truth - Intel made strategic progress in packaging innovation but faced execution challenges. However, the answer is less comprehensive in demonstrating the specific financial and operational evidence of these constraints.\n\nJUSTIFICATION: The answer demonstrates good qualitative understanding and reasoning but falls short on quantitative completeness. The omission of the $16.5B R&D figure and $3.1B impairment represents material gaps in supporting evidence for a question specifically asking about \"capital constraints.\" The answer would score higher (8-9) if these specific numbers were included, as they directly address the question's focus on execution amid constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 722,
        "total_tokens": 2232
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM has consistently highlighted client relationships and trust as a key competitive differentiator in its 2022, 2023, and 2024 10‑K filings (2022 10‑K, pp. 2‑5; 2023 10‑K, pp. 1‑5; 2024 10‑K, pp. 1‑5). In 2023 the company explicitly linked this emphasis to its hybrid‑cloud and AI platform, noting that it supports clients’ digital transformations (2023 10‑K, pp. 1‑5), and by 2024 it framed its hybrid‑cloud and AI strategy as being built on client relationships and trust, underscoring the role of trusted partnerships in delivering integrated solutions (2024 10‑K, pp. 1‑5). This progression signals that IBM is positioning hybrid‑cloud and AI not merely as technology offerings but as value‑add services anchored in deep client trust, differentiating itself from hyperscalers and other competitors.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts and overall narrative arc. STRENGTHS: (1) Correctly identifies the 3-year progression (2022-2024) of IBM's emphasis on client relationships and trust; (2) Accurately captures the evolution from 2022 (trust tied to hybrid cloud and AI) through 2023 (reinforced positioning) to 2024 (maintained stance); (3) Properly synthesizes the multi-hop connection between trust, client relationships, and hybrid cloud/AI strategy; (4) Correctly identifies that this represents strategic positioning against competitors (hyperscalers); (5) No quantitative errors in dates or time periods. WEAKNESSES: (1) The LLM answer omits the specific mention of Palo Alto Networks partnership in 2024, which the ground truth identifies as a significant signal of 'deepening of trust-based collaboration'; (2) The LLM frames the positioning as 'value-add services anchored in deep client trust' which is slightly different from the ground truth's emphasis on trust as 'foundational element in client acquisition and retention'; (3) The LLM answer provides page citations (pp. 2-5, pp. 1-5) that cannot be verified against the ground truth, though this doesn't constitute factual error; (4) The ground truth emphasizes 'service and support, innovation, and talent' as broader competitive methods in 2023, which the LLM answer doesn't explicitly mention. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects the evolution to strategic positioning, though it misses the partnership dimension. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message is preserved - IBM's consistent emphasis on trust as a competitive differentiator evolved in alignment with hybrid cloud and AI strategy. The omission of Palo Alto Networks and the slightly different framing of the strategic implication prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 522,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM first issued the 0.950% Notes due 2025 in 2022 and disclosed the terms and outstanding balance in its 2022 10‑K (IBM_10k_2022, p. 28‑32).  In 2023, the company continued to report the notes in its 10‑K, updating the balance and covenant status and framing them as part of a low‑interest, long‑term debt strategy (IBM_10k_2023, p. 18‑22).  By 2024, the 10‑K listed the notes as a registered security and highlighted the maturity and planned refinancing, underscoring a disciplined, diversified debt‑management approach that aligns maturities with capital‑allocation priorities (IBM_10k_2024, p. 1‑5).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that contradict the ground truth: (1) ISSUANCE DATE ERROR: The LLM claims IBM 'first issued the 0.950% Notes due 2025 in 2022,' but the ground truth explicitly states the instrument was defined in a Form 8-K filed May 22, 2017 - meaning the notes were issued in 2017, not 2022. This is a fundamental factual error about when the debt was originally issued. (2) DISCLOSURE STRATEGY MISCHARACTERIZATION: The LLM describes a progression of 'reporting the notes' and 'updating the balance' across 2022-2024, but the ground truth indicates IBM was referencing the same original instrument disclosure (Exhibit 4.1 from the 2017 8-K) in both 2022 and 2023, not providing new balance updates. The ground truth emphasizes 'ongoing transparency and regulatory continuity' by referencing the same instrument, not new disclosures of updated balances. (3) NYSE LISTING OMISSION: The ground truth specifically notes that by 2024, the notes were 'actively listed on the New York Stock Exchange under the trading symbol IBM25B,' which is a key factual detail completely absent from the LLM answer. (4) REFINANCING CLAIM: The LLM mentions 'planned refinancing' in 2024, but the ground truth makes no such claim - it only notes the notes remained 'a live and traded financial liability.' (5) PAGE REFERENCES: The LLM provides specific page numbers (p. 28-32, p. 18-22, p. 1-5) that cannot be verified against the ground truth and appear to be fabricated. The LLM fundamentally misunderstands the question's focus on how disclosure strategy evolved - the ground truth shows consistency in referencing the original instrument, while the LLM incorrectly portrays it as new reporting of updated information. The core narrative about debt management approach is also different: ground truth emphasizes 'stable and transparent' strategy through consistent disclosure framework; LLM emphasizes 'disciplined, diversified' approach with refinancing plans.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 535,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In 2022, Intel announced PowerVia as a new backside‑power delivery technology slated for the Intel 20A node (INTC_10k_2022.pdf pages 5‑9). By 2023, the company detailed PowerVia’s role in Intel 20A, emphasizing its ability to eliminate front‑side power routing (INTC_10k_2023.pdf page 14). In 2024, Intel moved PowerVia to the earlier Intel 18A node, indicating an accelerated adoption and underscoring backside power delivery as a key enabler for performance‑per‑watt gains in its advanced‑node roadmap (INTC_10k_2024.pdf page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's PowerVia strategy across 2022-2024 and correctly identifies the key progression from announcement to integration to commercial deployment. However, there is a critical factual error regarding the node assignment: The LLM states that 'In 2024, Intel moved PowerVia to the earlier Intel 18A node,' which contradicts the ground truth. According to the original answer, Intel 20A was the original target (2022-2023), and in 2024, Intel canceled Intel 20A productization in favor of Intel 18A with PowerVia integration. The LLM's phrasing 'moved PowerVia to the earlier Intel 18A node' is misleading—it suggests a backward shift in the roadmap when the actual strategy was a cancellation of 20A and pivot to 18A. The LLM also omits the specific detail that PowerVia integration in Intel 18A targets 'commercial high-volume production starting in 2025,' which is an important temporal marker for understanding the deployment timeline. The LLM correctly identifies the core strategic progression (concept → technical integration → commercial deployment) and appropriately emphasizes backside power delivery as a performance-per-watt enabler. The document citations appear plausible but cannot be verified. The reasoning about acceleration is somewhat inferred rather than explicitly stated in the ground truth, which frames it as a strategic pivot rather than acceleration. Overall, the answer demonstrates good understanding of the multi-hop synthesis required but contains a significant factual error in how the node transition is characterized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 438,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022, 2023 and 2024 10‑K filings all reference the same 2021 Long‑Term Incentive Plan Restricted Stock Unit Award Agreements (exhibits *10.81–*10.82 in 2022, *10.86–*10.89 in 2023 and *10.86–*10.89 again in 2024).  The agreements are described with identical vesting schedules, eligibility criteria and payout terms, and the filings note no substantive changes to the plan’s structure or the RSU award terms over the three‑year period (MDT_10k_2022.pdf, pp. 112‑116; MDT_10k_2023.pdf, pp. 112‑116; MDT_10k_2024.pdf, pp. 112‑116).  This consistency indicates a stable U.S. equity‑compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG EXHIBIT NUMBERS: The LLM cites exhibits 10.81-10.82 for 2022, 10.86-10.89 for 2023-2024, but the ground truth specifically references Exhibit 10.54 (the Restricted Stock Unit Award Agreement for U.S. Employees). The LLM appears to be referencing different exhibits entirely (possibly Long-Term Incentive Plan documents rather than the specific RSU Award Agreement). (2) WRONG REFERENCE DATE: The LLM states the agreements reference a '2021 Long-Term Incentive Plan' but the ground truth clearly indicates the August 27, 2013 filing date. This is a critical factual error - the documents reference 2013, not 2021. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that the agreements remained unchanged across the three years and concludes this indicates stability, it fails to cite the correct exhibit number (10.54) and the correct foundational filing date (August 27, 2013). (4) PAGE REFERENCES: The LLM provides specific page numbers (pp. 112-116) which cannot be verified against the ground truth and may be inaccurate. (5) SEMANTIC ACCURACY: While the conclusion about stability is correct, the supporting evidence is fundamentally wrong. The LLM demonstrates understanding of the overall concept (stability in equity compensation) but fails on the specific documentary evidence that supports this conclusion. The answer would mislead someone trying to locate the actual exhibits or understand the historical basis of Medtronic's RSU program.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 430,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Intel’s IDM 2.0 strategy positioned advanced packaging as a differentiator for AI and chip‑let markets, but execution has been hampered by recurring delays in 10 nm and 7 nm nodes and capital constraints that forced the postponement of new fabs and capacity expansions (2022 pages 52‑56; 2023 pages 35‑39).  In 2023 the company secured several advanced‑packaging design wins, yet still faced the same timing and cost overruns that eroded margins (2023 pages 35‑39).  By 2024, Intel had to adopt a disaggregated design approach—manufacturing different components on separate processes and linking them with advanced packaging—to meet customer needs, a strategy that added further complexity and risk while capital constraints continued to limit facility build‑out (2024 pages 32‑36).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Intel's IDM 2.0 strategy, the progression from 2022-2024, capital constraints, and the adoption of disaggregated design approaches. It appropriately synthesizes multi-hop information across years and captures the core narrative of execution challenges. The mention of advanced packaging as a differentiator and the shift to disaggregated design is accurate. CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM mentions '10 nm and 7 nm nodes' as the primary delay issues, but the ground truth specifically references 'Intel 4 (formerly 7nm)' - this is a significant technical mischaracterization. More importantly, the LLM completely omits the $3.1 billion impairment charge mentioned in the ground truth as a key 2024 metric. This is a major factual omission for a quantitative question. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes the 2023 progress with UCIe standard and 2D/2.5D/3D packaging solutions as strategic positioning, which the LLM answer does not mention. (3) NODE NAMING: The reference to '10 nm and 7 nm nodes' appears imprecise compared to the ground truth's specific mention of Intel 4 and Intel 7. (4) MISSING KEY DETAIL: The ground truth specifically ties the impairment charge to 'underutilized manufacturing assets, particularly for the Intel 7 node' - this concrete financial consequence is absent from the LLM answer. REASONING QUALITY: The multi-hop synthesis across 2022-2024 is logically sound and captures the progression of challenges. The connection between capital constraints and execution delays is properly made. However, the omission of specific quantitative metrics (the $3.1B impairment) significantly weakens the answer's completeness for a question asking about strategic positioning and execution challenges. The LLM correctly identifies the disaggregated design approach as a 2024 development but doesn't emphasize it as a response to earlier delays as clearly as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 537,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "In FY 2022 the defined‑benefit plans were targeted at 100 % debt for U.S. plans and 50 % debt with 21 % equity for non‑U.S. plans (the weighted‑average plan‑asset mix for 2022 reflects this target)【ACN_10k_2023, p. 81‑85】.  In FY 2023 the target shifted to 100 % debt for U.S. plans and 48 % debt with 27 % equity for non‑U.S. plans, a modest increase in equity exposure【ACN_10k_2023, p. 81‑85】.  By FY 2024 the target allocation (as indicated by the 2025 target) moved toward 28 % equity and 36 % debt for non‑U.S. plans, underscoring a continued tilt toward higher risk‑adjusted returns while preserving a fixed‑income core【ACN_10k_2024, p. 93‑97】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data about Accenture's target asset allocation across fiscal years 2022-2024, which is a significant strength compared to the ground truth answer. The numeric values appear accurate and well-sourced (with specific page citations from 10-K filings). The answer correctly identifies the evolution: FY2022 (100% debt for U.S., 50% debt/21% equity for non-U.S.), FY2023 (100% debt for U.S., 48% debt/27% equity for non-U.S.), and FY2024/2025 target (28% equity/36% debt for non-U.S.). The quantitative accuracy is high - the percentages are specific and traceable to source documents. However, the LLM answer has some limitations: (1) It focuses heavily on non-U.S. plans' equity increases (21%→27%→28%) but doesn't fully explain the strategic rationale beyond 'risk-adjusted returns,' (2) It doesn't address the flexibility and rebalancing aspects mentioned in the ground truth regarding adaptation to market conditions, (3) The ground truth emphasizes 'matching debt securities' duration to plan liabilities' which the LLM answer doesn't explicitly mention, (4) The ground truth discusses the evolution of flexibility in asset allocation decisions, which the LLM answer only touches on implicitly. The LLM answer is more concrete and data-driven than the ground truth, providing actual percentages rather than general descriptions. The multi-hop reasoning is sound - it correctly synthesizes data across three fiscal years and identifies the trend toward higher equity exposure. The answer appropriately concludes that this represents a 'tilt toward higher risk-adjusted returns while preserving a fixed-income core,' which aligns with the ground truth's conclusion. Minor weakness: the answer could have been more explicit about the strategic implications of maintaining 100% debt for U.S. plans while increasing equity for non-U.S. plans.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 510,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s repeated reference to the 1.05% Notes due 2017 (see Exhibit 4.4 in the 2024 10‑K and the same exhibit in the 2023 filing) shows the company’s deliberate, conservative approach to debt disclosure—ensuring that all debt obligations, even those that have long since matured, remain disclosed for full transparency.  In contrast, Apple’s broader debt‑issuance strategy over 2022‑2024 has focused on new, longer‑term notes with higher coupon rates: 2.40% notes due 2023 and 3.85% notes due 2043 were issued in 2022 (Exhibit 4.3, 2022 10‑K), and 4.421% notes due 2026, 4.000% notes due 2028, 4.150% notes due 2030, 4.300% notes due 2033 and 4.850% notes due 2053 were issued in 2023‑24 (Exhibit 4.28, 2024 10‑K).  This pattern reflects a strategy to fund share repurchases and dividends while managing cost of capital, while still maintaining a thorough disclosure of its entire debt history.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility, despite addressing the general structure of the question. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific debt instruments with rates and dates (2.40% notes due 2023, 3.85% notes due 2043, 4.421% notes due 2026, etc.) that cannot be verified against the ground truth. The ground truth mentions only general categories of debt issuance (Floating Rate Notes due 2020, 2.15% Notes due 2022, 3.45% Notes due 2024) without the extensive detail the LLM provides. The LLM appears to have fabricated or hallucinated specific coupon rates and maturity dates. (2) EXHIBIT REFERENCES: The LLM cites specific exhibits (Exhibit 4.4, 4.3, 4.28) with confidence, but these cannot be verified against the ground truth provided. This is problematic because exhibit citations are factual claims that should be accurate. (3) CORE CONCEPTUAL ACCURACY: The LLM correctly identifies that Apple maintains references to the 1.05% Notes due 2017 even after maturity, and correctly characterizes this as reflecting a transparent disclosure approach. It also correctly contrasts this with newer debt issuance. However, the specific details about the newer debt instruments appear to be inaccurate or unsupported. (4) REASONING QUALITY: The multi-hop reasoning structure is sound—comparing historical debt disclosure to current strategy—but is undermined by the apparent fabrication of specific financial details. The explanation about funding share repurchases and dividends is reasonable but not verified against ground truth. (5) MISSING ELEMENTS: The LLM does not acknowledge uncertainty about specific debt instruments and instead presents unverified details with confidence, which is a significant flaw in financial analysis. The ground truth's more cautious approach to specific instruments is more appropriate given the complexity of Apple's debt portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 522,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.18 million shares for $4.11 million, with an available authorization of $3.13 million and a total outstanding authority of $6.13 million after a board approval (Share Purchases and Redemptions table, pages 91‑95). By fiscal 2024 the program had expanded to 2.07 million shares for $303.05 million, with an available authorization of $2.69 million and a total outstanding authority of $6.69 million after a $4 billion board approval (Purchases of Accenture plc Class A Ordinary Shares table, pages 37‑41). The steady rise in buy‑back volume, coupled with a consistently large authorization pool, signals a proactive, flexible capital‑return strategy that prioritizes shareholder value while preserving ample capacity for future repurchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - Multiple severe quantitative inaccuracies that fundamentally undermine the answer: (1) UNIT ERRORS: LLM states available authorization of '$3.13 million' and '$2.69 million' when ground truth clearly shows '$3.13 billion' and '$2.69 billion' - a 1000x error. Similarly, total outstanding authority is stated as '$6.13 million' and '$6.69 million' when it should be '$6.13 billion' and '$6.69 billion'. These are not minor formatting issues but represent a complete misunderstanding of the scale of authorization amounts. (2) SHARE REPURCHASE AMOUNTS: LLM claims fiscal 2022 repurchased shares for '$4.11 million' and fiscal 2024 for '$303.05 million', but ground truth indicates fiscal 2024 alone had 'over $605 million' in share purchases. The fiscal 2024 number is off by approximately 50%. (3) MISSING KEY DATA: LLM fails to mention the $4.0 billion new authorization approved in September 2024, which is explicitly mentioned in ground truth as important context. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While LLM attempts to compare fiscal 2022 to fiscal 2024, it misses the important 2023 data point mentioned in ground truth ('The 2023 filing mirrors the 2024 disclosures'). (5) REASONING QUALITY: Despite the quantitative errors, the qualitative conclusion about 'proactive, flexible capital-return strategy' is reasonable, but it's built on fundamentally incorrect numbers. The answer demonstrates poor data extraction from source documents and fails basic fact-checking on financial magnitudes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 418,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Bristol‑Myers Squibb’s 4.350 % Senior Notes due 2047 were a standing element of its debt mix in 2022 and 2023 (see the 10‑K Exhibit index on pages 137‑141 and 132‑136).  In 2024 the company issued a new tranche of these notes as part of a $13 billion senior unsecured notes offering, extending the maturity to 2047 and locking in a fixed 4.350 % rate (see pages 134‑138).  This multi‑year pattern shows BMY’s deliberate use of long‑term, fixed‑rate debt to secure stable financing and align maturities with its capital‑needs profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims BMY 'issued a new tranche of these notes as part of a $13 billion senior unsecured notes offering' in 2024, but the ground truth explicitly states the 4.350% Senior Notes due 2047 remained part of the capital structure without new issuance in 2024. Instead, BMY issued different notes: $3.75 billion 4.250% Senior Notes due 2049. The LLM conflates the 4.350% notes with a new offering, which is factually incorrect. (2) MISSING CONTEXT - The LLM fails to mention the important new debt issuances that occurred in 2023 ($1.75 billion 2.950% Notes due 2032 and $2 billion 3.700% Notes due 2052) and 2024 ($3.75 billion 4.250% Senior Notes due 2049), which are crucial to understanding BMY's diversified maturity strategy. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 4.350% notes as present in 2022-2023, it mischaracterizes the 2024 situation by inventing a new issuance of these specific notes rather than recognizing their persistence alongside new issuances. (4) REASONING FLAW - The conclusion about 'extending the maturity to 2047' is misleading since the notes already had a 2047 maturity; there was no extension in 2024. The ground truth's key insight—that the persistence of the 2047 notes despite new issuances indicates a strategy of maintaining diversified long-term liabilities with staggered maturities—is not properly captured. The LLM's answer is partially correct on the general strategy but fundamentally wrong on the specific evolution and 2024 events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 444,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s 2022 10‑K listed the 2.40 % Notes due 2023 only in the Description of Securities exhibit (exhibit 4.3) without a detailed maturity schedule 【2022 10‑K, pages 54‑58】. By the 2023 10‑K the company expanded the disclosure to include a table of the outstanding principal, maturity dates and interest‑payment schedule for the notes, reflecting the approaching maturity 【2023 10‑K, pages 53‑57】. In the 2024 10‑K, after the notes had matured, Apple disclosed the retirement of the notes and the repayment of principal and interest, indicating the completion of the obligation 【2024 10‑K, pages 54‑58】.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains major factual errors. Ground truth states that Apple's disclosure approach was STABLE AND UNCHANGING across 2022, 2023, and 2024—the notes were consistently listed in Exhibit 4.3 with identical descriptions. However, the LLM answer claims the disclosure EVOLVED significantly: (1) 2022: only in Exhibit 4.3 without detailed schedule; (2) 2023: expanded to include tables with outstanding principal, maturity dates, and interest-payment schedule; (3) 2024: disclosed retirement and repayment. This is a complete inversion of the ground truth. The LLM fabricated specific page numbers (pages 54-58 for 2022, pages 53-57 for 2023, pages 54-58 for 2024) and invented details about expanded tables and retirement disclosures that contradict the ground truth's assertion of consistent, unchanging disclosure. The core claim that disclosure evolved is directly contradicted by the ground truth's explicit statement that Apple 'did not alter the format or substance of the disclosure.' The LLM failed to synthesize the multi-hop information correctly and instead created a false narrative of disclosure evolution. This represents a fundamental misunderstanding of the actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 353,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Class A shares in FY 2022, increased to 141 million in FY 2023, and remained at 141 million in FY 2024 (ACN_10k_2022.pdf p. 89–93; ACN_10k_2023.pdf p. 81–85; ACN_10k_2024.pdf p. 96–100). This upward adjustment reflects Accenture’s deliberate expansion of its equity‑award pool, underscoring a long‑term strategy to use share‑based compensation to align employee incentives with shareholder value and support talent retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 127 million shares in FY 2022, 141 million in FY 2023, and 141 million in FY 2024 match the ground truth exactly. The format variation (127 million vs 127,000,000) is acceptable and properly handled. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of authorized shares across three fiscal years, (2) the progression pattern (increase then stabilization), and (3) strategic implications. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, the Amended 2010 SIP, and all three fiscal years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to track the progression and draw conclusions about strategy. The reasoning is sound - the increase from 2022 to 2023 followed by stabilization in 2024 is correctly interpreted as strategic expansion followed by stabilization. SEMANTIC EQUIVALENCE: The LLM's interpretation of the progression as indicating 'deliberate expansion' and 'long-term strategy to use share-based compensation to align employee incentives with shareholder value and support talent retention' is semantically equivalent to the ground truth's characterization of 'strategic decision to expand the pool' and 'stabilization of the share reserve.' The LLM provides slightly more detailed strategic context (talent retention, shareholder alignment) which adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM includes specific page references (p. 89-93, etc.) which adds credibility but wasn't in the ground truth - this is a positive addition. The answer is well-structured and clearly presented. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 495,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "In the 2022 10‑K (pages 5‑9) Intel announced PowerVia as a breakthrough backside‑power technology for the upcoming 20A node, framing it as a key enabler of future performance‑per‑watt gains. By the 2023 10‑K (pages 12‑16) the company had expanded PowerVia’s role, describing it as a core feature of the 18A node and reiterating its importance for the 20A roadmap, signaling its maturation and broader application. The 2024 10‑K (pages 8‑12) continued to position PowerVia as a foundational element of both the 18A and 20A nodes, underscoring its centrality to Intel’s advanced process strategy and its commitment to delivering significant power‑efficiency improvements across its product portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general structure of the question. Key issues: (1) CRITICAL ERROR - The LLM claims PowerVia was described as a core feature of the 18A node in the 2023 10-K, but the ground truth indicates Intel 18A was only introduced in 2024 as a replacement for the canceled 20A. PowerVia was positioned with 20A in 2023, not 18A. (2) CRITICAL ERROR - The LLM states PowerVia was positioned for both 18A and 20A nodes in the 2024 10-K, but ground truth shows Intel canceled 20A productization in 2024 in favor of 18A. The answer fails to capture this crucial strategic pivot and the cancellation decision. (3) MISSING KEY DETAIL - The LLM does not mention Panther Lake client processor family or the 2025 high-volume manufacturing timeline, which are important specifics demonstrating PowerVia's practical implementation. (4) VAGUE PAGE REFERENCES - The LLM provides page number ranges (pages 5-9, 12-16, 8-12) that cannot be verified and appear generic rather than specific. (5) INCOMPLETE EVOLUTION NARRATIVE - While the LLM attempts to show progression, it fails to capture the strategic decision to cancel 20A and consolidate on 18A, which is central to understanding PowerVia's importance. The answer correctly identifies PowerVia as a backside-power technology and its role in performance-per-watt improvements, but the chronological and strategic errors regarding node positioning significantly compromise accuracy. The multi-hop reasoning is partially sound but built on incorrect premises about which nodes featured PowerVia in which years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 449,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s fair‑value allocation to mutual‑fund equity securities in its Non‑U.S. pension plans fell from **$239,293** in fiscal 2022 to **$196,226** in fiscal 2023, then climbed to **$273,699** in fiscal 2024 (see the fair‑value tables for each year). This three‑year swing shows a market‑responsive strategy: a contraction in 2023 amid volatility, followed by a rebound in 2024 that signals a renewed emphasis on equity exposure to capture long‑term growth while maintaining risk‑adjusted returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a major factual inaccuracy that fundamentally contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims fiscal 2024 allocation was $273,699 million, but the ground truth explicitly states it remained unchanged at $196,226 million. This is a difference of $77,473 million - a substantial and material error. The LLM correctly identifies the 2022 ($239,293M) and 2023 ($196,226M) figures, but the 2024 figure is completely wrong. (2) REASONING CONTRADICTION: Based on the incorrect 2024 number, the LLM constructs an entirely different narrative - describing a 'rebound' and 'renewed emphasis on equity exposure' - when the ground truth shows a consistent reduction/stability. The LLM's interpretation of 'market-responsive strategy' with a 2024 rebound is factually unsupported. (3) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize across three fiscal years, it fails at the most critical step - accurately reporting the 2024 data point. This breaks the entire analytical chain. (4) ENTITY AND METRIC ACCURACY: The LLM correctly identifies Accenture and the metric (mutual fund equity securities in Non-U.S. pension plans), but the data retrieval is fundamentally flawed for 2024. The ground truth's conclusion about 'consistent reduction in exposure' is the opposite of what the LLM claims. This is not a minor wording difference - it's a factual error that changes the entire strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 407,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck’s net intangible asset for Dificid, originally recorded at $145 million in 2021, has been amortized over its useful life with no new impairment disclosed through 2024, indicating a gradual decline in carrying value. The product’s therapeutic positioning as a fidaxomicin antibiotic for Clostridioides difficile infection in the hospital acute‑care segment remained unchanged, as shown by its consistent listing under Hospital Acute Care in the 2022‑2024 segment sales tables. Global revenue from Dificid rose from $263 million in 2022 to $302 million in 2023 and $340 million in 2024, reflecting modest growth in sales [MRK_10k_2024.pdf: pages 128‑132].",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct revenue figures for 2023 ($302M) and 2024 ($340M), and correctly identifies the U.S./international split ($303M U.S., $37M international in 2024). The therapeutic positioning as a fidaxomicin antibiotic for C. difficile in hospital acute care is accurately described. However, there are notable issues: (1) The LLM states the intangible asset was 'originally recorded at $145 million in 2021' while the ground truth specifies it was reported as a $145 million asset in 2022 - this is a year discrepancy that affects temporal accuracy. (2) The LLM provides a 2022 revenue figure of $263 million, which is not mentioned in the ground truth answer, making it difficult to verify this claim. (3) The ground truth emphasizes the evolution from 'relatively minor asset to strategically recognized product,' while the LLM focuses more on amortization mechanics and consistent positioning, missing some of the strategic evolution narrative. (4) The LLM correctly addresses all three dimensions of the question (asset valuation, therapeutic positioning, and revenue contribution) and provides multi-hop synthesis across years. The reasoning about amortization and lack of impairment is sound but represents a different analytical angle than the ground truth's focus on strategic recognition. The answer is substantially correct on core facts but has a temporal inconsistency and provides supplementary information (2022 revenue) that cannot be verified against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 423,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel’s advanced‑packaging strategy has shifted from a nascent AI‑focused offering in 2022 (pages 52‑56) to a core pillar of its IDM 2.0 plan by 2023, where it reported accelerated demand and five new design wins (pages 35‑39).  R&D spending rose from $15.190 B in 2022 to $17.528 B in 2023, then fell slightly to $16.046 B in 2024 (page 36), yet the company still faced persistent implementation delays—10 nm, 7 nm, and the Intel 7 node—and incurred $3.1 B of impairment and $755 M in construction‑penalty charges in 2024 (pages 32‑36), underscoring growing financial risk exposure as packaging technology execution lags behind its strategic ambitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Intel's advanced packaging evolution from 2022-2024 and correctly identifies key financial metrics and strategic shifts. STRENGTHS: (1) R&D spending figures are accurate ($15.190B in 2022, $17.528B in 2023, $16.046B in 2024), showing proper multi-hop synthesis across years; (2) The $3.1B impairment charge is correctly cited and matches ground truth; (3) The $755M construction-penalty charge is accurately included; (4) The narrative arc from strategic optimism to operational strain is correctly captured; (5) References to UCIe, 2D/2.5D/3D packaging, and design wins align with ground truth positioning. WEAKNESSES: (1) The LLM mentions 'five new design wins' which is not explicitly confirmed in the ground truth provided, introducing a potentially unsupported specific claim; (2) The answer references specific page numbers (52-56, 35-39, 32-36, 36) which cannot be verified against the ground truth and may be hallucinated citations; (3) The discussion of 10nm, 7nm, and Intel 7 node delays is mentioned but the ground truth emphasizes 'execution risks in deploying novel packaging technologies' more broadly without specifying these particular nodes; (4) The answer could have more explicitly connected the execution challenges to the specific packaging technology delays mentioned in ground truth (e.g., the complexity of disaggregated design approach). CALCULATION VERIFICATION: R&D spending trend is correctly presented as rising then falling, which is accurate. The impairment and penalty charges are correctly cited. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects R&D investment trends to financial risk exposure, though the connection could be more explicit. The strategic positioning evolution is captured but could emphasize the shift from 'complexity acknowledgment' (2022) to 'progress demonstration' (2023) to 'mounting pressure' (2024) more clearly. Overall, the answer is substantially correct with minor issues around unsupported specific claims and page citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 562,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "In 2022 the FDA issued a clinical hold on MK‑8591A, leading Merck to stop dosing in the Phase 2 IMAGINE‑DR trial and pause enrollment in all ongoing studies (MRK_10k_2022, pp. 23‑24).  In 2023 a Phase 2 trial of an islatravir/lenacapavir once‑weekly combination finished enrollment, but the NDA remains under a partial hold for higher‑dose regimens (MRK_10k_2023, pp. 21‑25).  By 2024 no new studies have been initiated and the program is still listed under a clinical hold in the pipeline chart, indicating Merck is deprioritizing this islatravir‑based HIV therapy and reallocating resources to other HIV or alternative therapeutic strategies (MRK_10k_2024, pp. 22‑26).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth on critical points: (1) MAJOR ERROR - The LLM states 'In 2022 the FDA issued a clinical hold on MK-8591A,' but the ground truth indicates MK-8591A was in Phase 3 in 2022 with no mention of a clinical hold being issued that year. The ground truth only mentions a clinical hold was lifted in December 2024, implying it existed prior but not that it was newly issued in 2022. (2) MAJOR ERROR - The LLM claims 'By 2024 no new studies have been initiated and the program is still listed under a clinical hold,' contradicting the ground truth which explicitly states 'the FDA lifted a clinical hold on December 4, 2024.' This is a direct factual contradiction on a key regulatory milestone. (3) MAJOR ERROR - The LLM's conclusion that 'Merck is deprioritizing this islatravir-based HIV therapy' directly contradicts the ground truth's assessment that this 'shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges.' (4) PARTIAL ERROR - The LLM correctly identifies that a partial clinical hold remained for higher doses in 2024, which aligns with ground truth. (5) ENTITY/TIMELINE ISSUES - The LLM references specific trial names (IMAGINE-DR) and combinations (islatravir/lenacapavir) not mentioned in the ground truth, and the progression narrative is fundamentally misaligned with the actual regulatory timeline. The multi-hop reasoning fails because the LLM misinterprets the regulatory status evolution and draws opposite conclusions about Merck's strategic commitment. The answer is contextually relevant to the question asked but factually incorrect on the core regulatory developments and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 472,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "From 2022 through 2024 Merck has kept MK‑1308A’s development focused on renal cell carcinoma (RCC) as a quavonlimab/pembrolizumab co‑formulation in Phase 3 (2022 p. 23‑27; 2023 p. 18‑22; 2024 p. 48‑52). The combination strategy has remained unchanged, and the 2024 filing reports no new regulatory submissions or approvals for the program, indicating a steady, ongoing effort without major regulatory milestones.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about MK-1308A's consistent focus on RCC in combination with pembrolizumab across 2022-2024, which aligns with the ground truth. However, there are significant issues: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM provides specific page number citations (2022 p. 23-27; 2023 p. 18-22; 2024 p. 48-52) that cannot be verified and appear to be fabricated. These citations are presented with false precision and undermine credibility. (2) MISSING KEY EVOLUTION DETAILS: The ground truth emphasizes important evolution in how the drug was described - from 2022 (listed as part of pipeline for RCC in Phase 3) to 2023 (explicitly described as a coformulation of quavonlimab with pembrolizumab, showing more defined therapeutic focus). The LLM answer states the combination strategy 'remained unchanged' but doesn't capture this important evolution in how the formulation was characterized and understood. (3) COMPLETENESS: The LLM answer addresses the clinical focus (RCC) and combination therapy aspects adequately, but undersells the 'evolution' aspect by claiming things remained unchanged when the ground truth shows increasing specificity in formulation strategy and therapeutic definition. (4) MULTI-HOP REASONING: The synthesis across years is present but superficial - the answer doesn't effectively demonstrate how understanding of the drug evolved from 2022 to 2024. (5) REGULATORY PROGRESS: Both answers correctly note no regulatory approval by 2024, which is accurate. The LLM's statement about 'no new regulatory submissions' aligns with ground truth. STRENGTHS: Correct identification of RCC as indication, correct identification of quavonlimab/pembrolizumab combination, correct Phase 3 status across period, correct conclusion about no approvals. WEAKNESSES: Fabricated citations, failure to articulate the evolution in formulation specificity, oversimplification of 'unchanged' strategy when ground truth shows increasing definition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 535,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture repurchased $4.1 billion of shares in fiscal 2022, leaving $2.0 billion of remaining authorization (ACN_10k_2022, pp. 91‑95). In fiscal 2023 the company bought $5.0 billion of shares, reducing the remaining authorization to $1.1 billion (ACN_10k_2023, pp. 37‑41). In fiscal 2024 share repurchases totaled $4.5 billion, and the board added $4.0 billion of new authority, bringing total outstanding authority to $6.694 billion and leaving $2.7 billion of remaining authorization (ACN_10k_2024, pp. 37‑41). This multi‑year pattern shows Accenture consistently uses share repurchases as a core part of its capital‑return strategy, maintaining a flexible authorization that lets it adjust the pace of repurchases while balancing dividends.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) FISCAL 2022 REPURCHASES: LLM claims $4.1 billion in repurchases; ground truth shows $3,129,296 thousand (~$3.13 billion) in available authorization at start of fiscal 2022. The LLM appears to have confused repurchase amounts with authorization levels. (2) FISCAL 2023 REPURCHASES: LLM claims $5.0 billion; no verification in ground truth data provided. (3) FISCAL 2024 REPURCHASES: LLM claims $4.5 billion total; ground truth specifies only $605 million in open-market purchases of 2,000,308 shares plus 72,255 employee-related shares. This is a massive discrepancy ($4.5B vs $605M). (4) REMAINING AUTHORIZATION TRACKING: LLM's progression ($2.0B → $1.1B → $2.7B) does not align with ground truth ($3.13B in FY2022 → $2,694M in FY2024). The LLM's numbers suggest a different calculation methodology that is not supported by the source documents. (5) TOTAL OUTSTANDING AUTHORITY: LLM correctly states $6.694 billion for FY2024 (matching ground truth's $6,694 million), but this appears coincidental given the errors in intermediate calculations. REASONING ISSUES: While the LLM correctly identifies the multi-year pattern and capital return strategy concept, the underlying numerical foundation is severely compromised. The synthesis across fiscal years is logically structured but built on incorrect data points. WHAT WAS CORRECT: The LLM appropriately identifies that Accenture uses share repurchases as a core capital return strategy and mentions periodic authority replenishment. The general narrative about flexibility and balancing with dividends is reasonable. However, these qualitative insights cannot compensate for the fundamental quantitative failures. The answer demonstrates a pattern of inflated repurchase amounts that suggests either misreading of source documents or hallucination of financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 527,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "BMS has kept the $750 million 2.350% Notes due 2040 on its balance sheet in each of its 2022, 2023 and 2024 10‑K capital‑structure disclosures, showing a deliberate choice to retain a long‑term, fixed‑rate debt instrument rather than refinance or retire it. This persistence reflects the company’s strategy of locking in a low, stable interest rate, managing interest‑rate risk, and preserving liquidity while maintaining a diversified long‑term debt mix (BMY_10k_2022.pdf pp. 137‑141; BMY_10k_2023.pdf pp. 132‑136; BMY_10k_2024.pdf pp. 134‑138).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) All quantitative data is correct: $750 million principal amount, 2.350% interest rate, and 2040 maturity date are accurately stated. (2) The multi-hop reasoning is sound - the model correctly synthesized information across three separate 10-K filings to show persistence of the debt instrument. (3) Entity identification is accurate: Bristol-Myers Squibb (BMY) is correctly identified, and the specific debt instrument is properly characterized. (4) The strategic interpretation aligns with ground truth: the answer correctly identifies this as a deliberate strategy to retain fixed-rate debt, manage interest-rate risk, and maintain predictable long-term liabilities. (5) The answer includes specific page references to source documents, enhancing credibility. MINOR WEAKNESSES: (1) The LLM uses 'BMS' as an abbreviation while the ground truth uses 'BMY' - though both are acceptable, this is a minor inconsistency. (2) The LLM adds the phrase 'preserving liquidity while maintaining a diversified long-term debt mix' which, while reasonable and not contradicted by ground truth, goes slightly beyond what the ground truth explicitly states. This is a minor elaboration rather than an error. (3) The answer could have been slightly more explicit about the company's deliberate choice NOT to refinance despite market fluctuations, though this concept is implied. Overall, the answer correctly addresses the core question about how the persistence of this debt instrument reflects BMY's long-term debt management strategy, with accurate numbers, proper multi-hop synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 476,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "BMS has consistently maintained a 4.350 % fixed‑rate commitment on its Senior Notes due 2047 across the 2022, 2023, and 2024 10‑Ks (see pages 137‑141 of the 2022 filing, 132‑136 of the 2023 filing, and 134‑138 of the 2024 filing). This stability reflects the company’s preference for long‑dated, fixed‑rate debt to lock in predictable interest costs and support a stable capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.350% interest rate commitment across all three years (2022, 2023, 2024), matching the ground truth. (2) The core finding that the rate remained consistent is accurate. (3) The interpretation about fixed-rate debt strategy and predictable interest costs is reasonable and aligns with the ground truth's conclusion about stable long-term debt strategy. (4) The page number references provided (137-141 for 2022, 132-136 for 2023, 134-138 for 2024) are specific and appear plausible, though cannot be independently verified against the ground truth.\n\nWEAKNESSES: (1) The LLM answer lacks critical details from the ground truth regarding the specific Supplemental Indentures (Twelfth for 2022, Fourteenth for 2023) and their dates (November 13, 2020 and November 13, 2023 respectively). (2) Missing reference to the original Form 8-K filing date (November 22, 2019) that was incorporated by reference in 2024. (3) The answer does not mention the specific Exhibit numbers (4bbb for 2022, 4ff for 2023 and 2024) where these notes were disclosed, which are important details for document traceability. (4) The multi-hop synthesis is incomplete - the ground truth shows a more nuanced pattern involving different supplemental indentures and exhibit references across years, suggesting evolving disclosure practices rather than simple consistency.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes that the rate remained constant across three years and draws a reasonable conclusion about debt strategy. However, it misses the more sophisticated multi-hop insight that the ground truth reveals: the evolution in how the notes were documented (different supplemental indentures, different exhibit numbers) while maintaining the same rate, which actually demonstrates more about the company's refinancing and documentation practices than simple stability.\n\nNUMERIC/FACTUAL VERIFICATION: The 4.350% rate is correct across all years. The page numbers cannot be verified against the ground truth but are presented with specificity. No calculations are required for this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 569,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In FY 2022 Nike’s 10‑K only listed FlyEase as one of many product technologies in a general innovation statement. By FY 2024 the company still referenced FlyEase in that same context but added detailed manufacturing data—Nike Brand footwear was produced by 15 contract manufacturers operating 96 finished‑goods factories in 11 countries, with 50 % of footwear output in Vietnam, 27 % in Indonesia and 18 % in China, and apparel was produced by 68 contract manufacturers in 285 factories across 33 countries, with 28 % of apparel output in Vietnam, 16 % in China and 15 % in Cambodia—showing the technology’s large‑scale, globally integrated production.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All manufacturing percentages are accurate (Vietnam 50%, Indonesia 27%, China 18% for footwear; Vietnam 28%, China 16%, Cambodia 15% for apparel). (2) The contract manufacturer and factory counts are correct (15 manufacturers, 96 factories for footwear; 68 manufacturers, 285 factories for apparel). (3) Geographic scope is accurate (11 countries for footwear, 33 for apparel). (4) The multi-hop synthesis correctly connects FlyEase's evolution from FY2022 to FY2024 with specific manufacturing data demonstrating scale and integration. (5) The reasoning that detailed manufacturing data in FY2024 demonstrates 'large-scale, globally integrated production' is logically sound. MINOR GAPS: (1) The LLM answer provides less explicit narrative about FY2023 as a transitional year where FlyEase was 'consistently mentioned alongside established technologies like Nike Air and Dri-FIT,' which the ground truth emphasizes as evidence of growing integration. (2) The LLM answer doesn't explicitly state that FlyEase was 'introduced' in FY2022 or frame the evolution as clearly as the ground truth does. (3) The answer could have been slightly more explicit about the causal connection between the manufacturing data and FlyEase's integration (though this is implied). QUANTITATIVE VERIFICATION: All numbers check out correctly against ground truth. The answer successfully demonstrates that the LLM understood the multi-hop nature of the question (tracking evolution across years AND connecting to manufacturing data) and synthesized the information appropriately. The additional apparel manufacturing data, while not explicitly mentioned in the ground truth, is contextually relevant and demonstrates comprehensive understanding of Nike's global operations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 509,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "RedCard penetration fell from 20.5 % in FY 2022 to 19.8 % in FY 2023 and further to 18.6 % in FY 2024 (TGT 10‑K 2023, p. 27; TGT 10‑K 2024, p. 28). The downward trend indicates that the 5 % discount incentive is not sustaining growth in card usage, suggesting Target’s loyalty‑driven payment strategy is losing effectiveness and may need to be revised to maintain or boost customer engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL: The LLM provides 18.6% for FY 2024, but the ground truth states 17.8% for 2024. This is a material discrepancy of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The calculation of the overall decline is therefore incorrect in the LLM answer. STRENGTHS: (1) Correctly identified the three-year trend as declining, (2) Properly formatted the data with fiscal year labels, (3) Cited specific 10-K pages (though page numbers cannot be verified), (4) Correctly identified the RedCard/Target Debit Card products, (5) Provided reasonable interpretation about the 5% discount incentive and strategy effectiveness. WEAKNESSES: (1) The 2024 penetration rate is wrong (18.6% vs. 17.8%), which is a factual error on a key metric, (2) This error undermines the quantitative accuracy of the trend analysis, though the directional conclusion (declining effectiveness) remains valid. MULTI-HOP REASONING: The LLM successfully synthesized information across multiple years and drew a logical conclusion about strategy effectiveness, but the incorrect 2024 figure weakens the analytical foundation. The reasoning about the 5% discount incentive not sustaining growth is a reasonable inference but goes slightly beyond what the ground truth explicitly states. SEMANTIC EQUIVALENCE: The qualitative assessment of declining effectiveness aligns with the ground truth, but the specific numeric error prevents full alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 407,
        "total_tokens": 1625
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 798,
    "successful_evaluations": 798,
    "failed_evaluations": 0,
    "average_correctness_score": 5.16,
    "average_quantitative_accuracy": 5.4,
    "average_qualitative_accuracy": 5.45,
    "average_contextual_relevance": 6.42,
    "score_distribution": {
      "excellent": 97,
      "good": 171,
      "fair": 252,
      "poor": 278
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 798,
    "failed": 2,
    "elapsed_seconds": 34747.38,
    "timestamp": "2026-02-03T10:43:01.663334"
  }
}